Citrus Sinensis ID: 027233
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 226 | 2.2.26 [Sep-21-2011] | |||||||
| Q5ZJH6 | 468 | Serine/threonine-protein | yes | no | 0.924 | 0.446 | 0.426 | 6e-45 | |
| Q3U3Q1 | 472 | Serine/threonine-protein | yes | no | 0.920 | 0.440 | 0.419 | 4e-42 | |
| D3ZHP7 | 472 | Serine/threonine-protein | yes | no | 0.920 | 0.440 | 0.419 | 8e-42 | |
| A7KAL2 | 960 | Serine/threonine-protein | yes | no | 0.911 | 0.214 | 0.358 | 2e-41 | |
| Q6PHR2 | 472 | Serine/threonine-protein | yes | no | 0.924 | 0.442 | 0.403 | 3e-41 | |
| Q86CS2 | 668 | Serine/threonine-protein | yes | no | 0.933 | 0.315 | 0.375 | 3e-41 | |
| Q4V7Q6 | 468 | Serine/threonine-protein | N/A | no | 0.924 | 0.446 | 0.412 | 1e-40 | |
| Q0CLX3 | 964 | Serine/threonine-protein | N/A | no | 0.911 | 0.213 | 0.354 | 1e-40 | |
| Q8IYT8 | 1036 | Serine/threonine-protein | no | no | 0.933 | 0.203 | 0.382 | 2e-40 | |
| Q9QY01 | 1037 | Serine/threonine-protein | no | no | 0.933 | 0.203 | 0.382 | 2e-40 |
| >sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 180 bits (457), Expect = 6e-45, Method: Compositional matrix adjust.
Identities = 95/223 (42%), Positives = 138/223 (61%), Gaps = 14/223 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ LN+ L E+ L ++ HP+I+ L D + I+L++EFCAGG+LS +IR+
Sbjct: 49 RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ AR FLQQL L+ L+ H+I H DLKP+NILLS ++ LK+ADFG + + P
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSPW 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL------ 176
+ + GSPLYMAPE++ Q+YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFASRSFAELEEKIRS 227
Query: 177 -------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
P L PDC D+ +LL + + R+SF EF+ H F+
Sbjct: 228 DRAIELPSRPPLSPDCRDLLQRLLERDPLKRISFEEFFAHPFV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Gallus gallus (taxid: 9031) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (433), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 94/224 (41%), Positives = 138/224 (61%), Gaps = 16/224 (7%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----- 176
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 177 --------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ P L DC D+ +LL + R+SF +F+ H ++
Sbjct: 227 SNRVIELPLRPQLSLDCRDLLQRLLERDPARRISFKDFFAHPWV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 94/224 (41%), Positives = 138/224 (61%), Gaps = 16/224 (7%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----- 176
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 177 --------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ P L DC D+ +LL + R+SF +F+ H ++
Sbjct: 227 SNRVIELPLRPQLSLDCRDLLQRLLERDPSHRISFQDFFAHPWV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 2e-41, Method: Composition-based stats.
Identities = 96/268 (35%), Positives = 143/268 (53%), Gaps = 62/268 (23%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L KLNK LK L E++ L ++HP+I+ L D ++ + I LV+E+CA G+LS +I+
Sbjct: 55 LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GL+ MLKIADFG + +L + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-----------VPALH 182
YMAPE+L++++YD K D+WSVG +L+E++ G PPF N+V+L+ P +
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGRPPFRATNHVELLRKIEKGEDRIRFPEDN 294
Query: 183 P---DCVDMCLKLLSANTVDRLSFNEFY 207
P D + LL N V+RL+F EF+
Sbjct: 295 PASDDIKKLIRGLLKRNPVERLNFPEFF 322
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6PHR2|ULK3_HUMAN Serine/threonine-protein kinase ULK3 OS=Homo sapiens GN=ULK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 90/223 (40%), Positives = 135/223 (60%), Gaps = 14/223 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K LNK L E+ L + HP+I++L D + I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDSDNIYLIMEFCAGGDLSRFIHTRRI 108
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 109 LPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSPW 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL------ 176
+ + GSPLYMAPE++ ++YD +VD+WS+G IL+E L G PPF+ R+ +L
Sbjct: 168 DEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEALFGQPPFASRSFSELEEKIRS 227
Query: 177 -------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ P L DC D+ +LL + R+SF +F+ H ++
Sbjct: 228 NRVIELPLRPLLSRDCRDLLQRLLERDPSRRISFQDFFAHPWV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (425), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 84/224 (37%), Positives = 135/224 (60%), Gaps = 13/224 (5%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
N L L+ E+ L ++H NI+RL+D E I++++E C GG+ S YIR H +
Sbjct: 47 NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E+ A F++QL GL+ L I+HRDLKP+N+LLS + +LKI DFG + + P
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------N 173
+ ++ CGSPLYMAPE+L + Y K D+WSVG IL+E+L G P ++ + N
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGIILYEMLVGEPAYNSGSVPDLLNQLQN 226
Query: 174 VQLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
++ +P+ + DC ++ LL + R+S+ +F++H++L N+
Sbjct: 227 KKIKLPSHISSDCQNLIYSLLQIDVEKRISWEDFFNHKWLNLNN 270
|
Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q4V7Q6|ULK3_XENLA Serine/threonine-protein kinase ULK3 OS=Xenopus laevis GN=ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (421), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 92/223 (41%), Positives = 134/223 (60%), Gaps = 14/223 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K LNK L E+ L +V+HP+I+ L D ++ IFL+ E+CAGG+LS +IR
Sbjct: 48 KSLNKAAVENLLTEIEILKTVHHPHILELKDFQWDQDYIFLITEYCAGGDLSRFIRTRRI 107
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ + FLQQL + L+ L+ +I H DLKP+NILLS LD LK+ADFG + +
Sbjct: 108 LPERIVQVFLQQLASALKFLHEKNISHLDLKPQNILLSRLDRP-HLKLADFGFAQHMSSE 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL------ 176
+ + + GSPLYMAPE++ + YD +VD+WSVG IL+E L G PF+ ++ +L
Sbjct: 167 DAPQALRGSPLYMAPEMVCSKHYDARVDLWSVGVILYEALFGKAPFASKSFSELEEKILS 226
Query: 177 -------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
P L P+C D+ +LL + R+SF EF+ H F+
Sbjct: 227 HKTIELPTRPRLSPECRDLLQQLLQRDPDKRISFIEFFAHLFV 269
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (420), Expect = 1e-40, Method: Composition-based stats.
Identities = 95/268 (35%), Positives = 141/268 (52%), Gaps = 62/268 (23%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L +LNK LK L E++ L + HP+I+ L D + + I LV+E+CA G+LS +IR
Sbjct: 59 LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GLD MLKIADFG + +L + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-----------VPALH 182
YMAPE+L++++YD K D+WSVG +L+E++ G PPF N+V+L+ P +
Sbjct: 239 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRASNHVELLRRIERGEDNIKFPPEN 298
Query: 183 P---DCVDMCLKLLSANTVDRLSFNEFY 207
P D + LL N V+R++F +F+
Sbjct: 299 PASDDIKALIRMLLKRNPVERMNFADFF 326
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 166 bits (419), Expect = 2e-40, Method: Composition-based stats.
Identities = 88/230 (38%), Positives = 130/230 (56%), Gaps = 19/230 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + H NI+ L+D + N +FLV+E+C GG+L+ Y++ G + E T R FL Q+
Sbjct: 56 EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
A + IL+S IIHRDLKP+NILLS + + +KIADFG + L+ A +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAATLC 175
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---------IVPA 180
GSP+YMAPEV+ Q YD K D+WS+G ++++ L G PPF + L ++P+
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPS 235
Query: 181 L----HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 226
+ P ++ L LL N DR+ F F+ H FL + P +P
Sbjct: 236 IPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQGPVKKSCPVPVP 285
|
Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (418), Expect = 2e-40, Method: Composition-based stats.
Identities = 88/230 (38%), Positives = 130/230 (56%), Gaps = 19/230 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + H NI+ L+D + N +FLV+E+C GG+L+ Y++ G + E T R FL Q+
Sbjct: 56 EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
A + IL+S IIHRDLKP+NILLS + + +KIADFG + L+ A +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLC 175
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---------IVPA 180
GSP+YMAPEV+ Q YD K D+WS+G ++++ L G PPF + L ++P+
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPS 235
Query: 181 L----HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 226
+ P ++ L LL N DR+ F F+ H FL + P +P
Sbjct: 236 IPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQVPVKKSCPVPVP 285
|
Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 226 | ||||||
| 359476946 | 260 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.815 | 0.759 | 1e-91 | |
| 255581995 | 321 | serine/threonine-protein kinase, putativ | 0.942 | 0.663 | 0.736 | 2e-90 | |
| 225431573 | 275 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.770 | 0.709 | 2e-88 | |
| 224116060 | 266 | predicted protein [Populus trichocarpa] | 0.938 | 0.796 | 0.685 | 9e-86 | |
| 357464547 | 290 | Serine/threonine protein kinase GE16371 | 0.955 | 0.744 | 0.627 | 2e-78 | |
| 297852566 | 266 | hypothetical protein ARALYDRAFT_314341 [ | 0.938 | 0.796 | 0.625 | 4e-78 | |
| 110736434 | 295 | similar to MAP/ERK kinase kinase 3 [Arab | 0.938 | 0.718 | 0.612 | 9e-77 | |
| 326487810 | 278 | predicted protein [Hordeum vulgare subsp | 0.938 | 0.762 | 0.587 | 3e-73 | |
| 357166816 | 279 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.759 | 0.563 | 3e-71 | |
| 7770326 | 392 | F27J15.5 [Arabidopsis thaliana] | 0.907 | 0.522 | 0.586 | 2e-70 |
| >gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 341 bits (874), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 161/212 (75%), Positives = 185/212 (87%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++LK+ LDCE+NFLSSV+HPNIIRL FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43 LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPAL 181
G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF GR NVQLI P L
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPFCGRTNVQLISPGL 222
Query: 182 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
HPDCVD+C KLLS N V RLSF+EF HRFLR
Sbjct: 223 HPDCVDLCTKLLSTNPVHRLSFDEFCRHRFLR 254
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 337 bits (864), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 168/228 (73%), Positives = 184/228 (80%), Gaps = 15/228 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLNKHLK+CLDCELNFLSSVNHPNIIRLF FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53 LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E+ AR+ +QQLGAGLEIL+SHHIIHRDLKPENILLSG DV+LKIADFGLS + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----- 176
G YAE VCGSPLYMAPEVLQFQ YD+K DMWSVG ILFELLNGYPPF GR N QL
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMWSVGVILFELLNGYPPFHGRTNFQLLQNIK 232
Query: 177 ----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
I+P LHPD VD+C +LLS N V RLSF EFY+HRFLR+
Sbjct: 233 SCACLPFSQFILPTLHPDSVDICSRLLSVNPVHRLSFVEFYNHRFLRK 280
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 331 bits (848), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 161/227 (70%), Positives = 185/227 (81%), Gaps = 15/227 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++LK+ LDCE+NFLSSV+HPNIIRL FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43 LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV------- 174
G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF GR NV
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPFCGRTNVQLLQNIE 222
Query: 175 --------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
QLI P LHPDCVD+C KLLS N V RLSF+EF HRFLR
Sbjct: 223 SCKMLPFSQLISPGLHPDCVDLCTKLLSTNPVHRLSFDEFCRHRFLR 269
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 322 bits (824), Expect = 9e-86, Method: Compositional matrix adjust.
Identities = 157/229 (68%), Positives = 182/229 (79%), Gaps = 17/229 (7%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38 LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97
Query: 62 RVPEQTARKFLQQLGAG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
RV E+ A++F QQ+G+G L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS +
Sbjct: 98 RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL--- 176
P NY E VCGSP YMAPEVLQFQRYD KVDMWSVG ILFELLNGYPPF GR N QL
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMWSVGVILFELLNGYPPFRGRTNFQLLQN 217
Query: 177 ------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
I+ LHPDCVD+C +LLSAN V RLSF+EFYHH+FLR
Sbjct: 218 IKSSSCLPFSQHILSGLHPDCVDICSRLLSANPVQRLSFDEFYHHKFLR 266
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 297 bits (761), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 145/231 (62%), Positives = 174/231 (75%), Gaps = 15/231 (6%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
L KLN HL++ LDCE+NFLSSVNHPNI+ L FQ C++LV+EFCAGGNL+SYIR H
Sbjct: 57 FLSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCH 116
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
RV + TA+KF+QQLG+GL++L+SH IIHRDLKPENILLS D +LKIADFGLS T+
Sbjct: 117 ERVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVR 176
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---- 176
PG Y E VCG+P YMAPEVLQFQRYD K DMWSVGA+LFELLNGYPPF+GRNNVQ+
Sbjct: 177 PGEYVETVCGTPSYMAPEVLQFQRYDHKADMWSVGAMLFELLNGYPPFNGRNNVQVLKNI 236
Query: 177 -----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
++ + C+D+C +LL N V+RLSF+EFY H FLR S
Sbjct: 237 RSCTCLPFSQSVLYGMDSACLDICSRLLCLNPVERLSFDEFYFHSFLRGKS 287
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 296 bits (759), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 142/227 (62%), Positives = 175/227 (77%), Gaps = 15/227 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L++CL+ EL FLSSV+HPNIIRL FQ E + +V+E+C GG LSSYI+ HG
Sbjct: 39 LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++FL+Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L P
Sbjct: 99 RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------ 175
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 218
Query: 176 ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
LI+ +HPDC+D+C +LLS N V RLSF++FY+H+FLR
Sbjct: 219 SSTSLPFSRLILQQMHPDCIDVCSRLLSINPVTRLSFDDFYNHKFLR 265
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110736434|dbj|BAF00185.1| similar to MAP/ERK kinase kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 291 bits (746), Expect = 9e-77, Method: Compositional matrix adjust.
Identities = 139/227 (61%), Positives = 174/227 (76%), Gaps = 15/227 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 68 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 127
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 128 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 187
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------ 175
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ
Sbjct: 188 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 247
Query: 176 ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
LI+ +HPDC+D+C +LLS N V RLSF+EFY H+FLR
Sbjct: 248 SSTALPFSRLILQQMHPDCIDVCSRLLSINPVTRLSFDEFYKHKFLR 294
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326487810|dbj|BAK05577.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 280 bits (716), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 134/228 (58%), Positives = 165/228 (72%), Gaps = 16/228 (7%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLH 60
L L L+ LDCEL FL++V+HPNIIRL D + CI+LV+E C GG+L+SYI R
Sbjct: 50 LAGLPARLRDSLDCELRFLAAVSHPNIIRLLDVIRTPGCIYLVMELCEGGDLASYIERSG 109
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
GRV E AR F++Q+GAGL++L HH++HRDLKPENILLS D MLKI+DFGLS L+
Sbjct: 110 GRVDESVARNFMRQIGAGLQVLRRHHVVHRDLKPENILLSCRGSDAMLKISDFGLSRVLH 169
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV------ 174
PG YAE CG+ LYMAPEV+ FQ+YD+KVD+WS+GAILFELLNGYPPF GR+NV
Sbjct: 170 PGEYAETACGTRLYMAPEVMLFQKYDDKVDLWSIGAILFELLNGYPPFRGRSNVQMLQCI 229
Query: 175 ---------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
QL+VP+LHPD +D+C +LL N V RLS EF +H FLR
Sbjct: 230 NRTGSLPFSQLVVPSLHPDSIDICTRLLCTNPVKRLSLQEFINHGFLR 277
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357166816|ref|XP_003580865.1| PREDICTED: serine/threonine-protein kinase atg1-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 273 bits (699), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 128/227 (56%), Positives = 167/227 (73%), Gaps = 15/227 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L L L+ LDCE+ FL++V+HPNIIRL D Q ++C++LV+E C GG+L+S+I G
Sbjct: 52 LAGLPGRLRDSLDCEVRFLAAVSHPNIIRLLDVIQTQSCLYLVMELCEGGDLASFIERSG 111
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E+ AR F++Q+GAGL++L HHIIHRDLKPENILLS + D +LKI+DFGLS L+P
Sbjct: 112 RVDERVARNFMKQIGAGLQVLRRHHIIHRDLKPENILLSCPNSDAILKISDFGLSRVLHP 171
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------ 175
G YA+ CG+ LYMAPEV+ FQ+Y++KVD+WS+GAILFELLNGYPPF GR+NVQ
Sbjct: 172 GEYADTACGTRLYMAPEVMLFQKYNDKVDLWSIGAILFELLNGYPPFCGRSNVQLLQCIN 231
Query: 176 ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
L++ +LHPD +D+C +LL N V RLS EF +H FLR
Sbjct: 232 RTTSLPFSELVMRSLHPDSIDICTRLLCTNPVKRLSLQEFINHGFLR 278
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 271 bits (693), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 129/220 (58%), Positives = 163/220 (74%), Gaps = 15/220 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 98 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------ 175
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 217
Query: 176 ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEF 206
LI+ +HPDC+D+C +LLS N L +F
Sbjct: 218 SSTALPFSRLILQQMHPDCIDVCSRLLSINPAATLGIEDF 257
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 226 | ||||||
| TAIR|locus:2028496 | 408 | AT1G49180 [Arabidopsis thalian | 0.907 | 0.502 | 0.586 | 7.4e-66 | |
| TAIR|locus:2084440 | 712 | AT3G53930 [Arabidopsis thalian | 0.933 | 0.296 | 0.524 | 8.4e-58 | |
| TAIR|locus:2065680 | 733 | AT2G37840 [Arabidopsis thalian | 0.933 | 0.287 | 0.515 | 3.6e-57 | |
| TAIR|locus:2079527 | 626 | AT3G61960 [Arabidopsis thalian | 0.933 | 0.337 | 0.491 | 2.5e-56 | |
| UNIPROTKB|Q5ZJH6 | 468 | ULK3 "Serine/threonine-protein | 0.920 | 0.444 | 0.433 | 1.7e-41 | |
| MGI|MGI:1918992 | 472 | Ulk3 "unc-51-like kinase 3" [M | 0.907 | 0.434 | 0.425 | 3.7e-39 | |
| RGD|1587417 | 472 | Ulk3 "unc-51-like kinase 3 (C. | 0.907 | 0.434 | 0.425 | 4.8e-39 | |
| DICTYBASE|DDB_G0292390 | 668 | atg1 "ULK family protein kinas | 0.933 | 0.315 | 0.388 | 1.1e-38 | |
| UNIPROTKB|F1N332 | 472 | ULK3 "Uncharacterized protein" | 0.902 | 0.432 | 0.423 | 1.3e-38 | |
| UNIPROTKB|F1SJ29 | 479 | ULK3 "Uncharacterized protein" | 0.902 | 0.425 | 0.423 | 1.3e-38 |
| TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
Identities = 129/220 (58%), Positives = 163/220 (74%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------ 175
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 219
Query: 176 ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEF 206
LI+ +HPDC+D+C +LLS N L +F
Sbjct: 220 SSTALPFSRLILQQMHPDCIDVCSRLLSINPAATLGIEDF 259
|
|
| TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
Identities = 118/225 (52%), Positives = 153/225 (68%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ +LNK L+ L E+ L +NHPNIIR D +A I LV+E+C GG+LS YI HG
Sbjct: 53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
VPE TA+ F+ QL AGL++L ++IIHRDLKP+N+LLS D+D LKIADFG + +L P
Sbjct: 113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---- 177
AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G PF+G + +QL+
Sbjct: 173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNII 232
Query: 178 ------VPA----LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
PA L DC D+C KLL N V+RL+F EF+HH FL
Sbjct: 233 RSTELHFPADCRDLSTDCKDLCQKLLRRNPVERLTFEEFFHHPFL 277
|
|
| TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 3.6e-57, P = 3.6e-57
Identities = 116/225 (51%), Positives = 159/225 (70%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ +LNK L+ L E+ L +NHPNIIRL D ++ + LV+E+C GG+LS Y++ HG
Sbjct: 45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
VPE TA+ F+QQL AGL++L ++IIHRDLKP+N+LLS ++D LKIADFG + +L P
Sbjct: 105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV 178
AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G PF+G + +QL I+
Sbjct: 165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNII 224
Query: 179 PA--LH-P--------DCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ LH P DC+D+C KLL N V+RL+F EF++H FL
Sbjct: 225 RSTELHFPGDCRDLSLDCIDLCQKLLRRNPVERLTFEEFFNHPFL 269
|
|
| TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 2.5e-56, P = 2.5e-56
Identities = 111/226 (49%), Positives = 157/226 (69%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K L+ ++ L E++ LS+++HPNIIR ++A + + IFLV+E+C+GG+L+ YI HG+
Sbjct: 44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
VPE A+ F++QL GL++L H IHRDLKP+N+LLS + +LKI DFG + +L P
Sbjct: 104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV- 178
+ AE CGSPLYMAPE+++ Q+YD K D+WS GAILF+L+ G PPF G N++QL IV
Sbjct: 164 SMAETFCGSPLYMAPEIIRNQKYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVR 223
Query: 179 ------PA-----LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
P +HPDCVD+C LL N ++RL+F EF++H FLR
Sbjct: 224 DTELKFPEDTRNEIHPDCVDLCRSLLRRNPIERLTFREFFNHMFLR 269
|
|
| UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 1.7e-41, P = 1.7e-41
Identities = 97/224 (43%), Positives = 141/224 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
+ LN+ L E+ L ++ HP+I+ L D FQ ++ I+L++EFCAGG+LS +IR+
Sbjct: 49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR FLQQL L+ L+ H+I H DLKP+NILLS ++ LK+ADFG + + P
Sbjct: 108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV--- 178
+ + GSPLYMAPE++ Q+YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFASRSFAELEEKIR 226
Query: 179 ----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
P L PDC D+ +LL + + R+SF EF+ H F+
Sbjct: 227 SDRAIELPSRPPLSPDCRDLLQRLLERDPLKRISFEEFFAHPFV 270
|
|
| MGI|MGI:1918992 Ulk3 "unc-51-like kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 3.7e-39, P = 3.7e-39
Identities = 94/221 (42%), Positives = 137/221 (61%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----- 176
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 177 ---IV-----PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
++ P L DC D+ +LL + R+SF +F+ H
Sbjct: 227 SNRVIELPLRPQLSLDCRDLLQRLLERDPARRISFKDFFAH 267
|
|
| RGD|1587417 Ulk3 "unc-51-like kinase 3 (C. elegans)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 4.8e-39, P = 4.8e-39
Identities = 94/221 (42%), Positives = 137/221 (61%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----- 176
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 177 ---IV-----PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
++ P L DC D+ +LL + R+SF +F+ H
Sbjct: 227 SNRVIELPLRPQLSLDCRDLLQRLLERDPSHRISFQDFFAH 267
|
|
| DICTYBASE|DDB_G0292390 atg1 "ULK family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 1.1e-38, P = 1.1e-38
Identities = 87/224 (38%), Positives = 136/224 (60%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
N L L+ E+ L ++H NI+RL+D E I++++E C GG+ S YIR H +
Sbjct: 47 NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E+ A F++QL GL+ L I+HRDLKP+N+LLS + +LKI DFG + + P
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF-SGR-----NNVQ- 175
+ ++ CGSPLYMAPE+L + Y K D+WSVG IL+E+L G P + SG N +Q
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGIILYEMLVGEPAYNSGSVPDLLNQLQN 226
Query: 176 --LIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ +P+ + DC ++ LL + R+S+ +F++H++L N+
Sbjct: 227 KKIKLPSHISSDCQNLIYSLLQIDVEKRISWEDFFNHKWLNLNN 270
|
|
| UNIPROTKB|F1N332 ULK3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 1.3e-38, P = 1.3e-38
Identities = 94/222 (42%), Positives = 138/222 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
K LNK L E+ L + HP+I++L D FQ ++N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 106
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + +
Sbjct: 107 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 165
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---- 176
P + + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 166 PRDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKI 225
Query: 177 ----IV-----PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
++ P L DC D+ +LL + R+SF +F+ H
Sbjct: 226 RSNRVIELPLRPQLSHDCRDLLQRLLERDPSRRISFQDFFAH 267
|
|
| UNIPROTKB|F1SJ29 ULK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 1.3e-38, P = 1.3e-38
Identities = 94/222 (42%), Positives = 138/222 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
K LNK L E+ L + HP+I++L D FQ ++N I+L++EFCAGG+LS +I
Sbjct: 56 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 113
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + +
Sbjct: 114 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 172
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---- 176
P + + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L
Sbjct: 173 PWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKI 232
Query: 177 ----IV-----PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
++ P L DC D+ +LL + R+SF +F+ H
Sbjct: 233 RSNRVIELPLRPLLSQDCRDLLQRLLERDPNRRISFQDFFAH 274
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034887001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (275 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 226 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-78 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-52 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-47 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-47 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-46 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-46 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-45 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-42 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-40 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-39 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-38 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-37 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-35 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-34 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-33 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-32 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-31 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-31 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-31 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-30 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-30 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-30 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-30 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-29 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-29 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-29 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-28 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-26 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-26 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-25 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-23 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-23 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-22 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-21 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-20 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-19 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 3e-78
Identities = 89/229 (38%), Positives = 129/229 (56%), Gaps = 21/229 (9%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K E+ L + HPNI+RL+D F+ E+ ++LV+E+C GG+L +
Sbjct: 29 IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR+ E AR +L+Q+ + LE L+S I+HRDLKPENIL LD+D +K+ADFGL+
Sbjct: 89 KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLAR 145
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
L PG G+P YMAPEVL + Y + VD+WS+G IL+ELL G PPF G + + +
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLEL 205
Query: 178 --------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ P+ D+ KLL + RL+ E H F
Sbjct: 206 FKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 9e-64
Identities = 88/235 (37%), Positives = 127/235 (54%), Gaps = 27/235 (11%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
+K L K + E+ L ++HPNI+RL DAF+ ++ ++LV+E+C GG+L Y
Sbjct: 29 VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88
Query: 57 IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ G + E A+K Q+ GLE L+S+ IIHRDLKPENIL LD++ ++KIADFGL+
Sbjct: 89 LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145
Query: 117 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
L + G+P YMAPEVL Y KVD+WS+G IL+ELL G PPFSG N +
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL 205
Query: 175 QLIV-----------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ + + D+ K L+ + R + E H +
Sbjct: 206 DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-58
Identities = 82/210 (39%), Positives = 114/210 (54%), Gaps = 17/210 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N LS +NHP I++L AFQ E ++LV+E+ GG L S++ GR E+ AR + ++
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 134
LE L+S II+RDLKPENIL LD D +K+ DFGL+ L CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENIL---LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN---VQLIV-------PALHPD 184
+APEVL + Y + VD WS+G +L+E+L G PPF + + I+ L P+
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPE 219
Query: 185 CVDMCLKLLSANTVDRL---SFNEFYHHRF 211
D+ LL + RL E H F
Sbjct: 220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-55
Identities = 81/215 (37%), Positives = 116/215 (53%), Gaps = 30/215 (13%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K S L E+ L +NHPNI++L+ F+ EN ++LV+E+C GG+L +
Sbjct: 23 IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82
Query: 58 -RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
G++ E + L Q+ GLE L+S+ IIHRDLKPENILL D+ +K+ADFGLS
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140
Query: 117 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
L + + + G+P YMAPEVL + Y EK D+WS+G IL+EL
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187
Query: 175 QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
P+ D+ K+L + R S E H
Sbjct: 188 --------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-52
Identities = 65/206 (31%), Positives = 113/206 (54%), Gaps = 19/206 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
E+ L +NHPNII+ +++F+ + + +V+E+ GG+LS I+ + PE+ +
Sbjct: 49 EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 130
QL L+ L+S I+HRD+KP+NI L + ++K+ DFG+S L + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------VPALHP 183
+P Y++PE+ Q + Y+ K D+WS+G +L+EL PF G N ++L P +
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS 225
Query: 184 ----DCVDMCLKLLSANTVDRLSFNE 205
+ ++ LL + +R S +
Sbjct: 226 QYSSELRNLVSSLLQKDPEERPSIAQ 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-52
Identities = 76/235 (32%), Positives = 121/235 (51%), Gaps = 29/235 (12%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ K+ + E + LS P +++L+ +FQ + ++LV+E+ GG+L+S + G
Sbjct: 30 DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 116
+ E AR ++ ++ LE L+S+ IIHRDLKP+NIL +D + LK+ DFGLS
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVR 146
Query: 117 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
L + ++ G+P Y+APEV+ Q + + VD WS+G IL+E L G PPF G
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ET 205
Query: 174 VQLI-------------VPALHPDCVDMCLKLLSANTVDRL---SFNEFYHHRFL 212
+ I + + +D+ KLL + RL S E +H F
Sbjct: 206 PEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-50
Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 27/223 (12%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
L+ E+ LSS+ HPNI+R + + + E N + + +E+ +GG+LSS ++ G++PE
Sbjct: 44 EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 125
RK+ +Q+ GL L+S+ I+HRD+K NIL+ D ++K+ADFG + L G
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN-VQLI------- 177
V G+P +MAPEV++ + Y D+WS+G + E+ G PP+S N + +
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG 220
Query: 178 ----VPA-LHPDCVD---MCLKLLSANTVDRLSFNEFYHHRFL 212
+P L + D CL+ + R + +E H FL
Sbjct: 221 EPPEIPEHLSEEAKDFLRKCLRR---DPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 1e-47
Identities = 58/155 (37%), Positives = 91/155 (58%), Gaps = 4/155 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L HPNI++ + ++ ++ +++V+EFC+GG+L ++ + E ++
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L GLE L+S+ IIHRD+K NILL+ D +K+ DFGLS L + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV+ + YD K D+WS+G EL G PP+S
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 3e-47
Identities = 78/230 (33%), Positives = 111/230 (48%), Gaps = 40/230 (17%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L L+ HP II+L+ FQ E ++ V+E+ G L YIR +G + E+ R + ++
Sbjct: 55 LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 119
LE L+S IIHRDLKPENIL LD D+ +KI DFG + L
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 120 --YPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
N G+ Y++PE+L + + D+W++G I++++L G PPF G N
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 176 L---IV-------PALHPDCVDMCLKLLSANTVDRLSFNEFY----HHRF 211
I+ P PD D+ KLL + DRL NE Y H F
Sbjct: 230 TFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-46
Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 28/235 (11%)
Query: 2 LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK + K + + E L NHP I++L+ F+ + I++++E+C GG L +
Sbjct: 23 LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+R G E TAR ++ + E L++ II+RDLKPEN+L LD + +K+ DFG
Sbjct: 83 ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL---LDSNGYVKLVDFGF 139
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ L G CG+P Y+APE++ + YD VD WS+G +L+ELL G PPF +
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199
Query: 176 LIV--------------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRF 211
+ + + D+ +LL N +RL + H++
Sbjct: 200 MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-46
Identities = 76/213 (35%), Positives = 119/213 (55%), Gaps = 20/213 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L S+ HP ++ L+ +FQ ++ ++LV+E+ GG L S++R GR PE AR + Q+
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S I++RDLKPEN+L LD D +KI DFG + + Y +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IVPA-------LHPDC 185
APE++ + Y + VD W++G +++E+L GYPPF N +Q+ I+ PD
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDA 225
Query: 186 VDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
D+ LL + RL N+ +H +
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 7e-45
Identities = 64/187 (34%), Positives = 100/187 (53%), Gaps = 15/187 (8%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
+ + K L E+N L + HPNI+R +D ++ +++V+E+C GG+L+ I
Sbjct: 37 NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96
Query: 58 RLHGRVPEQTARKFLQQLGAGLE-----ILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
+ + E+ + L QL L + ++HRDLKP NI L D + +K+ D
Sbjct: 97 KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGD 153
Query: 113 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
FGL+ L + K G+P YM+PE L YDEK D+WS+G +++EL PPF+ R
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213
Query: 172 NNVQLIV 178
N +QL
Sbjct: 214 NQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 9e-44
Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L +NHP ++ L+ +FQ E ++LVV+ GG+L ++ + E+ + ++ ++
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S IIHRD+KP+NIL LD+ + I DF ++ + P G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNIL---LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN------VQLIV------PALHP 183
APEVL Q Y VD WS+G +E L G P+ G + PA
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS 226
Query: 184 -DCVDMCLKLLSANTVDRLSFN 204
+ +D KLL + RL N
Sbjct: 227 TEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-42
Identities = 73/249 (29%), Positives = 110/249 (44%), Gaps = 66/249 (26%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E++ L + HPNI++L D E ++LV E+C +L Y+ + + + Q
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +SH I+HRDLKP+NIL ++ D +LK+ADFGL+ + G PL
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153
Query: 134 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL----- 176
Y APE+L + Y VD+WSVG I E++ G P F G + + QL
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213
Query: 177 ---------------------------------IVPALHPDCVDMCLKLLSANTVDRLSF 203
++P L P+ +D+ K+L N R+S
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273
Query: 204 NEFYHHRFL 212
E H +
Sbjct: 274 KEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-42
Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E+ L+SVNHPNII +AF N + +V+E+ G+LS I +PEQ +
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
QL GL+ L+ I+HRDLK NILL D +KI D G+S + N A+ G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL-----------IVPA 180
P YMAPEV + + Y K D+WS+G +L+E+ PPF R+ L I P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNE 205
D + +L R + ++
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDK 249
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-40
Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 20/206 (9%)
Query: 16 ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + ++HPN+++L + E +++V+E+ GG+L SY+R + ++ F
Sbjct: 51 EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 132
Q+ G+E L S + IHRDL N L + +++++KI+DFGLS LY +Y K G P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI-------VPALHP 183
+ +MAPE L+ ++ K D+WS G +L+E+ G P+ G +N +++ P
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226
Query: 184 DCVDMCLKLLS----ANTVDRLSFNE 205
+C L+ + DR +F+E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-40
Identities = 62/157 (39%), Positives = 96/157 (61%), Gaps = 5/157 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L V+HP IIRLF + +++++E+ GG L SY+R GR T + ++
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S I++RDLKPENIL LD + +K+ DFG + L + +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENIL---LDKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
APEV+Q + +++ VD W++G +++E+L GYPPF N
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-40
Identities = 76/243 (31%), Positives = 118/243 (48%), Gaps = 49/243 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L+ + P I++L+ +FQ E ++LV+E+ GG+L + + PE+TAR ++ +L
Sbjct: 51 ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 118
L+ ++ IHRD+KP+NIL +D D +K+ADFGL
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 119 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
L+ N A G+P Y+APEVL+ Y + D WS+G IL+E+L G+
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 166 PPFSGRNNVQ-----------LIVPALH---PDCVDMCLKLLSANTVDRL-SFNEFYHHR 210
PPF + L P P+ +D+ +LL + DRL SF E H
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHP 286
Query: 211 FLR 213
F +
Sbjct: 287 FFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-40
Identities = 64/167 (38%), Positives = 96/167 (57%), Gaps = 11/167 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + HP +++L D F + LV+E+ LS +R R +PE + +++
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 131
L G+ ++++ I+HRDLKP N+L+S D +LKIADFGL+ Y+ +V +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L R YD VD+W+VG I ELLNG P F G N++ QL
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-39
Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 16 ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++HPNI++L + E + +V+E+ GG+L Y+R + + F
Sbjct: 51 EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 131
Q+ G+E L S + IHRDL N L+ +++++KI+DFGLS LY +Y + G
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI-------VPALH 182
P+ +MAPE L+ ++ K D+WS G +L+E+ G P+ G +N +++
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP 226
Query: 183 PDCVDMCLKLLS----ANTVDRLSFNE 205
P+C KL+ + DR +F+E
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 72/225 (32%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
C E L+ HP + +L FQ ++ +F V+E+ GG+L +I+ GR E AR
Sbjct: 41 CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
+ ++ GL+ L+ II+RDLK +N+L LD + +KIADFG+ C + G
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVL---LDSEGHIKIADFGM-CKEGILGGVTTSTF 156
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---------IVP 179
CG+P Y+APE+L +Q Y VD W++G +L+E+L G PF G + +L P
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP 216
Query: 180 -ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 223
L + + L+ N RL I PF
Sbjct: 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ-------DIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-38
Identities = 68/205 (33%), Positives = 110/205 (53%), Gaps = 23/205 (11%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L+ +FQ+++ ++LV+E+ GG+ +S I+ G +PE A++++ ++ G+E L+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
IIHRD+KPEN+L +D LK+ DFGLS G +K G+P Y+APE +
Sbjct: 117 GIIHRDIKPENLL---IDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170
Query: 146 DEKVDMWSVGAILFELLNGYPPFSG-----------RNNVQL---IVPALHPDCVDMCLK 191
D+ D WS+G ++FE L GYPPF + + P+ VD+ +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 192 LLSANTVDRLSFN---EFYHHRFLR 213
LL + RL N E H F +
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-38
Identities = 54/167 (32%), Positives = 95/167 (56%), Gaps = 8/167 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + + ++HPNI+RL +++V E+ GG+L ++R HG + + + Q
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+E L S + +HRDL N L+ +++++KI+DFGLS +Y +Y K G L
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI 177
+MAPE L+ ++ K D+WS G +L+E+ G P+ G +N +++
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 214
|
Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-38
Identities = 66/177 (37%), Positives = 101/177 (57%), Gaps = 11/177 (6%)
Query: 2 LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK++ K L L+ E + L++ +++L AFQ + ++L +E+ GG+ +
Sbjct: 31 LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ G + E AR ++ ++ ++ L+ IHRDLKPEN L+ D +K+ DFGL
Sbjct: 91 LLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGL 147
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
S + YA V GSP YMAPEVL+ + YD VD WS+G +L+E L G+PPFSG
Sbjct: 148 SKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-37
Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 16/213 (7%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
L+ E+ LS + HPNI++ + E+ +++ +E GG+L+ ++ +G PE R +
Sbjct: 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+Q+ GLE L+ + +HRD+K NIL +D + ++K+ADFG++ + ++A+ GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------VPA--- 180
+MAPEV+ Q Y D+WS+G + E+ G PP+S V + +P
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD 225
Query: 181 -LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
L + D LK L + R + E H F+
Sbjct: 226 HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-37
Identities = 53/157 (33%), Positives = 89/157 (56%), Gaps = 5/157 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + P I++ + ++ +++V+E+C G++S +++ + E+ L Q
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
GLE L+S+ IHRD+K NILL +++ K+ADFG+S L V G+P
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
+MAPEV+Q Y+ K D+WS+G E+ G PP+S
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-37
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 30/189 (15%)
Query: 3 KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
KK+ K S +C E+ L +N HPNI++L + F+ + ++ V E+ G NL +
Sbjct: 30 KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88
Query: 58 RLHGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ P E R + Q+ GL ++ H HRDLKPEN+L+SG + ++KIADFGL
Sbjct: 89 KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145
Query: 116 SCTLYPGNYAEKVCGSP---------LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGY 165
A ++ P Y APE+ L+ Y VD+W++G I+ EL
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
Query: 166 PPFSGRNNV 174
P F G + +
Sbjct: 197 PLFPGSSEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 9e-37
Identities = 55/171 (32%), Positives = 94/171 (54%), Gaps = 5/171 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + LKS + E++ L ++ HPNI++ + + + +++++E+ G+L I+ G
Sbjct: 37 KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
PE ++ Q+ GL L+ +IHRD+K NIL + D ++K+ADFG++ L
Sbjct: 96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
V G+P +MAPEV++ D+WS+G + ELL G PP+ N
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 75/198 (37%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N L +V HP I+ L AFQ ++L++E+ +GG L ++ G E TA +L ++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 133
LE L+ II+RDLKPENIL LD +K+ DFGL C +++ G CG+
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL---LDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NVQLIVPA-LHP 183
YMAPE+L + + VD WS+GA+++++L G PPF+ N +L +P L P
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTP 225
Query: 184 DCVDMCLKLLSANTVDRL 201
+ D+ KLL N RL
Sbjct: 226 EARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-36
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 20/225 (8%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ K + + L+CE+ L ++ H I++ + + + + + +E+ GG++ ++ +G
Sbjct: 42 PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
+ E RK+ +Q+ G+E L+S+ I+HRD+K NIL D +K+ DFG S L
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157
Query: 122 ---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
G + V G+P +M+PEV+ + Y K D+WSVG + E+L PP++ + I
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217
Query: 179 ------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211
+ PD + + N R S E H F
Sbjct: 218 KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-36
Identities = 61/163 (37%), Positives = 94/163 (57%), Gaps = 12/163 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
E+ +S NHPN+++ + +F + ++LV+ + +GG+L ++ G + E L
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 128
+++ GLE L+S+ IHRD+K NIL L +D +KIADFG+S +L G+ KV
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 129 -CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q YD K D+WS G EL G P+S
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 7e-36
Identities = 72/180 (40%), Positives = 99/180 (55%), Gaps = 16/180 (8%)
Query: 16 ELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF 71
E+ L+S+NHP NI++L+D FQ E ++LV+E+ GG+L ++ GR + E A
Sbjct: 47 EIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFI 106
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--- 128
L Q+ + LE L+S IIHRD+KPENILL D ++K+ DFGL+ L +
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
Query: 129 ----CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPAL 181
G+P YMAPEVL D+WS+G L+ELL G PPF G N L
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-36
Identities = 58/174 (33%), Positives = 94/174 (54%), Gaps = 17/174 (9%)
Query: 16 ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
E+ L + HPN+++ + + + + IF+ E+C+GG L + HGR+ E R +
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 127
QL GL L+SH I+HRD+KP NI LD + ++K+ DFG + T G +
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
Query: 128 VCGSPLYMAPEVLQFQRYDEK---VDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
+ G+P YMAPEV+ + D+WS+G ++ E+ G P+S +N I+
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-35
Identities = 65/163 (39%), Positives = 93/163 (57%), Gaps = 9/163 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L +NHPNII+L D F+ + ++LV EF +L I+ R +PE + +L Q
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
L GL +SH I+HRDLKPEN+L++ LK+ADFGL+ + Y V +
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
Y APE+L + Y VD+WSVG I ELL+ P F G++ +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-35
Identities = 55/147 (37%), Positives = 89/147 (60%), Gaps = 5/147 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
HPNI+ +D++ + +++V+E+ GG+L+ I + R+ E +++ GLE L
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 141
+S ++IHRD+K +NILLS D V K+ADFG + L V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y KVD+WS+G + E+ G PP+
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-35
Identities = 57/175 (32%), Positives = 90/175 (51%), Gaps = 16/175 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
E + + HPN++RL E ++LV+E+ GG+L Y+R + +
Sbjct: 46 EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
F Q+ G+E L S +HRDL N L+ +D V+ KI+DFGLS +Y +Y
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162
Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI 177
K G L +MAPE L+ + K D+WS G +L+E+ G P+ G +N +++
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL 217
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-35
Identities = 76/250 (30%), Positives = 129/250 (51%), Gaps = 41/250 (16%)
Query: 2 LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+KK+NK L++ + E + L+ +P ++ +F +F+ + + +V+E+ GG+ ++
Sbjct: 31 MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ G +P AR + + LE L+++ I+HRDLKP+N+L++ + +K+ DFGL
Sbjct: 91 LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147
Query: 116 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159
S LY G+ ++VCG+P Y+APEV+ Q Y + VD W++G IL+
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207
Query: 160 ELLNGYPPFSGRN---------NVQLIVP----ALHPDCVDMCLKLLSANTVDRLSFN-- 204
E L G PF G + + P AL D D+ +LL N ++RL
Sbjct: 208 EFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGA 267
Query: 205 -EFYHHRFLR 213
E HRF
Sbjct: 268 FEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 7e-35
Identities = 62/160 (38%), Positives = 97/160 (60%), Gaps = 19/160 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L ++HP I+ + +FQ EN ++ ++EF GG L +++R GR P A+ + +L
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 128
E L+S II+RDLKPEN+L LD+ +K+ DFG +A+KV
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLL---LDNKGHVKVTDFG---------FAKKVPDRTFTL 175
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
CG+P Y+APEV+Q + + + VD W++G +L+E + GYPPF
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-34
Identities = 56/180 (31%), Positives = 100/180 (55%), Gaps = 8/180 (4%)
Query: 2 LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
L K+N+ + +D E L+ ++ IIR +++F + + +V+E+ G+L +++
Sbjct: 35 LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93
Query: 61 G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+PE +F Q+ GL L+S I+HRD+K N+ L D+ +KI D G++
Sbjct: 94 RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150
Query: 119 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
L N+A + G+P Y++PE+ + + Y+EK D+W++G +L+E G PF N LI
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-34
Identities = 63/153 (41%), Positives = 93/153 (60%), Gaps = 4/153 (2%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
HP + LF FQ + +F V+E+ GG+L +I+ GR E AR + ++ GL+ L+
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N+LL D D +KIADFG+ + A CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+Y+E VD WS G +L+E+L G PF G + +L
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-34
Identities = 65/160 (40%), Positives = 99/160 (61%), Gaps = 8/160 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E + L+ VNHP I++L AFQ E ++L+++F GG+L + RL V E+ + +L
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
+L L+ L+S II+RDLKPENILL D++ +K+ DFGLS ++ A CG+
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
YMAPEV+ + + + D WS G ++FE+L G PF G++
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 76/228 (33%), Positives = 116/228 (50%), Gaps = 25/228 (10%)
Query: 3 KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
KK KH+ + E N L +V HP ++ L +FQ + ++ V+++ GG L +++
Sbjct: 36 KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 119
PE AR + ++ + L L+S +II+RDLKPENILL D + + DFGL C +
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGI 147
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL--- 176
CG+P Y+APEVL+ Q YD VD W +GA+L+E+L G PPF R+ ++
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207
Query: 177 -------IVPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLR 213
+ P + + LL + RL F E +H F
Sbjct: 208 ILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 61/178 (34%), Positives = 95/178 (53%), Gaps = 7/178 (3%)
Query: 12 CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
C E L+ + HP + L FQ ++ +F V+E+ GG+L I+ + E +R
Sbjct: 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
+ ++ L L+ H +I+RDLK +NILL D + K+ADFG+ C + G
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM-CKEGILNGVTTTTF 156
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALHPDCV 186
CG+P Y+APE+LQ Y VD W++G +++E++ G PPF N L LH D +
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-33
Identities = 59/180 (32%), Positives = 96/180 (53%), Gaps = 8/180 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + L E+ L ++H NI++ E + + +E+ GG++ S +R +GR
Sbjct: 45 DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 119
EQ R F +Q+ GL L+S I+HRDLK +N+L +D D + KI+DFG+ S +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
Y + + GS +MAPEV+ Y KVD+WS+G ++ E+ G P+S + +
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-33
Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 27/219 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FLS P I + + +F + +++++E+C GG+ ++ G++ E L+++
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
GLE L+ IHRD+K NILLS ++ +K+ADFG+S L + K G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLIVPALHP------- 183
+MAPEV++ YDEK D+WS+G EL G PP S + V ++P +P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNK 222
Query: 184 ------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
D V +CL + +R S E H+F+++
Sbjct: 223 FSKPFKDFVSLCLNK---DPKERPSAKELLKHKFIKKAK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-32
Identities = 57/168 (33%), Positives = 95/168 (56%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L ++HPNII ++ F + + +V+E+ GG L+ YI+ + E T F
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ L +++ I+HRDLK +NILL +++KI DFG+S L + A V G+P
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPAL 181
Y++PE+ + + Y++K D+W++G +L+EL + F N +PAL
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPAL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L S P +++ + AF E I +V+E+ GG+L+ ++ G++PE +Q+
Sbjct: 49 ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCG 130
GL+ L HIIHRD+KP N+L++ +V KIADFG L TL N G
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF---VG 162
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI----------VPA 180
+ YM+PE +Q + Y D+WS+G L E G PF P+
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS 222
Query: 181 LHPDC--------VDMCLKLLSANTVDRLSFNEFYHHRFLR 213
L + + CL+ R S E H F++
Sbjct: 223 LPAEEFSPEFRDFISACLQKDPK---KRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-32
Identities = 75/225 (33%), Positives = 114/225 (50%), Gaps = 21/225 (9%)
Query: 5 LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
LN+ + + E N L +V HP ++ L +FQ ++ V++F GG L +++
Sbjct: 34 LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 121
PE AR + ++ + L L+S +I++RDLKPENILL V+ DFGL C +
Sbjct: 94 PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPAL 181
+ CG+P Y+APEV++ Q YD VD W +GA+L+E+L G PPF R+ ++ L
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
Query: 182 HPDCV----------DMCLKLLSANTVDRL----SFNEFYHHRFL 212
H V + +LL + RL F E H F
Sbjct: 210 HKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L +I+ G+ E A + ++ GL L+S
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C ++ G CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVP----------ALHPDCVDMCLKLL 193
Y + VD W+ G +L+E+L G PPF G + +L +L + V +C LL
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLL 236
Query: 194 SANTVDRLSFN-----EFYHHRFLRR 214
+ + RL + H F RR
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 63/164 (38%), Positives = 88/164 (53%), Gaps = 13/164 (7%)
Query: 20 LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
L S HPNI+RL D + + + LV E +L++Y+ + +P +T + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+QL G++ L+SH I+HRDLKP+NIL++ D +KIADFGL+ +Y A
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
L Y APEVL Y VDMWSVG I EL P F G +
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-31
Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
E+ LS + HPNII ++ F +N + + +E+ GG L I + E+ +L
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 130
Q+ + + ++ I+HRD+K NI L+ ++K+ DFG+S L Y AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
+P YM+PE+ Q +Y+ K D+W++G +L+ELL F N + L+V
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 57/152 (37%), Positives = 87/152 (57%), Gaps = 7/152 (4%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
+S HP ++ LF FQ E+ + V+E+ AGG+L +I E A + + GL+
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQ 115
Query: 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPE 138
L+ + I++RDLK +N+LL D + +KIADFGL C + G+ CG+P ++APE
Sbjct: 116 YLHENKIVYRDLKLDNLLL---DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
VL Y VD W +G +++E+L G PF G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-31
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 30/198 (15%)
Query: 3 KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
KK++ +D E+ L + H NII L D + N +++V E +
Sbjct: 31 KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89
Query: 53 LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
L I+ + + + FL Q+ GL+ L+S ++IHRDLKP NIL+ + + LKI D
Sbjct: 90 LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICD 146
Query: 113 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLN 163
FGL+ + P ++ L Y APE+ L RY + +D+WSVG I ELL
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
Query: 164 GYPPFSGRNNV---QLIV 178
P F GR+ + LIV
Sbjct: 203 RKPLFPGRDYIDQLNLIV 220
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 68/238 (28%), Positives = 105/238 (44%), Gaps = 48/238 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E++ + + H NI+RL D EN + LV E+ +L Y+ HG + T + F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
QL G+ + + ++HRDLKP+N+L++ LK+ADFGL+ P N +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNN----------------- 173
Y AP+VL R Y +D+WSVG I+ E++ G P F G NN
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223
Query: 174 ----------------------VQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
+Q + P P +D+ +LL N R+S ++ H
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-31
Identities = 74/212 (34%), Positives = 111/212 (52%), Gaps = 22/212 (10%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
NHP + +L+ FQ + +F V+EF GG+L +I+ R E AR + ++ + L L+
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 141
II+RDLK +N+L LD + K+ADFG+ C ++ G CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVL---LDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NVQLIVPA-LHPDCVDMCLK 191
Y VD W++G +L+E+L G+ PF N N +++ P L D VD+
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 192 LLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 223
++ N RL L AILR PF
Sbjct: 230 FMTKNPTMRLGSLT------LGGEEAILRHPF 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-31
Identities = 67/177 (37%), Positives = 100/177 (56%), Gaps = 11/177 (6%)
Query: 3 KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
KK KH+ S E N L +V HP ++ L +FQ + ++ V+++ GG L +++
Sbjct: 36 KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 119
E AR + ++ + L L+S +I++RDLKPENILL D + + DFGL C +
Sbjct: 92 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL-CKENI 147
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
CG+P Y+APEVL Q YD VD W +GA+L+E+L G PPF RN ++
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-31
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 22/218 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ ++ +NHP+IIR+ A ++ L VE+ AGG++S + +G E + +QL
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 130
GL L+ + IIHRD+K N+L+ L+IADFG + L G + ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR---NNVQLI---------- 177
+ +MAPEVL+ ++Y D+WSVG ++ E+ PP++ N++ LI
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230
Query: 178 -VPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
+P L P D+ L+ L DR E H R
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 8e-31
Identities = 61/166 (36%), Positives = 95/166 (57%), Gaps = 6/166 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
L ++ HP ++ L +FQ ++ V+++ GG L +++ E AR + ++ +
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
+ L+S +II+RDLKPENILL D + + DFGL C + P CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALH 182
PEVL+ + YD VD W +GA+L+E+L G PPF R+ Q+ LH
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-31
Identities = 60/169 (35%), Positives = 88/169 (52%), Gaps = 28/169 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E++ L +NHPNI+RL D +EN ++LV EF +L Y+ + +L
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
QL G+ +SH ++HRDLKP+N+L +D + LK+ADFGL+ + G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153
Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSG 170
Y APE+L R Y VD+WS+G I E++N P F G
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
E+ L + HPNI+RL + + + I++V E+ +L+ + + E + ++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 129
+QL GL+ L+S+ I+HRD+K NIL+ ++D +LK+ADFGL+ +Y +V
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 130 GSPL-YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL---------I 177
L Y PE+L RY +VDMWSVG IL EL G P F G + QL
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 178 VPALHPDCVDMCL-KLLSANTVDRLSFNEFYHHRF 211
P + + L + EF+ H
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLI 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 55/152 (36%), Positives = 95/152 (62%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F ++ NHP ++ L FQ E+ +F V+EF +GG+L +++ ++PE+ AR + ++
Sbjct: 49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD + +K+ D+G+ C + PG+ CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 22/170 (12%)
Query: 14 DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
DC E++ L ++HPN+I+ +F N + +V+E G+LS I + R +PE+T
Sbjct: 48 DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 124
K+ QL + LE ++S I+HRD+KP N+ ++ ++K+ D GL G +
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158
Query: 125 ----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF G
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 74/221 (33%), Positives = 113/221 (51%), Gaps = 23/221 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
E++ L+S +HPNI++L DAF EN +++++EFCAGG + + + L + E R +Q
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
L L+ + IIHRDLK NIL + LD D+ K+ADFG+S + G+P
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------PAL 181
+MAPEV+ + YD K D+WS+G L E+ PP N +++++ P L
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
Query: 182 ------HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ D K L N R + + H F+ NS
Sbjct: 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-30
Identities = 62/179 (34%), Positives = 90/179 (50%), Gaps = 30/179 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
E++ L HPNI+ F ++ + +++V+E+C GG+L Y G + E Q A R+
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
L+ GL L+ IHRD+K NILL+ +D +K+ADFG+S L K
Sbjct: 110 TLK----GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKS 160
Query: 128 VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALHP 183
G+P +MAPEV +R YD K D+W++G EL PP LHP
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD----------LHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 54/258 (20%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA 77
L++++HP + L+ +FQ E + LV+++C GG L ++ + E+ AR + ++
Sbjct: 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------- 126
LE L+ I++RDLKPENILL +ML +DF LS
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 127 ---------KVC----------GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
G+ Y+APEV+ + VD W++G +L+E+L G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 168 FSGRN------NV---QLIVPALHP---DCVDMCLKLLSANTVDRLSF----NEFYHHRF 211
F G N N+ ++ P P D+ KLL + RL E H F
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
Query: 212 LRR-NSAILR--APFHIP 226
R N A++R P IP
Sbjct: 292 FRGVNWALIRHTTPPIIP 309
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-30
Identities = 55/152 (36%), Positives = 93/152 (61%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD + +K+ D+G+ C L PG+ CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-30
Identities = 61/158 (38%), Positives = 89/158 (56%), Gaps = 5/158 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L V+ I+ L AF+ ++ + LV+ GG+L +I G PE A +
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ GLE L+ I++RDLKPEN+LL DD ++I+D GL+ L G + G+P
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
YMAPEVLQ + YD VD +++G L+E++ G PF R
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 76/212 (35%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L+ VN P I+ L +FQ+ ++LV+ F GG L +++ GR AR + +L
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
LE L+ ++I+RDLKPENIL LD + + DFGL C L + CG+P
Sbjct: 103 LCALENLHKFNVIYRDLKPENIL---LDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-----LIVPALHPDCV-- 186
Y+APE+L Y + VD W++G +L+E+L G PPF N + L P PD
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDR 218
Query: 187 ---DMCLKLLSANTVDRLSFN---EFYHHRFL 212
D+ + LLS + RL +N E +H F
Sbjct: 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-29
Identities = 66/165 (40%), Positives = 92/165 (55%), Gaps = 18/165 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ LS HPNI+ L++A+ EN +++++EFC GG L S + R E R +Q
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 129
+ L L+SH +IHRDLK NILL+ LD DV K+ADFG+S N +
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164
Query: 130 GSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ + YD K D+WS+G L EL PP
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-29
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 16/211 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV-PEQTARKFLQ 73
E+ L+ + HPNI+ F +FQ +F+V+E+C GG+L I R G + E +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
Q+ GL+ ++ I+HRD+K +NI LS + ++ K+ DFG++ L C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-----------PAL 181
Y++PE+ Q + Y+ K D+WS+G +L+EL PF G N QL++ P
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF 226
Query: 182 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
D + +L + DR S FL
Sbjct: 227 SRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-29
Identities = 61/155 (39%), Positives = 92/155 (59%), Gaps = 6/155 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
+P + L+ FQ + +F V+EF GG+L +I+ GR A + ++ GL+ L+
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 141
S II+RDLK +N++L D D +KIADFG+ C ++ N A CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVML---DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+Y VD WS G +L+E+L G PF G + +L
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L +I+ G+ E A + ++ GL L+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C + G CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVP----------ALHPDCVDMCLKLL 193
Y + VD W+ G +L+E+L G PPF G + +L +L + V +C L+
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236
Query: 194 SANTVDRLSFN-----EFYHHRFLRR 214
+ + RL + H F RR
Sbjct: 237 TKHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-29
Identities = 58/167 (34%), Positives = 92/167 (55%), Gaps = 11/167 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ L + H NI+ L +AF+ + ++LV E+ L + G +P R ++ Q
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 131
L + +SH+IIHRD+KPENIL+S + +LK+ DFG + L + V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 132 PLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L Y + VD+W++G I+ ELL+G P F G +++ QL
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 67/179 (37%), Positives = 99/179 (55%), Gaps = 24/179 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E+ FL + +HPNI++L + +AEN I+LV E+ +L + IR + + R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
QL L+ ++S ++IHRDLKP NILL + D +K+ADFGL+ +L +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENP---ENP 167
Query: 133 L---------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGR---NNVQLIV 178
+ Y APE+L RY + VDMWSVG IL E+L G P F G N ++ I+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-29
Identities = 71/218 (32%), Positives = 118/218 (54%), Gaps = 25/218 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
EL+ L++ +H I++ FD F++++ + L++E+ +GG+L+ I RL +P E
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 126
Q+ L+ ++S ++HRDLK NI L +G+ +K+ DFG S + A
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALH---- 182
CG+P Y+APE+ + +RY +K DMWS+G IL+ELL + PF G + +++ L+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289
Query: 183 --PDCVDMCLK-----LLSANTVDRLSFNEFYHHRFLR 213
P V +K LLS N R + + H FL+
Sbjct: 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-29
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ + + L++++ GG L +++ E R ++ ++ L+ L+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ 143
II+RD+K ENIL LD + + + DFGLS A CG+ YMAPEV++
Sbjct: 125 GIIYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 144 R--YDEKVDMWSVGAILFELLNGYPPF--SGRNNVQ------------LIVPALHPDCVD 187
+D+ VD WS+G + FELL G PF G N Q + + D
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARD 241
Query: 188 MCLKLLSANTVDRLSFN---EFYHHRFLR 213
KLL + RL N E +H F +
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 54/152 (35%), Positives = 93/152 (61%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + ++P ++ L FQ + +FLV+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD D +K+ D+G+ C L PG+ CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 67/188 (35%), Positives = 100/188 (53%), Gaps = 22/188 (11%)
Query: 3 KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
K + KH KS L+ N L ++ HPNI+RL FD + + LV E N
Sbjct: 30 KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85
Query: 53 LSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
L I+ R +PE+ + ++ QL L+ ++ + I HRD+KPENIL+ D +LK+A
Sbjct: 86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141
Query: 112 DFGLSCTLYP-GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFG +Y Y E + + Y APE +L Y K+D+W+VG + FE+L+ +P F
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 170 GRNNVQLI 177
G N + I
Sbjct: 201 GTNELDQI 208
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 56/153 (36%), Positives = 91/153 (59%), Gaps = 6/153 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L I+ GR E A + ++ GL L+S
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C ++ G + CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y + VD W+ G +L+E+L G PF G + +L
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-28
Identities = 68/209 (32%), Positives = 111/209 (53%), Gaps = 30/209 (14%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGAGLEI 81
HPNI+ D++ + +++V+E+ AGG+L+ + Q A R+ LQ LE
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEF 130
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 140
L+S+ +IHRD+K +NILL G+D V K+ DFG + P + + G+P +MAPEV+
Sbjct: 131 LHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------VPAL-HP--------D 184
+ Y KVD+WS+G + E++ G PP+ N ++ + P L +P D
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 185 CVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
++ CL++ + R S E H FL+
Sbjct: 248 FLNRCLEM---DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 64/167 (38%), Positives = 89/167 (53%), Gaps = 12/167 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
E+ L + HPNII L D F ++ I LV EF +L I+ + A + ++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIK-DKSIVLTPADIKSYML 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 131
GLE L+S+ I+HRDLKP N+L + D +LK+ADFGL+ + P +V +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L R Y VDMWSVG I ELL P G +++ QL
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
+ L + KS L E+N + + H NI+R D F +A +++++EFC G+LS I
Sbjct: 49 RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108
Query: 58 -RLHGRVPEQTARKFLQQLGAGLEIL-------NSHHIIHRDLKPENILLS--------- 100
++ G++ E +QL L N ++HRDLKP+NI LS
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 101 -----GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVDMWS 153
L+ + KI DFGLS + + A G+P Y +PE+L + + YD+K DMW+
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 154 VGAILFELLNGYPPFSGRNNVQLIVPAL 181
+G I++EL +G PF NN ++ L
Sbjct: 229 LGCIIYELCSGKTPFHKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-28
Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 10/182 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + + L E+ L + H NI++ + + + + +E+ GG++++ + +G
Sbjct: 43 KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
E R F++Q+ GL L++ IIHRD+K NIL +D+ +KI+DFG+S L
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VDNKGGIKISDFGISKKLEAN 159
Query: 122 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ GS +MAPEV++ Y K D+WS+G ++ E+L G PF +Q
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
Query: 176 LI 177
I
Sbjct: 220 AI 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-28
Identities = 68/244 (27%), Positives = 105/244 (43%), Gaps = 57/244 (23%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ L + H NI+RL+D ++ + LV E+C +L Y +G + + + F+ Q
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP- 132
L GL +SH+++HRDLKP+N+L++ + LK+ADFGL+ + V C S
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA-----RAFGIPVRCYSAE 159
Query: 133 ----LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG----------------------- 164
Y P+VL + Y +DMWS G I EL N
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
Query: 165 -----------------YPPFSGRNNVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 207
YP + ++ +VP L+ D+ LL N V R+S E
Sbjct: 220 PTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279
Query: 208 HHRF 211
H +
Sbjct: 280 QHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 67/272 (24%)
Query: 1 MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
ML+K H+++ E + L+ ++P +++L+ +FQ EN ++L++E+ GG++ + +
Sbjct: 39 MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT- 118
E+ R ++ + ++ ++ IHRD+KP+N+L LD +K++DFGL CT
Sbjct: 95 KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LDAKGHIKLSDFGL-CTG 150
Query: 119 --------LY-------PGNYAEKVC------------------------GSPLYMAPEV 139
Y P N+ + + G+P Y+APEV
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-----------LIVPA---LHPDC 185
Y+++ D WS+G I++E+L GYPPF N + L P L P+
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEA 270
Query: 186 VDMCLKLLSANTVDRLSF---NEFYHHRFLRR 214
D+ +L RL NE H F +
Sbjct: 271 KDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 56/153 (36%), Positives = 90/153 (58%), Gaps = 5/153 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P I+ L +FQ ++ ++LV ++ +GG L +++ GR E A+ ++ +L LE L+ +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
I++RDLKPENIL LD + + DFGLS L CG+ Y+APEVL ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 145 -YDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y + VD WS+G ++FE+ G+ PF + Q+
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 55/153 (35%), Positives = 90/153 (58%), Gaps = 5/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L+ +NHP + L+ +F+ E+ ++LV+EF GG +++R + R P + Q+
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
E L S +I++RDLKPEN+L LD D +K+ DFG + + Y +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APE+L + + D W++G ++E+L G PPF
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-27
Identities = 72/218 (33%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
EL+ L N P I+ + AF I + +E+ GG+L ++ GR+PE+ K
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 75 LGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ GL L H IIHRD+KP NIL++ +K+ DFG+S L + A+ G+
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN--------VQLIV----PAL 181
YMAPE +Q Y K D+WS+G L EL G P+ N+ +Q IV P L
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL 224
Query: 182 -----HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
PD D L + +R S+ E H F+++
Sbjct: 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-27
Identities = 75/226 (33%), Positives = 108/226 (47%), Gaps = 45/226 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H +K LQ++
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115
Query: 76 -------GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
GA GL L+SH IHRD+K NILL+ + +K+ADFG + + P N
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169
Query: 127 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV----- 178
G+P +MAPEV+ +YD KVD+WS+G EL PP N + +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 179 --PALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
P L + VD CL+ + DR S E HRF+ R
Sbjct: 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQ---DRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-27
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E LS ++HP I++ +F + ++ E+C G +L + + E ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 130
QL G+ ++ I+HRDLK +NI L + +LKI DFG+S L + A G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------PALHP 183
+P YM+PE L+ Q YD K D+WS+G IL+E+ F G+N + +++ P+L P
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-P 226
Query: 184 DCVDMCL-----KLLSANTVDRLSFNEFYHHRFL 212
+ L +L+ + R S E + F+
Sbjct: 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-26
Identities = 55/168 (32%), Positives = 95/168 (56%), Gaps = 10/168 (5%)
Query: 10 KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
K+ DC E++ L +NHPN+I+ D+F +N + +V+E G+LS I+ + +
Sbjct: 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
PE+T K+ QL + +E ++S ++HRD+KP N+ ++ ++K+ D GL
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF G
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-26
Identities = 57/166 (34%), Positives = 99/166 (59%), Gaps = 6/166 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
E L+ + HPNI+ ++F+A+ +++V+E+C GG+L I+L G++ PE T ++
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
Q+ G++ ++ ++HRD+K +NI L+ + +K+ DFG + L PG YA G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
Y+ PE+ + Y+ K D+WS+G IL+EL PF + LI+
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-26
Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E A +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ I++RDLKPENILL DD ++I+D GL+ + G + G+
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS------GRNNVQLIVPALH----- 182
YMAPEV++ +RY D W++G +L+E++ G PF R V+ +V +
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226
Query: 183 ---PDCVDMCLKLLSANTVDRLSFNE-----------FYHHRFLRRNSAILRAPF 223
PD +C LL + +RL F F R + +L PF
Sbjct: 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 53/165 (32%), Positives = 92/165 (55%), Gaps = 9/165 (5%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
S L+CE+ L ++ H I++ + + AE + + +E+ GG++ ++ +G + E
Sbjct: 49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
RK+ +Q+ G+ L+S+ I+HRD+K NIL D +K+ DFG S L G
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +M+PEV+ + Y K D+WS+G + E+L PP++
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
EL S P I++ + AF ++ + I + +E+C GG+L S ++ +V ++ R +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105
Query: 74 QLG-------AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
LG GL L+S IIHRD+KP NIL L +K+ DFG+S L + A
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVSGELV-NSLAG 161
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF--SGRNNVQLI 177
G+ YMAPE +Q + Y D+WS+G L E+ PF G + I
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI 214
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 58/154 (37%), Positives = 89/154 (57%), Gaps = 4/154 (2%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
HP + L+ FQ + +F V+E+ GG+L +I+ + A + ++ GL+ L+
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 142
S I++RDLK +NILL D D +KIADFG+ G+ CG+P Y+APE+L
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Q+Y+ VD WS G +L+E+L G PF G + +L
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-26
Identities = 55/168 (32%), Positives = 95/168 (56%), Gaps = 10/168 (5%)
Query: 10 KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
K+ DC E++ L +NHPN+I+ + +F +N + +V+E G+LS I+ + +
Sbjct: 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
PE+T K+ QL + LE ++S ++HRD+KP N+ ++ ++K+ D GL
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF G
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 55/174 (31%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
E++ L ++ I+RL D E ++LV E+ +L ++ +GR +P
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 122
+T + F+ QL G+ + H ++HRDLKP+N+L+ +LKIAD GL ++
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+Y ++ + Y APEVL Y VD+WSVG I E+ P F G + +Q
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-26
Identities = 82/257 (31%), Positives = 119/257 (46%), Gaps = 39/257 (15%)
Query: 3 KKLNK-HLK-----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
KKLNK LK E L+ V+ I+ L AFQ + + LV+ GG+L +
Sbjct: 24 KKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYH 83
Query: 57 I----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
I + PE A + Q+ +GLE L+ II+RDLKPEN+LL D+D ++I+D
Sbjct: 84 IYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISD 140
Query: 113 FGLSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
GL+ L G K G+P +MAPE+LQ + YD VD +++G L+E++ PF R
Sbjct: 141 LGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200
Query: 172 ----NNVQLIVPALH----------PDCVDMCLKLLSANTVDRLSF-----NEFYHHRFL 212
N +L L+ P C LL+ + RL F + H
Sbjct: 201 GEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
Query: 213 RR------NSAILRAPF 223
R + +L PF
Sbjct: 261 RDLNWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 60/188 (31%), Positives = 87/188 (46%), Gaps = 35/188 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
EL L H NII + D + +++V++ +L I + E+ R F
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
L QL GL+ ++S ++IHRDLKP N+L++ D L+I DFG+ A + S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160
Query: 132 PL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-- 174
P Y APE+L Y +DMWSVG I E+L F G+N V
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220
Query: 175 -QLIVPAL 181
+LI+ L
Sbjct: 221 LKLILSVL 228
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 54/163 (33%), Positives = 89/163 (54%), Gaps = 6/163 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ + + V+E+ GG L ++ E AR + ++
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ L L+S +++RDLK EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-26
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
+ L+CE+ L ++ H I++ + + E + + +E GG++ ++ +G + E
Sbjct: 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
RK+ +Q+ G+ L+S+ I+HRD+K NIL + + +K+ DFG S L G
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV------ 178
+ V G+P +M+PEV+ + Y K D+WSVG + E+L PP++ + I
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 225
Query: 179 --PALHPDCVDMC---LKLLSANTVDRLSFNEFYHHRFL 212
P L P D C LK + R S +E H F+
Sbjct: 226 TNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-26
Identities = 58/170 (34%), Positives = 97/170 (57%), Gaps = 10/170 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
E+ L++ NHP I++L AF + +++++EFC GG + + + L + E + +Q
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
+ L+ L+S IIHRDLK N+LL+ LD D+ K+ADFG+S + + G+P
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
+MAPEV+ + YD K D+WS+G L E+ PP N +++++
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 225
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 71/268 (26%)
Query: 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
H+K+ E + L+ ++ +++L+ +FQ ++ ++ V+++ GG++ S + G E
Sbjct: 47 HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY------- 120
AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT +
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGFRWTHDSK 158
Query: 121 ---PGNY-----------------------------------AEKVCGSPLYMAPEVLQF 142
G++ A + G+P Y+APEVL
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF----SGRNNVQLI-------VPA---LHPDCVDM 188
Y + D WSVG IL+E+L G PPF +++I +P+ L + D+
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL 278
Query: 189 CLKLLSANTVDRLSFN---EFYHHRFLR 213
L+L DRL N E H F +
Sbjct: 279 ILRLC-CGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-26
Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 30/218 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + Q A R+ L
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 131
Q LE L+S+ +IHRD+K +NILL G+D V K+ DFG + P + + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 179
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------- 177
P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 178 --VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
+ A+ D ++ CL + + R S E H+FL+
Sbjct: 240 EKLSAIFRDFLNRCLDM---DVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-26
Identities = 60/171 (35%), Positives = 88/171 (51%), Gaps = 20/171 (11%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
E N L NHPNI + AF +N ++LV+E C GG +L +R G R+
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
E+ L++ GL L+ + +IHRD+K +NILL+ + +K+ DFG+S L
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168
Query: 125 AEKVC-GSPLYMAPEVL----QFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q YD + D+WS+G EL +G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-25
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 5/158 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E+ A +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ I++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
YMAPEV++ +RY D W +G +++E++ G PF R
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 58/164 (35%), Positives = 92/164 (56%), Gaps = 20/164 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
E + ++ N I++L AFQ + +++V+E+ GG+L S+Y +PE+ AR +
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 128
++ L+ ++S IHRD+KP+N+L LD LK+ADFG +C N +
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFG-TCMKMDANGMVRCDTA 203
Query: 129 CGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPF 168
G+P Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-25
Identities = 60/161 (37%), Positives = 88/161 (54%), Gaps = 9/161 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
EL L + H NII L D F I+ V E G +L + + +Q + FL Q
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ GL+ ++S ++HRDLKP NIL+ +++ LKI DFGL+ P + Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYY 171
Query: 135 MAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
APE+ L +Q+YD +VD+WS G I E+L G P F G+++V
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 24/215 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + + +PNI+ D+F + +F+V+E+ AGG+L+ + Q A R+ L
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
Q LE L+++ +IHRD+K +N+LL G+D V K+ DFG + P + G+
Sbjct: 126 Q----ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------VPALH-- 182
P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ + P L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 183 ----PDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
P D + L + R S E H FL+
Sbjct: 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-25
Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 12/176 (6%)
Query: 16 ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
E+ + + HPNI+R + F + +++V++ G L +S R E+
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
Q+ L L+ I+HRDL P NI+L G DD V I DFGL+ P + V
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IVPALH 182
G+ LY PE+++ + Y EK D+W+ G IL+++ PPF N + L IV A++
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-25
Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E+ A +
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ + ++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--------------NVQLIVP 179
YMAPEVL QRY D W +G +++E++ G PF GR ++
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226
Query: 180 ALHPDCVDMCLKLLSANTVDRLSFNE-----------FYHHRFLRRNSAILRAPF 223
+ +C LL+ + RL E F + F R + +L PF
Sbjct: 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-25
Identities = 55/158 (34%), Positives = 82/158 (51%), Gaps = 5/158 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL + P I+ + AF EN I + +EF G+L + G +P + K +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L N H I+HRD+KP NIL++ +K+ DFG+S L + A+ G+ Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
M+PE +Q +Y K D+WS+G + EL G PF+ N
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-25
Identities = 54/160 (33%), Positives = 93/160 (58%), Gaps = 17/160 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E+ + HPNI+ ++ ++ + +++V+EF GG L+ I H R+ E Q A L
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------ 128
L A L L++ +IHRD+K ++ILL+ D +K++DFG C +++V
Sbjct: 125 LKA-LSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSL 175
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ Y +VD+WS+G ++ E+++G PP+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 20/173 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
E+ L + H N++ L + F A+ ++L+ ++ A +L I+ H + +P
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 120
+ L Q+ G+ L+S+ ++HRDLKP NIL+ G + ++KI D GL+ L
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ V + Y APE+L R Y + +D+W++G I ELL P F GR
Sbjct: 171 DLD---PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-25
Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L S+ H NI++ +N I + +EF GG++SS + G +PE K+ +Q+
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 128
G+ L+++ ++HRD+K N++L + ++K+ DFG + N + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---------VP 179
G+P +MAPEV+ Y K D+WS+G +FE+ G PP + + + + +P
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP 228
Query: 180 ALHPD-----CVDMCLKLLSANTVDRLSFNEFYHHRFL 212
L PD +D L+ + +R S + H FL
Sbjct: 229 RL-PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-25
Identities = 51/163 (31%), Positives = 91/163 (55%), Gaps = 9/163 (5%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
L+CE+ L ++ H I++ + + E + + VE+ GG++ ++ +G + E R+
Sbjct: 51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 126
+ +Q+ G+ L+S+ I+HRD+K NIL D +K+ DFG S T+ G +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIK 167
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +M+PEV+ + Y K D+WSV + E+L PP++
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-24
Identities = 56/223 (25%), Positives = 110/223 (49%), Gaps = 27/223 (12%)
Query: 16 ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E+ LS + PNI + + ++ +++++E+ GG++ + ++ G + E+ +
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGS 131
+++ L+ ++ +IHRD+K NIL++ +V L DFG++ L + G+
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFVGT 164
Query: 132 PLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNN---VQLIVPALHP---- 183
P +MAPEV+ + YD K D+WS+G ++E+ G PP+S + + LI + P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED 224
Query: 184 --------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218
+ V CL +RLS E ++++ +S
Sbjct: 225 NGYSKLLREFVAACLD---EEPKERLSAEELLKSKWIKAHSKT 264
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 58/172 (33%), Positives = 95/172 (55%), Gaps = 21/172 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L ++H N+I L D F E+ ++LV G +L++ ++ ++ + +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ Q+ GL+ ++S IIHRDLKP NI +++D LKI DFGL+ +++
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARHT-----DDEMT 173
Query: 130 G---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
G + Y APE+ L + Y++ VD+WSVG I+ ELL G F G +++ QL
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-24
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P I R + ++ +++++E+ GG+ ++ G + E L+++
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
GL+ L+S IHRD+K N+LLS D +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLIVPALHP--------- 183
MAPEV++ YD K D+WS+G EL G PP S + V ++P P
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 184 ---DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
+ V+ C L+ + R + E H+F+ R
Sbjct: 228 PFKEFVEAC---LNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 62/168 (36%), Positives = 92/168 (54%), Gaps = 11/168 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E+ L ++ HPNI+ L + + + IFLV+E+C +L+S + + E + +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 130
QL GL+ L+ + IIHRDLK N+LL+ D LKIADFGL+ T L KV
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 131 SPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
+ Y APE+L Y +DMW+VG IL ELL P G++ ++ +
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 2e-24
Identities = 67/219 (30%), Positives = 113/219 (51%), Gaps = 32/219 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + Q A R+ L
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
Q L+ L+S+ +IHRD+K +NILL G+D V K+ DFG + P + G+
Sbjct: 126 Q----ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------- 177
P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 178 --VPALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 213
+ A+ D ++ CL++ VDR S E H FL+
Sbjct: 239 ERLSAVFRDFLNRCLEM----DVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-24
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQT 67
LK+ E L +HPNI+RL + I++V+E GG+ +++R G R+ +
Sbjct: 36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
+ ++ AG+E L S H IHRDL N L++ + +LKI+DFG+S G YA
Sbjct: 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAST 152
Query: 128 --VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN---------- 173
+ P+ + APE L + RY + D+WS G +L+E + G P++ +N
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212
Query: 174 VQLIVPALHPDCV 186
V+L P L PD V
Sbjct: 213 VRLPCPELCPDAV 225
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-24
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ ++HP I+RL + E + LV+E G L Y++ +P ++ Q+
Sbjct: 46 EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 132
G+ L S H +HRDL N+LL + KI+DFG+S L G+ Y G P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIV----------PA 180
L + APE + + ++ K D+WS G L+E + G P+ ++I P
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE 221
Query: 181 LHPDCV-DMCLKLLSANTVDRLSFNEFYHHRFLRR 214
P + + L DR +F+E RR
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSEL--ESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-24
Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 15/178 (8%)
Query: 16 ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
EL L H NI L+D N ++L E +L IR + + +
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 125
F+ Q+ GL+ ++S +++HRDLKP N+L++ D LKI DFGL+ +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166
Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALH 182
+ + Y APE+ L FQ Y + +D+WSVG IL ELL P F G++ V + L
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-24
Identities = 61/172 (35%), Positives = 92/172 (53%), Gaps = 7/172 (4%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
N+ +K EL L ++ NI+ L +AF+ ++LV E+ L + VP
Sbjct: 40 NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
+ R ++ QL + + + I+HRD+KPEN+L+S D +LK+ DFG + L G
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
NY E V + Y +PE+L Y + VDMWSVG IL EL +G P F G + +
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-24
Identities = 69/275 (25%), Positives = 127/275 (46%), Gaps = 70/275 (25%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
E+ + ++H NI+++++ N +++V E +L++ + G
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ AR F+ QL GL+ ++S +++HRDLKP N+ ++ +D++LKI DFGL+ + P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDP 167
Query: 122 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN-- 173
G +E + + Y +P +L Y + +DMW+ G I E+L G P F+G +
Sbjct: 168 HYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
Query: 174 -VQLIV-------------------------------------PALHPDCVDMCLKLLSA 195
+QLI+ P ++P+ +D ++L+
Sbjct: 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTF 286
Query: 196 NTVDRLSFNEFYHHRFLRRNS-----AILRAPFHI 225
N +DRL+ E H ++ S + PFHI
Sbjct: 287 NPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHI 321
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-24
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 22/216 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ +++++E+ GG+ +R G E L+++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 134
GL+ L+S IHRD+K N+LLS D +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--VPALHP--------- 183
MAPEV+Q YD K D+WS+G EL G PP S + ++++ +P +P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK 227
Query: 184 ---DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ +D C L+ + R + E H+F+ +N+
Sbjct: 228 PFKEFIDAC---LNKDPSFRPTAKELLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-24
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 78/277 (28%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ H+K+ E + L+ ++ ++RL+ +FQ ++ ++ V+++ GG++ S +
Sbjct: 40 LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
G PE AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT +
Sbjct: 96 GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGF 151
Query: 121 ----------------------------PGN---------------------YAEKVCGS 131
P N A + G+
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-----------LIVPA 180
P Y+APEVL Y + D WSVG IL+E+L G PPF + ++ L +P
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP 271
Query: 181 ---LHPDCVDMCLKL-------LSANTVDRLSFNEFY 207
L P+ D+ +KL L N D + + F+
Sbjct: 272 QAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-24
Identities = 55/163 (33%), Positives = 91/163 (55%), Gaps = 6/163 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L AFQ + + V+E+ GG L ++ E+ AR + ++
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ LE L+S +++RD+K EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-24
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 74/274 (27%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
LN++ + + E + L+ ++ +++L+ +FQ ++ ++ V+++ GG++ S + P
Sbjct: 40 LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
E AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CTGFRWTH 155
Query: 119 ---------------LYPGNY----------------------------AEKVCGSPLYM 135
+ P + A + G+P Y+
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-----------LIVPA---L 181
APEVL + Y + D WSVG ILFE+L G PPF + L +P L
Sbjct: 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKL 275
Query: 182 HPDCVDMCLKL-------LSANTVDRLSFNEFYH 208
P+ VD+ KL L N D + + F+
Sbjct: 276 SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-24
Identities = 56/159 (35%), Positives = 93/159 (58%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ N P +++LF AFQ + +++V+E+ GG+L + + + VPE+ A+ + ++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
L+ ++S +IHRD+KP+N+L LD LK+ADFG + + G+P
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
Y++PEVL+ Q Y + D WSVG LFE+L G PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-24
Identities = 68/235 (28%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G EQ A +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+L GLE L I++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR--------------NNVQLIVP 179
YMAPEV+ ++Y D W +G +++E++ G PF R + +
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226
Query: 180 ALHPDCVDMCLKLLSANTVDRLSFNE-----------FYHHRFLRRNSAILRAPF 223
D +C LL+ N +RL F + F R + +L PF
Sbjct: 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-23
Identities = 62/166 (37%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 17 LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
L L + HPN++RLFD E + LV E +L++Y+ VP +T +
Sbjct: 55 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ QL GL+ L+SH ++HRDLKP+NIL++ +K+ADFGL+ +Y A
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169
Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
L Y APEVL Y VD+WSVG I E+ P F G ++V
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-23
Identities = 59/234 (25%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 1 MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
++KKLN + + + E LS + HPNI+ ++++ E+ +++V+ FC GG+L
Sbjct: 29 VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87
Query: 55 SYIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
Y +L + +PE ++ Q+ L+ L+ HI+HRDLK +N+ L+ + ++K+
Sbjct: 88 -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
D G++ L A + G+P YM+PE+ + Y+ K D+W++G ++E+ F+
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
Query: 170 GRNNVQLI-------VPAL----HPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
++ L+ +P + P+ ++ +LS R S ++
Sbjct: 204 AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-23
Identities = 72/220 (32%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H + P Q
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 128
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILL+ + +K+ADFG + P N G+P
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN---SFVGTPY 182
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------PALHP 183
+MAPEV+ +YD KVD+WS+G EL PP N + + P L
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQS 242
Query: 184 D--------CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ VD CL+ + +R + E H F+RR+
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQ---ERPASAELLRHDFVRRD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-23
Identities = 69/254 (27%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL ++ + H NI+ L D + + I LV++ A +L + R+ E + L Q+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 131
GL +L+ + +HRDL P NI + + + KIADFGL+ Y ++
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 132 P-----------LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL-- 176
Y APE+L ++Y VDMWSVG I ELL G P F G N + QL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 177 -----------------------------------IVPALHPDCVDMCLKLLSANTVDRL 201
I P D +D+ LL N ++R+
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 202 SFNEFYHHRFLRRN 215
S E H + + +
Sbjct: 306 SAKEALKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-23
Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E+ LS++ HPNI++ ++F+ +++V+++C GG+L Y +++ + PE +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPEDQILDW 106
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-G 130
Q+ L+ ++ I+HRD+K +NI L+ D +K+ DFG++ L + C G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIG 163
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-----------P 179
+P Y++PE+ + + Y+ K D+W++G +L+E+ F N L++
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSS 223
Query: 180 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
D ++ +L N DR S N F+
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-23
Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 29/170 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
E++ L + HPNI+ L D E+ ++L+ EF + +L Y + + + + +L
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
Q+ G+ +S ++HRDLKP+N+L +D+ ++K+ADFGL+ + G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154
Query: 133 L-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
+ Y APEVL RY VD+WS+G I E+ P F G
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-23
Identities = 73/219 (33%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I+ + E+ +LV+E+C G + S + +H + P Q
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILLS + ++K+ DFG + + P N G+P
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------PALHP 183
+MAPEV+ +YD KVD+WS+G EL PP N + + PAL
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236
Query: 184 --------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
+ VD CL+ + DR + HRF+ R
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQ---DRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-23
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E L +HPNI++L + I++V+E GG+L +++R R+ + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSP 132
AG+E L S + IHRDL N L+ ++ +LKI+DFG+S G Y + + P
Sbjct: 102 AAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ----------LIVPA 180
+ + APE L + RY + D+WS G +L+E + G P+ G +N Q + P
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ 218
Query: 181 LHPDCV-DMCLKLLSANTVDRLSFNEFY 207
L P+ + + L+ + + +R SF+E Y
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-23
Identities = 72/219 (32%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H + P Q
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 132
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILL+ + +K+ADFG + P N G+P
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPY 186
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------PALHP 183
+MAPEV+ +YD KVD+WS+G EL PP N + + P L
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS 246
Query: 184 --------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
+ VD CL+ + DR + E H F+ R
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQ---DRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-23
Identities = 56/159 (35%), Positives = 92/159 (57%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ N P +++LF AFQ + +++V+E+ GG+L + + + VPE+ AR + ++
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
L+ ++S IHRD+KP+N+L LD LK+ADFG + + G+P
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-23
Identities = 60/168 (35%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
EL + VNH NII L + F + ++LV+E NL I++ H R+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ E++ G F G +++
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-23
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ + +++++E+ GG+ + G + E L+++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
GL+ L+S IHRD+K N+LLS + +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLIVPALHP--------- 183
MAPEV++ YD K D+WS+G EL G PP S + V ++P +P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK 227
Query: 184 ---DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ V+ C L+ R + E H+F+ R +
Sbjct: 228 PLKEFVEAC---LNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-23
Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 67/249 (26%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E++ L +NHPNI++L D EN ++LV EF +L ++ +P + +L
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
QL GL +SH ++HRDLKP+N+L ++ + +K+ADFGL+ + G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154
Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSG----------- 170
Y APE+L + Y VD+WS+G I E++ F G
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 214
Query: 171 ----------------------------RNNVQLIVPALHPDCVDMCLKLLSANTVDRLS 202
R + +VP L D D+ ++L + R+S
Sbjct: 215 RTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS 274
Query: 203 FNEFYHHRF 211
H F
Sbjct: 275 AKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-23
Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 77/295 (26%)
Query: 1 MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
M KK H+K+ E + L+ + P ++ L+ +FQ ++L++EF GG+L + +
Sbjct: 39 MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ E R ++ + +E ++ IHRD+KP+NIL +D +K++DFGLS
Sbjct: 95 YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---IDRGGHIKLSDFGLSTGF 151
Query: 120 YP---GNYAEKV---------------------------------------------CGS 131
+ Y +K+ G+
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-----------LIVP- 179
P Y+APE+ Q Y ++ D WS+GAI+FE L G+PPF N+ + L P
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD 271
Query: 180 --ALHPDCVDMCLKLLSA--NTVDRLSFNEFYHHRFLRR-NSAILR---APFHIP 226
L + D+ +L++ N + R +E H F R + +R APF IP
Sbjct: 272 DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPF-IP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 5e-23
Identities = 58/180 (32%), Positives = 102/180 (56%), Gaps = 13/180 (7%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
L + +C E + L + ++ I L AFQ EN ++LV+++ GG+L + + + R+
Sbjct: 40 LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 121
PE AR +L ++ ++ ++ H +HRD+KP+NIL +D + +++ADFG SC +
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 155
Query: 122 GNYAEKVC-GSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
G V G+P Y++PE+LQ +Y + D WS+G ++E+L G PF + V+
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-23
Identities = 59/174 (33%), Positives = 95/174 (54%), Gaps = 5/174 (2%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+K +K E+ L + H N++ L + F+ + ++LV EF L + + E
Sbjct: 40 DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 124
RK+L Q+ G+E +SH+IIHRD+KPENIL+S ++K+ DFG + TL PG
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156
Query: 125 AEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
+ Y APE+L +Y VD+W+VG ++ E+L G P F G +++ +
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 7e-23
Identities = 60/176 (34%), Positives = 89/176 (50%), Gaps = 33/176 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
E+N L + HPNI+ + + N I++V+E+ +L S + + Q+ K L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
QL +G+ L+ + I+HRDLK N+LL+ G+ LKI DFGL+ + G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157
Query: 131 SPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
SPL Y APE+L + Y +DMWSVG I ELL P F G++ +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-23
Identities = 64/194 (32%), Positives = 93/194 (47%), Gaps = 29/194 (14%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
MLK + K D E+ + + H NII L E +++VVE+ A GNL ++
Sbjct: 49 MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107
Query: 58 RLHGRVPEQTARK-----------------FLQQLGAGLEILNSHHIIHRDLKPENILLS 100
R R P + A F Q+ G+E L S IHRDL N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166
Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAI 157
+D VM KIADFGL+ ++ +Y K L +MAPE L + Y + D+WS G +
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 158 LFELLN-GYPPFSG 170
L+E+ G P+ G
Sbjct: 224 LWEIFTLGGSPYPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-23
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 13/190 (6%)
Query: 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
H ++ E + + HPNI+ L D+ +A +F V E+ G L + G +P
Sbjct: 20 HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
+T R LQ L A L ++ I+HRDLKP+NI++S K+ DFG+ TL PG
Sbjct: 80 ETGRLMLQVLDA-LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRD 137
Query: 123 ------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+V G+P Y APE L+ + D+++ G I E L G G + ++
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEI 197
Query: 177 IVPALHPDCV 186
+ L P V
Sbjct: 198 LYQQLSPVDV 207
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-22
Identities = 54/182 (29%), Positives = 91/182 (50%), Gaps = 23/182 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
E +S + HPNI+ L E ++ E+ A G+L ++ + + A
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 71 --------FLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
FL Q+ AG+E L+SHH +HRDL N L+ + + +KI+DFGLS +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174
Query: 120 YPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
Y +Y S L +M PE + + ++ + D+WS G +L+E+ + G P+ G +N +
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
Query: 176 LI 177
+I
Sbjct: 235 VI 236
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-22
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E + LS N P I +L AFQ ++ ++LV+E+ GG+L S + R + E A+ +L +
Sbjct: 51 ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
L + ++ +HRD+KPEN+L +D +K+ADFG + L ++ G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 133 LYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------- 178
Y+APEVL Y + D WS+G I +E++ G PF + +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227
Query: 179 ------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211
P + D +D+ LL +RL + H F
Sbjct: 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-22
Identities = 55/171 (32%), Positives = 91/171 (53%), Gaps = 6/171 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ ++ + V+E+ GG L ++ E R + ++
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ L+ L+S I++RDLK EN++L D D +KI DFGL C + + CG+P
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALHPD 184
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L L D
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-22
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 19/152 (12%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
++PN I+L+ + L++++ G+L ++ G++ E +K ++QL L L+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 136
H+IIH D+K EN+L D + + D+GL K+ G+P Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE ++ YD D W+VG + +ELL G PF
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-22
Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK + ++ L E + ++++ HPN+++L N +++V E+ A G+L Y+R
Sbjct: 36 CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94
Query: 61 GR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--- 115
GR + F + G+E L + +HRDL N+L+S +D++ K++DFGL
Sbjct: 95 GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
S G K + APE L+ +++ K D+WS G +L+E+
Sbjct: 152 ASQGQDSGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-22
Identities = 60/184 (32%), Positives = 101/184 (54%), Gaps = 16/184 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
MLK+ +C E N L + + I L AFQ EN ++LV+++ GG+L + + +
Sbjct: 39 MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 117
R+PE AR ++ ++ + ++ H +HRD+KP+N+L LD + +++ADFG SC
Sbjct: 96 EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151
Query: 118 TLYPGNYAEKVC-GSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
G V G+P Y++PE+LQ +Y + D WS+G ++E+L G PF
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 172 NNVQ 175
+ V+
Sbjct: 212 SLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-22
Identities = 61/165 (36%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L VNH NII L + F + ++LV+E NL I H + +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ EL+ G F G +++
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-22
Identities = 54/165 (32%), Positives = 89/165 (53%), Gaps = 8/165 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + HPN++ L + F+ + + LV E+C L+ + VPE +K + Q
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 133
+ + H+ IHRD+KPENIL++ +K+ DFG + L +Y + V +
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165
Query: 134 YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L +Y VD+W++G + ELL G P + G+++V QL
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-22
Identities = 50/168 (29%), Positives = 90/168 (53%), Gaps = 8/168 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E N + ++ H ++RL+ E I+++ E+ A G+L +++ G+V F
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ N+L+S + +M KIADFGL+ + Y A + P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIV 178
+ + APE + F + K D+WS G +L+E++ G P+ G +N ++
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS 215
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-22
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ + + V+E+ GG L ++ E AR + ++
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 76 GAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 132
+ L+ L+S ++++RDLK EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---------VP-ALH 182
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L P L
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS 220
Query: 183 PDCVDMCLKLLSANTVDRL-----SFNEFYHHRFL 212
P+ + LL + RL E H+F
Sbjct: 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-22
Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 41/176 (23%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
E++ L + H NI+RL D +E ++LV E+ + + + RL
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+ +L Q+ G+ +SH ++HRDLKP+N+L+ + LK+ADFGL+
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA---------- 150
Query: 127 KVCGSPL-----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSG 170
+ G P+ Y APE+L R Y VD+WSVG I E++N P F G
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-22
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
E + + N +++RL +V+E A G+L SY+R R PE
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116
Query: 67 TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
T +KF+Q ++ G+ L + +HRDL N +++ +D+ +KI DFG++ +Y +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI-- 177
Y K L +MAPE L+ + K D+WS G +L+E+ P+ G +N +++
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233
Query: 178 -----VPALHPDCVDMCLKLLSA----NTVDRLSFNEFYH 208
L +C D L+L+ N R +F E
Sbjct: 234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-22
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 18/199 (9%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E R + ++
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNN------------VQLIVP-ALH 182
PEVLQ YD D +S+G +LF+LL G+ PF + + +P +
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 223
Query: 183 PDCVDMCLKLLSANTVDRL 201
P+ + LL + RL
Sbjct: 224 PELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-21
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 16 ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
E+ L + H N++ L + A +LV EFC AG L S + +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 120
E +K ++ L GL ++ + I+HRD+K NIL++ D +LK+ADFGL+
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173
Query: 121 ---PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-Q 175
P Y +V + Y PE+L +R Y +DMW G I+ E+ P G Q
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 176 L---------IVPALHPDCVDMCL 190
L I P + P + L
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLEL 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-21
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 9 LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
L +D E + S++H N+IRL+ + +V E G+L +R G
Sbjct: 36 LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 119
T + Q+ G+ L S IHRDL NILL+ DD V KI DFGL L
Sbjct: 95 LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151
Query: 120 --YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
Y KV P + APE L+ + + D+W G L+E+ G P++G + Q
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208
Query: 176 LI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207
++ A D ++ L+ + N DR +F
Sbjct: 209 ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-21
Identities = 56/172 (32%), Positives = 92/172 (53%), Gaps = 19/172 (11%)
Query: 13 LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
++ E N L S+ NHPN+++ + F +A+ + +LV+E C GG+++ + R
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E L GL+ L+++ IIHRD+K NILL+ + +K+ DFG+S L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181
Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ ++ YD + D+WS+G EL +G PP
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-21
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + L + H NI+ L D + + LV E+ +L Y+ G + R FL Q
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGN-YAEKVCGSP 132
L GL + ++HRDLKP+N+L+S + LK+ADFGL+ P Y+ +V +
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVV-TL 167
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALHPDCVDMCLK 191
Y P+VL Y +DMW VG I +E+ G P F G +V+ D + +
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--------DQLHKIFR 219
Query: 192 LLSANTVDR----LSFNEFYHHRF 211
+L T + S EF + F
Sbjct: 220 VLGTPTEETWPGVSSNPEFKPYSF 243
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 56/167 (33%), Positives = 85/167 (50%), Gaps = 17/167 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L H NII + D + N +++V E +L I+ + +
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 125
FL Q+ GL+ ++S +++HRDLKP N+LL+ D LKI DFGL + G
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167
Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
E V + Y APE+ L + Y + +D+WSVG IL E+L+ P F G+
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-21
Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 9/156 (5%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ + + L++++ GG L +++ R EQ + + ++ LE L+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 143
II+RD+K ENIL LD + + + DFGLS + A CG+ YMAP++++
Sbjct: 125 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 144 R--YDEKVDMWSVGAILFELLNGYPPFS--GRNNVQ 175
+D+ VD WS+G +++ELL G PF+ G N Q
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-21
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
EL+ L P I+ + AF E +++ +E+ G+L +PE R+
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108
Query: 73 QQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
+ GL+ L H+IIHRD+KP N+L++G + +K+ DFG+S L + A+ G
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164
Query: 132 PLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNG---YPPFSGRN---NVQLIV- 178
YMAPE + Q Y + D+WS+G + E+ G YPP + N + IV
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224
Query: 179 -------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
D D K L+ R ++ + H +L
Sbjct: 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-21
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PE K +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
M+PE LQ Y + D+WS+G L E+ G YP
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-21
Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 5/153 (3%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E+ R + ++
Sbjct: 48 LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163
Query: 137 PEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF 168
PEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-21
Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E + ++H +++L+ + I++V E+ + G L +Y+R HG+ + + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L S IHRDL N L +DD +K++DFGLS + Y V GS
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ PEVL + ++ K D+W+ G +++E+ + G P+ NN + +
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-21
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 7 KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
K L+ + L+ + H PN++ L +E+ +FLV++ GG L S+I +P
Sbjct: 24 KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
E+ +++ ++ L+ L+ I+ RDL P NIL LDD +++ F +
Sbjct: 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVEDSCD 140
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
E V +Y APEV E D WS+GAILFELL G
Sbjct: 141 GEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-21
Identities = 57/213 (26%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ +++++ + +++V+EF GG L+ I H R+ E+ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L +L++ +IHRD+K ++ILL+ D +K++DFG + K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG----------RNNVQLIVPALH-- 182
MAPE++ Y +VD+WS+G ++ E+++G PP+ R+N+ + LH
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKV 242
Query: 183 -PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
P +LL + R + E H FL +
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-21
Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 25/188 (13%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + + +LV+ F G
Sbjct: 45 IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L ++ H ++ E + + Q+ GL+ +++ IIHRDLKP N+ +++D LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ ++ G + Y APEV L + Y + VD+WSVG I+ E+L G P
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 167 PFSGRNNV 174
F G +++
Sbjct: 215 LFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-21
Identities = 52/155 (33%), Positives = 85/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E L VN P I+ L AF+++ + LV+ GG+L +I G + R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ L+S I++RD+KPEN+LL DD +++D GL+ L G + G+
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPE+L+ + Y VD +++G ++E++ G PF
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-21
Identities = 54/150 (36%), Positives = 88/150 (58%), Gaps = 13/150 (8%)
Query: 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHH 86
I L AFQ EN ++LV+++ GG+L + + + R+PE AR +L ++ ++ ++
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQFQ 143
+HRD+KP+N+L LD + +++ADFG SC L G V G+P Y++PE+LQ
Sbjct: 123 YVHRDIKPDNVL---LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 144 -----RYDEKVDMWSVGAILFELLNGYPPF 168
RY + D WS+G ++E+L G PF
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-20
Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 24 NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
+HPN+++L F+A + +++ F G+L S++ RL G ++P QT KF
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
+ + G+E L++ + IHRDL N + L +D+ + +ADFGLS +Y G+Y + +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM---LREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPALH----- 182
+ ++A E L + Y K D+W+ G ++E+ G P+ G N ++ H
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235
Query: 183 --PDCVDMCLKLLS----ANTVDRLSFNE 205
DC+D L+ A+ DR +F +
Sbjct: 236 QPEDCLDELYDLMYSCWRADPKDRPTFTK 264
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-20
Identities = 48/181 (26%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------- 61
E L++ H NI++ + + +V E+ G+L+ ++R HG
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ + Q+ +G+ L S H +HRDL N L+ D+++KI DFG+S +Y
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174
Query: 122 GNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
+Y +V G + +M PE + ++++ + D+WS G +L+E+ G P+ G +N ++
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 177 I 177
I
Sbjct: 234 I 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PEQ K +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
M+PE LQ Y + D+WS+G L E+ G P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-20
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H NI+ F ++ + +++ +EFC GG+L + G + E ++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
GL L+S +HRD+K NILL+ D+ +K+ADFG+S + K G+P +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172
Query: 135 MAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 167
MAPEV +R Y++ D+W+VG EL PP
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-20
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R V
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ + +E L + IHRDL N L+ ++ ++K+ADFGLS + Y A P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI-----------VP 179
+ + APE L + ++ K D+W+ G +L+E+ G P+ G + Q+
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE 228
Query: 180 ALHPDCVDMCLKLLSANTVDRLSFNEFYH 208
P ++ N DR SF E +
Sbjct: 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-20
Identities = 61/186 (32%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL + VNH NII L + F + +++V+E NL I++ + +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV---QLIVPALHPDCV 186
+ Y APEV+ Y E VD+WSVG I+ E++ G F G +++ ++ L C
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 187 DMCLKL 192
+ KL
Sbjct: 247 EFMKKL 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-20
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
LK + + E+ L + H ++I LF ++++ E G+L +++R
Sbjct: 38 LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97
Query: 61 GRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
G+V P + Q+ G+ L + IHRDL NIL+ +D++ K+ADFGL+ +
Sbjct: 98 GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154
Query: 120 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN---V 174
Y P + APE + K D+WS G +L+E+ G P+ G NN
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 175 QLIV-------PALHPDCV-DMCLKLLSANTVDRLSF 203
I PA P + + L+ +A DR SF
Sbjct: 215 DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-20
Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + L + H NI+ L D + + V E+ +L+ Y+ H G + R F+ Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
L GL ++ HI+HRDLKP+N+L+S L + LK+ADFGL + ++ Y+ +V +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVV-TL 167
Query: 133 LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
Y P+VL Y +D+W G I E+L G P F G ++V
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-20
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L + P II + AF EN I + EF GG+L Y ++PE + +
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GL L S I+HRD+KP N+L++ +K+ DFG+S L + A+ G+ YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNG---YPPFSGRNN----VQLIVPALHPDCVDM 188
APE + ++Y D+WS+G EL G YP +QL+ + D +
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220
Query: 189 CLKLLSANTVD------------RLSFNEFYHHRFLRR 214
+ S V R + H F+ +
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-20
Identities = 51/173 (29%), Positives = 93/173 (53%), Gaps = 19/173 (10%)
Query: 13 LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
++ E N L ++ +HPN+++ + + ++ ++LV+E C GG+++ +++ R
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E L + GL+ L+ + IHRD+K NILL+ + +K+ DFG+S L
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177
Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ ++ YD + D+WS+G EL +G PP +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-20
Identities = 55/183 (30%), Positives = 93/183 (50%), Gaps = 31/183 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
E N L VNHP++I+L+ A + + L+VE+ G+L S++R +V
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 64 ------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
P++ A F Q+ G++ L ++HRDL N+L++ + +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169
Query: 112 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
DFGLS +Y + Y ++ G P+ +MA E L Y + D+WS G +L+E++ G P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 168 FSG 170
+ G
Sbjct: 230 YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-20
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 17/179 (9%)
Query: 16 ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
E +FL S NH NI+RL F+++E AGG+L S++R + PE+ +
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 70 KFLQQL-------GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
++ L G + L +H IHRD+ N LL+ + KIADFG++ +Y
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+Y K + L +M PE + K D+WS G +L+E+ + GY P+ GR N +++
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-20
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P I++ + F ++ +F+ +E + R+ G +PE K + L L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 86 H-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL---- 140
H +IHRD+KP NIL LD +K+ DFG+S L + G YMAPE +
Sbjct: 134 HGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN--------VQLIVPALHP--------- 183
+YD + D+WS+G L EL G P+ +Q P+L P
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250
Query: 184 DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
VD+C L+ + R + E H F+RR
Sbjct: 251 SFVDLC---LTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-20
Identities = 46/154 (29%), Positives = 89/154 (57%), Gaps = 5/154 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + +H N++ +++++ + +++V+EF GG L+ I H R+ E+ +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L L++ +IHRD+K ++ILL+ D +K++DFG + K + G+P +
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
MAPEV+ Y +VD+WS+G ++ E+++G PP+
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 7e-20
Identities = 60/162 (37%), Positives = 85/162 (52%), Gaps = 13/162 (8%)
Query: 17 LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
L L + +HPNI+RL D E + LV E +L +Y+ +P +T +
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
++Q GL+ L+++ I+HRDLKPENIL++ +K+ADFGL+ +Y A V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
+ Y APEVL Y VDMWSVG I E+ P F G
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-20
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 20 LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
+ +HPN++RL Q E+ + +++ F G+L S++ L+ R+ P Q
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
KF+ + +G+E L+S IHRDL N + L++++ + +ADFGLS +Y G+Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDYYR 169
Query: 127 --KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPALH 182
++ P+ ++A E L + Y K D+WS G ++E+ G P+ G N + I L
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLR 228
Query: 183 --------PDCVDMCLKLLSA----NTVDRLSFNEFY 207
PDC+D L+S+ N DR SF
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR 265
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E L +VNHP++IR+ D A C+ L +L +Y+ + +P A
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 130
+Q+ GL L++ IIHRD+K ENI + +D + I D G + + P + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
+ APEVL +Y+ K D+WS G +LFE+L YP
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYP 253
|
Length = 357 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-19
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 20/193 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ E + L++++ +GG + +++ E R + ++ LE L+
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 143
I++RD+K ENIL LD + + + DFGLS CG+ YMAPE+++ +
Sbjct: 125 GIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 144 R-YDEKVDMWSVGAILFELLNGYPPFS--GRNNVQLIV------------PALHPDCVDM 188
+ + VD WS+G ++FELL G PF+ G N Q V + P+ D+
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241
Query: 189 CLKLLSANTVDRL 201
KLL + RL
Sbjct: 242 LHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-19
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 7/175 (4%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV 63
L + LK E L +HPNI++L I++V+E GG+ S++R +
Sbjct: 31 LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDEL 90
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ KF AG+ L S + IHRDL N L+ ++ +LKI+DFG+S G
Sbjct: 91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGI 147
Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
Y+ P+ + APE L + RY + D+WS G +L+E + G P+ G N Q
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ R+PE+ K +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
M+PE LQ Y + D+WS+G L EL G YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R ++PE+ T +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +L+E+ G P+ G
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-19
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R RVP++ T +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +++VM KIADFGL+ + +Y +K
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-19
Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HPN+++L+ + IF+V E+ A G L +Y+R G++ +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
+ +E L S+ IHRDL N L+ +D ++K++DFGL+ + Y G+ P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + PEV + R+ K D+WS G +++E+ + G P+ +N +++
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-19
Identities = 59/188 (31%), Positives = 101/188 (53%), Gaps = 25/188 (13%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F N ++LV G
Sbjct: 47 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ +++D LKI
Sbjct: 106 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 161
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ + +++ G + Y APE+ L + Y++ VD+WSVG I+ ELL G
Sbjct: 162 LDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
Query: 167 PFSGRNNV 174
F G +++
Sbjct: 217 LFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-19
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R +VPE+ + +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +L+E+ G P+ G
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-19
Identities = 50/177 (28%), Positives = 94/177 (53%), Gaps = 23/177 (12%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
S + HPNI+ L E + ++ +C+ +L ++ + H V ++T + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 74 ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
Q+ AG+E L+SHH++H+DL N+L+ D + +KI+D GL +Y +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + S L +M+PE + + ++ D+WS G +L+E+ + G P+ G +N +I
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-19
Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR-VPEQTARKFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ G+ +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ L S + IHRDL NIL+ ++++ KIADFGL+ + Y + G+
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDEYTARE-GAKF 166
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI----------VP 179
+ APE + R+ K D+WS G +L E++ G P+ G N +++ P
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP 226
Query: 180 ALHPDCV-DMCLKLLSANTVDRLSFNEFYHHRF 211
P+ + D+ L+ + +R +F E+
Sbjct: 227 PNCPEELYDLMLQCWDKDPEERPTF-EYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-19
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 20/212 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ ++ ++ +++++EF GG L+ + R+ E+ + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESV 126
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
L L+S +IHRD+K ++ILL+ LD V K++DFG C + ++ + G+P
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTPY 182
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------PALH---- 182
+MAPEV+ Y +VD+WS+G ++ E+++G PP+ + VQ + P L
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK 242
Query: 183 --PDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
P D ++L+ +R + E H FL
Sbjct: 243 ISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-19
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 41/201 (20%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
L K + + E + L + ++++F +FQ + ++L++EF GG++ + + +
Sbjct: 40 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
E+ + ++ + ++ ++ IHRD+KP+N+L LD +K++DFGL CT
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGL-CTGLKKAH 155
Query: 119 ---LY-------PGNY---------------------AEKVCGSPLYMAPEVLQFQRYDE 147
Y P ++ A G+P Y+APEV Y++
Sbjct: 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215
Query: 148 KVDMWSVGAILFELLNGYPPF 168
D WS+G I++E+L GYPPF
Sbjct: 216 LCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-19
Identities = 58/165 (35%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL + VNH NII L + F + ++LV+E NL I++ + +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ E++ F GR+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-19
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 14/162 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
E+ S + H NI++ + + +E GG+LS+ +R + EQT +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
+Q+ GL+ L+ + I+HRD+K +N+L+ SG+ +KI+DFG S L N E
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169
Query: 129 CGSPLYMAPEVL-QFQR-YDEKVDMWSVGAILFELLNGYPPF 168
G+ YMAPEV+ + R Y D+WS+G + E+ G PPF
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-19
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 13/175 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + +S+ NHPNI++L ++++E GG+L SY+R L++L
Sbjct: 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 76 GA-------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 126
G L H IHRDL N L+S G D D ++KI DFGL+ +Y +Y
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
K L +MAPE L ++ + D+WS G +++E+L G P+ NN +++
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-19
Identities = 58/166 (34%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-QTARKFL 72
H NII L E ++++VE+ A GNL ++R +VPE Q + K L
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 73 ----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDIDYYKKT 193
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-19
Identities = 47/167 (28%), Positives = 88/167 (52%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HP +++L+ + I LV EF G LS Y+R G+ ++T
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L S ++IHRDL N L+ ++ ++K++DFG++ + Y G+
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ +PEV F +Y K D+WS G +++E+ + G P+ R+N +++
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-19
Identities = 50/157 (31%), Positives = 88/157 (56%), Gaps = 11/157 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E ++ ++H N++RL N +++V+E + GNL +++R GR V +F
Sbjct: 49 ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ G+E L S ++HRDL NIL+S +D + K++DFGL+ G K+ P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APE L+ +++ K D+WS G +L+E+ + G P+
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-19
Identities = 55/159 (34%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E++ L ++ H NI+ L D E C+ LV E+ +L Y+ G + + F+ Q
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
L GL + I+HRDLKP+N+L+ ++ LK+ADFGL+ ++ Y+ +V +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
Y P+VL Y +DMW VG IL+E+ G P F G
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-18
Identities = 59/188 (31%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F N ++LV G
Sbjct: 45 VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ ++ + + QL GL+ ++S IIHRDLKP N+ +++D L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ +++ G + Y APE+ L + Y++ VD+WSVG I+ ELL G
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
Query: 167 PFSGRNNV 174
F G + +
Sbjct: 215 LFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-18
Identities = 47/172 (27%), Positives = 91/172 (52%), Gaps = 14/172 (8%)
Query: 17 LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
L+FL+ +HPNIIRL + ++ E+ G+L ++R + G+
Sbjct: 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 127
L+ + +G++ L+ + +HRDL NIL++ +++ K++DFGLS L Y K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 128 VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
P+ + APE + ++++ D+WS G +++E+++ G P+ +N +I
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-18
Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 41/244 (16%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+ + + E+ LS ++ PNI RL + + +++E+ G+L+ +++ H
Sbjct: 59 SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 66 QTARKFLQ-----------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
A Q+ +G+ L S + +HRDL N L+ +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175
Query: 115 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN--GYPPF 168
+S LY +Y +V G +MA E + ++ K D+W+ G L+E+L P+
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 169 SGRNNVQLIVPALH------------------PDCVDMCLKLLSANTVDRLSFNEFYHHR 210
+ Q+I A H D ++ L+ + DR +F E H
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HL 292
Query: 211 FLRR 214
FL+R
Sbjct: 293 FLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-18
Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 7/163 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + L + H NI+ L D + + LV E+ +L Y+ H G + + + FL Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 133
L GL ++ +I+HRDLKP+N+L+S D LK+ADFGL+ P + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLW 168
Query: 134 YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
Y P+V L Y +DMW VG I E++ G F G ++Q
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 24/183 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
E + ++ ++HPNI+ L E + ++ E+ G+L ++ + H V + T
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 68 ARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ L Q+ AG+E L+SH +H+DL NIL+ + + +KI+D GLS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+Y +Y S L +M PE + + ++ D+WS G +L+E+ + G P+ G +N
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
Query: 175 QLI 177
++I
Sbjct: 234 EVI 236
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 39/177 (22%)
Query: 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
++++F +FQ + ++L++EF GG++ + + + E+ + ++ + ++ ++
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--------------------- 126
IHRD+KP+N+L LD +K++DFGL L + E
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 127 ---------------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+P Y+APEV Y++ D WS+G I++E+L GYPPF
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-18
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 11/167 (6%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
++SV+HP+++RL + + L+ + G L Y+R H + Q + Q+ G
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 135
+ L ++HRDL N+L+ +KI DFGL+ L G P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPAL 181
A E + + Y K D+WS G ++EL+ G P+ G V+ +P L
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDL 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 39/112 (34%), Positives = 72/112 (64%), Gaps = 3/112 (2%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
+NK++ + E + L+ P I+ L+ + Q+ N ++LV+E+ GG++ S + ++G
Sbjct: 43 INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
E+ A K++ ++ L+ L+ H IIHRDLKP+N+L+S ++ +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-18
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 35/191 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
E ++ +HPNI++L + L+ E+ A G+L+ ++R R P
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115
Query: 68 -ARKFLQ---------------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
ARK Q+ AG+ L+ +HRDL N L+ ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172
Query: 112 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
DFGLS +Y +Y K + +M PE + + RY + D+W+ G +L+E+ + G
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231
Query: 167 PFSGRNNVQLI 177
P+ G + ++I
Sbjct: 232 PYYGMAHEEVI 242
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-18
Identities = 47/180 (26%), Positives = 94/180 (52%), Gaps = 22/180 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
E L+++ H +I++ + + + +V E+ G+L+ ++R HG
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ + QQ+ AG+ L S H +HRDL N L+ +++++KI DFG+S +Y
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173
Query: 123 NYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+Y +V G + +M PE + ++++ + D+WS+G +L+E+ G P+ +N ++I
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-18
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
E+N L +H NI + AF +N ++LV+EFC G+++ I+ + E+
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
+++ GL L+ H +IHRD+K +N+LL+ ++ +K+ DFG+S L
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ YD K D+WS+G E+ G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 31/188 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
E+ L + HPN++ L D + + +V +LS L ++ E
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
+ ++ QL G+ L+ +HI+HRD+K NIL +D+ +LKIADFGL+
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGLARPYDGPPPN 171
Query: 126 EKVCGSPL------------YMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSG-- 170
K G Y PE +L +RY VD+W +G + E+ P G
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 171 -RNNVQLI 177
+ + LI
Sbjct: 232 DIDQLHLI 239
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-18
Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 14/170 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
E + + HP +I+L+ E I++V E G+L Y++ ++P+
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DM 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
Q+ +G+ L + + IHRDL N+L+ ++ + K+ADFGL+ + Y + G+
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE-GA 164
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE + R+ K D+WS G +L E++ G P+ G N +++
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 60/176 (34%), Positives = 93/176 (52%), Gaps = 16/176 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
EL + ++NH NII L D + + E IFL V+EF + Y++ + R +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
P + + QL L ++S I HRDLKP+N+L+ + LK+ DFG + L G
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225
Query: 124 YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
+ S Y APE+ L Y +D+WS+G I+ E++ GYP FSG+++V +V
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 64/180 (35%), Positives = 95/180 (52%), Gaps = 32/180 (17%)
Query: 13 LDCELN--FLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQT 67
+ C LN F S V H + + D EN I LV+++ G+L I+ + T
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKK-DPRNPENVLMIALVLDYANAGDLRQEIKSRAK----T 136
Query: 68 ARKFLQQLGAGL---EIL------NSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 116
R F + AGL ++L +S H+IHRD+K NILL +GL +K+ DFG S
Sbjct: 137 NRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-----VKLGDFGFS 190
Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+Y ++ V CG+P Y+APE+ + + Y +K DM+S+G +L+ELL PF G N
Sbjct: 191 -KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-18
Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E N + ++ H +++L A + I+++ EF A G+L +++ + P F
Sbjct: 51 EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ NIL+S ++ KIADFGL+ + Y A + P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE + F + K D+WS G +L E++ G P+ G +N ++I
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-18
Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 29/183 (15%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
EL L + +HPNII L A + +++ +E+ GNL ++R HG
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111
Query: 62 RVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
T+++ LQ + G++ L+ IHRDL N+L+ +++ KIADFGLS
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166
Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
G Y +K G P+ +MA E L + Y K D+WS G +L+E+++ G P+ G
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224
Query: 174 VQL 176
+L
Sbjct: 225 AEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-18
Identities = 59/189 (31%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
LKK+ ++ + C EL L H N++ D Q + I++V E
Sbjct: 30 LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L I + + FL Q+ GL+ L+S I+HRD+KP N+L ++ + +LKI
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145
Query: 112 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ P E V + Y APE+L + Y VD+WSVG I ELL
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
Query: 167 PFSGRNNVQ 175
F ++ +Q
Sbjct: 204 LFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-17
Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
E + ++HP +++L+ + +++V EF G L +Y+R G++ + Q
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+E L + IHRDL N L+S ++K++DFG++ + Y G+
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ PEV F +Y K D+WS G +++E+ G PF ++N +++
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-17
Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 23/168 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L + H N+I L D F + +LV+ + +L + + E +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQ 120
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KV 128
+ Q+ GL+ ++S IIHRDLKP N+ +++D LKI DFGL+ +A+ ++
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEM 171
Query: 129 CG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
G + Y APEV L + Y++ VD+WSVG I+ E+L G F G++
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 63/185 (34%), Positives = 95/185 (51%), Gaps = 15/185 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L ++H N+I + D +A N +++V E +L IR + + +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVC 129
FL QL GL+ ++S +++HRDLKP N+LL+ D LKI DFGL+ T G++ +
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYV 169
Query: 130 GSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ---LIVPAL-HPD 184
+ Y APE+ L Y +D+WSVG I ELL P F G++ V LI L P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229
Query: 185 CVDMC 189
D+
Sbjct: 230 EEDLG 234
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 50/168 (29%), Positives = 89/168 (52%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
E+N L +H NI + AF ++ ++LV+EFC G+++ ++ G ++
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 68 ARKFL-QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
++ +++ GL L++H +IHRD+K +N+LL+ ++ +K+ DFG+S L
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 178
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ YD + D+WS+G E+ G PP
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-17
Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+ LK L E N + +++P I+R+ +AE+ + LV+E G L+ +++ + V E
Sbjct: 36 DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 123
+ + + Q+ G++ L + +HRDL N+LL KI+DFGLS L
Sbjct: 95 KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151
Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
Y K G P+ + APE + + ++ K D+WS G +++E + G P+ G
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-17
Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
E N + + HP ++RL+ A + I+++ E+ G+L +++ ++
Sbjct: 51 EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ NIL+S + + KIADFGL+ + Y A + P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE + + + K D+WS G +L E++ G P+ G N ++I
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-17
Identities = 51/178 (28%), Positives = 92/178 (51%), Gaps = 21/178 (11%)
Query: 16 ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
E + +HPN+I+L A +++ F G+L +++ L R
Sbjct: 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+P QT +F+ + +G+E L+S + IHRDL N + L++++ + +ADFGLS +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM---LNENMTVCVADFGLSKKIYSG 166
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
+Y + C S L ++A E L Y D+W+ G ++E++ G P++G N ++
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-17
Identities = 53/179 (29%), Positives = 74/179 (41%), Gaps = 23/179 (12%)
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
Y L +PE+ K L L IIHRD+KP NIL LD + +K+ DFG
Sbjct: 97 YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKLCDFG 153
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
+S L + G YMAPE + YD + D+WS+G L+E+ G P+
Sbjct: 154 ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213
Query: 172 NNV--QL--IV----PALHPD---CVDMCLK-----LLSANTVDRLSFNEFYHHRFLRR 214
N+V QL +V P L L + R + E H F++
Sbjct: 214 NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 11/163 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E++ L +++H II L A++ ++ C+ + C +L +Y+ G +P + A +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+L L L+ IIHRD+K ENI L ++ V+ DFG +C L + G
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKLDAHPDTPQCYGWSG 249
Query: 134 YM---APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ +PE+L Y K D+WS G +LFE+ G+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-17
Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 7/161 (4%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
S + E+ + H NI+ F ++ + +++ +E+C GG+L + G + E
Sbjct: 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
++ GL L+S +HRD+K NILL+ D+ +K+ADFG++ + K
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFI 167
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 167
G+P +MAPEV ++ Y++ D+W+VG EL PP
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-17
Identities = 52/183 (28%), Positives = 96/183 (52%), Gaps = 16/183 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++ + H N+++L E +++V E+ A G+L Y+R GR + KF
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L +++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPALHP----DCV 186
+ + APE L+ +++ K D+WS G +L+E+ + G P+ R ++ +VP + D
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAP 221
Query: 187 DMC 189
D C
Sbjct: 222 DGC 224
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-17
Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E++ L + H NI+ L D E + LV E+ +L Y+ G + + FL Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
L GL + ++HRDLKP+N+L+ ++ LK+ADFGL+ ++ Y+ +V +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVV-TL 168
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
Y P++L Y ++DMW VG I +E+ G P F G
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-17
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
E+ L +++H NI++ + L++E+ G+L Y++ H ++ + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVC 129
Q+ G++ L S IHRDL NIL ++ + ++KI+DFGL+ L Y ++
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP+ + APE L+ ++ D+WS G L+EL
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-17
Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 19/189 (10%)
Query: 4 KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
K+ +K+C FL +HP+I++L EN +++V+E G
Sbjct: 34 KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92
Query: 53 LSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
L SY++++ + + + QL L L S +HRD+ N+L+S D +K+
Sbjct: 93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149
Query: 112 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
DFGLS L Y P+ +MAPE + F+R+ D+W G ++E+L G PF
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
Query: 169 SGRNNVQLI 177
G N +I
Sbjct: 210 QGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-17
Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 24/196 (12%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
LK+ ++ + E L+ + H +I+R + + +V E+ G+L+ ++R HG
Sbjct: 43 LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102
Query: 62 ---RVPEQ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
++ T + L Q+ +G+ L S H +HRDL N L+ +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
++KI DFG+S +Y +Y +V G + +M PE + ++++ + D+WS G +L+E+
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
Query: 163 N-GYPPFSGRNNVQLI 177
G P+ +N + I
Sbjct: 219 TYGKQPWYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-17
Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L VNHPN+++ D F I +++EF GG+L + AR+ L
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--- 178
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGS 131
+G+ L+ HI+HRD+KP N+L ++ +KIADFG L+ T+ P N + G+
Sbjct: 179 -SGIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231
Query: 132 PLYMAPEV----LQFQRYDEKV-DMWSVGAILFELLNGYPPF 168
YM+PE L YD D+WS+G + E G PF
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-17
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E++ L + H NI+ L D + + LV E+ +L Y+ G + + FL Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
+ GL + ++HRDLKP+N+L++ + LK+ADFGL+ ++ Y+ +V +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVV-TL 168
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
Y P+VL Y ++DMW VG I FE+ +G P F G
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-17
Identities = 45/169 (26%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + + +HPNII L + +V E+ G+L +++R H G+ L+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 130
+ +G++ L+ +HRDL NIL+ + +++ K++DFGLS L Y +
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
P+ + APE + ++++ D+WS G +++E+++ G P+ +N +I
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-17
Identities = 49/180 (27%), Positives = 94/180 (52%), Gaps = 18/180 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +HPNII L + ++ EF G L S++R + G+ L+
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 126
+ AG++ L+ + +HRDL NIL ++ +++ K++DFGLS L Y +
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 127 KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPALHPD 184
K+ P+ + APE + ++++ D+WS G +++E+++ G P+ +N Q ++ A+ D
Sbjct: 172 KI---PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQD 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-16
Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 10/153 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E+N L ++ H NI++ + Q + L++E+ G+L Y+ H Q F Q
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 130
Q+ G+ L+S H IHRDL N+L LD+D ++KI DFGL+ + G+ +V
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 131 SPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP++ A E L+ ++ D+WS G L+ELL
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 23/174 (13%)
Query: 16 ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L + HP+I I L + + I++V E +L I+ + + + +
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--------CTLYPG 122
FL QL L+ +++ ++ HRDLKP+NIL + D LKI DFGL+ ++
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 123 NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+Y + Y APE+ F +Y +D+WS+G I E+L G P F G+N V
Sbjct: 165 DYV----ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-16
Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 29/183 (15%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
EL L + +HPNII L A + ++L +E+ GNL ++R +
Sbjct: 45 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104
Query: 62 RVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+++ F + G++ L+ IHRDL NIL+ ++ + KIADFGLS
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159
Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
G Y +K G P+ +MA E L + Y D+WS G +L+E+++ G P+ G
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217
Query: 174 VQL 176
+L
Sbjct: 218 AEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-16
Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 9/156 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
+ S++H I+RL + + LV + G+L ++R H + Q + Q+ G
Sbjct: 63 MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 135
+ L H ++HR+L NILL D +++IADFG++ LYP + Y +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
A E + F RY + D+WS G ++E+++ G P++G
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-16
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
E+ +S + +PNIIRL +++ + ++ E+ G+L+ ++ +P
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 67 TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ L Q+ +G++ L S + +HRDL N L + + +KIADFG+S LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183
Query: 124 YAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSGRNNVQLI 177
Y ++ G + +MA E + ++ D+W+ G L+E+ L P+S ++ Q+I
Sbjct: 184 YY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242
Query: 178 -----------------VPALHPDCV-DMCLKLLSANTVDRLSFNEFYHHRFLR 213
L P V + ++ S + DR +FN+ +H FLR
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH--FLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-16
Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 31/233 (13%)
Query: 1 MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
++K L K +L+S EL+ ++H N++RL + ++++E+ G+L +
Sbjct: 39 LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98
Query: 57 IRLHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
+R E+ L Q+ G++ L++ +HRDL N L+S
Sbjct: 99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155
Query: 108 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164
+K++ LS +Y Y + + PL ++APE +Q + K D+WS G +++E+ G
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 165 YPPFSGRNNVQLIVPA--------LHPDCVDMCLKLL----SANTVDRLSFNE 205
PF G ++ +++ + C KL+ + N DR SF+E
Sbjct: 216 ELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE 268
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-16
Identities = 48/183 (26%), Positives = 92/183 (50%), Gaps = 25/183 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
E L+++ H +I++ + + + +V E+ G+L+ ++R HG P Q
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 68 ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ Q+ +G+ L S H +HRDL N L+ ++++KI DFG+S +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
Y +Y +V G + +M PE + ++++ + D+WS G IL+E+ G P+ +N
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 175 QLI 177
++I
Sbjct: 233 EVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-16
Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E + +++P I+R+ +AE + LV+E +GG L+ + L G+ + + +
Sbjct: 45 EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 130
Q+ G++ L + +HRDL N+LL + KI+DFGLS L + Y + G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158
Query: 131 S-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
PL + APE + F+++ + D+WS G ++E + G P+
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-15
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 1 MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
MLK + + L EL +S + NH NI+ L A I ++ E+C G+L +++R
Sbjct: 72 MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131
Query: 59 LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
+ FL Q+ G+ L S + IHRDL N+LL+ ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181
Query: 110 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--- 161
I DFGL+ + NY K G+ P+ +MAPE + Y + D+WS G +L+E+
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 162 -LNGYP 166
N YP
Sbjct: 240 GSNPYP 245
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-15
Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
E + + H +++L+ A +E I++V E+ + G+L +++ GR +P
Sbjct: 51 EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ AG+ + + IHRDL+ NIL+ D ++ KIADFGL+ + Y A +
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
P+ + APE + R+ K D+WS G +L EL+ G P+ G NN +++
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-15
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 15/160 (9%)
Query: 20 LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---FLQQL 75
+ +HPN++ L +E +V+ + G+L ++IR P T + F Q+
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQV 107
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL 133
G+E L S +HRDL N +L D+ +K+ADFGL+ +Y Y G+ L
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
+MA E LQ Q++ K D+WS G +L+EL+ G PP+
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-15
Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E+ + HPNI+ +F ++ +++V A G+ ++ H PE L+
Sbjct: 49 EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 132
+ L+ ++S IHR +K +ILLSG D V+L + S ++ G V P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165
Query: 133 LY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
++PEVLQ Q Y+EK D++SVG EL NG+ PF
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-15
Identities = 46/169 (27%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E + + H +++L+ A +E I++V E+ + G+L +++ + R+P+
Sbjct: 51 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y A +
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL-LNGYPPFSGRNNVQLI 177
P+ + APE + R+ K D+WS G +L EL G P+ G N +++
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-15
Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 30/174 (17%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------QT 67
HPNII L A + ++L +E+ GNL ++R RV E Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 125
F + G++ L+ IHRDL NIL+ ++ + KIADFGLS G Y
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178
Query: 126 EKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
+K G P+ +MA E L + Y D+WS G +L+E+++ G P+ G +L
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-15
Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E + + H ++ L+ A +E I++V EF G+L +++ + ++P+
Sbjct: 51 EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ G+ + + IHRDL+ NIL+ D+++ KIADFGL+ + Y A +
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
P+ + APE + R+ K D+WS G +L EL+ G P+ G N +++
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-15
Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
E+ L + HPN+I L F ++ ++L+ ++ A +L I+ H ++P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
+ L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G + L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
P + V + Y APE+L R Y + +D+W++G I ELL P F R
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
Query: 179 PALHPDCVDMCLKLL 193
H D +D ++
Sbjct: 227 NPFHHDQLDRIFSVM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-15
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
E+ L + HPN+I L F A+ ++L+ ++ A +L I+ H ++P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
+ L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G + L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
P + V + Y APE+L R Y + +D+W++G I ELL P F R
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
Query: 179 PALHPDCVDMCLKLL 193
H D +D ++
Sbjct: 227 NPYHHDQLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-14
Identities = 46/171 (26%), Positives = 84/171 (49%), Gaps = 19/171 (11%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-----LGA 77
+NHPN+++ LV+EFC G+L +Y+R + + Q A+K + Q + +
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 134
GL L+ IH DL N L+ D+ +KI D+GL+ YP +Y + +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 135 MAPEVLQFQRYDEKV-------DMWSVGAILFELL-NGYPPFSGRNNVQLI 177
+APE+++ + D ++WS+G ++EL P+ ++ Q++
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-14
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 26/200 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
E + + N +++RL +++E G+L SY+R R + +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117
Query: 68 ARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
+K +Q G G+ LN++ +HRDL N +++ +D +KI DFG++ +Y +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPA 180
K L +M+PE L+ + D+WS G +L+E+ P+ G +N Q++
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 181 LH------PD-CVDMCLKLL 193
+ PD C DM +L+
Sbjct: 235 MEGGLLDKPDNCPDMLFELM 254
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 41/238 (17%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
NK+ ++ E+ +S + PNIIRL + + ++ E+ G+L+ ++ H E
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117
Query: 66 Q------------TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
T Q+ +G++ L+S + +HRDL N L+ + +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174
Query: 114 GLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN--GYPP 167
G+S LY G+Y ++ G + +M+ E + ++ D+W+ G L+E+L P
Sbjct: 175 GMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233
Query: 168 FSGRNNVQLI-----------------VPALHPDCV-DMCLKLLSANTVDRLSFNEFY 207
+S ++ Q+I PAL PD + + L N +R SF E +
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-14
Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 21/168 (12%)
Query: 62 RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE K + LE L+S +IHRD+KP N+L ++ + +K+ DFG+S L
Sbjct: 99 TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLV 155
Query: 121 PGNYAEKVCGSPLYMAPE----VLQFQRYDEKVDMWSVGAILFELLNG-YP------PFS 169
G YMAPE L + YD K D+WS+G + EL G +P PF
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
Query: 170 G-RNNVQLIVPAL-----HPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211
+ V+ P L P+ D K L N +R ++ E H F
Sbjct: 216 QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-14
Identities = 49/180 (27%), Positives = 89/180 (49%), Gaps = 27/180 (15%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----- 60
NK+ ++ E+ LS + PNIIRL E+ + ++ E+ G+L+ ++ H
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118
Query: 61 -----------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
+P + L Q+ +G++ L+S + +HRDL N L+ ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+KIADFG+S LY G+Y ++ G + +MA E + ++ D+W+ G L+E+L
Sbjct: 176 TIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-14
Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
E + + +++RL +V+E A G+L SY+R GR P T
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117
Query: 68 ARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
++ +Q ++ G+ LN+ +HRDL N +++ D +KI DFG++ +Y +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
K L +MAPE L+ + DMWS G +L+E+ + P+ G +N Q++
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-13
Identities = 47/168 (27%), Positives = 86/168 (51%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +H NIIRL ++ E+ G L Y+R H G L+
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVCGS 131
+ AG++ L+ + +HRDL NIL+ + ++ K++DFGLS L P G Y
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
P+ + APE + ++++ D+WS G +++E+++ G P+ +N +++
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 10/166 (6%)
Query: 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
K LD E ++SV++P++ RL + + L+ + G L Y+R H + Q
Sbjct: 54 KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+ L ++HRDL N+L+ +KI DFGL+ L
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHA 168
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G + +MA E + + Y + D+WS G ++EL+ G P+ G
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 70/240 (29%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 16 ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
E+ L +NH NI+ L D + + +LV E+ G L S G
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110
Query: 63 V--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
V E + F++QL GL + + +HRD+K NIL L++ +K+ADFGL+ LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLA-RLY 166
Query: 121 PGN----YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV- 174
Y KV + Y PE +L +RY +D+WS G IL EL P F +
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
Query: 175 --QLI-------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHI 225
+LI PA+ PD + + FN + RR LR F
Sbjct: 226 QLELISRLCGSPCPAVWPDVIKLPY------------FNTMKPKKQYRRR---LREEFSF 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 41/103 (39%), Positives = 60/103 (58%), Gaps = 11/103 (10%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS ++ ++KI DFGL+ +Y +Y K G
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--GDA 235
Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
PL +MAPE + + Y + D+WS G +L+E+ + G P+ G
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 43/103 (41%), Positives = 62/103 (60%), Gaps = 11/103 (10%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS +++V +KI DFGL+ +Y +Y K GS
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVRK--GSA 236
Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
PL +MAPE + + Y + D+WS G +L+E+ + G P+ G
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 58/183 (31%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
L EL+ NHPNI+ F A+N +++V F A G+ I H + E
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
LQ + L+ ++ +HR +K +IL+S +D V L GL L N+ ++
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLRV 160
Query: 128 VCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
V P Y ++PEVLQ Q YD K D++SVG EL NG+ PF Q+++
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 179 PAL 181
L
Sbjct: 221 EKL 223
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ----QLGAG 78
+ HPNI++ LV E+C G+L SY+ + LQ ++ AG
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 135
+ ++ H+ +H DL N L+ D+ +K+ D+G+ + Y +Y E C ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 136 APE-VLQFQ------RYDEKVDMWSVGAILFELLNG----YPPFSGR 171
APE V +F + ++W++G L+EL Y S R
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-12
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 16 ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
E+ L S+ H NI++ + A + LV+E+ G+L Y++ H R+ +
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEK 127
+ Q+ G+E L S +HRDL NIL ++ + +KI DFGL+ L P + Y +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNIL---VESENRVKIGDFGLTKVL-PQDKEYYKVR 168
Query: 128 VCG-SPLY-MAPEVLQFQRYDEKVDMWSVGAILFEL 161
G SP++ APE L ++ D+WS G +L+EL
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-12
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
E L +H NI+RL N + +V E+ + G L S++R H G++
Sbjct: 52 GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 129
L L +G++ L+ +H+ L +L++ D++ KI+ F L Y
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 130 GSP-LYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP L+ APE +Q+ + D+WS G +++E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-12
Identities = 40/101 (39%), Positives = 59/101 (58%), Gaps = 7/101 (6%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS ++ ++KI DFGL+ +Y +Y K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
PL +MAPE + + Y + D+WS G +L+E+ + G P+ G
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-12
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E+ L ++ H NI++ + N I L++EF G+L Y+ R ++ + K+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEK-VC 129
Q+ G++ L S +HRDL N+L ++ + +KI DFGL+ + Y K
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 130 GSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP++ APE L ++ D+WS G L+ELL
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 7e-12
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
++S++HP+++RL + I LV + G L Y+ H + Q + Q+ G
Sbjct: 63 MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 135
+ L ++HRDL N+L+ + +KI DFGL+ L G + +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
A E + ++++ + D+WS G ++EL+ G P+ G
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
+ L E L ++H NI+ + + F++ + GNL +++ +
Sbjct: 53 TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112
Query: 70 KFLQ--------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
Q+ G+ L+ +IH+D+ N ++ D+++ +KI D LS L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169
Query: 122 GNYAEKVC-----GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+Y C P+ +MA E L + Y D+WS G +L+EL
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L ++NHP+II+L F L++ +L Y+ + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVCGS 131
++ L+ + IIHRD+K ENI ++ D + + DFG +C +P N G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWAGT 246
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
APE+L Y VD+WS G +LFE+ +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-11
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
E L ++HP ++ L D C+ L +L +Y+ R + + TA
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTA-- 264
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
+QL + ++ ++ IIHRD+K EN+L++G +D + + DFG +C +A
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315
Query: 131 SPLYM---------APEVLQFQRYDEKVDMWSVGAILFE 160
+P + APEVL Y VD+WS G ++FE
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 14/170 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
++K++N + S E+ + + HPNI++L ++E +L+ E+ G NLS +R
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775
Query: 61 GRVPEQTARKFLQQLGAGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ + RK + L L+ ++ +L PE I++ G D+ L+++ GL C
Sbjct: 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLC 833
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
T K S Y+APE + + EK D++ G IL ELL G P
Sbjct: 834 T------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
F Q+ G+E L S + +HRDL N+LL+ ++KI DFGL+ ++ NY K
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK-- 296
Query: 130 GSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
GS +MAPE + Y D+WS G +L+E+ + G P+ G
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-09
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
K LD E ++ V P + RL + + LV + G L Y+R + R+ Q
Sbjct: 54 KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+ L ++HRDL N+L+ + +KI DFGL+ L
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHA 168
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G + +MA E + +R+ + D+WS G ++EL+ G P+ G
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 12/103 (11%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
F Q+ G+E L S + +HRDL N+L+ + ++KI DFGL+ + NY K
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK-- 298
Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
GS PL +MAPE + Y D+WS G +L+E+ L G P
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-09
Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
L+ E+ L +NH NI+++ + ++E +++ +F +L S++
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
R + R ++QL +E ++ +IHRD+K ENI L+ D + + DFG +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFE 318
Query: 120 ---YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
+Y G+ +PE+L Y E D+WS G IL ++L+
Sbjct: 319 KEREAFDYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-09
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 9 LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L++C + L L + HPNI+ + F + ++++ F A G+ +S ++ +
Sbjct: 35 LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93
Query: 62 RVPEQTARKFLQQL--GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
PE + + + GA GL L+ + IHR++K +IL+SG D V L GLS
Sbjct: 94 -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLS----GLSH 147
Query: 117 --CTLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGY 165
+ G A+ V P + ++PE+L+ Y+ K D++SVG EL G
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
Query: 166 PPFSGRNNVQLIVPAL 181
PF Q+++ L
Sbjct: 208 VPFQDMLRTQMLLQKL 223
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-09
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 26/113 (23%)
Query: 77 AGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY 120
A +E ++S ++HRDLKP+NILL L+++ +L I D Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICY 182
Query: 121 -----PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PG K+ G+P YMAPE L E D++++G IL+++L P+
Sbjct: 183 SSMTIPG----KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 35 FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLK 93
FQ E +V G L +I HG + + + Q G L+ ++ H++H DLK
Sbjct: 200 FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259
Query: 94 PENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
PENIL+ D D ++I D G C A + + Y +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA--IVSTRHYRSPEVV 317
Query: 141 QFQRYDEKVDMWSVGAILFELLNG 164
+ DMWS+G I++EL G
Sbjct: 318 LGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 39/133 (29%), Positives = 58/133 (43%), Gaps = 19/133 (14%)
Query: 51 GNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
+L+ + + GR + E+ Q L L HR K NILL+ D +LK
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALREL------HRQAKSGNILLT---WDGLLK 51
Query: 110 IADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ G S + P +MAPEV+Q Q Y EK D++S+G L+E L+ P
Sbjct: 52 L--DG-SVAFKTPEQSR---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP-- 103
Query: 170 GRNNVQLIVPALH 182
N + + L
Sbjct: 104 -YNEERELSAILE 115
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 38/107 (35%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV 128
+F Q+ G++ L S + IHRD+ N+LL+ D + KI DFGL+ + NY K
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK- 271
Query: 129 CGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G+ P+ +MAPE + Y + D+WS G +L+E+ + G P+ G
Sbjct: 272 -GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-08
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVC 129
F Q+ G+ L S + IHRDL NILL+ + KI DFGL+ + NY K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVK-- 273
Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G+ P+ +MAPE + Y + D+WS G +L+E+ + G P+ G
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-08
Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLG--- 76
S+ H N+++ LV+EFC G+L Y+R R E LQ++
Sbjct: 51 SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEI 109
Query: 77 -AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
GL L+ ++ IH DL N LL+ D+ +KI D+GLS Y +Y +++
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 133 LYMAPEV-------LQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
++APE+ L ++ ++WS+G ++EL G P+ ++ Q++
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 20/43 (46%), Positives = 29/43 (67%)
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
E++ G+P Y+APE+L + + VD W++G LFE L G PPF
Sbjct: 538 ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF 580
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-06
Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 21/151 (13%)
Query: 51 GNLSSYIRLHGRVPEQTA---------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
G L ++ ++P+ + ++Q+ GL L+ I+HRD+KPEN+L++
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYMAPEVLQFQRYDEKVDMWSVGAIL- 158
D +KI DFG + + G + G P Y PE L + + ++ A+L
Sbjct: 345 ---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLS 401
Query: 159 -FELLNGYPPF-----SGRNNVQLIVPALHP 183
F L G P +G +Q+ VP L P
Sbjct: 402 PFAWLYGRPDLFDSYTAGVLLMQMCVPELRP 432
|
Length = 507 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-06
Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 10/136 (7%)
Query: 43 LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS- 100
+V EF G L +R GRVP QQL + L L +++H ++ +NILL+
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152
Query: 101 -GLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGA 156
GL + +K++D G+S T + E+V P ++APE + D WS G
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTAL--SREERVERIP-WIAPECVPGGNSLSTAADKWSFGT 209
Query: 157 ILFEL-LNGYPPFSGR 171
L E+ +G P R
Sbjct: 210 TLLEICFDGEVPLKER 225
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 4/72 (5%)
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEK 127
+ ++Q+ L+ L+S I+HRD+KP+NI+ S + KI D G + L G NY K
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 128 -VCGSPLYMAPE 138
P Y APE
Sbjct: 316 EFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 38/175 (21%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 1 MLKKLNKHLKSCLDCEL---NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+LK L+K ++ + + +S ++H +++ + + +V E+ G+L +Y+
Sbjct: 31 LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90
Query: 58 RL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-----MLKIA 111
+ + + +QL L L + H ++ +N+LL +D +K++
Sbjct: 91 KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150
Query: 112 DFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG 164
D G+S T+ P E++ P ++ PE ++ Q D WS G L+E+ +G
Sbjct: 151 DPGISITVLPKEILLERI---P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 14/161 (8%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQLGA 77
+S ++H ++++L+ + I +V E+ G L ++ K +QL +
Sbjct: 55 MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLAS 112
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPL 133
L L ++H ++ +NIL++ + +K++D G+ T+ + E+V P
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--LSREERVERIP- 169
Query: 134 YMAPEVLQ--FQRYDEKVDMWSVGAILFELL-NGYPPFSGR 171
++APE ++ D WS G L E+ NG P S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQL 75
+ + V+H +I+ L+ + +V EF G L ++ T KF +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLS--GLDDDV--MLKIADFGLSCTLYPGNYAEKVCGS 131
+ L L ++H ++ +NILL+ G+D + +K++D G+ T+ + E V
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL--SRQECVERI 172
Query: 132 PLYMAPEVLQFQRYDEKV-----DMWSVGAILFEL-LNGYPPFSGR 171
P ++APE ++ D K D WS G L+E+ NG P +
Sbjct: 173 P-WIAPECVE----DSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 28/200 (14%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNL 53
KK +K K +D E+ L ++ NI++++ F + + L++E+C G L
Sbjct: 51 FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY-GFIIDIVDDLPRLSLILEYCTRGYL 109
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
+ + +T GL L + +++L + L+ ++ LKI
Sbjct: 110 REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIIC 166
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFSG 170
GL L + K +Y + ++L F Y K D++S+G +L+E+ G PF
Sbjct: 167 HGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
Query: 171 -----------RNNVQLIVP 179
N L +P
Sbjct: 225 LTTKEIYDLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.001
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 13/94 (13%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
VN P + D +V+E+ G L I +G + +R+ + +G L
Sbjct: 61 VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVG----KL 111
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+S IIH DL N++LSG + L I DFGL+
Sbjct: 112 HSAGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141
|
Length = 211 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.004
Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 15/108 (13%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L L+ P + ++ + +++ +L++E+ G L V E+ +QL
Sbjct: 45 LQLLARKGLP-VPKVLASGESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLA 96
Query: 77 AGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
L L+ + H DL P NIL +DD +L I D+ P
Sbjct: 97 ELLAKLHQLPLLVLCHGDLHPGNIL---VDDGKILGIIDWE-YAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 226 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.8 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.44 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.19 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.14 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.1 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.34 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.16 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 98.03 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.49 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.49 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.93 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.91 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.68 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.39 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.56 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.96 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.45 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.4 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.38 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.34 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.19 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.23 | |
| PLN02236 | 344 | choline kinase | 92.76 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.49 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.33 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 92.27 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.93 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.8 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 90.72 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.65 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.43 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=317.58 Aligned_cols=207 Identities=30% Similarity=0.529 Sum_probs=189.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
++..++++.+|+++++.++|||||.+|+.|..++ .+.|+||||+||||+++++..+++++..+..++.++++||.|||+
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~ 196 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE 196 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 7888999999999999999999999999999988 499999999999999999988999999999999999999999995
Q ss_pred -CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 -~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||||||+|+|+ +..+.+||||||.+...... ......||..|||||++.+..|+.++||||||+.++|++.
T Consensus 197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~ 272 (364)
T KOG0581|consen 197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI 272 (364)
T ss_pred ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence 999999999999999 78999999999999887655 5567789999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--c--------------cccccC-CChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 164 GYPPFSGRNN--V--------------QLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~--~--------------~~~~~~-~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|..||..... . ...+.. .|+++++||..||++||.+|+|+.|+++|||+++..
T Consensus 273 GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 273 GRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999987411 1 111444 889999999999999999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-53 Score=325.00 Aligned_cols=205 Identities=35% Similarity=0.631 Sum_probs=187.3
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
.+.+|+++|++|+|||||+++++++.....|+|+||++||+|.+++-.++.+.+..-.-+++|++.|+.|||+.||+|||
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD 301 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD 301 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence 46799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC--C-cchhHHHHHHHHHHHHhCCCCC
Q 027233 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY--D-EKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 92 l~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~-~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|||+|||+.....+-.+||+|||+|+..+........+||+.|.|||.+.+... . .+.|+||+||++|-+++|..||
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF 381 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF 381 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence 999999996544567799999999999998888999999999999999976543 3 3789999999999999999999
Q ss_pred CCCCccc---------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 169 SGRNNVQ---------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 169 ~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+..... ..+..++.+..++|++||..||++|||++|+|+||||+..+
T Consensus 382 S~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 382 SEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 8765443 12777899999999999999999999999999999999755
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=324.25 Aligned_cols=214 Identities=34% Similarity=0.622 Sum_probs=197.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+..+++.+.+|+++.++|+|||||+++++|++.+++|+|.|+|..++|..+++..++++|..++.+++||+.|+.|||++
T Consensus 58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 56789999999999999999999999999999999999999999999999999889999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+|+|||||..|+++ +.+..+||+|||+|.....+ ......+||+.|.|||++.....+..+||||+||++|-|+.|
T Consensus 138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G 214 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG 214 (592)
T ss_pred Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence 99999999999999 78889999999999988754 667789999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCC
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~ 222 (226)
.+||...+..+. .+..++.+.+++|.+||++||.+|||++++|.|+||+......+-|
T Consensus 215 ~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 215 RPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 999998754333 2788999999999999999999999999999999996654444444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=295.37 Aligned_cols=219 Identities=48% Similarity=0.875 Sum_probs=199.8
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
+.....+.+..|+++|+.++|||||.++++...++.+|+|||||+||+|.+|+++++.+++..++.++.||+.|+++||+
T Consensus 48 l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~ 127 (429)
T KOG0595|consen 48 LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE 127 (429)
T ss_pred cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46678889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCC---ccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
++|+||||||.||+++....+ ..+||.|||+++...+.......+|++.|||||.++.+.|+.|+|+||+|+++|++
T Consensus 128 ~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~ 207 (429)
T KOG0595|consen 128 NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC 207 (429)
T ss_pred CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence 999999999999999643122 67999999999999888888889999999999999999999999999999999999
Q ss_pred HhCCCCCC-------------CCCcccccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCCC
Q 027233 162 LNGYPPFS-------------GRNNVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 223 (226)
Q Consensus 162 ~~g~~p~~-------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~ 223 (226)
++|..||. +.+.....+...+..+.+++...+..++.+|.+..+.+.|+++..++......+
T Consensus 208 l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~~~~~ 282 (429)
T KOG0595|consen 208 LTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDRADAF 282 (429)
T ss_pred HhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccccCcc
Confidence 99999999 444444557778888999999999999999999999999999999876555443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=273.91 Aligned_cols=216 Identities=33% Similarity=0.562 Sum_probs=197.1
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
++++.....+.+.+|+++-+.|+||||+++.+.+.+.+..|+|+|+++|++|..-+-...-+++..+...++||+++|.|
T Consensus 46 ~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~y 125 (355)
T KOG0033|consen 46 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAY 125 (355)
T ss_pred hhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 46677778899999999999999999999999999999999999999999998777766678999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+|++||+|||++|+|+++.......-+||+|||.+...+.+.......|++.|+|||..+..+++..+|+|+-|++++-+
T Consensus 126 CH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiL 205 (355)
T KOG0033|consen 126 CHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 205 (355)
T ss_pred HHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHH
Confidence 99999999999999999987777888999999999999866667778899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 162 LNGYPPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
+.|..||.+.+.... ..+.++++.++++++||..||.+|.|+.|+|+|||+.+...
T Consensus 206 L~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 206 LVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred HhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 999999988543222 26778999999999999999999999999999999987543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=290.84 Aligned_cols=205 Identities=35% Similarity=0.604 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCC--eEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+.+.+|+++|++++|||||++++...... .++++|||+++|+|.+++.+.+ ++++..+..+.+|+++||+|||++|
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999999999999855444 6999999999999999999887 7999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCC-CccEEEeeeccccccCC----CCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~-~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~ 160 (226)
++|+||||.||++ +. ++.++|.|||.+..... ........|++.|+|||.+.. .....++|||||||++.|
T Consensus 138 ~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 138 IVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred EeccCcccceEEE---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 9999999999999 56 68999999999877653 223445679999999999984 334459999999999999
Q ss_pred HHhCCCCCCCC-------------CcccccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 161 LLNGYPPFSGR-------------NNVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 161 l~~g~~p~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
|++|..||... .....++..+|.+.++|+.+|+..+|.+|||++++|+|||++....
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999872 1123447789999999999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=294.14 Aligned_cols=207 Identities=34% Similarity=0.592 Sum_probs=189.1
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
++...+.+..|-..|.+| .||+|++++..|.++..+|+|+||+++|+|.+++++.+.+++...+-++.+|+.||.|||+
T Consensus 113 ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~ 192 (604)
T KOG0592|consen 113 KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS 192 (604)
T ss_pred hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh
Confidence 344556788899999999 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--------------ccccCCccccCcccccccCCCcchh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQFQRYDEKVD 150 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~D 150 (226)
+||+||||||+|||+ +.+++++|+|||.++.+...... ...+||..|.+||++.....++++|
T Consensus 193 ~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sD 269 (604)
T KOG0592|consen 193 NGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSD 269 (604)
T ss_pred cCceeccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccc
Confidence 999999999999999 89999999999999877542111 3367899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 151 MWSVGAILFELLNGYPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 151 v~slG~~~~~l~~g~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+|+|||++|+|+.|..||.+....-.. +..+++++.++|+++|..||.+|+|++||.+||||.+.
T Consensus 270 iWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 270 LWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred hHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 999999999999999999988754332 88899999999999999999999999999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=299.34 Aligned_cols=204 Identities=30% Similarity=0.581 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...++-+.+|+.+|+..+|+|||++++.|.-.+.+++||||++||+|.|.+... .++|.++..+++.++.||+|||.+|
T Consensus 311 Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g 389 (550)
T KOG0578|consen 311 QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG 389 (550)
T ss_pred CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc
Confidence 345678899999999999999999999998889999999999999999988755 6999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+|+|||.+||++ +.++.+||+|||++....... .....+|++.|||||......|.++.||||||++++||+.|+
T Consensus 390 IiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 390 IIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred eeeeccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 9999999999999 788889999999998887655 455678999999999999999999999999999999999999
Q ss_pred CCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 166 PPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 166 ~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.||-..+....+ +..+|+.+++|+.+||+.|+.+|+++.|+|+||||+-
T Consensus 467 PPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 467 PPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 999865544333 7778999999999999999999999999999999954
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=293.04 Aligned_cols=204 Identities=40% Similarity=0.712 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|+.+++.++ ||||+++++++.....+|+||||+.||+|.+++.+.+++.+.....+++|++.|++|+|++|
T Consensus 61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g 140 (370)
T KOG0583|consen 61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG 140 (370)
T ss_pred ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC
Confidence 34567779999999998 99999999999999999999999999999999999889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCC-ccEEEeeecccccc-CCCCccccccCCccccCcccccccC-CC-cchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Dv~slG~~~~~l~ 162 (226)
|+||||||+|+++ +.+ +.++|+|||++... .........+|++.|+|||.+.+.. |+ .++||||+|+++|.|+
T Consensus 141 i~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 141 IVHRDLKPENILL---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred EeeCCCCHHHEEe---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 9999999999999 555 89999999999888 4666677889999999999999877 76 7999999999999999
Q ss_pred hCCCCCCCCCcccc----------cccCC-ChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 163 NGYPPFSGRNNVQL----------IVPAL-HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 163 ~g~~p~~~~~~~~~----------~~~~~-~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+|..||...+.... .+..+ +.++++++++||..+|.+|+|+.+++.||||+.
T Consensus 218 ~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 218 CGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred hCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999998543221 15556 999999999999999999999999999999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=278.93 Aligned_cols=206 Identities=38% Similarity=0.638 Sum_probs=188.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+...+|..+|++++||.||+++..|.+.+..|+|++|+.||.|...+++.+.+++..+.-++..|+.||.|||++|
T Consensus 66 ~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g 145 (357)
T KOG0598|consen 66 KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG 145 (357)
T ss_pred hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC
Confidence 34677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+||||||+|||+ +..++++|+|||+++.... +..+...+||+.|+|||.+.+..++.+.|-||||+++|+|++|.
T Consensus 146 IiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~ 222 (357)
T KOG0598|consen 146 IIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK 222 (357)
T ss_pred eeeccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence 9999999999999 8999999999999985544 45566679999999999999999999999999999999999999
Q ss_pred CCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccC----CHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rp----t~~~~l~~~~~~~~ 215 (226)
.||.+.+..... +.-++.+.+++++++|..+|.+|. ++.++-+||||.+-
T Consensus 223 pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 223 PPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred CCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999887643222 333899999999999999999994 79999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=277.43 Aligned_cols=205 Identities=31% Similarity=0.583 Sum_probs=182.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
++..++-..+|+++|++|+|+|+|.+++.|...+..++|+|||+..-|. -+... ..++...+.++++|++.|+.|+|+
T Consensus 41 d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk 119 (396)
T KOG0593|consen 41 DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCHK 119 (396)
T ss_pred cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhhh
Confidence 4667788899999999999999999999999999999999999764444 45544 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~ 162 (226)
++++||||||+||++ +.++.++|||||+|+... ++..-...+.|.+|.|||.+.+ .+|....|||++||++.||+
T Consensus 120 ~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~ 196 (396)
T KOG0593|consen 120 NNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL 196 (396)
T ss_pred cCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh
Confidence 999999999999999 789999999999999887 3444445678899999999987 78999999999999999999
Q ss_pred hCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCccccC
Q 027233 163 NGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
+|+..|++.++.+.+ .+.++..+.+++++||..||.+|+
T Consensus 197 ~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~ 276 (396)
T KOG0593|consen 197 TGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL 276 (396)
T ss_pred cCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc
Confidence 999999998876554 455677899999999999999999
Q ss_pred CHhHHhcCccccc
Q 027233 202 SFNEFYHHRFLRR 214 (226)
Q Consensus 202 t~~~~l~~~~~~~ 214 (226)
+.+|++.|+||.+
T Consensus 277 sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 277 SCEQLLHHPYFDG 289 (396)
T ss_pred cHHHHhcChHHHH
Confidence 9999999999965
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=296.79 Aligned_cols=209 Identities=35% Similarity=0.679 Sum_probs=192.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+-..+.+|+-+|+-+.|||++.+|+.++.+..+|+|.||++||.|++++..++++++....++++||+.|+.|+|..
T Consensus 52 s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~ 131 (786)
T KOG0588|consen 52 SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF 131 (786)
T ss_pred ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 34456678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCC-cchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~~~~l~~g 164 (226)
+|+|||+||+|+++ +..+.+||+|||+|....++.....-+|++.|.+||.++|.+|+ .++||||-|+++|.+++|
T Consensus 132 ~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG 208 (786)
T KOG0588|consen 132 NICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTG 208 (786)
T ss_pred cceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence 99999999999999 66667999999999888788778888999999999999999885 689999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
..||++.+-... ++..++++++++|++||..||.+|.|.+|+++|||+.+...
T Consensus 209 ~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 209 KLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 999996543222 28889999999999999999999999999999999998643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=271.53 Aligned_cols=206 Identities=35% Similarity=0.699 Sum_probs=189.8
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.++.-..|+.+|+++ .||+|+++.++|+++...++|+|.|+.|.|+|++.+.-.+++....++++|+.++++|||.
T Consensus 62 ~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 62 PYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH
Confidence 345677888999999999 7999999999999999999999999999999999998899999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc------cCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~~~ 158 (226)
++|+|+||||+||++ +++..++|+|||+++...++......+|+++|+|||.+.+ ..|+...|+|+.|+++
T Consensus 142 ~~IVHRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 142 RNIVHRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred hhhhhcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 999999999999999 7888999999999999999988889999999999999864 3578899999999999
Q ss_pred HHHHhCCCCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 159 FELLNGYPPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
|.++.|..||......-+ .+.+++..++++|+++|+.||.+|.|++|+|.||||.-
T Consensus 219 yTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 219 YTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999976543322 27788999999999999999999999999999999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=265.22 Aligned_cols=207 Identities=34% Similarity=0.656 Sum_probs=192.7
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
++-.+.+...+|.++|+.+.||.++++++.+.+.+.+|+||||.+||.|++++++.+++++..++-++.+|+.||+|||+
T Consensus 83 VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~ 162 (355)
T KOG0616|consen 83 VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS 162 (355)
T ss_pred HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh
Confidence 46678889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
++|++||+||+||++ +.++.++|+|||+++..... +...+||+.|+|||.+.+.++..+.|=|+||+++|||+.|
T Consensus 163 ~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG 237 (355)
T KOG0616|consen 163 LDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAG 237 (355)
T ss_pred cCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcC
Confidence 999999999999999 79999999999999887544 6678899999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc----------ccCCChHHHHHHHHhhccCcccc-----CCHhHHhcCccccccC
Q 027233 165 YPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDR-----LSFNEFYHHRFLRRNS 216 (226)
Q Consensus 165 ~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~R-----pt~~~~l~~~~~~~~~ 216 (226)
..||...+..... ++-++++++++++++|+.|-.+| ...+++..||||++..
T Consensus 238 ~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 238 YPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred CCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 9999887764443 78899999999999999999999 4678999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=281.31 Aligned_cols=200 Identities=32% Similarity=0.519 Sum_probs=180.7
Q ss_pred HHHHHHHHHhcCC-CCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 12 CLDCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 12 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.-.+|++.|++|. ||||+++.+.+.+.. .+|+||||| ..+|-+.++.+ +.+++..+..|+.||++||+++|++|+.
T Consensus 54 ~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfF 132 (538)
T KOG0661|consen 54 MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFF 132 (538)
T ss_pred HHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 4468999999997 999999999998877 999999999 68999998766 4799999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccc-cccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|||+||+|||+ ..+..+||+|||+|+......+-...+.|.+|.|||++ +...|+...|+|++||+++|+++.+..
T Consensus 133 HRDlKPENiLi---~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 133 HRDLKPENILI---SGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred cccCChhheEe---cccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence 99999999999 55888999999999988877766778899999999986 567789999999999999999999999
Q ss_pred CCCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 168 FSGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 168 ~~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
|+|.+..+.+ .+..+.+..++|.+|++.||.+|||+.|+|
T Consensus 210 FPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 210 FPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 9988755443 344788999999999999999999999999
Q ss_pred cCcccccc
Q 027233 208 HHRFLRRN 215 (226)
Q Consensus 208 ~~~~~~~~ 215 (226)
+||||+-.
T Consensus 290 ~~pffq~~ 297 (538)
T KOG0661|consen 290 QHPFFQVG 297 (538)
T ss_pred cCcccccc
Confidence 99999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=282.27 Aligned_cols=204 Identities=30% Similarity=0.519 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.....+.+|+.++++++||||+++++.+..++..++||||+++++|.+++...+.+++..+..++.||+.||+|||++|+
T Consensus 37 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 116 (323)
T cd05571 37 DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34456788999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 117 vHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 193 (323)
T cd05571 117 VYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCC
Confidence 999999999999 6788899999999865422 223334568999999999998899999999999999999999999
Q ss_pred CCCCCCccc----------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccc
Q 027233 167 PFSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 214 (226)
Q Consensus 167 p~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~ 214 (226)
||...+... ..+..++.++.++|++||+.||.+|| ++.++++||||..
T Consensus 194 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 194 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 997654322 12567899999999999999999999 8999999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=279.75 Aligned_cols=196 Identities=35% Similarity=0.538 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+.+.+|+.++++++|||||+++|++.+.. ...+||||+++|+|.+++.+ ++.++...+..++.||+.|+.|||+++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 779999999999999999999999999887 79999999999999999987 578999999999999999999999999
Q ss_pred -ceeeccCCCCeEeeeCCCCc-cEEEeeeccccccCCC-CccccccCCccccCccccc--ccCCCcchhHHHHHHHHHHH
Q 027233 87 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 87 -i~H~dl~~~nili~~~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~~~~~l 161 (226)
|+|||||+.|+|+ +.+. ++||+|||+++..... .......||..|+|||.+. +..++.++||||+|+++||+
T Consensus 163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 9999999999999 5665 9999999999877654 3344467999999999999 66899999999999999999
Q ss_pred HhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..||.+...... .+...++.+..++.+|++.||..||++.+++.
T Consensus 240 ~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 240 LTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999998764222 15558899999999999999999999999873
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=277.20 Aligned_cols=203 Identities=35% Similarity=0.630 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.+.+.+++..+..++.|++.||++||++|+
T Consensus 43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 122 (291)
T cd05612 43 KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||++....... ....++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 123 ~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~p 197 (291)
T cd05612 123 VYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT--WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197 (291)
T ss_pred eecCCCHHHeEE---CCCCCEEEEecCcchhccCCc--ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999 678899999999987654322 234578899999999988899999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|.+.+.... .+..++..++++|++||+.||.+|++ ++++++||||+..
T Consensus 198 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 198 FFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 987653221 24567889999999999999999995 9999999999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=273.66 Aligned_cols=205 Identities=30% Similarity=0.526 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+++|++.++.++||||++++..|..+..+|+||.+|.+||+.+.++.. ..++|..+.-+++++++||.|||.+|
T Consensus 67 ~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G 146 (516)
T KOG0582|consen 67 DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG 146 (516)
T ss_pred hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 3688999999999999999999999999999999999999999999999876 35999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-----ccccCCccccCccccc--ccCCCcchhHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~~~~ 159 (226)
.+|||||+.||++ +.+|.|+|+|||.+..+...... ....+++.|+|||.++ ...|+.|+||||||+++.
T Consensus 147 ~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 147 HIHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred ceecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999 79999999999988766554321 3347899999999964 346889999999999999
Q ss_pred HHHhCCCCCCCCCccccc--------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 160 ELLNGYPPFSGRNNVQLI--------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~--------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|+.+|..||......+.+ ...++..++++|..||+.||.+|||++++|+|+||+..+
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 999999999876654432 334567899999999999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=268.58 Aligned_cols=196 Identities=30% Similarity=0.571 Sum_probs=172.3
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeee-EEEeC-CeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAE-NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~-~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~ 78 (226)
.++..++++..|+.+|++|+||||+++++ .+..+ ..++|+||+|++|+|...++.. +.+++..+|+++.|++.|
T Consensus 57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A 136 (375)
T KOG0591|consen 57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA 136 (375)
T ss_pred ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence 47789999999999999999999999998 55544 4499999999999999998743 469999999999999999
Q ss_pred HHHHHh--CC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHH
Q 027233 79 LEILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 79 l~~lh~--~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
|..+|. .. ++||||||.||++ +.++.+||+|||+++...... .....+||+.||+||.+.+.+|+.++||||
T Consensus 137 L~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs 213 (375)
T KOG0591|consen 137 LYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWS 213 (375)
T ss_pred HHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHH
Confidence 999998 44 9999999999999 789999999999998886543 345678999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcccc-----------cc-cCCChHHHHHHHHhhccCccccCCH
Q 027233 154 VGAILFELLNGYPPFSGRNNVQL-----------IV-PALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~-----------~~-~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
+||++|||+..+.||.+..-... .+ ..+|.++..+|.-|++.||..||+.
T Consensus 214 lGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 214 LGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999988742211 13 4578899999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=276.78 Aligned_cols=206 Identities=34% Similarity=0.563 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
......+.+|+.++++++||||+++++.+...+..++|+||+++++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 34 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 113 (312)
T cd05585 34 RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113 (312)
T ss_pred hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34456778899999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 114 i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 114 VIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred eEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence 9999999999999 67889999999998754322 2233456889999999999889999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC---CHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL---SFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~~l~~~~~~~~ 215 (226)
.||...+.... .+..+++++.++|.+||+.||.+|| ++.|+++||||...
T Consensus 191 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 191 PPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99976543221 2566889999999999999999997 57999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=279.36 Aligned_cols=203 Identities=32% Similarity=0.610 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++.+.+++..+++|||+.|++|.+++.+.+.+++..+..++.|++.||.|||++|+
T Consensus 60 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 139 (329)
T PTZ00263 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139 (329)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||++....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 140 vH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 214 (329)
T PTZ00263 140 IYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214 (329)
T ss_pred eecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCC
Confidence 999999999999 678899999999987664332 234688899999999988899999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|.+.+.... .+..++..++++|++||+.||.+|++ ++++++||||.+.
T Consensus 215 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 215 FFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 976543221 14557889999999999999999997 7999999999873
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=276.46 Aligned_cols=205 Identities=31% Similarity=0.520 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.....+.+|+++++.++||||+++++.+...+..++||||+++++|..++...+.+++..++.++.||+.||.|||++|+
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 116 (323)
T cd05595 37 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34556778999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 117 vH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~ 193 (323)
T cd05595 117 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred EecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCC
Confidence 999999999999 67889999999988654322 22234568899999999988889999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||...+.... .+..+++++.++|++||+.||.+|+ ++.++++||||...
T Consensus 194 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 194 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9976543221 2567899999999999999999998 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=276.92 Aligned_cols=207 Identities=34% Similarity=0.619 Sum_probs=190.1
Q ss_pred HHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.++.+.+|+.+|++++ ||||+.+++.+++...+++|||++.||.|.+.+... .+++..+..+++|++.+++|+|+.|+
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv 156 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV 156 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4579999999999997 999999999999999999999999999999999876 49999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCC-CccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+|++|+|+++..... .+.++++|||++............+|++.|+|||.+....++...|+||+|+++|.|++|..
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 99999999999975443 45899999999999888667788899999999999999999999999999999999999999
Q ss_pred CCCCCCccc--------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||.+.+... .....++..++++|+.||..||.+|+|+.++|+|||++...
T Consensus 237 PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 237 PFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 998876332 22777899999999999999999999999999999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=263.13 Aligned_cols=216 Identities=31% Similarity=0.600 Sum_probs=193.3
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~l 82 (226)
.+..++|++..... .|||||.+++.|+. ...+.+|||.++||.|++.++.++. +++..+.+|++||..|+.||
T Consensus 98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH
Confidence 45667888887777 69999999998864 4568899999999999999998864 99999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|+.+|.||||||+|+++.....+..+||+|||+++....+......+.++.|.|||.+....++...|+||+|+++|-++
T Consensus 178 H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL 257 (400)
T KOG0604|consen 178 HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_pred HhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh
Confidence 99999999999999999877778889999999998887777777788899999999998889999999999999999999
Q ss_pred hCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCCCC
Q 027233 163 NGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFH 224 (226)
Q Consensus 163 ~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~~ 224 (226)
+|+.||-+...... .+..+|.+.+++|+++|..+|.+|.|++|+++|||+.....+...|++
T Consensus 258 CGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 258 CGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred cCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 99999976544221 177789999999999999999999999999999999999999888876
Q ss_pred C
Q 027233 225 I 225 (226)
Q Consensus 225 ~ 225 (226)
+
T Consensus 338 t 338 (400)
T KOG0604|consen 338 T 338 (400)
T ss_pred h
Confidence 4
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=277.18 Aligned_cols=205 Identities=30% Similarity=0.494 Sum_probs=181.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.....+.+|+++++.++||||+++++.+...+..++||||+++++|.+++...+.+++..+..++.||+.||.|||++|+
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 116 (328)
T cd05593 37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116 (328)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44567888999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 117 vHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 193 (328)
T cd05593 117 VYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (328)
T ss_pred EecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCC
Confidence 999999999999 67889999999998654322 22334568899999999988889999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||...+.... .+..++.++.++|++||+.||.+|+ ++.|+++||||.+.
T Consensus 194 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 194 PFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9976543221 2566889999999999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=278.53 Aligned_cols=203 Identities=31% Similarity=0.576 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++||||+++++++.+.+..+++|||+.+++|.+++...+.+++..+..++.|++.||.|||+.|+
T Consensus 73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 152 (340)
T PTZ00426 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152 (340)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||++...... .....++..|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus 153 vHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~P 227 (340)
T PTZ00426 153 VYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227 (340)
T ss_pred EccCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCC
Confidence 999999999999 67889999999998765432 2345688899999999888899999999999999999999999
Q ss_pred CCCCCccc----------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 168 FSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
|...+... ..+..++..+.++|++||+.+|.+|+ |++++++||||.+.
T Consensus 228 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 228 FYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 98765321 12566788999999999999999995 89999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=284.25 Aligned_cols=207 Identities=33% Similarity=0.623 Sum_probs=188.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+++++.++||||+.+++.|+.....++|+||+.| +|..++...+.++++.+..++.+++.||.|||+.+|
T Consensus 43 k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ri 121 (808)
T KOG0597|consen 43 KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRI 121 (808)
T ss_pred HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCc
Confidence 3445699999999999999999999999999999999999976 999999999999999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
.|+|+||.||++ ..++.+|+||||+++.+..+.. .....|++.|+|||...+++++..+|+|||||++||++.|+.
T Consensus 122 lhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 122 LHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred ccccCCcceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 999999999999 7899999999999998876543 345679999999999999999999999999999999999999
Q ss_pred CCCCCCcc----------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 167 PFSGRNNV----------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 167 p~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
||-..... ...+...+.++..|+..+|.+||.+|.|..+++.|||.++.-..
T Consensus 199 PF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 199 PFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred CchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence 99765432 22366789999999999999999999999999999999885433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=269.60 Aligned_cols=203 Identities=31% Similarity=0.491 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+|++++++++|++|+++++.+.+++..++++||+++++|.+++... ..+++..+..++.|++.||.|||++|+
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 346788999999999999999999999999999999999999999887643 368999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++||||+|++++++++|..|
T Consensus 124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence 999999999999 67888999999998776444333445688999999999988999999999999999999999999
Q ss_pred CCCCCccc--------------ccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 168 FSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|....... .....++.++.+++++||+.||.+||+ ++++++||||++.
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 201 FRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred CCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 98654311 124568899999999999999999997 8999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=273.11 Aligned_cols=206 Identities=31% Similarity=0.515 Sum_probs=179.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++.....+++..+..++.|++.|+.|||++
T Consensus 43 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (331)
T cd06649 43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122 (331)
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 34566789999999999999999999999999999999999999999999999888899999999999999999999986
Q ss_pred -CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 -~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+++|+||+|+||++ +.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 123 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 198 (331)
T cd06649 123 HQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198 (331)
T ss_pred CCEEcCCCChhhEEE---cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 69999999999999 67888999999998765432 22344678899999999988899999999999999999999
Q ss_pred CCCCCCCCcccc----------------------------------------------------------cccCCChHHH
Q 027233 165 YPPFSGRNNVQL----------------------------------------------------------IVPALHPDCV 186 (226)
Q Consensus 165 ~~p~~~~~~~~~----------------------------------------------------------~~~~~~~~~~ 186 (226)
..||...+..+. ....++.+++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (331)
T cd06649 199 RYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQ 278 (331)
T ss_pred CCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHH
Confidence 999864321100 0124678999
Q ss_pred HHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 187 DMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 187 ~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++|.+||+.||++|||++++++||||+..
T Consensus 279 ~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 279 EFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 99999999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=274.72 Aligned_cols=204 Identities=37% Similarity=0.606 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
....+.+|+.+++.++||||+++++.+..++..|++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++
T Consensus 43 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 122 (323)
T cd05584 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII 122 (323)
T ss_pred hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34567889999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++||||||+++++|++|..|
T Consensus 123 H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 123 YRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred cCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 99999999999 67889999999998654322 223345688999999999888889999999999999999999999
Q ss_pred CCCCCccc----------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 168 FSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
|...+... ..+..++.++.++|++||+.+|.+|| +++++++||||.+.
T Consensus 200 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 200 FTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 98765322 12566789999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=272.93 Aligned_cols=212 Identities=28% Similarity=0.483 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+|++++++++||||+++++++... ...++++||+ +++|.+++.....+++..+..++.|++.||.|||
T Consensus 42 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 42 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999987543 3589999999 5799999988888999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccc--cCCCcchhHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAI 157 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~ 157 (226)
++|++||||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||+|++
T Consensus 121 ~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 121 TANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HCCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 9999999999999999 6788999999999875432211 123467889999999865 578899999999999
Q ss_pred HHHHHhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccC
Q 027233 158 LFELLNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~ 196 (226)
+++|++|..||.+.+.... ..+..++++.+++.+||+.+
T Consensus 198 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 277 (338)
T cd07859 198 FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277 (338)
T ss_pred HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcC
Confidence 9999999999976432110 02346788999999999999
Q ss_pred ccccCCHhHHhcCccccccCcccCCCCC
Q 027233 197 TVDRLSFNEFYHHRFLRRNSAILRAPFH 224 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~~~~~~~~~~ 224 (226)
|.+|||++|+++||||+......+.+-.
T Consensus 278 P~~Rpt~~e~l~hp~f~~~~~~~~~~~~ 305 (338)
T cd07859 278 PKDRPTAEEALADPYFKGLAKVEREPSA 305 (338)
T ss_pred cccCCCHHHHhcCchhhhcCcccccccc
Confidence 9999999999999999987776655443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=268.48 Aligned_cols=202 Identities=31% Similarity=0.521 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++|+||+++++.+..++..++|+||++++++..+......+++..+..++.|++.||.+||+.|+
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999888777665555679999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 122 ~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 198 (287)
T cd07848 122 VHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198 (287)
T ss_pred ecCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence 999999999999 6788999999999876543221 22345788899999998888999999999999999999999
Q ss_pred CCCCCCCccccc------------------------------------------ccCCChHHHHHHHHhhccCccccCCH
Q 027233 166 PPFSGRNNVQLI------------------------------------------VPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 166 ~p~~~~~~~~~~------------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
.||.+.+..+.. ...++.++.+++++||+.||.+|||+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~ 278 (287)
T cd07848 199 PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT 278 (287)
T ss_pred CCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence 999764321110 12367789999999999999999999
Q ss_pred hHHhcCccc
Q 027233 204 NEFYHHRFL 212 (226)
Q Consensus 204 ~~~l~~~~~ 212 (226)
+|+++||||
T Consensus 279 ~~~l~hp~f 287 (287)
T cd07848 279 EQCLNHPAF 287 (287)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=272.32 Aligned_cols=205 Identities=35% Similarity=0.572 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+..|..+++.+ +||||+++++.+...+..++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ 116 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3455677888888877 799999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 117 ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (320)
T cd05590 117 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH 193 (320)
T ss_pred eEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCC
Confidence 9999999999999 6788999999999865432 22233456889999999999888999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH------hHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~------~~~l~~~~~~~~ 215 (226)
.||...+.... .+..++.++.+++++||+.||.+|+++ +++++||||++.
T Consensus 194 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 194 APFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99987653321 245678999999999999999999998 999999999873
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=274.16 Aligned_cols=195 Identities=27% Similarity=0.525 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+++|++|+|++||++++.+..++.++|||||++.|+|.+|++. ...+.......++.||++|++||+++++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~ 324 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY 324 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence 46788999999999999999999999998899999999999999999997 3578899999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccc--cCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~--~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+||||...|||| +.+..+||+|||+++....+...... .-...|.|||.+....++.++||||||++++|+++ |
T Consensus 325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 999999999999 78889999999999965554443222 23456999999999999999999999999999999 9
Q ss_pred CCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 165 YPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 165 ~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
..||++.+..+.. +...|.++.+++..|+..+|++|||++.+.
T Consensus 402 ~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 402 RVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999998876554 788999999999999999999999998665
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=270.66 Aligned_cols=206 Identities=30% Similarity=0.599 Sum_probs=184.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.++.|=.+|...+++.||+++..|.+...+|+||||++||++..++.+.+.+++..++.++.+++.|+..+|+.
T Consensus 181 ~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 181 KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 55677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCC----------------------CCcc------------------
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------GNYA------------------ 125 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~----------------------~~~~------------------ 125 (226)
|++||||||+|+|+ +..|++||+|||++..... ....
T Consensus 261 gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w 337 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTW 337 (550)
T ss_pred CcccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHH
Confidence 99999999999999 7999999999999854311 0000
Q ss_pred --------ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCCh
Q 027233 126 --------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHP 183 (226)
Q Consensus 126 --------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~ 183 (226)
...+|++.|+|||++.+..++...|-|||||++|||+.|..||.+.+..... ....+.
T Consensus 338 ~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~ 417 (550)
T KOG0605|consen 338 KRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSD 417 (550)
T ss_pred HhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccH
Confidence 0235899999999999999999999999999999999999999987765443 455789
Q ss_pred HHHHHHHHhhccCccccCC---HhHHhcCcccccc
Q 027233 184 DCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN 215 (226)
Q Consensus 184 ~~~~~i~~~l~~~p~~Rpt---~~~~l~~~~~~~~ 215 (226)
+.+|+|.++|. ||.+|.. ++||-+||||++.
T Consensus 418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999 9999974 9999999999995
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=271.45 Aligned_cols=204 Identities=31% Similarity=0.600 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+..|..+++++ +||||+++++.+...+..++||||++|++|.+++.+.+++++..+..++.|++.||.|||++|
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 116 (329)
T cd05588 37 EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116 (329)
T ss_pred hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456688999999999 799999999999999999999999999999999988889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||+|+++|++++|.
T Consensus 117 ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 193 (329)
T cd05588 117 IIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred eEecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC
Confidence 9999999999999 678899999999986532 223334456889999999999889999999999999999999999
Q ss_pred CCCCCCCccc-------------------ccccCCChHHHHHHHHhhccCccccCC------HhHHhcCccccc
Q 027233 166 PPFSGRNNVQ-------------------LIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRR 214 (226)
Q Consensus 166 ~p~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt------~~~~l~~~~~~~ 214 (226)
.||....... ..+..++.++.++|++||+.||.+|+| ++++++||||..
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 194 SPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9996321110 115567889999999999999999997 789999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=274.13 Aligned_cols=204 Identities=30% Similarity=0.524 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i 87 (226)
....+.+|+++++.++||||+++++.+..++..++||||+++++|.+++.....+++..+..++.||+.||.|||+ .|+
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i 117 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 4456778999999999999999999999999999999999999999999888889999999999999999999997 799
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 118 vHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~ 194 (325)
T cd05594 118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194 (325)
T ss_pred EecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCC
Confidence 999999999999 6788999999999865432 222334568899999999988889999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..+++++.++|++||+.||.+|+ ++.++++||||.+.
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 9976543221 2556899999999999999999997 99999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=273.08 Aligned_cols=203 Identities=33% Similarity=0.590 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++||||+++++.+...+..++||||++|++|.+++...+.+++..+..++.|++.||.+||++|+
T Consensus 43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 122 (333)
T cd05600 43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122 (333)
T ss_pred hHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||++..... ......++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 123 vH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 123 IHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred cccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCC
Confidence 999999999999 6788999999999876543 23345688999999999988999999999999999999999999
Q ss_pred CCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|...+..+.. ...++.++.++|.+||+.+|.+|||++++++||||.+.
T Consensus 198 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9765432211 11458899999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=274.48 Aligned_cols=203 Identities=35% Similarity=0.594 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
....+.+|++++++++||||+++++.+.+++..|+|+||+++++|.+++.+...+++..++.++.|++.||.|||++|++
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 120 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 44567889999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||+|+||++ +.++.++|+|||.+...... .......++..|+|||...+..++.++|+||||+++++|++|..|
T Consensus 121 H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 197 (318)
T cd05582 121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197 (318)
T ss_pred cCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCC
Confidence 99999999999 67888999999998765443 223345678899999999888889999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCccccc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 214 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~ 214 (226)
|...+.... .+..++.++.++|++||+.||.+||| ++++++||||..
T Consensus 198 ~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 198 FQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 987543221 14567899999999999999999999 778999999976
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=274.30 Aligned_cols=207 Identities=31% Similarity=0.549 Sum_probs=190.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe-EEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~l 82 (226)
....++...+|+.+++++.||||+.+.+.|..++. .+|+|+||+||+|.+.+.+.+ -++++.+..|+.|++.|+.||
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl 122 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL 122 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 45567789999999999999999999999999888 999999999999999998664 589999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|+++|+||||++.||++ +.++.++|+|||+++.++... ......|++.|++||.+.+.+|..++|+|||||++|||
T Consensus 123 H~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 123 HENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred Hhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHH
Confidence 99999999999999999 788889999999999998776 67778899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcc-----------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 162 LNGYPPFSGRNNV-----------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 162 ~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++-+.+|...+-. ...+..++.+++.+|+.||..+|..||++.++|.+|.+...
T Consensus 200 ~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 200 CTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999999876533 23378899999999999999999999999999999988853
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=275.28 Aligned_cols=211 Identities=23% Similarity=0.328 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.++.+.+|++++++++||||+++++++...+..++++|++ +++|.+++.....+++..++.++.|++.||.|||++||+
T Consensus 126 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~Iv 204 (391)
T PHA03212 126 QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRII 204 (391)
T ss_pred hhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3456789999999999999999999999999999999999 579999998878899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC--CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
||||||+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 205 HrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 205 HRDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cCCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999 67788999999998654321 12233468899999999988899999999999999999999987
Q ss_pred CCCCCCccc---------------------c-------------------------------cccCCChHHHHHHHHhhc
Q 027233 167 PFSGRNNVQ---------------------L-------------------------------IVPALHPDCVDMCLKLLS 194 (226)
Q Consensus 167 p~~~~~~~~---------------------~-------------------------------~~~~~~~~~~~~i~~~l~ 194 (226)
|+-...... . ....++.++.++|.+||+
T Consensus 282 p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~ 361 (391)
T PHA03212 282 SLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361 (391)
T ss_pred CcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhc
Confidence 754321100 0 011245689999999999
Q ss_pred cCccccCCHhHHhcCccccccCcccCCCC
Q 027233 195 ANTVDRLSFNEFYHHRFLRRNSAILRAPF 223 (226)
Q Consensus 195 ~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~ 223 (226)
.||.+|||++|+|+||||+..+....+|+
T Consensus 362 ~dP~~Rpta~elL~hp~f~~~~~~~~~~~ 390 (391)
T PHA03212 362 FDAHHRPSAEALLDFAAFQDIPDPYPNPM 390 (391)
T ss_pred CChhhCCCHHHHhcChhhccCCCCCCCCC
Confidence 99999999999999999998665555554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=251.07 Aligned_cols=207 Identities=32% Similarity=0.514 Sum_probs=182.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.........+|++.|+.++|+||+.+++.|...+...+|+||+ ..+|+..++... .++...+..++.+++.|++|+|+
T Consensus 41 kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~ 119 (318)
T KOG0659|consen 41 KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS 119 (318)
T ss_pred ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 3334567889999999999999999999999999999999999 579999887653 68999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-ccccCCccccCccccccc-CCCcchhHHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~ 162 (226)
+.|+|||+||+|+++ +.++.+||.|||+++..+..... ...+.+.+|.|||.+.|. .|+...|+||.||++.|++
T Consensus 120 ~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 120 KWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred hhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence 999999999999999 78999999999999988765433 334678999999998764 6899999999999999999
Q ss_pred hCCCCCCCCCccccc--------------------------------------ccCCChHHHHHHHHhhccCccccCCHh
Q 027233 163 NGYPPFSGRNNVQLI--------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~--------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
.|..-|.+.++.+.+ .+..+.+..+++.+|+..||.+|+|+.
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 999888887765443 334567789999999999999999999
Q ss_pred HHhcCccccccC
Q 027233 205 EFYHHRFLRRNS 216 (226)
Q Consensus 205 ~~l~~~~~~~~~ 216 (226)
|+|+|+||+..+
T Consensus 277 qaL~~~yf~~~P 288 (318)
T KOG0659|consen 277 QALKHPYFKSLP 288 (318)
T ss_pred HHhcchhhhcCC
Confidence 999999999743
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=260.90 Aligned_cols=212 Identities=34% Similarity=0.558 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.-..++..+|+++|+.++|+||+.+.+.+.. -+.+|+|+|++ +.+|.+.++....+++..+.-++.|++.||+|
T Consensus 62 ~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKy 140 (359)
T KOG0660|consen 62 QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKY 140 (359)
T ss_pred hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcch
Confidence 3456788899999999999999999998864 35699999999 78999999988779999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCC---CCccccccCCccccCcccc-cccCCCcchhHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~ 157 (226)
+|+.+++||||||.|+++ +.+..+|++|||+|+.... .......+.|.+|.|||.+ ....|+.+.||||+||+
T Consensus 141 iHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI 217 (359)
T KOG0660|consen 141 IHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCI 217 (359)
T ss_pred hhcccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHH
Confidence 999999999999999999 7888899999999988754 3334566788999999987 45689999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccC
Q 027233 158 LFELLNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~ 196 (226)
++||++|...|.+.+....+ .+..++...+++.+||..|
T Consensus 218 ~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fd 297 (359)
T KOG0660|consen 218 LAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFD 297 (359)
T ss_pred HHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccC
Confidence 99999999999988755443 5567888999999999999
Q ss_pred ccccCCHhHHhcCccccccCcccCCC
Q 027233 197 TVDRLSFNEFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~~~~~~~~ 222 (226)
|.+|+|++|+|.|||+....-.-.-|
T Consensus 298 P~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 298 PKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred ccccCCHHHHhcChhhhhhcCCccCC
Confidence 99999999999999999864443333
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=268.83 Aligned_cols=205 Identities=34% Similarity=0.606 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+..+.+..|..+++.+ +||||+++++.+...+..++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|
T Consensus 37 ~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 116 (318)
T cd05570 37 DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116 (318)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456677899999888 799999999999999999999999999999999988889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++|+||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 117 ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~ 193 (318)
T cd05570 117 IIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193 (318)
T ss_pred eEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCC
Confidence 9999999999999 67889999999988653222 2233345788999999999999999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH-----hHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~-----~~~l~~~~~~~~ 215 (226)
.||.+.+.... .+..++.++.++|++||+.||.+|||+ .++++||||+..
T Consensus 194 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 194 SPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99976543222 245678999999999999999999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=269.91 Aligned_cols=205 Identities=31% Similarity=0.537 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+..+.+..|.+++..+ +||||+++++.+...+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 116 (321)
T cd05591 37 DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116 (321)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4455677888998876 899999999999999999999999999999999988889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 117 ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 193 (321)
T cd05591 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193 (321)
T ss_pred eeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCC
Confidence 9999999999999 67889999999998654322 2233445788999999999888999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-------CHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-------SFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-------t~~~~l~~~~~~~~ 215 (226)
.||...+.... .+..++.++.+++++||+.+|.+|+ +++++++||||.+.
T Consensus 194 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 194 PPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 99987653322 1445789999999999999999999 99999999999773
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=264.70 Aligned_cols=199 Identities=32% Similarity=0.546 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+.+|++++++++||||+++++++..++..++|+||++ ++|.+++...+ .+++..+..++.||+.||.+||++|++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4567789999999999999999999999999999999996 49999887654 578999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
||||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 678899999999986543322 2233457888999998865 567899999999999999999999
Q ss_pred CCCCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 167 PFSGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 167 p~~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
||.+.+..+.. ....+.+..++|++||+.||.+|||++|+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 203 MFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 99764421100 23467889999999999999999999999
Q ss_pred hcCccc
Q 027233 207 YHHRFL 212 (226)
Q Consensus 207 l~~~~~ 212 (226)
++||||
T Consensus 283 l~hp~f 288 (288)
T cd07871 283 LRHSYF 288 (288)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=267.44 Aligned_cols=208 Identities=31% Similarity=0.515 Sum_probs=179.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|++++++++|+||+++++++.+++..+++|||+.+++|.+++...+.+++..+..++.|++.|+.|||+.
T Consensus 43 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 122 (333)
T cd06650 43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122 (333)
T ss_pred CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 34556789999999999999999999999999999999999999999999999888899999999999999999999975
Q ss_pred -CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 -~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+++|+||+|+||++ +.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 123 ~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g 198 (333)
T cd06650 123 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198 (333)
T ss_pred CCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 79999999999999 67788999999998655332 12234578899999999988899999999999999999999
Q ss_pred CCCCCCCCcccc--------------------------------------------------------cccCCChHHHHH
Q 027233 165 YPPFSGRNNVQL--------------------------------------------------------IVPALHPDCVDM 188 (226)
Q Consensus 165 ~~p~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~ 188 (226)
..||........ ....++.+++++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 278 (333)
T cd06650 199 RYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDF 278 (333)
T ss_pred CCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHH
Confidence 999864321100 011356789999
Q ss_pred HHHhhccCccccCCHhHHhcCccccccCc
Q 027233 189 CLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 189 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
+.+||+.||.+|||+.|++.||||+....
T Consensus 279 i~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 279 VNKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred HHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 99999999999999999999999988643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=258.69 Aligned_cols=201 Identities=29% Similarity=0.566 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|++++++++||||+++++++..+...++++||+++++|.+++...+.+++..+..++.|++.|+.+||+.|++
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 126 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34678999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+...+.++|+||+|++++++++|
T Consensus 127 H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 127 HRDIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred cCCCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 99999999999 67888999999998755432111 223467789999999988899999999999999999999
Q ss_pred CCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 165 YPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 165 ~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
..||...+... ..+..++.++.+++++||+.+|.+|||+.++++|+||
T Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 204 KPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99997643321 1255678999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=262.19 Aligned_cols=203 Identities=33% Similarity=0.505 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+.+..|+++++.++|+||+++.+.+..++..+++|||++|++|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35677899999999999999999999999999999999999999988743 34689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus 117 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g 193 (280)
T cd05608 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193 (280)
T ss_pred CcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 99999999999999 6788899999999876544322 2234578899999999988999999999999999999999
Q ss_pred CCCCCCCCccc--------------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
..||....... ..+..++..+.+++.+||+.||.+|| |++++++||||++.
T Consensus 194 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 194 RGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99997643210 11355789999999999999999999 88999999999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=279.75 Aligned_cols=205 Identities=31% Similarity=0.558 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
......+.+|+.+++.++||||+++++++..++..++||||++|++|.+++.. ..++++..+..++.|++.||.++
T Consensus 106 ~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 185 (478)
T PTZ00267 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185 (478)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 44556788999999999999999999999999999999999999999988753 34689999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
|++|++||||||+||++ +.++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||++++
T Consensus 186 H~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 262 (478)
T PTZ00267 186 HSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262 (478)
T ss_pred HhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHH
Confidence 99999999999999999 6788999999999976643321 23445889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 160 ELLNGYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+|++|..||...+.... .+..++.+++++|.+||+.+|.+|||+.+++.|+|++.
T Consensus 263 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 263 ELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999976543221 24567889999999999999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=263.34 Aligned_cols=206 Identities=34% Similarity=0.661 Sum_probs=191.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+++..-.+++|+++++.|+||||+.+|+.|+..+.+.|||||..+|.|-||+...+.+++.....+++||+.|+.|+|.+
T Consensus 93 deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn 172 (668)
T KOG0611|consen 93 DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN 172 (668)
T ss_pred cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc
Confidence 44556689999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g 164 (226)
+++|||||.+||++ +.++.++|.|||++..+.........+|++.|.+||...+.+| .+..|.||||+++|.++.|
T Consensus 173 rVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 173 RVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred cceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 99999999999999 7888999999999999988888888999999999999999987 4899999999999999999
Q ss_pred CCCCCCCCccccc---------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 165 YPPFSGRNNVQLI---------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 165 ~~p~~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
..||++.+..... .+..+++..-+|++||-.||.+|-|++++-.|.|+.-
T Consensus 250 tMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 9999998754332 5667888999999999999999999999999999864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=269.44 Aligned_cols=201 Identities=34% Similarity=0.604 Sum_probs=174.5
Q ss_pred HHHHHH-HHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 12 CLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 12 ~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
.+..|. .+++.++||||+++++.+...+..++||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||
T Consensus 41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~ 120 (323)
T cd05575 41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120 (323)
T ss_pred HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 344444 4567889999999999999999999999999999999999988899999999999999999999999999999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 169 (226)
||+|.||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++++|++|..||.
T Consensus 121 dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 121 DLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred CCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 999999999 6788999999999865432 222334568889999999998899999999999999999999999998
Q ss_pred CCCccc----------ccccCCChHHHHHHHHhhccCccccCCH----hHHhcCcccccc
Q 027233 170 GRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRRN 215 (226)
Q Consensus 170 ~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~----~~~l~~~~~~~~ 215 (226)
+.+... .....++.++.++|++||+.+|.+||++ .++++||||...
T Consensus 198 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 198 SRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 764322 1255679999999999999999999987 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=271.27 Aligned_cols=204 Identities=25% Similarity=0.510 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++.+++|+||+++++.+.+....++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++||
T Consensus 43 ~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 43 EQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC------------------------------------ccccccCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGS 131 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~------------------------------------~~~~~~~~ 131 (226)
+||||||+||++ +.++.++|+|||++....... ......|+
T Consensus 123 vHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 199 (363)
T cd05628 123 IHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGT 199 (363)
T ss_pred EecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCC
Confidence 999999999999 678899999999986542210 01134688
Q ss_pred ccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------------c--cCCChHHHHHHHHhhccCc
Q 027233 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------V--PALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 132 ~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------------~--~~~~~~~~~~i~~~l~~~p 197 (226)
..|+|||.+.+..++.++|+||||+++++|++|..||.+.+..... + ..++.+++++|.+|+. +|
T Consensus 200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~ 278 (363)
T cd05628 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW 278 (363)
T ss_pred ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence 9999999999889999999999999999999999999875432211 1 2367899999999875 44
Q ss_pred c---ccCCHhHHhcCcccccc
Q 027233 198 V---DRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 198 ~---~Rpt~~~~l~~~~~~~~ 215 (226)
. .||+++|+++||||++.
T Consensus 279 ~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 279 EHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred hhcCCCCCHHHHhCCCCCCCC
Confidence 4 46899999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=268.31 Aligned_cols=205 Identities=30% Similarity=0.574 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|+.++.++ +||||+++++.+...+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 37 ~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 116 (329)
T cd05618 37 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116 (329)
T ss_pred hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3455678899998887 899999999999999999999999999999999988889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 117 ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (329)
T cd05618 117 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred eeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC
Confidence 9999999999999 6788999999999865322 22233456889999999999889999999999999999999999
Q ss_pred CCCCCCCcc-------------------cccccCCChHHHHHHHHhhccCccccCC------HhHHhcCcccccc
Q 027233 166 PPFSGRNNV-------------------QLIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt------~~~~l~~~~~~~~ 215 (226)
.||...... ...+...+.++.+++++||+.||.+|+| +.++++||||+..
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 194 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999531110 1125667889999999999999999998 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=267.18 Aligned_cols=204 Identities=34% Similarity=0.562 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|..++... +||||+++++.+.+++..|+||||+.|++|.+++...+.+++..+..++.|++.||+|||++|+
T Consensus 38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 117 (316)
T cd05620 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 445667788888765 8999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 118 vHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 194 (316)
T cd05620 118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred EecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 999999999999 6788999999998864322 222334568899999999998899999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH-hHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF-NEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.+++++|++||+.||.+|+++ +++++||||+..
T Consensus 195 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 195 PFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 9976543221 245578899999999999999999998 589999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=261.51 Aligned_cols=202 Identities=31% Similarity=0.495 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+|+.+++.++|+||+++++.+..++..+++|||+.+++|.+++... ..+++..+..++.|++.|+.|||+.|+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 455778999999999999999999999999999999999999999988654 368999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 124 vH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred EecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 999999999999 67788999999998765443333344678899999999888899999999999999999999999
Q ss_pred CCCCCccc--------------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccc
Q 027233 168 FSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 214 (226)
Q Consensus 168 ~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~ 214 (226)
|.+..... .....++..+.+++.+|++.||.+|| +++++++||||..
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 201 FRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 98754321 11446789999999999999999999 8999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=268.41 Aligned_cols=204 Identities=30% Similarity=0.497 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|+++++.+ +|++|+++++.+..++..+++|||+++++|.+++.....+++..+..++.||+.||.|||++|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 126 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 445688899999999 5999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g 164 (226)
+||||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++||||||+++++|++|
T Consensus 127 vHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 127 VYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred EecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 999999999999 678899999999987653322 22345688999999998765 478899999999999999999
Q ss_pred CCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 165 YPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
..||...... ...+..++..+.+++.+||+.||.+|| +++++++||||++.
T Consensus 204 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 204 ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999643211 112456789999999999999999999 88899999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=264.76 Aligned_cols=206 Identities=30% Similarity=0.469 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+.+|+.+++.++||||+++++++.++...++|+||+. ++|.+++... +.+++..+..++.|++.||.|||++|++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 125 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3467789999999999999999999999999999999994 6888887654 4689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+||||+||++ +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 126 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 126 HRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred cCCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 67888999999998654322 22234457888999998765 457889999999999999999999
Q ss_pred CCCCCCccccc-------------------------------------------ccCCChHHHHHHHHhhccCccccCCH
Q 027233 167 PFSGRNNVQLI-------------------------------------------VPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 167 p~~~~~~~~~~-------------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
||.+....... ...+++++.+++.+||+.||.+|||+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~ 282 (303)
T cd07869 203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282 (303)
T ss_pred CCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence 99764321000 11245678999999999999999999
Q ss_pred hHHhcCccccccCccc
Q 027233 204 NEFYHHRFLRRNSAIL 219 (226)
Q Consensus 204 ~~~l~~~~~~~~~~~~ 219 (226)
+|+++||||+..+..+
T Consensus 283 ~~~l~h~~f~~~~~~~ 298 (303)
T cd07869 283 QAALSHEYFSDLPPRL 298 (303)
T ss_pred HHHhcCcccccCChhh
Confidence 9999999999875443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=259.38 Aligned_cols=202 Identities=29% Similarity=0.497 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+..|++++++++||||+++++.+..+...+++|||++|++|.+++.... .+++..+..++.|++.|+.+||+.|+
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 116 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3455679999999999999999999999999999999999999999886543 58889999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||++.............++..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 117 vH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p 193 (277)
T cd05607 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193 (277)
T ss_pred EEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCC
Confidence 999999999999 67888999999998776544333345678899999999888899999999999999999999999
Q ss_pred CCCCCccc---------------ccccCCChHHHHHHHHhhccCccccCCH----hHHhcCccccc
Q 027233 168 FSGRNNVQ---------------LIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRR 214 (226)
Q Consensus 168 ~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~----~~~l~~~~~~~ 214 (226)
|....... .....++.++.+++++||+.||.+||++ ++++.|+||+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 194 FKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 97542210 0124678999999999999999999999 77889999977
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=266.24 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (226)
+..-....+||.+|++|+||||+++.+...+. +.+|+|+|||+ -+|.-++...+ +|++.++.-+++||+.||.|+|
T Consensus 157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH 235 (560)
T KOG0600|consen 157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH 235 (560)
T ss_pred CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh
Confidence 34455788999999999999999999998876 78999999995 68988887654 8999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~ 160 (226)
.+|++|||||..|||+ ++++.++|+|||+|+.+.... .....+-|.+|.|||.+.| ..|+.+.|+||.||++.|
T Consensus 236 ~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~E 312 (560)
T KOG0600|consen 236 SRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAE 312 (560)
T ss_pred hcCeeeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHH
Confidence 9999999999999999 789999999999999776543 3455677999999999876 479999999999999999
Q ss_pred HHhCCCCCCCCCccccc---------------------------------------ccCCChHHHHHHHHhhccCccccC
Q 027233 161 LLNGYPPFSGRNNVQLI---------------------------------------VPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
|+.|...|.+.+..+.+ ...++....+|+..||..||.+|.
T Consensus 313 l~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~ 392 (560)
T KOG0600|consen 313 LFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG 392 (560)
T ss_pred HHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc
Confidence 99999999887654433 445678899999999999999999
Q ss_pred CHhHHhcCcccccc
Q 027233 202 SFNEFYHHRFLRRN 215 (226)
Q Consensus 202 t~~~~l~~~~~~~~ 215 (226)
|+.++|+++||...
T Consensus 393 tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 393 TASSALQSEYFTTE 406 (560)
T ss_pred cHHHHhcCcccccC
Confidence 99999999999443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=272.30 Aligned_cols=204 Identities=30% Similarity=0.604 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.....+.+|+.+++.++|+||+++++.+.+++..++||||+.|++|.+++...+.+++..+..++.|++.||.|||++|+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i 122 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44567889999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---------------------------------------cccc
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------------------------AEKV 128 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---------------------------------------~~~~ 128 (226)
+||||+|+||++ +.++.++|+|||++........ ....
T Consensus 123 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 123 IHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199 (364)
T ss_pred EeccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence 999999999999 6788999999998865432110 0123
Q ss_pred cCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhc
Q 027233 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLS 194 (226)
Q Consensus 129 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~ 194 (226)
.|++.|+|||.+.+..++.++|+||||+++++|++|..||.+.+..... ...+++++.++|++|+.
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~ 279 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC 279 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence 5788999999998888999999999999999999999999875432111 12468899999999996
Q ss_pred cCccccCC---HhHHhcCcccccc
Q 027233 195 ANTVDRLS---FNEFYHHRFLRRN 215 (226)
Q Consensus 195 ~~p~~Rpt---~~~~l~~~~~~~~ 215 (226)
+|.+|++ ++|+++||||++.
T Consensus 280 -~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 280 -EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred -CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999998 9999999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=272.90 Aligned_cols=204 Identities=35% Similarity=0.668 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++..++|+||+++++.+.+++..++||||+++++|.+++.+.+.+++..++.++.|++.||.+||++|+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45567899999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC------------------------------ccccccCCccccCc
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAP 137 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~------------------------------~~~~~~~~~~~~aP 137 (226)
+||||+|+||++ +.++.++|+|||++....... ......++..|+||
T Consensus 123 iH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 123 IHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred eccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence 999999999999 678899999999987665433 12334578899999
Q ss_pred ccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc------------c--ccCCChHHHHHHHHhhccCccccCC-
Q 027233 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL------------I--VPALHPDCVDMCLKLLSANTVDRLS- 202 (226)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------------~--~~~~~~~~~~~i~~~l~~~p~~Rpt- 202 (226)
|.+.+..++.++||||||+++++|++|..||........ . ...+++++.++|.+|+. +|.+|++
T Consensus 200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s 278 (350)
T cd05573 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS 278 (350)
T ss_pred HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC
Confidence 999989999999999999999999999999977643211 1 22358999999999997 9999999
Q ss_pred HhHHhcCcccccc
Q 027233 203 FNEFYHHRFLRRN 215 (226)
Q Consensus 203 ~~~~l~~~~~~~~ 215 (226)
++++++||||++.
T Consensus 279 ~~~ll~hp~~~~~ 291 (350)
T cd05573 279 FEEIKSHPFFKGI 291 (350)
T ss_pred HHHHhcCCCcCCC
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=273.11 Aligned_cols=205 Identities=31% Similarity=0.562 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+..+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 42 ~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 42 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34556788999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc------------------------------------------
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------------------ 124 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~------------------------------------------ 124 (226)
++||||||+||++ +.++.++|+|||+++.......
T Consensus 122 ivHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (377)
T cd05629 122 FIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWK 198 (377)
T ss_pred eeccCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 9999999999999 6788999999999853211000
Q ss_pred ------cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCChH
Q 027233 125 ------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHPD 184 (226)
Q Consensus 125 ------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~ 184 (226)
.....|+..|+|||.+.+..++.++|+||+|+++++|++|..||.+.+..+.. ...++.+
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (377)
T cd05629 199 KNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278 (377)
T ss_pred hcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHH
Confidence 00235788999999998888999999999999999999999999765432211 1246789
Q ss_pred HHHHHHHhhccCcccc---CCHhHHhcCcccccc
Q 027233 185 CVDMCLKLLSANTVDR---LSFNEFYHHRFLRRN 215 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~R---pt~~~~l~~~~~~~~ 215 (226)
++++|++||. +|.+| +|+.|++.||||++.
T Consensus 279 ~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 279 AEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred HHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999997 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=265.28 Aligned_cols=204 Identities=37% Similarity=0.633 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|..++..+ +||||+++++.+..++..++||||++|++|.+++...+.+++..+..++.|++.||.|||++|+
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 117 (316)
T cd05592 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 344556677777655 8999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 118 vH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~ 194 (316)
T cd05592 118 IYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred EeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCC
Confidence 999999999999 67889999999998754322 22334568899999999998889999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH-hHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF-NEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.++.+++++||+.+|.+||++ +++++||||...
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 195 PFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 9987653221 245678899999999999999999986 589999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=265.37 Aligned_cols=205 Identities=30% Similarity=0.572 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|..++.++ +|++|+++++.+...+..++||||++|++|.+++...+.+++..+..++.|++.||+|||++|
T Consensus 37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ 116 (327)
T cd05617 37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116 (327)
T ss_pred hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4556788999999998 699999999999999999999999999999999988889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 117 ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~ 193 (327)
T cd05617 117 IIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193 (327)
T ss_pred eeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence 9999999999999 678889999999986532 223334456889999999999889999999999999999999999
Q ss_pred CCCCCCCccc-----------------ccccCCChHHHHHHHHhhccCccccCC------HhHHhcCcccccc
Q 027233 166 PPFSGRNNVQ-----------------LIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt------~~~~l~~~~~~~~ 215 (226)
.||....... ..+..++..+.+++++||+.||.+|++ ++++++||||+..
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 194 SPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9996432111 125567889999999999999999998 5699999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=269.68 Aligned_cols=207 Identities=29% Similarity=0.532 Sum_probs=187.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
++..+++++|+.++.+++++||.++|+.+..+..++++||||.||++.+.++....+++..+.-++++++.|+.|+|.++
T Consensus 52 ~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~ 131 (467)
T KOG0201|consen 52 EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK 131 (467)
T ss_pred chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc
Confidence 45667899999999999999999999999999999999999999999999988777799999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
.+|+||++.||++ ...+.++|+|||.+........ ....+|++.|||||++.+..|+.++||||||++++||++|.
T Consensus 132 kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 132 KIHRDIKAANILL---SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred eecccccccceeE---eccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 9999999999999 5669999999999977765433 35678999999999999889999999999999999999999
Q ss_pred CCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 166 PPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 166 ~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.|+........+ ...+++.+++|+..||+.||+.|||+.++|+|+|++..+
T Consensus 209 PP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999877654333 446788899999999999999999999999999999854
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=272.28 Aligned_cols=207 Identities=30% Similarity=0.532 Sum_probs=182.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC--eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
+++..+++..|+.+|+.|+|+||+++|+++.+.. .+.+|+|.+.+|+|+.|.++.+..+...+..|++||++||.|||
T Consensus 81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLH 160 (632)
T KOG0584|consen 81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLH 160 (632)
T ss_pred ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhh
Confidence 3445689999999999999999999999998754 48899999999999999999999999999999999999999999
Q ss_pred hCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 84 SHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 84 ~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
++. |+|||||.+||+|+ +..|.|||+|+|+|+......... ..||+.|||||+.- ..|....||||||+|++||
T Consensus 161 s~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEM 236 (632)
T KOG0584|consen 161 SQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSHAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEM 236 (632)
T ss_pred cCCCCccccccccceEEEc--CCcCceeecchhHHHHhhccccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHH
Confidence 986 99999999999997 678999999999998887665544 78999999999987 7899999999999999999
Q ss_pred HhCCCCCCCCCccc-c------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 162 LNGYPPFSGRNNVQ-L------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 162 ~~g~~p~~~~~~~~-~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
+++.-||..=.... + +..--++++++||.+||.. ..+|+|+.|+|+||||...-.
T Consensus 237 vT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 237 VTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 99999996432221 1 1233378899999999999 899999999999999998644
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=256.70 Aligned_cols=202 Identities=30% Similarity=0.553 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++...+.+++..+..++.|++.|+.+||+.|+
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i 127 (267)
T cd06628 48 SMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127 (267)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 34578999999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-------cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+||||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|+++++
T Consensus 128 vH~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~ 204 (267)
T cd06628 128 IHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204 (267)
T ss_pred ccccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence 999999999999 6788899999999876642211 112346778999999988888999999999999999
Q ss_pred HHhCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 161 LLNGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 161 l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+++|..||...+... ..+...+..+.++|++||+.+|.+||++.|+++||||
T Consensus 205 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 205 MLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999997653321 1245678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.80 Aligned_cols=204 Identities=35% Similarity=0.581 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+....|..++..+ +||||+++++++.+.+..++||||++|++|.+++.....+++..+..++.|++.||.|||++|+
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 117 (316)
T cd05619 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117 (316)
T ss_pred hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 344566777888765 9999999999999999999999999999999999887889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 118 vHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (316)
T cd05619 118 VYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred EeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 999999999999 67889999999998654222 22334567889999999998889999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHh-HHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFN-EFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.+++++|.+||+.+|.+||++. ++++||||+..
T Consensus 195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 195 PFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 9976543221 2445788999999999999999999996 99999999884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=264.29 Aligned_cols=205 Identities=34% Similarity=0.634 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHHhcCCC-CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+..|.+++..++| ++|+++++.+...+..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++|
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 455677889999999965 5688999999999999999999999999999988888999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 122 ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 198 (324)
T cd05587 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198 (324)
T ss_pred eEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCC
Confidence 9999999999999 6788999999999865322 22233456889999999999888999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH-----hHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~-----~~~l~~~~~~~~ 215 (226)
.||.+.+.... .+..++.++.+++++||+.+|.+|++. +++++||||.+.
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 199 PPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99987653322 255688999999999999999999986 899999999873
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=270.27 Aligned_cols=205 Identities=31% Similarity=0.568 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++|+||+++++.+.+.+..++||||++|++|.+++...+.+++..+..++.||+.||.+||+.||
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~gi 122 (381)
T cd05626 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122 (381)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45567899999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--------------------------------------------
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------------------------------- 123 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-------------------------------------------- 123 (226)
+||||||+||++ +.++.++|+|||++.......
T Consensus 123 vHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred eecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 999999999999 678899999999875321000
Q ss_pred ----ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCChHH
Q 027233 124 ----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHPDC 185 (226)
Q Consensus 124 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~ 185 (226)
......|+..|+|||.+.+..++.++|+||||+++++|++|..||...+..... ...+++++
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 279 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA 279 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHH
Confidence 011235888999999998888999999999999999999999999765432111 22478999
Q ss_pred HHHHHHhhc--cCccccCCHhHHhcCcccccc
Q 027233 186 VDMCLKLLS--ANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 186 ~~~i~~~l~--~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.++|.+|+. .++..|++++++++||||.+.
T Consensus 280 ~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 280 VDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999664 555569999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=266.36 Aligned_cols=204 Identities=27% Similarity=0.432 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|+++++.++|+||+++++++..++..++++||+++++|.+. ...++..+..++.||+.||.|||++
T Consensus 112 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~ 187 (353)
T PLN00034 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRR 187 (353)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345567899999999999999999999999999999999999999998753 3456788889999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-----cCCCcchhHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILF 159 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~~~ 159 (226)
|++||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.. ...+.++||||||+++|
T Consensus 188 ~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~ 264 (353)
T PLN00034 188 HIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264 (353)
T ss_pred CEeecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHH
Confidence 99999999999999 678899999999987654322 1234468889999998742 23456899999999999
Q ss_pred HHHhCCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 160 ELLNGYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++++|..||...... ......++.+++++|.+||+.||.+|||+.|+++||||.+..
T Consensus 265 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 265 EFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999743221 112456788999999999999999999999999999999963
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=271.14 Aligned_cols=205 Identities=33% Similarity=0.613 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|++++++++|+||+++++.+.+++..++||||+++++|.+++.+.+.+++..+..++.||+.||.+||++|
T Consensus 42 ~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ 121 (382)
T cd05625 42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121 (382)
T ss_pred HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34566889999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC--------------------------------------------
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------------------------------------------- 122 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-------------------------------------------- 122 (226)
|+||||||+||++ +.++.++|+|||++......
T Consensus 122 ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (382)
T cd05625 122 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR 198 (382)
T ss_pred eecCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcc
Confidence 9999999999999 67889999999987432100
Q ss_pred ----CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCChH
Q 027233 123 ----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHPD 184 (226)
Q Consensus 123 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~ 184 (226)
.......|+..|+|||.+.+..++.++|+||+|+++++|++|..||.+.+..... ...++++
T Consensus 199 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (382)
T cd05625 199 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPE 278 (382)
T ss_pred ccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHH
Confidence 0011235788999999999889999999999999999999999999875432111 2457899
Q ss_pred HHHHHHHhhccCccccCC---HhHHhcCcccccc
Q 027233 185 CVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN 215 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~Rpt---~~~~l~~~~~~~~ 215 (226)
+.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 279 ~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 279 ASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999987 59999997 9999999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=264.02 Aligned_cols=203 Identities=33% Similarity=0.570 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHH---hcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFL---SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|.+++ +.++||||+++++++...+..|+||||++|++|..++.. +.+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 445677776665 456799999999999999999999999999999988764 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 121 ~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G 197 (324)
T cd05589 121 KIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197 (324)
T ss_pred CeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhC
Confidence 99999999999999 67889999999988654322 223345688899999999988899999999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
..||.+.+.... .+..++.++.++|++||+.||.+|| ++.++++||||++.
T Consensus 198 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 198 ESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999987653221 2556889999999999999999999 79999999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=246.41 Aligned_cols=206 Identities=33% Similarity=0.602 Sum_probs=188.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....++++|+++.+.|+||||+++|++|.+...+|+++||..+|+|...++ ..+++++...+.+++|++.|+.|+|.
T Consensus 63 ~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~ 142 (281)
T KOG0580|consen 63 TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL 142 (281)
T ss_pred hcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc
Confidence 3456789999999999999999999999999999999999999999999998 55789999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
++++||||+|+|+++ +..+.+++.|||-+.... .+.....+|+..|.|||+..+...+...|+|++|++.+|++.|
T Consensus 143 k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg 218 (281)
T KOG0580|consen 143 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG 218 (281)
T ss_pred CCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence 999999999999999 788999999999886654 5556778899999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 165 YPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 165 ~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
..||.+....+.. +..++.+++|+|.+|+..+|.+|.+..|++.|||+...+
T Consensus 219 ~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 219 LPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred CCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 9999987643322 788999999999999999999999999999999998754
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=266.46 Aligned_cols=202 Identities=34% Similarity=0.605 Sum_probs=174.9
Q ss_pred HHHHHHHH-HHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 11 SCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
..+..|.. +++.++||||+++++.+...+..++||||+.|++|..++.+.+++++..+..++.||+.||.|||++|++|
T Consensus 40 ~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH 119 (325)
T cd05604 40 KHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 44445544 56778999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus 120 ~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf 196 (325)
T cd05604 120 RDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196 (325)
T ss_pred cCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCC
Confidence 9999999999 6788999999999865322 22233456889999999999888999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH----hHHhcCcccccc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRRN 215 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~----~~~l~~~~~~~~ 215 (226)
...+.... .....+..+.+++++||+.+|.+||++ .++++||||...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 197 YCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 87653322 145678899999999999999999977 599999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=271.65 Aligned_cols=203 Identities=32% Similarity=0.589 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++|+||+++++.+.+++..++||||++|++|.+++.+.+.+++..+..++.||+.||+|||++||
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 122 (376)
T cd05598 43 NQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122 (376)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC--------------------------------------------C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------N 123 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~--------------------------------------------~ 123 (226)
+||||||+||++ +.++.++|+|||++...... .
T Consensus 123 vHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred EeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 999999999999 67889999999987432100 0
Q ss_pred ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCChHHHHHH
Q 027233 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHPDCVDMC 189 (226)
Q Consensus 124 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i 189 (226)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.. ...+++++.++|
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 279 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI 279 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHH
Confidence 001235888999999999889999999999999999999999999876532211 235788999999
Q ss_pred HHhhccCccccC---CHhHHhcCccccc
Q 027233 190 LKLLSANTVDRL---SFNEFYHHRFLRR 214 (226)
Q Consensus 190 ~~~l~~~p~~Rp---t~~~~l~~~~~~~ 214 (226)
.+|+ .+|.+|+ |+.++++||||+.
T Consensus 280 ~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 280 LRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred HHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9977 5999999 9999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=268.27 Aligned_cols=203 Identities=32% Similarity=0.549 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+..+.+.+|+.+++.++|+||+++++.+.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||.+||++|
T Consensus 43 ~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ 122 (330)
T cd05601 43 ETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122 (330)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45667899999999999999999999999999999999999999999999876 68999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCccccc------ccCCCcchhHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~~~ 158 (226)
++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+. +..++.++|+||+|+++
T Consensus 123 i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 123 YVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred eEcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 9999999999999 6788999999999976654332 22345788999999986 45677899999999999
Q ss_pred HHHHhCCCCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 159 FELLNGYPPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
++|++|..||........ ....+++++.+++.+||+ +|.+|||++++++||||..
T Consensus 200 ~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 200 YEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 999999999976543211 123578899999999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=259.68 Aligned_cols=202 Identities=36% Similarity=0.558 Sum_probs=178.3
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeC--C---eEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--N---CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~---~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
+.-.+|+++|+.++|||||++..+|... + ...+|+||+ ..+|...++. +.+++.-.++-+.+||+.||+|
T Consensus 62 r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~y 140 (364)
T KOG0658|consen 62 RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAY 140 (364)
T ss_pred CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHH
Confidence 3456899999999999999999888643 2 345899999 4799988874 4678888999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~ 160 (226)
||+.||+||||||.|++++ ..++.+||||||+|+....+........+..|.|||.+.+ ..|+.+.||||.|||+.|
T Consensus 141 Lh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 141 LHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred HHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 9999999999999999996 5679999999999999988888788888999999999876 479999999999999999
Q ss_pred HHhCCCCCCCCCccccc---------------------------------------ccCCChHHHHHHHHhhccCccccC
Q 027233 161 LLNGYPPFSGRNNVQLI---------------------------------------VPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
|+.|+..|++.+..+.+ ....+++..+++.++|..+|.+|.
T Consensus 219 Ll~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred HhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 99999999987654333 455789999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 027233 202 SFNEFYHHRFLRRN 215 (226)
Q Consensus 202 t~~~~l~~~~~~~~ 215 (226)
++.|++.||||+..
T Consensus 299 ~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 299 SALEALAHPFFDEL 312 (364)
T ss_pred CHHHHhcchhhHHh
Confidence 99999999999974
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=253.67 Aligned_cols=205 Identities=34% Similarity=0.636 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+++++.++|+||+++++.+.+++..++++||+++++|.+++.+...+++..+..++.|++.||.+||++|+
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 114 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI 114 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 45678999999999999999999999999999999999999999999999988789999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|+||++ +.++.++|+|||.+.............++..|++||...+..++.++|+||+|++++++++|..|
T Consensus 115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence 999999999999 67888999999998776544333344577889999998888889999999999999999999999
Q ss_pred CCCCCc--cc------------ccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 168 FSGRNN--VQ------------LIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~--~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|..... .. ..+...+.++.+++.+||+.+|.+||+ +.|+++||||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 976651 11 113445789999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=253.69 Aligned_cols=202 Identities=29% Similarity=0.546 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++.+..++++..+..++.|++.++++||+.|+
T Consensus 44 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (265)
T cd06631 44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567999999999999999999999999999999999999999999999887889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-------CccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||...+..++.++|+||||+++++
T Consensus 124 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 124 VHRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200 (265)
T ss_pred ccCCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence 999999999999 67889999999988654221 11123346778999999988888999999999999999
Q ss_pred HHhCCCCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 161 LLNGYPPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 161 l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+++|..||...+... ..+..++.++.++|++||+.+|.+|||+.|+++||||
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 201 MATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999997644221 2255578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=257.50 Aligned_cols=204 Identities=36% Similarity=0.670 Sum_probs=182.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++...+..++++||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i 122 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45677899999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|.||++ +.++.++|+|||++...... .....++..|+|||...+...+.++|+||||++++++++|..|
T Consensus 123 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 123 VYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred ecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999 67888999999998776444 3344578889999999888888999999999999999999999
Q ss_pred CCCCCccc----------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccccC
Q 027233 168 FSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 216 (226)
|...+... ..+..++..++++|++||+.+|.+|+ +++|+++||||....
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 198 FFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 97655321 12456789999999999999999999 999999999998854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=267.89 Aligned_cols=203 Identities=31% Similarity=0.532 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++.. ..+++..+..++.|++.||+|||++|++
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iv 164 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFI 164 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 445678899999999999999999999999999999999999999998875 4688999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCccccccc----CCCcchhHHHHHHHHHHHH
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~~~~l~ 162 (226)
||||+|+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||||+++|+|+
T Consensus 165 HrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell 241 (370)
T cd05596 165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (370)
T ss_pred ccCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence 99999999999 678899999999987654332 12345688999999998653 3788999999999999999
Q ss_pred hCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 163 NGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
+|..||.+.+..... ...++.++.++|++||+.+|.+ |+|++++++||||+..
T Consensus 242 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 242 VGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred hCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999875432111 2247899999999999999987 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=263.15 Aligned_cols=201 Identities=33% Similarity=0.570 Sum_probs=173.4
Q ss_pred HHHHHHH-HHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 11 SCLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
..+..|. .+++.++||||+++++.+.+.+..++||||++|++|.+++.....+++..+..++.||+.||.|||++|++|
T Consensus 40 ~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH 119 (321)
T cd05603 40 NHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119 (321)
T ss_pred HHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 3444454 467888999999999999999999999999999999999988788999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus 120 ~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 196 (321)
T cd05603 120 RDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196 (321)
T ss_pred ccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCC
Confidence 9999999999 6788999999999865322 22233456788999999998888999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH----hHHhcCccccc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRR 214 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~----~~~l~~~~~~~ 214 (226)
...+.... .+...+.++.+++.+||+.+|.+|+++ .++++|+||..
T Consensus 197 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 197 YSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 77643211 245678899999999999999999875 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=251.87 Aligned_cols=204 Identities=26% Similarity=0.490 Sum_probs=178.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|++++++++||||+++++++.+++..++++||++|++|.+++... ..+++..++.++.+++.|+.+||
T Consensus 39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH 118 (256)
T cd08529 39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118 (256)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556778999999999999999999999999999999999999999999999774 47889999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++++
T Consensus 119 ~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd08529 119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195 (256)
T ss_pred HCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 9999999999999999 6778899999998876644322 22345678899999998888899999999999999999
Q ss_pred hCCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 163 NGYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 163 ~g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|..||...+.... ....++.++.+++.+|++.+|++||++.++++|||+
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 196 TGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999976653211 133678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=262.13 Aligned_cols=211 Identities=33% Similarity=0.625 Sum_probs=193.7
Q ss_pred hhhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 027233 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 4 ~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l 82 (226)
+++.-....+..|++-|+.++|||||++|+....+..+|+|.|.-++|+|.||+-++. .+.+....+++.||+.|+.|+
T Consensus 55 KlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC 134 (864)
T KOG4717|consen 55 KLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC 134 (864)
T ss_pred ccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH
Confidence 3456677789999999999999999999999999999999999999999999998774 799999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCC-cchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~~~~l 161 (226)
|...++||||||+|+++. .+-+-+||.|||++..+.++......+|+..|.|||.+.+..|+ ++.||||||+++|-+
T Consensus 135 HqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyML 212 (864)
T KOG4717|consen 135 HQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYML 212 (864)
T ss_pred hhhhhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHH
Confidence 999999999999999885 56788999999999999888888888999999999999998886 799999999999999
Q ss_pred HhCCCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 162 LNGYPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++|+.||......+.+ +..++.+++++|..||..||++|-+.++|..++|++..-
T Consensus 213 VCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 213 VCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 9999999877655443 778899999999999999999999999999999999853
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=263.42 Aligned_cols=198 Identities=34% Similarity=0.604 Sum_probs=172.7
Q ss_pred HHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccC
Q 027233 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (226)
Q Consensus 14 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (226)
.++..+++.++|+||+++++.+...+..++||||++|++|.+++...+.+++..+..++.||+.||.|||++|++|||||
T Consensus 44 ~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlk 123 (325)
T cd05602 44 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 123 (325)
T ss_pred HHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 33344577889999999999999999999999999999999999988889999999999999999999999999999999
Q ss_pred CCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 027233 94 PENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (226)
Q Consensus 94 ~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 172 (226)
|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++++|++|..||.+.+
T Consensus 124 p~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 124 PENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred HHHeEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 999999 6788999999999865432 222334568899999999998899999999999999999999999998654
Q ss_pred cccc----------cccCCChHHHHHHHHhhccCccccCCHh----HHhcCccccc
Q 027233 173 NVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFN----EFYHHRFLRR 214 (226)
Q Consensus 173 ~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~----~~l~~~~~~~ 214 (226)
.... ....++..+.++|++||+.+|.+|+++. ++++|+||..
T Consensus 201 ~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 201 TAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 3221 2456899999999999999999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=258.56 Aligned_cols=198 Identities=35% Similarity=0.541 Sum_probs=167.7
Q ss_pred HHHHHHHHHHhcC---CCCCeeeeeeEEE-----eCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 11 ~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~ 80 (226)
..+.+|+.+++.+ +||||+++++++. .....++++||++ ++|.+++... ..+++..+..++.|++.||.
T Consensus 46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 124 (290)
T cd07862 46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124 (290)
T ss_pred HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence 3455677776665 6999999999875 2456899999995 6999998764 35899999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
|||++|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++
T Consensus 125 ~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 201 (290)
T cd07862 125 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 201 (290)
T ss_pred HHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence 9999999999999999999 6788999999999977655444445567889999999988889999999999999999
Q ss_pred HHhCCCCCCCCCcccc-------------------------------------cccCCChHHHHHHHHhhccCccccCCH
Q 027233 161 LLNGYPPFSGRNNVQL-------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~-------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
+++|..||.+....+. ..+.++..+.+++.+||+.+|++|||+
T Consensus 202 l~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 281 (290)
T cd07862 202 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281 (290)
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH
Confidence 9999999976543111 023567889999999999999999999
Q ss_pred hHHhcCccc
Q 027233 204 NEFYHHRFL 212 (226)
Q Consensus 204 ~~~l~~~~~ 212 (226)
.|+++||||
T Consensus 282 ~~~l~hp~f 290 (290)
T cd07862 282 YSALSHPYF 290 (290)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=255.82 Aligned_cols=202 Identities=32% Similarity=0.531 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+.+++.++|++|+++++.+...+..++++||+.|++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 456778999999999999999999999999999999999999999998654 358999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 999999999999 67788999999998765433333344688899999999888899999999999999999999999
Q ss_pred CCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCccccc
Q 027233 168 FSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 214 (226)
Q Consensus 168 ~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~ 214 (226)
|...... ......+++++.+++++||+.||.+||| ++|+++||||++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 201 FQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9864321 1114567889999999999999999999 899999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=253.09 Aligned_cols=199 Identities=37% Similarity=0.645 Sum_probs=174.4
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
....+|+.++++++|+||+++++++...+..++++|++.+++|.+++.....+++..+..++.|++.||.+||++|++|+
T Consensus 43 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~ 122 (260)
T PF00069_consen 43 EENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHR 122 (260)
T ss_dssp HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred chhhhhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34456999999999999999999999999999999999988999999977899999999999999999999999999999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeecccccc-CCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||+|+||++ +.++.++|+|||.+... ..........++..|.|||... +...+.++|+||+|+++++|++|..||
T Consensus 123 dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~ 199 (260)
T PF00069_consen 123 DIKPENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPF 199 (260)
T ss_dssp SBSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSS
T ss_pred ccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999 78889999999998763 2233344566788999999988 788999999999999999999999999
Q ss_pred CCCCccccc-----------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 169 SGRNNVQLI-----------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 169 ~~~~~~~~~-----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
......+.. ....+..+.+++++||+.||.+|||+.++++||||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 200 EESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 876211111 11123799999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=267.63 Aligned_cols=205 Identities=27% Similarity=0.565 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+..+.+.+|+.++.+++|++|+++++.+.+++..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++|
T Consensus 42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g 121 (360)
T cd05627 42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121 (360)
T ss_pred hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566788999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC------------------------------------ccccccC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCG 130 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~------------------------------------~~~~~~~ 130 (226)
++||||||+||++ +.++.++|+|||++....... ......|
T Consensus 122 ivHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 198 (360)
T cd05627 122 FIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVG 198 (360)
T ss_pred eEccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCC
Confidence 9999999999999 678899999999886442110 0112458
Q ss_pred CccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------------c--cCCChHHHHHHHHhhccC
Q 027233 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------V--PALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 131 ~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------------~--~~~~~~~~~~i~~~l~~~ 196 (226)
+..|+|||.+.+..++.++|+||||+++++|++|..||.+.+..... + ..++.+++++|.+|+ .+
T Consensus 199 t~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~ 277 (360)
T cd05627 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TD 277 (360)
T ss_pred CccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cC
Confidence 88999999999999999999999999999999999999776533211 1 236889999999987 49
Q ss_pred ccccC---CHhHHhcCcccccc
Q 027233 197 TVDRL---SFNEFYHHRFLRRN 215 (226)
Q Consensus 197 p~~Rp---t~~~~l~~~~~~~~ 215 (226)
|.+|+ +++++++||||++.
T Consensus 278 p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 278 SENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred hhhcCCCCCHHHHhcCCCCCCC
Confidence 99998 58999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=251.39 Aligned_cols=200 Identities=31% Similarity=0.560 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|++++++++|+||+++++.+.+....++++||+++++|.+++... ..+++..+..++.|++.|+.+||+.|++
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~ 121 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 678999999999999999999999999999999999999999999999764 4789999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 678889999999987665433 22234467789999999888899999999999999999999999
Q ss_pred CCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 168 FSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 168 ~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|......... ...++.++.+++.+|++.+|.+|||+.|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 8765432211 23466789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=261.13 Aligned_cols=204 Identities=32% Similarity=0.602 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|..++..+ .|++|+++++.+.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|+
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred HHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 344567788888887 6899999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 123 vHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 123 IYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred EecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 999999999999 6788999999999875432 222334568899999999999999999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH-----hHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~-----~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.++.+++.+||+.+|.+|++. .++++||||+..
T Consensus 200 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 200 PFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9987653322 145688999999999999999999984 899999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=263.00 Aligned_cols=201 Identities=31% Similarity=0.599 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
+.+++|+.+|++|.|||||++++...+ .+.+|+|+|||..|.+.. ....++ +++.+.+.++++++.||.|||.+||
T Consensus 153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi 231 (576)
T KOG0585|consen 153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGI 231 (576)
T ss_pred HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 688999999999999999999999876 467999999999888764 333345 8999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC------CccccccCCccccCcccccccC----CCcchhHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAI 157 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~ 157 (226)
+||||||.|+|+ +.++++||+|||.+.....+ .......||+.|+|||...+.. .+.+.||||+|++
T Consensus 232 iHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 232 IHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred eccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 999999999999 68899999999998766322 2223467999999999986532 3568999999999
Q ss_pred HHHHHhCCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 158 LFELLNGYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+|.++.|+.||-+....+.. .+.+..+++++|++||++||.+|.++.++..|||..+.
T Consensus 309 LYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 99999999999876433222 33467899999999999999999999999999999886
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=253.25 Aligned_cols=204 Identities=32% Similarity=0.550 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
+..+.+.+|++++++++|+||+++++++.+.+..++++||+.|++|.+++...+++++..+..++.|++.|+.+||++|+
T Consensus 45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i 124 (268)
T cd06630 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45688999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+|+||+|.||+++ ..+..++|+|||.+........ .....++..|+|||...+..++.++|+||+|+++++++
T Consensus 125 ~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 202 (268)
T cd06630 125 IHRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202 (268)
T ss_pred ecCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence 9999999999993 2334699999999876654321 12234677899999998888899999999999999999
Q ss_pred hCCCCCCCCCccc---------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 163 NGYPPFSGRNNVQ---------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 163 ~g~~p~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
+|..||....... ..+..+++++.+++.+|+..+|.+|||+.++++||||+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 203 TAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999996543211 12445788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=259.14 Aligned_cols=208 Identities=26% Similarity=0.380 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.+++... ..+++..++.++.|++.||.|||++
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 120 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45567889999999999999999999999999999999999999999999753 4589999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--------ccccccCCccccCcccccc--cCCCcchhHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVG 155 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG 155 (226)
|++|+||+|+||++ +.++.+++.||+......... ......++..|+|||.+.+ ..++.++|+||+|
T Consensus 121 ~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG 197 (327)
T cd08227 121 GYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197 (327)
T ss_pred CEecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHH
Confidence 99999999999999 677889999987653332111 1112235567999999865 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCCcccc--------------------------------------------------------ccc
Q 027233 156 AILFELLNGYPPFSGRNNVQL--------------------------------------------------------IVP 179 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~~--------------------------------------------------------~~~ 179 (226)
++++++++|..||........ ...
T Consensus 198 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (327)
T cd08227 198 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNR 277 (327)
T ss_pred HHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccccc
Confidence 999999999999964321100 012
Q ss_pred CCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 180 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 180 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
.+++.+.+++++||+.||.+|||++|+++||||+..+..
T Consensus 278 ~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 278 TFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred ccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 346789999999999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=256.77 Aligned_cols=206 Identities=32% Similarity=0.523 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (226)
....+.+.+|++++++++||||+++++.+..++..++++||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (308)
T cd06615 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119 (308)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 445667889999999999999999999999999999999999999999999988889999999999999999999997 5
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+++|+||+|+||++ +.++.++|+|||.+....... .....++..|+|||...+..++.++|+||+|++++++++|.
T Consensus 120 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 120 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred CEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 89999999999999 567889999999886553322 23345788899999998888899999999999999999999
Q ss_pred CCCCCCCccccc------------------------------------------------ccCCChHHHHHHHHhhccCc
Q 027233 166 PPFSGRNNVQLI------------------------------------------------VPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 166 ~p~~~~~~~~~~------------------------------------------------~~~~~~~~~~~i~~~l~~~p 197 (226)
.||...+..... ...++.++++++.+||+.+|
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (308)
T cd06615 196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275 (308)
T ss_pred CCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCCh
Confidence 998643211000 12357789999999999999
Q ss_pred cccCCHhHHhcCccccccC
Q 027233 198 VDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+|||+.|+++||||.+..
T Consensus 276 ~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 276 KERADLKELTKHPFIKRAE 294 (308)
T ss_pred hhCcCHHHHhcChhhhhcc
Confidence 9999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=253.27 Aligned_cols=208 Identities=33% Similarity=0.517 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+++++.++|+||+++++++..++..++++||+++++|..++.+ ..++++..+..++.|++.||.+||+.
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~ 122 (282)
T cd06643 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122 (282)
T ss_pred HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34566788899999999999999999999999999999999999999998765 45789999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccc-----ccCCCcchhHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~~ 159 (226)
|++||||+|+||++ +.++.++++|||++....... ......++..|+|||.+. +..++.++|+||+|++++
T Consensus 123 ~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 123 KIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred CeeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 99999999999999 678889999999886543321 123345778899999873 345778999999999999
Q ss_pred HHHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 160 ELLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
++++|..||...+.... .+..++.+++++|.+||+.+|.+|||++++++||||+..+.
T Consensus 200 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 200 EMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 99999999876543211 13457889999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=250.42 Aligned_cols=205 Identities=30% Similarity=0.542 Sum_probs=178.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+..+.+.+|++++++++|+|++++++.+...+..++|+||+++++|.+++... ..+++..+..++.+++.++++||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 118 (256)
T cd08220 39 TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118 (256)
T ss_pred ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3455778999999999999999999999999999999999999999999999864 35899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|++|+||+|+||+++ ..+..++|+|||.+.............++..|+|||...+...+.++|+||+|++++++++
T Consensus 119 ~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 119 TKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred hCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh
Confidence 99999999999999994 2445689999999987765544444567888999999988888999999999999999999
Q ss_pred CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 164 GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 164 g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|..||...+... ......+.++.+++.+||+.+|.+|||+.|++.||||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 999997654211 1244578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=261.69 Aligned_cols=201 Identities=33% Similarity=0.490 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
...+.+.+|+.+++.++||||+++++++... ...+++|||++ ++|.+.+. ..+++..+..++.|++.||.|
T Consensus 62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~ 138 (359)
T cd07876 62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKH 138 (359)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999988644 35799999995 56776664 368889999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||++|++||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++++|
T Consensus 139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 999999999999999999 67889999999998765444434445678899999999988999999999999999999
Q ss_pred HhCCCCCCCCCccccc----------------------------------------------------ccCCChHHHHHH
Q 027233 162 LNGYPPFSGRNNVQLI----------------------------------------------------VPALHPDCVDMC 189 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~i 189 (226)
++|..||.+.+..... ....+++++++|
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 9999999765421100 112356789999
Q ss_pred HHhhccCccccCCHhHHhcCccccc
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.+||+.||.+|||+.|+++||||+.
T Consensus 296 ~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 296 SKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHhccCcccCCCHHHHhcCchhhh
Confidence 9999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=266.19 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=174.6
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
...+|++++++++||||+++++.+...+..+++|+++ +++|.+++.....+++..+..++.||+.||.|||++|++|||
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrD 210 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD 210 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 4568999999999999999999999999999999999 579999997778899999999999999999999999999999
Q ss_pred cCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 92 l~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 211 lkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 211 VKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred CCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999 6788999999999876543322 22346889999999999888999999999999999999999998
Q ss_pred CCCCcccc-----------------------------------------------cccCCChHHHHHHHHhhccCccccC
Q 027233 169 SGRNNVQL-----------------------------------------------IVPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 169 ~~~~~~~~-----------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
.+...... ....++.+++++|++||..+|++||
T Consensus 288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp 367 (392)
T PHA03207 288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367 (392)
T ss_pred CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence 65432100 0123467889999999999999999
Q ss_pred CHhHHhcCccccccCc
Q 027233 202 SFNEFYHHRFLRRNSA 217 (226)
Q Consensus 202 t~~~~l~~~~~~~~~~ 217 (226)
|+.|+|.||||+..+.
T Consensus 368 sa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 368 SAQDILSLPLFTKEPI 383 (392)
T ss_pred CHHHHhhCchhhccch
Confidence 9999999999987543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=256.77 Aligned_cols=205 Identities=31% Similarity=0.525 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|++.++.++|+||+++++.+.+.+..++++||+.|++|.+++... ..+++..+..++.|++.+|.+||+.
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 122 (316)
T cd05574 43 NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC
Confidence 35567899999999999999999999999999999999999999999998764 4689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc------------------------------cccccCCcccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYM 135 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~------------------------------~~~~~~~~~~~ 135 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+
T Consensus 123 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~ 199 (316)
T cd05574 123 GIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199 (316)
T ss_pred CeeccCCChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCc
Confidence 99999999999999 6778899999998765432111 11224677899
Q ss_pred CcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCC-
Q 027233 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLS- 202 (226)
Q Consensus 136 aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt- 202 (226)
|||...+..++.++|+||||++++++++|..||.+.+..... ...++.++.+++.+||+.+|.+|||
T Consensus 200 aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 200 APEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred CHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence 999998888899999999999999999999999766432211 2226889999999999999999999
Q ss_pred ---HhHHhcCcccccc
Q 027233 203 ---FNEFYHHRFLRRN 215 (226)
Q Consensus 203 ---~~~~l~~~~~~~~ 215 (226)
++|++.||||+..
T Consensus 280 ~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 280 KRGAAEIKQHPFFRGV 295 (316)
T ss_pred hhhHHHHHcCchhhcC
Confidence 9999999999884
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=252.08 Aligned_cols=207 Identities=29% Similarity=0.544 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.....+.+|+++++.++|+||+++++++.++...++++||+++++|.+++... ++++..++.++.|++.|+.+||+.++
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i 119 (274)
T cd06609 41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK 119 (274)
T ss_pred hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567889999999999999999999999999999999999999999998865 88999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 120 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 120 IHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred ccCCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 678899999999987765432 2233456778999999988889999999999999999999999
Q ss_pred CCCCCCcccc-----------cccC-CChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 167 PFSGRNNVQL-----------IVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 167 p~~~~~~~~~-----------~~~~-~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
||...+.... .... ++.++.+++.+||..+|++|||++++++||||++.+..
T Consensus 197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 197 PLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred CcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 9975432211 1222 78899999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=265.20 Aligned_cols=204 Identities=31% Similarity=0.550 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++||||+++++.+.+++..++||||++|++|.+++... .+++..+..++.||+.||++||++|+
T Consensus 85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~I 163 (370)
T cd05621 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGL 163 (370)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34556889999999999999999999999999999999999999999998754 68999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccC----CCcchhHHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~~~~l 161 (226)
+||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||+|+++++|
T Consensus 164 vHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 164 IHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred EecCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 999999999999 6788999999999976643322 22456899999999986543 67899999999999999
Q ss_pred HhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 162 LNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
++|..||.+.+..... ...++..+++++.+||..++.+ |+|++|+++||||+..
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 241 LVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999765431111 1246888999999999855543 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=253.87 Aligned_cols=194 Identities=19% Similarity=0.268 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+.+.+|+.++++++||||+++++++.+ ....++++||+++++|.+++.+.+.+++.....++.+++.|+.+||+.
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 5678899999999999999999999876 356899999999999999999888899999999999999999999984
Q ss_pred -CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc--cCCCcchhHHHHHHHHHHHH
Q 027233 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 -~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~~~~l~ 162 (226)
+++||||+|+||++ +.++.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+++
T Consensus 142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 89999999999999 678899999999987654322 23456788999999876 67899999999999999999
Q ss_pred hCCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 NGYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|..||...+..+.. +...+.++++++.+||+.||.+|||++++++
T Consensus 217 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 217 TGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 999999876532211 3357889999999999999999999999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=265.81 Aligned_cols=201 Identities=28% Similarity=0.506 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.++.-..+|+-|++|+|+||+.+.+.+.....++||||||..|.|...++...++.......|.++|+.++.|||.+.|+
T Consensus 155 V~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKII 234 (904)
T KOG4721|consen 155 VRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKII 234 (904)
T ss_pred HhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHh
Confidence 34444568899999999999999999999999999999999999999999988999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|||||.-|||| ..+..+||+|||-++....-.+.....|+..|||||++++.+-+.+.||||+|+|+|||++|+.||
T Consensus 235 HRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY 311 (904)
T KOG4721|consen 235 HRDLKSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY 311 (904)
T ss_pred hhccCCCceEe---eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc
Confidence 99999999999 678899999999998887777888899999999999999999999999999999999999999999
Q ss_pred CCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 169 SGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 169 ~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
...+...++ +...+..++-++++||+..|.+||++.|+|.|--+
T Consensus 312 kdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 312 KDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 876654443 66778889999999999999999999999988543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=252.25 Aligned_cols=204 Identities=35% Similarity=0.523 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++.+...+..++|+||+++++|.+++.+.+ .+++..+..++.|++.|+.+||+.|
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 115 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35566789999999999999999999999999999999999999999998765 6899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
++|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 116 i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 192 (277)
T cd05577 116 IVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192 (277)
T ss_pred cccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence 9999999999999 6788899999998876544333334456778999999888888999999999999999999999
Q ss_pred CCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||...... ...+..+++.+.++|++||+.+|.+|| ++.++++||||.+-
T Consensus 193 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 193 PFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred CCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 99765431 111456789999999999999999999 88889999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=268.80 Aligned_cols=201 Identities=30% Similarity=0.491 Sum_probs=166.3
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeC--------CeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l 79 (226)
...+|+.+++.++|+||+++++++... ...+++|||++ ++|.+++.. ...+++..++.++.||+.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 456799999999999999999876432 24679999996 578777653 35789999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCcchhHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL 158 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~ 158 (226)
.|||++||+||||||+||+++ ..++.++|+|||++.............++..|+|||.+.+. .++.++|+||+|+++
T Consensus 184 ~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 261 (440)
T PTZ00036 184 AYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII 261 (440)
T ss_pred HHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 999999999999999999994 23457999999999876554444455678899999988654 689999999999999
Q ss_pred HHHHhCCCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccc
Q 027233 159 FELLNGYPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVD 199 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~ 199 (226)
++|++|..||.+....+. .+...+.++.++|++||+.+|.+
T Consensus 262 ~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~ 341 (440)
T PTZ00036 262 AEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK 341 (440)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhH
Confidence 999999999976542110 02245788999999999999999
Q ss_pred cCCHhHHhcCcccccc
Q 027233 200 RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 200 Rpt~~~~l~~~~~~~~ 215 (226)
|||+.|+++||||...
T Consensus 342 R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 342 RLNPIEALADPFFDDL 357 (440)
T ss_pred CcCHHHHhCChhHHhh
Confidence 9999999999999874
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=254.26 Aligned_cols=205 Identities=30% Similarity=0.546 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+..++.++|+||+++++++...+..++++||+++++|.+++... .+++..+..++.+++.|+.+||+.|++
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~ 137 (296)
T cd06655 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVI 137 (296)
T ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4567889999999999999999999999999999999999999999988754 689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 138 H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 138 HRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred cCCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 6788899999998876543322 2234567889999999888889999999999999999999999
Q ss_pred CCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 168 FSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 168 ~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
|...+.... .+..+++.+.++|++||..+|.+|||+.++++||||+....
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 215 YLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred CCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 976543211 14457889999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=252.10 Aligned_cols=202 Identities=32% Similarity=0.555 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++.+.+....++++||+.|++|.+++.+..++++..+..++.|++++|.+||+.|+
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45678999999999999999999999999999999999999999999999887889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+...+.++|+||+|++++++++|..|
T Consensus 122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 999999999999 67888999999998776554333445577889999999888889999999999999999999999
Q ss_pred CCCCCc-------------ccccccCCChHHHHHHHHhhccCccccCCH--hHHhcCccc
Q 027233 168 FSGRNN-------------VQLIVPALHPDCVDMCLKLLSANTVDRLSF--NEFYHHRFL 212 (226)
Q Consensus 168 ~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~--~~~l~~~~~ 212 (226)
|..... ....+...+.++.++|.+||+.+|.+||++ +|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 199 YRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 987652 222355678999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=251.34 Aligned_cols=203 Identities=32% Similarity=0.523 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+++++.++|+||+.+.+.+..++..++++||+.+++|.+++... .++++..+..++.|++.||.+||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 455788999999999999999999999999999999999999999888653 368999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 999999999999 67788999999988665433333345678999999999888899999999999999999999999
Q ss_pred CCCCCccc--------------ccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 168 FSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|....... .....++.++.+++.+|++.+|.+||| +.+++.|+||+..
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 201 FRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 97654321 124567889999999999999999999 8899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=247.53 Aligned_cols=204 Identities=29% Similarity=0.511 Sum_probs=178.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|+.++++++|+||+++++++.+.+..++++||+++++|.+++... ..+++..+..++.|++.++.+||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (256)
T cd08221 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118 (256)
T ss_pred chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566678899999999999999999999999999999999999999999999865 46899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||...+..++.++|+||+|+++++++
T Consensus 119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 9999999999999999 677889999999987664433 223445788899999998888899999999999999999
Q ss_pred hCCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 163 NGYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 163 ~g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|..||......+. ....++.++.+++.+|++.+|.+|||+.++++|+|+
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 196 TLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999976543221 134568899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=257.62 Aligned_cols=205 Identities=32% Similarity=0.617 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+..|..++..+. |++|+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||.+||++|
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 121 (323)
T cd05615 42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34456778889998885 67788999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 122 ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 198 (323)
T cd05615 122 IIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198 (323)
T ss_pred eeccCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCC
Confidence 9999999999999 678889999999986543222 233445889999999999888999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
.||.+...... .+..++.++.+++.+||+.+|.+|++ .+++++||||+.-
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 199 PPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99987653321 25567899999999999999999997 4789999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=251.66 Aligned_cols=205 Identities=32% Similarity=0.559 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS- 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~- 84 (226)
....+.+.+|++++++++||||+++++.+..++..++++||+++++|.+++... ..+++..+..++.|++.++++||+
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (265)
T cd06605 40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119 (265)
T ss_pred hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence 456678899999999999999999999999999999999999999999999876 789999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
.|++|+||+|+||++ +.++.++|+|||.+......... ...++..|+|||...+..++.++|+||+|++++++++|
T Consensus 120 ~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 120 HKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999 67888999999988665432222 25577889999999888899999999999999999999
Q ss_pred CCCCCCCCcc-----c-----------ccccC-CChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 165 YPPFSGRNNV-----Q-----------LIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~-----~-----------~~~~~-~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..||...... . ..... ++.++.++|.+|+..+|.+|||+.|++.||||+..
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9998765210 0 01222 68889999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=249.79 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
....+.+|+.+++.++||||+++++.+...+..++++||+++++|.+++...+.+++..++.++.|++.++.+||+.|++
T Consensus 49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 128 (267)
T cd06645 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34567889999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHhC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 129 H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 129 HRDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred cCCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 99999999999 678889999999986654322 223445788899999874 45678899999999999999999
Q ss_pred CCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 165 YPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 165 ~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
..||......... ...++..+.+++++||+.+|++|||++++++|||
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 206 QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 9998543321110 1245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=249.71 Aligned_cols=201 Identities=29% Similarity=0.506 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++... .++++..+..++.|++.|+.+||++|
T Consensus 42 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~ 121 (262)
T cd06613 42 DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121 (262)
T ss_pred hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999999999999999999999999999999999999876 68999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc---CCCcchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~~~~l~ 162 (226)
++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+. .++.++|+||+|+++++|+
T Consensus 122 i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 122 KIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ceecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999999 678889999999987654322 22334567789999998766 7889999999999999999
Q ss_pred hCCCCCCCCCcccc---------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 163 NGYPPFSGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 163 ~g~~p~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
+|..||........ ....++.++.+++++|++.+|.+|||+++++.|+|
T Consensus 199 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 199 ELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999876542211 12335678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=262.54 Aligned_cols=203 Identities=29% Similarity=0.461 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+.+|+++++.++|+||+++++++...+ ..|+|+||+. ++|.+++.....+++..+..++.|++.||.|||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999998766 7899999995 689998887788999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCccccccc-CCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~ 160 (226)
++|++||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 197 (372)
T cd07853 121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197 (372)
T ss_pred hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence 9999999999999999 678899999999987653322 12233567889999998764 47889999999999999
Q ss_pred HHhCCCCCCCCCcccc------------------------------------------cccCCChHHHHHHHHhhccCcc
Q 027233 161 LLNGYPPFSGRNNVQL------------------------------------------IVPALHPDCVDMCLKLLSANTV 198 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~------------------------------------------~~~~~~~~~~~~i~~~l~~~p~ 198 (226)
|++|..||.+.+.... .....+.++.++|.+||+.||.
T Consensus 198 l~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 277 (372)
T cd07853 198 LLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277 (372)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence 9999999976542110 1234577899999999999999
Q ss_pred ccCCHhHHhcCcccccc
Q 027233 199 DRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 199 ~Rpt~~~~l~~~~~~~~ 215 (226)
+|||+.|+++||||++.
T Consensus 278 ~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 278 KRISAADALAHPYLDEG 294 (372)
T ss_pred hCcCHHHHhcCHhhCCC
Confidence 99999999999999884
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=248.12 Aligned_cols=202 Identities=33% Similarity=0.589 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
+..+.+.+|+.+++.++|+||+++++++.+.+..++++||+++++|.+++.+.+.+++..+..++.|++.++++||+.|+
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 123 (258)
T cd06632 44 EAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45678999999999999999999999999999999999999999999999888789999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccC-CCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+.............++..|++||...... ++.++|+||+|++++++++|..
T Consensus 124 ~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred ccCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999 678899999999887665444334455778899999987665 8899999999999999999999
Q ss_pred CCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 167 PFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 167 p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
||....... ..+..++.++.+++++|++.+|.+|||+.+++.|||+
T Consensus 201 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 201 PWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 997654211 1245678899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=251.87 Aligned_cols=201 Identities=29% Similarity=0.535 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|++++++++|+|++++++++...+..++++||+++++|..+......+++..+..++.|++.+|.+||+.|++
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~ 122 (286)
T cd07847 43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122 (286)
T ss_pred ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 34567899999999999999999999999999999999999999988877767899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+ ..++.++|+||+|++++++++|..
T Consensus 123 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~ 199 (286)
T cd07847 123 HRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199 (286)
T ss_pred ecCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence 99999999999 677889999999987664432 1223346778999999865 457889999999999999999999
Q ss_pred CCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 167 PFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 167 p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
||.+.+..+. ....++..+.+++.+||+.+|.+|||+.|
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 200 LWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred CCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 9976542110 02356788999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
++.||||
T Consensus 280 il~~~~f 286 (286)
T cd07847 280 LLEHPYF 286 (286)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=247.52 Aligned_cols=212 Identities=32% Similarity=0.528 Sum_probs=183.2
Q ss_pred hhhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 4 KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 4 ~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
+...+.+.++.+|++++.++ .|+||++++++|+++...|+|||-+.||+|.+.+.+++-+++....++.++|+.||.+|
T Consensus 113 Kq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFl 192 (463)
T KOG0607|consen 113 KQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFL 192 (463)
T ss_pred cCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHH
Confidence 33567899999999999999 69999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCccccc-----ccCCCcch
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQ-----FQRYDEKV 149 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~-----~~~~~~~~ 149 (226)
|++||.|||+||+||+....+.---+|||||.+......... ....+|+..|||||+.. ...|+.+.
T Consensus 193 H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC 272 (463)
T KOG0607|consen 193 HTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC 272 (463)
T ss_pred hhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccc
Confidence 999999999999999996444445589999988765433211 12346777899999863 24578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCccccc-----------------------------ccCCChHHHHHHHHhhccCcccc
Q 027233 150 DMWSVGAILFELLNGYPPFSGRNNVQLI-----------------------------VPALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 150 Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----------------------------~~~~~~~~~~~i~~~l~~~p~~R 200 (226)
|.||||+++|.|+.|+.||.+....+.- +..+|.+.+++|+.+|..++.+|
T Consensus 273 DlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 273 DLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQR 352 (463)
T ss_pred cHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhh
Confidence 9999999999999999999876542111 56688999999999999999999
Q ss_pred CCHhHHhcCcccccc
Q 027233 201 LSFNEFYHHRFLRRN 215 (226)
Q Consensus 201 pt~~~~l~~~~~~~~ 215 (226)
.++.++++|||+++-
T Consensus 353 lsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 353 LSAAQVLNHPWVQRC 367 (463)
T ss_pred hhhhhccCCcccccc
Confidence 999999999999984
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=248.37 Aligned_cols=217 Identities=32% Similarity=0.533 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
++...+++.|-+||+.++||.++.+|+.++.+...+++||||+||+|....+++ +.+++..++-++..++.||+|||-
T Consensus 118 rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm 197 (459)
T KOG0610|consen 118 RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM 197 (459)
T ss_pred hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh
Confidence 445567888999999999999999999999999999999999999999988876 469999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC--------------------------------C-c-------
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------N-Y------- 124 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~--------------------------------~-~------- 124 (226)
.||++|||||+|||+ .+++++.|.||.++...... . .
T Consensus 198 lGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~ 274 (459)
T KOG0610|consen 198 LGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDE 274 (459)
T ss_pred hceeeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccc
Confidence 999999999999999 78999999999876432100 0 0
Q ss_pred -----------------cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc----------
Q 027233 125 -----------------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---------- 177 (226)
Q Consensus 125 -----------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------- 177 (226)
....+||-.|+|||.+.|...+.+.|=|+||+++|||+.|.-||.+.+..+.+
T Consensus 275 ~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F 354 (459)
T KOG0610|consen 275 SASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF 354 (459)
T ss_pred cccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC
Confidence 01123566799999999999999999999999999999999999998766544
Q ss_pred --ccCCChHHHHHHHHhhccCccccCC----HhHHhcCccccccCc-cc--CCCCCCC
Q 027233 178 --VPALHPDCVDMCLKLLSANTVDRLS----FNEFYHHRFLRRNSA-IL--RAPFHIP 226 (226)
Q Consensus 178 --~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~~l~~~~~~~~~~-~~--~~~~~~~ 226 (226)
.+.++..++|+|+++|.+||.+|.. ++||-+||||++..+ .+ ..|..||
T Consensus 355 p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 355 PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 3356689999999999999999998 999999999999633 22 3455554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=246.99 Aligned_cols=203 Identities=25% Similarity=0.545 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|++++++++|+|++++.+.+.. ++..++++||+++++|.+++... ..+++..+..++.+++.++.+||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH 119 (257)
T cd08223 40 RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999988764 45689999999999999999763 35899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|+++++++
T Consensus 120 ~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08223 120 EKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196 (257)
T ss_pred hCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999 678899999999987654322 223345678899999999888999999999999999999
Q ss_pred hCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 163 NGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 163 ~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|..||...+... ..+..+++.+.+++.+|++.+|.+|||+.++++||||
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 197 TLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999997654322 1245578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=259.86 Aligned_cols=202 Identities=32% Similarity=0.469 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
...+.+.+|+.+++.++||||+++++.+... ...+++|||++ ++|.+++. ..++...+..++.|++.||.+
T Consensus 58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~ 134 (355)
T cd07874 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKH 134 (355)
T ss_pred HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHh--hcCCHHHHHHHHHHHHHHHHH
Confidence 4456778899999999999999999987543 35799999995 57777765 358889999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||++|++||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++++|
T Consensus 135 LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (355)
T cd07874 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211 (355)
T ss_pred HHhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999 67889999999999776554444455688899999999988899999999999999999
Q ss_pred HhCCCCCCCCCcccc----------------------------------------------------cccCCChHHHHHH
Q 027233 162 LNGYPPFSGRNNVQL----------------------------------------------------IVPALHPDCVDMC 189 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~i 189 (226)
++|..||.+.+..+. .....+.+++++|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHH
Confidence 999999976542110 0112346789999
Q ss_pred HHhhccCccccCCHhHHhcCcccccc
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.+||+.||.+|||+.|+++||||...
T Consensus 292 ~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 292 SKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHhcCCchhcCCHHHHhcCcchhcc
Confidence 99999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=262.62 Aligned_cols=201 Identities=33% Similarity=0.543 Sum_probs=171.9
Q ss_pred HHHHHHHHHhcC---CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 12 CLDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 12 ~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
....|..++..+ +||||+++++.+...+..++||||+.+++|.+++...+.+++..+..++.||+.||+|||++|++
T Consensus 39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~iv 118 (330)
T cd05586 39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118 (330)
T ss_pred HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 344566666655 69999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+. .++.++||||+|+++++|++|..
T Consensus 119 HrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~ 195 (330)
T cd05586 119 YRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS 195 (330)
T ss_pred eccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence 99999999999 67888999999998654322 223345688999999998654 47899999999999999999999
Q ss_pred CCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccC----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rp----t~~~~l~~~~~~~~ 215 (226)
||...+..... ...++.++.++|++||+.+|.+|| +++++++||||.+.
T Consensus 196 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 196 PFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99776533211 234789999999999999999998 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=249.69 Aligned_cols=202 Identities=30% Similarity=0.498 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+..+.+.+|++++++++||||+++++++...+..++++||+++++|..+ ..+++..+..++.|++.|+.+||+.|
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ 115 (279)
T cd06619 40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK 115 (279)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44566788999999999999999999999999999999999999999764 35788899999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
++|+||+|+||++ +.++.++|+|||++....... .....++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred EeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999999 678899999999987654332 233467889999999988889999999999999999999999
Q ss_pred CCCCCCccc-------------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQ-------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||....... .....+++++.+++.+|++.+|.+||+++++++||||+...
T Consensus 192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 192 PYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 986532110 01234678999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=245.61 Aligned_cols=205 Identities=30% Similarity=0.471 Sum_probs=178.7
Q ss_pred HHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 13 LDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
-.+|+.+|.+++|||||.+.+..... +.+|+|||||+ .+|.+.+.+.+ ++....+.-+..|++.|++|||.+.|+|
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilH 200 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILH 200 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEe
Confidence 46899999999999999999987653 57999999994 69999998876 8999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||++|+++ +..+.++++|||+|+.++.+. .....+-|.+|.|||.+-+. .|+.+.|+||+||++.|++.+...
T Consensus 201 RDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 201 RDLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred cccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 9999999999 789999999999999987663 33456679999999998765 589999999999999999999999
Q ss_pred CCCCCccccc------------------------------------------ccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 168 FSGRNNVQLI------------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 168 ~~~~~~~~~~------------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
|.+....+.+ ...++..-.+++..+|..||.+|.|++|
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 8877644333 1115578899999999999999999999
Q ss_pred HhcCccccccCcccCC
Q 027233 206 FYHHRFLRRNSAILRA 221 (226)
Q Consensus 206 ~l~~~~~~~~~~~~~~ 221 (226)
.|+|.||.+.+....+
T Consensus 358 ~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 358 GLKHEYFRETPLPIDP 373 (419)
T ss_pred hhcccccccCCCCCCh
Confidence 9999999997665544
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=254.61 Aligned_cols=205 Identities=29% Similarity=0.500 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+.+|+.++++++|+||+++++++..++..++++||++ ++|.+++...+ .+++..+..++.|++.||.+||++|++
T Consensus 48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 126 (309)
T cd07872 48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126 (309)
T ss_pred chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3467789999999999999999999999999999999996 58888887654 578999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
||||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 127 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred cCCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 678889999999986543322 2233456788999998764 457889999999999999999999
Q ss_pred CCCCCCcccc----------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 167 PFSGRNNVQL----------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 167 p~~~~~~~~~----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
||.+.+..+. ....++.+++++|.+||+.||.+|||+.|+
T Consensus 204 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 283 (309)
T cd07872 204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283 (309)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence 9976542111 012467889999999999999999999999
Q ss_pred hcCccccccCcc
Q 027233 207 YHHRFLRRNSAI 218 (226)
Q Consensus 207 l~~~~~~~~~~~ 218 (226)
++||||+..++.
T Consensus 284 l~h~~~~~~~~~ 295 (309)
T cd07872 284 MKHAYFRSLGTR 295 (309)
T ss_pred hcChhhhhcccc
Confidence 999999986533
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=251.00 Aligned_cols=206 Identities=33% Similarity=0.522 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|++++++++|+||+++++.+..++..++++||+++++|.+++.+. ..+++..+..++.|++.++.+||+.
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 122 (280)
T cd06611 43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345567889999999999999999999999999999999999999999998764 4799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccc-----ccCCCcchhHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~~ 159 (226)
|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+. ...++.++|+||+|+++|
T Consensus 123 ~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 123 KVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CcccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 99999999999999 678899999999876553322 223345778899999874 345678999999999999
Q ss_pred HHHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 160 ELLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++++|..||...+.... .+..++.++.+++.+||+.+|.+|||++++++||||...
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999976543221 134578899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=260.12 Aligned_cols=201 Identities=32% Similarity=0.484 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
...+.+.+|+.+++.++||||+++++.+... ...|+||||++ ++|.+++. ..++...+..++.|++.||.+
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHH--hcCCHHHHHHHHHHHHHHHHH
Confidence 4456788899999999999999999887543 45799999995 57887775 357889999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||++|++||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++++|
T Consensus 142 LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 142 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred HhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 999999999999999999 67889999999999776554444455688999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccccc----------------------------------------------------ccCCChHHHHHH
Q 027233 162 LNGYPPFSGRNNVQLI----------------------------------------------------VPALHPDCVDMC 189 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~i 189 (226)
++|..||.+.+..+.. ....+..++++|
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 9999999764321100 011245789999
Q ss_pred HHhhccCccccCCHhHHhcCccccc
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.+||+.||.+|||++|+|+||||..
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCccccc
Confidence 9999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=248.85 Aligned_cols=202 Identities=28% Similarity=0.534 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+..+.+.+|+.++++++|+||+++++++.. ....++++||+++++|.+++...+.+++..++.++.|++.|+++||+.
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345678999999999999999999998865 367889999999999999998877899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||...+..++.++|+||+|++++++
T Consensus 126 ~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el 202 (266)
T cd06651 126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202 (266)
T ss_pred CeeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 99999999999999 677889999999986553211 11223467789999999888889999999999999999
Q ss_pred HhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 162 LNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
++|..||........ .+..++..+++++ +|+..+|.+|||++|+++||||+
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 203 LTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999999976542221 1345678889998 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=254.69 Aligned_cols=205 Identities=25% Similarity=0.497 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|+..++.++|+||+++++.+...+..++++||+++++|.+++.. +.+++..+..++.||+.|+.+||++|
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ 138 (292)
T cd06658 60 QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG 138 (292)
T ss_pred HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566788999999999999999999999999999999999999999998754 47899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||+|++++++++|.
T Consensus 139 ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~ 215 (292)
T cd06658 139 VIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215 (292)
T ss_pred EeecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 6778899999998865433221 22345778899999998888899999999999999999999
Q ss_pred CCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||...+..... ...++..+.+++.+|+..+|.+|||++|+++||||+..
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 216 PPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred CCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 999765432211 23467889999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=261.28 Aligned_cols=204 Identities=31% Similarity=0.551 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|..+++.++||||+++++.+.+++..++||||++|++|.+++... .+++..+..++.||+.||.+||++|+
T Consensus 85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i 163 (371)
T cd05622 85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGF 163 (371)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34556789999999999999999999999999999999999999999998754 68999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccC----CCcchhHHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~~~~l 161 (226)
+||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|
T Consensus 164 vHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel 240 (371)
T cd05622 164 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (371)
T ss_pred EeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence 999999999999 6788999999999876643321 23456899999999986543 77899999999999999
Q ss_pred HhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 162 LNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
++|..||.+.+..... ...++..++++|.+||..++.+ |++++++++|+||++.
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999875432111 2357899999999999844433 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=249.93 Aligned_cols=208 Identities=29% Similarity=0.465 Sum_probs=175.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|+.+++.++|+||+++++.+..++..+++|||+++++|..++.+ ...+++..+..++.|++.++.+||+
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~ 128 (292)
T cd06644 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128 (292)
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 345567788999999999999999999999999999999999999999988765 3578999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccc-----ccCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~ 158 (226)
.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+. ...++.++|+||||+++
T Consensus 129 ~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 129 MKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred CCeeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 999999999999999 678889999999876543321 122344677899999874 34567899999999999
Q ss_pred HHHHhCCCCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 159 FELLNGYPPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|++++|..||...+... .....++.++.+++++||+.+|.+||+++++++||||....
T Consensus 206 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 206 IEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999987643211 11345678999999999999999999999999999998743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=244.98 Aligned_cols=202 Identities=36% Similarity=0.613 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|+..+++++|+||+++++.+... +..++++|++++++|.+++.+...+++..++.++.|++.++++||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4578899999999999999999999999988 88999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|.|||...+...+.++|+||||+++++++
T Consensus 121 ~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 121 GIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred CccccCCCHHHEEE---cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999 6788999999999877765543 34456778899999998888999999999999999999
Q ss_pred hCCCCCCCCC-------------cccccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 163 NGYPPFSGRN-------------NVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 163 ~g~~p~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|..||.... .....+...+..+.+++.+|++.+|.+|||+.+++.||||
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 198 TGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999997764 1222355678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=254.40 Aligned_cols=202 Identities=27% Similarity=0.476 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~ 78 (226)
...+.+|++++++++||||+++++.+.. +...++++||+ +++|.+++... ..+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3467889999999999999999998854 45689999999 56898887532 248899999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeC-CCCccEEEeeeccccccCCCC----ccccccCCccccCccccccc-CCCcchhHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~-~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~ 152 (226)
|.|||++|++||||+|+||++... +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+|
T Consensus 121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07868 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence 999999999999999999999532 345689999999997654322 12234578889999998764 578899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc---------------------------c----------------------------
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL---------------------------I---------------------------- 177 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~---------------------------~---------------------------- 177 (226)
|+|++++++++|..||.+...... .
T Consensus 201 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07868 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 280 (317)
T ss_pred HHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHH
Confidence 999999999999999864321100 0
Q ss_pred --ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 178 --VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 178 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
....+.++.++|++||+.||.+|||++|+|+||||
T Consensus 281 ~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01124568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=247.98 Aligned_cols=200 Identities=33% Similarity=0.553 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|+.++++++|+|++++++++...+..++|+||+++++|.+++.+.+.+++..+..++.|++.|+.+||++|++|
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 131 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH 131 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 45788999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccC--CCcchhHHHHHHHHHHHHhC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~~~~l~~g 164 (226)
+||+|+||++ +.++.++++|||.+....... ......++..|+|||...+.. ++.++|+||+|++++++++|
T Consensus 132 ~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g 208 (272)
T cd06629 132 RDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208 (272)
T ss_pred cCCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence 9999999999 678899999999986553221 122334677899999987654 78899999999999999999
Q ss_pred CCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 165 YPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 165 ~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
..||........ ....++.++.+++.+|++.+|.+|||++++++|||+
T Consensus 209 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 209 RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999865432110 123468899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=247.15 Aligned_cols=204 Identities=29% Similarity=0.479 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++... ..+ ++..+..++.|++.|+++||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH 125 (268)
T cd06624 46 SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125 (268)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH
Confidence 345668899999999999999999999999999999999999999999999865 455 88889999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccC--CCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~~~~ 160 (226)
++|++|+||+|+||+++ ...+.++|+|||.+........ .....++..|+|||...+.. ++.++|+||+|+++++
T Consensus 126 ~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 126 DNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred HCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHH
Confidence 99999999999999994 2366899999998866543221 22334678899999986543 7789999999999999
Q ss_pred HHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 161 LLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 161 l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+++|..||...... ...+..++.++.+++++||+.+|.+|||+.|++.||||
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 204 MATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999998654321 11244577899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=264.90 Aligned_cols=207 Identities=34% Similarity=0.487 Sum_probs=178.3
Q ss_pred hhHHHHHHHHHHHHHHhcCC-C-----CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVN-H-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLG 76 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~ 76 (226)
.+..-.++...|+++|..|+ | -|+|+++++|...++.|||+|.+ +.+|-++++.++ .++...++.++.||+
T Consensus 221 N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil 299 (586)
T KOG0667|consen 221 NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQIL 299 (586)
T ss_pred cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHH
Confidence 34455667788999999996 3 47999999999999999999999 789999998774 688999999999999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
.||..||+.||+|+||||+|||+.+. ....+||+|||+++....... ....+..|.|||++.|.+|+.+.|+|||||
T Consensus 300 ~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 300 TALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred HHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhh
Confidence 99999999999999999999999653 344899999999988766554 455688899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccc-----------------------------------------------------------
Q 027233 157 ILFELLNGYPPFSGRNNVQLI----------------------------------------------------------- 177 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~~----------------------------------------------------------- 177 (226)
+++||++|...|.+.+..+.+
T Consensus 377 IlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 377 ILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred hHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 999999999989877644333
Q ss_pred ---c-----------cCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 178 ---V-----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 178 ---~-----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+ ......+.+|+++||..||.+|+|+.|+|+||||...
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 1 0123458999999999999999999999999999953
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=252.67 Aligned_cols=203 Identities=30% Similarity=0.526 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.+++.++|+||+++++.+..+...++|+||+++++|.+++.. ..+++..+..++.|++.||.+||+.|++
T Consensus 60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~ 138 (296)
T cd06654 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138 (296)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 456788999999999999999999999999999999999999999999864 4688999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+...+.++|+||+|++++++++|..|
T Consensus 139 H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred cCCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999 6778899999998865533221 2234577889999999888889999999999999999999999
Q ss_pred CCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|........ .+..++..+.+++.+||..+|.+|||+.++++||||...
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 976543111 134577889999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=251.68 Aligned_cols=205 Identities=29% Similarity=0.513 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.+++.+ ..+++..+..++.|++.++.+||+.|++
T Consensus 59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~ 137 (297)
T cd06656 59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVI 137 (297)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 456788999999999999999999999999999999999999999999875 4688899999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..|
T Consensus 138 H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~p 214 (297)
T cd06656 138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (297)
T ss_pred cCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999 6788999999998866543322 2234567789999999888889999999999999999999999
Q ss_pred CCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 168 FSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 168 ~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
|...+.... .+..++..+.+++.+||+.+|.+|||+.++++||||+..+.
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 215 YLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 976443211 13456788999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=252.32 Aligned_cols=197 Identities=34% Similarity=0.557 Sum_probs=165.4
Q ss_pred HHHHHHHHHhcC---CCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 12 ~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.+.+|+.+++.+ +||||+++++++.. ....++++|++. ++|.+++... ..+++..+..++.|++.||.|
T Consensus 45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 123 (288)
T cd07863 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123 (288)
T ss_pred HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 455677776665 79999999998764 345899999996 5899988764 348999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||++|++|+||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|++++++
T Consensus 124 lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 200 (288)
T cd07863 124 LHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200 (288)
T ss_pred HHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHH
Confidence 999999999999999999 67889999999998766544333445578889999999888899999999999999999
Q ss_pred HhCCCCCCCCCcccc-------------------------------------cccCCChHHHHHHHHhhccCccccCCHh
Q 027233 162 LNGYPPFSGRNNVQL-------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~-------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
++|..||.+....+. ..+.++.++.++|.+||+.||.+|||+.
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (288)
T cd07863 201 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF 280 (288)
T ss_pred HhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence 999998865432110 1235678899999999999999999999
Q ss_pred HHhcCccc
Q 027233 205 EFYHHRFL 212 (226)
Q Consensus 205 ~~l~~~~~ 212 (226)
|++.||||
T Consensus 281 ~~l~hp~f 288 (288)
T cd07863 281 RALQHPFF 288 (288)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=256.07 Aligned_cols=206 Identities=30% Similarity=0.567 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|..+++.++|+||+++++.+.+++..++|+||++|++|.+++.+. ..+++..+..++.||+.||.|||++
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (331)
T cd05597 42 RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121 (331)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345567889999999999999999999999999999999999999999999763 5789999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccc-----cCCCcchhHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~~ 158 (226)
|++||||+|+||++ +.++.++|+|||++......... ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 122 ~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l 198 (331)
T cd05597 122 GYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCM 198 (331)
T ss_pred CeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHH
Confidence 99999999999999 67889999999998665433221 22458899999999863 3467899999999999
Q ss_pred HHHHhCCCCCCCCCcccc---------------cccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 159 FELLNGYPPFSGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
++|++|..||.+.+..+. ....++.++++++++||..++++ |++++++++||||.+.
T Consensus 199 ~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 199 YEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999976542211 12347889999999999754443 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=247.29 Aligned_cols=200 Identities=26% Similarity=0.449 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++|+||+++++++..++..++++||+++++|.+++...+++++..+..++.|++.|+.+||++|++
T Consensus 49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34568889999999999999999999999999999999999999999998878899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHhC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|+|++|.||++ +.++.++|+|||.+....... ......++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 129 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 129 HRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ccCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999 677889999999987664322 123345778899999874 34577899999999999999999
Q ss_pred CCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 165 YPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 165 ~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
..||......... ...++..+.+++++||+.+|.+|||++++++|+|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 206 QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9998543321110 2345789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=259.11 Aligned_cols=200 Identities=27% Similarity=0.371 Sum_probs=166.6
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.....|+.++++++|+||+++++++...+..+++++++ .++|.+++.+. ..+++..+..++.||+.||.|||++|++|
T Consensus 102 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (357)
T PHA03209 102 GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180 (357)
T ss_pred cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 34567999999999999999999999999999999999 56888888654 57899999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC-
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF- 168 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~- 168 (226)
|||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|+++++..++
T Consensus 181 rDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 181 RDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred CCCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 9999999999 678889999999987544333334456888999999999888999999999999999999854443
Q ss_pred CCCCcc-----------------------ccc------------------------------ccCCChHHHHHHHHhhcc
Q 027233 169 SGRNNV-----------------------QLI------------------------------VPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 169 ~~~~~~-----------------------~~~------------------------------~~~~~~~~~~~i~~~l~~ 195 (226)
...... ... ...++.++.++|.+||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence 221100 000 113456777899999999
Q ss_pred CccccCCHhHHhcCccccc
Q 027233 196 NTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~~~ 214 (226)
||.+|||+.|+|+||||+.
T Consensus 338 dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 338 DAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CcccCcCHHHHhcCchhcc
Confidence 9999999999999999975
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=246.14 Aligned_cols=203 Identities=27% Similarity=0.538 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+.+.+|+.++++++|+||+++++.+...+..++++||+.+++|.+++.... .+++..+..++.|++.|+.+||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119 (256)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3455688999999999999999999999999999999999999999999987643 57899999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+...+.++|+||+|++++++++
T Consensus 120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence 999999999999999 6778899999998876543321 123346778999999988888999999999999999999
Q ss_pred CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 164 GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 164 g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|..||...+..+ ..+..++.++.++|++|++.+|.+||++.++++||||
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999987554221 1245678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=245.76 Aligned_cols=205 Identities=31% Similarity=0.525 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~ 86 (226)
...+.+.+|+..+++++|+||+++++++...+..++++||+++++|.+++....++++..++.++.|++.++.+||+ .|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~ 120 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence 45678999999999999999999999999999999999999999999999988889999999999999999999999 99
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++|.
T Consensus 121 ~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred CccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 67889999999998766543322 2345678899999998888899999999999999999999
Q ss_pred CCCCCCCc--------------ccccccC-CChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNN--------------VQLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~--------------~~~~~~~-~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||..... ....... ++..+.++|.+||+.+|.+|||+.|+++|||++..
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 198 FPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99977641 1111333 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=249.39 Aligned_cols=205 Identities=26% Similarity=0.534 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++|+||+++++++...+..++++||++|++|.+++.. +++++..+..++.|++.|+++||++|+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i 136 (285)
T cd06648 58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV 136 (285)
T ss_pred hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4456788999999999999999999999999999999999999999999887 678999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 137 ~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 137 IHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred ecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999999 678899999999876543322 1223457788999999988888999999999999999999999
Q ss_pred CCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||...+.... ....++..+.+++.+||+.+|.+|||+.++++||||+...
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 214 PYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9876442211 1233678999999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=251.84 Aligned_cols=200 Identities=34% Similarity=0.559 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
....+.+|+.++++++|+||+++++++.+.+..++++||++ ++|.+++.+ .+.+++..++.++.||+.||.+||+.|+
T Consensus 42 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 120 (284)
T cd07839 42 VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120 (284)
T ss_pred CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34567889999999999999999999999999999999995 588888765 4578999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++|++|.
T Consensus 121 ~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 121 LHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred ecCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 999999999999 678899999999987654322 12234467889999988664 4688999999999999999998
Q ss_pred CCCCCCCcc----------------------------------------cccccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 166 PPFSGRNNV----------------------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 166 ~p~~~~~~~----------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
.|+...... ....+.+++++.++|.+||+.||.+|||+++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 198 RPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 885322110 0012356889999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
+++||||
T Consensus 278 il~h~~f 284 (284)
T cd07839 278 ALQHPYF 284 (284)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=249.72 Aligned_cols=200 Identities=31% Similarity=0.519 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|+.++++++||||+++++++..++..++|+||+. ++|.+++... ..+++..++.++.|++.||.+||++
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34678899999999999999999999999999999999996 6898888653 4689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||||++++++++
T Consensus 121 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 121 RVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred CeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 99999999999999 6788999999999875543221 1233457789999987654 46889999999999999999
Q ss_pred CCCCCCCCCccc---------------------------------------ccccCCChHHHHHHHHhhccCccccCCHh
Q 027233 164 GYPPFSGRNNVQ---------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 164 g~~p~~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|..||.+..... .....+++++.++|++||+.||.+|||++
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 999987543210 00234788999999999999999999999
Q ss_pred HHhcCccc
Q 027233 205 EFYHHRFL 212 (226)
Q Consensus 205 ~~l~~~~~ 212 (226)
++++||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=254.26 Aligned_cols=198 Identities=29% Similarity=0.503 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeC-CeEEEEEeecCCCCHHHHHHhc-------------------------
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~------------------------- 60 (226)
...+.+.+|+.+++++ +||||+++++++... +..+++|||+++++|.+++...
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (338)
T cd05102 52 SEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131 (338)
T ss_pred HHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhh
Confidence 4456789999999999 899999999987754 4688999999999999999753
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCC
Q 027233 61 -------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (226)
Q Consensus 61 -------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~ 103 (226)
.++++..+..++.|++.||.|||++|++||||||+||++ +
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~ 208 (338)
T cd05102 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---S 208 (338)
T ss_pred ccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---c
Confidence 236778889999999999999999999999999999999 6
Q ss_pred CCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc---
Q 027233 104 DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL--- 176 (226)
Q Consensus 104 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~--- 176 (226)
.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+......
T Consensus 209 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~ 288 (338)
T cd05102 209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288 (338)
T ss_pred CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence 788899999999876533211 112234567999999988889999999999999999997 9999986542211
Q ss_pred ---------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 177 ---------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 177 ---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 14457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=251.86 Aligned_cols=204 Identities=29% Similarity=0.485 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+.+|+.++++++|+||+++++++...+..++++||++ ++|.+++... ..+++..+..++.|++.||.+||+.|++
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~ 126 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4467789999999999999999999999999999999996 6999988764 4688999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+ ..++.++|+||||+++++|++|..
T Consensus 127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 678899999999986554322 2223446788999998765 357889999999999999999999
Q ss_pred CCCCCCcccc----------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 167 PFSGRNNVQL----------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 167 p~~~~~~~~~----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
||...+..+. ....++++++++|.+||+.||.+|||++|+
T Consensus 204 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 204 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 9876442100 023568889999999999999999999999
Q ss_pred hcCccccccCc
Q 027233 207 YHHRFLRRNSA 217 (226)
Q Consensus 207 l~~~~~~~~~~ 217 (226)
++||||+..+.
T Consensus 284 l~h~~f~~~~~ 294 (301)
T cd07873 284 MKHPYFHCLGE 294 (301)
T ss_pred hcCcccccccc
Confidence 99999988654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=246.09 Aligned_cols=201 Identities=32% Similarity=0.552 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|++.++.++|+||+++++.+...+..++++|++++++|.+++... ..+++..+..++.|++.|+++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999999999999999999999999999999999999999764 3589999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-----ccccCCccccCccccccc-CCCcchhHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~ 159 (226)
|++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||.+... ..+.++|+||+|++++
T Consensus 122 ~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~ 198 (267)
T cd06610 122 GQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198 (267)
T ss_pred CeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence 99999999999999 67788999999998766543222 233467889999998766 7889999999999999
Q ss_pred HHHhCCCCCCCCCccccc----------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 160 ELLNGYPPFSGRNNVQLI----------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
++++|..||...+..... ...++..+.+++.+|++.+|.+|||++++++||||
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 199 ELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999765432111 13567899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=243.48 Aligned_cols=202 Identities=34% Similarity=0.582 Sum_probs=176.8
Q ss_pred HHHHHHHHHHhcCCCCC-eeeeeeEEEeCC------eEEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l 79 (226)
....+|+.+++.++|+| |+.+++++.+.+ ..++|+||+ .-+|..++.... .++...++.+++||+.|+
T Consensus 55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl 133 (323)
T KOG0594|consen 55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL 133 (323)
T ss_pred chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence 46689999999999999 999999998766 899999999 579999998765 477789999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccccc-CCCcchhHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~ 157 (226)
+|||+++|+||||||.||++ ++.+.+||+|||+++....+ ..-...+.+.+|.|||.+.+. .|+...|+||+||+
T Consensus 134 ~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 134 AFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI 210 (323)
T ss_pred HHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence 99999999999999999999 67999999999999877633 334566789999999998876 79999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCc
Q 027233 158 LFELLNGYPPFSGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p 197 (226)
++||+++...|.+....+.. .+..+++..+++.+||+.+|
T Consensus 211 faEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p 290 (323)
T KOG0594|consen 211 FAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP 290 (323)
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence 99999999999876543332 33345689999999999999
Q ss_pred cccCCHhHHhcCccccccC
Q 027233 198 VDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+|.|+..+|.||||....
T Consensus 291 ~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 291 AKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccCcCHHHHhcChhhcccc
Confidence 9999999999999999864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=249.51 Aligned_cols=205 Identities=33% Similarity=0.580 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+++++.++||||+++++.+..++..++++||++|++|.+++...+.+++..+..++.|++.|+.+||++|+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (305)
T cd05609 43 NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122 (305)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----------------ccccccCCccccCcccccccCCCcchhH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv 151 (226)
+|+||+|.||++ +.++.++++|||.+....... ......++..|+|||.+.+..++.++|+
T Consensus 123 ~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 123 VHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred cccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999 678899999999875321100 0011245677999999988889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCC---HhHHhcCcccccc
Q 027233 152 WSVGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN 215 (226)
Q Consensus 152 ~slG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~~l~~~~~~~~ 215 (226)
||||++++++++|..||.+.+..... ...++.++.+++++|++.+|.+||+ +.++++||||...
T Consensus 200 ~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 200 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 99999999999999999765432211 2256888999999999999999998 7999999999664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=265.12 Aligned_cols=206 Identities=34% Similarity=0.624 Sum_probs=189.0
Q ss_pred hhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
+.++..+....|.++++.. +||.++.++..|.+..++|+||||+.||++..+ +..+.+++..+.-++..++.||.|||
T Consensus 407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH 485 (694)
T KOG0694|consen 407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLH 485 (694)
T ss_pred eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHH
Confidence 3677888999999999988 699999999999999999999999999996554 44568999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
++||+|||||.+||++ +..|.+||.|||+++... .+..+...+||+.|+|||.+.++.|+.+.|=||||+++|||+
T Consensus 486 ~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 486 ENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred hcCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 9999999999999999 799999999999998765 677788899999999999999999999999999999999999
Q ss_pred hCCCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCC-----HhHHhcCccccc
Q 027233 163 NGYPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 214 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~ 214 (226)
.|+.||.+.+..+.. +..+|.+..++++++|..+|.+|.. ++++..||||+.
T Consensus 563 ~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 563 VGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 999999987655433 7788999999999999999999985 589999999998
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=247.08 Aligned_cols=206 Identities=35% Similarity=0.619 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++|+||+++++.+..++..++++||+.+++|.+++.+.+.+++..+..++.|++.||.+||+.|+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 114 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI 114 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 45678999999999999999999999999999999999999999999999887789999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---------ccccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
+|+||+|+||++ +.++.++|+|||++....... ......++..|++||...+...+.++|+||||+++
T Consensus 115 ~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 115 IHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred ecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 999999999999 678899999999886554331 12233467789999999888888999999999999
Q ss_pred HHHHhCCCCCCCCCccccc----------ccC--CChHHHHHHHHhhccCccccCCH---hHHhcCccccccC
Q 027233 159 FELLNGYPPFSGRNNVQLI----------VPA--LHPDCVDMCLKLLSANTVDRLSF---NEFYHHRFLRRNS 216 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~----------~~~--~~~~~~~~i~~~l~~~p~~Rpt~---~~~l~~~~~~~~~ 216 (226)
+++++|..||......... +.. .+..+.+++++|++.+|.+|||+ .++++||||++..
T Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 192 YEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 9999999999765432211 222 38899999999999999999999 9999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=244.66 Aligned_cols=199 Identities=34% Similarity=0.637 Sum_probs=170.0
Q ss_pred HHHHHHH-HhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 13 LDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 13 ~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
+..|... ....+|+|++++++.+..++..++++||+++++|.++++..+.+++..+..++.|++.||.+||+.|++|+|
T Consensus 43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d 122 (260)
T cd05611 43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122 (260)
T ss_pred HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 3444444 445589999999999999999999999999999999998888899999999999999999999999999999
Q ss_pred cCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 027233 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171 (226)
Q Consensus 92 l~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 171 (226)
|+|.||++ +.++.++|+|||.+..... .....++..|+|||...+..++.++|+||+|++++++++|..||...
T Consensus 123 l~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 123 IKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CCHHHeEE---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 99999999 6778899999998865433 22334677899999998888899999999999999999999999765
Q ss_pred Ccccc--------------cccCCChHHHHHHHHhhccCccccC---CHhHHhcCccccccCc
Q 027233 172 NNVQL--------------IVPALHPDCVDMCLKLLSANTVDRL---SFNEFYHHRFLRRNSA 217 (226)
Q Consensus 172 ~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~~l~~~~~~~~~~ 217 (226)
+.... ....+++.+.+++.+||+.+|.+|| +++|+++||||++.++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 43221 1335789999999999999999999 5579999999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=248.09 Aligned_cols=200 Identities=25% Similarity=0.491 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~ 70 (226)
....+.+.+|++.+++++||||+++++++...+..++++||+++++|.+++... ..+++..++.
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 128 (283)
T cd05048 49 PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHH
Confidence 345677899999999999999999999999988999999999999999999764 3578889999
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCc
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
++.|++.||++||++|++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||...+..++.
T Consensus 129 ~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05048 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT 205 (283)
T ss_pred HHHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch
Confidence 99999999999999999999999999999 678889999999987553322 122334567799999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++|+||||++++++++ |..||.+....+. .+..++.++.+++++|++.+|.+|||+.|++++
T Consensus 206 ~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999997 9999876443221 145678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=255.00 Aligned_cols=205 Identities=30% Similarity=0.568 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|..++..++|++|+++++.+.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.|+.+||++|
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ 122 (332)
T cd05623 43 AETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122 (332)
T ss_pred hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34556889999999999999999999999999999999999999999999873 57899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCccccc-----ccCCCcchhHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~~ 159 (226)
++||||||+||++ +.++.++|+|||++........ .....|+..|+|||.+. ...++.++|+||+|++++
T Consensus 123 iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ 199 (332)
T cd05623 123 YVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY 199 (332)
T ss_pred eEecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHH
Confidence 9999999999999 6788999999999865533222 22346889999999875 345788999999999999
Q ss_pred HHHhCCCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 160 ELLNGYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
++++|..||...+..... ...++.++++++++|+..++++ |++++|+++||||.+.
T Consensus 200 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 200 EMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999765432111 2356899999999999765544 6899999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=249.67 Aligned_cols=207 Identities=34% Similarity=0.530 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
....+..|++++++++|+||+++++++.+.+..++|+||+ +++|.+++.... .+++..+..++.|+++||.+||++|+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 123 (298)
T cd07841 45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123 (298)
T ss_pred hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4556778999999999999999999999999999999999 899999998776 79999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||.+.+ ..++.++|+||+|++++++++|.
T Consensus 124 ~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 124 LHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred eecCCChhhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999 678899999999987665432 1222345677999998754 45788999999999999999997
Q ss_pred CCCCCCCcccc--------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 166 PPFSGRNNVQL--------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 166 ~p~~~~~~~~~--------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
.+|.+.+..+. .....+.++.++|.+||+.+|.+|||+.|++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 201 PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred ccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 77754432110 0234577899999999999999999999999
Q ss_pred cCccccccCccc
Q 027233 208 HHRFLRRNSAIL 219 (226)
Q Consensus 208 ~~~~~~~~~~~~ 219 (226)
+|+||++....-
T Consensus 281 ~~~~~~~~~~~~ 292 (298)
T cd07841 281 EHPYFSNDPAPT 292 (298)
T ss_pred hCccccCCCCCC
Confidence 999999975544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=244.74 Aligned_cols=204 Identities=33% Similarity=0.594 Sum_probs=176.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l 79 (226)
.....+.+.+|++++++++|+||+++++++.. +...++++||+++++|.+++... .++++..++.++.|++.||
T Consensus 39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l 118 (265)
T cd08217 39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118 (265)
T ss_pred CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999997754 45689999999999999998753 5789999999999999999
Q ss_pred HHHH-----hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHH
Q 027233 80 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh-----~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
.+|| +.+++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+...+.++|+||
T Consensus 119 ~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s 195 (265)
T cd08217 119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS 195 (265)
T ss_pred HHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence 9999 8899999999999999 6788999999999877654432 33445788899999998888899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
||++++++++|..||...+... ..+..++..+.+++.+|++.+|.+|||+.++++|||+
T Consensus 196 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 196 LGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999998764221 1255678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=275.07 Aligned_cols=211 Identities=31% Similarity=0.544 Sum_probs=176.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l 79 (226)
.......+..|+.++++|+||||+++++++.. ...+|+||||+++++|.+++... ..+++..++.++.||+.||
T Consensus 52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL 131 (1021)
T PTZ00266 52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131 (1021)
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence 44566788999999999999999999998854 45789999999999999998753 5799999999999999999
Q ss_pred HHHHhC-------CceeeccCCCCeEeeeC--------------CCCccEEEeeeccccccCCCCccccccCCccccCcc
Q 027233 80 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138 (226)
Q Consensus 80 ~~lh~~-------~i~H~dl~~~nili~~~--------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 138 (226)
.|||+. +|+|+||+|+||++... +....++|+|||++.............+++.|+|||
T Consensus 132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE 211 (1021)
T ss_pred HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence 999984 49999999999999521 123458999999997765444444556899999999
Q ss_pred cccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 139 VLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 139 ~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
.+.+ ..++.++||||||+++|+|++|..||......... ....+.++.++|.+||+.+|.+|||+.|
T Consensus 212 vL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 212 LLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred HHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 9854 45788999999999999999999999765432211 3456889999999999999999999999
Q ss_pred HhcCccccccC
Q 027233 206 FYHHRFLRRNS 216 (226)
Q Consensus 206 ~l~~~~~~~~~ 216 (226)
+|.|+|++...
T Consensus 292 lL~h~~ik~i~ 302 (1021)
T PTZ00266 292 CLGYQIIKNVG 302 (1021)
T ss_pred HhccHHHhhcC
Confidence 99999998653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=248.52 Aligned_cols=205 Identities=27% Similarity=0.498 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|++++++++|+||+++++.+..++..++|+||+++++|.+++.. ..+++..+..++.|++.|+.+||++|
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (277)
T cd06642 43 EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER 121 (277)
T ss_pred hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 34567899999999999999999999999999999999999999999998864 47889999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|.
T Consensus 122 ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06642 122 KIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198 (277)
T ss_pred eeccCCChheEEE---eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCC
Confidence 9999999999999 5778899999999876543322 22234677899999998888899999999999999999999
Q ss_pred CCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.|+....... ......+.++.+++.+|++.+|.+|||+.++++||||...
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 199 PPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 9986543221 1133567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=245.68 Aligned_cols=206 Identities=27% Similarity=0.510 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|+.++++++|+||+++++.+.+++..++++||++|++|.+++.. .++++..+..++.|++.|+.++|+.+
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06640 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK 121 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999999875 57899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++|+||+|+||++ +.++.++++|||.+........ .....++..|.|||...+...+.++|+||||++++++++|.
T Consensus 122 ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06640 122 KIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred ccCcCCChhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 6788899999999866543221 22234677899999998888999999999999999999999
Q ss_pred CCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 166 PPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 166 ~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.||....... .....++..+.+++.+||+.+|.+||++.++++|+||....
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 199 PPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred CCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9987543221 11334678899999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=262.36 Aligned_cols=200 Identities=23% Similarity=0.319 Sum_probs=167.0
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
..+.+|++++++++|+||+++++++..++..+++++++ .++|.+++... ..+++..+..++.|++.||.|||++||+|
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 45678999999999999999999999999999999999 57888888764 46999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|++++|..
T Consensus 284 rDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 284 RDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred CcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 9999999999 6778899999999876533211 223458899999999998899999999999999999998765
Q ss_pred CCCCCCcc---------------------ccc-------------------------------ccCCChHHHHHHHHhhc
Q 027233 167 PFSGRNNV---------------------QLI-------------------------------VPALHPDCVDMCLKLLS 194 (226)
Q Consensus 167 p~~~~~~~---------------------~~~-------------------------------~~~~~~~~~~~i~~~l~ 194 (226)
++-..... ... ...++.++.++|++||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 43211100 000 01345689999999999
Q ss_pred cCccccCCHhHHhcCccccc
Q 027233 195 ANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 195 ~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.||.+|||+.|+|+||||+.
T Consensus 441 ~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 441 FDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cChhhCcCHHHHhhCcccCC
Confidence 99999999999999999975
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=250.68 Aligned_cols=201 Identities=26% Similarity=0.458 Sum_probs=162.8
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l 79 (226)
..+.+|++++++++||||+++++++.. +...++++||+. ++|.+++... ..+++..++.++.|++.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 121 (317)
T cd07867 43 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence 467889999999999999999998853 567899999995 6888887532 2478899999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeC-CCCccEEEeeeccccccCCCCc----cccccCCccccCccccccc-CCCcchhHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~-~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~s 153 (226)
.+||+.|++|+||+|+||++... +.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||
T Consensus 122 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 201 (317)
T cd07867 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred HHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHh
Confidence 99999999999999999999532 3466899999999976643321 2234568889999998764 5789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcccc---------------------------------------------------------
Q 027233 154 VGAILFELLNGYPPFSGRNNVQL--------------------------------------------------------- 176 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~--------------------------------------------------------- 176 (226)
+|++++++++|..||........
T Consensus 202 lG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (317)
T cd07867 202 IGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEK 281 (317)
T ss_pred HHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhc
Confidence 99999999999999864321100
Q ss_pred cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 177 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 177 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
.....+..+.+++.+||+.||.+|||++|+|+||||
T Consensus 282 ~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 282 HKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 011234568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=248.24 Aligned_cols=207 Identities=27% Similarity=0.484 Sum_probs=175.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+.+|++++++++|+||+++++.+..++..++++||+++++|.+++... ..+++..+..++.|++.|+.+|
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 118 (286)
T cd06622 39 DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118 (286)
T ss_pred CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3444578889999999999999999999999999999999999999999998763 3789999999999999999999
Q ss_pred Hh-CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc------CCCcchhHHHHH
Q 027233 83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ------RYDEKVDMWSVG 155 (226)
Q Consensus 83 h~-~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG 155 (226)
|+ .|++|+||+|+||++ +.++.++|+|||.+....... .....++..|+|||.+.+. .++.++|+||+|
T Consensus 119 H~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 119 KEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred HhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 97 599999999999999 668889999999986653322 2233467789999988543 347899999999
Q ss_pred HHHHHHHhCCCCCCCCCccc--------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 156 AILFELLNGYPPFSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++++++++|..||....... ..+..++.++.+++.+|++.+|.+||++++++.||||....
T Consensus 195 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 195 LSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999996543211 12455789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=254.60 Aligned_cols=201 Identities=30% Similarity=0.544 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..+.+.+|++++++++|+||+++++++... ...+++++++ +++|.+++. ...+++..+..++.|++.||.||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~L 134 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999887543 3478999988 889998776 45799999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
|++|++||||+|+||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++++|
T Consensus 135 H~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 135 HSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred HHCCeecccCChhhEEE---CCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 99999999999999999 67889999999998765432 223457889999999876 5678899999999999999
Q ss_pred HhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCcccc
Q 027233 162 LNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~R 200 (226)
++|..||.+.+..... ....++.+.++|.+||+.||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 9999999754321100 12356678999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 027233 201 LSFNEFYHHRFLRRNS 216 (226)
Q Consensus 201 pt~~~~l~~~~~~~~~ 216 (226)
||+.|+++||||....
T Consensus 290 ~s~~ell~hp~~~~~~ 305 (343)
T cd07878 290 ISASEALAHPYFSQYH 305 (343)
T ss_pred CCHHHHhcCcchhccC
Confidence 9999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=244.76 Aligned_cols=185 Identities=28% Similarity=0.531 Sum_probs=162.9
Q ss_pred CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCC
Q 027233 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (226)
Q Consensus 24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~ 103 (226)
+|+||+++++.+...+..++|+||+++++|.+++....++++..+..++.|++.|+.+||+.|++|+||+|+||++.
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~--- 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD--- 143 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence 79999999999999999999999999999999998877999999999999999999999999999999999999994
Q ss_pred CCc-cEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc-------
Q 027233 104 DDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------- 175 (226)
Q Consensus 104 ~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------- 175 (226)
.++ .++|+|||.+....... ...++..|+|||.+.+..++.++|+||+|++++++++|..||.......
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred CCCCeEEEecCccceecCCCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 455 89999999887654322 2346788999999988889999999999999999999999997543221
Q ss_pred -------ccccCCChHHHHHHHHhhccCccccCC-HhHHhcCccccc
Q 027233 176 -------LIVPALHPDCVDMCLKLLSANTVDRLS-FNEFYHHRFLRR 214 (226)
Q Consensus 176 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt-~~~~l~~~~~~~ 214 (226)
......++.++++|.+||+.+|.+|++ ++|+++||||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 221 KRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 114458899999999999999999996 699999999973
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=254.55 Aligned_cols=208 Identities=26% Similarity=0.483 Sum_probs=175.5
Q ss_pred hhhhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHH
Q 027233 3 KKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLE 80 (226)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~ 80 (226)
...+.+..+-+.+|+..|.+| .|.+|+++++|-..++.+|+|||+- ..+|.+++++++.. +...++.+.+||+.|+.
T Consensus 396 ~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~ 474 (677)
T KOG0596|consen 396 LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVK 474 (677)
T ss_pred hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHH
Confidence 344677888999999999999 6999999999999999999999975 68999999987643 33588899999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccC-----------CC
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR-----------YD 146 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-----------~~ 146 (226)
++|.+||+|.||||.|+++ ..|.+||+|||.|.......+ ...++||..|||||.+.... .+
T Consensus 475 ~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~ 550 (677)
T KOG0596|consen 475 TIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKIS 550 (677)
T ss_pred HHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeec
Confidence 9999999999999999998 689999999999988766543 45688999999999985432 45
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcc------------cccccCC-C-hHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 147 EKVDMWSVGAILFELLNGYPPFSGRNNV------------QLIVPAL-H-PDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~g~~p~~~~~~~------------~~~~~~~-~-~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
.++|||||||++|+|+.|..||...... +...+.+ + .++.++++.||+.||++|+|+.++|+|||+
T Consensus 551 r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 551 RKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFL 630 (677)
T ss_pred CccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence 7899999999999999999999754311 1111222 2 239999999999999999999999999999
Q ss_pred ccc
Q 027233 213 RRN 215 (226)
Q Consensus 213 ~~~ 215 (226)
+-.
T Consensus 631 ~~~ 633 (677)
T KOG0596|consen 631 QIQ 633 (677)
T ss_pred ccc
Confidence 873
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=250.29 Aligned_cols=205 Identities=26% Similarity=0.519 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+++.. ..+++..++.++.|++.||.+||+.|+
T Consensus 60 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i 138 (297)
T cd06659 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGV 138 (297)
T ss_pred chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3456788999999999999999999999999999999999999999997764 578999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 139 vH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 215 (297)
T cd06659 139 IHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215 (297)
T ss_pred ecCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 6788999999998865433221 233457888999999988889999999999999999999999
Q ss_pred CCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||...+.... ....++.++.+++.+||+.+|.+||+++++++||||....
T Consensus 216 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 216 PYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9875542211 1345678999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=263.95 Aligned_cols=207 Identities=28% Similarity=0.493 Sum_probs=177.4
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC--------eEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQ 73 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ 73 (226)
.......+.+|+..+..++|+||+++++.+.... ..++|+||+++++|.+++... ..+++..+..++.
T Consensus 71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ 150 (496)
T PTZ00283 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150 (496)
T ss_pred CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence 4556678899999999999999999988765322 378999999999999998653 4689999999999
Q ss_pred HHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCcccccccCCCcchh
Q 027233 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (226)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~D 150 (226)
|++.||.|||++|++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|
T Consensus 151 qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 151 QVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHH
Confidence 99999999999999999999999999 67889999999998765432 1223456889999999999888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 151 MWSVGAILFELLNGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 151 v~slG~~~~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|||||+++|++++|..||.+.+... ..+..+++++.+++.+||+.+|.+|||+.++++|||++..
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 9999999999999999998654321 2256788999999999999999999999999999998764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=239.69 Aligned_cols=200 Identities=33% Similarity=0.577 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+..+++++|+|++++++.+..++..++++||+++++|.+++... ..+++..+..++.|++.++.+||++|+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 119 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 5678999999999999999999999999999999999999999999999876 588999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++ +.++.++|+|||.+.............++..|+|||...+...+.++|+||+|++++++++|..|
T Consensus 120 ~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 196 (253)
T cd05122 120 IHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196 (253)
T ss_pred ecCCCCHHHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999 67889999999998776554323445678889999999888889999999999999999999999
Q ss_pred CCCCCccc-----------ccccC--CChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 168 FSGRNNVQ-----------LIVPA--LHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 168 ~~~~~~~~-----------~~~~~--~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
|...+... ..... ++..+.++|++|++.+|.+|||+.|+++|||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 197 YSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 97662211 11222 3788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=246.55 Aligned_cols=203 Identities=30% Similarity=0.535 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|++++++++|+||+++++++..++..++++||++++.+..+..+...+++..++.++.|++.|+.+||+.|
T Consensus 41 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (288)
T cd07833 41 EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120 (288)
T ss_pred ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567889999999999999999999999999999999999988777777766667999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+. .++.++|+||+|++++++++
T Consensus 121 i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 121 IIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred eecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 9999999999999 678899999999987665433 22334567789999998877 78899999999999999999
Q ss_pred CCCCCCCCCcccc------------------------------------------cccCCChHHHHHHHHhhccCccccC
Q 027233 164 GYPPFSGRNNVQL------------------------------------------IVPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 164 g~~p~~~~~~~~~------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
|..||.+....+. ....++.++.++|++||+.+|.+||
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 277 (288)
T cd07833 198 GEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc
Confidence 9998865321100 0223488899999999999999999
Q ss_pred CHhHHhcCccc
Q 027233 202 SFNEFYHHRFL 212 (226)
Q Consensus 202 t~~~~l~~~~~ 212 (226)
|++++++||||
T Consensus 278 s~~~il~~~~f 288 (288)
T cd07833 278 TCDELLQHPYF 288 (288)
T ss_pred cHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=247.53 Aligned_cols=206 Identities=30% Similarity=0.530 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.+. .+++..+..++.|++.|+++||++|+
T Consensus 58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi 136 (293)
T cd06647 58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 136 (293)
T ss_pred hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34567889999999999999999999999999999999999999999998754 67889999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|++||...+..++.++|+||+|++++++++|..
T Consensus 137 ~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 137 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred eeccCCHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 6778899999998765543322 223346778999999988888999999999999999999999
Q ss_pred CCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 167 PFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 167 p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
||...+..... ...++..+.+++++||+.+|.+||++++++.|+||+....
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 214 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 99765432211 2345778999999999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=241.68 Aligned_cols=202 Identities=30% Similarity=0.559 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++|+||++++++....+..++++||+++++|.+++.....+++..+..++.+++.|+.+||+.|+
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 120 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence 46788999999999999999999999999999999999999999999999887778999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc-----cccCCccccCcccccccC---CCcchhHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILF 159 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~~~ 159 (226)
+|+||+|+||++ +.++.++|+|||.+.......... ...++..|+|||...+.. .+.++|+||+|++++
T Consensus 121 ~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~ 197 (264)
T cd06626 121 VHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197 (264)
T ss_pred ccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence 999999999999 678889999999987765432211 234677899999987665 788999999999999
Q ss_pred HHHhCCCCCCCCCccc------------cccc--CCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 160 ELLNGYPPFSGRNNVQ------------LIVP--ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~------------~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
++++|..||....... ..+. .++..+.++|.+|++.+|.+|||+.+++.|||+
T Consensus 198 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 198 EMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999997542211 1122 347889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=245.55 Aligned_cols=203 Identities=33% Similarity=0.584 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.++++++|+||+++++++...+..++|+||+ +++|.+++... ..+++..++.++.|++.+|.+||+.
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 118 (286)
T cd07832 40 GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118 (286)
T ss_pred chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344568899999999999999999999999999999999999 99999998654 5789999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCccccccc-CCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~ 162 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+. .++.++|+||+|+++++++
T Consensus 119 ~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 195 (286)
T cd07832 119 GIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL 195 (286)
T ss_pred CeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH
Confidence 99999999999999 6688899999999876654321 2234577889999988654 4688999999999999999
Q ss_pred hCCCCCCCCCccc----------------------------------------ccccCCChHHHHHHHHhhccCccccCC
Q 027233 163 NGYPPFSGRNNVQ----------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 163 ~g~~p~~~~~~~~----------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
+|..+|.+..... ......+.++.++|.+||+.+|.+|||
T Consensus 196 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 196 NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred cCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 9988776543210 012356789999999999999999999
Q ss_pred HhHHhcCcccc
Q 027233 203 FNEFYHHRFLR 213 (226)
Q Consensus 203 ~~~~l~~~~~~ 213 (226)
++++++||||.
T Consensus 276 ~~~~l~h~~~~ 286 (286)
T cd07832 276 AAEALRHPYFT 286 (286)
T ss_pred HHHHhhCcCcC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=246.38 Aligned_cols=199 Identities=32% Similarity=0.534 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+..+.+.+|++.+++++||||+++++++...+..++|+||+++++|.+++... ..++...+..++.|++.||.|||+
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~ 121 (259)
T PF07714_consen 42 EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS 121 (259)
T ss_dssp HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 445789999999999999999999999999888899999999999999999986 679999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
++++|++|++.||++ +.++.++|+|||++........ .........|+|||.+.+..++.++||||||++++|+
T Consensus 122 ~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 122 NNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999 6788999999999877632211 2233456779999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||...+..+.. +...+..+.+++.+||+.+|.+|||+.++++
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99 77998776543321 5567899999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=243.84 Aligned_cols=190 Identities=31% Similarity=0.543 Sum_probs=165.0
Q ss_pred cCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeee
Q 027233 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101 (226)
Q Consensus 22 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~ 101 (226)
..+|++|+.+++.+..++..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|++|+||+|+||++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~-- 130 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL-- 130 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE--
Confidence 347999999999999999999999999999999999888889999999999999999999999999999999999999
Q ss_pred CCCCccEEEeeeccccccCCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc-----
Q 027233 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ----- 175 (226)
Q Consensus 102 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----- 175 (226)
+.++.++|+|||++....... .....++..|+|||... +..++.++|+||+|++++++++|..||.......
T Consensus 131 -~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 208 (279)
T cd05633 131 -DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (279)
T ss_pred -CCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH
Confidence 678899999999986554322 22345788999999875 4567899999999999999999999997543211
Q ss_pred --------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 176 --------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 176 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
..+..++.++.++|++||+.||.+|+ |++++++||||++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 209 RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 11456789999999999999999999 69999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=245.15 Aligned_cols=199 Identities=25% Similarity=0.523 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-------------CCCHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFLQ 73 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~ 73 (226)
....+.+.+|+.++++++|+||+++++++...+..++++||+++++|.+++...+ .+++..++.++.
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 127 (288)
T cd05093 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127 (288)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999997543 389999999999
Q ss_pred HHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchh
Q 027233 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (226)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~D 150 (226)
|++.||++||++|++||||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|
T Consensus 128 ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 204 (288)
T cd05093 128 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 204 (288)
T ss_pred HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhh
Confidence 99999999999999999999999999 6788899999999875533221 11222456799999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 151 MWSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 151 v~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+||||+++++|++ |..||....... ......+.++.+++.+||+.+|.+|||++++++
T Consensus 205 iwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 205 VWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999998 899987654321 124457889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=245.45 Aligned_cols=198 Identities=25% Similarity=0.524 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKF 71 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~ 71 (226)
...+.+.+|+..+++++|+||+++++++...+..+++|||+++++|.+++...+ .+++..++.+
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 128 (291)
T cd05094 49 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHH
Confidence 345678999999999999999999999999999999999999999999997643 3788999999
Q ss_pred HHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcc
Q 027233 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
+.||+.|+++||++|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+..++.+
T Consensus 129 ~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 205 (291)
T cd05094 129 ASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 205 (291)
T ss_pred HHHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch
Confidence 9999999999999999999999999999 6788999999999876543221 122345677999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 149 VDMWSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|+||||++++++++ |..||....... ......+..+.+++.+|++.+|.+|||+.++++
T Consensus 206 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 206 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999999999999998 999986644321 124456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=264.82 Aligned_cols=198 Identities=28% Similarity=0.571 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFL 72 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~ 72 (226)
.+++++|++|+..+..|+|||||+++|.+..++-.++|+||+..|+|.+|++... +++..+.+.++
T Consensus 530 ~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA 609 (774)
T KOG1026|consen 530 NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIA 609 (774)
T ss_pred HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHH
Confidence 3489999999999999999999999999999999999999999999999997542 27788999999
Q ss_pred HHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcch
Q 027233 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV 149 (226)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~ 149 (226)
.||+.|+.||-++.++||||-..|++| ..+..|||+|||+++....... .....-..+|||||.+...+++.++
T Consensus 610 ~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS 686 (774)
T KOG1026|consen 610 TQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES 686 (774)
T ss_pred HHHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh
Confidence 999999999999999999999999999 7899999999999987754332 2234456789999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 150 DMWSVGAILFELLN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 150 Dv~slG~~~~~l~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
||||+|+++||+++ |..||.+.++.+.+ +...|.++.+++..|++.+|++||++.||-
T Consensus 687 DVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 687 DVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999 99999998877665 778899999999999999999999999974
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=245.21 Aligned_cols=204 Identities=32% Similarity=0.581 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++.++.++|+|++++++.+...+..++++||+++++|.+++.... .++...+..++.|++.+|++||+.|+
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46678899999999999999999999999999999999999999999999876 89999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 138 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 138 IHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred eeCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 999999999999 6788899999998765543221 123346778999999988888999999999999999999999
Q ss_pred CCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||......... ...++.+++++|++|++.+|.+|||+.++++|+||++.
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 215 PYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 98765432111 22367889999999999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=243.86 Aligned_cols=201 Identities=29% Similarity=0.527 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l 79 (226)
....+..|+.+++++ +|+||+++++++... ...++++||+.+++|.+++... ..+++..+..++.|++.|+
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 346788999999999 799999999998653 4689999999999999998864 3688999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccc-----ccCCCcchhHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~s 153 (226)
+|||+++++|+||+|.||++ +.++.++|+|||++...... .......++..|+|||.+. +..++.++|+||
T Consensus 125 ~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred HHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 99999999999999999999 67888999999998765332 1223345778899999875 335778999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|++++++++|..||....... ......+.++.+++.+||+.+|.+|||+.++++||||
T Consensus 202 lGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 202 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999999999986533211 1134567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=244.97 Aligned_cols=206 Identities=28% Similarity=0.444 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (226)
....+.+.+|+++++.++||||+++++++...+..++++||+++++|.+++.+.+.+++..+..++.+++.++.|||+ .
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 445678899999999999999999999999999999999999999999999888889999999999999999999997 5
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+++|+||+|+||++ +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199 (284)
T ss_pred CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence 89999999999999 678889999999876543222 22345788999999988888899999999999999999999
Q ss_pred CCCCCCCcc-----------c-----------cc-ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 166 PPFSGRNNV-----------Q-----------LI-VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 166 ~p~~~~~~~-----------~-----------~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.||...... . .. ...++.++.+++++|++.||.+|||+.|+++|+||....
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999754331 0 00 122677899999999999999999999999999997753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=239.04 Aligned_cols=202 Identities=27% Similarity=0.570 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++|+|++++++++.+.+..+++++++++++|.+++.....+++..++.++.|++.++.+||+.|+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 120 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 46678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 121 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~ 197 (254)
T cd06627 121 IHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197 (254)
T ss_pred ccCCCCHHHEEE---CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 999999999999 5678999999999877654432 223456778999999887778899999999999999999999
Q ss_pred CCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 167 PFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 167 p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
||....... ..+..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 198 PYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 987543221 1245678899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=240.41 Aligned_cols=201 Identities=40% Similarity=0.653 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|++++++++|+||+++++.+..++..++++|++.+++|.+++.....+++..+..++.|++.|+.++|+.+++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~ 115 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 56688999999999999999999999999999999999999999999999887899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++ +.++.++|+|||.+...... .......++..|.|||...+...+.++|+||||++++++++|..|
T Consensus 116 H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred ecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999 67788999999998776443 223344567789999999888889999999999999999999999
Q ss_pred CCCCCccc----------ccccCCChHHHHHHHHhhccCccccCCH---hHHhcCccc
Q 027233 168 FSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRLSF---NEFYHHRFL 212 (226)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~---~~~l~~~~~ 212 (226)
|...+... ..+...+.++.+++++||..+|++|||+ +++++||||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 193 FYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 97665321 1255568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=241.72 Aligned_cols=202 Identities=29% Similarity=0.552 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|++++++++|+||+++++++.+. ...++++||+++++|.+++...+.+++..+..++.|++.+|.+||++
T Consensus 46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (265)
T cd06652 46 KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456889999999999999999999988663 56889999999999999998877889999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+...+.++|+||||++++++
T Consensus 126 ~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 126 MIVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CEecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999 678899999999887543211 11223467789999999888889999999999999999
Q ss_pred HhCCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 162 LNGYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 162 ~~g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
++|..||....... ..+..++..+.+++++|+. +|.+|||++++++|||+.
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999997543221 1244567789999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=248.90 Aligned_cols=208 Identities=25% Similarity=0.389 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|++++++++|+||+++++.+...+..++++||+++++|.+++... ..+++..+..++.|++.||.|||
T Consensus 39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH 118 (314)
T cd08216 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118 (314)
T ss_pred chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999999999999999999999999999999864 46889999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccc--cCCCcchhHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWS 153 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~s 153 (226)
++|++|+||+|+||++ +.++.++++||+.+........ .....++..|+|||.+.+ ..++.++|+||
T Consensus 119 ~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws 195 (314)
T cd08216 119 SKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS 195 (314)
T ss_pred HCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHH
Confidence 9999999999999999 6778899999998765432111 122335667999999865 35788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccc--------------------------------------------ccCCChHHHHHH
Q 027233 154 VGAILFELLNGYPPFSGRNNVQLI--------------------------------------------VPALHPDCVDMC 189 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~~--------------------------------------------~~~~~~~~~~~i 189 (226)
+|++++++++|..||......... ...++.++.+++
T Consensus 196 ~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 275 (314)
T cd08216 196 VGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFV 275 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHH
Confidence 999999999999999754321100 122346788999
Q ss_pred HHhhccCccccCCHhHHhcCccccccC
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+||+.+|.+|||++|+++||||+..+
T Consensus 276 ~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 276 ELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred HHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=260.14 Aligned_cols=208 Identities=30% Similarity=0.491 Sum_probs=180.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+..+++.-|+.+|..++||+||++++.|..++.++++.|+|.||-....+-. ...+.+..+.-+++|++.||.|||+
T Consensus 69 seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs 148 (1187)
T KOG0579|consen 69 SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS 148 (1187)
T ss_pred chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh
Confidence 455667888899999999999999999998888999999999999998887654 4589999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCccccc-----ccCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~ 158 (226)
++|+||||+..||++ +-+|.++|.|||.+..... ........|++.|||||+.+ ..+|+.++||||||+++
T Consensus 149 ~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITL 225 (1187)
T KOG0579|consen 149 QNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITL 225 (1187)
T ss_pred cchhhhhccccceEE---EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHH
Confidence 999999999999999 7899999999998754432 23345678999999999875 46899999999999999
Q ss_pred HHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 159 FELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+|..+..|-........+ +..-+..+.||+++||.+||..||++.|+|+|||++..+
T Consensus 226 IEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 226 IEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 9999999997655443222 556678899999999999999999999999999999643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=241.81 Aligned_cols=202 Identities=33% Similarity=0.619 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|+++++.++|+||+++++.+...+..++++||+++++|.+++.... .+++..+..++.|++.|+.+||+.
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456678899999999999999999999999999999999999999999997653 478999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCC-ccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+++|+||+|+||+++ .+ ..++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++
T Consensus 121 ~i~H~dl~~~nil~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 121 KILHRDIKSQNIFLS---KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred CcccccCCHHHEEEc---CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999994 44 4579999998876644322 122347778999999888888999999999999999999
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|..||........ .....+.++.+++++|++.+|.+|||+.++++||||
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999976532211 244567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=246.10 Aligned_cols=198 Identities=27% Similarity=0.499 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-------------------CCCHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQT 67 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~ 67 (226)
...+..+.+|++++++++||||+++++++.+.+..++++||+.+++|.+++.... .++...
T Consensus 60 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05096 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139 (304)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHH
Confidence 4456789999999999999999999999999999999999999999999986532 356778
Q ss_pred HHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccC
Q 027233 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 144 (226)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~ 144 (226)
+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..
T Consensus 140 ~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 89999999999999999999999999999999 6788999999999876543221 12223467799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh--CCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHh
Q 027233 145 YDEKVDMWSVGAILFELLN--GYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~--g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
++.++|+||||++++++++ +..||........ .++..+..+.+++.+|++.+|.+|||++
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 9999999999999999986 5667765432211 1345678999999999999999999999
Q ss_pred HHh
Q 027233 205 EFY 207 (226)
Q Consensus 205 ~~l 207 (226)
|+.
T Consensus 297 ~i~ 299 (304)
T cd05096 297 DIH 299 (304)
T ss_pred HHH
Confidence 994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=260.94 Aligned_cols=203 Identities=24% Similarity=0.323 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+|++++++++|+||+++++++...+..|++++++ +++|.+++... .......+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999 56787776532 12345677889999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
++||+||||||+||++ +.++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||+++++|
T Consensus 285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999 6788999999999976644322 2235688999999999988999999999999999999
Q ss_pred HhCCC-CCCCCCccc----------------cc----------------------------ccCCChHHHHHHHHhhccC
Q 027233 162 LNGYP-PFSGRNNVQ----------------LI----------------------------VPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 162 ~~g~~-p~~~~~~~~----------------~~----------------------------~~~~~~~~~~~i~~~l~~~ 196 (226)
++|.. |+....... .. ...++.++.++|.+||+.|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 99765 443221100 00 1134567888899999999
Q ss_pred ccccCCHhHHhcCcccccc
Q 027233 197 TVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+|||+.|+|.||||...
T Consensus 442 P~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 442 WHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccCcCHHHHhhChhhhcC
Confidence 9999999999999999874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=237.25 Aligned_cols=209 Identities=28% Similarity=0.511 Sum_probs=178.8
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..++.+++...+.++... ++|+||+++++|..+..+++.||.+ +..++..++. +++++|..+-.+...++.||.||.
T Consensus 130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK 208 (391)
T KOG0983|consen 130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK 208 (391)
T ss_pred CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence 345666777778877666 6999999999999999999999988 5667766654 368999999999999999999998
Q ss_pred hC-CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHH
Q 027233 84 SH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 84 ~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~ 159 (226)
++ |++|||+||+||++ +..+.+||||||.+.++..+.......|...|+|||.+. ...|+.++||||||++++
T Consensus 209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlv 285 (391)
T KOG0983|consen 209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLV 285 (391)
T ss_pred HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchh
Confidence 64 89999999999999 789999999999999988877777778999999999985 446889999999999999
Q ss_pred HHHhCCCCCCCCCcc-ccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 160 ELLNGYPPFSGRNNV-QLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~-~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
|+.+|+.||.+-+.. +.+ ...+|+++.+|+..||.+|+.+||.+.++|+|||+.+..+.
T Consensus 286 eLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 286 ELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred hhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 999999999874321 111 23378999999999999999999999999999999987543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=239.90 Aligned_cols=203 Identities=32% Similarity=0.600 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (226)
.+..+.+.+|++.+++++|+|++++.+.+...+..++++|++++++|.+++... ..++...+..++.+++.|+.+|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 119 (258)
T cd08215 40 EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999999999999999999999999999999999999864 6789999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+...+.++|+||+|++++++
T Consensus 120 h~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l 196 (258)
T cd08215 120 HSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196 (258)
T ss_pred HhCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHH
Confidence 99999999999999999 678889999999987665443 22334577889999998888889999999999999999
Q ss_pred HhCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 162 LNGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 162 ~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
++|..||...+... ..+..++..+.+++.+||+.+|.+|||+.++++||||
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 197 CTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999987654221 1245678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=240.68 Aligned_cols=198 Identities=29% Similarity=0.511 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l 79 (226)
..+.+.+|++.++.++|+||+++++++...+..++++||+++++|.+++... ..+++..++.++.|++.|+
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999999875 6799999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
++||++|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|+
T Consensus 119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 99999999999999999999 677999999999997765432 122344677899999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 157 ILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 157 ~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++++++ |..||....... ..+..++.++.+++.+|++.+|.+|||++|++++
T Consensus 196 il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 196 LLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999998 689987764321 1255678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=242.66 Aligned_cols=198 Identities=24% Similarity=0.507 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQ 73 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~ 73 (226)
+..+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++...+ .+++..+..++.
T Consensus 50 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 129 (280)
T cd05049 50 DARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129 (280)
T ss_pred HHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHH
Confidence 356789999999999999999999999999999999999999999999997642 377889999999
Q ss_pred HHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcchh
Q 027233 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (226)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~D 150 (226)
|++.|+.+||++|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|
T Consensus 130 ~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (280)
T cd05049 130 QIASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 206 (280)
T ss_pred HHHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhh
Confidence 99999999999999999999999999 678999999999986543221 112223456799999999899999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 151 MWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 151 v~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+||||++++++++ |..||........ .....+..+.+++.+||+.+|.+|||++|+++
T Consensus 207 i~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 207 VWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999998 9999876543221 14567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=251.25 Aligned_cols=206 Identities=28% Similarity=0.559 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|..++..++|++|+++++++.+++..|+||||+.|++|.+++.+ ...+++..+..++.|++.||.+||++
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 42 RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 33455688999999999999999999999999999999999999999999987 45789999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccc-----cCCCcchhHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~~ 158 (226)
|++||||+|+||++ +.++.++|+|||++......... ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 122 ~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil 198 (331)
T cd05624 122 HYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCM 198 (331)
T ss_pred CeeeccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhh
Confidence 99999999999999 67888999999998766443221 23458899999998865 4578899999999999
Q ss_pred HHHHhCCCCCCCCCcccc---------------cccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 159 FELLNGYPPFSGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
|+|++|..||...+..+. ....++.++++++.+||...+.+ |++++++++||||++.
T Consensus 199 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 199 YEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred hhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 999999999976542211 12346889999999999876554 5699999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=241.28 Aligned_cols=198 Identities=21% Similarity=0.372 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|+..+++++||||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.|+++||++|
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ 127 (266)
T cd05064 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127 (266)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44567889999999999999999999999999999999999999999999874 47899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++|+||+|+||++ +.++.++++|||.+......... ....++..|+|||...+..++.++|+||+|++++++++
T Consensus 128 iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 204 (266)
T cd05064 128 YVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred EeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence 9999999999999 67889999999987554322111 12223467999999988899999999999999999775
Q ss_pred CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||....... ..+...+..+.+++.+|++.+|.+|||++++++
T Consensus 205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 205 GERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999997654321 124557889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=239.07 Aligned_cols=200 Identities=30% Similarity=0.497 Sum_probs=169.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+....+.+|++++++++|+||+++++++...+..++|+||+++++|.+++...+ .+++..++.++.|++.||.|||+
T Consensus 33 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 112 (252)
T cd05084 33 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112 (252)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35567789999999999999999999999999999999999999999999997654 68999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc---cccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+|++|+||+|.||++ +.++.++|+|||.+.......... ....+..|+|||.+.+..++.++|+||||++++++
T Consensus 113 ~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~ 189 (252)
T cd05084 113 KHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEA 189 (252)
T ss_pred CCccccccchheEEE---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 999999999999999 677889999999986544321111 11123469999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||....... ..+...+..+.+++.+|++.+|.+|||++++++
T Consensus 190 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 190 FSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 97 888886544221 114456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=245.08 Aligned_cols=206 Identities=25% Similarity=0.521 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|+.+++.++|+||+++++.+..++..++++||+++++|.+++.. ..+++..+..++.|++.++++||+.|
T Consensus 58 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g 136 (292)
T cd06657 58 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG 136 (292)
T ss_pred hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566789999999999999999999999999999999999999999998754 47899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|.
T Consensus 137 ivH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 137 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred eecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 677889999999876554322 122345678899999988888899999999999999999999
Q ss_pred CCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 166 PPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 166 ~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.||.+...... ....++..+.+++.+||+.+|.+||++.++++||||.+..
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 214 PPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99976543211 1234688999999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=264.24 Aligned_cols=216 Identities=30% Similarity=0.500 Sum_probs=189.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~l 82 (226)
+.+..+-+.+|+...++|+|.|||++.|.+.+++..-|.||-.+||||.+.++.. +++ .+.++.-+.+||++||.||
T Consensus 612 dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYL 691 (1226)
T KOG4279|consen 612 DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYL 691 (1226)
T ss_pred cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhh
Confidence 4455667899999999999999999999999999999999999999999999876 566 8889999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCccccccc--CCCcchhHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILF 159 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~~~ 159 (226)
|++.|+|||||-+|++++ +-.+.+||.|||-+++... ++.+...-|+.-|||||.+..+ .|..++|||||||++.
T Consensus 692 Hen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v 769 (1226)
T KOG4279|consen 692 HENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV 769 (1226)
T ss_pred hhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence 999999999999999996 6789999999999887754 4445566799999999999755 4788999999999999
Q ss_pred HHHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCCC
Q 027233 160 ELLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 223 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~ 223 (226)
||.+|..||-..... ..++..++.+.+.||.+|+.++|.+||++.++|..||++.++...+++.
T Consensus 770 EMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l 846 (1226)
T KOG4279|consen 770 EMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL 846 (1226)
T ss_pred eeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence 999999998654322 2236778889999999999999999999999999999999866666654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=243.57 Aligned_cols=201 Identities=31% Similarity=0.554 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCC------eEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGA 77 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~ 77 (226)
..+.+.+|+.+++++ +|+||+++++++.... ..++++||+++++|.+++... ..+++..+..++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 456789999999999 7999999999987644 489999999999999998653 47899999999999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-----cCCCcchhH
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDM 151 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv 151 (226)
||.+||+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.. ..++.++|+
T Consensus 125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999999999999999999999 678889999999886553322 2233456788999998753 346778999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 152 WSVGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 152 ~slG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
||+|++++++++|..||......... ...++.++.++|++||+.||++|||++|+++|||+
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999754322111 22367789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=243.58 Aligned_cols=202 Identities=28% Similarity=0.534 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe------CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~ 78 (226)
.....+..|+.+++++ +|+||+++++++.. ....+++|||+++++|.+++... ..+++..+..++.|++.|
T Consensus 54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a 133 (282)
T cd06636 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133 (282)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence 4456788999999999 79999999998853 46789999999999999999764 357888899999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccc-----ccCCCcchhHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW 152 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~ 152 (226)
+.|||+.|++|+||+|.||++ +.++.++|+|||.+...... .......++..|+|||.+. ...++.++|+|
T Consensus 134 l~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw 210 (282)
T cd06636 134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210 (282)
T ss_pred HHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence 999999999999999999999 67888999999988655322 1223345778899999875 34577899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|||++++++++|..||........ ....++.++.++|.+||+.||.+|||+.|+++||||
T Consensus 211 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 211 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999965432111 133578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=242.14 Aligned_cols=203 Identities=27% Similarity=0.442 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l 79 (226)
......+.+|+.+++.++|+||+++++++.+.+..++++||+.|++|.+++...+ .+++..+..++.||+.|+
T Consensus 50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 129 (277)
T cd05036 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3445678889999999999999999999998888999999999999999997653 478899999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
.+||+++++|+||+|+||+++.......++|+|||.+......... .....+..|+|||.+.+..++.++|+||||+
T Consensus 130 ~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 9999999999999999999964333457999999998765322211 1122345799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 157 ILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 157 ~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++++++ |..||.+.+.... .+..++..+.+++.+|++.+|.+|||+.++++|
T Consensus 210 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999996 9999976543221 145678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=247.47 Aligned_cols=207 Identities=31% Similarity=0.471 Sum_probs=171.9
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+|+.++++++|+||+++++++.+. +..++|+||+. ++|.+++... ..+++..++.++.|++.|+.+||+.|++
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 130 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII 130 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456799999999999999999998764 56899999995 5898888764 5789999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 131 H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 131 HRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred cCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 99999999999 678899999999987765432 1222334677999998865 457889999999999999999999
Q ss_pred CCCCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 167 PFSGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 167 p~~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
||...+..... ....++++.++|++||+.||.+|||++|+
T Consensus 208 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i 287 (309)
T cd07845 208 LLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287 (309)
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 98654322110 12257889999999999999999999999
Q ss_pred hcCccccccCcccCCC
Q 027233 207 YHHRFLRRNSAILRAP 222 (226)
Q Consensus 207 l~~~~~~~~~~~~~~~ 222 (226)
+.||||++.....++.
T Consensus 288 l~h~~f~~~~~~~~~~ 303 (309)
T cd07845 288 LESSYFKEKPLPCEPE 303 (309)
T ss_pred hcChhhccCCCCCCCC
Confidence 9999999876665543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=241.53 Aligned_cols=205 Identities=29% Similarity=0.486 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....+.+|+++++.++||||+++++++.+ .+..++++||+++++|.+++.. ...+++..+..++.|++.||.|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999998864 3578999999999999998753 2458899999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||+.|++|+||+|+||++ +.++.++|+|||.+........ ....++..|+|||...+..++.++|+||+|++++++
T Consensus 121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred HHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999 5677899999999865543222 233467789999999888899999999999999999
Q ss_pred HhCCCCCCCCCcc-----c-----------ccc------cCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 162 LNGYPPFSGRNNV-----Q-----------LIV------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 162 ~~g~~p~~~~~~~-----~-----------~~~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++|..||...... + ... ...++.+.+++.+||+.+|.+|||+.|+++||||+...
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 9999999765210 0 001 12356899999999999999999999999999997753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=243.80 Aligned_cols=202 Identities=30% Similarity=0.545 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~ 78 (226)
....+.+|+.+++++ +|||++++++++... +..++++||+++++|.+++.. ...+++..++.++.|++.|
T Consensus 61 ~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 140 (291)
T cd06639 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140 (291)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Confidence 345678899999999 899999999988643 468999999999999998863 3578999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-----CCCcchhHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-----RYDEKVDMW 152 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~ 152 (226)
|.+||+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+... .++.++|+|
T Consensus 141 l~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 141 LQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999999999999999999999 677889999999987654322 12234567889999987543 367899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
|+|++++++++|..||........ .+...+..+.++|.+|++.+|.+||++.|+++||||+
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 999999999999999876543211 1334567899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=241.70 Aligned_cols=206 Identities=25% Similarity=0.524 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|+.++++++ |||++++++++..++..++++||+++++|.+++.. +.+++..++.++.|++.++.+||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh 118 (277)
T cd06917 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH 118 (277)
T ss_pred chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 345567889999999996 99999999999999999999999999999999875 47899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+ ..++.++|+||+|++++++
T Consensus 119 ~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l 195 (277)
T cd06917 119 KVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195 (277)
T ss_pred hCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHH
Confidence 9999999999999999 5688999999999876654332 223357778999998764 4568899999999999999
Q ss_pred HhCCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 162 LNGYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++|..||......... ...++.++.+++.+||+.+|.+|||+.++++|+||++..
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 196 ATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999765432111 223678999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=238.78 Aligned_cols=198 Identities=25% Similarity=0.434 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|+.+++.++|+||+++++++.. ...++++||+++++|.+++.....+++..+..++.|++.|+.+||++|
T Consensus 37 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 115 (257)
T cd05116 37 PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456789999999999999999999998764 457899999999999999988788999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
++|+||+|.||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||+++++++
T Consensus 116 i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 116 FVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred EeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 9999999999999 67788999999998766443221 1122346799999998888899999999999999999
Q ss_pred h-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 N-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+ |..||......+ ..+...+.+++++|.+|++.||.+||+++++.+
T Consensus 193 t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 193 SYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred hCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 7 999997653321 125568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=239.33 Aligned_cols=195 Identities=28% Similarity=0.417 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecc
Q 027233 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (226)
..+|...+....||||+++++++.+....++++||++|++|.+++.+...+++..+..++.|++.||.+||++|++|+||
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 111 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 34555556666899999999999999999999999999999999988778999999999999999999999999999999
Q ss_pred CCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 027233 93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (226)
Q Consensus 93 ~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 172 (226)
+|+||++ +.++.+++.|||.+....... ....++..|+|||...+..++.++|+||+|++++++++|..|+....
T Consensus 112 kp~Nil~---~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~ 186 (237)
T cd05576 112 NPNNILL---DDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186 (237)
T ss_pred CHHHEEE---cCCCCEEEecccchhcccccc--ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCc
Confidence 9999999 678889999999876554322 22334667999999988888999999999999999999998765432
Q ss_pred cc------cccccCCChHHHHHHHHhhccCccccCCH-----hHHhcCccc
Q 027233 173 NV------QLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFL 212 (226)
Q Consensus 173 ~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~-----~~~l~~~~~ 212 (226)
.. ...+..++..++++|++||+.||.+|+|+ +++++||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 187 SGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 11 11255678899999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=252.81 Aligned_cols=199 Identities=26% Similarity=0.439 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-------------------------
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------- 60 (226)
.+..+.+.+|+++++.+ +|+||+++++.+...+..+++|||+++++|.+++...
T Consensus 82 ~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (374)
T cd05106 82 TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161 (374)
T ss_pred HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccc
Confidence 34566788999999999 8999999999999999999999999999999998643
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCC
Q 027233 61 ---------------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95 (226)
Q Consensus 61 ---------------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~ 95 (226)
.++++..+.+++.|++.||.|||++|++||||+|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 241 (374)
T cd05106 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR 241 (374)
T ss_pred hhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchh
Confidence 13677889999999999999999999999999999
Q ss_pred CeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 027233 96 NILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGR 171 (226)
Q Consensus 96 nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~ 171 (226)
||++ +.++.++|+|||++......... ....++..|+|||.+.+..++.++|+||+|++++++++ |..||...
T Consensus 242 Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 242 NVLL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eEEE---eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 9999 57788999999998765433211 11223457999999988889999999999999999997 99999765
Q ss_pred Ccccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 172 NNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 172 ~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..... .+...++++.+++.+||+.+|.+|||+.++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 319 LVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 43211 13446899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=240.32 Aligned_cols=195 Identities=31% Similarity=0.537 Sum_probs=168.1
Q ss_pred HHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCe
Q 027233 18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENI 97 (226)
Q Consensus 18 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~ni 97 (226)
+.++...||+|+++.+.+.+.+..++|+||+.|++|.+++.+.+.+++..+..++.|++.|+.|||+.+++|+||+|+||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni 128 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI 128 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence 34455689999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc-
Q 027233 98 LLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ- 175 (226)
Q Consensus 98 li~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~- 175 (226)
++ +.++.++|+|||.+....... .....++..|+|||...+ ..++.++|+||+|++++++++|..||.......
T Consensus 129 li---~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~ 204 (278)
T cd05606 129 LL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204 (278)
T ss_pred EE---CCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence 99 678889999999986553322 223457889999999864 468899999999999999999999997652211
Q ss_pred ------------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccccC
Q 027233 176 ------------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRNS 216 (226)
Q Consensus 176 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 216 (226)
..+...+.++.+++.+||..+|.+|| ++.++++||||++..
T Consensus 205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 205 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 11445789999999999999999999 999999999998853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=247.87 Aligned_cols=205 Identities=32% Similarity=0.511 Sum_probs=174.6
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
.+.+|++++++++|+||+++++++..++..++++||+. ++|.+++.....+++..+..++.|++.||.+||+.|++|+|
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 57789999999999999999999999999999999995 69999998877899999999999999999999999999999
Q ss_pred cCCCCeEeeeCCCCccEEEeeeccccccCCCC---------------ccccccCCccccCccccccc-CCCcchhHHHHH
Q 027233 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (226)
Q Consensus 92 l~~~nili~~~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG 155 (226)
|+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|
T Consensus 145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 221 (335)
T PTZ00024 145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221 (335)
T ss_pred ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence 99999999 678889999999887654111 11122356779999998754 468899999999
Q ss_pred HHHHHHHhCCCCCCCCCcccc--------------------------------------cccCCChHHHHHHHHhhccCc
Q 027233 156 AILFELLNGYPPFSGRNNVQL--------------------------------------IVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~~--------------------------------------~~~~~~~~~~~~i~~~l~~~p 197 (226)
++++++++|..||.+.+..+. .....+.++.++|.+||+.+|
T Consensus 222 ~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 301 (335)
T PTZ00024 222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301 (335)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence 999999999999875542110 023457889999999999999
Q ss_pred cccCCHhHHhcCccccccCcccC
Q 027233 198 VDRLSFNEFYHHRFLRRNSAILR 220 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~~~~~~ 220 (226)
.+|||++|++.||||+.....+.
T Consensus 302 ~~R~s~~~~l~~~~~~~~~~~~~ 324 (335)
T PTZ00024 302 LERISAKEALKHEYFKSDPLPCD 324 (335)
T ss_pred hhccCHHHHhcCcccCCCCCCCC
Confidence 99999999999999999877765
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=241.60 Aligned_cols=200 Identities=23% Similarity=0.493 Sum_probs=170.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC---------------CCCHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARK 70 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~ 70 (226)
.....+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++...+ .+++..+..
T Consensus 47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 126 (280)
T cd05092 47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126 (280)
T ss_pred CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence 34556789999999999999999999999999999999999999999999997643 378899999
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCc
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
++.|++.|++|||++|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.
T Consensus 127 ~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (280)
T cd05092 127 IASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 203 (280)
T ss_pred HHHHHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc
Confidence 99999999999999999999999999999 6788899999999865533221 11222356799999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|+||||++++++++ |..||......+ ..+..+++.+.+++.+||+.+|.+||+++++++
T Consensus 204 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 204 ESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999998 899986543321 114567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=244.71 Aligned_cols=200 Identities=32% Similarity=0.563 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++.+.+..++++||+. ++|.+++... ..+++..+..++.|++.|++|||+.|
T Consensus 42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (284)
T cd07860 42 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120 (284)
T ss_pred cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578899999999999999999999999999999999995 6899988653 46889999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccC-CCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~~~~l~~g 164 (226)
++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+.. ++.++|+||||++++++++|
T Consensus 121 i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred eecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999 6788999999999866543221 22234577899999876544 58899999999999999999
Q ss_pred CCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 165 YPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 165 ~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
..||...+.... ....++.++.++|.+||+.||.+|||+++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 198 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 999865432110 02346788999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07860 278 ALAHPFF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=246.66 Aligned_cols=200 Identities=28% Similarity=0.458 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~ 69 (226)
....+.+.+|+.++.++ +|+||+++++++..++..++++||+++++|.+++...+ .+++..++
T Consensus 48 ~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 127 (303)
T cd05088 48 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127 (303)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHH
Confidence 34566888999999999 89999999999999999999999999999999997543 46888999
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcch
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 149 (226)
.++.|++.|+.+||++|++||||+|+||++ +.++.++|+|||++..............+..|+|||...+..++.++
T Consensus 128 ~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (303)
T cd05088 128 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 204 (303)
T ss_pred HHHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccc
Confidence 999999999999999999999999999999 67888999999988543221111122235569999999888889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 150 DMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 150 Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|+||||++++++++ |..||...+..+. .+...+.++.+++.+|++.+|.+|||+++++..
T Consensus 205 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 205 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999998 9999875543221 133467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=239.31 Aligned_cols=202 Identities=34% Similarity=0.521 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
......+.+|++++++++|+||+++.+.+.+....++++||+++++|.+++.. ...+++..++.++.|++.|+++|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 119 (256)
T cd08530 40 QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119 (256)
T ss_pred HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566788899999999999999999999999999999999999999999876 34689999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|+.|++|+||+|+||++ +.++.++|+|||.+...... ......++..|+|||...+..++.++|+||+|+++++++
T Consensus 120 h~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 195 (256)
T cd08530 120 HEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195 (256)
T ss_pred hhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999 56788999999998776544 233345778899999998888999999999999999999
Q ss_pred hCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 163 NGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 163 ~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|..||...+... .....++.++.+++.+|++.+|.+|||+.++++||++
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 196 TFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999998765321 1244578889999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=258.60 Aligned_cols=203 Identities=25% Similarity=0.433 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhcCCC------CCeeeeeeEEEeC-CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSVNH------PNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
.+....|+++++.++| .+++++++++..+ +..++|++++ |++|.+++.+.+.+++..+..++.||+.||.||
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456678888777754 4588888888764 5788999988 789999998888999999999999999999999
Q ss_pred Hh-CCceeeccCCCCeEeeeCC-------------CCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcc
Q 027233 83 NS-HHIIHRDLKPENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 83 h~-~~i~H~dl~~~nili~~~~-------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
|+ .||+||||||+||+++..+ ....++|+|||.+...... .....++..|+|||.+.+..++.+
T Consensus 248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~~~~ 325 (467)
T PTZ00284 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGLGWMYS 325 (467)
T ss_pred HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcCCCCcH
Confidence 98 5999999999999995211 1125999999987543322 234568899999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCccccc---------------------------------------------------
Q 027233 149 VDMWSVGAILFELLNGYPPFSGRNNVQLI--------------------------------------------------- 177 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------------------------------------------- 177 (226)
+|||||||++|+|++|..||.+.+..+..
T Consensus 326 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 326 TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 99999999999999999999765432110
Q ss_pred -ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 178 -VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 178 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
....++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 00013457799999999999999999999999999985
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=240.49 Aligned_cols=204 Identities=26% Similarity=0.501 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+..+++++|+||+++++++..++..++|+||+++++|.+++.. ..+++..+..++.+++.++.+||+.|+
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (277)
T cd06641 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122 (277)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCe
Confidence 3456789999999999999999999999999999999999999999999874 478999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+...+.++|+||+|++++++++|..
T Consensus 123 ~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (277)
T cd06641 123 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred ecCCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999 6778899999998865543221 122346778999999988888999999999999999999999
Q ss_pred CCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||....... .....++.++.+++.+|+..+|.+||++.++++||||...
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 200 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 987543221 1244578899999999999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=243.46 Aligned_cols=206 Identities=30% Similarity=0.504 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++|+||+++++++.+.+..++|+||++ ++|.+++.... .+++..++.++.||+.||.+||++|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 122 (294)
T PLN00009 44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122 (294)
T ss_pred chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678899999999999999999999999999999999995 58888876543 3578889999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g 164 (226)
++|+||+|+||+++ ..++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus 123 i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 123 VLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred eeCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999994 2456799999999866543221 1233457789999988653 578899999999999999999
Q ss_pred CCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 165 YPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 165 ~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
..||...+..+. ....++.++.+++.+||+.+|.+||++.+
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 280 (294)
T PLN00009 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280 (294)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence 999865432110 02356888999999999999999999999
Q ss_pred HhcCccccccCc
Q 027233 206 FYHHRFLRRNSA 217 (226)
Q Consensus 206 ~l~~~~~~~~~~ 217 (226)
+++||||++...
T Consensus 281 ~l~~~~~~~~~~ 292 (294)
T PLN00009 281 ALEHEYFKDLGD 292 (294)
T ss_pred HhcCchHhHHhc
Confidence 999999998654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=244.11 Aligned_cols=201 Identities=32% Similarity=0.571 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+++++.++|+||+++++++..++..++++||+++++|..+......+++..++.++.|++.|+.|||+.|++
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 122 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678899999999999999999999999999999999999999998877666799999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+ ..++.++|+||+|++++++++|..
T Consensus 123 h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 123 HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred ccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 99999999999 6788999999999876543322 123346778999998865 346789999999999999999998
Q ss_pred CCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 167 PFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 167 p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
||......+. ..+.++..+.+++.+||+.+|.+|||+.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 200 LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred CCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 8865432110 02456888999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
+++||||
T Consensus 280 il~~~~~ 286 (286)
T cd07846 280 LLHHEFF 286 (286)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=262.21 Aligned_cols=207 Identities=25% Similarity=0.464 Sum_probs=175.8
Q ss_pred hHHHHHHHHHHHHHHhcCC-CCCeeeeee-EEE---eCC---eEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFD-AFQ---AEN---CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL 75 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~-h~~i~~~~~-~~~---~~~---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i 75 (226)
++..-+.+++|+++|++|+ |+|||.+++ ... .++ .++|+||||.|+.|-|+++++ ..+++.++++|+.|+
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv 153 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV 153 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence 7788899999999999995 999999999 332 122 478999999999999999855 469999999999999
Q ss_pred HHHHHHHHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc----------cccCCccccCcccc---
Q 027233 76 GAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------KVCGSPLYMAPEVL--- 140 (226)
Q Consensus 76 ~~~l~~lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~aPE~~--- 140 (226)
++|+++||... |+|||||-+|||+ ..++.+||||||.++......... ...-|+.|.|||++
T Consensus 154 ~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly 230 (738)
T KOG1989|consen 154 CEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY 230 (738)
T ss_pred HHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence 99999999998 9999999999999 688899999999997665443211 12357889999987
Q ss_pred cccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 141 ~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
.+.++++|+|||+|||++|.|+....||+......++ .+.++..+++||+.||+.||.+||++-|++++-+.
T Consensus 231 sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 231 SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 5778999999999999999999999999987444333 46789999999999999999999999999976654
Q ss_pred ccc
Q 027233 213 RRN 215 (226)
Q Consensus 213 ~~~ 215 (226)
-..
T Consensus 311 l~~ 313 (738)
T KOG1989|consen 311 LAN 313 (738)
T ss_pred Hhc
Confidence 443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=238.25 Aligned_cols=197 Identities=23% Similarity=0.448 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|+.++++++||||+++++++...+..++++||+.+++|.+++... ..+++..++.++.|++.|+.+||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 356889999999999999999999999888899999999999999999764 3689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~ 165 (226)
|+||+|.||++ +.++.++|+|||.+.......... ...++..|.|||...+..++.++|+||||++++++++ |.
T Consensus 123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 99999999999 678889999999887654332211 1224567999999988889999999999999999998 99
Q ss_pred CCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 166 PPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 166 ~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.||........ .....+..+.+++.+||+.+|.+|||+.+++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 200 MPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99876543211 144567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=242.44 Aligned_cols=198 Identities=29% Similarity=0.485 Sum_probs=167.2
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+|+.++++++||||+++++++... +..++++||++ ++|.+++.... .+++..+..++.|++.||.+||+.|+
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 127 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3567899999999999999999998877 88999999996 59999887654 58999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+. ..+.++|+||+|++++++++|.
T Consensus 128 ~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 128 LHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred eeccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 999999999999 678899999999887665432 22334467789999988654 4688999999999999999999
Q ss_pred CCCCCCCcccc-----------------------------------------cccC-CChHHHHHHHHhhccCccccCCH
Q 027233 166 PPFSGRNNVQL-----------------------------------------IVPA-LHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 166 ~p~~~~~~~~~-----------------------------------------~~~~-~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
.||........ .+.. +++.+.++|++||+.+|.+|||+
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~ 284 (293)
T cd07843 205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284 (293)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence 98865432110 0111 47889999999999999999999
Q ss_pred hHHhcCccc
Q 027233 204 NEFYHHRFL 212 (226)
Q Consensus 204 ~~~l~~~~~ 212 (226)
.|+++||||
T Consensus 285 ~ell~~~~f 293 (293)
T cd07843 285 EDALKHPYF 293 (293)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=248.79 Aligned_cols=209 Identities=22% Similarity=0.347 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+..+.+.+|+.+++.++||||+++++++..++..++++||+.+++|.+++.... .+++..+..++.|++.||+|||+
T Consensus 40 ~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~ 119 (328)
T cd08226 40 EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ 119 (328)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999999999999999999988653 58899999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--------ccccCCccccCccccccc--CCCcchhHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQ--RYDEKVDMWSV 154 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~--~~~~~~Dv~sl 154 (226)
+|++|+||+|+||++ ..++.+++.||+.+......... ....++..|+|||.+.+. .++.++|+||+
T Consensus 120 ~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (328)
T cd08226 120 NGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196 (328)
T ss_pred CCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence 999999999999999 56788999998754332211110 111234569999998653 46889999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccc---------------------------------------------------------
Q 027233 155 GAILFELLNGYPPFSGRNNVQLI--------------------------------------------------------- 177 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~~--------------------------------------------------------- 177 (226)
|++++++++|..||.........
T Consensus 197 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T cd08226 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276 (328)
T ss_pred HHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchh
Confidence 99999999999999754321100
Q ss_pred ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 178 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 178 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
...++..+.+++++||+.||.+|||+.|+++||||+..+..
T Consensus 277 ~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 12346679999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=251.63 Aligned_cols=199 Identities=28% Similarity=0.450 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-------------------------
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------- 61 (226)
...+.+.+|+.+++.+ +||||+++++++...+..++||||+++++|.+++....
T Consensus 80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (375)
T cd05104 80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE 159 (375)
T ss_pred HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence 3456788999999999 89999999999999999999999999999999986432
Q ss_pred --------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 62 --------------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 62 --------------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
.+++..+..++.||+.||.|||++|++|||
T Consensus 160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~D 239 (375)
T cd05104 160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239 (375)
T ss_pred ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 367788899999999999999999999999
Q ss_pred cCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CCCC
Q 027233 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167 (226)
Q Consensus 92 l~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p 167 (226)
|+|.||++ +.+..++|+|||++........ .....++..|+|||...+..++.++|+||||++++++++ |..|
T Consensus 240 lkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p 316 (375)
T cd05104 240 LAARNILL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316 (375)
T ss_pred CchhhEEE---ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 99999999 5677899999999876543221 111223456999999998899999999999999999997 8889
Q ss_pred CCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 168 FSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 168 ~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|....... ..+...+.++++++.+||+.||.+|||+.|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 317 YPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 87653221 1134467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=241.20 Aligned_cols=196 Identities=32% Similarity=0.555 Sum_probs=165.2
Q ss_pred HHHHHHHHHhcC-CCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 12 CLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 12 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+|+..++++ +|+|++++++++.+. +..++|+||++ ++|.+++... ..+++..++.++.|++.||.+||+.|+
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 345688889988 599999999999887 88999999996 5888887754 578999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +. +.++|+|||.+.............++..|+|||... +..++.++|+||+|++++++++|..
T Consensus 122 ~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 122 FHRDIKPENILI---KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred eecccCHHHEEE---cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 999999999999 45 899999999997765443333445678899999764 4557889999999999999999999
Q ss_pred CCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 167 PFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 167 p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
||.+.+..+. ....++.++.++|++||+.+|.+|||+++++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 9976432110 0235678999999999999999999999999
Q ss_pred cCccc
Q 027233 208 HHRFL 212 (226)
Q Consensus 208 ~~~~~ 212 (226)
+||||
T Consensus 278 ~~~~~ 282 (282)
T cd07831 278 RHPYF 282 (282)
T ss_pred hCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=249.46 Aligned_cols=211 Identities=31% Similarity=0.528 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.+.+|+.++++++|+||+++++++.. ....++|+||+. ++|.+++...+.+++..++.++.|++.||.+||+
T Consensus 47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 125 (334)
T cd07855 47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125 (334)
T ss_pred chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45677889999999999999999988753 356899999995 6999999877789999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
+|++|+||+|+||++ +.++.++|+|||.+........ .....++..|.|||.+.+ ..++.++|+||+|+++
T Consensus 126 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l 202 (334)
T cd07855 126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202 (334)
T ss_pred CCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence 999999999999999 6788999999999866543221 123357788999998765 4578899999999999
Q ss_pred HHHHhCCCCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhccCc
Q 027233 159 FELLNGYPPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~~p 197 (226)
+++++|..||.+.+... ......+.++.++|++||+.+|
T Consensus 203 ~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 282 (334)
T cd07855 203 AEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDP 282 (334)
T ss_pred HHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCCh
Confidence 99999999996543210 0124568899999999999999
Q ss_pred cccCCHhHHhcCccccccCcccCCCC
Q 027233 198 VDRLSFNEFYHHRFLRRNSAILRAPF 223 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~~~~~~~~~ 223 (226)
.+|||+.+++.||||...+.....+.
T Consensus 283 ~~Rpt~~~~l~~~~~~~~~~~~~~~~ 308 (334)
T cd07855 283 EERITVEQALQHPFLAQYHDPDDEPT 308 (334)
T ss_pred hhCcCHHHHHhChhhhhccCCccccc
Confidence 99999999999999988665554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=241.55 Aligned_cols=200 Identities=34% Similarity=0.583 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++|+|++++++++.+.+..++++||+ +++|.+++.... .+++..+..++.|++.||.+||+++
T Consensus 41 ~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~ 119 (283)
T cd07835 41 VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119 (283)
T ss_pred chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456888999999999999999999999999999999999 469999998765 6899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g 164 (226)
++||||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus 120 ~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 120 VLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred eeCCCCCHHHEEE---cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999 568889999999986553321 11223457789999987654 568899999999999999999
Q ss_pred CCCCCCCCccc---------------------------------------ccccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 165 YPPFSGRNNVQ---------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 165 ~~p~~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
..||...+... .....++.++.++|.+|++.+|.+|||++|
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99986543210 013456788999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
+++||||
T Consensus 277 il~~~~~ 283 (283)
T cd07835 277 ALQHPYF 283 (283)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=242.53 Aligned_cols=199 Identities=26% Similarity=0.449 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHH
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK 70 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~ 70 (226)
...+.+.+|+.++.++ +||||+++++++...+..++++||+++++|.+++.+.. .+++..+..
T Consensus 44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 123 (297)
T cd05089 44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123 (297)
T ss_pred HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence 3456788999999999 79999999999999999999999999999999997542 477889999
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchh
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 150 (226)
++.|++.|+++||++|++|+||+|+||++ +.++.++|+|||++..............+..|+|||...+..++.++|
T Consensus 124 i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (297)
T cd05089 124 FASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD 200 (297)
T ss_pred HHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh
Confidence 99999999999999999999999999999 678889999999885432221111222345699999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 151 MWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 151 v~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+||||+++++|++ |..||......+. .+..++.++.+++.+|++.+|.+|||++++++.
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999997 9999976543221 134578899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=236.66 Aligned_cols=197 Identities=26% Similarity=0.439 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+++++.++|+||+++++++.. ...++++||+.+++|.+++.....+++..+..++.|++.++.+||++|+
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i 116 (257)
T cd05060 38 AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCe
Confidence 345678899999999999999999998764 4579999999999999999988789999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc----cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|+||+|+||++ +.++.++|+|||.+.......... ...++..|+|||...+..++.++|+||||++++++++
T Consensus 117 ~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 117 VHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred eccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 999999999999 678889999999987664432211 1112356999999988889999999999999999997
Q ss_pred -CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||...+..+ ..+...+..+++++.+|++.+|.+|||+.++++
T Consensus 194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 194 YGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999997654322 125567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=248.15 Aligned_cols=201 Identities=32% Similarity=0.491 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
...+.+.+|+.++++++|+||+++++++... ...++|+||+. ++|.+.+... +++..+..++.|++.||.+
T Consensus 57 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~ 133 (353)
T cd07850 57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKH 133 (353)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHH
Confidence 3455677899999999999999999987643 35799999995 6888887643 8899999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||++|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|+++++|
T Consensus 134 LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 134 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred HHhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHH
Confidence 999999999999999999 67888999999999776544333344577889999999988999999999999999999
Q ss_pred HhCCCCCCCCCccccc-----------------------------------------------------ccCCChHHHHH
Q 027233 162 LNGYPPFSGRNNVQLI-----------------------------------------------------VPALHPDCVDM 188 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 188 (226)
++|..||...+..... ....+..+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 9999998754321000 11245578999
Q ss_pred HHHhhccCccccCCHhHHhcCccccc
Q 027233 189 CLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 189 i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
|.+||+.||.+|||+.|+|+||||+.
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHhh
Confidence 99999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=238.99 Aligned_cols=199 Identities=28% Similarity=0.461 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~ 69 (226)
....+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++.... .+++..+.
T Consensus 36 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 115 (270)
T cd05047 36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115 (270)
T ss_pred HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHH
Confidence 45567888999999999 89999999999999999999999999999999997543 36788999
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcch
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 149 (226)
.++.|++.|+++||++|++|+||+|+||++ +.++.++++|||++..............+..|+|||...+..++.++
T Consensus 116 ~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~ 192 (270)
T cd05047 116 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 192 (270)
T ss_pred HHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchh
Confidence 999999999999999999999999999999 67889999999987533221111112234569999999888899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 150 DMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 150 Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|+||||++++++++ |..||.+.+..+. .....+.++.+++.+|++.+|.+|||+++++.
T Consensus 193 Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 193 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999999999997 9999976542211 13446788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=237.69 Aligned_cols=196 Identities=27% Similarity=0.473 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|++.++.++|+||+++++++..++..++++||+++++|.+++.... .+++..++.++.|++.+|++||++|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 125 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4568889999999999999999999999999999999999999999997643 58899999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||.+.......... ....+..|+|||...+..++.++|+||||++++++++ |
T Consensus 126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 999999999999 678899999999987664432211 1223457999999988889999999999999999998 8
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||.+.+..+. .+...+.++.+++.+|++.+|.+|||+.++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 203 MSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 999876543211 14567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=239.14 Aligned_cols=199 Identities=23% Similarity=0.375 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGA 77 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~ 77 (226)
..+..+.+|+.+++.++|+||+++++++...+..++++||+++++|.+++.+.+ .++...+..++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 130 (277)
T cd05062 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHH
Confidence 345678899999999999999999999999899999999999999999997532 2467788999999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHH
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 154 (226)
||.+||+.|++|+||+|+||++ +.++.++|+|||++......... ....++..|+|||.+.+..++.++|+|||
T Consensus 131 ~l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05062 131 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207 (277)
T ss_pred HHHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence 9999999999999999999999 67888999999998655332211 11234567999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 155 GAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 155 G~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|++++++++ |..||.+..... ......+..+.+++.+|++.+|.+|||+.|++++
T Consensus 208 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 208 GVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999998 788887654322 1245567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=241.28 Aligned_cols=205 Identities=28% Similarity=0.488 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....+.+|+..+.++. |+||+++++++..++..++++|++. .++.++.. ....+++..+..++.+++.|++|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999995 9999999999998889999999984 57666442 23578999999999999999999
Q ss_pred HHhC-CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc---CCCcchhHHHHHHH
Q 027233 82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAI 157 (226)
Q Consensus 82 lh~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~ 157 (226)
||+. |++||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 123 lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 123 LKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred HhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 9974 99999999999999 67788999999998766544333444578889999998765 68899999999999
Q ss_pred HHHHHhCCCCCCCCCcc------------ccc----ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 158 LFELLNGYPPFSGRNNV------------QLI----VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~------------~~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++++++|..||...... ... ...++.++.+++++|++.+|.+|||++++++||||++..
T Consensus 200 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 99999999998654311 001 223678899999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=240.68 Aligned_cols=200 Identities=29% Similarity=0.569 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeeeEEE-----eCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l 79 (226)
.+.+.+|+.+++.+ +|+||+++++++. .++..+++|||++|++|.+++.. ...+++..+..++.|++.|+
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 45788899999999 7999999999874 34578999999999999998753 24688999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-----cCCCcchhHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~s 153 (226)
.+||+.+++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||
T Consensus 138 ~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 138 QHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 99999999999999999999 677789999999987654322 2223457888999998742 44788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+|++++++++|..||......... +...+.++.+++.+||+.+|.+|||+.|+++|+||
T Consensus 215 lGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 999999999999998765432111 23356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=235.87 Aligned_cols=196 Identities=23% Similarity=0.486 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++... +.+++..+..++.|++.||.+||++|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 457888999999999999999999999999999999999999999998754 4689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~ 165 (226)
|+||+|+||++ +.++.++++|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++ |.
T Consensus 123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 99999999999 677889999999887654322211 1223457999999988889999999999999999999 89
Q ss_pred CCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 166 PPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 166 ~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.||...+..+. .+...+..+.+++++|++.+|.+|||++++++
T Consensus 200 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 200 MPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99976653322 14446778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=236.25 Aligned_cols=197 Identities=24% Similarity=0.480 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|+.+++.++|+||+++++++...+..++++||++|++|.+++... ..+++..+..++.|++.|+++||++|++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 122 (256)
T cd05059 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 346788999999999999999999999999999999999999999999764 4689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~ 165 (226)
|+||+|+||++ +.++.++|+|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++ |.
T Consensus 123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 99999999999 678889999999887654322111 1123346999999988889999999999999999998 78
Q ss_pred CCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 166 PPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 166 ~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.||...+..+. .+...+..+.+++.+|++.+|.+|||++|+++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 200 MPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99876543221 144578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=247.67 Aligned_cols=210 Identities=31% Similarity=0.539 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....+.+.+|+.+++.++|+||+++.+++.... ..|++++|+. ++|.+++....++++..++.++.+++.||++
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence 345568899999999999999999999987764 7899999996 6899999877789999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCccccccc-CCCcchhHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA 156 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~ 156 (226)
||+.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+
T Consensus 119 LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 119 LHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred HHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 999999999999999999 677899999999998765543 12334567789999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhcc
Q 027233 157 ILFELLNGYPPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~ 195 (226)
+++++++|..||.+.+..+ ...+.++.++.++|.+||+.
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 275 (330)
T cd07834 196 IFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF 275 (330)
T ss_pred HHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccC
Confidence 9999999999996544211 01234688899999999999
Q ss_pred CccccCCHhHHhcCccccccCcccC
Q 027233 196 NTVDRLSFNEFYHHRFLRRNSAILR 220 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~~~~~~~~~ 220 (226)
+|.+|||+++++.||||++.+....
T Consensus 276 ~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 276 DPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred ChhhCCCHHHHHhCccHHhhccccc
Confidence 9999999999999999998655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=247.54 Aligned_cols=210 Identities=31% Similarity=0.516 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+|+.+++.++|+||+++++++... ...++++||+ +++|.+++...+.+++..+..++.|++.||.+||
T Consensus 47 ~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 125 (337)
T cd07858 47 DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125 (337)
T ss_pred hhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999987643 3489999999 5799999988888999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
++|++|+||+|+||++ +.++.++|+|||++...... .......++..|+|||...+ ..++.++|+||||++++++
T Consensus 126 ~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 202 (337)
T cd07858 126 SANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202 (337)
T ss_pred hCCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence 9999999999999999 67788999999998765433 22223346778999998754 4588999999999999999
Q ss_pred HhCCCCCCCCCcc-----------------------------------------cccccCCChHHHHHHHHhhccCcccc
Q 027233 162 LNGYPPFSGRNNV-----------------------------------------QLIVPALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 162 ~~g~~p~~~~~~~-----------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R 200 (226)
++|..||.+.+.. ....+..+.++.++|++||+.+|.+|
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 282 (337)
T cd07858 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282 (337)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence 9999998654310 00134578889999999999999999
Q ss_pred CCHhHHhcCccccccCcccCCC
Q 027233 201 LSFNEFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 201 pt~~~~l~~~~~~~~~~~~~~~ 222 (226)
||++++++||||.........|
T Consensus 283 ps~~ell~h~~~~~~~~~~~~~ 304 (337)
T cd07858 283 ITVEEALAHPYLASLHDPSDEP 304 (337)
T ss_pred cCHHHHHcCcchhhhcCcccCc
Confidence 9999999999998754443333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=252.26 Aligned_cols=207 Identities=38% Similarity=0.676 Sum_probs=189.4
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+...++.+.+|++++..++|||||+++.+.+....+|+||||+.++.+++|+.+++...+.....++.|++.|++|+|++
T Consensus 95 n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k 174 (596)
T KOG0586|consen 95 NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK 174 (596)
T ss_pred ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc
Confidence 34455668999999999999999999999999999999999999999999999999998999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g 164 (226)
+|+|||||.+|+++ +.+..++|+|||++..+..+......+|++.|.|||...+..+ .++.|+||+|+++|.++.|
T Consensus 175 ~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~G 251 (596)
T KOG0586|consen 175 NIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEG 251 (596)
T ss_pred ceeccccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeec
Confidence 99999999999999 6777799999999999988888888999999999999988776 4799999999999999999
Q ss_pred CCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..||++.+-.... +.-++.++.++|+++|..+|.+|++.+++.+|+|....
T Consensus 252 sLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 252 SLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ccccCCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 9999986543222 56678899999999999999999999999999998763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=241.64 Aligned_cols=202 Identities=32% Similarity=0.492 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+..+.+.+|+.+++.++||||+++.+++...+..++|+||+. +++.+++.. ...+++..+..++.|++.||.|||+.|
T Consensus 57 ~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~ 135 (307)
T cd06607 57 EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135 (307)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999999999999999999996 577777654 457899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|+||++ +.++.++|+|||++...... ....++..|+|||... ...++.++|+||+|++++++++
T Consensus 136 i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t 209 (307)
T cd06607 136 RIHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (307)
T ss_pred ceecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc
Confidence 9999999999999 67889999999988654322 2334677899999874 3557889999999999999999
Q ss_pred CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 164 GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|..||.+.+.... .....+..+.++|.+||+.+|.+|||+.+++.||||....
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 210 RKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999876442211 1334677899999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=239.04 Aligned_cols=205 Identities=25% Similarity=0.399 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG 78 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~ 78 (226)
....+.+|+..++.++|+||+++++++.+.+..+++|||+++++|.+++...+ ..+...+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999899999999999999999997532 23566788999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
|.+||++|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||+|
T Consensus 132 l~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG 208 (288)
T cd05061 132 MAYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208 (288)
T ss_pred HHHHHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH
Confidence 999999999999999999999 6788899999998865433221 1112335679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc------CccccccC
Q 027233 156 AILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH------HRFLRRNS 216 (226)
Q Consensus 156 ~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~------~~~~~~~~ 216 (226)
++++++++ |..||.+.+..+. .....+..+.+++.+||+.+|.+|||+.++++ ||||.+.+
T Consensus 209 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 209 VVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 99999998 7888876543221 13455789999999999999999999999987 99998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=235.89 Aligned_cols=196 Identities=26% Similarity=0.465 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+.++++++|+||+++++++...+..++++||+++++|.+++.... .++...+..++.|++.|+.+||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 124 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4678899999999999999999999999999999999999999999997654 68999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||++.......... .......|+|||...+..++.++|+||||++++++++ |
T Consensus 125 ~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 125 IHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred eeccCCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence 999999999999 678889999999987765332211 1112346999999988889999999999999999998 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||.+...... .....+..+.+++.+|++.+|.+||+++++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 202 RMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999976543211 13456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=236.25 Aligned_cols=200 Identities=20% Similarity=0.330 Sum_probs=164.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+....+.+|+.+++.++||||+++++++..+...++++||+++++|..++... ..+++..+..++.||+.|++|||++
T Consensus 45 ~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (262)
T cd05077 45 RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK 124 (262)
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 344557888999999999999999999999988999999999999999998754 4689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCC----CCccEEEeeeccccccCCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~ 160 (226)
|++|+||+|.||+++... ....++++|||.+...... ....++..|+|||.+. +..++.++||||||+++|+
T Consensus 125 ~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 201 (262)
T cd05077 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201 (262)
T ss_pred CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence 999999999999995211 1123899999988654322 2334677899999886 4668889999999999999
Q ss_pred HH-hCCCCCCCCCcccc---------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LL-NGYPPFSGRNNVQL---------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~-~g~~p~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++ .|..|+......+. .....+.++.+++.+||+.||.+||++.+++++
T Consensus 202 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 202 ICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 97 58888865432211 123346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=236.05 Aligned_cols=200 Identities=28% Similarity=0.524 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|.+++... ..+++..+..++.|++.|+.+||+
T Consensus 39 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 118 (255)
T cd08219 39 SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118 (255)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345678889999999999999999999999999999999999999999988653 357899999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|++|+||+|+||++ +.++.++++|||.+....... ......++..|+|||...+...+.++|+||+|++++++++
T Consensus 119 ~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 119 KRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred CCcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh
Confidence 999999999999999 678889999999987654322 2233457788999999988889999999999999999999
Q ss_pred CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||...+... ..+..++..+.+++.+||+.+|.+|||+.+++.-
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999998654221 1245578899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=240.89 Aligned_cols=202 Identities=38% Similarity=0.678 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|.+++++++ |+||+++++.+...+..+++||++.+++|.+++.+.+.+++..++.++.|++.|+.+||+.|
T Consensus 43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44577889999999998 99999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---------------------cccccCCccccCcccccccCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQRY 145 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~ 145 (226)
++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+..+
T Consensus 123 ~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred eeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 9999999999999 6788899999999876543221 112235678999999888888
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCccc----------ccccCCChHHHHHHHHhhccCccccCCH----hHHhcCcc
Q 027233 146 DEKVDMWSVGAILFELLNGYPPFSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRF 211 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~----~~~l~~~~ 211 (226)
+.++|+||||++++++++|..||....... ..+..+++.+.+++.+||+.+|.+|||+ +++++|||
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 999999999999999999999998764321 1256678899999999999999999999 99999999
Q ss_pred c
Q 027233 212 L 212 (226)
Q Consensus 212 ~ 212 (226)
|
T Consensus 280 ~ 280 (280)
T cd05581 280 F 280 (280)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=240.44 Aligned_cols=202 Identities=32% Similarity=0.509 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|+++++.++|+|++++++++.+....++++||+. ++|.+++.. ..++++..+..++.|++.++.+||++|
T Consensus 63 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 141 (313)
T cd06633 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141 (313)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 344678899999999999999999999999999999999995 578777765 357899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|+||++ +.++.++|+|||.+..... .....++..|+|||.+. +..++.++|+||+|++++++++
T Consensus 142 i~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~ 215 (313)
T cd06633 142 MIHRDIKAGNILL---TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215 (313)
T ss_pred eecCCCChhhEEE---CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999 6778899999998854322 22345778899999974 3567889999999999999999
Q ss_pred CCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 164 GYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|..||...+... .....++..+++++.+||+.+|.+||++.+++.||||+...
T Consensus 216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 216 RKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999987654321 11334677899999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=235.89 Aligned_cols=199 Identities=28% Similarity=0.525 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++.. ...+++..++.++.|++.|+.+|
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 122 (267)
T cd08229 43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122 (267)
T ss_pred HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999999999999999999999999999864 24589999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+...+.++|+||+|++++++
T Consensus 123 H~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 99999999999999999 6778899999998876543322 2234577889999999888899999999999999999
Q ss_pred HhCCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..||.+.... ......++.++++++.+|++.+|++|||++++++
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999998654321 0112346789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=236.41 Aligned_cols=201 Identities=22% Similarity=0.433 Sum_probs=171.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+..+.+|+..+++++|+||+++++++...+..++++||+++++|.+++... +.++...+..++.|++.|+.+||+
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 45 SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3455678889999999999999999999999999999999999999999999764 478999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||++++++
T Consensus 125 ~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 125 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred CCcccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 999999999999999 6788899999999987642111 1112234679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 162 LN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++ |..||....... ......+..+.+++.+|++.+|.+||++++++++
T Consensus 202 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 202 MSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 97 999986544321 1144568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=234.85 Aligned_cols=197 Identities=28% Similarity=0.449 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+..+.+.+|++.+++++|+||+++++.+.. ...++++||+++++|.+++.... .+++..++.++.|++.||.+||++
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 567789999999999999999999999888 88999999999999999998764 689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||+++++|
T Consensus 117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el 193 (257)
T cd05040 117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193 (257)
T ss_pred CccccccCcccEEE---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHH
Confidence 99999999999999 577899999999987664421 11123456779999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||...+..+. .....+..+.+++.+|++.+|.+|||+.++++
T Consensus 194 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 194 FTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 98 9999965433221 13456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=240.16 Aligned_cols=200 Identities=34% Similarity=0.599 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
....+.+|++++++++|+||+++++++..++..++++||++ ++|.+++... ..+++..+..++.|++.||.+||+.|+
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45678889999999999999999999999999999999996 5888888764 588999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||...+. .++.++|+||+|++++++++|.
T Consensus 120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999 678889999999987765443 22234467789999998766 7889999999999999999999
Q ss_pred CCCCCCCcccc----------------------------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 166 PPFSGRNNVQL----------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 166 ~p~~~~~~~~~----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
.||...+..+. ....++.++.++|.+||+.+|.+||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 99865442111 12346788999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
++.||||
T Consensus 277 ll~~~~~ 283 (283)
T cd05118 277 ALAHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=236.32 Aligned_cols=201 Identities=27% Similarity=0.505 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
..+....+.+|+++++.++||||+++++++.+.+..++++||+++++|.+++.. ...+++..+..++.|++.|+.+
T Consensus 42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 121 (267)
T cd08228 42 DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121 (267)
T ss_pred CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 345567789999999999999999999999999999999999999999998853 2357899999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+...+.++|+||+|+++++
T Consensus 122 LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~e 198 (267)
T cd08228 122 MHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred HhhCCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999999 6778899999998876543221 223457778999999988888999999999999999
Q ss_pred HHhCCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLNGYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++|..||...... ......++..+.+++.+|++.+|.+|||++++++.
T Consensus 199 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 199 MAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999998654321 01123567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=239.90 Aligned_cols=198 Identities=31% Similarity=0.528 Sum_probs=165.8
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
..+.+|++++++++|+||+++++++.+++..++|+||+. ++|.+++... ..+++..+..++.|++.||.+||++|++|
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H 126 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 456789999999999999999999999999999999996 5999988764 46889999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+ ..++.++|+||+|++++++++|..|
T Consensus 127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 678889999999886543221 1122335678999998865 4578899999999999999999999
Q ss_pred CCCCCccc-----------------------------------------ccccCCC--hHHHHHHHHhhccCccccCCHh
Q 027233 168 FSGRNNVQ-----------------------------------------LIVPALH--PDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 168 ~~~~~~~~-----------------------------------------~~~~~~~--~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|....... ......+ .++.+++.+||+.+|.+|||+.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~ 283 (291)
T cd07844 204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283 (291)
T ss_pred CCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence 96543100 0012334 7889999999999999999999
Q ss_pred HHhcCccc
Q 027233 205 EFYHHRFL 212 (226)
Q Consensus 205 ~~l~~~~~ 212 (226)
++++||||
T Consensus 284 e~l~~~~f 291 (291)
T cd07844 284 EAMKHPYF 291 (291)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=239.66 Aligned_cols=199 Identities=27% Similarity=0.449 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|+.+++++ +|+||+++++++...+..++++||+.+++|.+++.... .+++..+..++.|++.|+.|||
T Consensus 79 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH 158 (302)
T cd05055 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158 (302)
T ss_pred hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44556789999999999 79999999999999999999999999999999997643 3899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
++|++|+||+|.||++ +.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++
T Consensus 159 ~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~e 235 (302)
T cd05055 159 SKNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235 (302)
T ss_pred HCCeehhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHH
Confidence 9999999999999999 6778899999999876543321 112234567999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++ |..||........ .....+..+.+++.+|++.+|++|||+.|+++
T Consensus 236 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 236 IFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 998 9999876443211 13356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=234.22 Aligned_cols=198 Identities=23% Similarity=0.445 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.++++++|+||+++++++.. ...++|+||+++++|.+++.. ...+++..++.++.|++.|+.+||++
T Consensus 36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 114 (257)
T cd05115 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114 (257)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 3445678999999999999999999998754 568999999999999999875 35789999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|.||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++
T Consensus 115 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 191 (257)
T cd05115 115 NFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191 (257)
T ss_pred CeeecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999 67888999999998755433211 111224579999998888889999999999999999
Q ss_pred Hh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||......+. .+...+.++.+++.+|++.+|.+||++.++.+
T Consensus 192 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 192 FSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred hcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 96 9999976543221 24556889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=235.23 Aligned_cols=202 Identities=26% Similarity=0.533 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+..+.+.+|+.++++++|+||+++++++.+. +..++++||+++++|.+++.+.+.+++..+..++.|++.|+.+||+
T Consensus 45 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~ 124 (264)
T cd06653 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124 (264)
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567899999999999999999999998763 5688999999999999999887789999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+...+.++|+||||+++++
T Consensus 125 ~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 201 (264)
T cd06653 125 NMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201 (264)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHH
Confidence 999999999999999 678889999999987653211 1122346788999999988888999999999999999
Q ss_pred HHhCCCCCCCCCcc------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 161 LLNGYPPFSGRNNV------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 161 l~~g~~p~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+++|..||...... ...+..++..+.+++.+|+. +|..|||+.+++.|||.
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 202 MLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999764322 22366688899999999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=237.30 Aligned_cols=199 Identities=24% Similarity=0.500 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----------------CCCHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------RVPEQTARK 70 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~ 70 (226)
...+.+.+|+.++++++|+||+++++++...+..++++||+++++|.+++.... .+++..+..
T Consensus 49 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (283)
T cd05090 49 QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHH
Confidence 344678899999999999999999999999999999999999999999985332 367888999
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCc
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.
T Consensus 129 i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05090 129 IAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205 (283)
T ss_pred HHHHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence 99999999999999999999999999999 6778899999999976543221 12223456799999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++|+||||++++++++ |..||.+..... ..+..++..+.+++.+|++.+|.+||++.+++++
T Consensus 206 ~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999999999998 888987654321 1145578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=237.98 Aligned_cols=200 Identities=30% Similarity=0.530 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+..|+.+++.++||||+++++++.+.+..++++||+++++|.+++.. ...+++..++.++.|++.|+.+||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 344677899999999999999999999998899999999999999998864 2468999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
.|++|+||+|+||+++ ++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++
T Consensus 125 ~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 200 (260)
T cd08222 125 RRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200 (260)
T ss_pred cCccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999993 35699999998876543322 223446778999999888888899999999999999999
Q ss_pred CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 164 GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 164 g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|..||....... .....++.++.++|.+|++.+|.+||++.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 201 LAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999987543321 1245678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=238.15 Aligned_cols=198 Identities=28% Similarity=0.461 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc------------------------CCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRV 63 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~~~ 63 (226)
...+.+.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++... .++
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 124 (290)
T cd05045 45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124 (290)
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccccc
Confidence 34567889999999999999999999999999999999999999999998643 246
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccc
Q 027233 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL 140 (226)
Q Consensus 64 ~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~ 140 (226)
+...++.++.|++.||.+||++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||..
T Consensus 125 ~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 788899999999999999999999999999999999 6778899999999875432211 1122345679999998
Q ss_pred cccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 141 QFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 141 ~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.+..++.++|+||||++++++++ |..||.+...... .+...+.++.+++.+|++.+|.+||++.++++
T Consensus 202 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 202 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 88888999999999999999998 9999976543221 14557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=239.99 Aligned_cols=201 Identities=31% Similarity=0.513 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCe-----EEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~ 78 (226)
...+.+|+.+++.+ +|+||+++++++..... .|+++||+++ +|.+++... ..+++..++.++.||+.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 35678899999999 56999999999877655 8999999975 898888643 357999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~ 156 (226)
|.|||++|++|+||+|+||+++ ..++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 9999999999999999999994 227889999999887553321 1122345778999998764 45688999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc--------------------------------------cccCCChHHHHHHHHhhccCcc
Q 027233 157 ILFELLNGYPPFSGRNNVQL--------------------------------------IVPALHPDCVDMCLKLLSANTV 198 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~--------------------------------------~~~~~~~~~~~~i~~~l~~~p~ 198 (226)
++++|++|..||.+.+.... ....++.++.++|.+||..+|.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 99999999999875432110 0245788999999999999999
Q ss_pred ccCCHhHHhcCcccc
Q 027233 199 DRLSFNEFYHHRFLR 213 (226)
Q Consensus 199 ~Rpt~~~~l~~~~~~ 213 (226)
+|||+.|++.||||+
T Consensus 281 ~R~~~~eil~~~~~~ 295 (295)
T cd07837 281 KRISAKAALTHPYFD 295 (295)
T ss_pred hcCCHHHHhcCCCcC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=240.40 Aligned_cols=199 Identities=29% Similarity=0.482 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHH
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~ 70 (226)
.....+.+|+.+++.+ +|+||+++++++..++..++++||+.+++|.+++... ..+++..+..
T Consensus 57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 136 (293)
T cd05053 57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136 (293)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence 4456788999999999 8999999999999999999999999999999999642 3578999999
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCc
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
++.|++.||.|||+.|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+..++.
T Consensus 137 i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 137 FAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence 99999999999999999999999999999 6788999999999876543321 11222345799999988888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++|+||||++++++++ |..||......+. .+...+.++.+++.+|+..+|.+|||+.+++++
T Consensus 214 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 214 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999999999997 8899876543221 144567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=233.46 Aligned_cols=195 Identities=24% Similarity=0.467 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.++++++|+||+++++++...+..++++||+++++|.+++.... .+++..+..++.|++.|+.+||++|
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~ 122 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45788999999999999999999999998899999999999999999998765 6899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~ 165 (226)
++|+||+|+||++ +.++.++|+|||.+........ ....+..|.|||...+...+.++|+||+|++++++++ |.
T Consensus 123 i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~ 197 (256)
T cd05039 123 FVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred ccchhcccceEEE---eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence 9999999999999 6788899999999877643322 2334567999999988888999999999999999997 99
Q ss_pred CCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 166 PPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 166 ~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.||....... ......++.+.+++++||+.+|.+|||+.++++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 198 VPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9987654321 124457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=238.77 Aligned_cols=198 Identities=30% Similarity=0.480 Sum_probs=164.3
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
..+.+|+.+++.++|+||+++++++..++..++++||+. ++|.+++... ..++...+..++.|++.||.+||+.|++|
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 126 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 467789999999999999999999999999999999995 6777776543 46788889999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+. .++.++|+||||++++++++|..|
T Consensus 127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred CCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 678889999999886543221 12233467889999998653 578899999999999999999999
Q ss_pred CCCCCcccc-----------------------------c--------------ccCCChHHHHHHHHhhccCccccCCHh
Q 027233 168 FSGRNNVQL-----------------------------I--------------VPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 168 ~~~~~~~~~-----------------------------~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|........ . ....+.++.+++.+|++.||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~ 283 (291)
T cd07870 204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ 283 (291)
T ss_pred CCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence 865432100 0 012356899999999999999999999
Q ss_pred HHhcCccc
Q 027233 205 EFYHHRFL 212 (226)
Q Consensus 205 ~~l~~~~~ 212 (226)
|++.||||
T Consensus 284 ~~l~h~~~ 291 (291)
T cd07870 284 DALLHPYF 291 (291)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=234.74 Aligned_cols=197 Identities=26% Similarity=0.464 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.+++.++|+||+++++++.+.+..++++||+++++|.+++.+. ..++...+..++.|++.|+.+||++|
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 124 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4667899999999999999999999999999999999999999999999864 36889999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g 201 (261)
T cd05148 125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201 (261)
T ss_pred eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999999 67889999999998766433221 12234567999999988889999999999999999998 8
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||......+. .....+..+.+++.+|++.+|.+|||+.++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 202 QVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999976543321 14567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=235.15 Aligned_cols=199 Identities=23% Similarity=0.348 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.+ .+.+++..+..++.|++.||.|||++|
T Consensus 58 ~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (274)
T cd05076 58 DIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN 137 (274)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 3455788899999999999999999999999999999999999999999875 357899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeC----CCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGL----DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 87 i~H~dl~~~nili~~~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
++||||+|.||+++.. .....++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||++++++
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999531 11234899999987543222 22346778999998865 5678999999999999998
Q ss_pred H-hCCCCCCCCCccc---------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 162 L-NGYPPFSGRNNVQ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 162 ~-~g~~p~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+ +|..||....... ..+...++++.+++.+||+.+|.+|||+.+++++
T Consensus 215 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 215 CFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5 6889987654321 1234456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=231.83 Aligned_cols=199 Identities=30% Similarity=0.498 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+....+.+|++++++++||||+++++++...+..++++||+++++|.+++... ..+++..+..++.+++.++.++|++
T Consensus 33 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 112 (250)
T cd05085 33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112 (250)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 445567889999999999999999999999999999999999999999998754 4678999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++|+||+|+||++ +.++.++|+|||++......... .....+..|+|||...+..++.++|+||+|++++++++
T Consensus 113 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred CeeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 99999999999999 67888999999988654332211 11223456999999988888999999999999999998
Q ss_pred -CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||....... .....++..+.+++.+|++.+|.+|||+.++++
T Consensus 190 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 190 LGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999997654321 114557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=238.37 Aligned_cols=199 Identities=26% Similarity=0.466 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL 75 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i 75 (226)
....+.+.+|++++++++|+||+++++++..++..++++|++.+++|.+++.... .+++..++.++.|+
T Consensus 60 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05051 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139 (296)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHH
Confidence 3567788999999999999999999999999999999999999999999998765 68999999999999
Q ss_pred HHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHH
Q 027233 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
+.||.+||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|||
T Consensus 140 ~~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (296)
T cd05051 140 ASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216 (296)
T ss_pred HHHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhh
Confidence 999999999999999999999999 6778999999999876543221 1223345679999999888899999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 153 SVGAILFELLN--GYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 153 slG~~~~~l~~--g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|||++++++++ +..||........ .....+.++.+++.+|++.+|.+|||+.|+++
T Consensus 217 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 99999999988 6677765432211 13345689999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=234.35 Aligned_cols=197 Identities=26% Similarity=0.507 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.+++.++|+||+++++.+...+..++++||+++++|.+++... ..++...+..++.|++.|+++||+.+
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~ 123 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4568899999999999999999999999999999999999999999999754 46888899999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++
T Consensus 124 i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 124 YIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred eeccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 9999999999999 67888999999999765432211 12234567999999988888999999999999999998
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||........ ....++.++.+++.+|++.+|.+|||++++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 201 GKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999976543211 13456889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=235.39 Aligned_cols=197 Identities=26% Similarity=0.397 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+|++++++++||||+++++++... ...+++|||+++++|.+++... .+++..+..++.|++.|+.+||++
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3567788999999999999999999987653 4688999999999999998764 699999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+...+.++|+||||++++++
T Consensus 127 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred CeeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 99999999999999 6778899999999876543221 1122345569999999888889999999999999999
Q ss_pred HhCCCCCCCCCcc---------------c-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNNV---------------Q-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~~---------------~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..||...... . ..+...+.++.+++.+|++.+|.+|||++++++
T Consensus 204 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 204 LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999887543210 0 003446789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=237.36 Aligned_cols=199 Identities=33% Similarity=0.561 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+.+.+|+.++++++|+||+++++++.+.+..++++||++ ++|.+++... ..+++..+..++.|++.||.+||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567789999999999999999999999999999999996 5899888754 35899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g 164 (226)
++|+||+|+||++ +.++.++|+|||.+....... ......++..|++||...+. .++.++|+||+|++++++++|
T Consensus 121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (284)
T cd07836 121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197 (284)
T ss_pred eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999 678889999999886553321 11233457789999987653 468899999999999999999
Q ss_pred CCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 165 YPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 165 ~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
..||.+.+..+. ..+..+.++.+++.+|++.+|.+|||+.|
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 999976542211 02345788999999999999999999999
Q ss_pred HhcCccc
Q 027233 206 FYHHRFL 212 (226)
Q Consensus 206 ~l~~~~~ 212 (226)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07836 278 ALQHPWF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=241.24 Aligned_cols=218 Identities=34% Similarity=0.524 Sum_probs=194.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.+.......+|-++|++++.+.||.+-..|++.+.+++|+..|+||+|.-++.+.+ .+++..+.-++.+|+.||.+||
T Consensus 225 kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH 304 (591)
T KOG0986|consen 225 KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH 304 (591)
T ss_pred HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH
Confidence 34455677889999999999999999999999999999999999999999888776 7999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+++|++||+||+||++ ++.++++|+|+|+|..+.........+||.+|||||++.+..|+...|-|||||++|+|+.
T Consensus 305 ~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~ 381 (591)
T KOG0986|consen 305 RRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA 381 (591)
T ss_pred hcceeeccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc
Confidence 9999999999999999 7999999999999999988888888899999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--------------ccccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc-----Cccc
Q 027233 164 GYPPFSGRNN--------------VQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN-----SAIL 219 (226)
Q Consensus 164 g~~p~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~-----~~~~ 219 (226)
|..||..... ...++..+|++.+++.+.+|..||.+|.. ++++.+||||++. .+.+
T Consensus 382 G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagm 461 (591)
T KOG0986|consen 382 GHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGM 461 (591)
T ss_pred ccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccC
Confidence 9999975432 12237889999999999999999999964 6799999999984 3445
Q ss_pred CCCCCCC
Q 027233 220 RAPFHIP 226 (226)
Q Consensus 220 ~~~~~~~ 226 (226)
-+|.++|
T Consensus 462 l~PPfiP 468 (591)
T KOG0986|consen 462 LEPPFIP 468 (591)
T ss_pred CCCCCCC
Confidence 5666665
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=240.77 Aligned_cols=203 Identities=28% Similarity=0.490 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~ 81 (226)
..+.+.+|+.++++++||||+++++++.+. +..++|+||++ ++|.+++... ..+++..++.++.|++.|+.+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 123 (316)
T cd07842 45 ISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123 (316)
T ss_pred ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHH
Confidence 346678899999999999999999999887 78999999995 5787776532 268899999999999999999
Q ss_pred HHhCCceeeccCCCCeEeee-CCCCccEEEeeeccccccCCCCc----cccccCCccccCccccccc-CCCcchhHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~-~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG 155 (226)
||+.|++|+||+|+||+++. .+.++.++|+|||++........ .....++..|+|||...+. .++.++|+||||
T Consensus 124 lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 203 (316)
T cd07842 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203 (316)
T ss_pred HHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence 99999999999999999932 11288899999999876543322 1233467789999987654 578899999999
Q ss_pred HHHHHHHhCCCCCCCCCccc---------------------------------c-----------cc------------c
Q 027233 156 AILFELLNGYPPFSGRNNVQ---------------------------------L-----------IV------------P 179 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~---------------------------------~-----------~~------------~ 179 (226)
++++++++|..||.+..... . .. .
T Consensus 204 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (316)
T cd07842 204 CIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHK 283 (316)
T ss_pred HHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhcc
Confidence 99999999999987543321 0 00 1
Q ss_pred CCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 180 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 180 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
..+.++.+++.+||+.+|.+|||+.|+++||||
T Consensus 284 ~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 284 KPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=239.53 Aligned_cols=199 Identities=27% Similarity=0.452 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~ 69 (226)
....+.+.+|+++++++ +||||+++++++...+..++++||+++++|.+++... ..++...+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (314)
T cd05099 58 DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137 (314)
T ss_pred hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHH
Confidence 34456788999999999 6999999999999989999999999999999999763 247888899
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCC
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++
T Consensus 138 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (314)
T cd05099 138 SCAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT 214 (314)
T ss_pred HHHHHHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC
Confidence 999999999999999999999999999999 6778899999999976543211 1112233569999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.++|+||||++++++++ |..||......+. .+...+.++++++.+|++.+|.+|||+.++++
T Consensus 215 ~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 215 HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999998 8888876543211 14456789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=236.37 Aligned_cols=199 Identities=24% Similarity=0.496 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF 71 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~ 71 (226)
..++.+.+|+.+++.++||||+++++++...+..+++++|+.+++|.+++... ..++...+..+
T Consensus 50 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (283)
T cd05091 50 PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence 45677899999999999999999999999999999999999999999998532 24778889999
Q ss_pred HHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcc
Q 027233 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
+.|++.||.++|++|++||||+|.||++ +.++.++|+|||++........ .....++..|+|||...+..++.+
T Consensus 130 ~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (283)
T cd05091 130 VTQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID 206 (283)
T ss_pred HHHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc
Confidence 9999999999999999999999999999 6778899999998876543221 122334568999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 149 VDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+|+||||++++++++ |..||.+....+. .+...+..+.+++.+|++.+|.+||++++++..
T Consensus 207 ~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 207 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 999999999999998 8888876543211 145688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=237.02 Aligned_cols=204 Identities=28% Similarity=0.476 Sum_probs=168.1
Q ss_pred HHHHHHHHH-HhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 11 SCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 11 ~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+..|+.. ++.++|+||+++++++..++..++++||++ ++|.+++... ..+++..++.++.|++.|+.+||++
T Consensus 44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (283)
T cd06617 44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122 (283)
T ss_pred HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 344455554 566699999999999999999999999995 6888887642 3689999999999999999999997
Q ss_pred -CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc----cCCCcchhHHHHHHHHHH
Q 027233 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 86 -~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~~~~~ 160 (226)
+++||||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 123 ~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 123 LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 99999999999999 6788999999999876544333333457788999998754 446789999999999999
Q ss_pred HHhCCCCCCCCCcc-c------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 161 LLNGYPPFSGRNNV-Q------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 161 l~~g~~p~~~~~~~-~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
+++|..||...... + .....++.++.++|.+||+.+|.+|||++++++||||+.....
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 99999998653211 1 1123578899999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=235.85 Aligned_cols=198 Identities=24% Similarity=0.410 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGA 77 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~ 77 (226)
.....+.+|+.+++.++|+||+++++++...+..++++||+++++|.+++.... .+++..+..++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999999999999999997532 3577889999999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHH
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 154 (226)
||.|||+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+|||
T Consensus 131 ~l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 131 GMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred HHHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 9999999999999999999999 6788999999999876543321 122334667999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 155 GAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 155 G~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|++++++++ |..||...+... ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 208 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 208 GVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999998 899987654221 125557899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=232.82 Aligned_cols=199 Identities=19% Similarity=0.323 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+ .+++..+..++.|++.|+++||++|
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678889999999999999999999999889999999999999999998654 5899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCC-----CccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~-----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~ 160 (226)
++|+||+|+||+++..+. ...++++|||.+...... ....++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred eecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHH
Confidence 999999999999953111 123799999988655332 22346778999999876 357889999999999999
Q ss_pred HHhCC-CCCCCCCccc---------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLNGY-PPFSGRNNVQ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~g~-~p~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++|. .|+...+... ..+...+.++.+++.+||+.+|++|||++++++.
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99984 6665443321 1244566889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=249.31 Aligned_cols=200 Identities=27% Similarity=0.446 Sum_probs=173.1
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+++.+.|++|+.++++-+|.||+-+.|++...+. .||+.+|+|-+|-.++.-. .+++....+.|++|+++|+.|||
T Consensus 427 pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH 505 (678)
T KOG0193|consen 427 PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH 505 (678)
T ss_pred CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh
Confidence 356789999999999999999999999999999887 9999999999999998654 47999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCcccccc---cCCCcchhHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAI 157 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~ 157 (226)
.++|+|+|||..||++ .+++.|+|+|||++...... .......+...|+|||+++. .+++..+||||+|+|
T Consensus 506 AK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV 582 (678)
T KOG0193|consen 506 AKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIV 582 (678)
T ss_pred hhhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHH
Confidence 9999999999999999 67799999999998655332 11222346677999999863 478999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 158 LFELLNGYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|||++|..||........+ ....++++++++..|+..++++||.+.+||.
T Consensus 583 ~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 583 WYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 99999999999955444333 4445679999999999999999999999987
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=235.95 Aligned_cols=205 Identities=29% Similarity=0.483 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+++++++ +|+||+++++.+..++..++++||+++++|.+++....++++..+..++.|++.||.+||+.|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 126 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 446788899999999 6999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCccccccc--CCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+. ..+.++|+||+|++++++++
T Consensus 127 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 127 IYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred eccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence 999999999999 678899999999887654322 12234577889999998653 46789999999999999999
Q ss_pred CCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccccC
Q 027233 164 GYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 216 (226)
|..||...... ...+..+++.+.+++++|++.+|.+|| ++++++.||||+...
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 204 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 99998642211 111445788899999999999999997 899999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=250.95 Aligned_cols=200 Identities=30% Similarity=0.478 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+..+|+.++... +||||++..+.+.++...|+|||.+.|+-+.+-+...+.+. ..+..|+.+|+.|+.+||++|++
T Consensus 359 ~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvv 437 (612)
T KOG0603|consen 359 ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVV 437 (612)
T ss_pred ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCee
Confidence 44566777777666 79999999999999999999999999998888777654444 66778999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||||+||++. +..++++|+|||.+...... ....+-+..|.|||......++++.|+||||+++|+|++|..||
T Consensus 438 hRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 438 HRDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred ecCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence 999999999994 46788999999999776554 22335677899999999999999999999999999999999999
Q ss_pred CCCCccccc---------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 169 SGRNNVQLI---------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 169 ~~~~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
......... ...+|.+.+++|.+||+.||.+|+++.|++.||||..
T Consensus 514 ~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 514 AAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred ccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 876654222 3678999999999999999999999999999999943
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=237.59 Aligned_cols=200 Identities=35% Similarity=0.632 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|+.++++++|+|++++++++.+.+..++++|+++ ++|.+++... ..+++..+..++.|++.||.+||++|+
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567789999999999999999999999999999999996 6999999876 589999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+||||+|+||++ +.++.++|+|||.+....... .......+..|+|||...+. .++.++|+||+|++++++++|.
T Consensus 120 ~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 120 LHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred ccCCCChheEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999 678899999999987664432 22233456779999998766 7889999999999999999999
Q ss_pred CCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 166 PPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 166 ~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
.||.+.+..+. ..+.++..+.++|++||+.+|.+||+++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 197 PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred CCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 99876532110 022457889999999999999999999999
Q ss_pred hcCccc
Q 027233 207 YHHRFL 212 (226)
Q Consensus 207 l~~~~~ 212 (226)
++||||
T Consensus 277 l~~p~~ 282 (282)
T cd07829 277 LKHPYF 282 (282)
T ss_pred hhCcCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=245.51 Aligned_cols=199 Identities=27% Similarity=0.450 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-------------------------
Q 027233 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------- 60 (226)
....+.+.+|++++++++ ||||+++++++...+..++||||+++++|.+++.+.
T Consensus 81 ~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (400)
T cd05105 81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD 160 (400)
T ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccc
Confidence 445678999999999995 999999999999999999999999999999998642
Q ss_pred -----------------------------------------------------------------------CCCCHHHHH
Q 027233 61 -----------------------------------------------------------------------GRVPEQTAR 69 (226)
Q Consensus 61 -----------------------------------------------------------------------~~~~~~~~~ 69 (226)
..+++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~ 240 (400)
T cd05105 161 ESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLL 240 (400)
T ss_pred ccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHH
Confidence 136677888
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCC
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++
T Consensus 241 ~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 241 SFTYQVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 999999999999999999999999999999 5678899999999876543221 1223356779999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.++||||||++++++++ |..||....... ......+.++.+++.+||+.+|.+|||+.++.+
T Consensus 318 ~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 318 TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 99999999999999997 889987643211 114457889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=232.84 Aligned_cols=199 Identities=23% Similarity=0.440 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.++++++||||+++++++..++..++++||+++++|.+++... +.++...+..++.|++.|+.+||++
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (267)
T cd05066 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125 (267)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999999999999999999999999999999999999999765 4689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++++|||.+......... ....++..|+|||...+..++.++|+||+|++++++
T Consensus 126 ~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 126 GYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred CEeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 99999999999999 67888999999998766433211 111224579999999888899999999999999998
Q ss_pred Hh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||......+. .....+..+.+++.+|++.+|.+|||+.++++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 203 MSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 86 9999876543211 13456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=230.10 Aligned_cols=198 Identities=31% Similarity=0.519 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+....+.+|++++++++|+||+++++++...+..++++||+++++|.+++... ..++...+..++.+++.++.+||++|
T Consensus 34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~ 113 (251)
T cd05041 34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113 (251)
T ss_pred HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999999999999999999999999999999999999764 46889999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|+||++ +.++.++|+|||.+......... .....+..|+|||...+..++.++|+||||++++++++
T Consensus 114 i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 114 CIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred EehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 9999999999999 67889999999998755422211 11223456999999988889999999999999999998
Q ss_pred -CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||....... ..+...+..+.+++.+|++.+|.+|||++|+++
T Consensus 191 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 191 LGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 888886654211 114456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=234.28 Aligned_cols=200 Identities=27% Similarity=0.458 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe------CCeEEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ 74 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~ 74 (226)
....+.+.+|+.+++.++|+||+++++++.. ....++++||+.+++|.+++... ..+++..+..++.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 4556788999999999999999999987643 13478999999999999988432 34789999999999
Q ss_pred HHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhH
Q 027233 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (226)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv 151 (226)
++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........ ......+..|++||...+..++.++|+
T Consensus 121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 197 (272)
T cd05075 121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197 (272)
T ss_pred HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence 9999999999999999999999999 6788899999999876643321 112234567999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 152 WSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 152 ~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
||||++++++++ |..||.+..... ......+..+++++.+||+.+|.+|||++++++.
T Consensus 198 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 198 WSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999998 788987653321 1245577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=236.20 Aligned_cols=199 Identities=26% Similarity=0.490 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC------------CCCHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQ 74 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~ 74 (226)
...++.+.+|++++++++|+|++++++++...+..+++|||+.+++|.+++.... .++...++.++.|
T Consensus 58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 137 (295)
T cd05097 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137 (295)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999986532 3678889999999
Q ss_pred HHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhH
Q 027233 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (226)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv 151 (226)
++.|+.+||+.|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+
T Consensus 138 i~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 214 (295)
T cd05097 138 IASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214 (295)
T ss_pred HHHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH
Confidence 9999999999999999999999999 5677899999999866533221 112233567999999988889999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 152 WSVGAILFELLN--GYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 152 ~slG~~~~~l~~--g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
||||++++++++ +..||........ .....++.+.+++.+|++.+|.+|||++++++
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999988 5677765432111 13446789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=250.59 Aligned_cols=209 Identities=31% Similarity=0.551 Sum_probs=188.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
...+..++++|+.+|+++.||+||.+...++..+.++.|||-+.| +....+- +.+++++....-++.||+.||.|||
T Consensus 603 p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH 681 (888)
T KOG4236|consen 603 PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLH 681 (888)
T ss_pred CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh
Confidence 445668999999999999999999999999999999999999955 5555553 3468999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
-++|+|+||||+||++.+.+.=.++||||||+++..++.......+|++.|+|||++.++.|....|+||+|+++|--++
T Consensus 682 ~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS 761 (888)
T KOG4236|consen 682 FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS 761 (888)
T ss_pred hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec
Confidence 99999999999999997666677899999999999999888899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|..||......... +..++....++|..+|+..-.+|.|+++.|.|||+++.
T Consensus 762 GTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 762 GTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999876543221 67789999999999999999999999999999999986
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=231.06 Aligned_cols=197 Identities=30% Similarity=0.554 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+..|+..++.++|+||+++++.+.+.+..++++|++++++|.+++..... +++..+..++.|++.|+++||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 567899999999999999999999999999999999999999999999986544 899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++|+||+|+||++ +.++.++|+|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++
T Consensus 124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 9999999999999 677799999999987665432211 1225678999999988888999999999999999998
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||...+.... .....+.++.+++.+|++.+|.+|||+.|+++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 201 GESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7888875443221 14557899999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.09 Aligned_cols=209 Identities=30% Similarity=0.540 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+|+.++++++|+||+++++++... ...++++||+. ++|.+.+.. ..+++..++.++.|++.||.+||
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH 123 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIH 123 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 455678899999999999999999887543 35899999995 588887753 57999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
+.|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil 200 (336)
T cd07849 124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200 (336)
T ss_pred hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999 6788999999999876543221 122356788999998654 4678899999999999
Q ss_pred HHHHhCCCCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhccCc
Q 027233 159 FELLNGYPPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~~p 197 (226)
+++++|..||.+.+... ...+..+.++.+++.+||+.+|
T Consensus 201 ~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 280 (336)
T cd07849 201 AEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP 280 (336)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh
Confidence 99999999996543110 0023467889999999999999
Q ss_pred cccCCHhHHhcCccccccCcccCCC
Q 027233 198 VDRLSFNEFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~~~~~~~~ 222 (226)
.+|||+.|+++||||+.....-..|
T Consensus 281 ~~Rpt~~e~l~hp~~~~~~~~~~~~ 305 (336)
T cd07849 281 HKRITVEEALAHPYLEQYHDPSDEP 305 (336)
T ss_pred hhCcCHHHHhcCccccccCCCCCcc
Confidence 9999999999999998765443333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=233.40 Aligned_cols=201 Identities=26% Similarity=0.452 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~ 80 (226)
.....+.+|+.+++.++||||+++++++...+..++++||+++++|.+++... ..+++..+..++.|++.|++
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999999989999999999999999999753 23678899999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCC--CCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~--~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
|||+.+++|+||+|+||+++..+ ....++++|||++........ ......+..|+|||.+.+..++.++|+||||
T Consensus 121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 200 (269)
T cd05044 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200 (269)
T ss_pred HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence 99999999999999999995311 123799999999865533211 1122345679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 156 AILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 156 ~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++++++++ |..||......+ ......+..+.+++.+||+.+|.+|||++++++
T Consensus 201 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 201 VLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999998 999987553222 124567889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=249.21 Aligned_cols=201 Identities=27% Similarity=0.456 Sum_probs=176.5
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..++++.++.+|++++++++|||||++||+.....-+++|||+|+||+|.+++++.+ .++..+...++.+.+.||+|||
T Consensus 200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh 279 (474)
T KOG0194|consen 200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH 279 (474)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence 457889999999999999999999999999999999999999999999999999987 4999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc-cccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+++++||||-..|+|+ ..++.+||+|||++.......... ...-...|+|||.+...-++.++||||+|+++||++
T Consensus 280 ~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 280 SKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred HCCCcchhHhHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 9999999999999999 667778999999986554222222 223457799999999899999999999999999999
Q ss_pred h-CCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 N-GYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+ |..||.+....+.. +..-+.++..++.+|+..+|.+|||+.++.+
T Consensus 357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 8 78899987644322 5667888999999999999999999998763
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=236.72 Aligned_cols=200 Identities=28% Similarity=0.456 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~ 69 (226)
....+.+.+|+.+++.+ +||||+++++++...+..++++||+.+++|.+++.+.. .++...+.
T Consensus 61 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05101 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140 (304)
T ss_pred hHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHH
Confidence 34556789999999999 89999999999999999999999999999999997642 36778889
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCC
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++
T Consensus 141 ~~~~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (304)
T cd05101 141 SCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217 (304)
T ss_pred HHHHHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC
Confidence 999999999999999999999999999999 6778899999999876643221 1222345679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.++|+||||++++++++ |..||.+....+. .....+.++++++.+||+.+|.+|||+.++++.
T Consensus 218 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 218 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999999999998 7788865543221 134567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=235.72 Aligned_cols=205 Identities=31% Similarity=0.500 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+++++++ +|+||+++++.+..++..++|+||+.+++|.+++.....+++..+..++.|++.+|.+||+.|+
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~ 126 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI 126 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 456788999999999 6999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccC--CCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~~~~l~~ 163 (226)
+|+||+|.||++ +.++.++|+|||.+........ .....++..|++||...+.. .+.++|+||+|++++++++
T Consensus 127 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 127 IYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred eccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 999999999999 6778899999998866543321 12234678899999986654 6789999999999999999
Q ss_pred CCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCC---HhHHhcCccccccC
Q 027233 164 GYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~~l~~~~~~~~~ 216 (226)
|..||...... ...+..++..+++++.+||+.+|.+||| +.++++||||+...
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 204 GASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred CCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99998643211 1114557889999999999999999998 56789999998853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=246.44 Aligned_cols=206 Identities=32% Similarity=0.603 Sum_probs=195.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+..+.+.+..|-++|.+++.|.||++|..|.+...+|++||-|-||.|+..++.++.+++.+..-++..+++|+.|||++
T Consensus 460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k 539 (732)
T KOG0614|consen 460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK 539 (732)
T ss_pred chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc
Confidence 66778889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
||++|||||+|.++ +.++.+||.|||+++..+.+..+...+|++.|.|||.+-++..+.+.|.|+||++++|+++|.
T Consensus 540 ~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~ 616 (732)
T KOG0614|consen 540 GIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS 616 (732)
T ss_pred CceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999 789999999999999999999888999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCC-----HhHHhcCccccc
Q 027233 166 PPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 214 (226)
Q Consensus 166 ~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~ 214 (226)
.||.+.+..... +..++....++|+++...+|.+|.. +.+|-+|.||.+
T Consensus 617 pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 617 PPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred CCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999998766443 7888999999999999999999976 899999999998
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=232.89 Aligned_cols=200 Identities=23% Similarity=0.436 Sum_probs=169.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+..|+.++++++||||+++++++..++..++++||+++++|.+++... +.++...+..++.|++.|+.+||+
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~ 124 (269)
T cd05065 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124 (269)
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556778999999999999999999999999999999999999999999999764 468999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcccc----c--cCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK----V--CGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~----~--~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
+|++|+||+|+||++ +.+..++|+|||.+........... . ..+..|+|||...+..++.++|+||+|+++
T Consensus 125 ~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l 201 (269)
T cd05065 125 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201 (269)
T ss_pred CCEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHH
Confidence 999999999999999 6788899999998865543221111 1 113469999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 159 FELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 159 ~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++ |..||...+.... .....+..+.+++.+|++.+|.+||++++++.
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99886 9999876543211 13456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=237.89 Aligned_cols=199 Identities=28% Similarity=0.449 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHH
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK 70 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~ 70 (226)
...+.+.+|+.+++.+ +|+||+++++++...+..++++||+++++|.+++...+ .++...++.
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (307)
T cd05098 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144 (307)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 4456788899999999 79999999999999999999999999999999997642 378889999
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCc
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.
T Consensus 145 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 145 CAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 99999999999999999999999999999 6778899999999876543211 11122345799999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++|+||||++++++++ |..||......+ ..+...+.++++++.+|+..+|.+|||+.+++++
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 9999999999999998 888886544321 1144568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=238.15 Aligned_cols=198 Identities=26% Similarity=0.480 Sum_probs=162.2
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCC--------eEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~ 81 (226)
..+.+|++++++++||||+++++++...+ ..++++||+. ++|.+++.... .+++..++.++.|++.||.+
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 35668999999999999999999876543 4699999995 58888877553 78999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCccccccc-CCCcchhHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG 155 (226)
||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+. .++.++|+||+|
T Consensus 135 lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 135 IHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred HHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 999999999999999999 6788999999999876543221 1223456779999987654 467899999999
Q ss_pred HHHHHHHhCCCCCCCCCccccc------------------------------------------ccCCChHHHHHHHHhh
Q 027233 156 AILFELLNGYPPFSGRNNVQLI------------------------------------------VPALHPDCVDMCLKLL 193 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~~~------------------------------------------~~~~~~~~~~~i~~~l 193 (226)
++++++++|..||.+.+..... ....+..+.++|.+||
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l 291 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHh
Confidence 9999999999988654321000 1113567889999999
Q ss_pred ccCccccCCHhHHhcCccc
Q 027233 194 SANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 194 ~~~p~~Rpt~~~~l~~~~~ 212 (226)
+.||.+|||++|+++||||
T Consensus 292 ~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 292 VLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cCChhhccCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=231.38 Aligned_cols=195 Identities=24% Similarity=0.422 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEE-eCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|+.++++++|+|++++++++. .++..++++||+++++|.+++.+.. .+++..+..++.|++.||++||++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3457889999999999999999998754 5567899999999999999998654 378899999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
|++|+||+|+||++ +.++.++|+|||++........ ....+..|+|||...+..++.++|+||+|++++++++ |
T Consensus 122 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g 196 (256)
T cd05082 122 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred CEeccccchheEEE---cCCCcEEecCCccceeccccCC--CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999 6788999999999875543221 2234567999999988889999999999999999997 9
Q ss_pred CCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||....... ......++.+.+++.+|++.+|.+|||+.++++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 197 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99987543221 124567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=231.24 Aligned_cols=199 Identities=23% Similarity=0.426 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...++.+.+|++++++++|+||+++.+++...+..+++|||+++++|.+++... +.+++..+..++.|++.|+.+||+.
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 126 (268)
T cd05063 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445678899999999999999999999999999999999999999999999764 5789999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc----cccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++++|||.+.......... ....+..|+|||...+..++.++|+||+|++++++
T Consensus 127 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 127 NYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred CeeccccchhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 99999999999999 678889999999987654322111 11123469999999888889999999999999999
Q ss_pred Hh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||...+..+.. ....+.++.+++.+|++.+|.+||+++++++
T Consensus 204 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 204 MSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 87 99998655432111 3456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=234.98 Aligned_cols=208 Identities=26% Similarity=0.493 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+...+++..|+.++++++.|++|++|+.|-.+..+++|||||..|+..+.++.+ +++++..+..++++.+++|.|||..
T Consensus 69 ~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~ 148 (502)
T KOG0574|consen 69 DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL 148 (502)
T ss_pred cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999999865 5899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
.-+||||+..||++ +.++..+|.|||.+..+..- .......|++.|+|||++..-.|..++|+||||++..||..|
T Consensus 149 ~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG 225 (502)
T KOG0574|consen 149 KKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG 225 (502)
T ss_pred HHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence 99999999999999 78999999999998665432 223456799999999999988899999999999999999999
Q ss_pred CCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 165 YPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 165 ~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
..||..-...... +..-+.++-+|+++||-++|++|-|+.++++|||++..+.
T Consensus 226 ~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 226 RPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred CCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 9999765443222 3334778999999999999999999999999999998654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=222.91 Aligned_cols=201 Identities=22% Similarity=0.309 Sum_probs=166.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLG 76 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~ 76 (226)
..+..+...+|++..++++|||+++.+++... ....|++++|...|||.+.++.. .-+++..++.++.+++
T Consensus 58 ~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic 137 (302)
T KOG2345|consen 58 SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC 137 (302)
T ss_pred chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence 35678889999999999999999999988643 23599999999999999999754 2589999999999999
Q ss_pred HHHHHHHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---Cc-------cccccCCccccCcccccc--
Q 027233 77 AGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NY-------AEKVCGSPLYMAPEVLQF-- 142 (226)
Q Consensus 77 ~~l~~lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~-------~~~~~~~~~~~aPE~~~~-- 142 (226)
+||.+||+.. ++|+||||.||++ ...+.+++.|||+++...-. .. ......+..|.|||....
T Consensus 138 ~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~ 214 (302)
T KOG2345|consen 138 RGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS 214 (302)
T ss_pred HHHHHHhccCCcccccCCCcceeEe---cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence 9999999998 9999999999999 56889999999998765321 10 112336788999999853
Q ss_pred -cCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 143 -QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 143 -~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
.-.+.++|||||||++|.++.|..||+....... ....+|..+.++|++||+.||.+||++.+++
T Consensus 215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 215 HCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred CcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 4567899999999999999999999974321100 0445899999999999999999999999998
Q ss_pred cC
Q 027233 208 HH 209 (226)
Q Consensus 208 ~~ 209 (226)
.+
T Consensus 295 ~~ 296 (302)
T KOG2345|consen 295 SK 296 (302)
T ss_pred HH
Confidence 64
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=232.59 Aligned_cols=199 Identities=26% Similarity=0.479 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe------EEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL 75 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i 75 (226)
...+.+.+|+..++.++|+||+++++++...+. .++++||+++++|.+++... ..+++..+..++.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i 122 (273)
T cd05035 43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122 (273)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence 445678999999999999999999998765443 79999999999999998543 258899999999999
Q ss_pred HHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHH
Q 027233 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
+.||.|||+.|++|+||+|+||++ +.++.++|+|||.+......... .....+..|+|||...+..++.++|+|
T Consensus 123 ~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~ 199 (273)
T cd05035 123 ALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 199 (273)
T ss_pred HHHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence 999999999999999999999999 67789999999998765433211 112235579999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 153 SVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 153 slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|+|++++++++ |..||.+...... .+...+..+.+++.+|++.||.+|||+.|++++
T Consensus 200 SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 200 AFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999998 8889876543221 255678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=230.09 Aligned_cols=195 Identities=18% Similarity=0.307 Sum_probs=162.4
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+.+|+.++++++|+||+++++++.. +..++++||+++++|.+++.... .++...+..++.|++.||.|||++|++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 5788899999999999999999999887 77899999999999999998766 789999999999999999999999999
Q ss_pred eeccCCCCeEeeeCC----CCccEEEeeeccccccCCCCccccccCCccccCccccccc--CCCcchhHHHHHHHHHHHH
Q 027233 89 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 89 H~dl~~~nili~~~~----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~~~~l~ 162 (226)
|+||+|+||+++... ....++|+|||.+..... .....+...|+|||.+.+. .++.++|+||+|+++++++
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999995211 112699999999876543 2233456679999998766 7889999999999999999
Q ss_pred h-CCCCCCCCCcccc---------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 N-GYPPFSGRNNVQL---------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+ |..||...+.... .+......+.+++.+|++.+|.+|||+.++++
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred hCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8 5777765532111 12223478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=234.38 Aligned_cols=199 Identities=26% Similarity=0.506 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------------CCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVP 64 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~ 64 (226)
.+..+.+.+|+.++++++||||+++++++..+...++++||+++++|.+++.... .++
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 128 (288)
T cd05050 49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccC
Confidence 4456789999999999999999999999999889999999999999999997532 367
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCccccc
Q 027233 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ 141 (226)
Q Consensus 65 ~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~ 141 (226)
+..++.++.|++.||.+||++|++|+||+|.||++ +.++.++|+|||.+........ ......+..|+|||...
T Consensus 129 ~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 78889999999999999999999999999999999 6788899999998865432211 11223455699999998
Q ss_pred ccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 142 FQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 142 ~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+..++.++|+||||++++++++ |..||.+....+. .+...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 206 ~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 206 YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8889999999999999999997 8788865432221 13456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=231.68 Aligned_cols=199 Identities=27% Similarity=0.481 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+..+.+.+|+.++++++|+||+++++++.+ +..++++||+++++|.+++.+.. .+++..++.++.|++.||.+||+.
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 126 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567789999999999999999999998876 45789999999999999998654 589999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++|+||+|+||++ +.++.++|+|||++......... ....+...|+|||...+..++.++|+||||++++++++
T Consensus 127 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 203 (270)
T cd05056 127 RFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203 (270)
T ss_pred CeeccccChheEEE---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999999 57788999999998765433211 12223457999999888889999999999999999886
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||...+..+. .+...+..+.+++.+|+..+|.+|||+.++++.
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 204 LGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999976653221 245678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=234.09 Aligned_cols=199 Identities=36% Similarity=0.570 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHhcC---CCCCeeeeeeEEEeCCe-----EEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 10 ~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l 79 (226)
...+.+|+.+++++ +|+|++++++++..... .++++|++. ++|.+++.... .+++..++.++.|++.||
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 34566777777666 59999999999987766 999999996 58999887643 589999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
.+||+.|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++
T Consensus 121 ~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~ 197 (287)
T cd07838 121 DFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197 (287)
T ss_pred HHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence 99999999999999999999 567899999999987765443333444677899999998888999999999999999
Q ss_pred HHHhCCCCCCCCCcccc-------------------------------------cccCCChHHHHHHHHhhccCccccCC
Q 027233 160 ELLNGYPPFSGRNNVQL-------------------------------------IVPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
++++|..||......+. ....++..+.++|.+||+.||.+||+
T Consensus 198 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~ 277 (287)
T cd07838 198 ELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277 (287)
T ss_pred HHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC
Confidence 99999988875432110 01235678899999999999999999
Q ss_pred HhHHhcCccc
Q 027233 203 FNEFYHHRFL 212 (226)
Q Consensus 203 ~~~~l~~~~~ 212 (226)
++|++.||||
T Consensus 278 ~~~il~~~~~ 287 (287)
T cd07838 278 AFEALQHPYF 287 (287)
T ss_pred HHHHhcCcCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=235.43 Aligned_cols=202 Identities=31% Similarity=0.491 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+..+.+.+|++++++++|+|++++++++.++...++++||+.| +|.+++.. ..++++..+..++.+++.|+.+||++|
T Consensus 67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 145 (317)
T cd06635 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145 (317)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4456788999999999999999999999999999999999964 77777654 457899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|+||++ +.++.++|+|||.+..... .....++..|+|||.+. ....+.++|+||+|++++++++
T Consensus 146 i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 146 MIHRDIKAGNILL---TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred cccCCCCcccEEE---CCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence 9999999999999 6788899999998765432 22345677899999873 3567889999999999999999
Q ss_pred CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 164 GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|..||........ .....+..+.+++.+|++.+|.+|||+.++++|+|+....
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 9999866432211 1335678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=236.32 Aligned_cols=201 Identities=30% Similarity=0.497 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+++.+|+++++.++|+|++++.+++......++|+||+. ++|.+++.. ..++++..+..++.|++.++.+||+++
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~ 135 (308)
T cd06634 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135 (308)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 344567889999999999999999999999999999999996 588877754 356899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|.||++ +.++.++|+|||.+...... ....++..|+|||... ....+.++|+||||++++++++
T Consensus 136 i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 136 MIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred cccCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence 9999999999999 67788999999988665432 2334677899999874 3457889999999999999999
Q ss_pred CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|..||...+.... ....++..+.++|++||+.+|.+||+++++++|||+...
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred CCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999866443211 133577889999999999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=234.16 Aligned_cols=200 Identities=33% Similarity=0.557 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|++++++++|+|++++++++... +..++++||++ ++|.+++... ..+++..++.++.|++.|+++||+.
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445688899999999999999999999887 88999999996 5999988765 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+ ..++.++|+||||+++++++
T Consensus 120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 99999999999999 6788999999999877654431 223345678999998764 45789999999999999999
Q ss_pred hCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCccccC
Q 027233 163 NGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
+|..||...+..... ...++.++.+++++||+.+|.+||
T Consensus 197 t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (287)
T cd07840 197 LGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276 (287)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence 999998654321100 111388899999999999999999
Q ss_pred CHhHHhcCccc
Q 027233 202 SFNEFYHHRFL 212 (226)
Q Consensus 202 t~~~~l~~~~~ 212 (226)
|+.++++||||
T Consensus 277 ~~~~~l~~~~~ 287 (287)
T cd07840 277 SADQALQHEYF 287 (287)
T ss_pred CHHHHhhCcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=237.66 Aligned_cols=199 Identities=25% Similarity=0.393 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.+++.++||||+++++++... ..+++++|+.+++|.+++... ..++...++.++.|++.||+|||++
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (316)
T cd05108 50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128 (316)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence 45567889999999999999999999998765 467899999999999999875 3688899999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++||||+|+||++ +.++.++|+|||++......... .....+..|++||.+.+..++.++|+||||+++|+++
T Consensus 129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~ 205 (316)
T cd05108 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205 (316)
T ss_pred CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999 67788999999999776543221 1122345799999998889999999999999999998
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+ |..||.+....+. .+...+.++.+++.+|++.+|.+|||+.+++.+
T Consensus 206 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 206 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred cCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7 9999976543211 144567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=230.09 Aligned_cols=199 Identities=27% Similarity=0.511 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+.+.+|++++++++|+||+++++.+...+..++++||+++++|.+++... ..+++..+..++.+++.|+.+|
T Consensus 43 ~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (267)
T cd08224 43 AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122 (267)
T ss_pred hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 445778999999999999999999999999999999999999999999998642 3588999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||...+..++.++|+||+|++++++
T Consensus 123 h~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 123 HSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HhCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence 99999999999999999 678889999999886554322 12234567789999999888899999999999999999
Q ss_pred HhCCCCCCCCCcc-------------cccc-cCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNNV-------------QLIV-PALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~~-------------~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..||...... ...+ ..++..+.++|.+|+..+|.+|||+.++++
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999998654311 0012 257779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=229.97 Aligned_cols=195 Identities=24% Similarity=0.420 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+++++.++|+|++++++++.. +..+++|||+.+++|.+++.... .+++..+..++.|++.||.+||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 123 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4578889999999999999999988754 56789999999999999997643 47889999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|.||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 124 ~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g 200 (260)
T cd05069 124 IHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred eecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence 999999999999 67888999999998765433221 12234567999999988889999999999999999998 8
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||.+...... .....+..+.+++++||+.+|.+||+++++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 201 RVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999976543211 13457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=230.41 Aligned_cols=197 Identities=25% Similarity=0.475 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.++++++|+||+++++++......++++|++++++|.+++.... .++...+..++.+++.|+.+||++|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~ 123 (261)
T cd05034 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123 (261)
T ss_pred CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678999999999999999999999998889999999999999999997653 6899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++|+||+|+||++ +.++.++|+|||.+......... .....+..|+|||...+..++.++|+||+|++++++++
T Consensus 124 i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 124 YIHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred cccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 9999999999999 67889999999998765432111 11223457999999988889999999999999999998
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+.+.... .+...+.++.+++.+|++.+|.+|||++++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 201 GRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999976543221 14456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.07 Aligned_cols=200 Identities=28% Similarity=0.504 Sum_probs=179.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~ 78 (226)
+.+...+|.+|..+|++++|||||+++|.+.+.+..+|++|||.||+|.+|+++. ..++..+...++.||++|
T Consensus 735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G 814 (1025)
T KOG1095|consen 735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG 814 (1025)
T ss_pred CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence 5678889999999999999999999999999999999999999999999999976 248899999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cc-c-ccCCccccCcccccccCCCcchhHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AE-K-VCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~-~-~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
.+||++++++||||...|+|+ +....+||+|||+|+....... .. . ......|||||.+....++.++||||||
T Consensus 815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFG 891 (1025)
T KOG1095|consen 815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFG 891 (1025)
T ss_pred hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhH
Confidence 999999999999999999999 6779999999999985543322 11 1 2344679999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 156 AILFELLN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 156 ~~~~~l~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++||+++ |..||++.++.+.. +...+..+.+++.+|++.+|.+||++..+++
T Consensus 892 VllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 892 VLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999 89999998876554 6667889999999999999999999999987
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.53 Aligned_cols=199 Identities=26% Similarity=0.469 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL 75 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i 75 (226)
...++.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++.... .+++..+..++.|+
T Consensus 60 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05095 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI 139 (296)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999997642 25677899999999
Q ss_pred HHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHH
Q 027233 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
+.|+++||+.|++|+||+|+||++ +.++.++|+|||++........ ......+..|++||...+..++.++|+|
T Consensus 140 ~~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 140 ASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred HHHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999999999999 6788899999999876543221 1112235679999988878899999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 153 SVGAILFELLN--GYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 153 slG~~~~~l~~--g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|||++++++++ |..||......+. .+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999998 6778865432111 13456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=232.26 Aligned_cols=198 Identities=23% Similarity=0.435 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l 79 (226)
..+.+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++.... .+++..+..++.|++.+|
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 56789999999999999999999999999889999999999999999998765 689999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
.|||+.|++|+||+|+||++ +.++.++++|||++....... ......++..|+|||...+...+.++|+||||++
T Consensus 131 ~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 207 (275)
T cd05046 131 DHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207 (275)
T ss_pred HHhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence 99999999999999999999 678889999999876442211 1122234566999999888888999999999999
Q ss_pred HHHHHh-CCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 158 LFELLN-GYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 158 ~~~l~~-g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++++++ |..||....... .....++..+.+++.+||+.+|.+|||+.|++..
T Consensus 208 l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 208 MWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 999998 788886543221 1144578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=240.62 Aligned_cols=196 Identities=26% Similarity=0.385 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+|.+|+.++.+++|||+|+++||+.+.+ ..++|+||++.|+|.+++.... ++++....+|+.+++.||+|||+..
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 456999999999999999999999999988 5999999999999999997664 8899999999999999999999864
Q ss_pred ---ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccc-cCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 87 ---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 87 ---i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|+|||||++||++ +.+...||+|||++..... ....... .|+.+|++||+......+.++||||+|++++|+
T Consensus 195 ~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL 271 (361)
T ss_pred CCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence 9999999999999 7899999999999955543 3222223 789999999999988999999999999999999
Q ss_pred HhCCCCCCCCCcccc--c---------------------c-cCCCh-----HHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNNVQL--I---------------------V-PALHP-----DCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~--~---------------------~-~~~~~-----~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..+.+....... . . ..++. .+..+..+|++.+|.+||++.|+++
T Consensus 272 itgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 272 ITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 999987664321100 0 1 23332 2567788899999999999999743
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=241.65 Aligned_cols=203 Identities=30% Similarity=0.533 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe------EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
...+.+.+|+.++++++|+||+++.+++...+. .++++||+ +++|.+++.. ..+++..++.++.|++.|+.+
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~ 133 (343)
T cd07851 56 IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKY 133 (343)
T ss_pred hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence 344667789999999999999999988765543 89999999 7799998875 479999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~ 160 (226)
||+.|++|+||+|+||++ +.++.++|+|||.+...... .....++..|+|||...+ ..++.++|+||||+++++
T Consensus 134 LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 134 IHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred HHHCCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence 999999999999999999 67888999999998766433 223346778999998765 367889999999999999
Q ss_pred HHhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCccc
Q 027233 161 LLNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANTVD 199 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~ 199 (226)
+++|..||.+...... .....+.++.++|++||+.+|.+
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 9999999975443211 01245889999999999999999
Q ss_pred cCCHhHHhcCccccccCc
Q 027233 200 RLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 200 Rpt~~~~l~~~~~~~~~~ 217 (226)
|||+.++++||||+....
T Consensus 289 Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 289 RITAAEALAHPYLAEYHD 306 (343)
T ss_pred CCCHHHHhcCCCccccCC
Confidence 999999999999987533
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=237.65 Aligned_cols=199 Identities=30% Similarity=0.495 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhc-------------------------
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~------------------------- 60 (226)
...+.+..|+.+++++ +|+||+++++++.. +...++++||+++++|.+++...
T Consensus 52 ~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (337)
T cd05054 52 SEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131 (337)
T ss_pred HHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccc
Confidence 3446778899999999 89999999998764 45688999999999999998642
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCC
Q 027233 61 ------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104 (226)
Q Consensus 61 ------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~ 104 (226)
.++++..+..++.|++.||.|||++|++||||+|.||++ +.
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~ 208 (337)
T cd05054 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SE 208 (337)
T ss_pred ccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eC
Confidence 257888899999999999999999999999999999999 56
Q ss_pred CccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc----
Q 027233 105 DVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL---- 176 (226)
Q Consensus 105 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~---- 176 (226)
++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+....+.
T Consensus 209 ~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~ 288 (337)
T cd05054 209 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288 (337)
T ss_pred CCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH
Confidence 78899999999976543221 122334567999999998999999999999999999997 9999976432111
Q ss_pred --------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 177 --------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 177 --------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.+...++++.+++.+|++.+|.+|||++|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 134567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=228.58 Aligned_cols=197 Identities=26% Similarity=0.507 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|++++++++|||++++++++......++++||+++++|.+++... .++++..++.++.+++.++++||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 122 (256)
T cd05112 43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 356889999999999999999999999989999999999999999998764 4689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~ 165 (226)
|+||+|.||++ +.++.++|+|||.+......... .....+..|+|||...+..++.++|+||+|++++++++ |.
T Consensus 123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999 67788999999988765433221 12224467999999988889999999999999999998 89
Q ss_pred CCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 166 PPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 166 ~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.||....... ..+...+..+.+++++||+.+|.+|||+.++++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 200 TPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 9987554221 1134468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=235.49 Aligned_cols=205 Identities=28% Similarity=0.508 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS-H 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (226)
....+..|+.++.+. +|+||+++++++.+....++++||+ +++|.++... ...+++..+..++.|++.+++|||+ .
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 134 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 445566677766666 5999999999999999999999998 5578877765 3578999999999999999999997 5
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccC----CCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||||++++++
T Consensus 135 ~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el 211 (296)
T cd06618 135 GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211 (296)
T ss_pred CEecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHH
Confidence 99999999999999 678899999999987664433333445677899999986543 78899999999999999
Q ss_pred HhCCCCCCCCCcc-c-----------cc--ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 162 LNGYPPFSGRNNV-Q-----------LI--VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 162 ~~g~~p~~~~~~~-~-----------~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
++|..||...... + .. ...++.++.+++.+||+.+|.+|||++++++||||+....
T Consensus 212 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 212 ATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 9999999763221 0 00 1236788999999999999999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=229.32 Aligned_cols=195 Identities=23% Similarity=0.430 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|++++++++|+||+++++++.+ +..++++||+++++|.+++.+. ..+++..+..++.|++.||+++|+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4578899999999999999999988754 5578999999999999999764 357889999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|.||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 124 ~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred cccccCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999 67788999999998765433221 12234567999999988889999999999999999999 8
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||........ .....+..+.+++.+|++.+|.+|||+.++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 201 RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 888876543221 13457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=237.81 Aligned_cols=201 Identities=28% Similarity=0.452 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~ 69 (226)
....+.+.+|+++++++ +|+||+++++.+...+..++++||+++++|.+++.... .++...+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (334)
T cd05100 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137 (334)
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHH
Confidence 34567889999999999 89999999999999999999999999999999997532 36778889
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCC
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++
T Consensus 138 ~~~~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (334)
T cd05100 138 SCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT 214 (334)
T ss_pred HHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC
Confidence 999999999999999999999999999999 6778899999999876543221 1112234569999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCc
Q 027233 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 210 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~ 210 (226)
.++|+||||++++++++ |..||.+.+..+. .+...+..+.+++.+|++.+|.+|||+.|++++-
T Consensus 215 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99999999999999998 8888876542221 1445678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=231.14 Aligned_cols=199 Identities=24% Similarity=0.374 Sum_probs=167.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|+.+++.++|+||+++++++... ..+++++|+++++|.+++... +.+++..+..++.|++.||+|||+
T Consensus 49 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 49 SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345567888999999999999999999988754 467899999999999999764 468999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+|++|+||+|+||++ +.++.++|+|||++......... ....++..|+|||...+..++.++|+||||++++++
T Consensus 128 ~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 128 VRLVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred CCeeccccccceEEE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 999999999999999 66778999999998766433221 112235679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||....... ......+.++.+++.+|++.||++||++.++++
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 205 MTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 98 899987644321 114557889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=230.31 Aligned_cols=196 Identities=26% Similarity=0.439 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
....+..|+..+++++||||+++++++.. ...++++||+++++|.+++... +.+++..+..++.|++.|+.|||++|+
T Consensus 52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 130 (279)
T cd05111 52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 44577888889999999999999998754 4577899999999999999764 478999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++|++++
T Consensus 131 iH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~ 207 (279)
T cd05111 131 VHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207 (279)
T ss_pred eccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 999999999999 6788899999999876543221 122335567999999988889999999999999999998
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+...... .+...+.++.+++.+|+..+|.+|||+.|+++
T Consensus 208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999976543211 13345678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=228.57 Aligned_cols=195 Identities=25% Similarity=0.444 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+.++++++|+|++++++++.. +..+++|||+++++|.+++... ..+++..++.++.+++.|+.+||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 123 (260)
T cd05070 45 PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4578899999999999999999998754 5688999999999999998764 358999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 124 ~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g 200 (260)
T cd05070 124 IHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred ccCCCccceEEE---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcC
Confidence 999999999999 56788999999998765433221 11223457999999988889999999999999999998 8
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||...+..+. .....+..+.+++.+|++.+|.+|||++++.+
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 201 RVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899876543221 14456789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=231.50 Aligned_cols=200 Identities=24% Similarity=0.393 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|+.++++++|+||+++++++... ...++++||++|++|.+++.+.. .+++..+..++.|++.||++||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH 126 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44556899999999999999999999988765 56899999999999999997653 6899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||++++
T Consensus 127 ~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 127 SRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HCCeeecccchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 9999999999999999 6778899999999876543221 12233556799999988888999999999999999
Q ss_pred HHHhCCCCCCCCC--------------------------cccccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 160 ELLNGYPPFSGRN--------------------------NVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 160 ~l~~g~~p~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++++..|..... ........++..+.+++.+||+.+|.+|||++++++.
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9998765432110 0001144578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=235.87 Aligned_cols=208 Identities=34% Similarity=0.535 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++++++||||+++.+++.. ....++++||+ +++|.++++. .++++..+..++.|++.||.+||+.|
T Consensus 51 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~ 128 (328)
T cd07856 51 VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG 128 (328)
T ss_pred chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345678899999999999999999998865 56789999999 6799988764 46888889999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++|+||+|.||++ +.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||+|++++++++|.
T Consensus 129 iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 203 (328)
T cd07856 129 VVHRDLKPSNILI---NENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203 (328)
T ss_pred cccCCCCHHHEeE---CCCCCEEeCccccccccCCCc--CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999 678889999999987543321 23346778999998765 56889999999999999999999
Q ss_pred CCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhccCccccCCHh
Q 027233 166 PPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 166 ~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
.||....... ...+.++.++.++|++||+.+|.+|||++
T Consensus 204 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 283 (328)
T cd07856 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283 (328)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 9986543210 00234678999999999999999999999
Q ss_pred HHhcCccccccCcccCCC
Q 027233 205 EFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 205 ~~l~~~~~~~~~~~~~~~ 222 (226)
+++.||||.........|
T Consensus 284 ell~~~~~~~~~~~~~~~ 301 (328)
T cd07856 284 EALAHPYLAPYHDPTDEP 301 (328)
T ss_pred HHhcCCccccccCCcccc
Confidence 999999998765554444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=232.68 Aligned_cols=197 Identities=29% Similarity=0.545 Sum_probs=168.0
Q ss_pred HHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 12 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+|+..+++++ |+||+++++.+..++..++++||+ +++|.+++.... .+++..+..++.|++.+|.+||++|++
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 121 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4557899999998 999999999999999999999999 789999887764 789999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|.||++ +.++.++|+|||.+.............++..|+|||... +..++.++|+||+|++++++++|..|
T Consensus 122 H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~ 198 (283)
T cd07830 122 HRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL 198 (283)
T ss_pred cCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence 99999999999 678899999999987665443333445677899999874 44578999999999999999999998
Q ss_pred CCCCCcccc----------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 168 FSGRNNVQL----------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 168 ~~~~~~~~~----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
|......+. .....+.++.++|++|++.+|.+|||++|++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 865432110 0123367899999999999999999999999
Q ss_pred cCccc
Q 027233 208 HHRFL 212 (226)
Q Consensus 208 ~~~~~ 212 (226)
.||||
T Consensus 279 ~~~~~ 283 (283)
T cd07830 279 QHPYF 283 (283)
T ss_pred hCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=240.34 Aligned_cols=204 Identities=29% Similarity=0.615 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--------------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 73 (226)
...+.+.+|++++++++||||+++++.+... ...++++||++ ++|.+++.. ..+++..++.++.
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ 121 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMY 121 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHH
Confidence 3456788899999999999999999876543 35789999996 699888764 4789999999999
Q ss_pred HHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccc-cCCCcc
Q 027233 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEK 148 (226)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~ 148 (226)
||+.|+.+||+.|++|+||+|+||+++ ..+..++++|||.+....... ......++..|.|||.+.+ ..++.+
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence 999999999999999999999999994 345678999999987653221 1122346778999997654 457889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcccc----------------------------------------cccCCChHHHHH
Q 027233 149 VDMWSVGAILFELLNGYPPFSGRNNVQL----------------------------------------IVPALHPDCVDM 188 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 188 (226)
+|+||||++++++++|..||........ ....++.++.++
T Consensus 200 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 200 IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 9999999999999999999965421100 023577889999
Q ss_pred HHHhhccCccccCCHhHHhcCcccccc
Q 027233 189 CLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 189 i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+.+||+.||.+|||++|+++||||+..
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCccccc
Confidence 999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=227.23 Aligned_cols=200 Identities=44% Similarity=0.803 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|++.+++++|+||+++++++......++++|++.+++|.+++.....++...++.++.+++.++.+||+.+++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 68999999999999999999999999999999999999998899999987766899999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 169 (226)
+||+|.||++ +.++.++++|||.+.............+...|++||...+..++.++|+||+|++++++++|..||.
T Consensus 111 ~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 111 RDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred CCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999 6678999999999987765544445567888999999988888999999999999999999999997
Q ss_pred CCCccccc------------cc--CCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 170 GRNNVQLI------------VP--ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 170 ~~~~~~~~------------~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
........ .. .++.++.+++.+|+..+|++||++.++++||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 188 GDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 63221111 11 178899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=227.12 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEE-eCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|+.+++.++||||+++++++. .++..+++++|+.+++|.+++.+. ...+...+..++.|++.||.+||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 117 (262)
T cd05058 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117 (262)
T ss_pred HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45668889999999999999999999765 456688999999999999999764 3467778889999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++
T Consensus 118 ~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 194 (262)
T cd05058 118 KFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194 (262)
T ss_pred CccccccCcceEEE---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHH
Confidence 99999999999999 6778899999999865432211 112234567999999988889999999999999999
Q ss_pred HHhC-CCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLNG-YPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~g-~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++| ..||...+..+ ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 195 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 195 LMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9995 56665433211 1133467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=248.27 Aligned_cols=201 Identities=32% Similarity=0.516 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+.=+++..|+++|+++.|||++.+.+.|.-+...|+||||| -||-.|.+.-. +++-+..+..|..+.+.||+|||+.+
T Consensus 68 EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~ 146 (948)
T KOG0577|consen 68 EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 146 (948)
T ss_pred HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh
Confidence 44568999999999999999999999999999999999999 67999988765 58899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
.+|||||..||++ ++.+.|+|+|||.+....+ ....+|++.|||||++. .+.|+-+.||||||++..++..
T Consensus 147 ~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE 220 (948)
T KOG0577|consen 147 RIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 220 (948)
T ss_pred HHhhhccccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhh
Confidence 9999999999999 7899999999999977643 44678999999999873 5678999999999999999999
Q ss_pred CCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..+|.-+++....+ .+.-+..+..|+..||++-|.+|||.+++|.|+|..+.
T Consensus 221 RkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 221 RKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred cCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 99998776654333 44456789999999999999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=228.47 Aligned_cols=197 Identities=23% Similarity=0.411 Sum_probs=160.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+|+..++.++|+||+++++.+...+..+++|||+++++|.+++.... ..++..+..++.||+.|++||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 116 (269)
T cd05042 37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH
Confidence 345577889999999999999999999999999999999999999999997653 245778889999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccc-------cCCCcchhHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVDMW 152 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~ 152 (226)
|++|++||||+|.||++ +.++.++|+|||.+........ .....++..|+|||.... ...+.++|+|
T Consensus 117 H~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 193 (269)
T cd05042 117 HQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW 193 (269)
T ss_pred HhcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHH
Confidence 99999999999999999 6788999999998865432211 122234566999998642 3567899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 153 SVGAILFELLN-GYPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 153 slG~~~~~l~~-g~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|+|++++++++ |..||......+. ....++..+.+++..|+ .+|.+|||++++++
T Consensus 194 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 194 SLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 99999999998 7788876543211 13457788899998888 69999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=229.69 Aligned_cols=200 Identities=22% Similarity=0.385 Sum_probs=168.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLG 76 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~ 76 (226)
.....+.+.+|+.++++++|+||+++++++.. +...+++++|+++++|.+++... ..+++..++.++.|++
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~ 127 (280)
T cd05043 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127 (280)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHH
Confidence 34567788999999999999999999998765 56788999999999999998764 3478999999999999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHH
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
.||.|||+.+++|+||+|.||++ +.++.++++|||+++........ ....++..|+|||...+..++.++|+||
T Consensus 128 ~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 204 (280)
T cd05043 128 CGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWS 204 (280)
T ss_pred HHHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHH
Confidence 99999999999999999999999 67889999999998765432211 1223456799999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 154 VGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 154 lG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
||++++++++ |..||......+. .....+.++.+++.+|++.+|++|||+.++++
T Consensus 205 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 205 FGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred hHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999998 9999976432211 13456789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=254.21 Aligned_cols=199 Identities=23% Similarity=0.370 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQLG 76 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~ 76 (226)
..++++.+|++++++++||||+++++++.+++..+++|||++|++|.+++... ...+...+..++.|++
T Consensus 44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa 123 (932)
T PRK13184 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123 (932)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999998642 2345667889999999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-------------------ccccccCCccccCc
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------YAEKVCGSPLYMAP 137 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-------------------~~~~~~~~~~~~aP 137 (226)
.||.+||++|++||||||+||++ +.++.++|+|||++....... ......|++.|+||
T Consensus 124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 99999999999999999999999 678889999999987652110 01123588999999
Q ss_pred ccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHh
Q 027233 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|...+..++.++|+||+|+++++|++|..||......... ...+++.+.+++.+||+.||.+|++..
T Consensus 201 E~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ 280 (932)
T PRK13184 201 ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSV 280 (932)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999889999999999999999999999999764432111 235788899999999999999998765
Q ss_pred HHhcC
Q 027233 205 EFYHH 209 (226)
Q Consensus 205 ~~l~~ 209 (226)
+.+..
T Consensus 281 eeLl~ 285 (932)
T PRK13184 281 QELKQ 285 (932)
T ss_pred HHHHH
Confidence 55543
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=226.83 Aligned_cols=196 Identities=24% Similarity=0.482 Sum_probs=166.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++|+||+++++.+.. ...++++||+++++|.+++.+. ..++...+..++.|++.||.+||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~ 122 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45678899999999999999999999887 7789999999999999999764 35788899999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++
T Consensus 123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 9999999999999 67889999999988665432211 12234466999999988888999999999999999998
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||...+.... .....+.++.+++.+|++.+|.+||++.++++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 200 GRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8999976543211 14557789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=235.02 Aligned_cols=203 Identities=33% Similarity=0.520 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+.+|+.+++++ +|+||+++++.... ....+++++++ +++|.+++.....+++..+..++.|++.||.+||
T Consensus 44 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH 122 (332)
T cd07857 44 LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122 (332)
T ss_pred hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999 69999999987543 24578888988 5799999988888999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccc-cCCCcchhHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~ 157 (226)
+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+ ..++.++|+||+|++
T Consensus 123 ~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 123 SANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred hCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 9999999999999999 6788899999999876543221 122357788999998765 467899999999999
Q ss_pred HHHHHhCCCCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhccC
Q 027233 158 LFELLNGYPPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~~ 196 (226)
++++++|..||...+... ......+..+.+++.+||+.+
T Consensus 200 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 200 LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence 999999999987543110 012345788999999999999
Q ss_pred ccccCCHhHHhcCcccccc
Q 027233 197 TVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+|||+.+++.||||..-
T Consensus 280 P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 280 PTKRISVEEALEHPYLAIW 298 (332)
T ss_pred cccCCCHHHHhcChhhhhh
Confidence 9999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=228.29 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
......+.+|+..+++++|+||+++++++.. ...++++||+++++|.+++... ..+++..+..++.|++.|+++||++
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 128 (279)
T cd05057 50 PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128 (279)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456788899999999999999999999887 7789999999999999999875 4689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc---cccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++|+||+|+||++ +.++.++|+|||.+.......... ....+..|+|||......++.++|+||+|+++++++
T Consensus 129 ~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05057 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205 (279)
T ss_pred CEEecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHh
Confidence 99999999999999 678889999999987654322111 111245699999988888899999999999999999
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+ |..||.+....+. .+...+.++.+++.+|+..+|++|||+.++++
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 206 TFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred cCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8 9999977543211 13446788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=269.19 Aligned_cols=204 Identities=29% Similarity=0.529 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.-+.+.+|..+++.++|||+|++|+.-......+|.||||+||+|.+.++..+..++.....+-.|++.|++|||++||+
T Consensus 1277 ~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIV 1356 (1509)
T KOG4645|consen 1277 TFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIV 1356 (1509)
T ss_pred cCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCce
Confidence 44578899999999999999999999999999999999999999999999877788888888999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccC---CCcchhHHHHHHHHHH
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFE 160 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~~~~ 160 (226)
||||||.||++ +.++.+|++|||.|.....+.. .....||+.|||||.+.+.. -.-+.||||||||+.|
T Consensus 1357 HRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1357 HRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred ecCCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence 99999999999 6788999999999987765531 13467999999999997543 4568999999999999
Q ss_pred HHhCCCCCCCCCcc------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 161 LLNGYPPFSGRNNV------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 161 l~~g~~p~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|++|..||...+.. ...+..++++-++||..||+.||.+|-++.|+++|.|=+..
T Consensus 1434 M~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1434 MATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred eecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999876542 22377799999999999999999999999999999987654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=236.02 Aligned_cols=203 Identities=30% Similarity=0.526 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..+.+.+|+.++++++|+||+++++++... ...+++++++ |++|.++++. ..+++..++.++.|++.|+.+|
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~L 136 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 136 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999987643 3477888877 8899988764 4789999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
|++|++|+||+|+||++ +.++.++|+|||++...... .....++..|+|||...+ ..++.++|+||+|++++++
T Consensus 137 H~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 137 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred HHCCeeecCCChHHEEE---cCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHH
Confidence 99999999999999999 67888999999998654322 223456788999998765 4678899999999999999
Q ss_pred HhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCcccc
Q 027233 162 LNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~R 200 (226)
++|..||...+..... ....++++.++|.+||+.+|.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 9999999654321100 11357789999999999999999
Q ss_pred CCHhHHhcCccccccCcc
Q 027233 201 LSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 201 pt~~~~l~~~~~~~~~~~ 218 (226)
||+.+++.||||+.....
T Consensus 292 ~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 292 ITAAQALAHAYFAQYHDP 309 (345)
T ss_pred CCHHHHhcChhhhhcCCC
Confidence 999999999999975433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=228.99 Aligned_cols=199 Identities=26% Similarity=0.395 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|++++++++||||+++++++.. ....++++||+++++|.+++.+. ..+++..+..++.|++.||++||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH 125 (284)
T cd05081 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456688999999999999999999997643 35689999999999999999764 46899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
++|++|+||+|+||++ +.++.++|+|||++......... ....++..|+|||...+..++.++|+||||++++
T Consensus 126 ~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 126 SKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HCCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 9999999999999999 67888999999998765432211 1112334589999998888999999999999999
Q ss_pred HHHhCCCCCCCCCcc---------c------------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 160 ELLNGYPPFSGRNNV---------Q------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~---------~------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++++|..++...... . ......+.++.+++.+|++.+|.+|||+.++++
T Consensus 203 el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 203 ELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999986654322110 0 012456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.91 Aligned_cols=199 Identities=26% Similarity=0.422 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCC----------eEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~ 78 (226)
...+.+|++++++++||||+++++++.+.. ..++++||+++ ++.+++... ..+++..+..++.|++.|
T Consensus 50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a 128 (302)
T cd07864 50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG 128 (302)
T ss_pred hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence 356778999999999999999999886644 78999999965 777777654 468999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccc-cCCCcchhHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVG 155 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG 155 (226)
|++||+.|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||+|
T Consensus 129 L~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 205 (302)
T cd07864 129 LNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 205 (302)
T ss_pred HHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence 999999999999999999999 6788999999999876543321 122234667999998754 3468899999999
Q ss_pred HHHHHHHhCCCCCCCCCcccc----------------------------------------cccCCChHHHHHHHHhhcc
Q 027233 156 AILFELLNGYPPFSGRNNVQL----------------------------------------IVPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~~----------------------------------------~~~~~~~~~~~~i~~~l~~ 195 (226)
++++++++|..||...+.... ....++..+.+++.+||+.
T Consensus 206 ~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 285 (302)
T cd07864 206 CILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285 (302)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccC
Confidence 999999999999865332100 0224688999999999999
Q ss_pred CccccCCHhHHhcCccc
Q 027233 196 NTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~ 212 (226)
+|.+|||+.++++||||
T Consensus 286 ~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 286 DPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=226.72 Aligned_cols=195 Identities=23% Similarity=0.469 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+.++++++|+||+++++++. .+..++++|++.+++|.+++... .+++...+..++.|++.||++||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i 123 (260)
T cd05067 45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 357889999999999999999999874 45689999999999999998754 368899999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence 999999999999 67888999999998665422211 12234567999999988888999999999999999998 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||.+.+.... .....+.++.+++.+|++.+|.+|||++++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 201 RIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999976543221 14456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=225.36 Aligned_cols=194 Identities=25% Similarity=0.458 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.+++.++|+||+++++.+..++ .++++||+.+++|.+++.... .+++..+..++.|++.|+.+||+.|
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567889999999999999999999987654 789999999999999997653 5789999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~ 165 (226)
++||||+|+||++ +.++.++|+|||.+....... .....+..|+|||...+..++.++|+||||++++++++ |.
T Consensus 121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred eeccccCcceEEE---cCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999 678889999999886543221 12223567999999988889999999999999999997 89
Q ss_pred CCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 166 PPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 166 ~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.||...+... .....++..+.+++.+|++.+|.+|||++++++
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 196 APYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9987654321 114457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=234.87 Aligned_cols=203 Identities=36% Similarity=0.570 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+|+.+++++ +|+||+++++++... ...++|+||+. ++|.+++... .+++.....++.|++.||.+||+
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~ 125 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS 125 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445677899999999 999999999988653 46899999996 5999998765 78888999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC------ccccccCCccccCcccccc-cCCCcchhHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~ 157 (226)
.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ...+.++|+||+|++
T Consensus 126 ~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~ 202 (337)
T cd07852 126 GNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202 (337)
T ss_pred CCeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence 999999999999999 688899999999887654322 1122346778999998754 457889999999999
Q ss_pred HHHHHhCCCCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhccC
Q 027233 158 LFELLNGYPPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~~ 196 (226)
++++++|..||.+..... .....++.++.++|.+|++.+
T Consensus 203 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 282 (337)
T cd07852 203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN 282 (337)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC
Confidence 999999999986543211 012336888999999999999
Q ss_pred ccccCCHhHHhcCcccccc
Q 027233 197 TVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+|||+.++++||||+..
T Consensus 283 P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 283 PNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred cccccCHHHHhhChhhhhh
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=235.69 Aligned_cols=200 Identities=31% Similarity=0.544 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..+.+.+|++++++++|+||+++++.+..+. ..++|++++ |++|.+++.. ..+++..++.++.|++.|+.+|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~L 134 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999886543 468999999 7899988764 5799999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
|+.|++|+||+|+||++ +.++.++|+|||.+....... ....++..|+|||...+ ..++.++|+||+|++++++
T Consensus 135 H~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 135 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred HhCCeecCCCCHHHEEE---cCCCCEEEeecccccccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999 678889999999987654322 23346778999998865 3578899999999999999
Q ss_pred HhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCcccc
Q 027233 162 LNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~R 200 (226)
++|..||...+.... .....+.++.++|.+||+.||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 999999975432100 023567789999999999999999
Q ss_pred CCHhHHhcCcccccc
Q 027233 201 LSFNEFYHHRFLRRN 215 (226)
Q Consensus 201 pt~~~~l~~~~~~~~ 215 (226)
||+.+++.||||+..
T Consensus 290 ~t~~~~l~~~~~~~~ 304 (343)
T cd07880 290 ITAAEALAHPYFEEF 304 (343)
T ss_pred CCHHHHhcCccHhhh
Confidence 999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=236.21 Aligned_cols=201 Identities=31% Similarity=0.529 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+.+|+.+++.++|+||+++++++... ...+++++|+. .+|.++.. ..+++..+..++.|++.|+.+|
T Consensus 57 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~L 133 (342)
T cd07879 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYI 133 (342)
T ss_pred chhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999988654 34689999994 57877653 4688999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
|+.|++||||+|+||++ +.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||++++++
T Consensus 134 H~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el 208 (342)
T cd07879 134 HSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208 (342)
T ss_pred HHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHH
Confidence 99999999999999999 67889999999998654322 123346778999999865 4578899999999999999
Q ss_pred HhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCcccc
Q 027233 162 LNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p~~R 200 (226)
++|..||.+.+.... ..+..+.++.++|++||+.||.+|
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 288 (342)
T cd07879 209 LTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKR 288 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhC
Confidence 999999976542110 013467789999999999999999
Q ss_pred CCHhHHhcCccccccCc
Q 027233 201 LSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 201 pt~~~~l~~~~~~~~~~ 217 (226)
||+++++.||||+....
T Consensus 289 ~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 289 LTATEALEHPYFDSFRD 305 (342)
T ss_pred cCHHHHhcCcchhhccc
Confidence 99999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=226.46 Aligned_cols=200 Identities=27% Similarity=0.499 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHhc-CCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....++.+|+.++.+ ++|+||+++++++.+++..++++||++|++|.+++.. ...+++..++.++.|++.++.+
T Consensus 49 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 128 (269)
T cd08528 49 DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128 (269)
T ss_pred hHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 3445567788888876 6999999999999999999999999999999998743 2468999999999999999999
Q ss_pred HHh-CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 82 LNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~-~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
||+ .|++|+||+|.||++ +.++.++|+|||.+.............++..|.+||...+..++.++|+||||+++++
T Consensus 129 lh~~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~ 205 (269)
T cd08528 129 LHKEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205 (269)
T ss_pred hccCCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHH
Confidence 996 789999999999999 6788999999999877654433344557788999999988888999999999999999
Q ss_pred HHhCCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLNGYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++|..||....... .....++.++.+++.+|++.||.+||++.|+..+
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 206 MCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999987643221 1122568899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=226.12 Aligned_cols=196 Identities=24% Similarity=0.397 Sum_probs=160.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+|+.++++++||||+++++.+.+....+++|||+++++|.+++.... ..+...+..++.|++.|+.+||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 44578889999999999999999999998888999999999999999997532 3566778899999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCccccccc-------CCCcchhHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWS 153 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~s 153 (226)
+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+. .++.++|+||
T Consensus 118 ~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 KNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred HCCEeccccCcceEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 9999999999999999 6778899999998865433221 1223456779999987532 3578999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 154 VGAILFELLN-GYPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 154 lG~~~~~l~~-g~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|++++++++ |..||......+. .....+..+.+++..|+ .+|.+|||+++++.
T Consensus 195 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 9999999996 9999976543221 12246778999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=233.88 Aligned_cols=198 Identities=28% Similarity=0.526 Sum_probs=161.6
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeC--------CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~ 81 (226)
..+.+|+++++.++|+||+++++++.+. ...+++++|+. .+|.+.+... ..+++..+..++.|+++||.+
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~ 130 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999987543 34799999995 5777776643 479999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc------------ccccCCccccCccccccc-CCCcc
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------------EKVCGSPLYMAPEVLQFQ-RYDEK 148 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~~-~~~~~ 148 (226)
||++|++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+. .++.+
T Consensus 131 lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 131 LHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred HHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 999999999999999999 67889999999988655432211 112346779999987643 57889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcccc----------------------------------------cccCCChHHHHH
Q 027233 149 VDMWSVGAILFELLNGYPPFSGRNNVQL----------------------------------------IVPALHPDCVDM 188 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 188 (226)
+|+||+|++++++++|..||.+.+.... .....++++.++
T Consensus 208 ~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDL 287 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHH
Confidence 9999999999999999999865432110 013445789999
Q ss_pred HHHhhccCccccCCHhHHhcCccc
Q 027233 189 CLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 189 i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|.+||+.+|.+|||+.+++.||||
T Consensus 288 i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHcccCcccCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=236.01 Aligned_cols=200 Identities=26% Similarity=0.426 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC------------------------
Q 027233 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------ 61 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------ 61 (226)
....+.+.+|++++.++. ||||+++++.+...+..++|+||+.+++|.+++...+
T Consensus 81 ~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (401)
T cd05107 81 SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTP 160 (401)
T ss_pred hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccc
Confidence 344567889999999997 9999999999999999999999999999999996432
Q ss_pred --------------------------------------------------------------------------CCCHHH
Q 027233 62 --------------------------------------------------------------------------RVPEQT 67 (226)
Q Consensus 62 --------------------------------------------------------------------------~~~~~~ 67 (226)
.++...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 240 (401)
T cd05107 161 LSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMD 240 (401)
T ss_pred ccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHH
Confidence 245667
Q ss_pred HHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccC
Q 027233 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR 144 (226)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~ 144 (226)
+..++.|++.||.|||+.+++|+||+|.||++ +.++.++|+|||++....... ......++..|+|||.+.+..
T Consensus 241 ~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 317 (401)
T cd05107 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL 317 (401)
T ss_pred HHHHHHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC
Confidence 88899999999999999999999999999999 567889999999987653221 112234567799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 145 YDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++.++|+||+|++++++++ |..||......+. .+...+.++.+++.+|++.+|.+||++.++++.
T Consensus 318 ~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 318 YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999998 8889875432211 134568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=223.65 Aligned_cols=197 Identities=19% Similarity=0.357 Sum_probs=160.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
...+.+.+|+..++.++||||+++++.+......+++|||+++++|.+++.+. ...+...+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999754 24567778899999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccc-------cCCCcchhHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-------QRYDEKVDMWS 153 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~s 153 (226)
+.+++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.... ..++.++|+||
T Consensus 117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 9999999999999999 678889999999875432211 1223456778999998742 24577999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCccc----------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 154 VGAILFELLN-GYPPFSGRNNVQ----------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 154 lG~~~~~l~~-g~~p~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|++++++++ |..||...+..+ .....++..+.+++..|+ .+|.+|||++++++
T Consensus 194 lG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 9999999986 567876543211 113457888999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=221.86 Aligned_cols=207 Identities=29% Similarity=0.512 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....-+|+..++.++|||++.+...+.. +..+++++||.+ -+|.+.+.-+ +.++...+.++++||+.|+.|||
T Consensus 71 S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 71 SMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred CHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh
Confidence 3466789999999999999999998877 788999999995 6999888633 46899999999999999999999
Q ss_pred hCCceeeccCCCCeEeee-CCCCccEEEeeeccccccCCCC----ccccccCCccccCccccccc-CCCcchhHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~-~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~ 157 (226)
++-+.||||||.||++.. ....+.+||+|+|+++.+..+- .....+.|.+|.|||.+-+. .|+++.|+|++||+
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCI 229 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCI 229 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHH
Confidence 999999999999999953 2345999999999998876542 22345578899999998765 68999999999999
Q ss_pred HHHHHhCCCCCCCCCcccc----c----------------------------------------------------ccCC
Q 027233 158 LFELLNGYPPFSGRNNVQL----I----------------------------------------------------VPAL 181 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~----~----------------------------------------------------~~~~ 181 (226)
+.|+++.+..|.+....-. . ...-
T Consensus 230 faElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k 309 (438)
T KOG0666|consen 230 FAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVK 309 (438)
T ss_pred HHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCC
Confidence 9999999888876532100 0 1223
Q ss_pred ChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 182 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 182 ~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
++...+++.+||+.||-+|.|++|+|+|+||...+-
T Consensus 310 ~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 310 DPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred CchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 455889999999999999999999999999998743
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=229.16 Aligned_cols=207 Identities=25% Similarity=0.405 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHHhcCC--CC----CeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVN--HP----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~--h~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~ 78 (226)
..-++...-|+++++++. .| -++++.++|.-.+..+||+|.+ |.|+.+|+.++ .+++...+..+++|++++
T Consensus 126 ~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~s 204 (415)
T KOG0671|consen 126 DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLES 204 (415)
T ss_pred HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHH
Confidence 456778888999999992 22 2667777889999999999998 88999999876 479999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeee-----------------CCCCccEEEeeeccccccCCCCccccccCCccccCccccc
Q 027233 79 LEILNSHHIIHRDLKPENILLSG-----------------LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~-----------------~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 141 (226)
+++||+.+++|.||||+||++.+ ...+..++++|||.++...... ...+.|..|.|||.+.
T Consensus 205 v~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViL 282 (415)
T KOG0671|consen 205 VAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVIL 282 (415)
T ss_pred HHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchhee
Confidence 99999999999999999999841 1123458999999998765443 4566789999999999
Q ss_pred ccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------------------------------------
Q 027233 142 FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------------------------------------- 177 (226)
Q Consensus 142 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------------------------------------------- 177 (226)
+-.++...||||+||++.|+++|...|...++.+.+
T Consensus 283 gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~ 362 (415)
T KOG0671|consen 283 GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVF 362 (415)
T ss_pred ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhh
Confidence 999999999999999999999999988776644321
Q ss_pred ------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 178 ------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 178 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.......+.|++++||..||.+|+|+.|+|.||||++..
T Consensus 363 ~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 363 EPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred cCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 111123488999999999999999999999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=225.45 Aligned_cols=197 Identities=26% Similarity=0.436 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|++.++.++|+||+++++++.. ....++++||+++++|.+++.... .+++..+..++.|++.||++||+.
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999999999999998877 557899999999999999998654 689999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|.||++ +.++.++|+|||.+......... ....+...|++||...+..++.++|+||||++++++
T Consensus 129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 99999999999999 67789999999998776532211 112334569999999888889999999999999999
Q ss_pred HhCCCCCCCCCccc--------------------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNNVQ--------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..|+....... ......+.++.+++.+|++.+|.+|||+.|+++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99998876432111 002345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=227.15 Aligned_cols=198 Identities=25% Similarity=0.419 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.....+.+|+.+++.++||||+++++++... ..+++++|+++++|.+++.... .+++..+..++.|++.||.|||++|
T Consensus 51 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 129 (303)
T cd05110 51 KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 3345788999999999999999999988754 4678999999999999988654 6889999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||++++++++
T Consensus 130 ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 130 LVHRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred eeccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 9999999999999 5677899999999976543221 112234567999999988889999999999999999997
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||.+...... .....+.++.+++.+|+..+|.+||++.++++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 207 FGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899876432211 134467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=234.17 Aligned_cols=199 Identities=28% Similarity=0.483 Sum_probs=175.8
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (226)
...+.++.|..|+.++++++||||++++|.+.+.. .+||||.++-|.|..|++.++ .++......++.||+.|++|||
T Consensus 430 ~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 430 CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred CChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence 35667899999999999999999999999998855 789999999999999998765 6899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+..++||||...||++ .....+||+|||+++.......- ........|+|||.+.-..++.++|||.||+|+||+
T Consensus 509 SkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred hhchhhhhhhhhheee---cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 9999999999999999 56778999999999888655332 223345569999999888999999999999999999
Q ss_pred Hh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 162 LN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
+. |..||.+..+.+.+ ++..|+.+..+..+|++.+|.+||++.|+.
T Consensus 586 l~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 87 99999887665554 788899999999999999999999998865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.35 Aligned_cols=216 Identities=29% Similarity=0.453 Sum_probs=179.1
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CC---CCHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GR---VPEQTARKFLQQLG 76 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~---~~~~~~~~~~~~i~ 76 (226)
||.+-.+-.+.+++|+..|+.- +||||+++++.-.+....||..|.| ..+|.+++... .. ...-..+.++.|++
T Consensus 538 VKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~ 616 (903)
T KOG1027|consen 538 VKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIA 616 (903)
T ss_pred HHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHH
Confidence 5666777788899999999999 6999999999999999999999999 68999999874 11 12245678899999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeC--CCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchh
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~--~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~D 150 (226)
.||++||+.+|+||||+|.||+|... ....+++|.|||+++....+.. .....|+.+|.|||.+.....+.+.|
T Consensus 617 ~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avD 696 (903)
T KOG1027|consen 617 SGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVD 696 (903)
T ss_pred HHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccc
Confidence 99999999999999999999999743 2346799999999998865432 34567899999999999888888999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 151 MWSVGAILFELLNG-YPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 151 v~slG~~~~~l~~g-~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
+||+||++|++++| ..||+.....+.. .+....+..++|.+|++++|..||++.++|.||+|=....+
T Consensus 697 iFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 697 IFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred hhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 99999999999985 8999865433211 22222389999999999999999999999999999665443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=228.61 Aligned_cols=199 Identities=30% Similarity=0.496 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcC------------------------
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG------------------------ 61 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------------------ 61 (226)
...+.+.+|+.++.++ +|+||+++++++.. +...++++||+++++|.+++....
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (343)
T cd05103 52 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS 131 (343)
T ss_pred HHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchh
Confidence 3456788999999999 68999999998765 456889999999999999986531
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeE
Q 027233 62 -------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENIL 98 (226)
Q Consensus 62 -------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil 98 (226)
.++...+..++.|++.||+|||++|++|+||+|.||+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 211 (343)
T cd05103 132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNIL 211 (343)
T ss_pred hhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEE
Confidence 2567778899999999999999999999999999999
Q ss_pred eeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 027233 99 LSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174 (226)
Q Consensus 99 i~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~ 174 (226)
+ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||||++++++++ |..||......
T Consensus 212 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 212 L---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred E---cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 9 6788899999999876532211 111224566999999988889999999999999999996 89998764321
Q ss_pred c------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 175 Q------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 175 ~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
. ..+...++++.+++.+|++.+|.+|||+.++++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 289 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 1133467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=210.38 Aligned_cols=214 Identities=26% Similarity=0.451 Sum_probs=178.5
Q ss_pred ChhhhhHHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHH
Q 027233 1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA 77 (226)
Q Consensus 1 ~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~ 77 (226)
|+|.+++-.++.+.+|+++|+.|+ +|||+++++...+. ....+|+||.+..+...... .++...+.-.+.+++.
T Consensus 67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLk 143 (338)
T KOG0668|consen 67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLK 143 (338)
T ss_pred EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHH
Confidence 466777888899999999999995 99999999998764 56889999998877776544 6778889999999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHH
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~ 156 (226)
||.|+|+.||+|||+||.|++++ .....++|+|||++.++.++..-...+.+..|..||.+.. +.++.+.|+|||||
T Consensus 144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 221 (338)
T ss_pred HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence 99999999999999999999995 4566799999999988876654455566777899999864 56888999999999
Q ss_pred HHHHHHhCCCCCC-CCCccccc-----------------------------------------------ccCCChHHHHH
Q 027233 157 ILFELLNGYPPFS-GRNNVQLI-----------------------------------------------VPALHPDCVDM 188 (226)
Q Consensus 157 ~~~~l~~g~~p~~-~~~~~~~~-----------------------------------------------~~~~~~~~~~~ 188 (226)
+++.|+....||- +.++.+.+ ..-.+++..++
T Consensus 222 mlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDl 301 (338)
T KOG0668|consen 222 MLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDL 301 (338)
T ss_pred HHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHH
Confidence 9999999888864 44433332 23346899999
Q ss_pred HHHhhccCccccCCHhHHhcCccccccCccc
Q 027233 189 CLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 219 (226)
Q Consensus 189 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~ 219 (226)
+.++|..|-++|+|+.|++.||||.-.....
T Consensus 302 ldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 302 LDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred HHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 9999999999999999999999998754433
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=221.70 Aligned_cols=208 Identities=32% Similarity=0.531 Sum_probs=189.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.++....-..|-++|+..+||.+..+...|..++++++||||..||.|.-.+...+-+++...+-+...|+.||.|||++
T Consensus 208 akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 208 AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC
Confidence 44555666778899999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+|++||+|.+|.++ +.+++++|.|||+++... .+......+|++.|+|||++....|..+.|-|.+|+++|||++|
T Consensus 288 ~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCG 364 (516)
T KOG0690|consen 288 NIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCG 364 (516)
T ss_pred Ceeeeechhhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhc
Confidence 99999999999999 899999999999997654 45567788999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccccC
Q 027233 165 YPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRNS 216 (226)
Q Consensus 165 ~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 216 (226)
..||...+..... +..++++.+.++..+|.+||.+|. ++.|+.+|+||...-
T Consensus 365 RLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 365 RLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred cCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 9999887654332 888999999999999999999996 589999999999853
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=219.83 Aligned_cols=200 Identities=26% Similarity=0.473 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC------eEEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ 74 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~ 74 (226)
....+.+.+|++++++++||||+++++++.... ..+++++|+.+++|.+++... ..++...+..++.|
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 121 (273)
T cd05074 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121 (273)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence 345667889999999999999999999876432 347889999999999887532 24788899999999
Q ss_pred HHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhH
Q 027233 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (226)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv 151 (226)
++.|++|||++|++|+||+|+||++ +.+..++++|||.+........ .....++..|++||...+..++.++|+
T Consensus 122 i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi 198 (273)
T cd05074 122 IASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV 198 (273)
T ss_pred HHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhh
Confidence 9999999999999999999999999 6788899999999876543221 112234467899999988888999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 152 WSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 152 ~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
||||++++++++ |..||.+.+..+. .....+..+.+++.+|++.+|.+|||+.++++.
T Consensus 199 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 199 WAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999998 8888875543211 134567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.37 Aligned_cols=207 Identities=30% Similarity=0.546 Sum_probs=182.9
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
+++.....|..|=.+|..-+.+=|++++..|.++.++|+||||++||+|-..+.+..++++.+++.++..|+.||..+|+
T Consensus 114 lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 114 LKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh
Confidence 45666778999999998889999999999999999999999999999999999998899999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccc-----cCCCcchhHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAI 157 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~ 157 (226)
.|+|||||||+||++ +..|+++|.|||.+-.+..+... ...+|||.|.|||.+.. +.|++..|=||+|++
T Consensus 194 mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~ 270 (1317)
T KOG0612|consen 194 MGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF 270 (1317)
T ss_pred ccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence 999999999999999 79999999999999888755442 45679999999999852 468899999999999
Q ss_pred HHHHHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCC---HhHHhcCcccccc
Q 027233 158 LFELLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN 215 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~~l~~~~~~~~ 215 (226)
+|||+.|.-||...+-.+.+ ...+|...+++|++.+ -+|..|.. ++++..||||.+-
T Consensus 271 ~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 271 MYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence 99999999999754322221 2558999999999998 56778887 9999999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=218.14 Aligned_cols=199 Identities=33% Similarity=0.493 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..++..+|...+..+.|+||++++.++.-. ...|+|||++ ..+|...+. -.++...+..++.|++.|+++|
T Consensus 58 ~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~l 134 (369)
T KOG0665|consen 58 HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHL 134 (369)
T ss_pred cchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHH
Confidence 345778899999999999999999998643 3589999999 579998877 4678899999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|+.||+||||||+||++ ..+..+|++|||++......-.....+.+..|.|||.+.+..+....||||+||++.||+
T Consensus 135 hs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 135 HSAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI 211 (369)
T ss_pred HhcceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh
Confidence 99999999999999999 788899999999998776653445566788899999999988999999999999999999
Q ss_pred hCCCCCCCCCccccc----------------------------------------------------ccCCChHHHHHHH
Q 027233 163 NGYPPFSGRNNVQLI----------------------------------------------------VPALHPDCVDMCL 190 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~i~ 190 (226)
+|...|.+.+..+.. ...-+...++++.
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS 291 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH
Confidence 999999876543332 1123445889999
Q ss_pred HhhccCccccCCHhHHhcCcccc
Q 027233 191 KLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 191 ~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
+||..+|++|.|++++|+|||++
T Consensus 292 ~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 292 KMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccChhhcccHHHHhcCCeee
Confidence 99999999999999999999997
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=232.27 Aligned_cols=200 Identities=26% Similarity=0.499 Sum_probs=174.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+++|.+|+++|.+|+||||+++++.+..++-+++|+||++.|+|.+|+.++. ...-....+++.||+.|++||.
T Consensus 575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe 654 (807)
T KOG1094|consen 575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE 654 (807)
T ss_pred chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999999873 2345556679999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+.+++|||+.+.|+++ +.+.++||+|||.++.+..+..- ...+...+|+|||.+...+++.++|+|++|+++||
T Consensus 655 s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 655 SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred hhchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 9999999999999999 78999999999999866554332 23345678999999999999999999999999999
Q ss_pred HHh--CCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLN--GYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~--g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++ .+.||...++.+.. +.-.++++.+++-+|++.+..+||+++++..
T Consensus 732 ~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 865 78898876544332 6678899999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=241.38 Aligned_cols=200 Identities=24% Similarity=0.443 Sum_probs=180.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+.++.+|..|+.||-+++||||+++.+......-..||+|||++|+|.+|++++ +++..-++..|++.|+.|++||-+
T Consensus 670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence 3678999999999999999999999999999999999999999999999999876 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cc---cccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
.|++||||...|||+ +.+..+|+.|||+++...++.. .. ...-..+|.|||.+...+++.++||||+|++|||
T Consensus 750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE 826 (996)
T KOG0196|consen 750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 826 (996)
T ss_pred cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence 999999999999999 7899999999999987755431 11 1122467999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++ |+.||..+++.+.+ +.+.|..+.+++..|+++|-.+||.+.||+.
T Consensus 827 VmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 827 VMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 988 99999988876655 6778999999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=238.57 Aligned_cols=108 Identities=34% Similarity=0.648 Sum_probs=100.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
......+..|+.++..++|+||+++++.+...+..|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 45 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g 124 (669)
T cd05610 45 KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG 124 (669)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34457889999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
|+|+||+|+||++ +.++.++|+|||++.
T Consensus 125 IiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 125 IIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999 677889999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=220.84 Aligned_cols=206 Identities=31% Similarity=0.532 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH- 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~- 86 (226)
-.+..-+|.++.+.|+||.||++|+++.- .+..+-|.|||+|.+|.-|++.++-+++.....|+.||+.||.||.+..
T Consensus 510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikp 589 (775)
T KOG1151|consen 510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKP 589 (775)
T ss_pred HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCC
Confidence 34566789999999999999999999975 4678899999999999999999999999999999999999999999874
Q ss_pred -ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCccccccc----CCCcchhHHH
Q 027233 87 -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ----RYDEKVDMWS 153 (226)
Q Consensus 87 -i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~s 153 (226)
|+|-||+|.||++.+.+..+.++|+|||+++.+..... +....|+.+|++||++.-. .++.+.||||
T Consensus 590 PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWS 669 (775)
T KOG1151|consen 590 PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWS 669 (775)
T ss_pred CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEe
Confidence 99999999999998777788999999999988865432 2345689999999997533 4678999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccc----------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQLI----------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+|+++|.++.|..||+.......+ .+.++++.++||++||+....+|.+..|+-.||+|.-
T Consensus 670 vGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 670 VGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 999999999999999875432211 5668999999999999999999999999999999964
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=215.49 Aligned_cols=190 Identities=15% Similarity=0.207 Sum_probs=154.7
Q ss_pred HHHHHHhcCCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 15 CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 15 ~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
.+...+..++|++++++++...... ..+++++++ ..++.+.+......++..+..++.|++.|+.+||+++++||
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3445566778999999998765443 346777877 56787777765567888999999999999999999999999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCCC--------ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
||||+||++ +.++.++|+|||++....... ......++..|+|||...+..++.++||||+|+++++++
T Consensus 151 DiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 151 DIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred CCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999 677889999999987653221 112235888999999999899999999999999999999
Q ss_pred hCCCCCCCCCccc------------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 NGYPPFSGRNNVQ------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~g~~p~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|..||.+..... ......+..+.++++.|++.+|.+||+++++++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999998763211 114456788999999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=226.15 Aligned_cols=203 Identities=27% Similarity=0.479 Sum_probs=175.5
Q ss_pred hhhhhHH--HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHH
Q 027233 2 LKKLNKH--LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGA 77 (226)
Q Consensus 2 ~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~ 77 (226)
||-++++ ..++|..|+.+|+.++|||+|++++.|..+.-.|||+|||..|+|.+|++... -++--.++.++.||..
T Consensus 297 VKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsS 376 (1157)
T KOG4278|consen 297 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISS 376 (1157)
T ss_pred hhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHH
Confidence 3444444 45689999999999999999999999999999999999999999999998764 3566677899999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcccc--ccCCccccCcccccccCCCcchhHHHHH
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
|+.||..++++||||...|+++ ..+..+++.|||+++.+..+..+.. ..-...|.|||.+.-..++.++|||+||
T Consensus 377 aMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFG 453 (1157)
T KOG4278|consen 377 AMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFG 453 (1157)
T ss_pred HHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHH
Confidence 9999999999999999999999 7888999999999998866544322 1234569999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 156 AILFELLN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 156 ~~~~~l~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
+++||+.+ |-.||++-+-.+.+ +.+.++.+.++++.|++.+|.+||++.|+-
T Consensus 454 VLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 454 VLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999998 88999887643332 788999999999999999999999998874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=195.76 Aligned_cols=205 Identities=34% Similarity=0.564 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..-....+|+-+++.++|+|||++++...+++...+|+|+| ..+|..|..+ ++.++.+.+..++.|++.++.++|+++
T Consensus 43 gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn 121 (292)
T KOG0662|consen 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN 121 (292)
T ss_pred CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh
Confidence 34457789999999999999999999999999999999999 5789888875 468999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccC-CCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~~~~l~~- 163 (226)
+.|||++|.|.++ +.++.+++.|||+++-.+-+. .-+..+.+.+|.+|..+.+.. ++...|+||-||++.|+..
T Consensus 122 vlhrdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana 198 (292)
T KOG0662|consen 122 VLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_pred hhhccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence 9999999999999 789999999999998776553 234456788999999987764 7889999999999999988
Q ss_pred CCCCCCCCCccccc---------------------------------------ccCCChHHHHHHHHhhccCccccCCHh
Q 027233 164 GYPPFSGRNNVQLI---------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 164 g~~p~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|...|++.+..+.+ .+.+...-++++.++|.-+|.+|.+++
T Consensus 199 grplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae 278 (292)
T KOG0662|consen 199 GRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE 278 (292)
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence 66667766543332 344556678999999999999999999
Q ss_pred HHhcCccccccC
Q 027233 205 EFYHHRFLRRNS 216 (226)
Q Consensus 205 ~~l~~~~~~~~~ 216 (226)
++++||||.+.+
T Consensus 279 aalqhpyf~d~s 290 (292)
T KOG0662|consen 279 AALQHPYFSDFS 290 (292)
T ss_pred HHhcCccccccC
Confidence 999999998865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=213.18 Aligned_cols=206 Identities=27% Similarity=0.421 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
..+.+++..|.+...+- ++||||++||..-.++..|+-||.+ ..||..+-+ ++..++++.+-.+....+.||.
T Consensus 103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~ 181 (361)
T KOG1006|consen 103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALD 181 (361)
T ss_pred hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHH
Confidence 45556777788776666 7999999999988888899999999 578877653 2346889988899899999999
Q ss_pred HHHh-CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc--cCCCcchhHHHHHHH
Q 027233 81 ILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAI 157 (226)
Q Consensus 81 ~lh~-~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~ 157 (226)
||.+ ..|+|||+||+||++ +..+.+||||||.+..+..+-......|...|+|||.+.. ..++.++|+||||++
T Consensus 182 yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGIT 258 (361)
T KOG1006|consen 182 YLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGIT 258 (361)
T ss_pred HHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcce
Confidence 9985 589999999999999 7889999999999988776666667778899999999853 358899999999999
Q ss_pred HHHHHhCCCCCCCCCccc-cc----------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 158 LFELLNGYPPFSGRNNVQ-LI----------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~-~~----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++|+.+|..||.+.+..- .+ -..++..+..+|.-||-+|-++||.+.+++++||++.+-
T Consensus 259 L~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 259 LYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred EeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999999999998765321 11 234788999999999999999999999999999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.98 Aligned_cols=208 Identities=28% Similarity=0.559 Sum_probs=178.5
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGA 77 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~ 77 (226)
+.+..+++..|.++++.. .|||++.+++++.. ++.+|+|||||.|||..|.+++. ..+.+..+.=|++.++.
T Consensus 55 ~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lr 134 (953)
T KOG0587|consen 55 TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILR 134 (953)
T ss_pred CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHH
Confidence 456677899999999999 79999999998853 46899999999999999999865 46889999999999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccccc-----CCCcchhH
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-----RYDEKVDM 151 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv 151 (226)
|+.+||...++|+|++-.||++ +.++.+||+|||.+...... .......|++.|||||++.+. .++.++|+
T Consensus 135 gl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~ 211 (953)
T KOG0587|consen 135 GLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL 211 (953)
T ss_pred HHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccch
Confidence 9999999999999999999999 89999999999998766432 234456799999999998643 46779999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 152 WSVGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 152 ~slG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||||++..||..|..|+-..-....+ +..-++++.+||..||.+|-.+||+..++|+|||+++.+
T Consensus 212 WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 212 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 99999999999999998665443332 333467899999999999999999999999999999765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=226.86 Aligned_cols=203 Identities=31% Similarity=0.477 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHHhcCC------CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAG 78 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~ 78 (226)
-..+.=..|+++|++|. --|+++++..|...+++|+|+|.+ ..+|.+.+++.+ .+....+..++.|+..|
T Consensus 470 ~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflA 548 (752)
T KOG0670|consen 470 VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLA 548 (752)
T ss_pred HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHH
Confidence 34455678999999994 347999999999999999999988 789999999876 47889999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
|..|...|++|.||+|+|||++ .....++|||||.|...+.+..+.. ..+..|.|||.+.|.+|+...|+||+||++
T Consensus 549 LklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~eneitPY-LVSRFYRaPEIiLG~~yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 549 LKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEITPY-LVSRFYRAPEIILGLPYDYPIDTWSVGCTL 625 (752)
T ss_pred HHHHHhcCeeecccCccceEec--cCcceeeeccCccccccccccccHH-HHHHhccCcceeecCcccCCccceeeceee
Confidence 9999999999999999999995 4577799999999988877665433 246679999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccccc-------------------------------------------------------------
Q 027233 159 FELLNGYPPFSGRNNVQLI------------------------------------------------------------- 177 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~------------------------------------------------------------- 177 (226)
||+++|...|++.++-.++
T Consensus 626 YElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l 705 (752)
T KOG0670|consen 626 YELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSEL 705 (752)
T ss_pred EEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHH
Confidence 9999999999988754433
Q ss_pred --ccCCC-------hHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 178 --VPALH-------PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 178 --~~~~~-------~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.+.++ ..+.+|+.+||..||.+|.|+.|+|.||||+.
T Consensus 706 ~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 706 IAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 11122 34889999999999999999999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=223.95 Aligned_cols=164 Identities=32% Similarity=0.566 Sum_probs=145.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~ 78 (226)
..++..-+|++++++++|+|||++++.-++. ....++||||.||||...+++. ..+++..++.++.++..|
T Consensus 53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~a 132 (732)
T KOG4250|consen 53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSA 132 (732)
T ss_pred chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHH
Confidence 4567888999999999999999999886553 3578999999999999999864 469999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCC-CCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~ 156 (226)
+.+||++||+||||||.||++.... ..-..||+|||.|+....+......+||..|.+||..-. +.++...|.||+|+
T Consensus 133 l~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 133 LRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred HHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 9999999999999999999986433 334479999999999988888888999999999999984 78899999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 027233 157 ILFELLNGYPPFSGR 171 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~ 171 (226)
++|+++||..||-..
T Consensus 213 tlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 213 TLYECATGELPFIPF 227 (732)
T ss_pred HHHHHhccCCCCCcC
Confidence 999999999998644
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=225.78 Aligned_cols=202 Identities=23% Similarity=0.382 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+|.+|+.+|.+|+|+|++++||...+ .-..+|+|.++.|||.+.+.+. ..+....+..++.||+.|+.||..++
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 67899999999999999999999999988 4577999999999999999873 35788899999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcccc----ccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~----~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
++||||-..|+++ .....+||+|||+.+-++.+..... ..-...|+|||.++...++.++|||++|+++|||+
T Consensus 233 lvHRDLAARNlll---asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF 309 (1039)
T KOG0199|consen 233 LVHRDLAARNLLL---ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF 309 (1039)
T ss_pred hhhhhhhhhhhee---cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence 9999999999999 5688899999999988876544332 22345699999999999999999999999999999
Q ss_pred h-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 163 N-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+ |+.||.+.....++ +...+.++.+++++|+..+|.+|||+..|.+.-++.+
T Consensus 310 tyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 310 TYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9 89999887654443 6667899999999999999999999999987666554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=213.26 Aligned_cols=206 Identities=33% Similarity=0.624 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+..+.-..|-++|..- +-|.+++++..|..-+++|+||||+.||+|--.++.-+++.+..+.-++..|+.||-+||++
T Consensus 390 dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k 469 (683)
T KOG0696|consen 390 DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK 469 (683)
T ss_pred cCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC
Confidence 34444555677777666 67889999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
||++|||+.+||++ +.+++++|.|||+++.... ..++...+|++.|+|||.+..++|+.+.|-||+|+++|||+.|
T Consensus 470 gIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaG 546 (683)
T KOG0696|consen 470 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 546 (683)
T ss_pred CeeeeeccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcC
Confidence 99999999999999 7899999999999976654 4566778999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
+.||++.+..+.. +..+|.+..++++..|.+.|.+|.. -.++..||||++-
T Consensus 547 QpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 547 QPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred CCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 9999998765443 7889999999999999999999975 3679999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=214.86 Aligned_cols=205 Identities=31% Similarity=0.582 Sum_probs=176.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+.+...++.|=.||..-+.+-||++|..|.+++.+|+||+|++||++-+++-+.+-|+|...+.++..+..|+.++|.-
T Consensus 669 ~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 669 MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 45566778899999999999999999999999999999999999999999999889999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccC---------CCCcc-------------------------------
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---------PGNYA------------------------------- 125 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~---------~~~~~------------------------------- 125 (226)
|++||||||+|||| +.++++||+|||+++.+. .+...
T Consensus 749 GFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r 825 (1034)
T KOG0608|consen 749 GFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQR 825 (1034)
T ss_pred cceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhh
Confidence 99999999999999 789999999999986441 10000
Q ss_pred ---ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCChHHHHH
Q 027233 126 ---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHPDCVDM 188 (226)
Q Consensus 126 ---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~ 188 (226)
...+|+..|+|||++....++...|-||.|+++++|+.|+.||-..+..+.. ...++.++.++
T Consensus 826 ~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 826 ILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred hhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 0235788899999999999999999999999999999999999765433221 56689999999
Q ss_pred HHHhhccCccccC---CHhHHhcCccccc
Q 027233 189 CLKLLSANTVDRL---SFNEFYHHRFLRR 214 (226)
Q Consensus 189 i~~~l~~~p~~Rp---t~~~~l~~~~~~~ 214 (226)
|.++. -+++.|. .++|+-.||||+.
T Consensus 906 i~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 906 IQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred HHHHh-cChhhhhcccchhhhhcCccccc
Confidence 99876 3556665 5788999999987
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=223.96 Aligned_cols=200 Identities=30% Similarity=0.506 Sum_probs=171.8
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~ 68 (226)
...+++.+..|++++..+ +|+||+.+.+.+...+..++|.||+..|+|.+|++..+ .++...+
T Consensus 341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL 420 (609)
T KOG0200|consen 341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL 420 (609)
T ss_pred CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence 446788999999999999 79999999999999999999999999999999998775 3888999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--cccc--CCccccCcccccccC
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVC--GSPLYMAPEVLQFQR 144 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~--~~~~~~aPE~~~~~~ 144 (226)
..++.||+.|++||++..++||||-..||++ ..+..++++|||+++.......- .... -...|+|||.+....
T Consensus 421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 421 LSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred HHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence 9999999999999999999999999999999 68889999999999865443222 1111 245599999999999
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcc-c-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 145 YDEKVDMWSVGAILFELLN-GYPPFSGRNNV-Q-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~-~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++.++||||+|+++||+++ |..||++.... + ..+...+.++.++++.|++.+|.+||++.++.+
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 9999999999999999998 88999873311 1 114555899999999999999999999998763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=200.76 Aligned_cols=205 Identities=30% Similarity=0.583 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+..+-++.|-.+.++- +||.+|-++..|..+.++++|.||.+||+|--.++...+++++...-+...|+.||.|||++
T Consensus 291 dedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r 370 (593)
T KOG0695|consen 291 DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER 370 (593)
T ss_pred cccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence 34455677788888888 79999999999999999999999999999999999889999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeecccccc-CCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
||+++|||.+|+++ +..+.++|+|+|.++.. .++.+++..+|++.|.|||.+++..|....|-|+||++++||+.|
T Consensus 371 giiyrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmag 447 (593)
T KOG0695|consen 371 GIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 447 (593)
T ss_pred CeeeeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcC
Confidence 99999999999999 78999999999998754 456677889999999999999999999999999999999999999
Q ss_pred CCCCCCC--Cccccc----------------ccCCChHHHHHHHHhhccCccccC------CHhHHhcCccccc
Q 027233 165 YPPFSGR--NNVQLI----------------VPALHPDCVDMCLKLLSANTVDRL------SFNEFYHHRFLRR 214 (226)
Q Consensus 165 ~~p~~~~--~~~~~~----------------~~~~~~~~~~~i~~~l~~~p~~Rp------t~~~~l~~~~~~~ 214 (226)
..||+-. ++.+.. +..+|-....+++.-|++||.+|. .+.++-.|+||+.
T Consensus 448 rspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 448 RSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred CCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 9999732 222211 667777888999999999999995 4789999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=223.52 Aligned_cols=181 Identities=21% Similarity=0.328 Sum_probs=134.6
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeeccCCC
Q 027233 36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95 (226)
Q Consensus 36 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~ 95 (226)
..+...++++||+.+++|.+++..... .....+..++.|++.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 345679999999999999999875421 113346689999999999999999999999999
Q ss_pred CeEeeeCCCCccEEEeeeccccccCCC--CccccccCCccccCccccccc----------------------CCCcchhH
Q 027233 96 NILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ----------------------RYDEKVDM 151 (226)
Q Consensus 96 nili~~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Dv 151 (226)
||+++ ..++.++|+|||++...... .......+++.|+|||.+... .+..+.||
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99994 34578999999999755322 223345678899999965321 12345699
Q ss_pred HHHHHHHHHHHhCCCCCCCCCc------------cc----cccc--------------CCChHHHHHHHHhhccCccccC
Q 027233 152 WSVGAILFELLNGYPPFSGRNN------------VQ----LIVP--------------ALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 152 ~slG~~~~~l~~g~~p~~~~~~------------~~----~~~~--------------~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
||+|+++++|+++..+++.... .. .... ..+...++||++||+.||.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 9999999999987665432100 00 0011 1123456899999999999999
Q ss_pred CHhHHhcCccccccCcc
Q 027233 202 SFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 202 t~~~~l~~~~~~~~~~~ 218 (226)
|+.|+|+||||++....
T Consensus 443 ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 443 SAKAALAHPYFDREGLL 459 (566)
T ss_pred CHHHHhCCcCcCCCCcc
Confidence 99999999999986554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=196.48 Aligned_cols=202 Identities=25% Similarity=0.471 Sum_probs=167.5
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEe--------CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (226)
...+|+++|+.|+|+|++.+++.+.. ....|+|+.+| ..+|.-.+.+. -+++...+..++++++.||.|+
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999999987643 34589999999 46888888765 4789999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccc-cCCCcchhHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~ 156 (226)
|+..|+|||+|+.|+++ +.++.++|.|||+++....... -...+.+.+|.+||.+-+ ..+++..|+|+-||
T Consensus 141 Hr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 141 HRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 99999999999999999 7899999999999965543211 123455889999999865 46899999999999
Q ss_pred HHHHHHhCCCCCCCCCccccc---------------------------------------------ccCCChHHHHHHHH
Q 027233 157 ILFELLNGYPPFSGRNNVQLI---------------------------------------------VPALHPDCVDMCLK 191 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~~---------------------------------------------~~~~~~~~~~~i~~ 191 (226)
++.+|+++...+.+.+....+ +-.-+++..+++.+
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 999999998887766543222 11124578899999
Q ss_pred hhccCccccCCHhHHhcCccccccCc
Q 027233 192 LLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 192 ~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
+|..||.+|+++++++.|.||...+.
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred HhccCcccCcchHhhhchhhhhcCCc
Confidence 99999999999999999999987543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=235.84 Aligned_cols=194 Identities=18% Similarity=0.239 Sum_probs=147.4
Q ss_pred hcCCC-CCeeeeeeEE-------EeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 21 SSVNH-PNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 21 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
+.++| +||+.+++++ ......+.++|++ +++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34456 6888888877 2334577788887 77999999754 4689999999999999999999999999999
Q ss_pred cCCCCeEeee----------------CCCCccEEEeeeccccccCCCC-----------------ccccccCCccccCcc
Q 027233 92 LKPENILLSG----------------LDDDVMLKIADFGLSCTLYPGN-----------------YAEKVCGSPLYMAPE 138 (226)
Q Consensus 92 l~~~nili~~----------------~~~~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE 138 (226)
|||+||++.. .+.+..++++|||+++...... ......+++.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999941 0223456677777665321100 001134677899999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-c-----ccc---cCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-Q-----LIV---PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~-----~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.+.+..++.++|||||||++|||++|..|+...... . ..+ ....+...+++.+||+++|.+|||+.|+++|
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 999899999999999999999999988887543211 0 001 1124567889999999999999999999999
Q ss_pred cccccc
Q 027233 210 RFLRRN 215 (226)
Q Consensus 210 ~~~~~~ 215 (226)
|||...
T Consensus 266 ~~~~~~ 271 (793)
T PLN00181 266 EFINEP 271 (793)
T ss_pred hhhhhh
Confidence 999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=233.98 Aligned_cols=186 Identities=26% Similarity=0.413 Sum_probs=149.9
Q ss_pred HHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceee
Q 027233 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN---SHHIIHR 90 (226)
Q Consensus 14 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~H~ 90 (226)
..|++.+++++||||+++++++.+.+..++||||+++++|.+++. .+++..+..++.|++.|++||| +.+++||
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 456899999999999999999999999999999999999999986 4788999999999999999999 6699999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 170 (226)
|++|+||++ +.+...++. ++....... .....++..|+|||...+..++.++||||+|+++||+++|+.||+.
T Consensus 808 dlkp~Nil~---~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 808 NLSPEKIII---DGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCHHhEEE---CCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 999999999 455555553 443322211 1123567889999999988999999999999999999999999854
Q ss_pred CCcccc----------------------cc------cCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 171 RNNVQL----------------------IV------PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 171 ~~~~~~----------------------~~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
...... .. .....++.+++.+|++.+|.+|||+.|+++.
T Consensus 881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 881 EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 211100 00 0111246789999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=188.68 Aligned_cols=177 Identities=44% Similarity=0.756 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|++.++.++|++++++++++......++++|+++|++|.+++... ..++...+..++.+++.++.+||+.|++
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 114 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 478999999999999999999999999999999999999989999999876 4789999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCC-CccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 027233 89 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+||+|.||++ +. ++.++|+||+.+....... ......+...|.+||..... ..+.+.|+|++|++++++
T Consensus 115 H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---- 187 (215)
T cd00180 115 HRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---- 187 (215)
T ss_pred ccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----
Confidence 99999999999 45 7889999999987665432 12334467789999998776 778999999999999998
Q ss_pred CCCCCCCcccccccCCChHHHHHHHHhhccCccccCCHhHHhcCc
Q 027233 166 PPFSGRNNVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 210 (226)
Q Consensus 166 ~p~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~ 210 (226)
..+.+++.+|++.+|.+||++.++++++
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6899999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=210.34 Aligned_cols=198 Identities=23% Similarity=0.323 Sum_probs=148.3
Q ss_pred HHHHHHHHhcCCCCCe-----eeeeeEEEe--------CCeEEEEEeecCCCCHHHHHHhcC------------------
Q 027233 13 LDCELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG------------------ 61 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~------------------ 61 (226)
...|+.++.+++|.++ +++++++.. .+..++|+||+++++|.+++....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3446777777766544 566666643 356899999999999999886421
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc--cccCCcc
Q 027233 62 ------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL 133 (226)
Q Consensus 62 ------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~ 133 (226)
..+...+..++.|++.+|.++|+.+++|+||+|.||++ +.++.++|+|||++.......... ....++.
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~ 375 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence 23456788899999999999999999999999999999 677889999999986654322211 2234678
Q ss_pred ccCcccccccCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCcc-----------c----
Q 027233 134 YMAPEVLQFQRY----------------------DEKVDMWSVGAILFELLNGYP-PFSGRNNV-----------Q---- 175 (226)
Q Consensus 134 ~~aPE~~~~~~~----------------------~~~~Dv~slG~~~~~l~~g~~-p~~~~~~~-----------~---- 175 (226)
|+|||.+..... ..+.|+||+|+++++|+++.. |+...... .
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 999998753221 124699999999999999875 55421100 0
Q ss_pred --------ccccCCChHHHHHHHHhhccCc---cccCCHhHHhcCcccc
Q 027233 176 --------LIVPALHPDCVDMCLKLLSANT---VDRLSFNEFYHHRFLR 213 (226)
Q Consensus 176 --------~~~~~~~~~~~~~i~~~l~~~p---~~Rpt~~~~l~~~~~~ 213 (226)
......++..++++.+||..+| .+|+|++|+|+||||.
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 0134567889999999999766 6899999999999995
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=220.72 Aligned_cols=168 Identities=32% Similarity=0.562 Sum_probs=134.8
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 40 CIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 40 ~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
..||-||||+..++.+++..+... .....|+++++|++||+|+|+.|++||||||.||++ +.++.|+|+|||+++.
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchh
Confidence 478999999988888888766443 578899999999999999999999999999999999 7899999999999987
Q ss_pred cC------------------C-CCccccccCCccccCccccccc---CCCcchhHHHHHHHHHHHHhCCCCCCCC-Ccc-
Q 027233 119 LY------------------P-GNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGR-NNV- 174 (226)
Q Consensus 119 ~~------------------~-~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~- 174 (226)
.. . .......+||..|+|||...+. .|+.|.|+||||++++||+. ||+.. ...
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~ 823 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS 823 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH
Confidence 21 0 1123456788999999998655 48999999999999999984 23211 000
Q ss_pred -------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 175 -------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 175 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
......--+.-+.+|++|++.||.+|||+.|+|++.||-
T Consensus 824 iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 824 ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 011222334578999999999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=182.46 Aligned_cols=162 Identities=29% Similarity=0.484 Sum_probs=139.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.++.+++.+|+.+.... .+|.+|.+|+.+...+..++.||.+ ..||..|-+ +.+..+|..+-+++..++.|+.+
T Consensus 85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~ 163 (282)
T KOG0984|consen 85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF 163 (282)
T ss_pred hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence 44556677788877666 8999999999988889999999999 679988754 34578999999999999999999
Q ss_pred HHhC-CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc----ccCCCcchhHHHHHH
Q 027233 82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ----FQRYDEKVDMWSVGA 156 (226)
Q Consensus 82 lh~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~Dv~slG~ 156 (226)
||++ .++|||+||+||++ +..+++|+||||.+..+.++-......|...|+|||.+. ...|+.++||||||+
T Consensus 164 L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGI 240 (282)
T KOG0984|consen 164 LHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGI 240 (282)
T ss_pred HHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhh
Confidence 9986 89999999999999 789999999999998776665555566888999999974 347899999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 027233 157 ILFELLNGYPPFSGRN 172 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~ 172 (226)
++.|+.++..||+...
T Consensus 241 tmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 241 TMIEMAILRFPYESWG 256 (282)
T ss_pred hhhhhhhccccccccC
Confidence 9999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=183.82 Aligned_cols=150 Identities=26% Similarity=0.302 Sum_probs=125.5
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcccccc
Q 027233 51 GNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129 (226)
Q Consensus 51 ~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 129 (226)
|+|.+++... .++++..++.++.|++.||.|||+++ ||+||++ +.++.+++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999874 46999999999999999999999998 9999999 67778888 99887654322 25
Q ss_pred CCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------------------ccCCCh--HHHHHH
Q 027233 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------------VPALHP--DCVDMC 189 (226)
Q Consensus 130 ~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------------------~~~~~~--~~~~~i 189 (226)
++..|+|||.+.+..++.++||||+|+++|++++|..||......... ...++. ++++++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 789999999999999999999999999999999999999754322111 111222 699999
Q ss_pred HHhhccCccccCCHhHHhcCcccccc
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.+||+.+|.+|||+.|+++|+|+...
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=194.21 Aligned_cols=208 Identities=27% Similarity=0.409 Sum_probs=163.2
Q ss_pred hHHHHHHHHHHHHHHhcCC--------CCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKF 71 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~ 71 (226)
.++-.+....||++|++++ ..+||++++.|.. +.++++|+|+. |..|..+|... +.++...+.+|
T Consensus 114 AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I 192 (590)
T KOG1290|consen 114 AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEI 192 (590)
T ss_pred hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHH
Confidence 3455678889999999993 2479999999865 45799999999 89999999865 57999999999
Q ss_pred HHHHHHHHHHHHhC-CceeeccCCCCeEeee-------------------------------------------------
Q 027233 72 LQQLGAGLEILNSH-HIIHRDLKPENILLSG------------------------------------------------- 101 (226)
Q Consensus 72 ~~~i~~~l~~lh~~-~i~H~dl~~~nili~~------------------------------------------------- 101 (226)
++|++.||.|||+. ||+|.||||+|||+-.
T Consensus 193 ~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~ 272 (590)
T KOG1290|consen 193 CRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKK 272 (590)
T ss_pred HHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHH
Confidence 99999999999965 9999999999999840
Q ss_pred ----------------------------------------------------------------C---------------
Q 027233 102 ----------------------------------------------------------------L--------------- 102 (226)
Q Consensus 102 ----------------------------------------------------------------~--------------- 102 (226)
.
T Consensus 273 ~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~ 352 (590)
T KOG1290|consen 273 MKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPES 352 (590)
T ss_pred HHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccch
Confidence 0
Q ss_pred -----------------------------------CCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCc
Q 027233 103 -----------------------------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 103 -----------------------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
....++||.|||.|++....-+ ....|.-|.|||++-+..|+.
T Consensus 353 ~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT--~DIQTRQYRapEVllGsgY~~ 430 (590)
T KOG1290|consen 353 QLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFT--EDIQTRQYRAPEVLLGSGYST 430 (590)
T ss_pred hcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhc--hhhhhhhccCcceeecCCCCC
Confidence 0011255566666555432221 223466799999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCccccc--------------------------------------------------
Q 027233 148 KVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------------------------------------------- 177 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------------------------------------------------- 177 (226)
.+|+||++|+++||+||...|+..+....-
T Consensus 431 ~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~ 510 (590)
T KOG1290|consen 431 SADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYE 510 (590)
T ss_pred chhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHH
Confidence 999999999999999999888654322110
Q ss_pred --------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 178 --------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 178 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
...-..++.+|+.-||+.+|.+|||+.++|+||||....
T Consensus 511 VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 511 VLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred HHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence 222345688999999999999999999999999999643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=209.69 Aligned_cols=197 Identities=26% Similarity=0.430 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+...++.+|+.+|.+++|||++++++++.... .-||++|+++|+|.+|++.++ ++.....+.|..||++|+.|||++
T Consensus 739 ~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q 817 (1177)
T KOG1025|consen 739 PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ 817 (1177)
T ss_pred chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc
Confidence 445678999999999999999999999998765 779999999999999998764 788899999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc---cccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+++||||-..|||+ ..-..+++.|||+++......... .....+.|+|-|.+....++.++||||+|+++||++
T Consensus 818 rlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElm 894 (1177)
T KOG1025|consen 818 RLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELM 894 (1177)
T ss_pred chhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHH
Confidence 99999999999999 678889999999998886654332 223345689999999999999999999999999999
Q ss_pred h-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 163 N-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
| |..|+.+....++. ++..+.++..++.+||-.|+..||++.++-
T Consensus 895 TFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 895 TFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred hcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 9 99999887654433 667788999999999999999999998865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=193.33 Aligned_cols=199 Identities=28% Similarity=0.426 Sum_probs=161.2
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC--CCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i 75 (226)
||.+..+.++.+.+|-++++.. +|+||+++++.-.-.. .+++|++|-+.|+|.+|++.+ ..++....+++..+
T Consensus 238 VKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~Sm 316 (534)
T KOG3653|consen 238 VKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESM 316 (534)
T ss_pred EEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHH
Confidence 6888999999999999999887 7999999998875444 799999999999999999865 88999999999999
Q ss_pred HHHHHHHHhC---------CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCccccccc
Q 027233 76 GAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQ 143 (226)
Q Consensus 76 ~~~l~~lh~~---------~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~ 143 (226)
+.||+|||+. .|+|||||..||++ .++.+.-|+|||++..+... ......+||.+|||||++.+.
T Consensus 317 arGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 317 ARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred HHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 9999999962 49999999999999 68999999999999877643 233457899999999998654
Q ss_pred C-C-----CcchhHHHHHHHHHHHHhCCCCCC-CC-Cccc--------------cc---------cc---------CCCh
Q 027233 144 R-Y-----DEKVDMWSVGAILFELLNGYPPFS-GR-NNVQ--------------LI---------VP---------ALHP 183 (226)
Q Consensus 144 ~-~-----~~~~Dv~slG~~~~~l~~g~~p~~-~~-~~~~--------------~~---------~~---------~~~~ 183 (226)
- + -.+.||||+|.++||+++.-.-.. +. ...+ .+ .+ ....
T Consensus 394 inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~ 473 (534)
T KOG3653|consen 394 INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMA 473 (534)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHH
Confidence 2 1 247999999999999988533221 10 0000 00 11 1234
Q ss_pred HHHHHHHHhhccCccccCCHh
Q 027233 184 DCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 184 ~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
.+.+.+..|+..|+..|.|+.
T Consensus 474 ~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 474 VLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHHHHHcCCchhhhhhhH
Confidence 588999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=189.32 Aligned_cols=203 Identities=26% Similarity=0.392 Sum_probs=166.2
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.-.++.+|+++|..+ .+.||+++.+.+..++...+|+||++..+..++.. .++...+..+++.++.||+++|.+||
T Consensus 77 ~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GI 153 (418)
T KOG1167|consen 77 SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGI 153 (418)
T ss_pred CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCc
Confidence 446789999999999 69999999999999999999999999999999877 56688999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC--------------Cc-----------------------------
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------NY----------------------------- 124 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~--------------~~----------------------------- 124 (226)
+||||||.|++++ ...+...|.|||++...... ..
T Consensus 154 vHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~ 231 (418)
T KOG1167|consen 154 VHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRP 231 (418)
T ss_pred cccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcc
Confidence 9999999999996 45677899999998722100 00
Q ss_pred --cccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCC-ccccc-----------------------
Q 027233 125 --AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGRN-NVQLI----------------------- 177 (226)
Q Consensus 125 --~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~----------------------- 177 (226)
.....|+++|.|||++.. ...+++.|+||.|++++.++++..||-... ..+.+
T Consensus 232 ~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~ 311 (418)
T KOG1167|consen 232 SERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRIL 311 (418)
T ss_pred ceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCcee
Confidence 012347889999999854 456789999999999999999998874221 10000
Q ss_pred --------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 178 --------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 178 --------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
...++..+.+++.+||+.||.+|.|++++|+||||.+..
T Consensus 312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 122345789999999999999999999999999999753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=183.49 Aligned_cols=200 Identities=24% Similarity=0.392 Sum_probs=169.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLG 76 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~ 76 (226)
.+-+...+..|.-.+..+.|||++...+...+ ....+.++.+..-++|..|+... ..++..++..++.|++
T Consensus 327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence 34456678888888999999999999998754 56788999999899999999832 1255667778999999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHH
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
.|+++||++|++|.||...|.++ ++..+++|+|=.+++...+.... ........|+++|.+.+..++.++|+||
T Consensus 407 ~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 407 MAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred HHHHHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 99999999999999999999999 67899999999988877654332 2333566799999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 154 VGAILFELLN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 154 lG~~~~~l~~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
||+++||+++ |+.|+..-+..+.. +...|.++..++.-|++..|++||+++|+..
T Consensus 484 fGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999998 89998877655443 7778999999999999999999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-30 Score=188.65 Aligned_cols=204 Identities=31% Similarity=0.495 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+.+|+++|..++|.|++...+...-.. .+|.++|.+ ..+|...+-+...++...+.-+++||+.||+|||
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH 173 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH 173 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh
Confidence 5567889999999999999999988765432 367788888 4688888777778999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCccccccc-CCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~ 160 (226)
+.+|.||||||.|.++ +.+-.+||||||+++....... ....+.+..|.|||.+++. .|+.+.||||+||++.|
T Consensus 174 sA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 174 TANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred hcchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 9999999999999999 7888899999999977654322 2334567789999999876 58999999999999999
Q ss_pred HHhCCCCCCCCCccccc--------------------------------------------ccCCChHHHHHHHHhhccC
Q 027233 161 LLNGYPPFSGRNNVQLI--------------------------------------------VPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~--------------------------------------------~~~~~~~~~~~i~~~l~~~ 196 (226)
++.....|......+.+ +..-..+...++.+|+.++
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 99888877655433222 1222345778999999999
Q ss_pred ccccCCHhHHhcCccccccC
Q 027233 197 TVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|.+|.+.++.+.|+++.+..
T Consensus 331 ~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 331 PDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred CcccccHhhhcccccccccc
Confidence 99999999999999987753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=185.65 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=161.1
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC--CCCCeeeeeeEEEeC----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i 75 (226)
||.+.....+...+|.+++++. +|+||+.+++.-..+ .+.++|++|-+.|||.||++. ..++.+...+++..+
T Consensus 239 VKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~ 317 (513)
T KOG2052|consen 239 VKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSI 317 (513)
T ss_pred EEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHH
Confidence 5777888889999999999998 999999999876533 469999999999999999997 589999999999999
Q ss_pred HHHHHHHHh-----C---CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-----ccccccCCccccCcccccc
Q 027233 76 GAGLEILNS-----H---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 76 ~~~l~~lh~-----~---~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~ 142 (226)
+.||++||. + .|.|||||+.||++ .+++.+-|.|+|+|....... .....+||.+|||||.+..
T Consensus 318 AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 318 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred hhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 999999995 2 39999999999999 789999999999997765432 2345679999999999864
Q ss_pred c------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCccccc-------------ccCCC---------hH
Q 027233 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSGRNNVQLI-------------VPALH---------PD 184 (226)
Q Consensus 143 ~------~~~~~~Dv~slG~~~~~l~~g----------~~p~~~~~~~~~~-------------~~~~~---------~~ 184 (226)
. ..-..+||||||.++||++.. +.||......+.. .+.++ ..
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~ 474 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRV 474 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHH
Confidence 3 223479999999999999752 4455433211110 11111 23
Q ss_pred HHHHHHHhhccCccccCCHhHHh
Q 027233 185 CVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
+..+++.|+..+|..|.|+-.+-
T Consensus 475 m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 475 MAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHHHHhhcCCchhhhHHHHHH
Confidence 77889999999999999976553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=200.53 Aligned_cols=207 Identities=27% Similarity=0.469 Sum_probs=175.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+..+-++.|+-+++.++|+||+.+++.+......++.||||.||+|.+.-.-.+++++.++.-+.+..+.+++|||+.
T Consensus 52 p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~ 131 (829)
T KOG0576|consen 52 PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ 131 (829)
T ss_pred CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC
Confidence 33455677889999999999999999999999999999999999999999877778999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccc---cccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~---~~~~~~~~~Dv~slG~~~~~l 161 (226)
|-+|||||-.||++ ++.+.+++.|||.+..+... .......|++.|+|||+. +...|....|+|++|++..|+
T Consensus 132 gk~hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 132 GKIHRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred Ccccccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 99999999999999 78999999999988666543 234567799999999986 345688999999999999999
Q ss_pred HhCCCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 162 LNGYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
...+.|-...-..... ...-++-+.+|++.+|-++|++|||++.+|.|||..-.
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 8777663222111111 33446779999999999999999999999999998653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=171.01 Aligned_cols=159 Identities=45% Similarity=0.799 Sum_probs=142.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++.++.++|+|++++++++......++++|++++++|.+++..... +++..+..++.+++.++.+||+.++
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 577999999999999999999999999988999999999999999999987766 8999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccc-cccCCCcchhHHHHHHHHHHHHhC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+|+|+++.||++ +.++.++|+|||.+....... ......+...|++||.. ....++.++|+|++|++++++++|
T Consensus 120 ~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 120 VHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred ecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999 567899999999987765543 33344567789999998 666778899999999999999999
Q ss_pred CCCCCC
Q 027233 165 YPPFSG 170 (226)
Q Consensus 165 ~~p~~~ 170 (226)
..||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=190.34 Aligned_cols=154 Identities=31% Similarity=0.609 Sum_probs=138.4
Q ss_pred HHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 13 LDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFC-AGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 13 ~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
+-.|+++|..++ |+||++++++|++++.+|++||.- +|.+|++++.-+..+++....-+++|++.|+++||+.||+
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~iv 692 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIV 692 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCce
Confidence 456999999996 999999999999999999999954 5689999999999999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|||||-+|+.+ +.++.++|+|||.+.....++ .....|+..|.|||.+.+.+| ....|||+||+++|.++..+.|
T Consensus 693 hrdikdenviv---d~~g~~klidfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 693 HRDIKDENVIV---DSNGFVKLIDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred ecccccccEEE---ecCCeEEEeeccchhhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 99999999999 789999999999987665444 456679999999999998876 4678999999999999988888
Q ss_pred CCC
Q 027233 168 FSG 170 (226)
Q Consensus 168 ~~~ 170 (226)
|..
T Consensus 769 yyn 771 (772)
T KOG1152|consen 769 YYN 771 (772)
T ss_pred CcC
Confidence 753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-27 Score=196.69 Aligned_cols=199 Identities=30% Similarity=0.501 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecc
Q 027233 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (226)
+..|+-+-..+.|+|++.......+.....-.||||++ +|.+++...+.+....+..+++|++.|+.|+|+.|+.|+|+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 66677777888999998888777666555555999998 99999998778999999999999999999999999999999
Q ss_pred CCCCeEeeeCCCCccEEEeeeccccccCCC-----CccccccCCccccCcccccccCCCc-chhHHHHHHHHHHHHhCCC
Q 027233 93 KPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQRYDE-KVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 93 ~~~nili~~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~~~~~l~~g~~ 166 (226)
|++|+++ +.++.++++|||.+.....+ .......|+..|+|||.+.+..+.+ ..||||.|+++..|.+|+.
T Consensus 447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 9999999 68889999999988655432 2234567889999999999998886 6999999999999999999
Q ss_pred CCCCCCcccc-------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNVQL-------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||......+. +...++...+.+|.+||+.+|.+|.|+++|++.+|++.-
T Consensus 524 ~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 524 PWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 9976543322 156678889999999999999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=168.76 Aligned_cols=202 Identities=25% Similarity=0.391 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeee-EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.++|.+|...=-.| -|.||+.-|+ .|...+.+++++||++.|+|.+-+.. ..+.+.....++.|++.|+.|+|++++
T Consensus 64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknl 142 (378)
T KOG1345|consen 64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNL 142 (378)
T ss_pred HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccch
Confidence 45677888776677 4999998876 46777889999999999999986664 367788999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc---c--CCCcchhHHHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---Q--RYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~--~~~~~~Dv~slG~~~~~l~ 162 (226)
+|||||.+||++-..+. .+++|||||.+...+.-. ...-....|.+||.... . ...+.+|+|+||++++.++
T Consensus 143 VHRdlK~eNiLif~~df-~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl 219 (378)
T KOG1345|consen 143 VHRDLKAENILIFDADF-YRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL 219 (378)
T ss_pred hhcccccceEEEecCCc-cEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence 99999999999975333 389999999987654321 12223456888887532 1 2457899999999999999
Q ss_pred hCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCcccc---CCHhHHhcCcccccc
Q 027233 163 NGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDR---LSFNEFYHHRFLRRN 215 (226)
Q Consensus 163 ~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~R---pt~~~~l~~~~~~~~ 215 (226)
+|..||......+. ....+++.+..+.++-|.+++++| -++.......|....
T Consensus 220 tG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 220 TGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred cCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 99999974322211 155678889999999999999999 566667777776553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-20 Score=148.08 Aligned_cols=204 Identities=41% Similarity=0.649 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHhcCCCC-CeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.+.+|+..++.+.|+ +|+++.+.+...+..+++++++.++++.+++.... .++......++.|++.++.++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 577899999999999887 79999999987777899999999999998887765 79999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCc-cEEEeeeccccccCCCC-------ccccccCCccccCcccccc---cCCCcchhHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWS 153 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~-~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~s 153 (226)
.|++|+|++|+||++ +..+ .++++|||.+....... ......++..|.+||...+ ...+...|+|+
T Consensus 120 ~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 KGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred CCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 999999999999999 5555 79999999987554432 2355678899999999987 57889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcc----ccc-------cc----CCC--------hHHHHHHHHhhccCccccCCHhHHhcCc
Q 027233 154 VGAILFELLNGYPPFSGRNNV----QLI-------VP----ALH--------PDCVDMCLKLLSANTVDRLSFNEFYHHR 210 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~----~~~-------~~----~~~--------~~~~~~i~~~l~~~p~~Rpt~~~~l~~~ 210 (226)
+|+++++++.|..||...... ... .. ... ..+.+++.+++..+|..|.+..+...++
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~ 276 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhch
Confidence 999999999999997766531 110 10 111 4789999999999999999999999887
Q ss_pred ccccc
Q 027233 211 FLRRN 215 (226)
Q Consensus 211 ~~~~~ 215 (226)
+....
T Consensus 277 ~~~~~ 281 (384)
T COG0515 277 LLAHL 281 (384)
T ss_pred HhhCc
Confidence 66654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-21 Score=151.21 Aligned_cols=197 Identities=23% Similarity=0.278 Sum_probs=159.6
Q ss_pred HHHHHHHHHhcCC----CCCeeeeeeEE-EeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 12 CLDCELNFLSSVN----HPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 12 ~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+..|..++..+. .+++..+++.+ ..++.-++||+.+ |.+|.++.... +.++..++..++.|++.+|.++|+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 6788999999986 36899999999 5778899999988 99999987554 479999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCC--CCccEEEeeecccc--ccCCCC--------c-cccccCCccccCcccccccCCCcchhH
Q 027233 85 HHIIHRDLKPENILLSGLD--DDVMLKIADFGLSC--TLYPGN--------Y-AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~--~~~~~~l~df~~~~--~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv 151 (226)
.|++||||||.|+.++... ....+.|.|||+++ ...... . .....|+..|+|+....+...+.+.|+
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 9999999999999996322 12569999999998 321111 1 123448899999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 152 WSVGAILFELLNGYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 152 ~slG~~~~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
||+++++.++..|..||.+....... ....+.++.++...+-+.+..++|.+..+...
T Consensus 221 es~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 221 ESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 99999999999999999765532111 12345678888888888899999999887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=144.76 Aligned_cols=196 Identities=18% Similarity=0.278 Sum_probs=162.6
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+++.|.+.++.| ..++|+..|.|..++.+-.+|+|.. |.||+|+..-.+ .|+..++..++.|++.-++++|++.
T Consensus 66 ~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~ 144 (449)
T KOG1165|consen 66 EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD 144 (449)
T ss_pred CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence 456889999999999 7999999999988888888999999 999999988664 7999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCC--CCccEEEeeeccccccCCCCcc--------ccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 87 IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 87 i~H~dl~~~nili~~~~--~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
+++|||||+|+||+... ....+.++|||+++.+.++.+. ....|+.+||+--.-.+...+.+.|+=|||.
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 99999999999997432 3455899999999998776543 2356888899988888888899999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 157 ILFELLNGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
++++.+-|..||.+...... +-..+|.++...++-.=+.+-.+-|+++-
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred hhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 99999999999988654322 14556777777777666666666666543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=173.46 Aligned_cols=193 Identities=20% Similarity=0.272 Sum_probs=150.0
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (226)
+...|++ ....++||.+++......++..|+|-+|. ..+|.|-+..+.-+..-+.+.++.|++.|+..+|+.||+|||
T Consensus 68 qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGD 145 (1431)
T KOG1240|consen 68 QRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGD 145 (1431)
T ss_pred HHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 3344444 45558999999999888888889999999 569999887766677778889999999999999999999999
Q ss_pred cCCCCeEeeeCCCCccEEEeeeccccccCCC--Cccc------cccCCccccCccccccc----------C-CCcchhHH
Q 027233 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAE------KVCGSPLYMAPEVLQFQ----------R-YDEKVDMW 152 (226)
Q Consensus 92 l~~~nili~~~~~~~~~~l~df~~~~~~~~~--~~~~------~~~~~~~~~aPE~~~~~----------~-~~~~~Dv~ 152 (226)
||.+||++ +.-+++.|+||...+...-+ ++.. .......|.|||++... + .+++-|||
T Consensus 146 IKsENILi---TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIF 222 (1431)
T KOG1240|consen 146 IKSENILI---TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIF 222 (1431)
T ss_pred cccceEEE---eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhh
Confidence 99999999 78999999999877543322 1111 11234569999987531 2 57899999
Q ss_pred HHHHHHHHHHh-CCCCCCC--------C--Ccccc-cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 153 SVGAILFELLN-GYPPFSG--------R--NNVQL-IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 153 slG~~~~~l~~-g~~p~~~--------~--~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|+||+++|+++ |..+|.- . ...+. +...-+..++.+|..|++.||.+|.++++.|+.
T Consensus 223 S~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 223 SAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 99999999988 6777742 1 11111 233345689999999999999999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=144.39 Aligned_cols=179 Identities=30% Similarity=0.446 Sum_probs=137.7
Q ss_pred CCCCeeeeeeEEEe---------------------------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 027233 24 NHPNIIRLFDAFQA---------------------------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76 (226)
Q Consensus 24 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~ 76 (226)
+||||+.+..+|.+ ....|+||... ..+|..|+-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999977622 24588999888 57999999865 445566677899999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeee-CCCCccEEEeeeccccccCC-------CCccccccCCccccCcccccccCC---
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYP-------GNYAEKVCGSPLYMAPEVLQFQRY--- 145 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~-~~~~~~~~l~df~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~--- 145 (226)
+|+.+||.+|+.|||+|.+||++.- .+.-.++.+.|||.+---.. ....-...|+-..+|||.....+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999952 23455689999997632211 111223446777899998753321
Q ss_pred ---CcchhHHHHHHHHHHHHhCCCCCCCCC------------cccccccCCChHHHHHHHHhhccCccccCCHh
Q 027233 146 ---DEKVDMWSVGAILFELLNGYPPFSGRN------------NVQLIVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 146 ---~~~~Dv~slG~~~~~l~~g~~p~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
-.++|.|+.|.+.||++....||.+.. ....++..+++.+++++..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 248999999999999999999987632 22334788999999999999999999999854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=152.48 Aligned_cols=186 Identities=25% Similarity=0.393 Sum_probs=151.5
Q ss_pred HhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-eeeccCCCCe
Q 027233 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI-IHRDLKPENI 97 (226)
Q Consensus 20 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i-~H~dl~~~ni 97 (226)
|+.+.|.|+.++++...+.+..++|.+||..|+|.|.+... -+++......++++|+.|+.|+|...+ .||.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46789999999999999999999999999999999999874 478888899999999999999998765 9999999999
Q ss_pred EeeeCCCCccEEEeeeccccccCC---CCccccccCCccccCccccccc-------CCCcchhHHHHHHHHHHHHhCCCC
Q 027233 98 LLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 98 li~~~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
++ +....+|++|||+...... ............|.|||.++.. ..+.+.|+||+|++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 6888899999998866532 1111122245569999998753 256789999999999999999999
Q ss_pred CCCCCcccc---------------c------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 168 FSGRNNVQL---------------I------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 168 ~~~~~~~~~---------------~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|+....... . .....+++..+++.|+..+|.+||+++++..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 976322111 0 1134557999999999999999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=141.39 Aligned_cols=193 Identities=22% Similarity=0.373 Sum_probs=155.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....++|.+|.-.|+-+.||||+.+++.+.+.....++..|++.+||.+.+..... .+..+..+++.+++.+++|||
T Consensus 227 t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 227 TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh
Confidence 445567889999999989999999999999999999999999999999998876533 567788899999999999999
Q ss_pred hCC--ceeeccCCCCeEeeeCCCCcc--EEEeeeccccccCCCCccccccCCccccCcccccccCCC---cchhHHHHHH
Q 027233 84 SHH--IIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD---EKVDMWSVGA 156 (226)
Q Consensus 84 ~~~--i~H~dl~~~nili~~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Dv~slG~ 156 (226)
+.. |--..++...+++ +++.+ +.+.|--++. ........+.|++||.+..++.+ .+.|+|||++
T Consensus 307 slep~ipr~~lns~hvmi---dedltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfai 377 (448)
T KOG0195|consen 307 SLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI 377 (448)
T ss_pred hcchhhhhhhcccceEEe---cchhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence 875 4445688999999 45444 4444432221 11233457789999999776544 4799999999
Q ss_pred HHHHHHhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 157 ILFELLNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
++||+.+.+.||......+. ++++++..+..+++-|++.||.+||.++.++
T Consensus 378 llwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 378 LLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999987655432 2888999999999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=159.16 Aligned_cols=195 Identities=30% Similarity=0.476 Sum_probs=171.3
Q ss_pred HHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 12 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
.-..|-.++..++ ||.++++...+..++..+++.++..|+.|...+.+...+++.........++-++..+|+.|++|+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr 121 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR 121 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence 4556778888885 999999999999999999999999999999988887888999999999999999999999999999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 170 (226)
|+|++||++ +.+|.+++.|||.++..-..... +|+..|+|||... ....+.|-||+|++++++++|..||.+
T Consensus 122 d~k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 122 DYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999999 78999999999999776554433 7899999999987 557799999999999999999999988
Q ss_pred CCc------ccccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCccccc
Q 027233 171 RNN------VQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 214 (226)
Q Consensus 171 ~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~ 214 (226)
... .-..+...+...++++..++..+|.+|.- +.|+.+|+||+.
T Consensus 194 ~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 194 DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 211 12226778889999999999999999964 589999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=133.67 Aligned_cols=193 Identities=18% Similarity=0.200 Sum_probs=156.9
Q ss_pred HHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 11 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.++..|.++++.|+ ..+|+.+..+..+...-.+||+.. |.||++..+-. ..++..+++-++-|++.-++|+|.++++
T Consensus 55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fi 133 (341)
T KOG1163|consen 55 PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFI 133 (341)
T ss_pred cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccc
Confidence 46788999999995 678999999999999999999999 99999988754 5799999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--------ccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
||||||+|++++-......+.++|||+++.+....+. ....||.+|.|--...+...+.+.|+-|+|+++.+
T Consensus 134 HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmY 213 (341)
T KOG1163|consen 134 HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMY 213 (341)
T ss_pred cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeee
Confidence 9999999999965455677999999999887654322 23457788888777777778899999999999999
Q ss_pred HHhCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHh
Q 027233 161 LLNGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
.-.|..||.+..+... +-.++|.++.-.+..|-..--.+-|+..
T Consensus 214 fnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 214 FNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred eecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 9999999987643211 1556777777777777665555556643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=142.89 Aligned_cols=154 Identities=23% Similarity=0.274 Sum_probs=105.9
Q ss_pred EEEEEeecCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeee
Q 027233 41 IFLVVEFCAGGNLSSYIRL---HGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113 (226)
Q Consensus 41 ~~lv~e~~~~~~L~~~~~~---~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df 113 (226)
.+++|+-+ .++|.+++.. ... ........+..|+++.+++||..|++|+||+|+|+++ +.++.+.|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcCh
Confidence 36778877 5788888652 222 2233334555789999999999999999999999999 78999999999
Q ss_pred ccccccCCCCccccccCCccccCcccccc--------cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------cc
Q 027233 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------VP 179 (226)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~ 179 (226)
+.....+..... ...+..|.|||.... ..++.+.|.|+||+++|.++++..||+........ -.
T Consensus 190 ~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~f~~C~ 267 (288)
T PF14531_consen 190 SSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWDFSRCR 267 (288)
T ss_dssp GGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGGGTTSS
T ss_pred HHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccccchhcC
Confidence 988776543332 234567899997643 25788999999999999999999999865322111 22
Q ss_pred CCChHHHHHHHHhhccCcccc
Q 027233 180 ALHPDCVDMCLKLLSANTVDR 200 (226)
Q Consensus 180 ~~~~~~~~~i~~~l~~~p~~R 200 (226)
.+|..++++|+++|+.+|.+|
T Consensus 268 ~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 268 DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---HHHHHHHHHHT-SSGGGS
T ss_pred CcCHHHHHHHHHHccCCcccC
Confidence 789999999999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7e-21 Score=152.57 Aligned_cols=167 Identities=31% Similarity=0.518 Sum_probs=131.8
Q ss_pred eEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccc
Q 027233 40 CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (226)
Q Consensus 40 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~ 116 (226)
..||.|++|...+|.+|+.... .-+......++.|+..++.| +|.+|+|++|.||+. ..+..++|+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhhe
Confidence 5889999999999999997543 35677888999999999999 999999999999999 56778999999998
Q ss_pred cccCCCC-------ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcc-cccccCCC-----
Q 027233 117 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY-PPFSGRNNV-QLIVPALH----- 182 (226)
Q Consensus 117 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~-~p~~~~~~~-~~~~~~~~----- 182 (226)
....... ......++..|++||.+.+..++.+.|||+||.+++|++.-. ..+...... +.....+|
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhh
Confidence 8776554 344567999999999999999999999999999999998722 222211111 11111122
Q ss_pred --hHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 183 --PDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 183 --~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
+.-.+|+.+|+.+.|.+||++.+.--|.|+
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 234689999999999999987777667665
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.6e-20 Score=139.20 Aligned_cols=201 Identities=16% Similarity=0.195 Sum_probs=148.8
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..+.-+..+-++.|.|||+++.++.+. ....+++||+..+++.+|+++. ..+......+|+.||+.||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 333445556677899999999998653 4588999999999999999864 3578889999999999999999
Q ss_pred HhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccCCCcchhHHHHH
Q 027233 83 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 83 h~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
|+.. ++|++++.+.|++ +.++-++++.-........-.. .....+.++|.+||.-.....+-++|||++|
T Consensus 193 hs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 193 HSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred hccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 9875 9999999999999 6777777764332211111000 1122356789999987767777899999999
Q ss_pred HHHHHHHhCCCCCCCCCccccc--------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 156 AILFELLNGYPPFSGRNNVQLI--------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 156 ~~~~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+++.+|.-++.--......... ......--++++.+|++.+|+.||++.+++.||-+-+.
T Consensus 270 mcAlemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HHHHHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 9999998877643322211111 22223345678999999999999999999999987653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=137.94 Aligned_cols=120 Identities=22% Similarity=0.230 Sum_probs=93.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeee-eeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIR-LFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..++.+.+|++++++++|+|+++ +++ .+..|++|||++|++|... . +.. ...++.+++.+|.+||++|
T Consensus 63 ~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g 131 (365)
T PRK09188 63 LARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG 131 (365)
T ss_pred HHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC
Confidence 35677999999999999999985 443 2458999999999999732 1 111 2467899999999999999
Q ss_pred ceeecc-CCCCeEeeeCCCCccEEEeeeccccccCCCCcc---------ccccCCccccCccccc
Q 027233 87 IIHRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------EKVCGSPLYMAPEVLQ 141 (226)
Q Consensus 87 i~H~dl-~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~~aPE~~~ 141 (226)
++|||| ||+||++ +.++.++|+|||++......... ....++..|.+||.+.
T Consensus 132 IiHrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 132 ITHNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CeeCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999999 9999999 56778999999999866543221 1234566788999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-19 Score=132.39 Aligned_cols=127 Identities=16% Similarity=0.239 Sum_probs=98.0
Q ss_pred HHHHHHHHhcCCCCCeeeeeeEEEeC--------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
+.+|++.+.++.|++|..+.+++... +..+++|||++|.+|.++.. .++ ....++..++..+|+
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~ 153 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ 153 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH
Confidence 68999999999999999999886643 35889999999999988732 233 346699999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
.|++|||++|.||++ +.++ ++++|||............. ......+..++|+||||+++....
T Consensus 154 ~gi~H~Dikp~Nili---~~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 154 HGMVSGDPHKGNFIV---SKNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cCCccCCCChHHEEE---eCCC-EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence 999999999999999 4555 99999998755432211111 222334557899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=122.56 Aligned_cols=147 Identities=18% Similarity=0.148 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
...+++|+++|++| .++++++++++ +..+++|+|+.|.+|.+.... ....++.|++.++.++|++|++
T Consensus 45 ~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIv 113 (218)
T PRK12274 45 WWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVA 113 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCc
Confidence 34688999999999 46889999885 446899999999999754321 1235778999999999999999
Q ss_pred eecc-CCCCeEeeeCCCCccEEEeeeccccccCCCCcc--------------ccccCCccccCcccccc-cCCC-cchhH
Q 027233 89 HRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQF-QRYD-EKVDM 151 (226)
Q Consensus 89 H~dl-~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--------------~~~~~~~~~~aPE~~~~-~~~~-~~~Dv 151 (226)
|+|| +|.||++ +.++.++|+|||++......... .....++.+++|+...- ...+ .+.+-
T Consensus 114 HrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w 190 (218)
T PRK12274 114 HNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW 190 (218)
T ss_pred cCCCCCcceEEE---cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence 9999 7999999 56778999999999855443321 01123455666654432 2333 67888
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 027233 152 WSVGAILFELLNGYPPFSG 170 (226)
Q Consensus 152 ~slG~~~~~l~~g~~p~~~ 170 (226)
++.|+-+|.++|+..+..+
T Consensus 191 ~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 191 FATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHhcchHHHHHhccCCccc
Confidence 8999999999998877543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8e-18 Score=124.81 Aligned_cols=105 Identities=21% Similarity=0.336 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHHhcC-----CCCCeeeeeeEEEeCC---eEE-EEEee--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---CIF-LVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQLGA 77 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~ 77 (226)
..+.+.+|+++++++ +||||++++++++++. ..+ +|+|| +.+++|.+++++. .+++. ..++.+++.
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~ 115 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLK 115 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHH
Confidence 456799999999999 5799999999998863 434 78999 4479999999764 56655 356778887
Q ss_pred HH-HHHHhCCceeeccCCCCeEeeeCC-CCccEEEeeeccc
Q 027233 78 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLS 116 (226)
Q Consensus 78 ~l-~~lh~~~i~H~dl~~~nili~~~~-~~~~~~l~df~~~ 116 (226)
++ +|||+++|+|+||||+||+++..+ .+..++|+|++.+
T Consensus 116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 77 999999999999999999996432 3457999995444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=122.33 Aligned_cols=104 Identities=22% Similarity=0.203 Sum_probs=84.2
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIH 89 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H 89 (226)
.....|++++.++.++++.....+.... .++||||++|+++.....+..+++...+..++.|++.+|.++ |+.|++|
T Consensus 64 ~~~~~E~~~l~~l~~~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH 141 (190)
T cd05147 64 TWAEKEMRNLKRLVTAGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHHCCCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3445699999999888875544433222 379999999887766544556899999999999999999999 7999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~ 120 (226)
|||||.||+++ ++.++|+|||++....
T Consensus 142 rDlkP~NIli~----~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 142 ADLSEYNLLYH----DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCCCHHHEEEE----CCcEEEEEccccccCC
Confidence 99999999993 4679999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=117.75 Aligned_cols=104 Identities=19% Similarity=0.165 Sum_probs=85.0
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcee
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH 89 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H 89 (226)
..+..|.+.+.++.++++.....+.... .++||||++|+++........+++......++.|++.++.++|. .|++|
T Consensus 64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH 141 (190)
T cd05145 64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 3457899999999999886655554433 47999999887654443334578888999999999999999999 99999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~ 120 (226)
+||+|.||++ + ++.++|+|||++....
T Consensus 142 rDlkP~NIll---~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILY---H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEE---E-CCCEEEEEcccceecC
Confidence 9999999999 4 6789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-18 Score=144.56 Aligned_cols=203 Identities=30% Similarity=0.492 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-h
Q 027233 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQLGAGLEILN-S 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~ 84 (226)
....+..|..+-..+. |+|++.+++........+++.++..|+++.+.+ .... ..+.......+.|+..++.|+| .
T Consensus 63 ~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~ 142 (601)
T KOG0590|consen 63 SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE 142 (601)
T ss_pred hhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc
Confidence 3445556777777775 999999999999999999999999999999988 4444 5777888899999999999999 9
Q ss_pred CCceeeccCCCCeEeeeCCCCc-cEEEeeeccccccCC-CCc---cccccC-CccccCccccccc-CCCcchhHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GNY---AEKVCG-SPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~-~~~l~df~~~~~~~~-~~~---~~~~~~-~~~~~aPE~~~~~-~~~~~~Dv~slG~~ 157 (226)
.++.|+|++|+|.++ +..+ ..++.|||++..+.. ... ....+| +..|.|||...+. ...+..|+||.|++
T Consensus 143 ~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 143 NGVTHRDIKPSNSLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIV 219 (601)
T ss_pred cccccCCCCCccchh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccc
Confidence 999999999999999 5666 899999999987765 322 234567 8899999998874 45678999999999
Q ss_pred HHHHHhCCCCCCCCCcccc---------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 158 LFELLNGYPPFSGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+..+++|..||........ ....++....+++.+++..+|..|.+.+++-.++|+..
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 9999999999865432211 26667888999999999999999999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-16 Score=134.70 Aligned_cols=181 Identities=23% Similarity=0.242 Sum_probs=138.3
Q ss_pred CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeC---
Q 027233 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL--- 102 (226)
Q Consensus 26 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~--- 102 (226)
+.|.++...+.-.+..++|++|.+-|||.++++..+.+++..+..++.|++..+..||..+|+||||||+|+++...
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 34555555556667788999999999999999988899999999999999999999999999999999999999632
Q ss_pred -CCCccEEEeeeccccccCCC---CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC-CCCCCccccc
Q 027233 103 -DDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP-FSGRNNVQLI 177 (226)
Q Consensus 103 -~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p-~~~~~~~~~~ 177 (226)
.....++|+|||.+..+... ......+.+..|-.+|+..|.+++...|.|+|+.+++-|+.|..- +.+...+...
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~ 913 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVK 913 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceecc
Confidence 23455999999999877532 233556778889999999999999999999999999999987532 2222222221
Q ss_pred c--cCC--ChHHHHHHHHhhccCccccCCHhHH
Q 027233 178 V--PAL--HPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 178 ~--~~~--~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
. +++ -..+..++..+|+.+-..=|.+.++
T Consensus 914 ~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 914 TNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred ccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 1 111 1236688889998555444555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-16 Score=135.29 Aligned_cols=138 Identities=39% Similarity=0.627 Sum_probs=116.7
Q ss_pred HHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----------------cccccCCccccCcc
Q 027233 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------------AEKVCGSPLYMAPE 138 (226)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----------------~~~~~~~~~~~aPE 138 (226)
++.+++|+|+.||+|+|++|+|.+| +.-++++++|||+++...-... ....++++.|.|||
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 3788999999999999999999999 7899999999998754321110 12347899999999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccC---C
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRL---S 202 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rp---t 202 (226)
++..+.|..-.|=|++|+++|+.+-|..||.+.+..+.+ -..++++.+++|.++|+.+|..|- .
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 999999999999999999999999999999887544332 445788999999999999999994 5
Q ss_pred HhHHhcCcccccc
Q 027233 203 FNEFYHHRFLRRN 215 (226)
Q Consensus 203 ~~~~l~~~~~~~~ 215 (226)
+-++.+|+||+..
T Consensus 309 a~evk~h~ff~~L 321 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLL 321 (1205)
T ss_pred hhhhhhccceeec
Confidence 7788999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-15 Score=111.38 Aligned_cols=101 Identities=23% Similarity=0.322 Sum_probs=88.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
...+.+|+.++..+.|++++....++...+..+++|||++|++|.+++..... ....++.+++.++.++|+.|++|
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H 118 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH 118 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence 45688999999999999988877777777788999999999999999875432 77889999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
+|++|.||++ + ++.++++|||.+..
T Consensus 119 ~Dl~p~Nil~---~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 119 GDLTTSNMIL---S-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCcccEEE---E-CCCEEEEECCcccC
Confidence 9999999999 3 67799999998855
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-14 Score=117.92 Aligned_cols=193 Identities=20% Similarity=0.287 Sum_probs=139.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i 87 (226)
..+.+.+.++.++.++||||+++++.++.++..|+|+|-+ ..|..++++-+ ...+.-.+.||+.||.+|| +.++
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~l 126 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KEEVCLGLFQILAALSFLNDDCNL 126 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCe
Confidence 3466888999999999999999999999999999999998 47888887544 6677888999999999997 5689
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|++|+-..|++ +..+..+|++|..+........ .........|..|+.+.... -..|.|.||+++++++.|..
T Consensus 127 vHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 127 VHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred eeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 999999999999 7999999999998755432221 11122223355555443221 35799999999999999833
Q ss_pred CCCCCCcccccccCCChHHHHHHHHhhccCccccCCHhHHh-----cCccccc
Q 027233 167 PFSGRNNVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY-----HHRFLRR 214 (226)
Q Consensus 167 p~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l-----~~~~~~~ 214 (226)
.-.. .-.....+++....+..+-+--.+..||...+.+ -|.||+.
T Consensus 202 ~~~~---~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n 251 (690)
T KOG1243|consen 202 LTKT---DLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRN 251 (690)
T ss_pred Ccch---hhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccc
Confidence 2111 1122344456677777676767777777744332 2666654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.9e-15 Score=109.37 Aligned_cols=99 Identities=23% Similarity=0.291 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+++.+|+++++.+.++++.....++...+..+++|||++|++|.+++..... .++.+++.++.++|+.|++|
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence 46788999999999988776666666666777899999999999998764321 78999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
||++|.||++ + ++.+++.|||.+...
T Consensus 114 ~Dl~~~Nil~---~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 114 GDLTTSNIIV---R-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCCCcceEEE---E-CCcEEEEECCCCcCC
Confidence 9999999999 4 678999999987553
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=122.39 Aligned_cols=98 Identities=20% Similarity=0.279 Sum_probs=86.6
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|+++++.++|++++....+.......++||||++|++|.+++. ....++.+++.++.+||+.|++|
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH 451 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH 451 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence 4678899999999999999988877777777889999999999999876 34678999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
||++|.||++ .++.++|+|||++...
T Consensus 452 rDlkp~NILl----~~~~~~liDFGla~~~ 477 (535)
T PRK09605 452 GDLTTSNFIV----RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCChHHEEE----ECCcEEEEeCcccccC
Confidence 9999999999 3567999999998654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=110.59 Aligned_cols=104 Identities=20% Similarity=0.216 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHHhcCCCCC--eeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+..+..|+.++.++.+.+ ++++++. +..++||||++|.+|..+...........+..++.|++.++.+||+.|
T Consensus 93 ~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 93 VRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 3456789999999996533 3444432 235799999999888776544456667778899999999999999999
Q ss_pred -ceeeccCCCCeEeeeCCCCccEEEeeeccccccC
Q 027233 87 -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (226)
Q Consensus 87 -i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~ 120 (226)
++|+||+|+||++ + ++.++|+|||.+....
T Consensus 169 ~iiH~Dikp~NIli---~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 169 ELVHGDLSEYNILV---H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CEEeCCCChhhEEE---E-CCCEEEEEChhhhccC
Confidence 9999999999999 4 6789999999886543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.5e-15 Score=120.35 Aligned_cols=199 Identities=24% Similarity=0.346 Sum_probs=164.3
Q ss_pred HHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhC
Q 027233 12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGA----GLEILNSH 85 (226)
Q Consensus 12 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~ 85 (226)
.=.+|+....++ .|++.++.+..+++.+..|+-+|.| +.+|.++...... +++..++..+.+... |+..+|..
T Consensus 163 ~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~ 241 (524)
T KOG0601|consen 163 RKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN 241 (524)
T ss_pred cccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC
Confidence 334566677777 5999999999999999999999999 6899998887765 889999999999999 99999999
Q ss_pred CceeeccCCCCeEeeeCCCC-ccEEEeeeccccccCCCCccc------cccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNYAE------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~-~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
+++|-+++|.||+. ..+ ..++++|||+....+.+.... ...+...|++||... .-++...|+|++|.++
T Consensus 242 ~~~~~~~kp~~i~~---~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~ 317 (524)
T KOG0601|consen 242 NIVHDDLKPANIFT---TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVI 317 (524)
T ss_pred cccccccchhheec---ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhh
Confidence 99999999999999 556 779999999998887654322 124667799999876 4567899999999999
Q ss_pred HHHHhCCCCCCCC--Cccccc---------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 159 FELLNGYPPFSGR--NNVQLI---------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 159 ~~l~~g~~p~~~~--~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.+..++..+...+ ..+..+ ....+.++...+..|++.++..|++.+.++.|+++...
T Consensus 318 l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 318 LEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred HhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 9999887765544 333333 34556778889999999999999999999999998854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=107.99 Aligned_cols=104 Identities=20% Similarity=0.247 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCe--eeeeeEEEeC-C---eEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNI--IRLFDAFQAE-N---CIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~-~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
..+..+.+|+.++..|.|++| +..+++.... + ..++|+|+++| .+|.+++.. .++++. .+.+++.++.
T Consensus 82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~ 156 (239)
T PRK01723 82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIA 156 (239)
T ss_pred hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHH
Confidence 345678899999999988875 6677664432 2 23599999997 699998764 355544 3568999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
+||++|++|+||+|.||++ +.++.++|+|||.+...
T Consensus 157 ~lH~~GI~HrDlkp~NILv---~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 157 RFHDAGVYHADLNAHNILL---DPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHCCCCCCCCCchhEEE---cCCCCEEEEECCCcccC
Confidence 9999999999999999999 55668999999988654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.7e-13 Score=98.68 Aligned_cols=99 Identities=24% Similarity=0.269 Sum_probs=78.7
Q ss_pred HHHHHHHHHHHhcCCCCC--eeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
+.....|+.++..+.+++ ++..++ .+..+++|||++|++|.+.... .....++.+++.++.++|+.|+
T Consensus 77 ~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi 146 (198)
T cd05144 77 RLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGI 146 (198)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCC
Confidence 345788999999997764 444443 2445899999999999865331 3456788999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~ 121 (226)
+|+||+|.||++ +.++.++|+|||.+.....
T Consensus 147 ~H~Dl~p~Nill---~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 147 IHGDLSEFNILV---DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcCCCCcccEEE---cCCCcEEEEECCccccCCC
Confidence 999999999999 5688999999999855543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.4e-12 Score=90.68 Aligned_cols=98 Identities=23% Similarity=0.374 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhcCCC--CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 027233 10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-- 85 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-- 85 (226)
...+.+|+..++.+++ .++++++++....+..++++||+.|.++..+ +......++.+++.+++.+|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~ 107 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL 107 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence 4678999999999965 5899999888888889999999988877754 4566778899999999999985
Q ss_pred -CceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 86 -~i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
+++|+|++|.||++ +..+.+++.||+.+.
T Consensus 108 ~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~ 137 (155)
T cd05120 108 LVLCHGDLHPGNILV---DDGKILGIIDWEYAG 137 (155)
T ss_pred eEEEecCCCcceEEE---ECCcEEEEEeccccc
Confidence 79999999999999 457889999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.6e-12 Score=89.32 Aligned_cols=100 Identities=21% Similarity=0.240 Sum_probs=81.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
-+.+-.+|++++.++.--+|....=+..+.+...|+|||++|..|.+.+... ...++..+=.-+.-||..||+
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~giv 114 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIV 114 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCee
Confidence 4567889999999997667776666666777778999999999999998865 245666777778889999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
||||+++||.++ +..+.++|||++...
T Consensus 115 HGDLTtsNiIl~----~~~i~~IDfGLg~~s 141 (204)
T COG3642 115 HGDLTTSNIILS----GGRIYFIDFGLGEFS 141 (204)
T ss_pred cCCCccceEEEe----CCcEEEEECCccccc
Confidence 999999999993 344999999998643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-11 Score=89.47 Aligned_cols=103 Identities=15% Similarity=0.138 Sum_probs=76.0
Q ss_pred HHHHHHHHHhcCCC--CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCce
Q 027233 12 CLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHII 88 (226)
Q Consensus 12 ~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~ 88 (226)
-.++|++.|+++.. -++++++++ ..-++||||+.+..+....-+...++......+..+++.++..+ |+.|++
T Consensus 72 wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 72 WAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 44599999999953 455566654 44579999997643322222223455566778889999999988 899999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~ 122 (226)
||||++.||++. ++.+.++|||.+....++
T Consensus 148 HGDLs~~NIL~~----~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 148 HADLSEYNMLWH----DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred cCCCCHHHEEEE----CCcEEEEECCCceeCCCC
Confidence 999999999993 467999999988666443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.5e-13 Score=110.20 Aligned_cols=142 Identities=18% Similarity=0.312 Sum_probs=111.1
Q ss_pred HHHHHHHHHHHHhC-CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----------ccccccCCccccCcccc
Q 027233 72 LQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------YAEKVCGSPLYMAPEVL 140 (226)
Q Consensus 72 ~~~i~~~l~~lh~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----------~~~~~~~~~~~~aPE~~ 140 (226)
+.+...|+.++|+. +++|++|.|++|++ +.++.+|+++|+++.....+. ..........|.+||++
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34456899999965 89999999999999 789999999999875543311 11112345669999999
Q ss_pred cccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 141 QFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 141 ~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
.+..-+.++|+||+|++++.+.. |...+...... -.....+++++++=+.+++..++.-||++.+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 88888899999999999999884 44444332111 1115678899999999999999999999999
Q ss_pred HhcCccccccC
Q 027233 206 FYHHRFLRRNS 216 (226)
Q Consensus 206 ~l~~~~~~~~~ 216 (226)
++..|||.+..
T Consensus 262 l~~~~ff~D~~ 272 (700)
T KOG2137|consen 262 LLSIPFFSDPG 272 (700)
T ss_pred hhcccccCCch
Confidence 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-11 Score=84.58 Aligned_cols=112 Identities=21% Similarity=0.261 Sum_probs=88.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
-.+.+..+|++.+.++.--+|.-..=++.+...-.+.|||++| .++.+++.+.. .........+++++-+.+.-||.
T Consensus 52 Ltr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ 131 (229)
T KOG3087|consen 52 LTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD 131 (229)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh
Confidence 3567889999999999765666555566666666799999976 58899988763 23333447889999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
.+++||||+.+||++.+.+....+.++|||++...
T Consensus 132 ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 132 NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99999999999999975455555699999998554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-10 Score=88.68 Aligned_cols=107 Identities=16% Similarity=0.143 Sum_probs=83.2
Q ss_pred HHHHHHHHHhcCCCCCee--eeeeEEEe-----CCeEEEEEeecCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSVNHPNII--RLFDAFQA-----ENCIFLVVEFCAGG-NLSSYIRL--HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.+.+|.+.+..|...+|. +++++.+. ....++|+|++++. +|.+++.. ..+.+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 477899999988544544 44556543 23578999999875 89999864 2355667788999999999999
Q ss_pred HHhCCceeeccCCCCeEeee----CCCCccEEEeeeccccc
Q 027233 82 LNSHHIIHRDLKPENILLSG----LDDDVMLKIADFGLSCT 118 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~----~~~~~~~~l~df~~~~~ 118 (226)
||..|++|||+++.||+++. ...+..+.++||+.+..
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999963 12356799999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.8e-12 Score=109.69 Aligned_cols=189 Identities=31% Similarity=0.488 Sum_probs=151.7
Q ss_pred CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCC
Q 027233 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104 (226)
Q Consensus 25 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~ 104 (226)
+|-++.....+......+++++|..|++|.+.+.+-+..+.+-....+..+..+..+||...+.|++++|.|.+. ..
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~ 939 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AY 939 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cc
Confidence 455555555555667789999999999999998887777777888888899999999999999999999999998 57
Q ss_pred CccEEEeeeccccccCC---------------------C-----------CccccccCCccccCcccccccCCCcchhHH
Q 027233 105 DVMLKIADFGLSCTLYP---------------------G-----------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 105 ~~~~~l~df~~~~~~~~---------------------~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
.+...+.+|+.....+. . .......++..|.+||...+......+|.|
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 77788888763211110 0 001223467889999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHh---HHhcCccccccC
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFN---EFYHHRFLRRNS 216 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~---~~l~~~~~~~~~ 216 (226)
+.|.++++.++|..||......... ....+...++++...+..++.+|..+. +.-.|+||+..-
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 9999999999999999876543332 455688899999999999999999988 999999999863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.3e-10 Score=92.98 Aligned_cols=175 Identities=18% Similarity=0.275 Sum_probs=132.0
Q ss_pred HHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCC-CCHHHHHH---------------hcCCCCHHHHHHHHHH
Q 027233 15 CELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAG-GNLSSYIR---------------LHGRVPEQTARKFLQQ 74 (226)
Q Consensus 15 ~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~~~---------------~~~~~~~~~~~~~~~~ 74 (226)
.-++.++++.|.|+|++.+.+.. +..+++|++|.++ .+|-++-= ...+.+++.+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 44788999999999999998863 4578999999975 46655431 1124789999999999
Q ss_pred HHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHH
Q 027233 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (226)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 154 (226)
+..||.++|+.|+...-|.+.+|++ +.+.+++|...|.......+.. +.+ ....+.|.-.|
T Consensus 402 LtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~d~~-------------~~l---e~~Qq~D~~~l 462 (655)
T KOG3741|consen 402 LTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQEDPT-------------EPL---ESQQQNDLRDL 462 (655)
T ss_pred HHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeecCCCC-------------cch---hHHhhhhHHHH
Confidence 9999999999999999999999999 5666889888777655433321 000 11347899999
Q ss_pred HHHHHHHHhCCCCCCCCC-----cccccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 155 GAILFELLNGYPPFSGRN-----NVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|.+++.+.+|..--...+ ..+.+...++.+++++|.-....++++ -++++++.+
T Consensus 463 G~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 463 GLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999854321211 133447778999999999999999886 677777643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-10 Score=85.71 Aligned_cols=94 Identities=23% Similarity=0.283 Sum_probs=70.7
Q ss_pred HHHHHHHhcCCCCC--eeeeeeEEEeCCeEEEEEeecCCC-----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 027233 14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGG-----NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (226)
Q Consensus 14 ~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~-----~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (226)
..|...+.++.+.+ ++++++. ...++++||++|+ +|.+... . .....++.+++.++.++|. .
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-----~-~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-----L-EDPEELYDQILELMRKLYREA 134 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh-----c-ccHHHHHHHHHHHHHHHhhcc
Confidence 56777777774433 4444443 2358999999884 3443221 1 5678899999999999999 9
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~ 121 (226)
|++|+||+|+||++ + ++.++++|||.+.....
T Consensus 135 ~ivH~Dl~p~Nili---~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 135 GLVHGDLSEYNILV---D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcCcCCCChhhEEE---E-CCcEEEEECcccccccC
Confidence 99999999999999 4 77899999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.3e-10 Score=84.37 Aligned_cols=111 Identities=19% Similarity=0.206 Sum_probs=87.2
Q ss_pred HHHHHHHHHHHHhcCCCCC--eeeeeeEEEeC----CeEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQAE----NCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.+....+|...+..|...+ .++++++.+.. ...++|+|++++ .+|.+++......+......++.++...++-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 4557888888888885443 45666666552 246899999987 4899999875557777888999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
||++|++|+|+++.||++...+....+.++||+.+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999964333457999999977543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.2e-10 Score=87.67 Aligned_cols=163 Identities=17% Similarity=0.222 Sum_probs=118.6
Q ss_pred EEEEEeecCCC-CHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeee
Q 027233 41 IFLVVEFCAGG-NLSSYIR------LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113 (226)
Q Consensus 41 ~~lv~e~~~~~-~L~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df 113 (226)
.-++|..+.|. .+..+.+ ...-+++....++++.++.+.+.||+.|.+-||++++|+++ .++..++|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence 56777777653 2222221 11236788899999999999999999999999999999999 57778888875
Q ss_pred ccccccCCCCccccccCCccccCccccc-----ccCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcccc--------c--
Q 027233 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNG-YPPFSGRNNVQL--------I-- 177 (226)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~~~l~~g-~~p~~~~~~~~~--------~-- 177 (226)
.....-..+......++...|.+||.-. +...+..+|.|.||+++++++.| ..||.+-..... +
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 5433332333334456888899999864 44567889999999999999886 889876421100 0
Q ss_pred ---------------------ccCCChHHHHHHHHhhccC--ccccCCHhHH
Q 027233 178 ---------------------VPALHPDCVDMCLKLLSAN--TVDRLSFNEF 206 (226)
Q Consensus 178 ---------------------~~~~~~~~~~~i~~~l~~~--p~~Rpt~~~~ 206 (226)
...++++++.++.+|+... +.-|||++-.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 4457889999999999754 4579997653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-11 Score=99.28 Aligned_cols=197 Identities=22% Similarity=0.256 Sum_probs=147.7
Q ss_pred HHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccC
Q 027233 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (226)
Q Consensus 15 ~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (226)
.|+.+...+ .|.+++.++..+......|+--|||.++++.........+++...+++..|++.++.++|+..++|+|++
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ 393 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK 393 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccccc
Confidence 344455555 5899999888888888888999999999988777555568888999999999999999999999999999
Q ss_pred CCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccc-cCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 027233 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (226)
Q Consensus 94 ~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 172 (226)
|+||++.+ ..+..+++||+....+...... ....+..| .++.......+..+.|++|||..+.+.+++...-....
T Consensus 394 psni~i~~--~~~~~~~~~~~~~t~~~~~~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 394 PSNILISN--DGFFSKLGDFGCWTRLAFSSGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred ccceeecc--chhhhhccccccccccceeccc-ccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 99999942 1267788999887653322211 11122333 35555566677889999999999999988876544333
Q ss_pred cccc-------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 173 NVQL-------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 173 ~~~~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.... ..+.....+..+.+.++.+++..||.+.++..|.=|.+
T Consensus 471 ~~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 471 QSLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cceeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 2222 14444578889999999999999999999988876654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.7e-10 Score=93.92 Aligned_cols=103 Identities=22% Similarity=0.242 Sum_probs=72.8
Q ss_pred HHHHHHHHHhcCC-----CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHh
Q 027233 12 CLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA-GLEILNS 84 (226)
Q Consensus 12 ~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~-~l~~lh~ 84 (226)
++.+|++.+.++. ++++.-..-+....+..+++|||++|.+|.++.... ...+ ...++..++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 4666777777662 344332222222234568999999999999876532 1222 3345566655 4788999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~ 120 (226)
.|++|+|++|.||++ ..++.++++|||++....
T Consensus 276 ~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999999 678899999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=95.48 Aligned_cols=213 Identities=23% Similarity=0.226 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe----EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
........|+..+.++.|+|++.++.+..+... ..+..++|...++.+.++.-...+.+..+.+..++.+++.++|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 455666778888889999999999988755322 3356689999999999998889999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEe--eeccccccCCCCccccccCCccccCcccccccCCC--cchhHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD--EKVDMWSVGAILF 159 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Dv~slG~~~~ 159 (226)
+....|.-+......-...+..+.+.++ ||+.+.................+.++|........ ...|+|++|....
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 9976666665553222222455556655 88887776655544444455567777776655444 4579999999999
Q ss_pred HHHhCCCCCCCCCccccc-ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccC
Q 027233 160 ELLNGYPPFSGRNNVQLI-VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 220 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~ 220 (226)
.+..|..+-........+ .........+...+|+..++++|+++.+++.|+|.+-+-....
T Consensus 384 ~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred hhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 998877654333222222 2222237899999999999999999999999999987655444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.8e-10 Score=82.97 Aligned_cols=94 Identities=24% Similarity=0.274 Sum_probs=70.1
Q ss_pred HHHHHHHHHHhcCCCCCe-eeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc--
Q 027233 11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI-- 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-- 87 (226)
..+..|+.+++.+...++ ++++.+.. ...++|||+++|.++.+. .. .....+.+++.+++.||..++
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~ 106 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPD 106 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCC
Confidence 456889999999865444 45554433 335799999999888753 11 123456789999999999885
Q ss_pred ---eeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 88 ---IHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 88 ---~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
+|||++|.||++ + ++.++++||+.+..
T Consensus 107 ~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~~ 136 (170)
T cd05151 107 LVPCHNDLLPGNFLL---D-DGRLWLIDWEYAGM 136 (170)
T ss_pred ceeecCCCCcCcEEE---E-CCeEEEEecccccC
Confidence 999999999999 3 55799999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.5e-10 Score=80.42 Aligned_cols=104 Identities=20% Similarity=0.323 Sum_probs=69.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCC--eeeeeeEEEeCCeEEEEEeecC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-
Q 027233 7 KHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI- 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~- 81 (226)
...+...++|.+.|.++..-+ +++++++ .. -++||||++ |..+..+... .++......++.+++..+..
T Consensus 49 ~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 49 YLIREWAKKEFRNLKRLYEAGVPVPKPYDY--NR--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHHHHCCCTT-SS--EEEE--ET--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCccCCcEEEE--eC--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHH
Confidence 345678899999999997664 5566544 23 359999998 6666554332 22234566777888885444
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccC
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~ 120 (226)
+|..|++|||+++.||+++ .+ .+.++|||.+....
T Consensus 123 ~~~~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 123 LHKAGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHCTTEEESS-STTSEEEE---TT-CEEE--GTTEEETT
T ss_pred HHhcCceecCCChhhEEee---cc-eEEEEecCcceecC
Confidence 6899999999999999994 33 89999999886654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-09 Score=90.89 Aligned_cols=73 Identities=26% Similarity=0.343 Sum_probs=51.5
Q ss_pred CeEEEEEeecCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCc----cE
Q 027233 39 NCIFLVVEFCAGGNLSSYI--RLHG----RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV----ML 108 (226)
Q Consensus 39 ~~~~lv~e~~~~~~L~~~~--~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~----~~ 108 (226)
+..+++|||++|+++.+.- ...+ .+.+..+..++ ..+...|++|+|++|.||+++ .++ ++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~-------~Qif~~GffHaDpHPGNIlv~---~~g~~~~~i 303 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF-------TQVFRDGFFHADMHPGNIFVS---YDPPENPRY 303 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-------HHHHhCCeeeCCCChHHeEEe---cCCCCCCeE
Confidence 4467999999999998753 2222 12233333333 344569999999999999994 444 89
Q ss_pred EEeeeccccccCC
Q 027233 109 KIADFGLSCTLYP 121 (226)
Q Consensus 109 ~l~df~~~~~~~~ 121 (226)
+++|||.......
T Consensus 304 ~llDFGivg~l~~ 316 (537)
T PRK04750 304 IALDFGIVGSLNK 316 (537)
T ss_pred EEEecceEEECCH
Confidence 9999999876643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=7e-08 Score=71.06 Aligned_cols=110 Identities=13% Similarity=0.140 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHHhcCCCCC--eeeeeeEEEe----CCeEEEEEeecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQA----ENCIFLVVEFCAG-GNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l 79 (226)
-+..+.+|+..+++|..-+ ++++...... .-..+||+|-++| .+|.+++... .+.+......++.++..++
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~i 141 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAF 141 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHH
Confidence 4578899999999994222 5555522222 1246799997743 6999998754 3457777789999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
+-||+.|+.|+|+.+.||+++. +....+.++||+.+...
T Consensus 142 a~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 142 KKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhccchh
Confidence 9999999999999999999952 12335999999977543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.1e-08 Score=74.94 Aligned_cols=101 Identities=19% Similarity=0.243 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHHhcCCCC--CeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+...++|.+.|+.|... .+++.+ +.++-.+|||+++|..|... +++.+..-.++..|++.+...-..|
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~----~~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPI----AWNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCcc----ccccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcC
Confidence 566788999999999765 677777 44566799999999777642 2245566677788888888888999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~ 121 (226)
++|||+++-||++ ++++.+.++||-.+....+
T Consensus 223 iVHGDlSefNIlV---~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 223 IVHGDLSEFNILV---TEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred ccccCCchheEEE---ecCCCEEEEeCcccccCCC
Confidence 9999999999999 6888999999988755543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.68 E-value=7.6e-08 Score=72.25 Aligned_cols=104 Identities=17% Similarity=0.274 Sum_probs=74.9
Q ss_pred HHHHHHHHHHHhcCCCCC--eeeeeeEEEeC---CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
...+..|+++++.+.+.+ +++++.+.... +..++++|+++|.++.+.+.. ..++......++.+++.++..||+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 567899999999996533 56777766553 367899999999888764421 245555556666666666666652
Q ss_pred --------------------------------------------------------CCceeeccCCCCeEeeeCCC--Cc
Q 027233 85 --------------------------------------------------------HHIIHRDLKPENILLSGLDD--DV 106 (226)
Q Consensus 85 --------------------------------------------------------~~i~H~dl~~~nili~~~~~--~~ 106 (226)
..++|||+++.||+++ . ++
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~ 194 (223)
T cd05154 118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPR 194 (223)
T ss_pred CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCc
Confidence 2468999999999994 4 45
Q ss_pred cEEEeeecccc
Q 027233 107 MLKIADFGLSC 117 (226)
Q Consensus 107 ~~~l~df~~~~ 117 (226)
.+.++||+.+.
T Consensus 195 ~~~iID~e~~~ 205 (223)
T cd05154 195 VVAVLDWELAT 205 (223)
T ss_pred EEEEEeccccc
Confidence 68899999773
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.2e-07 Score=68.78 Aligned_cols=65 Identities=22% Similarity=0.368 Sum_probs=51.3
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccc
Q 027233 40 CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (226)
Q Consensus 40 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~ 116 (226)
..++++||++|..|.+... +++ .+...+.+++..+|+.|+.|||.+|.|+++ + ++.+++.|++..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv---~-~~~i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV---S-NNGIRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE---E-CCcEEEEECccc
Confidence 4568999999999887532 222 244567788999999999999999999999 3 455999999755
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.34 E-value=1e-05 Score=59.61 Aligned_cols=102 Identities=26% Similarity=0.354 Sum_probs=76.9
Q ss_pred HHHHHHHHHHHHhcCC------CCCeeeeeeEEEeCCeEEEEEeecC------CCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCA------GGNLSSYIRLHGRVPEQTARKFLQQLG 76 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~~~~~~~~~~~~~i~ 76 (226)
..++..+|+..+.++. +.+|.+++|+.+++....+|+|.+. +.||.+++... .++. . +...+-
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~ 128 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALD 128 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHH
Confidence 3567777887777776 8899999999999988888888763 35899998643 4554 3 334445
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCc-cEEEee-ecc
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGL 115 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~-~~~l~d-f~~ 115 (226)
+...+|-+.+|+.+|++|.||++.....+. .+.|+| ||.
T Consensus 129 ~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 129 EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 556688889999999999999997655544 688887 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=5e-07 Score=75.81 Aligned_cols=198 Identities=21% Similarity=0.252 Sum_probs=136.6
Q ss_pred HHHHHHHHHHhcCCCCC-eeeeeeEEEeCCeEEEEEeecCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+-++++|.+++||| .+..++.+..+...++.++++.++ +-..-. .....+..-......+.-+++++++|+..-
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 45667889999999999 667777777788899999999776 211111 111123333344455556778899998866
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+| ||+. .+...+.++|+....+..........+++.++|||......+....|.|++|.-..++..|..|
T Consensus 358 ~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 7777 7775 4567788899887666554445566788999999999888889999999999876777666665
Q ss_pred CCCCCccccc-------ccCC-----ChHH-HHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 168 FSGRNNVQLI-------VPAL-----HPDC-VDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~~~-------~~~~-----~~~~-~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
-......... +.-. +... .++...|+...|..|+....++.|.+|.+=+
T Consensus 430 r~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 430 RSSPPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCCCccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 3321100000 0000 1111 1477889999999999999999999998844
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.5e-05 Score=54.72 Aligned_cols=99 Identities=24% Similarity=0.263 Sum_probs=76.2
Q ss_pred HHHHHHHhcCCC-CCeeeeeeEEEeCCeEEEEEeecCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 027233 14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQTARKFLQQLGAGLEILNS---HH 86 (226)
Q Consensus 14 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~ 86 (226)
..|.-+++.+.+ +++++++|++.. ++++||...+++.. .+......++....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888989954 689999998843 46889987665431 11112345788999999999999999987 45
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
+.-+|++++|+.+ +.++++++.|.......
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 8889999999999 67788999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1e-05 Score=61.83 Aligned_cols=47 Identities=13% Similarity=0.087 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHH
Q 027233 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56 (226)
Q Consensus 10 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 56 (226)
...+.+|+++++.+ ++--+++++++....+..++||++++|.+|.+.
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 34678899999888 344466888877776778999999999887644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.3e-05 Score=56.85 Aligned_cols=43 Identities=19% Similarity=0.188 Sum_probs=33.8
Q ss_pred HHHHHHHHHHHhcCCCCC--eeeeeeEEEeCCeEEEEEeecCCCC
Q 027233 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN 52 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~ 52 (226)
...+.+|.++++.+..-+ +++.+++....+...++|++++|.+
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 346789999999995433 5677888877777889999999864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.1e-05 Score=66.60 Aligned_cols=150 Identities=19% Similarity=0.242 Sum_probs=101.0
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
++...+++++++.|+|...++++... ..+..+|+|++ +.||.+++..+. +-..... .|+
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~~ 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AHG 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------ccc
Confidence 45667889999999999999988765 35688999999 789999887653 2221111 233
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 170 (226)
-+.- |++ ..+| -++... | .+..+++||||+|.++.++..|...+..
T Consensus 88 ~~~~-~~~----------~~td-~~~t~~-----------------~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 88 VLHL-NII----------YITD-HFLTKY-----------------P-----SPIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ccee-hhh----------hccc-cccccC-----------------C-----CCCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 2211 221 1222 000000 0 1112599999999999999988776654
Q ss_pred CCccccc----------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 171 RNNVQLI----------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 171 ~~~~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
....+.. .-..+..+.++.++|+...|..||...++.+++-|.+.
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 3322111 33456678899999999999999999999999998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.4e-05 Score=64.79 Aligned_cols=104 Identities=21% Similarity=0.268 Sum_probs=70.0
Q ss_pred HHHHHHHHHhcC-----CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHH-HHHHHh
Q 027233 12 CLDCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG-LEILNS 84 (226)
Q Consensus 12 ~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~-l~~lh~ 84 (226)
++.+|+..++++ +.+++.-..=+.+-.+.-.++|||++|..+.+..... ...+... ++..++.+ +..+-.
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHh
Confidence 455666666666 2454443333333335567999999999999885332 3455333 33444333 455566
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~ 121 (226)
.|+.|+|.+|.||++ ..++.+.+.|||......+
T Consensus 284 dgffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 899999999999999 6779999999999876643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.8e-05 Score=58.60 Aligned_cols=98 Identities=19% Similarity=0.166 Sum_probs=69.1
Q ss_pred HHHHHHHHHhcCCCC--CeeeeeeEEEeCCeEEEEEeecCCC-----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 12 CLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGG-----NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~-----~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
=..+|+..|+++.-. .+++.+.+.. -.++||++... .|.+ -+........+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 356788888888533 4455554432 35899999433 1221 122333577778888888888876
Q ss_pred -CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC
Q 027233 85 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122 (226)
Q Consensus 85 -~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~ 122 (226)
.+++||||+.-||++ . .+.+.++|++.+....++
T Consensus 185 ~a~LVHgDLSEyNiL~---~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 185 EAGLVHGDLSEYNILV---H-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hcCcccccchhhheEE---E-CCeEEEEECccccccCCC
Confidence 899999999999999 3 778999999998766543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00018 Score=54.24 Aligned_cols=48 Identities=17% Similarity=0.224 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHhcCCCC--CeeeeeeEEE---eCCeEEEEEeecCCCCHHH
Q 027233 8 HLKSCLDCELNFLSSVNHP--NIIRLFDAFQ---AENCIFLVVEFCAGGNLSS 55 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~~~L~~ 55 (226)
.....+.+|..+++.+... .+++++.+.. .....+.++++++|.++..
T Consensus 32 ~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 32 DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 3677888999999998433 3566666443 3456899999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0002 Score=54.39 Aligned_cols=46 Identities=9% Similarity=0.071 Sum_probs=30.5
Q ss_pred HHHHHHHHHHHHhcCCCC---CeeeeeeEEEeC---CeEEEEEeecCCCCHH
Q 027233 9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQAE---NCIFLVVEFCAGGNLS 54 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 54 (226)
....+.+|.++++.+... -++++++..... +..+++|++++|.++.
T Consensus 31 ~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 31 YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 355899999999888532 344555443322 2457899999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00092 Score=56.37 Aligned_cols=88 Identities=18% Similarity=0.288 Sum_probs=58.8
Q ss_pred eeeeeeEEEeCCeEEEEEeecCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeeccCCCCeEeeeC-C
Q 027233 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGL-EILNSHHIIHRDLKPENILLSGL-D 103 (226)
Q Consensus 28 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~i~H~dl~~~nili~~~-~ 103 (226)
|++++-.+. +.-.++|||++|..+.|.- .+. .++.. .++..+.++. ..+=..|++|+|-+|.||++... .
T Consensus 266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~ 339 (538)
T KOG1235|consen 266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPE 339 (538)
T ss_pred CCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCC
Confidence 445543333 3467999999998776543 332 45544 4455555542 33446789999999999999632 2
Q ss_pred CCccEEEeeeccccccCC
Q 027233 104 DDVMLKIADFGLSCTLYP 121 (226)
Q Consensus 104 ~~~~~~l~df~~~~~~~~ 121 (226)
.+..+.+.|||+.....+
T Consensus 340 ~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 340 GDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccEEEEcccccccccH
Confidence 477899999999866543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00085 Score=60.29 Aligned_cols=44 Identities=14% Similarity=0.375 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHhcCC-CCCe--eeeeeEEEeC---CeEEEEEeecCCCCH
Q 027233 10 KSCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGNL 53 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 53 (226)
...+.+|+++++.+. |.++ ++++.++.+. +..|+|||+++|..+
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 357889999999995 6665 6777776553 568899999988653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00074 Score=53.14 Aligned_cols=107 Identities=24% Similarity=0.280 Sum_probs=61.4
Q ss_pred HHHHHHHHHHHHHhcCCCCC--eeeeeeE------EEeCCeEEEEEeecCCCCHHH----HHH-------h----cCCCC
Q 027233 8 HLKSCLDCELNFLSSVNHPN--IIRLFDA------FQAENCIFLVVEFCAGGNLSS----YIR-------L----HGRVP 64 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~~~~~L~~----~~~-------~----~~~~~ 64 (226)
...+.+..|+++++.+...+ +++++.. ...++..+.++++++|.++.. ... + ...+.
T Consensus 48 ~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~ 127 (296)
T cd05153 48 VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFP 127 (296)
T ss_pred CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 34567788898888884322 4455432 233566789999999876532 100 0 00000
Q ss_pred --------HHHHHH------------HHHHHHHHHHHHHh-------CCceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 65 --------EQTARK------------FLQQLGAGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 65 --------~~~~~~------------~~~~i~~~l~~lh~-------~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
...... ....+..++..+.+ .+++|||++|.|+++ +.+..+.|.||+.+.
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~ 204 (296)
T cd05153 128 GERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFAC 204 (296)
T ss_pred ccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence 000000 11112233444443 479999999999999 455556899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0096 Score=47.85 Aligned_cols=107 Identities=21% Similarity=0.243 Sum_probs=69.8
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeccCCCCeEeeeCCCCccEEEeeeccc
Q 027233 38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (226)
Q Consensus 38 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~ 116 (226)
....|+++++- |+++... +....+++..++++.+..+.-+..+ .+-|+++...||++ + +|.+.|+||.++
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeee
Confidence 34567777775 6666532 2345678888999988888888765 58899999999999 5 889999999998
Q ss_pred cccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
+......... ...+--|..+.|. -+...+||-+...+
T Consensus 369 Rl~~~q~~is----y~rldhp~lF~G~-dd~QFeIYrlMr~l 405 (488)
T COG5072 369 RLSYSQGIIS----YNRLDHPDLFNGV-DDYQFEIYRLMRRL 405 (488)
T ss_pred ecccCCceee----ccccCchhhhcCc-cceeeeHHHHHHHH
Confidence 7433322211 1112233333322 25566777665443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0065 Score=43.74 Aligned_cols=99 Identities=19% Similarity=0.210 Sum_probs=69.4
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCee-eeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+.-+..+..|+++|+.+...++. +++.+..+ ++.|||+.|.+|.++.... +.. -+..+++.---|..
T Consensus 55 ~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~ 123 (201)
T COG2112 55 RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDR 123 (201)
T ss_pred CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHH
Confidence 345677899999999999877766 44444333 2559999998998765421 222 33455666666778
Q ss_pred CCceeeccC-CC-CeEeeeCCCCccEEEeeecccccc
Q 027233 85 HHIIHRDLK-PE-NILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 85 ~~i~H~dl~-~~-nili~~~~~~~~~~l~df~~~~~~ 119 (226)
.||-|+.++ |. ||++ +++.+.|+||..++..
T Consensus 124 ~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k 156 (201)
T COG2112 124 LGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFK 156 (201)
T ss_pred hccchhhhcCCceeEEe----cCCcEEEEEccchhhc
Confidence 899999995 44 5554 4558999999998744
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.002 Score=50.83 Aligned_cols=98 Identities=19% Similarity=0.251 Sum_probs=70.1
Q ss_pred HHHHHHHHHHhcCCCC--CeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 11 SCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
=...+|+..|+.|... -+++.+ +.++-++||+++.|.+|...-. ...+-.+...++..+--|..+|++
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlI 224 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLI 224 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCce
Confidence 3456788888888432 245555 3455679999999988875321 122334555667777788999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~ 121 (226)
|||.+--||++ ..+..++++||-......+
T Consensus 225 HgDFNEFNimv---~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 225 HGDFNEFNIMV---KDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred ecccchheeEE---ecCCCEEEeechHhhccCC
Confidence 99999999999 5688899999976654443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0051 Score=47.35 Aligned_cols=29 Identities=21% Similarity=0.385 Sum_probs=23.6
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.++|+|++|.||++ +.++ +.++||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~---~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVV---TPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEE---eCCC-CEEEeccccCc
Confidence 48999999999999 3444 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.008 Score=47.63 Aligned_cols=31 Identities=19% Similarity=0.396 Sum_probs=25.5
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
.++|||+++.|+++. +...+-+.||+.+..-
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence 489999999999994 4445999999988554
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.00022 Score=66.21 Aligned_cols=204 Identities=15% Similarity=0.028 Sum_probs=132.4
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l 79 (226)
.+-.++....|..-+++..|+++.....-... ...-+..++++.+|.+++.+-+. .++++.-+....++.+...
T Consensus 1269 sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence 34455555666666677789888876654432 34467888999999999998754 2344444544444445555
Q ss_pred HHHHhC---C--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHH
Q 027233 80 EILNSH---H--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~---~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
..+|+. | .+|.++++.|.++ ..+..++++++|+.+...+. .......+++.|+.++....-.++.++|+|.
T Consensus 1349 ~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred chhhhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence 665543 1 6789999999999 56777999999998733322 2223344566677778777777888899999
Q ss_pred HHHHHHHHHhCCCCCCCCC---------cc--cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 154 VGAILFELLNGYPPFSGRN---------NV--QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~---------~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
.|+-++....|..+|-... +. .......|.+.-.....+|-..-.+||.-...+..+.+
T Consensus 1426 ~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred HHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 9999998877766642110 00 01122234444555555666666678877777766554
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.015 Score=43.74 Aligned_cols=53 Identities=17% Similarity=0.226 Sum_probs=44.2
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeecCCCCHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 54 (226)
||..+++....+..|+.-|+.+. .-.+.+++....+.+..|+|+||.+-+.+.
T Consensus 44 vK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 44 VKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred EEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 56677888899999999998883 356889999999999999999999876554
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.029 Score=44.64 Aligned_cols=31 Identities=32% Similarity=0.644 Sum_probs=24.7
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.|++|||+++.||++ +.+....++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~---~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLF---EGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEE---ECCceEEEEecccccC
Confidence 479999999999999 4444457999998743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.044 Score=44.32 Aligned_cols=105 Identities=22% Similarity=0.176 Sum_probs=72.1
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceee
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHR 90 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~ 90 (226)
=...|++.|.++...+|+-.-...... -.+||+++.+..-..-.-+...++...+..+-.+++.-+.-|. ..+++|.
T Consensus 212 WAEKE~RNLkRl~~aGIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA 289 (520)
T KOG2270|consen 212 WAEKEMRNLKRLNNAGIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHA 289 (520)
T ss_pred HHHHHHHHHHHHHhcCCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence 346788999999877766555444433 3589999954322221222235666667777677777666664 5689999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~ 122 (226)
||+--|+++ .++.+.++|.+.+....++
T Consensus 290 DLSEfN~Ly----hdG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 290 DLSEFNLLY----HDGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred chhhhhheE----ECCEEEEEEccccccCCCh
Confidence 999999998 6788999999887655443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.23 Score=40.92 Aligned_cols=42 Identities=10% Similarity=-0.036 Sum_probs=28.9
Q ss_pred HHHHHHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeecCCCC
Q 027233 9 LKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 52 (226)
..++...|.+.|+.+. ..++++++.+.. ...++|||++++..
T Consensus 73 ~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lVME~L~~~~ 117 (401)
T PRK09550 73 TLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTVMEDLSDHK 117 (401)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEEEecCCCcc
Confidence 3456777888888872 345777776633 55789999997643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.035 Score=42.04 Aligned_cols=29 Identities=24% Similarity=0.401 Sum_probs=24.7
Q ss_pred CceeeccCCCCeEeeeCCC-CccEEEeeecccc
Q 027233 86 HIIHRDLKPENILLSGLDD-DVMLKIADFGLSC 117 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~-~~~~~l~df~~~~ 117 (226)
+++|+|+++.||+++ . ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~---~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYN---EEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEe---CCCCCEEEEEcccCC
Confidence 589999999999994 4 4679999999773
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.096 Score=41.44 Aligned_cols=28 Identities=32% Similarity=0.459 Sum_probs=23.5
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~ 116 (226)
.+++|||+++.||+++ . +.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECccc
Confidence 5789999999999994 3 56789999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.077 Score=42.04 Aligned_cols=30 Identities=40% Similarity=0.798 Sum_probs=24.9
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
.+++|||+++.|+++ +.++...++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLF---DGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEE---ECCceEEEeeccccc
Confidence 689999999999999 445556899999773
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.25 Score=40.52 Aligned_cols=30 Identities=27% Similarity=0.179 Sum_probs=24.4
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
...+|.|+.+.||+. .++.+.++||..+..
T Consensus 227 ~VfCHNDL~~gNIL~----~~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILD----FNQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEe----cCCCEEEEEeccccC
Confidence 457999999999987 345699999998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.34 Score=35.93 Aligned_cols=86 Identities=21% Similarity=0.319 Sum_probs=59.2
Q ss_pred HHHHHHHHHHHhcCC---CCCe--eeeeeEEEeC------------------CeEEEEEeecCCCCHHHHHHhcCCCCHH
Q 027233 10 KSCLDCELNFLSSVN---HPNI--IRLFDAFQAE------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 66 (226)
.+-|..|.+.+.+|+ +.++ ++++|+..-. ....||-||.+... .+...
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~ 168 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR 168 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh
Confidence 345777888777773 5566 8999987321 12457778775433 22223
Q ss_pred HHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccc
Q 027233 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (226)
Q Consensus 67 ~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~ 116 (226)
. +.+|..-+..+|..||+-+|+++.|..= -+|+|||.+
T Consensus 169 ~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 169 D----IPQMLRDLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred H----HHHHHHHHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 3 4566677788899999999999999862 288999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.091 Score=41.47 Aligned_cols=29 Identities=34% Similarity=0.465 Sum_probs=24.6
Q ss_pred CceeeccCCCCeEeeeCCC----CccEEEeeecccc
Q 027233 86 HIIHRDLKPENILLSGLDD----DVMLKIADFGLSC 117 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~----~~~~~l~df~~~~ 117 (226)
+++|+|+.+.||++ +. .+.+.++||+.+.
T Consensus 180 ~lcH~Dl~~~Nil~---~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILL---LNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEe---cCCCCCCCcEEEEeeCCCC
Confidence 58999999999999 44 3679999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.084 Score=41.04 Aligned_cols=49 Identities=33% Similarity=0.385 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHHHHHhC--CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 67 TARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 67 ~~~~~~~~i~~~l~~lh~~--~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.+...+..+-.++..++.. -++|+|+.|+|++. ++.+.+.|+||..+..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLL---TDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEE---cCCCcEEEEecccCCC
Confidence 3344555555555555544 58999999999999 5668999999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.12 Score=40.76 Aligned_cols=72 Identities=13% Similarity=0.056 Sum_probs=51.5
Q ss_pred HHHHHHHHHHHHhcCC-C--CCeeeeeeEEEe---CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVN-H--PNIIRLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+..|...++.|. + -.++++++.+.. .+..++|||+++|.++.+. ..+......+..+++++++.|
T Consensus 50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~L 124 (297)
T PRK10593 50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAW 124 (297)
T ss_pred cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHH
Confidence 3468999999999994 3 357788877654 4668999999999887651 122334455666777888888
Q ss_pred HhC
Q 027233 83 NSH 85 (226)
Q Consensus 83 h~~ 85 (226)
|..
T Consensus 125 H~~ 127 (297)
T PRK10593 125 HRI 127 (297)
T ss_pred hCC
Confidence 864
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.072 Score=38.92 Aligned_cols=29 Identities=17% Similarity=0.341 Sum_probs=23.6
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
-.+|+|+.|.|+++ ++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~---~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVH---SASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEE---ECCC-EEEEeCCcccC
Confidence 36899999999998 4444 88999998743
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.2 Score=40.50 Aligned_cols=31 Identities=23% Similarity=0.454 Sum_probs=25.4
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.++|+|+++.||+++ ..++.+.++||+.+..
T Consensus 201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMID--EETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence 589999999999994 2346799999998743
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.49 E-value=0.24 Score=39.71 Aligned_cols=28 Identities=43% Similarity=0.725 Sum_probs=23.1
Q ss_pred ceeeccCCCCeEeeeCCCCc-cEEEeeecccc
Q 027233 87 IIHRDLKPENILLSGLDDDV-MLKIADFGLSC 117 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~-~~~l~df~~~~ 117 (226)
++|+|+.+.||+++ .+. .+.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 99999999999994 444 48899998763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.25 Score=39.23 Aligned_cols=30 Identities=17% Similarity=0.207 Sum_probs=25.8
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
+++|||+.+.|+++ +.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 79999999999999 5667788999987744
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=92.27 E-value=1.7 Score=35.21 Aligned_cols=85 Identities=27% Similarity=0.198 Sum_probs=56.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc
Q 027233 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141 (226)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 141 (226)
.+.....++++.+.+..|..+... -.|--+.|+||++ +.+..+.+.-+|+-....+. -+.||.
T Consensus 81 ~~~k~~Klr~a~~~I~~l~e~~~t-r~~~~laPeNilf---~~~l~p~~vH~Glk~~lpPy-----------e~tee~-- 143 (434)
T COG4499 81 RKEKTRKLRLALQNIATLSELNNT-RYTFFLAPENILF---DGGLTPFFVHRGLKNSLPPY-----------EMTEER-- 143 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcc-ceeEEecchheEE---cCCCceEEEecchhccCCCC-----------CCCHHH--
Confidence 455667778788888877776543 4578899999999 67788888888865333111 122332
Q ss_pred ccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 027233 142 FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171 (226)
Q Consensus 142 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 171 (226)
=.-++-+++..++.|..+|...
T Consensus 144 --------f~~~ykA~~~~~fn~k~~Fe~l 165 (434)
T COG4499 144 --------FLKEYKALAIYAFNGKFSFESL 165 (434)
T ss_pred --------HHHHHHHHHHHHHcCCccHHHH
Confidence 1224667777888899888643
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.93 E-value=0.47 Score=34.98 Aligned_cols=34 Identities=29% Similarity=0.337 Sum_probs=24.5
Q ss_pred CCceeeccCCCCeEeeeCCC--CccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~--~~~~~l~df~~~~~ 118 (226)
..++|||+.+.|+++..... ...+.+.||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 45899999999999952111 12689999997733
|
subfamily of choline kinases |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.80 E-value=0.36 Score=35.93 Aligned_cols=31 Identities=35% Similarity=0.573 Sum_probs=20.5
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.++|+|+.+.||++. +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence 489999999999993 4678899999998743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.78 E-value=0.69 Score=38.27 Aligned_cols=61 Identities=21% Similarity=0.354 Sum_probs=46.2
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeeccCCCCeEee
Q 027233 39 NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLS 100 (226)
Q Consensus 39 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~dl~~~nili~ 100 (226)
....++-+|..|.++.-+++.. ..+++....++.-...|+-.+ --.+++|.|++|.||++.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3456777899999999988754 555666777777667765444 456899999999999996
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.91 E-value=0.16 Score=39.91 Aligned_cols=50 Identities=16% Similarity=0.190 Sum_probs=33.3
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeecCCC
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGG 51 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 51 (226)
||.........+..|+.-|+.|. .-.+++.++....++..++++||++.+
T Consensus 45 vK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 45 VKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 45555666788999999999993 455779999888777789999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.73 E-value=0.2 Score=39.10 Aligned_cols=30 Identities=27% Similarity=0.508 Sum_probs=23.4
Q ss_pred CceeeccCCCCeEeeeCCCCcc-EEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVM-LKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~-~~l~df~~~~~ 118 (226)
.++|||+++.||+++ .++. ..|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILID---EDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEe---CCCCEEEEECcHhccc
Confidence 489999999999994 3233 57999997743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=90.72 E-value=0.63 Score=37.39 Aligned_cols=31 Identities=29% Similarity=0.452 Sum_probs=25.4
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
++|+|+.+.||++. ..++.++++||+.+...
T Consensus 184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEe--CCCCcEEEEcccccCCC
Confidence 79999999999994 24568999999988443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.65 E-value=0.48 Score=37.97 Aligned_cols=28 Identities=29% Similarity=0.303 Sum_probs=22.9
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
.+++|||+.+.||++ ++ .+.++||+-+.
T Consensus 196 ~~liHgD~h~~NvL~---~d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILW---RD--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccc---cC--CcEEEeCCCCC
Confidence 468999999999999 32 46789999774
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.43 E-value=1.4 Score=35.40 Aligned_cols=46 Identities=22% Similarity=0.368 Sum_probs=28.9
Q ss_pred HHHHHHHHHHHHHHHHHHHh----CCceeeccCCCCeEeeeCCCCccEEE
Q 027233 65 EQTARKFLQQLGAGLEILNS----HHIIHRDLKPENILLSGLDDDVMLKI 110 (226)
Q Consensus 65 ~~~~~~~~~~i~~~l~~lh~----~~i~H~dl~~~nili~~~~~~~~~~l 110 (226)
.+-++-++-||+-..-.+-+ .+++|.||||+||++-+++....+++
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 327 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITL 327 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEE
Confidence 34456667777665433322 36999999999999964433333333
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 226 | ||||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-35 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-35 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-35 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-35 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-35 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-35 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-35 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-35 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-33 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-33 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-32 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-32 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-32 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-32 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-32 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-32 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-32 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-32 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-31 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-31 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-31 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-31 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-31 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-31 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-30 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-30 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-30 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-30 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-30 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-30 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-30 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-30 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-30 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-29 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-29 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-28 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-28 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-28 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-28 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-28 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-28 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-28 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-28 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-28 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-28 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-28 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-27 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-27 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-27 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-27 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-27 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-27 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-26 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-26 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-26 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-26 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-26 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-26 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-26 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-26 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-26 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-26 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-26 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-26 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-26 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-26 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-26 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-26 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-26 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-26 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-25 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-25 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-25 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-25 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-25 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-25 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-25 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-25 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-24 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-24 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-24 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-24 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-24 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-24 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-24 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-24 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-24 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-24 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-24 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-24 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-24 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-24 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-24 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-23 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-23 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-22 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-22 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-21 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-21 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-20 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 |
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-72
Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
+ L+ E+ S + HPNI+R+++ F I+L++EF G L ++ HGR
Sbjct: 56 GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
EQ + F+++L L + +IHRD+KPEN+L + LKIADFG S P
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NV 174
+CG+ Y+ PE+++ + +DEKVD+W G + +E L G PPF + NV
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
Query: 175 QLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 223
L P L D+ KLL + RL H +++ NS + P
Sbjct: 228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-72
Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
+ L+ E+ S + HPNI+RL+ F ++L++E+ G + ++ +
Sbjct: 51 GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
EQ ++ +L L +S +IHRD+KPEN+L L LKIADFG S P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NV 174
+CG+ Y+ PE+++ + +DEKVD+WS+G + +E L G PPF V
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222
Query: 175 QLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ P + D+ +LL N R E H ++ NS
Sbjct: 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 226 bits (576), Expect = 2e-70
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 9/184 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
++L+ + E+ + +NHPN++ + + L +E+C GG+L Y
Sbjct: 49 QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108
Query: 57 IRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + E R L + + L L+ + IIHRDLKPENI+L ++ KI D
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
G + L G + G+ Y+APE+L+ ++Y VD WS G + FE + G+ PF
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
Query: 174 VQLI 177
Sbjct: 229 PVQW 232
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 5e-70
Identities = 52/260 (20%), Positives = 95/260 (36%), Gaps = 54/260 (20%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
+ + E L +NH NI++LF + L++EFC G+L + +
Sbjct: 45 ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
Query: 61 GR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 116
+PE L+ + G+ L + I+HR++KP NI+ G D + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 168
L + G+ Y+ P++ + ++Y VD+WS+G + G PF
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 169 ----SGRNNVQL-----------------------------------IVPALHPDCVDMC 189
R N ++ + L +
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 190 LKLLSANTVDRLSFNEFYHH 209
+L A+ F++F+
Sbjct: 284 ANILEADQEKCWGFDQFFAE 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 6e-69
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 14/211 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ S+ H +++ F+ + +F+V+E C +L + + E AR +L+Q+
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
G + L+ + +IHRDLK N+ L++D+ +KI DFGL+ + Y G + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NVQLIVPA-LHPD 184
+APEVL + + +VD+WS+G I++ LL G PPF + +P ++P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241
Query: 185 CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ K+L + R + NE + F
Sbjct: 242 AASLIQKMLQTDPTARPTINELLNDEFFTSG 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 8e-69
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 14/211 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ S+ H +++ F+ + +F+V+E C +L + + E AR +L+Q+
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
G + L+ + +IHRDLK N+ L++D+ +KI DFGL+ + Y G + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NVQLIVPA-LHPD 184
+APEVL + + +VD+WS+G I++ LL G PPF + +P ++P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267
Query: 185 CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ K+L + R + NE + F
Sbjct: 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-68
Identities = 55/245 (22%), Positives = 105/245 (42%), Gaps = 34/245 (13%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 43 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 166 PPFSGRNN----VQLIV---------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
PF N + I+ D D+ L + R+S E H ++
Sbjct: 218 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277
Query: 213 RRNSA 217
+ +
Sbjct: 278 QIQTH 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-68
Identities = 55/244 (22%), Positives = 105/244 (43%), Gaps = 34/244 (13%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 166 PPFSGRNN----VQLIV---------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
PF N + I+ D D+ L + R+S E H ++
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 213 RRNS 216
+ +
Sbjct: 297 QIQT 300
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-67
Identities = 54/245 (22%), Positives = 104/245 (42%), Gaps = 34/245 (13%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 166 PPFSG-RNNVQLIV------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
PF N + + D D+ L + R+S E H ++
Sbjct: 265 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 213 RRNSA 217
+ +
Sbjct: 325 QIQTH 329
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-67
Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E+ + HP+I+ L++ F+ N ++LV+E C G ++ Y++ E AR F+ Q
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
+ G+ L+SH I+HRDL N+LL ++ +KIADFGL+ L P +CG+P
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN---------NVQLIVPA-LHP 183
Y++PE+ + + D+WS+G + + LL G PPF +P+ L
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
Query: 184 DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ D+ +LL N DRLS + H F+ RNS
Sbjct: 238 EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-66
Identities = 52/247 (21%), Positives = 93/247 (37%), Gaps = 53/247 (21%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
E L +NH NI++LF + L++EFC G+L + + +PE
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L+ + G+ L + I+HR++KP NI+ G D + K+ DFG + L +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 130 GSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF----SGRNNVQL- 176
G+ Y+ P++ + ++Y VD+WS+G + G PF R N ++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 177 ----------------------------------IVPALHPDCVDMCLKLLSANTVDRLS 202
+ L + +L A+
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 203 FNEFYHH 209
F++F+
Sbjct: 297 FDQFFAE 303
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-66
Identities = 57/161 (35%), Positives = 90/161 (55%), Gaps = 1/161 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + S++HPNIIRL++ F+ I+LV+E C GG L + E A + ++ +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ + + ++ HRDLKPEN L D LK+ DFGL+ PG G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+P+VL+ Y + D WS G +++ LL GYPPFS + ++
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-66
Identities = 66/161 (40%), Positives = 97/161 (60%), Gaps = 4/161 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L +NHP II++ + F AE+ ++V+E GG L + + R+ E T + + Q+
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
++ L+ + IIHRDLKPEN+LLS ++D ++KI DFG S L + +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
APEVL Y+ VD WS+G ILF L+GYPPFS
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 7e-66
Identities = 63/174 (36%), Positives = 94/174 (54%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ Q E+ +LV + GG L I
Sbjct: 42 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + +S+ I+HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF + +L
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-65
Identities = 66/174 (37%), Positives = 98/174 (56%), Gaps = 1/174 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
S + E+ L ++HPNI++LF+ + + ++V E GG L I R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A + ++Q+ +G+ ++ H+I+HRDLKPENILL + D +KI DFGLS
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ G+ Y+APEVL+ YDEK D+WS G IL+ LL+G PPF G+N +
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-65
Identities = 66/161 (40%), Positives = 97/161 (60%), Gaps = 4/161 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L +NHP II++ + F AE+ ++V+E GG L + + R+ E T + + Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
++ L+ + IIHRDLKPEN+LLS ++D ++KI DFG S L + +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
APEVL Y+ VD WS+G ILF L+GYPPFS
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-65
Identities = 63/174 (36%), Positives = 94/174 (54%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ Q E+ +LV + GG L I
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + +S+ I+HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF + +L
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-65
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 15/221 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L ++HPNI++L++ F+ + +LV E GG L I R E A + ++Q+
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ ++ + I+HRDLKPEN+LL D ++I DFGLS + G+ Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV--------------PAL 181
APEVL YDEK D+WS G IL+ LL+G PPF+G N ++ +
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 182 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
D+ K+L+ R+S + H +++ + +
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 6e-65
Identities = 73/221 (33%), Positives = 121/221 (54%), Gaps = 15/221 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L S++HPNII+LFD F+ + +LV EF GG L I + E A ++Q+
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ L+ H+I+HRD+KPENILL + + +KI DFGLS G+ Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV--------------PAL 181
APEVL+ ++Y+EK D+WS G I++ LL GYPPF G+N+ +I +
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 182 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
+ ++ +L+ + R + E + R++++ + +
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 9e-65
Identities = 73/229 (31%), Positives = 119/229 (51%), Gaps = 15/229 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
S + E+ L ++HPNI++LF+ + + ++V E GG L I R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A + ++Q+ +G+ ++ H+I+HRDLKPENILL + D +KI DFGLS
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV---- 178
+ G+ Y+APEVL+ YDEK D+WS G IL+ LL+G PPF G+N ++
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 179 ----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217
+ D D+ K+L+ + R++ + H ++++ S+
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-64
Identities = 57/178 (32%), Positives = 97/178 (54%), Gaps = 5/178 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
K ++ ++ E+ L S++HPNII++F+ F+ + +++V+E C GG L I
Sbjct: 57 KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ E + ++Q+ L +S H++H+DLKPENIL +KI DFGL+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
++ G+ LYMAPEV + + K D+WS G +++ LL G PF+G + ++
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-64
Identities = 75/238 (31%), Positives = 128/238 (53%), Gaps = 15/238 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
++ S L E+ L ++HPNI++L+D F+ + +LV+E GG L I +
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A ++Q+ +G+ L+ H+I+HRDLKPEN+LL + D ++KI DFGLS
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV---- 178
++ G+ Y+APEVL+ ++YDEK D+WS+G ILF LL GYPPF G+ + +++
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
Query: 179 ----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 226
+ D+ ++L ++ R+S + H +++ + + +P
Sbjct: 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-64
Identities = 75/224 (33%), Positives = 125/224 (55%), Gaps = 14/224 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+LN L E+ + +NHPNI++LF+ + E ++L++E+ +GG + Y+ HGR
Sbjct: 51 TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E+ AR +Q+ + ++ + I+HRDLK EN+L LD D+ +KIADFG S G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL----- 176
+ CG+P Y APE+ Q ++YD +VD+WS+G IL+ L++G PF G+N +L
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227
Query: 177 -----IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
I + DC ++ + L N + R + + R++
Sbjct: 228 RGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 6e-64
Identities = 73/211 (34%), Positives = 112/211 (53%), Gaps = 14/211 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L HP+II+L+ F+V+E+ +GG L YI HGRV E AR+ QQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ ++ + H ++HRDLKPEN+L LD + KIADFGLS + G + CGSP Y
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL---------IVPA-LHPD 184
APEV+ + Y +VD+WS G IL+ LL G PF + L +P L+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 185 CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + +L + + R + + H + +++
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-63
Identities = 55/235 (23%), Positives = 109/235 (46%), Gaps = 17/235 (7%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
+ +++ + E+ L+++ HPNI++ ++F+ +++V+++C GG+L I
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
E + Q+ L+ ++ I+HRD+K +NI L D +++ DFG++ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175
Query: 120 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI- 177
A G+P Y++PE+ + + Y+ K D+W++G +L+EL F + L+
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235
Query: 178 ------VPALH----PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
P + D + +L N DR S N F+ + +P
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-63
Identities = 64/177 (36%), Positives = 98/177 (55%), Gaps = 1/177 (0%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+KK S L+ E+ L + H NI+ L D +++ +LV++ +GG L I
Sbjct: 41 CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
G E+ A +QQ+ + ++ L+ + I+HRDLKPEN+L +++ + I DFGLS
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
G + CG+P Y+APEVL + Y + VD WS+G I + LL GYPPF +L
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-62
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
+K++ + + E+ L+ ++H NI+ + C+F+ +
Sbjct: 41 IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99
Query: 46 EFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
EFC G L +I R ++ + A + +Q+ G++ ++S +I+RDLKP NI L
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
D +KI DFGL +L + G+ YM+PE + Q Y ++VD++++G IL ELL+
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
Query: 164 -GYPPFSGRNNVQLIVPALHPDCV-----DMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
F + + D + KLLS DR + +E + + S
Sbjct: 217 VCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-62
Identities = 66/162 (40%), Positives = 92/162 (56%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L ++HPNII+L + F+ I LV+E GG L I G E+ A ++Q+
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ L+ + I+HRDLKPEN+L + D LKIADFGLS + + VCG+P Y
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
APE+L+ Y +VDMWSVG I + LL G+ PF Q +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-62
Identities = 68/168 (40%), Positives = 99/168 (58%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E++ L V+ HPNII+L D ++ FLV + G L Y+ + E+ RK ++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L + L+ +I+HRDLKPENIL LDDD+ +K+ DFG SC L PG +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 135 MAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+APE+++ Y ++VDMWS G I++ LL G PPF R + +
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-61
Identities = 61/159 (38%), Positives = 98/159 (61%), Gaps = 9/159 (5%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
HP+II L D++++ + +FLV + G L Y+ + E+ R ++ L + L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 141
+++I+HRDLKPENIL LDD++ ++++DFG SC L PG ++CG+P Y+APE+L+
Sbjct: 218 ANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 142 ----FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y ++VD+W+ G ILF LL G PPF R + +
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-61
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ +NH N+++ + + N +L +E+C+GG L I +PE A++F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+ N K+CG+
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNV----QLIVPA------- 180
Y+APE+L+ + + E VD+WS G +L +L G P+ ++
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 181 --LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + + K+L N R++ + R+ +
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-61
Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 1/175 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ E +L+ + GG L I
Sbjct: 47 KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + + ++HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 123 NYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
A G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF + +L
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-61
Identities = 57/162 (35%), Positives = 94/162 (58%), Gaps = 1/162 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+N L + HPNII L D F+ + + L++E +GG L ++ + E A +FL+Q+
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L + +K+ DFG++ + GN + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+APE++ ++ + DMWS+G I + LL+G PF G +
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-61
Identities = 53/177 (29%), Positives = 94/177 (53%), Gaps = 3/177 (1%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
++ + ++ + E+ L P +I L + ++ + I L++E+ AGG + S L
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
V E + ++Q+ G+ L+ ++I+H DLKP+NILLS + +KI DFG+S +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
++ G+P Y+APE+L + DMW++G I + LL PF G +N +
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-61
Identities = 57/174 (32%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+K ++K +++ E+ L HPNI++L + F + FLV+E GG L I+
Sbjct: 41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
E A +++L + + ++ ++HRDLKPEN+L + +D++ +KI DFG +
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 121 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
P N + C + Y APE+L YDE D+WS+G IL+ +L+G PF +
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-61
Identities = 41/241 (17%), Positives = 89/241 (36%), Gaps = 45/241 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
EL ++ + + + + ++++ E+ ++ + +P Q
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 68 ARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+ ++ + +++ +I HRD+KP NIL +D + +K++DFG S +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208
Query: 127 KVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------- 177
G+ +M PE + KVD+WS+G L+ + PFS + ++ +
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268
Query: 178 -----------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
L + +D L N +R++ + H +L
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
Query: 215 N 215
Sbjct: 329 T 329
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-61
Identities = 52/162 (32%), Positives = 90/162 (55%), Gaps = 1/162 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L V H N+I L D ++ + L++E +GG L ++ + E+ A F++Q+
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L++ I H DLKPENI+L +K+ DFGL+ + G + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+APE++ ++ + DMWS+G I + LL+G PF G +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-61
Identities = 56/162 (34%), Positives = 94/162 (58%), Gaps = 1/162 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + HPN+I L + ++ + + L++E AGG L ++ + E+ A +FL+Q+
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L +KI DFGL+ + GN + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+APE++ ++ + DMWS+G I + LL+G PF G +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 6e-61
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E+ LS V H NII++ D F+ + LV+E +G +L ++I H R+ E A +Q
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L + + L IIHRD+K ENI+ + +D +K+ DFG + L G CG+ Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 135 MAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNV---QLIVPA-LHPDCVDMC 189
APEVL Y +++MWS+G L+ L+ PF + P + + + +
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV 255
Query: 190 LKLLSANTVDRLSFNEFYHHRFLRRN 215
LL R + + ++ +
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQP 281
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-61
Identities = 54/162 (33%), Positives = 91/162 (56%), Gaps = 1/162 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L V HPNII L D ++ + L++E +GG L ++ + E+ A F++Q+
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L++ I H DLKPENI+L +K+ DFGL+ + G + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+APE++ ++ + DMWS+G I + LL+G PF G +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-61
Identities = 73/211 (34%), Positives = 116/211 (54%), Gaps = 14/211 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L HP+II+L+ + IF+V+E+ +GG L YI +GR+ E+ +R+ QQ+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G++ + H ++HRDLKPEN+L LD + KIADFGLS + G + CGSP Y
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL---------IVPA-LHPD 184
APEV+ + Y +VD+WS G IL+ LL G PF + L P L+P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS 242
Query: 185 CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + +L + + R + + H + +++
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-61
Identities = 75/211 (35%), Positives = 115/211 (54%), Gaps = 15/211 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+++L + HP+II+L+D I +V+E+ AGG L YI R+ E R+F QQ+
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+E + H I+HRDLKPEN+L LDD++ +KIADFGLS + GN+ + CGSP Y
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL----------IVPALHPD 184
APEV+ + Y +VD+WS G +L+ +L G PF L + L P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234
Query: 185 CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ +++ A+ + R++ E + N
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 9e-61
Identities = 64/237 (27%), Positives = 112/237 (47%), Gaps = 26/237 (10%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
+ + K L E+N L + HPNI+R +D +++V+E+C GG+L+S I
Sbjct: 41 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100
Query: 60 HGR----VPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + E+ + + QL L+ H ++HRDLKP N+ L D +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ L +A+ G+P YM+PE + Y+EK D+WS+G +L+EL PPF+
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
Query: 170 GRNNVQLI-------VPALH----PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ +L + + ++ ++L+ R S E + + +
Sbjct: 218 AFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-60
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ +NH N+++ + + N +L +E+C+GG L I +PE A++F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+ N K+CG+
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNV----QLIVPA------- 180
Y+APE+L+ + + E VD+WS G +L +L G P+ ++
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 181 --LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + + K+L N R++ + R+ +
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-60
Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ S+ HPNI+R + + +++E+ +GG L I GR E AR F QQL
Sbjct: 66 EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ +S I HRDLK EN LL G LKI DFG S + + + G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------VPA- 180
APEVL Q YD + D+WS G L+ +L G PF + +P
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 181 --LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ P+C + ++ A+ R+S E H + +N
Sbjct: 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-60
Identities = 71/276 (25%), Positives = 111/276 (40%), Gaps = 62/276 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
++++N + E+ + ++HPNI RL++ ++ E I LV+E C GG+L + +
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 62 RVP----------------------------------------EQTARKFLQQLGAGLEI 81
E+ ++Q+ + L
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
L++ I HRD+KPEN L S + +K+ DFGLS Y N E G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 137 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV--------------PA 180
PEVL + Y K D WS G +L LL G PF G N+ I
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
L P D+ LL+ N +R H ++ + S
Sbjct: 303 LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-60
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 16 ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
E+ L V+ +IRL D F+ + L++E +L +I G + E+ AR F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 131
Q+ + ++ ++HRD+K ENIL +D + LK+ DFG L G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 132 PLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNV---QLIVPA-LHPDCV 186
+Y PE +++ RY +WS+G +L++++ G PF + Q+ + +C
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 187 DMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ L+ DR +F E +H +++
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-60
Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 5/162 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
E + + HP+I+ L + + ++ +++V EF G +L I E A +
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 130
++Q+ L + ++IIHRD+KP +LL+ ++ +K+ FG++ L G A G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+P +MAPEV++ + Y + VD+W G ILF LL+G PF G
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-59
Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 2/153 (1%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
HPNII L D + +++V E GG L I E+ A L + +E L
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 83 NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 140
++ ++HRDLKP NIL + ++I DFG + L N C + ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ Q YD D+WS+G +L+ +L GY PF+ +
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-59
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
+ HP +IRL D F+ + LV+E +L YI G + E +R F Q+ A +
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
+ +S ++HRD+K ENIL+ K+ DFG L G+ +Y PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209
Query: 140 LQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNV---QLIVPA-LHPDCVDMCLKLLS 194
+ +Y +WS+G +L++++ G PF + +L PA + PDC + + L+
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLA 269
Query: 195 ANTVDRLSFNEFYHHRFLR 213
R S E +++
Sbjct: 270 PKPSSRPSLEEILLDPWMQ 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-59
Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 16/224 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ ++ ++HP +I L DAF+ + + L++EF +GG L I E +++Q
Sbjct: 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL+ ++ H I+H D+KPENI+ +KI DFGL+ L P + + +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV--------------PA 180
APE++ + DMW++G + + LL+G PF+G ++++ + +
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFH 224
+ P+ D LL RL+ ++ H +L+ + + L +
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-59
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 21/229 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K+ + D E+ V HP +RL A++ ++L E C G +L
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145
Query: 56 YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ G +PE +L+ L L+S ++H D+KP NI L K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF---LGPRGRCKLGDFG 202
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
L L E G P YMAPE+LQ Y D++S+G + E+ G
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGW 261
Query: 175 QLIV---------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
Q + L + + + +L + R + LR+
Sbjct: 262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 9e-59
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E+ L ++HPN+++L + E+ +++V E G + + E AR + Q
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 132
L G+E L+ IIHRD+KP N+L + +D +KIADFG+S + G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 133 LYMAPEVLQFQR--YD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV-------- 178
+MAPE L R + + +D+W++G L+ + G PF + L I
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261
Query: 179 -PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
P + D D+ ++L N R+ E H ++ R
Sbjct: 262 QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-58
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 23/230 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
E+ L + H N+I+L D E +++V+E+C G + + R P A +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 128
QL GLE L+S I+H+D+KP N+L L LKI+ G++ L+P +
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 129 CGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL---------- 176
GSP + PE+ + KVD+WS G L+ + G PF G N +L
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 177 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 226
I P D+ +L R S + H + R+ AP IP
Sbjct: 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIP 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-58
Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 16/217 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ +S + HP ++ L DAF+ +N + ++ EF +GG L + H ++ E A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ GL ++ ++ +H DLKPENI+ + + LK+ DFGL+ L P + G+ +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV--------------PA 180
APEV + + DMWSVG + + LL+G PF G N+ + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217
+ D D KLL A+ R++ ++ H +L +A
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-58
Identities = 59/162 (36%), Positives = 94/162 (58%), Gaps = 2/162 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
E++ ++ ++H N+I+L+DAF+++N I LV+E+ GG L I + E F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ G+ ++ +I+H DLKPENIL D +KI DFGL+ P + G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+APEV+ + DMWSVG I + LL+G PF G N+ +
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-58
Identities = 56/244 (22%), Positives = 95/244 (38%), Gaps = 49/244 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
E+ L+S+NH ++R + A+ +F+ +E+C G L I
Sbjct: 52 EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 63 -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 119
+ +Q+ L ++S IIHRDLKP NI +D+ +KI DFGL+ +
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168
Query: 120 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165
+ G+ +Y+A EVL Y+EK+DM+S+G I FE++ Y
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226
Query: 166 PPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211
P +G V ++ + L+ + R + +
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286
Query: 212 LRRN 215
L
Sbjct: 287 LPVK 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 8e-58
Identities = 50/162 (30%), Positives = 87/162 (53%), Gaps = 2/162 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
E++ L+ H NI+ L ++F++ + ++ EF +G ++ I + E+ ++ Q
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ L+ L+SH+I H D++PENI+ +KI +FG + L PG+ + +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
APEV Q DMWS+G +++ LL+G PF N Q+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-57
Identities = 59/163 (36%), Positives = 86/163 (52%), Gaps = 13/163 (7%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
H N++ L + F+ E+ +LV E GG++ S+I E A +Q + + L+ L+
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 135
+ I HRDLKPENIL + +KI DF L + + CGS YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 136 APEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
APEV+ + YD++ D+WS+G IL+ LL+GYPPF GR
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-57
Identities = 56/156 (35%), Positives = 89/156 (57%), Gaps = 6/156 (3%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+R+ D ++ C+ +V+E GG L S I R E+ A + ++ +G
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+S +I HRD+KPEN+L + + +LK+ DFG + N C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
EVL ++YD+ DMWS+G I++ LL GYPPF +
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-57
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL + + HP ++ L+ +FQ E +F+VV+ GG+L +++ + E+T + F+ +L
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
L+ L + IIHRD+KP+NIL LD+ + I DF ++ L + G+ YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGRNN------VQLIV-------P 179
APE+ ++ Y VD WS+G +ELL G P+ R++ V
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 180 ALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 213
A + V + KLL N R ++ + ++
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-56
Identities = 68/228 (29%), Positives = 118/228 (51%), Gaps = 27/228 (11%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+ + D ++ + C+ +++E GG L S I R E+ A + ++ +G
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+SH+I HRD+KPEN+L + + D +LK+ DFG + N + C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPAL------------HP-- 183
EVL ++YD+ DMWS+G I++ LL G+PPF Q I P + +P
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEW 257
Query: 184 DCV-----DMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 226
V + LL + +RL+ +F +H ++ ++ + + P H
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 305
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-56
Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + +S ++HP ++L+ FQ + ++ + + G L YIR G E R + ++
Sbjct: 80 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
+ LE L+ IIHRDLKPENIL L++D+ ++I DFG + L P + + G+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV-------PALH 182
Y++PE+L + + D+W++G I+++L+ G PPF N + I+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 256
Query: 183 PDCVDMCLKLLSANTVDRL 201
P D+ KLL + RL
Sbjct: 257 PKARDLVEKLLVLDATKRL 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-54
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E++ L +NHPN+I+ + +F +N + +V+E G+LS I+ + +PE+T K+
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 130
QL + LE ++S ++HRD+KP N+ + ++K+ D GL A + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG--RNNVQLI----------V 178
+P YM+PE + Y+ K D+WS+G +L+E+ PF G N L +
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258
Query: 179 PALH--PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
P+ H + + ++ + R Y
Sbjct: 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-53
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 26/243 (10%)
Query: 3 KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
K++ S D E+ L S HPN+IR F + ++ +E C L Y+
Sbjct: 54 KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112
Query: 62 RV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 118
LQQ +GL L+S +I+HRDLKP NIL+S + I+DFGL
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 119 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL-NGYPPFSG 170
L G ++ V G+ ++APE+L + VD++S G + + ++ G PF
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
Query: 171 RNNVQLIV-------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217
Q + ++ K+++ + R S H F
Sbjct: 233 SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
Query: 218 ILR 220
L+
Sbjct: 293 QLQ 295
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 29/220 (13%)
Query: 2 LKKLNK----------HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
+K L+K H + E L +VN P +++L +F+ + +++V+E+ AGG
Sbjct: 71 MKILDKQKVVKLKQIEHTLN----EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+ S++R GR E AR + Q+ E L+S +I+RDLKPEN+L +D +++
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVT 183
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
DFG + + +CG+P +APE++ + Y++ VD W++G +++E+ GYPPF
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 172 NNVQL---IV-------PALHPDCVDMCLKLLSANTVDRL 201
+Q+ IV D D+ LL + R
Sbjct: 242 QPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-52
Identities = 72/203 (35%), Positives = 109/203 (53%), Gaps = 29/203 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E LS V HP IIR++ FQ IF+++++ GG L S +R R P A+ + ++
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-------CTLYPGNYAEKV 128
LE L+S II+RDLKPENIL LD + +KI DFG + TL
Sbjct: 116 CLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAKYVPDVTYTL--------- 163
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV------- 178
CG+P Y+APEV+ + Y++ +D WS G +++E+L GY PF N ++ I+
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 223
Query: 179 PALHPDCVDMCLKLLSANTVDRL 201
P + D D+ +L++ + RL
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQRL 246
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-52
Identities = 59/252 (23%), Positives = 99/252 (39%), Gaps = 45/252 (17%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
L + + E+ L+ + HP I+R F+A+ +N +++ ++ C
Sbjct: 40 LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98
Query: 50 GGNLSSYIRLHGRV---PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
NL ++ + Q+ +E L+S ++HRDLKP NI D
Sbjct: 99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 155
Query: 107 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153
++K+ DFGL + G+ LYM+PE + Y KVD++S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
Query: 154 VGAILFELLNGYPPFSGRNNVQLI-------VPALH----PDCVDMCLKLLSANTVDRLS 202
+G ILFELL YP + V+ + P L P M +LS + ++R
Sbjct: 216 LGLILFELL--YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273
Query: 203 FNEFYHHRFLRR 214
+
Sbjct: 274 AINIIENAVFED 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 4e-52
Identities = 58/263 (22%), Positives = 111/263 (42%), Gaps = 47/263 (17%)
Query: 3 KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
K++ E+ L+ S +HPN+IR + + + +++ +E C NL +
Sbjct: 45 KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103
Query: 62 -------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS----------GLDD 104
E L+Q+ +G+ L+S IIHRDLKP+NIL+S +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 105 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKVDMW 152
++ + I+DFGL L G + + G+ + APE+L+ +R +D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 153 SVGAILFELL-NGYPPFSGRNNVQ---------------LIVPALHPDCVDMCLKLLSAN 196
S+G + + +L G PF + + + L +L + D+ +++ +
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 197 TVDRLSFNEFYHHRFLRRNSAIL 219
+ R + + H S L
Sbjct: 284 PLKRPTAMKVLRHPLFWPKSKKL 306
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-52
Identities = 75/218 (34%), Positives = 110/218 (50%), Gaps = 19/218 (8%)
Query: 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E N L V HP I+ L AFQ ++L++E+ +GG L + G E TA +
Sbjct: 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 130
L ++ L L+ II+RDLKPENI+ L+ +K+ DFGL +++ G CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV-------PA 180
+ YMAPE+L ++ VD WS+GA+++++L G PPF+G N + I+ P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
Query: 181 LHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
L + D+ KLL N RL E H F R
Sbjct: 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-51
Identities = 72/214 (33%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L VNHP I++L AFQ E ++L+++F GG+L + + E+ + +L +L
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 134
L+ L+S II+RDLKPENIL LD++ +K+ DFGLS ++ A CG+ Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---IV-------PALHPD 184
MAPEV+ + + + D WS G ++FE+L G PF G++ + I+ L P+
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 185 CVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
+ L N +RL E H F
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-51
Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 22/231 (9%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
L+K + K + E L + HP + L AFQ + + V+E+ GG L ++
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 117
E+ AR + ++ + LE L+S +++RD+K EN++ LD D +KI DFGL
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKE 154
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL- 176
+ G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +++ +L
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
Query: 177 --IV-------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
I+ L P+ + LL + RL E HRF
Sbjct: 215 ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-50
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 21/231 (9%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
L+ EL + ++ P I+ L+ A + + + +E GG+L I+ G +PE A
Sbjct: 93 LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 127
+L Q GLE L++ I+H D+K +N+LLS D + DFG + L P +
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 128 -----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV---- 178
+ G+ +MAPEV+ + D KVD+WS ++ +LNG P++ L +
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270
Query: 179 ---------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 220
P+ P + L V R S E
Sbjct: 271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-50
Identities = 69/237 (29%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
+KL K + E L + HPNI+R +D++ + + CI LV E G L +Y+
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ + + R + +Q+ GL+ L++ IIHRDLK +NI ++G V KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
TL ++A+ V G+P +MAPE+ + ++YDE VD+++ G + E+ P+S N
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236
Query: 176 ---LIV-----PALHPDCVD--------MCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
V PA C++ N +R S + +H F + +
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ---NKDERYSIKDLLNHAFFQEET 290
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-50
Identities = 72/228 (31%), Positives = 109/228 (47%), Gaps = 19/228 (8%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK L C E + HP + +F FQ + +F V+E+ GG+L +I
Sbjct: 50 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ + A + ++ GL+ L+S I++RDLK +NIL LD D +KIADFG+
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCK 166
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ CG+P Y+APE+L Q+Y+ VD WS G +L+E+L G PF G++ +L
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226
Query: 177 ---IV-------PALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 213
I L + D+ +KL RL + H R
Sbjct: 227 FHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-50
Identities = 68/233 (29%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 1 MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+LKK + K + E L + HP + L +FQ + + V+E+ GG L ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
E AR + ++ + L+ L+S +++RDLK EN++L D D +KI DFGL
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLC 296
Query: 117 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +++ +
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356
Query: 176 L---IV-------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
L I+ L P+ + LL + RL E HRF
Sbjct: 357 LFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-50
Identities = 40/227 (17%), Positives = 79/227 (34%), Gaps = 25/227 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ K N + L ++ + A +N LV E + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 61 GR-----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL--------SGLDDDVM 107
+P+ F ++ +E ++ IIH D+KP+N +L D
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 108 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
L + D G S + G C + + E+L + ++ ++D + V A ++ +L G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 165 YPPFSGRNNVQLIVPALHP---------DCVDMCLKLLSANTVDRLS 202
+ L + + L + + + L
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-50
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 40/261 (15%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
LK++ H + + E + NHPNI+RL E + +L++ F G L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 55 SYI----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ I + E L + GLE +++ HRDLKP NIL L D+ +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175
Query: 111 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAI 157
D G + + + Y APE+ Q + DE+ D+WS+G +
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 158 LFELLNGYPPFSGRN----NVQLIV---------PALHPDCVDMCLKLLSANTVDRLSFN 204
L+ ++ G P+ +V L V P + +++ + R
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295
Query: 205 EFYHHRFLRRNSAILRAPFHI 225
+ A + I
Sbjct: 296 LLLSQLEALQPPAPGQHTTQI 316
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-49
Identities = 75/231 (32%), Positives = 115/231 (49%), Gaps = 22/231 (9%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
L+K L K + + E N L +V HP ++ L +FQ + ++ V+++ GG L ++
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ E AR + ++ + L L+S +I++RDLKPENIL LD + + DFGL
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCK 187
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ + CG+P Y+APEVL Q YD VD W +GA+L+E+L G PPF RN ++
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
Query: 177 ---IV-------PALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLR 213
I+ P + + LL + RL F E H F
Sbjct: 248 YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 3e-49
Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 30/239 (12%)
Query: 2 LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
KKL K +K E L VN ++ L A++ ++ + LV+ GG+L
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273
Query: 56 YIRLHGRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+I G+ PE A + ++ GLE L+ I++RDLKPENILL DD ++I+D
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330
Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
GL+ + G + G+ YMAPEV++ +RY D W++G +L+E++ G PF R
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 174 V-------QLIV-------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
+L+ P +C +LL + +RL S E H +
Sbjct: 391 KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-49
Identities = 48/231 (20%), Positives = 91/231 (39%), Gaps = 33/231 (14%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
E+ + + H +++R F A+ ++ + + E+C GG+L+ I + R+ E +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 114
L Q+G GL ++S ++H D+KP NI +S + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ + + G ++A EVLQ + K D++++ + P +
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 174 VQLIVPALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
I P + ++ ++ + R S H L S
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-48
Identities = 71/233 (30%), Positives = 117/233 (50%), Gaps = 25/233 (10%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK + C E L+ P + +L FQ + ++ V+E+ GG+L +I
Sbjct: 53 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR E A + ++ GL L S II+RDLK +N++ LD + +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 168
Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
++ G + CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PF G + +
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
Query: 176 L---IV-------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
L I+ ++ + V +C L++ + RL + H F R
Sbjct: 229 LFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-48
Identities = 74/215 (34%), Positives = 107/215 (49%), Gaps = 18/215 (8%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK L C E LS NHP + +LF FQ + +F V+EF GG+L +I
Sbjct: 56 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ R E AR + ++ + L L+ II+RDLK +N+L LD + K+ADFG+
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCK 172
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ G CG+P Y+APE+LQ Y VD W++G +L+E+L G+ PF N L
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 177 ---IV-------PALHPDCVDMCLKLLSANTVDRL 201
I+ LH D + ++ N RL
Sbjct: 233 FEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-48
Identities = 69/243 (28%), Positives = 121/243 (49%), Gaps = 38/243 (15%)
Query: 2 LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K LNK LK +C E + L + + I L AFQ +N ++LV+++ GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163
Query: 56 YI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ + R+PE+ AR +L ++ ++ ++ H +HRD+KP+NIL +D + +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220
Query: 115 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYP 166
C + + G+P Y++PE+LQ RY + D WS+G ++E+L G
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 167 PFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFN---EFYH 208
PF + V+ V + + D+ +L+ + RL N +F
Sbjct: 280 PFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKK 338
Query: 209 HRF 211
H F
Sbjct: 339 HPF 341
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 30/239 (12%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
L K + E L+ V+ I+ L AF+ + + LV+ GG++ +I
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 58 ---RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ E A + Q+ +GLE L+ +II+RDLKPEN+LL DDD ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLG 334
Query: 115 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
L+ + G+P +MAPE+L + YD VD +++G L+E++ PF R
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 174 V-------QLIV-------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
Q ++ P D C LL + RL S + H R
Sbjct: 395 KVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-47
Identities = 69/239 (28%), Positives = 115/239 (48%), Gaps = 34/239 (14%)
Query: 2 LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L+K +K + E + ++ N P +++LF AFQ + +++V+E+ GG+L +
Sbjct: 99 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ + VPE+ AR + ++ L+ ++S IHRD+KP+N+L LD LK+ADFG
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214
Query: 116 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFS 169
+ G+P Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
Query: 170 GRNNVQL---IV-----------PALHPDCVDMCLKLLSANTVDRLSFN---EFYHHRF 211
+ V I+ + + ++ L+ RL N E H F
Sbjct: 275 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDRE-VRLGRNGVEEIKRHLF 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-47
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + + HPNII L E + LV+EF GG L+ L G+ +P + Q
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113
Query: 75 LGAGLEILNSHH---IIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 126
+ G+ L+ IIHRDLK NIL+ G + +LKI DFGL+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALH---- 182
G+ +MAPEV++ + + D+WS G +L+ELL G PF G + + +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 183 ---PDCVDMCLKLL-----SANTVDRLSFNE 205
P L + + R SF
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 9e-47
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 2 LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
+K L+K +K E LS V+ P I+ + AF + + +++ GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278
Query: 53 LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
L ++ HG E R + ++ GLE +++ +++RDLKP NIL LD+ ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGR 171
GL+C G+ YMAPEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 172 NNV------QLIV-------PALHPDCVDMCLKLLSANTVDRL 201
++ + + P+ + LL + RL
Sbjct: 395 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 437
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-47
Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E+ + + HPNI+ A + +V E+ + G+L + G + E+
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 73 QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 129
+ G+ L++ + I+HR+LK N+L+ D +K+ DFGLS ++
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALH------- 182
G+P +MAPEVL+ + +EK D++S G IL+EL P+ N Q++
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 183 PDCVDMCLKLL-----SANTVDRLSFNE 205
P ++ + + + R SF
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFAT 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-46
Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 28/235 (11%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
+ ++ + + N + + +++ ++ C NL ++
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
Q+ +E L+S ++HRDLKP NI D ++K+ DFGL +
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMD 215
Query: 120 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
G+ LYM+PE + Y KVD++S+G ILFELL +
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 168 FSGRNNV-----QLIVPAL----HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
R + L P L +P M +LS + +R + +
Sbjct: 276 QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-46
Identities = 30/232 (12%), Positives = 64/232 (27%), Gaps = 31/232 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
+ + +IR+ + F + G L S+ H +
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
+ Q+ L L+ + ++H L+P +I+ LD + + F
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVV 261
Query: 128 VCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
S + PE+ + D W++G +++ + P + +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321
Query: 177 I------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
+ + L DRL + + L A
Sbjct: 322 SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 373
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-46
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E L + P ++ L AFQ E + L++++ GG L +++ R E + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
+ LE L+ II+RD+K ENIL LD + + + DFGLS A CG+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNV-------QLIV----- 178
YMAP++++ +D+ VD WS+G +++ELL G PF+ + I+
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 179 --PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
+ D+ +LL + RL +E H F +
Sbjct: 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-45
Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 38/244 (15%)
Query: 2 LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K +NK + + C E + L + + I +L AFQ EN ++LV+E+ GG+L +
Sbjct: 91 MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 56 YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ G R+P + AR +L ++ ++ ++ +HRD+KP+NIL LD +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207
Query: 115 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGY 165
L + G+P Y++PE+LQ Y + D W++G +E+ G
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 166 PPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFN---EFY 207
PF + + + + D +LL RL +F
Sbjct: 268 TPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326
Query: 208 HHRF 211
H F
Sbjct: 327 THPF 330
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-45
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 27/158 (17%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+R+ D ++ C+ +V+E GG L S I R E+ A + ++ +G
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+S +I HRD+KPEN+L + + +LK+ DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
E ++YD+ DMWS+G I++ LL GYPPF + +
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-45
Identities = 67/242 (27%), Positives = 118/242 (48%), Gaps = 33/242 (13%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+KK + + E + F + NHP ++ L FQ E+ +F V+E+ GG+L ++
Sbjct: 42 VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 101
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ ++PE+ AR + ++ L L+ II+RDLK +N+L LD + +K+ D+G+
Sbjct: 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCK 158
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-- 174
L PG+ CG+P Y+APE+L+ + Y VD W++G ++FE++ G PF +
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
Query: 175 ----------QLIV-------PALHPDCVDMCLKLLSANTVDRL------SFNEFYHHRF 211
Q+I+ +L + L+ + +RL F + H F
Sbjct: 219 PDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
Query: 212 LR 213
R
Sbjct: 279 FR 280
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-45
Identities = 71/234 (30%), Positives = 117/234 (50%), Gaps = 25/234 (10%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK + C E L+ P + +L FQ + ++ V+E+ GG+L +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR E A + ++ GL L S II+RDLK +N++ LD + +KIADFG+ C
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 489
Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
++ G + CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PF G + +
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 176 L---IV-------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 214
L I+ ++ + V +C L++ + RL + H F R
Sbjct: 550 LFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 29/221 (13%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 137
L L+ II+RDLK +N+L LD + +K+ D+G+ L PG+ CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV------------QLIV------- 178
E+L+ + Y VD W++G ++FE++ G PF + Q+I+
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282
Query: 179 PALHPDCVDMCLKLLSANTVDRL------SFNEFYHHRFLR 213
+L + L+ + +RL F + H F R
Sbjct: 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-44
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---KFL 72
EL LS VNHPNI++L+ A C+ V+E+ GG+L + + +P TA +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 73 QQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
Q G+ L+S +IHRDLKP N+LL +LKI DFG +C + +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG-RNNVQLIVPALH------ 182
GS +MAPEV + Y EK D++S G IL+E++ PF I+ A+H
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 183 -PDCVDMCLKLL-----SANTVDRLSFNE 205
+ ++ L S + R S E
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-44
Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
E+ L H NI+ A I V ++C G +L ++ + + +
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 130
Q G++ L++ IIHRDLK NI L +D +KI DFGL+ + E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 131 SPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALH 182
S L+MAPEV++ Q Y + D+++ G +L+EL+ G P+S NN I+ +
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-44
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ +S++NHPNI++L+ + V+EF G+L + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 75 LGAGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 130
+ G+E + + + I+HRDL+ NI L LD V K+ADFGLS + + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188
Query: 131 SPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV---------- 178
+ +MAPE + + Y EK D +S IL+ +L G PF + ++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 179 PALHPDCVDMCLKLL----SANTVDRLSFNE 205
P + DC ++ S + R F+
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-43
Identities = 58/265 (21%), Positives = 96/265 (36%), Gaps = 43/265 (16%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
LK+L + + E+ F+ + HPNI++ A FL++
Sbjct: 58 LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 51 GNLSSYI---RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD 105
G L ++ G + T K Q ++ ++ IIHRDLK EN+LL +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQ 174
Query: 106 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 149
+K+ DFG + T+ +P+Y PE++ EK
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 150 DMWSVGAILFELLNGYPPFSGRN-----NVQLIVPALH---PDCVDMCLKLLSANTVDRL 201
D+W++G IL+ L PF N + +P + +L N +RL
Sbjct: 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294
Query: 202 SFNEFYHHRFLRRNSAILRAPFHIP 226
S E H + + I
Sbjct: 295 SIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-43
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
L E+ + H NI++ +F I + +E GG+LS+ +R G + EQT
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 128
+ +Q+ GL+ L+ + I+HRD+K +N+L++ + KI+DFG S L N +
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183
Query: 129 CGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------- 177
G+ YMAPE++ Y + D+WS+G + E+ G PPF Q
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243
Query: 178 ---VPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+P + + LK + R N+ FL+ +S
Sbjct: 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-42
Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 5/186 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PEQ K +
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76 GAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALHPDCVDMCLKLLS 194
M+PE LQ Y + D+WS+G L E+ G P + +L + D
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 195 ANTVDR 200
T R
Sbjct: 257 PRTPGR 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-42
Identities = 38/178 (21%), Positives = 73/178 (41%), Gaps = 20/178 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ H N++ A + + ++ C G L S +R V R+ Q+
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 128
+ G+ L++ I+H+DLK +N+ D+ + I DFGL +
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 129 CGSPLYMAPEVLQFQR---------YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
G ++APE+++ + + D++++G I +EL PF + +I
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-42
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 30/223 (13%)
Query: 16 ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
+L+ + S + P I++ F F +F+ +E R+ G +PE+ K
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 75 LGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ L L H +IHRD+KP NILL +K+ DFG+S L ++ G
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNV----QLIV----PA 180
YMAPE + YD + D+WS+G L EL G P+ ++ P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249
Query: 181 LHP---------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
L V CL + R +N+ H F++R
Sbjct: 250 LPGHMGFSGDFQSFVKDCLT---KDHRKRPKYNKLLEHSFIKR 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-42
Identities = 44/179 (24%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ + + HPN+++ + + + E+ GG L I+ P F +
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
+ +G+ L+S +IIHRDL N L+ ++ + +ADFGL+ + +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 128 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
V G+P +MAPE++ + YDEKVD++S G +L E++ +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-42
Identities = 28/228 (12%), Positives = 54/228 (23%), Gaps = 34/228 (14%)
Query: 24 NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
+ P +L L++ + L G QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
L S ++H P+N+ + D L + D G Y
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258
Query: 136 APEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----------------- 176
E L + ++ W +G ++ + + PF
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318
Query: 177 --IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
L + + L+ + RL E + + +
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSS 366
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-41
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
S ++H NI+ + D + ++C +LV+E+ G LS YI HG + TA F Q+ G++
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 135
+ I+HRD+KP+NIL +D + LKI DFG+ +L V G+ Y
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---------------IVPA 180
+PE + + DE D++S+G +L+E+L G PPF+G V + +
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 181 LHPDCVDMCLKLLSANTVDR 200
+ ++ L+ + +R
Sbjct: 240 IPQSLSNVILRATEKDKANR 259
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-41
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 26/176 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + H NII L + + L+ E+ +L Y+ + V + + FL QL
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76 GAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
G+ +S +HRDLKP+N+LLS + +LKI DFGL+ + G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191
Query: 134 -----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y PE+L + Y VD+WS+ I E+L P F G + + QL
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-40
Identities = 44/211 (20%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
E L +HPN++ + A Q+ L+ + G+L + + V + A KF
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 72 LQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ G+ L++ I L ++++ D+D+ +I+ + +
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPG----RM 169
Query: 130 GSPLYMAPEVLQFQRYD---EKVDMWSVGAILFELLNGYPPFSGRNNVQLIV-------- 178
+P ++APE LQ + D DMWS +L+EL+ PF+ +N+++ +
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 179 PALHPDCVDMCLKLL----SANTVDRLSFNE 205
P + P KL+ + + R F+
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDM 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-40
Identities = 58/175 (33%), Positives = 90/175 (51%), Gaps = 28/175 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L ++HPNI+ L D +E C+ LV EF +L + + + + +L Q
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L G+ + H I+HRDLKP+N+L ++ D LK+ADFGL+ + G P+
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y AP+VL ++Y VD+WS+G I E++ G P F G + QL
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-40
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 28/175 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + H NI++L+D + + LV E +L + + TA+ FL Q
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L G+ + ++HRDLKP+N+L ++ + LKIADFGL+ + G P+
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y AP+VL ++Y +D+WSVG I E++NG P F G + QL
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-40
Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 28/175 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + HPN++ L + F+ + + LV E+C + + + R VPE + Q
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ + H+ IHRD+KPENIL + ++K+ DFG + ++ P
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y +PE+L +Y VD+W++G + ELL+G P + G+++V QL
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 66/175 (37%), Positives = 92/175 (52%), Gaps = 28/175 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L ++HPNII L DAF ++ I LV +F +L I+ + V + ++
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
GLE L+ H I+HRDLKP N+L LD++ +LK+ADFGL+ K GSP
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L + Y VDMW+VG IL ELL P G +++ QL
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-40
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ + +++++E+ GG+ + G + E L+++
Sbjct: 70 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 134
GL+ L+S IHRD+K N+LLS + +K+ADFG++ L G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLIVPALHP--------- 183
MAPEV++ YD K D+WS+G EL G PP S + V ++P +P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK 245
Query: 184 ---DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
+ V+ CL R + E H+F+ RN+
Sbjct: 246 PLKEFVEACLN---KEPSFRPTAKELLKHKFILRNA 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-39
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 31/224 (13%)
Query: 16 ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
+L+ + +V+ P + + A E +++ +E Y I +PE K
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 72 LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
+ LE L+S +IHRD+KP N+L++ V K+ DFG+S L + G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171
Query: 131 SPLYMAPEV----LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV----QLIV---- 178
YMAPE L + Y K D+WS+G + EL P+ + +V
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231
Query: 179 PALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
P L D CLK N+ +R ++ E H F
Sbjct: 232 PQLPADKFSAEFVDFTSQCLK---KNSKERPTYPELMQHPFFTL 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-39
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 24/216 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + + E ++
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
LE L+S+ +IHRD+K +NILL +D V K+ DFG + P + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ---LI----VPALHP---- 183
MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ LI P L
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 184 -----DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
D ++ CL++ + R S E H+FL+
Sbjct: 243 SAIFRDFLNRCLEM---DVEKRGSAKELLQHQFLKI 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-39
Identities = 56/216 (25%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ ++ ++ +++++EF GG L+ + R+ E+ + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L L++ +IHRD+K ++ILL+ LD V K++DFG + K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ---LIV----PALHP---- 183
MAPEV+ Y +VD+WS+G ++ E+++G PP+ + VQ + P L
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 184 -----DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
D ++ L + +R + E H FL +
Sbjct: 268 SPVLRDFLERMLVR---DPQERATAQELLDHPFLLQ 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-39
Identities = 50/175 (28%), Positives = 87/175 (49%), Gaps = 28/175 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + H N++ L + + + +LV EF + + L + Q +K+L Q
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ +SH+IIHRD+KPENIL + ++K+ DFG + + +P
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L +Y + VD+W++G ++ E+ G P F G +++ QL
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-39
Identities = 31/229 (13%), Positives = 67/229 (29%), Gaps = 26/229 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
+ + +IR+ + + F + L S+ H +
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
+ Q+ L L+ + ++H L+P +I+ LD + + F +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 127 -KVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPA 180
+ P A +L F + D W++G ++ + P + +
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEW 328
Query: 181 LHPDCVDM-------CLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
+ C ++ L DRL + + L A
Sbjct: 329 IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 377
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-39
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E++ + + P++++ + ++ +++V+E+C G++S IRL + E LQ
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 133
GLE L+ IHRD+K NILL+ + K+ADFG++ L V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ---LI----VPALHP--- 183
+MAPEV+Q Y+ D+WS+G E+ G PP++ + ++ +I P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250
Query: 184 ------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
D V CL + R + + H F+R
Sbjct: 251 WSDNFTDFVKQCLVK---SPEQRATATQLLQHPFVRS 284
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 59/175 (33%), Positives = 86/175 (49%), Gaps = 32/175 (18%)
Query: 20 LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
L + HPN++RLFD E + LV E +L++Y+ P +T + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
QL GL+ L+SH ++HRDLKP+NIL+ +K+ADFGL+ ++
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA----------RIYSFQ 173
Query: 133 L----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
+ Y APEVL Y VD+WSVG I E+ P F G ++V QL
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-38
Identities = 66/251 (26%), Positives = 99/251 (39%), Gaps = 68/251 (27%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
L L + HPN++RL D + LV E +L +Y+ P +T +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
++Q GL+ L+++ I+HRDLKPENIL+ +K+ADFGL+ ++
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLA----------RIY 170
Query: 130 GSPL----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL-- 176
+ Y APEVL Y VDMWSVG I E+ P F G + QL
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230
Query: 177 ----------------------------------IVPALHPDCVDMCLKLLSANTVDRLS 202
+VP + + L++L+ N R+S
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 203 FNEFYHHRFLR 213
H +L
Sbjct: 291 AFRALQHSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 58/176 (32%), Positives = 85/176 (48%), Gaps = 29/176 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L + H NI+RL D ++ + LV EFC +L Y + + FL Q
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +S +++HRDLKP+N+L ++ + LK+A+FGL+ + G P+
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV-QL 176
Y P+VL + Y +DMWS G I EL N G P F G + QL
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 21 SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
+++NHP I+ ++D A ++V+E+ G L + G + + A + +
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 132
L + + IIHRD+KP NI++S +K+ DFG+ + + V G+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL--------------IV 178
Y++PE + D + D++S+G +L+E+L G PPF+G + V +
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 179 PALHPDCVDMCLKLLSANTVDR 200
L D + LK L+ N +R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-38
Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + H NI+ L D E + LV E+ +L Y+ G + + FL Q
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL + ++HRDLKP+N+L +++ LK+ADFGL+ + P
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y P++L Y ++DMW VG I +E+ G P F G QL
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 70/217 (32%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I+ + E+ +LV+E+C G + E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GL L+SH++IHRD+K NILLS V K+ DFG + + P N G+P +M
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPYWM 217
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGRNNVQ---LIV----PALHP-- 183
APEV+ YD KVD+WS+G EL PP N + I PAL
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277
Query: 184 ------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
+ VD CL+ DR + HRF+ R
Sbjct: 278 WSEYFRNFVDSCLQK---IPQDRPTSEVLLKHRFVLR 311
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 33/180 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
E++ + + H NI+RL+D EN + LV EF +L Y+ +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
F QL GL + + I+HRDLKP+N+L ++ LK+ DFGL+ +
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158
Query: 130 GSPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
G P+ Y AP+VL + Y +D+WS G IL E++ G P F G N+ QL
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-38
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 16 ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
+L+ + S + P I++ + A E ++ +E + Y L +PE+ K
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 71 FLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L L IIHRD+KP NILL ++ K+ DFG+S L +
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186
Query: 130 GSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFSGRNNV----QLIV--- 178
G YMAPE + YD + D+WS+G L+EL G P+ N+V +V
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 179 -PALHP-----------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
P L + V++CL + R + E H F+
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLT---KDESKRPKYKELLKHPFILM 291
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 38/206 (18%)
Query: 15 CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
E+ L + HPN+I L F A+ ++L+ ++ +L I+ H +
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 122
P + L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G +
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179
Query: 123 NYAEKVCGSPL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPP 167
++ SPL Y APE+L + Y + +D+W++G I ELL P
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235
Query: 168 FSGRNNVQLIVPALHPDCVDMCLKLL 193
F R H D +D ++
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVM 261
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-37
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L++ +HP I++L A+ + +++++EFC GG + + + R E + +Q
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 131
+ L L+S IIHRDLK N+L++ L+ D+ ++ADFG+S +K G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180
Query: 132 PLYMAPEV-----LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLIVPALHP- 183
P +MAPEV ++ YD K D+WS+G L E+ PP N V L + P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 184 -------------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
D + + L N R S + H F+
Sbjct: 241 TLLTPSKWSVEFRDFLKIALD---KNPETRPSAAQLLEHPFVSS 281
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 18/188 (9%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
+KK+ + + EL + ++H NI+RL F + E + LV+++ +
Sbjct: 84 IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141
Query: 56 YIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
R + R +P + ++ QL L ++S I HRD+KP+N+LL D +LK+
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199
Query: 112 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFG + L G +C S Y APE+ Y +D+WS G +L ELL G P F
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258
Query: 170 GRNNV-QL 176
G + V QL
Sbjct: 259 GDSGVDQL 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-37
Identities = 40/161 (24%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
+ P+++ + D + + +++ + G +L++ +R G + A ++Q+G+ L+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 136
++ HRD+KPENIL+S DD + DFG+ L G+ YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
PE + D++++ +L+E L G PP+ G + + ++
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVM 243
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-36
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 18/169 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
E+ +S +HPNI+ + +F ++ ++LV++ +GG++ I+ E +
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 72 ----LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
L+++ GLE L+ + IHRD+K NIL L +D ++IADFG+S L G +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179
Query: 128 ------VCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q + YD K D+WS G EL G P+
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-36
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 16 ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQ 66
E+N L +H NI + AF ++ ++LV+EFC G+++ I+ + E+
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+++ GL L+ H +IHRD+K +N+LL+ + +V K+ DFG+S L
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVGRR 186
Query: 127 K-VCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRN---NVQLI 177
G+P +MAPEV+ YD K D+WS+G E+ G PP + + LI
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246
Query: 178 V----PALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
P L ++ CL N R + + H F+R
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVK---NHSQRPATEQLMKHPFIRDQP 294
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
EL + V HPN++ L F + E + LV+E+ + R + + +P
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 124
+ ++ QL L ++S I HRD+KP+N+LL +LK+ DFG + L G
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198
Query: 125 AEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
+C S Y APE+ Y +D+WS G ++ EL+ G P F G + + QL
Sbjct: 199 VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
EL+ NHPNI+ F A+N +++V F A G+ I H + E LQ
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 129
+ L+ ++ +HR +K +IL+S D V ++ + ++ ++V
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 130 ----GSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
+++PEVLQ Q YD K D++SVG EL NG+ PF
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-36
Identities = 45/191 (23%), Positives = 89/191 (46%), Gaps = 19/191 (9%)
Query: 19 FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
FL+ V HP+I+++F+ + + ++V+E+ G +L ++P A +L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ L L+S +++ DLKPENI+L+ ++ + K+ D G + N + G+P
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL----IVPALHPDCVDMC 189
+ APE+++ D+++VG L L P +GR L V + +
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301
Query: 190 LKLLSANTVDR 200
+ + + R
Sbjct: 302 RRAIDPDPRQR 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-34
Identities = 61/187 (32%), Positives = 93/187 (49%), Gaps = 18/187 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + +++V+E
Sbjct: 55 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
NL I++ + + L Q+ G++ L+S IIHRDLKP NI++ D LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ G F G
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228
Query: 171 RNNV-QL 176
+++ Q
Sbjct: 229 TDHIDQW 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 62/187 (33%), Positives = 91/187 (48%), Gaps = 18/187 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + ++LV+E
Sbjct: 92 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
NL I+ + + L Q+ G++ L+S IIHRDLKP NI++ D LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ F G
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 171 RNNV-QL 176
R+ + Q
Sbjct: 266 RDYIDQW 272
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-34
Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
E + +HPN++ L ++E +V+ + G+L ++IR P + F
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 130
Q+ G++ L S +HRDL N +L + + K+ADFGL+ +Y Y G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191
Query: 131 SPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ L +MA E LQ Q++ K D+WS G +L+EL+ G PP+ N +
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-34
Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
EL + H NI+ + + ++L+ + G+L Y++L + + +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110
Query: 72 LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ + +GL L+ I HRDLK +NIL + + IAD GL+
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQST 167
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
V G+ YMAPEVL ++VD+W+ G +L+E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 173 NVQL 176
+ +
Sbjct: 228 DYKP 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 36/196 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + +LV+ F G
Sbjct: 55 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L ++ H ++ E + + Q+ GL +++ IIHRDLKP N+ + ++D LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 169
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
DFGL+ + S + Y APEV L + RY + VD+WSVG I+ E+
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 162 LNGYPPFSGRNNV-QL 176
+ G F G +++ QL
Sbjct: 220 ITGKTLFKGSDHLDQL 235
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
E + +NHPN++ L E +++ + G+L +IR R P + F
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
Q+ G+E L +HRDL N +L + +K+ADFGL+ + Y ++ +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
L + A E LQ R+ K D+WS G +L+ELL G PP+ + L
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
E + +HPN++ L ++E +V+ + G+L ++IR P + F
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
Q+ G++ L S +HRDL N +L + + K+ADFGL+ +Y + G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
L +MA E LQ Q++ K D+WS G +L+EL+ G PP+ N +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E ++SV++P++ RL + + L+ + G L Y+R H + Q + Q
Sbjct: 67 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
+ G+ L ++HRDL N+L+ +KI DFGL+ L G P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ +MA E + + Y + D+WS G ++EL+ G P+ G ++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-33
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 20/194 (10%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
+K N + + E + +HPN+IRL + Q +++ F G+L
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 54 SSYIRLH------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
+Y+ +P QT KF+ + G+E L++ + +HRDL N +L DD +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMTV 186
Query: 108 LKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163
+ADFGLS +Y G+Y + + + ++A E L + Y K D+W+ G ++E+
Sbjct: 187 -CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 164 GYPPFSGRNNVQLI 177
G P+ G N ++
Sbjct: 246 GMTPYPGVQNHEMY 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 21/179 (11%)
Query: 16 ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
E + +HP++ +L A +++ F G+L +++ R+ E
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133
Query: 70 -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+F+ + G+E L+S + IHRDL N +L+ +D+ + +ADFGLS +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSG 190
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+Y + C S L ++A E L Y D+W+ G ++E++ G P++G N ++
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-33
Identities = 59/188 (31%), Positives = 96/188 (51%), Gaps = 21/188 (11%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F + +LV+ F
Sbjct: 54 IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L + + E+ + + Q+ GL+ ++S ++HRDLKP N+ + ++D LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKI 167
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ V + Y APEV L + Y++ VD+WSVG I+ E+L G F
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 170 GRNNV-QL 176
G++ + QL
Sbjct: 226 GKDYLDQL 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+ L E+ L H NII +F+ + ++ ++++ E
Sbjct: 41 IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L I + + + F+ Q +++L+ ++IHRDLKP N+L+ + + LK+
Sbjct: 99 DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154
Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKVDMWSVGAILF 159
DFGL+ + Y APEV L +Y +D+WS G IL
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 160 ELLNGYPPFSGRNNV-QL 176
EL P F GR+ QL
Sbjct: 215 ELFLRRPIFPGRDYRHQL 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-33
Identities = 56/237 (23%), Positives = 98/237 (41%), Gaps = 29/237 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E +S NH NI+R F+++E AGG+L S++R P Q +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 70 -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ + G + L +H IHRD+ N LL+ + KI DFG++ +Y +Y K
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI------- 177
+ L +M PE + K D WS G +L+E+ GY P+ ++N +++
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262
Query: 178 ---VPALHPDCVDMCLKLL----SANTVDRLSFNEFYHH-RFLRRNSAILRAPFHIP 226
P +C +++ DR +F + ++ ++ I
Sbjct: 263 RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 316
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-33
Identities = 57/177 (32%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
+ L+ ++HPNI++L F + + +V+E+ L R + R P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127
Query: 65 EQTARKFLQQLGAGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ FL QL + L S ++ HRD+KP N+L++ D LK+ DFG + L P
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185
Query: 123 N-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
+C S Y APE+ Q Y VD+WSVG I E++ G P F G N+ QL
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-33
Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ + H NI+ A ++LV ++ G+L Y+ + V + K
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144
Query: 72 LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+GL L+ I HRDLK +NIL+ + IAD GL+
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ G+ YMAPEVL + ++ D++++G + +E+
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 173 NVQL 176
+ QL
Sbjct: 262 DYQL 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-32
Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ + H NI+ A + ++L+ ++ G+L Y++ + ++ K
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139
Query: 72 LQQLGAGL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+GL EI ++ I HRDLK +NIL + + IAD GL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDT 196
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ G+ YM PEVL + DM+S G IL+E+
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 173 NVQL 176
QL
Sbjct: 257 EYQL 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 26/180 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
E+ L + H N++ L + + + I+LV +FC +L+ + + +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
++ +Q L GL ++ + I+HRD+K N+L + D +LK+ADFGL+ + + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLA-RAF--SLAK 178
Query: 127 KVCGSPL--------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
+ Y PE+L + Y +D+W G I+ E+ P G QL
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-32
Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E + + N +++RL +++E G+L SY+R
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 70 ----KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
+ ++ G+ LN++ +HRDL N +++ +D +KI DFG++ +Y +Y
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 126 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
K L +M+PE L+ + D+WS G +L+E+ P+ G +N Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 29/237 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E +S NH NI+R F+++E AGG+L S++R P Q +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 70 -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ + G + L +H IHRD+ N LL+ + KI DFG++ +Y Y K
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI------- 177
+ L +M PE + K D WS G +L+E+ GY P+ ++N +++
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303
Query: 178 ---VPALHPDCVDMCLKLL----SANTVDRLSFNEFYHH-RFLRRNSAILRAPFHIP 226
P +C +++ DR +F + ++ ++ I
Sbjct: 304 RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 357
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-32
Identities = 43/167 (25%), Positives = 83/167 (49%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
+ + S++H +I+RL + + LV ++ G+L ++R H G + Q + Q
Sbjct: 65 HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L H ++HR+L N+LL +++ADFG++ L P + +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+MA E + F +Y + D+WS G ++EL+ G P++G ++
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 36/196 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F ++LV G
Sbjct: 59 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ +++D LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
DFGL+ + + Y APE+ L + Y++ VD+WSVG I+ EL
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 162 LNGYPPFSGRNNV-QL 176
L G F G +++ QL
Sbjct: 224 LTGRTLFPGTDHIDQL 239
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E ++SV++P++ RL + + L+ + G L Y+R H + Q + Q
Sbjct: 67 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L ++HRDL N+L+ +KI DFGL+ L G +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+MA E + + Y + D+WS G ++EL+ G P+ G ++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-32
Identities = 45/167 (26%), Positives = 87/167 (52%), Gaps = 11/167 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
E + ++ + H N+++L + + +++V E+ A G+L Y+R GR KF
Sbjct: 64 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L ++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE L+ +++ K D+WS G +L+E+ + G P+ ++
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-32
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 30/195 (15%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK++ + C E+ L H NII + D +A +++V +
Sbjct: 57 IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L ++ + FL Q+ GL+ ++S +++HRDLKP N+LL + LKI
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 170
Query: 112 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELL 162
DFGL+ P + L Y APE+ L + Y + +D+WSVG IL E+L
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 163 NGYPPFSGRNNV-QL 176
+ P F G++ + QL
Sbjct: 227 SNRPIFPGKHYLDQL 241
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-32
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 37/207 (17%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
+KK+ ++ D E+ L+ ++ H NI+ L + +A+N ++LV ++ +L
Sbjct: 39 VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ IR + + + QL ++ L+S ++HRD+KP NILL + + +K+ADF
Sbjct: 98 HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADF 153
Query: 114 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKVD 150
GLS + + Y APE+ L +Y + +D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213
Query: 151 MWSVGAILFELLNGYPPFSGRNNV-QL 176
MWS+G IL E+L G P F G + + QL
Sbjct: 214 MWSLGCILGEILCGKPIFPGSSTMNQL 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-32
Identities = 50/185 (27%), Positives = 93/185 (50%), Gaps = 32/185 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
E+ + ++H NI+++F+ +++V E+ +L++ + G
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ AR F+ QL GL+ ++S +++HRDLKP N+ ++ +D++LKI DFGL+ + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 122 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
L Y +P + L Y + +DMW+ G I E+L G F+G +
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 173 NV-QL 176
+ Q+
Sbjct: 230 ELEQM 234
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-32
Identities = 60/179 (33%), Positives = 79/179 (44%), Gaps = 18/179 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ L K K N N+I + + F N I + E NL I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192
Query: 61 G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
RKF + L+ L+ + IIH DLKPENILL +K+ DFG SC
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
Y S Y APEV+ RY +DMWS+G IL ELL GYP G + +
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-32
Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 14/170 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
E+ L+ +HPNI+ L D F ++LV E +L+ I R+ Q
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ F+ + GL +L+ ++HRDL P NILL D+ + I DF L+
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHY 193
Query: 129 CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+ +QF+ + + VDMWS G ++ E+ N F G QL
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-32
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 24 NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
PNII L D + LV E + + + + R ++ ++ L+
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 140
+S I+HRD+KP N+++ L++ D+GL+ +PG Y +V S + PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202
Query: 141 -QFQRYDEKVDMWSVGAILFELLNGYPP-FSGRNNV-QL 176
+Q YD +DMWS+G +L ++ P F G +N QL
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 50/220 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
LKK+ + + EL+ + ++H NII+L D F
Sbjct: 37 LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95
Query: 38 --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQLGAGL 79
+ +++E+ L ++ R +P ++ QL +
Sbjct: 96 VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 138
++S I HRD+KP+N+L++ D+ LK+ DFG + L P +C S Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211
Query: 139 V-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
+ L Y +D+WS+G + EL+ G P FSG ++ QL
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL 251
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 45/167 (26%), Positives = 88/167 (52%), Gaps = 11/167 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++ + H N+++L + + +++V E+ A G+L Y+R GR + KF
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L ++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE L+ +++ K D+WS G +L+E+ + G P+ ++
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-31
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ + +E L + IHRDL N L+ ++ ++K+ADFGLS L G+ G+
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE L + ++ K D+W+ G +L+E+ G P+ G + Q+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-31
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
+L+++N + D +I++L D F + + +V E G NL +
Sbjct: 68 LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119
Query: 57 IRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 110
I+ H +P ++ +QL GL+ ++ IIH D+KPEN+L+ +D + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
AD G +C + + + Y +PEVL + D+WS ++FEL+ G F
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 171 RNN 173
Sbjct: 238 DEG 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-31
Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK+ ++ + E L+ + H +I+R F + +V E+ G+L+ ++R H
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 61 GRVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
G + A Q+ AG+ L H +HRDL N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194
Query: 106 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+++KI DFG+S +Y +Y + L +M PE + ++++ + D+WS G +L+E+
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 163 N-GYPPFSGRNNVQLI 177
G P+ +N + I
Sbjct: 255 TYGKQPWYQLSNTEAI 270
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-31
Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 26/177 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ L + H NI++ A + + +L+ F G+LS +++ + V
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126
Query: 72 LQQLGAGLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ + GL L+ I HRD+K +N+L L +++ IADFGL+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183
Query: 122 GNYAEK---VCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYPPFSG 170
G A G+ YMAPEVL+ + ++DM+++G +L+EL + G
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEIL 82
+HPNI+RL + I++V+E GG+ +++R G + +T + + AG+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 139
S IHRDL N L++ + +LKI+DFG+S G YA + + APE
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 140 LQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI 177
L + RY + D+WS G +L+E G P+ +N Q
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 64/181 (35%), Positives = 79/181 (43%), Gaps = 20/181 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ +NKH I+ L F N + LV E NL +R
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149
Query: 61 GRVP--EQTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
RKF QQ+ L L + IIH DLKPENILL +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
C G + S Y +PEVL YD +DMWS+G IL E+ G P FSG N V
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 177 I 177
+
Sbjct: 267 M 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-31
Identities = 45/166 (27%), Positives = 86/166 (51%), Gaps = 7/166 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + ++HP +++ + E I++V E+ + G L +Y+R HG+ + +
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
+ G+ L SH IHRDL N L+ D+ +K++DFG++ + Y V P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APEV + +Y K D+W+ G +++E+ + G P+ N +++
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 7/166 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HP +++L+ + I LV EF G LS Y+R G +T
Sbjct: 53 EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
+ G+ L +IHRDL N L+ ++ ++K++DFG++ + Y P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ +PEV F RY K D+WS G +++E+ + G P+ R+N +++
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 48/198 (24%), Positives = 95/198 (47%), Gaps = 24/198 (12%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
LK L+ E + + HPN++ L + + ++ +C+ G+L ++ +
Sbjct: 46 TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105
Query: 60 HGRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
+ + + Q+ AG+E L+SHH++H+DL N+L+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFE 160
D + +KI+D GL +Y +Y + + S L +MAPE + + ++ D+WS G +L+E
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 161 LLN-GYPPFSGRNNVQLI 177
+ + G P+ G +N ++
Sbjct: 223 VFSYGLQPYCGYSNQDVV 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK + E L+++ H +I++ + + + +V E+ G+L+ ++R H
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 61 GRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104
G Q+ +G+ L S H +HRDL N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168
Query: 105 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
++++KI DFG+S +Y +Y + L +M PE + ++++ + D+WS G IL+E+
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 162 LN-GYPPFSGRNNVQLI 177
G P+ +N ++I
Sbjct: 229 FTYGKQPWFQLSNTEVI 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R V
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ + +E L + IHR+L N L+ ++ ++K+ADFGLS L G+ G+
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLI 177
+ APE L + ++ K D+W+ G +L+E+ G P+ G + Q+
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 38/206 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+N+ + +DC E+ L+ + IIRL+D ++ +++V+E A
Sbjct: 56 IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L + + E+ + L L G ++ IIHRDLKP N L L+ D +K+
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 147
DFGL+ T+ V Y APE+ L + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231
Query: 148 KVDMWSVGAILFELLNGYPPFSGRNN 173
+D+WS G I ELLN
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-30
Identities = 42/167 (25%), Positives = 84/167 (50%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ + +
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y + P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE + R+ K D+WS G +L EL G P+ G N +++
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-30
Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E N + + H ++RL+ A + I+++ E+ G+L +++ + +
Sbjct: 58 EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ + + IHRDL+ NIL+S D + KIADFGL+ + Y + G+
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE + + + K D+WS G +L E++ G P+ G N ++I
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 42/167 (25%), Positives = 84/167 (50%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ + +
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y + P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE + R+ K D+WS G +L EL G P+ G N +++
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-30
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 43/211 (20%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+ + + +DC E+ L+ +NH +++++ D ++ +++V+E A
Sbjct: 83 IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+ R + E + L L G++ ++S I+HRDLKP N L ++ D +K+
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 112 DFGLSCTLYPGNYAEKVCGSPL----------------------------YMAPEV-LQF 142
DFGL+ T+ Y APE+ L
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ Y E +D+WS+G I ELLN +
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-30
Identities = 47/181 (25%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 7 KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
K +K E F+ +++H +++L+ + IF++ E+ A G L +Y+R
Sbjct: 54 KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
R Q + + + +E L S +HRDL N L++ D ++K++DFGLS +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170
Query: 120 YPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
Y V P+ + PEVL + ++ K D+W+ G +++E+ + G P+ N +
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230
Query: 177 I 177
Sbjct: 231 A 231
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N + +++P I+R+ +AE+ LV+E G L+ Y++ + V ++ + + Q+
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 132
G++ L + +HRDL N+LL KI+DFGLS L NY + P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE + + ++ K D+WS G +++E + G P+ G ++
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +HP+I++L +++++E C G L S++++ + + + Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
L L L S +HRD+ N+L+S + +K+ DFGLS + Y + G P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+MAPE + F+R+ D+W G ++E+L G PF G N +I
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-29
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +HP+I++L +++++E C G L S++++ + + + Q
Sbjct: 66 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
L L L S +HRD+ N+L+S + +K+ DFGLS + Y + G P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+MAPE + F+R+ D+W G ++E+L G PF G N +I
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-29
Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E+N + S++H N+IRL+ + +V E G+L +R H G T ++ Q
Sbjct: 71 EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G+ L S IHRDL N+LL+ ++KI DFGL L ++ +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE L+ + + D W G L+E+ G P+ G N Q++
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 31/190 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
E N L VNHP++I+L+ A + + L+VE+ G+L ++R +V
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 67 ------------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
T + Q+ G++ L ++HRDL NIL++ + M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
DFGLS +Y + K + +MA E L Y + D+WS G +L+E++ G P
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 168 FSGRNNVQLI 177
+ G +L
Sbjct: 253 YPGIPPERLF 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-29
Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +HPNIIRL +V E+ G+L +++R H G+ L+
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
+GAG+ L+ +HRDL N+L+ +++ K++DFGLS L A
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
P+ + APE + F+ + D+WS G +++E+L G P+ N +I
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 48/167 (28%), Positives = 87/167 (52%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E N + ++ H +++L A + I+++ EF A G+L +++ + + F
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ G+ + + IHRDL+ NIL+S ++ KIADFGL+ + Y + P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + APE + F + K D+WS G +L E++ G P+ G +N ++I
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-29
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 33/195 (16%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+LKK+ + K N + + D F + + E G N +++ +
Sbjct: 69 VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115
Query: 61 GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 107
P R QL L L+ + + H DLKPENIL + + +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 108 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+++ADFG + + + + + Y PEV+ + + D+WS+G ILFE
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 163 NGYPPFSGRNNVQLI 177
G+ F N + +
Sbjct: 234 RGFTLFQTHENREHL 248
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-29
Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 10/167 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++HP+I++L + E ++++E G L Y+ + + T + Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ + L S + +HRD+ NIL++ +K+ DFGLS + +Y K + L
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+M+PE + F+R+ D+W ++E+L+ G PF N +I
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
EL +S + H NI+ L A + ++ E+C G+L +++R RV E
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 67 ---TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ R L Q+ G+ L S + IHRD+ N+LL+ + + KI DFGL+ +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215
Query: 121 PGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG-RNNVQ 175
+ + L +MAPE + Y + D+WS G +L+E+ + G P+ G N +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 176 LI 177
Sbjct: 276 FY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-28
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++P I+RL + LV+E GG L ++ +P + L Q
Sbjct: 60 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G++ L + +HRDL N+LL + KI+DFGLS L +Y
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE + F+++ + D+WS G ++E L+ G P+ +++
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 26/185 (14%)
Query: 16 ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
EL L + +H N++ L A + + ++VEFC GNLS+Y+R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 61 GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
T + Q+ G+E L S IHRDL NILLS + ++KI DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196
Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG-RN 172
+Y + + L +MAPE + + Y + D+WS G +L+E+ + G P+ G +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 173 NVQLI 177
+ +
Sbjct: 257 DEEFC 261
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 43/195 (22%), Positives = 80/195 (41%), Gaps = 33/195 (16%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ LN + + +++ + F+ I +V E G + +I+ +
Sbjct: 64 VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110
Query: 61 GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------SGL 102
G + RK Q+ + L+S+ + H DLKPENIL
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 103 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ +K+ DFG + Y + + + Y APEV+ + + D+WS+G IL E
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 163 NGYPPFSGRNNVQLI 177
G+ F ++ + +
Sbjct: 229 LGFTVFPTHDSKEHL 243
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 45/169 (26%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + + +HPNIIRL + +V E+ G+L S++R H + L+
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 132
+ +G++ L+ +HRDL NIL++ +++ K++DFGL L A G
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ + +PE + ++++ D+WS G +L+E+++ G P+ +N +I
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 43/168 (25%), Positives = 83/168 (49%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +H NIIRL + ++ E+ G L ++R G L+
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 133
+ AG++ L + + +HRDL NIL++ +++ K++DFGLS L A G +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE + ++++ D+WS G +++E++ G P+ +N +++
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 260
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 47/195 (24%), Positives = 74/195 (37%), Gaps = 37/195 (18%)
Query: 15 CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
+ + + H NI R LV+E+ G+L Y+ LH ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 70 KFLQQLGAGL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ + GL E+ H I HRDL N+L + +D I+DFGLS L
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171
Query: 121 PGNYAEK---------VCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNG 164
G+ YMAPEVL+ + ++VDM+++G I +E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 165 ---YPPFSGRNNVQL 176
P Q+
Sbjct: 232 CTDLFPGESVPEYQM 246
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 32/206 (15%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
MLK+ + +++ E ++ ++PNI++L + L+ E+ A G+L+ ++R
Sbjct: 84 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 60 HGRVPEQTAR------------------------KFLQQLGAGLEILNSHHIIHRDLKPE 95
+ +Q+ AG+ L+ +HRDL
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203
Query: 96 NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMW 152
N L+ ++ V+ KIADFGLS +Y +Y + + +M PE + + RY + D+W
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 153 SVGAILFELLN-GYPPFSGRNNVQLI 177
+ G +L+E+ + G P+ G + ++I
Sbjct: 261 AYGVVLWEIFSYGLQPYYGMAHEEVI 286
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-28
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 25/185 (13%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L ++ H NI++ N I L++EF G+L Y+ + ++ + K+
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G++ L S +HRDL N+L+ + +KI DFGL+ + Y K
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL---------------NGYPPFSGRN 172
SP+ + APE L ++ D+WS G L ELL P
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 173 NVQLI 177
+L+
Sbjct: 249 VTRLV 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-28
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 11/177 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
E+ L +++ I++ + LV+E+ G L +++ H R+ +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 130
Q+ G+E L S +HRDL NIL+ + +KIADFGL+ L +Y
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLIVPALHPD 184
SP+ + APE L + + D+WS G +L+EL S ++
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 25/184 (13%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E++ L ++ H +II+ + LV+E+ G+L Y+ H + F
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 130
QQ+ G+ L++ H IHRDL N+LL +D ++KI DFGL+ + G+ +V
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL---------------NGYPPFSGRNN 173
SP+ + APE L+ ++ D+WS G L+ELL
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 174 VQLI 177
++L
Sbjct: 258 LRLT 261
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 43/191 (22%), Positives = 73/191 (38%), Gaps = 32/191 (16%)
Query: 16 ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
E + L + + NI++ F + + L+ E G +L I + +
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 106
+ + ++ L L + H DLKPENILL
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
+K+ DFG + + +Y + + Y APEV+ +D DMWS G +L EL G
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 167 PFSGRNNVQLI 177
F +++ +
Sbjct: 258 LFRTHEHMEHL 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-27
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L S+ H NI++ + L++E+ G+L Y++ H R+ ++
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G+E L + IHRDL NIL+ ++ +KI DFGL+ L + K
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----------------NGYPPFSGR 171
G SP+ + APE L ++ D+WS G +L+EL G
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 172 NNVQLI 177
LI
Sbjct: 237 IVFHLI 242
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-27
Identities = 38/186 (20%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L K +++ + +S ++H +++ + + LV EF G+L +Y++ +
Sbjct: 47 VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 114
+ + +QL A + L + +IH ++ +NILL + + +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 115 LSCTLYPGNYAEKVCGSPL-YMAPEVLQ-FQRYDEKVDMWSVGAILFELL-NGYPPFSGR 171
+S T+ P + ++ + ++ PE ++ + + D WS G L+E+ G P S
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
Query: 172 NNVQLI 177
++ + +
Sbjct: 223 DSQRKL 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L S+ H NI++ + L++E+ G+L Y++ H R+ ++
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G+E L + IHRDL NIL+ ++ +KI DFGL+ L Y K
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----------------NGYPPFSGR 171
G SP+ + APE L ++ D+WS G +L+EL G
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 172 NNVQLI 177
LI
Sbjct: 268 IVFHLI 273
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-27
Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
E+ + + H NII L A + ++++VE+ + GNL Y+R +
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 67 -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
T + + QL G+E L S IHRDL N+L++ ++ ++KIADFGL+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ +Y +K L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 175 QLI 177
+L
Sbjct: 267 ELF 269
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-27
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR----- 69
E+ + + H NII L A + ++++VE+ + GNL Y+R + +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 70 -----------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
QL G+E L S IHRDL N+L++ +++VM KIADFGL+
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ +Y +K L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 175 QLI 177
+L
Sbjct: 313 ELF 315
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++P I+RL + LV+E GG L ++ +P + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G++ L + +HR+L N+LL + KI+DFGLS L +Y
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI 177
+ APE + F+++ + D+WS G ++E L+ G P+ +++
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-27
Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---- 69
EL L + +HPNII L A + ++L +E+ GNL ++R + A
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 70 ------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
F + G++ L+ IHRDL NIL+ ++ + KIADFGLS
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190
Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
K L +MA E L + Y D+WS G +L+E+++ G P+ G
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
Query: 174 VQLI 177
+L
Sbjct: 248 AELY 251
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 30/203 (14%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
MLK + HL EL LS + NH NI+ L A ++ E+C G+L +++
Sbjct: 60 MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 58 R---------------LHGRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILL 99
R + L Q+ G+ L S + IHRDL NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178
Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGA 156
+ + KI DFGL+ + + + L +MAPE + Y + D+WS G
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 157 ILFELLN-GYPPFSGR-NNVQLI 177
L+EL + G P+ G + +
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFY 258
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 24/183 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
E+ + + H NII L A + ++++VE+ + GNL Y++ +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 67 -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+++ + Q+ G+E L S IHRDL N+L++ +D ++KIADFGL+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
++ +Y +K L +MAPE L + Y + D+WS G +L+E+ G P+ G
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 175 QLI 177
+L
Sbjct: 301 ELF 303
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-26
Identities = 30/198 (15%), Positives = 55/198 (27%), Gaps = 48/198 (24%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
LS ++ P + R+ D +V E+ GG+L P R +Q L A
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAA 142
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
+ + + P + +S D DV +A M
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPA-------------------TMPDA- 179
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-----------------VPALH 182
+ + D+ +GA L+ LL P + +
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233
Query: 183 PDCVDMCLKLLSANTVDR 200
+ + + + R
Sbjct: 234 FQISAVAARSVQGDGGIR 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-26
Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 32/192 (16%)
Query: 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
EL ++ + +H NI+ L A I+L+ E+C G+L +Y+R
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 61 -------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ T L Q+ G+E L +HRDL N+L++ V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
DFGL+ + + + L +MAPE L Y K D+WS G +L+E+ + G
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 167 PFSG-RNNVQLI 177
P+ G +
Sbjct: 274 PYPGIPVDANFY 285
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-23
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS HP+++ L N + L+ ++ GNL + L+G + + Q+L
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142
Query: 76 ----GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 126
GA GL L++ IIHRD+K NIL LD++ + KI DFG+S
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198
Query: 127 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
V G+ Y+ PE R EK D++S G +LFE+L
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 3e-20
Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 70/246 (28%)
Query: 2 LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
+K K +H E+ L SV N PN +++L D F+ C +V
Sbjct: 67 MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124
Query: 46 EFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGL 102
E G +L +I + +P +K +QQ+ GL+ L++ IIH D+KPENILLS
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183
Query: 103 DDDVM----------------------------------------------LKIADFGLS 116
+ + +KIAD G +
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
C + + + + Y + EVL Y+ D+WS + FEL G F + +
Sbjct: 244 C--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
Query: 177 IVPALH 182
H
Sbjct: 302 TRDEDH 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-19
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 28/179 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA----RKF 71
E+ +S H N++RL LV + A G+++S L R Q ++
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134
Query: 72 LQQLGA--GLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
LG+ GL L H IIHRD+K NIL LD++ + DFGL+ L
Sbjct: 135 RIALGSARGLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA-KLMDYKD 188
Query: 125 AE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPA 180
V G+ ++APE L + EK D++ G +L EL+ +G+ L A
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI------TGQRAFDLARLA 241
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 8e-19
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 30/179 (16%)
Query: 16 ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQT- 67
E+ ++ H N++ L F LV + G+L RL
Sbjct: 80 EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130
Query: 68 --ARKFLQQLGA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ GA G+ L+ +H IHRD+K NIL LD+ KI+DFGL+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA-RASEKF 186
Query: 124 YAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV 178
++ G+ YMAPE L+ K D++S G +L E++ G P QL++
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 6e-18
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ Q+ G+E L S IHRDL NILLS + ++KI DFGL+ +Y +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 130 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG-RNNVQLI 177
+ L +MAPE + + Y + D+WS G +L+E+ + G P+ G + + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 7/136 (5%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
MLK+ L EL L + +H N++ L A + + ++VEFC GNLS+Y+
Sbjct: 59 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
R K + + + I DLK ++ +
Sbjct: 119 RSKRNEFVPYKTKGARF----RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
Query: 118 TLYPGNYAEKVCGSPL 133
+ E + L
Sbjct: 175 DVEEEEAPEDLYKDFL 190
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-10
Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 3/117 (2%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+++ K E L + P F+ + F+V+E G +L
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+G + T + ++ LE ++ + +H D+K N+LL G + + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-10
Identities = 32/195 (16%), Positives = 69/195 (35%), Gaps = 30/195 (15%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
K+ L EL F P I+ + + + F++
Sbjct: 71 KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130
Query: 45 VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
++ G +L + + +T + ++ LE ++ H +H D+K N+LL
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188
Query: 104 DDVMLKIADFGLSCTLYPGN------YAEKVC--GSPLYMAPEVLQFQRYDEKVDMWSVG 155
+ + + D+GL+ P K C G+ + + + + D+ +G
Sbjct: 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248
Query: 156 AILFELLNGYPPFSG 170
+ + L G+ P+
Sbjct: 249 YCMIQWLTGHLPWED 263
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-10
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 16/157 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84
I + + +V+E G +L R +T Q+ + +E ++S
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLYMA 136
+ IHRD+KP+N L+ ++ I DFGL+ Y E + G+ Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 137 PEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
R D D+ S+G +L G P+ G
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQG 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 16/159 (10%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEIL 82
I + + LV++ G +L R +T Q+ +E +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLY 134
+S +HRD+KP+N L+ + I DFGL+ + Y E + G+ Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
+ R D D+ S+G +L L G P+ G
Sbjct: 180 ASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQG 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
I ++ Q LV++ G +L + L GR +T +Q+ A ++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 85 HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS------CTLYPGNYAEK--VCGSPLY 134
+++RD+KP+N L+ + M+ + DFG+ T Y EK + G+ Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
M+ + R D D+ ++G + L G P+ G
Sbjct: 185 MSINTHLGREQSRRD---DLEALGHVFMYFLRGSLPWQG 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-08
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
I +++ +V+E G +L L R +T QL + +E ++S
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 85 HHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLY--PGN-----YAEK--VCGSPL 133
++I+RD+KPEN L+ G ++ I DF L+ Y P Y E + G+
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA-KEYIDPETKKHIPYREHKSLTGTAR 182
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
YM+ + R D D+ ++G + L G P+ G
Sbjct: 183 YMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLPWQG 219
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-08
Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 4/77 (5%)
Query: 42 FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
FLV+ G +L S + + + + E++ + +L LE L+ + +H ++ ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
Query: 100 SGLDDDVMLKIADFGLS 116
+D + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-07
Identities = 27/139 (19%), Positives = 46/139 (33%), Gaps = 17/139 (12%)
Query: 38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPEN 96
++ +F+V+EF GG +R A+ L QL A L + S HRDL N
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 97 ILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
+L L + K+ + + +V Y
Sbjct: 193 VL---LKKTSLKKLHYTLNGKSSTIPSCGLQVSI------------IDYTLSRLERDGIV 237
Query: 157 ILFELLNGYPPFSGRNNVQ 175
+ ++ F+G + Q
Sbjct: 238 VFCDVSMDEDLFTGDGDYQ 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 226 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.48 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.73 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 94.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.08 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.13 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 84.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.22 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.09 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=341.70 Aligned_cols=206 Identities=29% Similarity=0.562 Sum_probs=180.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....++.+.+|++++++++|||||++++++.+ ++.+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|
T Consensus 65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y 144 (290)
T 3fpq_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999999865 35689999999999999999998999999999999999999999
Q ss_pred HHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 82 lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
||++| |+||||||+|||++ ..++.+||+|||+|+.... ......+||+.|+|||.+.+ .++.++||||||+++|
T Consensus 145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvily 220 (290)
T 3fpq_A 145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 220 (290)
T ss_dssp HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHH
Confidence 99998 99999999999993 2467899999999975433 34456689999999998864 6999999999999999
Q ss_pred HHHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 160 ELLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+|++|..||.+...... .....+++++++|.+||+.||.+|||++|+|+||||++.
T Consensus 221 elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999976543211 245567899999999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=346.67 Aligned_cols=205 Identities=31% Similarity=0.594 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||
T Consensus 74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~I 153 (311)
T 4aw0_A 74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153 (311)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34578999999999999999999999999999999999999999999999998999999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+||||||+||++ +.++.+||+|||+++..... ......+||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 154 iHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 230 (311)
T 4aw0_A 154 IHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230 (311)
T ss_dssp ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHS
T ss_pred ccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999 78899999999999876533 233456899999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhH------HhcCcccccc
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNE------FYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~------~l~~~~~~~~ 215 (226)
..||.+.+.... .+..++++++++|++||+.||.+|||++| +++||||++-
T Consensus 231 ~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 231 LPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999987654322 26778999999999999999999999998 5899999884
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-56 Score=351.03 Aligned_cols=206 Identities=25% Similarity=0.533 Sum_probs=186.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+...++.+.+|++++++++|||||++++++.+++.+|+|||||+||+|.+++.+ +++++..+..++.||+.||.|||++
T Consensus 111 ~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~ 189 (346)
T 4fih_A 111 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ 189 (346)
T ss_dssp GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344566789999999999999999999999999999999999999999999875 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
||+||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||.+.+..++.++|||||||++|+|++|
T Consensus 190 ~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 266 (346)
T 4fih_A 190 GVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266 (346)
T ss_dssp TEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999 78889999999999877544 334567899999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..||.+.+..+.. ...+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 267 ~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 267 EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp SCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 9999876543221 45688999999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=339.67 Aligned_cols=205 Identities=36% Similarity=0.699 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+..+.+.+|++++++++||||+++++++.+++..|+||||+ +++|.+++.+.+++++..+..++.||+.||+|||++|
T Consensus 54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ 132 (275)
T 3hyh_A 54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132 (275)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678999999999999999999999999999999999999 7899999999999999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+||||||+||++ +.++.++|+|||+++...........+||+.|+|||.+.+..+ +.++||||+|+++|+|++|.
T Consensus 133 IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~ 209 (275)
T 3hyh_A 133 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209 (275)
T ss_dssp CCCCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence 9999999999999 6888999999999987766655666789999999999988876 57999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||.+.+.... .+..+|++++++|++||+.||.+|||++|+++||||+..
T Consensus 210 ~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 210 LPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 99987653322 256789999999999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-56 Score=350.55 Aligned_cols=207 Identities=26% Similarity=0.520 Sum_probs=186.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....++.+.+|++++++|+|||||++++++.+++.+|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH 142 (350)
T 4b9d_A 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142 (350)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999999999999999999999999999999997553 5789999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
++||+||||||+|||+ +.++.+||+|||+++...... .....+||+.|+|||.+.+..++.++|||||||++|+|+
T Consensus 143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999 788899999999998765432 233467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 163 NGYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 163 ~g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+|..||.+.+..+. ....+|++++++|.+||+.||.+|||++|+|+||||++.
T Consensus 220 tG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 220 TLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999987654322 256789999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=342.19 Aligned_cols=204 Identities=35% Similarity=0.582 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
....+.+|++++++++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+
T Consensus 69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii 148 (304)
T 3ubd_A 69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148 (304)
T ss_dssp ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 34578899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||||+||++ +.++.++|+|||+++..... ......+||+.|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 149 HRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 225 (304)
T 3ubd_A 149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225 (304)
T ss_dssp CSSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC
Confidence 99999999999 78889999999999765433 334456799999999999999999999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|.+.+..+. .+..+|++++++|++||+.||.+||| ++|+++||||++-
T Consensus 226 F~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 226 FQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 987654322 26678999999999999999999998 5899999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=351.97 Aligned_cols=205 Identities=25% Similarity=0.534 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...++.+.+|+.+|++++|||||++++++.+++.+|+|||||+||+|.+++.. +++++..+..++.||+.||.|||++|
T Consensus 189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~ 267 (423)
T 4fie_A 189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG 267 (423)
T ss_dssp CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567789999999999999999999999999999999999999999999875 57999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 268 IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 344 (423)
T 4fie_A 268 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344 (423)
T ss_dssp EECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 78889999999999876544 3345678999999999999999999999999999999999999
Q ss_pred CCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||.+.+..... ...+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 345 ~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 345 PPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 999876543221 45689999999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=334.91 Aligned_cols=200 Identities=30% Similarity=0.454 Sum_probs=177.3
Q ss_pred HHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccC
Q 027233 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (226)
Q Consensus 14 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (226)
.+|+.++++++|||||++++++.+++.+|+|||||+|++|.+++++.+++++..+..++.||+.||.|||++||+|||||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 177 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence 47999999999999999999999999999999999999999999998999999999999999999999999999999999
Q ss_pred CCCeEeeeCCCCc-cEEEeeeccccccCCCCc------cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 94 PENILLSGLDDDV-MLKIADFGLSCTLYPGNY------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 94 ~~nili~~~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+|||+ +.++ .+||+|||+++....... ....+||+.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 178 p~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 178 ADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp GGGEEE---CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEE---eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 999999 5555 699999999987654321 123469999999999999999999999999999999999999
Q ss_pred CCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHH-------------hcCccccccC
Q 027233 167 PFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEF-------------YHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~-------------l~~~~~~~~~ 216 (226)
||.+.+.... .++.++++++++|.+||+.||.+|||+.|+ ++|||+...+
T Consensus 255 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 255 PWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9987654322 256789999999999999999999999997 5799998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=323.59 Aligned_cols=206 Identities=23% Similarity=0.500 Sum_probs=181.9
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-------------CCCCHHHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------GRVPEQTARKF 71 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~ 71 (226)
...+.++++.+|++++++++|||||++++++.+++..++|||||++|+|.+++.+. ..+++..+..+
T Consensus 54 ~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i 133 (299)
T 4asz_A 54 ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133 (299)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHH
T ss_pred CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHH
Confidence 35567788999999999999999999999999999999999999999999999764 36899999999
Q ss_pred HHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcc
Q 027233 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
+.|++.||.|||+++|+||||||+||++ +.++.+||+|||+++....... .....+++.|+|||.+.+..++.+
T Consensus 134 ~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k 210 (299)
T 4asz_A 134 AQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 210 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch
Confidence 9999999999999999999999999999 7888999999999976644322 223457899999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 149 VDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+||||||+++|||++ |..||.+.+..+. .+...|+++.+++.+||+.||.+|||++|+ ++||++.
T Consensus 211 ~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 211 SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 999999999999998 8999988654322 266789999999999999999999999999 5677764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=319.60 Aligned_cols=205 Identities=27% Similarity=0.480 Sum_probs=165.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC------------eEEEEEeecCCCCHHHHHHhcCC---CCHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~ 70 (226)
....++.+.+|++++++++|||||++++++.+.+ ..|++||||+|++|.+++..... .+...++.
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~ 122 (299)
T 4g31_A 43 RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122 (299)
T ss_dssp SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHH
Confidence 3456678999999999999999999999987543 37999999999999999987654 34566889
Q ss_pred HHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-------------cccccCCccccCc
Q 027233 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAP 137 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-------------~~~~~~~~~~~aP 137 (226)
++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++....... ....+||+.|+||
T Consensus 123 i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCH
T ss_pred HHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence 99999999999999999999999999999 6788999999999987654321 1234699999999
Q ss_pred ccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-c-----------ccccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-Q-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
|.+.+..++.++||||||+++|+|++ ||...... . ......++.+.++|++||+.||.+|||+.|
T Consensus 200 E~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 276 (299)
T 4g31_A 200 EQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276 (299)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999999999999999999996 66543211 0 012334567889999999999999999999
Q ss_pred HhcCccccccC
Q 027233 206 FYHHRFLRRNS 216 (226)
Q Consensus 206 ~l~~~~~~~~~ 216 (226)
+++||||++..
T Consensus 277 il~h~~~~~~~ 287 (299)
T 4g31_A 277 IIENAVFEDLD 287 (299)
T ss_dssp HHTSGGGCCC-
T ss_pred HhcCHhhCCCC
Confidence 99999999753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=320.33 Aligned_cols=202 Identities=23% Similarity=0.462 Sum_probs=172.9
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---------------CCCCHHHHH
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTAR 69 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~ 69 (226)
.+...++.+.+|++++++++|||||++++++.+.+..++|||||++|+|.+++.+. +++++..+.
T Consensus 82 ~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 161 (329)
T 4aoj_A 82 ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161 (329)
T ss_dssp CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHH
Confidence 35667789999999999999999999999999999999999999999999999754 358999999
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCC
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
.++.|++.||.|||+++|+||||||+||++ +.++.+||+|||+++...... ......+++.|+|||.+.+..++
T Consensus 162 ~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 999999999999999999999999999999 688899999999998664332 22345689999999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.++||||||+++|||++ |..||.+.+..+. .+..+++++.+++.+||+.||.+|||++|++++
T Consensus 239 ~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999999998 8999987654322 256789999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=313.96 Aligned_cols=200 Identities=25% Similarity=0.427 Sum_probs=170.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+..+.+.+|++++++++|||||++++++.+ +..++|||||+||+|.+++... .++++..+..++.|++.||+|||+
T Consensus 72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~ 150 (307)
T 3omv_A 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150 (307)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999999998765 5689999999999999999765 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCcccccc---cCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~~ 158 (226)
++|+||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||.+.+ .+++.++||||||+++
T Consensus 151 ~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 151 KNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp TTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred CCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence 999999999999999 67889999999999765432 22344579999999999864 3588999999999999
Q ss_pred HHHHhCCCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 159 FELLNGYPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|||++|..||.+.+.... ....++.++++++.+||+.||.+|||+.|++++
T Consensus 228 ~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 228 YELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999987543211 145678899999999999999999999988654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=322.90 Aligned_cols=205 Identities=29% Similarity=0.490 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
....+.+.+|+++|++++||||+++++++.. .+.+|+|||||+ ++|.+++.+.+++++..+..++.||+.||.
T Consensus 94 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ 172 (398)
T 4b99_A 94 VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172 (398)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 4456778899999999999999999998754 367999999995 689999998889999999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-----CccccccCCccccCccccccc-CCCcchhHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV 154 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~sl 154 (226)
|||++||+||||||+||++ +.++.++|+|||+++..... ......+||+.|+|||.+.+. .++.++||||+
T Consensus 173 ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 173 YMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp HHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred HHHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 9999999999999999999 78889999999999765432 223456899999999998765 46899999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhh
Q 027233 155 GAILFELLNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLL 193 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l 193 (226)
||++|+|++|..||.+.+..+.. .+..++++.+||++||
T Consensus 250 G~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 329 (398)
T 4b99_A 250 GCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRML 329 (398)
T ss_dssp HHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHC
Confidence 99999999999999876532211 2356889999999999
Q ss_pred ccCccccCCHhHHhcCcccccc
Q 027233 194 SANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 194 ~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+.||.+|||++|+|+||||+..
T Consensus 330 ~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 330 RFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp CSSTTTSCCHHHHTTSGGGTTT
T ss_pred cCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=313.63 Aligned_cols=199 Identities=23% Similarity=0.487 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF 71 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~ 71 (226)
..++.+.+|+.++++++|||||++++++.+++..++|||||++|+|.+++... ..+++..+..+
T Consensus 71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 150 (308)
T 4gt4_A 71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150 (308)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999653 35889999999
Q ss_pred HHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcc
Q 027233 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
+.||+.|++|||+++|+||||||.||++ +.++.+||+|||+++...... ......+++.|+|||.+.+..++.+
T Consensus 151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k 227 (308)
T 4gt4_A 151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 227 (308)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence 9999999999999999999999999999 788899999999997654322 2334568899999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 149 VDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+||||||+++||+++ |..||.+.+..+. .+...+.++.+++.+||+.||.+|||+.|++++
T Consensus 228 sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 228 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999998 8999987654322 266788999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=335.87 Aligned_cols=210 Identities=30% Similarity=0.539 Sum_probs=188.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|+++|+.++||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||+
T Consensus 194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~ 273 (573)
T 3uto_A 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273 (573)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4456778999999999999999999999999999999999999999999999644 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+||+||||||+||+++. ...+.++|+|||++............+|++.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 274 ~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 274 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp TTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999942 13478999999999988776666677899999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 165 YPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 165 ~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
..||.+.+..+.. ...+++++++||++||+.||.+|||++|+|+||||+...
T Consensus 353 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 353 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp CCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred CCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9999876543221 456899999999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=315.23 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...++.+|+++++.+ +||||+++++++.+.+.+|+||||++|++|.++++ .+++..+..++.||+.||+|||++||
T Consensus 62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gI 138 (361)
T 4f9c_A 62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGI 138 (361)
T ss_dssp CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345688999999999 69999999999999999999999999999999885 68999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----------------------------cccccCCccccCcc
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------------------------AEKVCGSPLYMAPE 138 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----------------------------~~~~~~~~~~~aPE 138 (226)
+||||||+||+++ ...+.++|+|||+|+....... ....+||+.|+|||
T Consensus 139 iHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 139 VHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp ECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred EeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 9999999999995 3447899999999975543211 12346899999999
Q ss_pred ccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-c-----------------------------------------
Q 027233 139 VLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNV-Q----------------------------------------- 175 (226)
Q Consensus 139 ~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~----------------------------------------- 175 (226)
.+.+. .++.++|+||+||++++|++|..||...+.. +
T Consensus 217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 296 (361)
T 4f9c_A 217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCE 296 (361)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHH
T ss_pred HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHH
Confidence 98765 4889999999999999999999999543321 0
Q ss_pred -----------------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 176 -----------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 176 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.....+|+++++||++||+.||.+|+|++|+|+||||++-
T Consensus 297 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 297 RLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred hhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0024578899999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=330.92 Aligned_cols=198 Identities=30% Similarity=0.516 Sum_probs=178.2
Q ss_pred HHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccC
Q 027233 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (226)
Q Consensus 14 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (226)
+.++.+++.++|||||++++.+.+.+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+|||||
T Consensus 240 ~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred HHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 44567778889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 027233 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (226)
Q Consensus 94 ~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 172 (226)
|+|||+ +.++.++|+|||+|+...... ....+||+.|+|||.+. +..++.++|+|||||++|+|++|..||.+.+
T Consensus 320 PeNILl---d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 320 PANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred hHHeEE---eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 788999999999998765443 34568999999999986 4579999999999999999999999997643
Q ss_pred ccc-------------ccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 173 NVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 173 ~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
... ..+..+|++++++|++||+.||.+|++ ++|+++||||++-
T Consensus 396 ~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 396 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred hHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 221 126778999999999999999999998 7999999999984
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=311.47 Aligned_cols=206 Identities=30% Similarity=0.494 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHHHhcCCC-CCeeeeeeEEEeC-CeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~ 68 (226)
....+.+.+|++++++++| ||||++++++.+. +..++|||||++|+|.+++++. ..+++..+
T Consensus 108 ~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~ 187 (353)
T 4ase_A 108 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187 (353)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence 4556789999999999965 8999999998764 5689999999999999999753 24789999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCC
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~ 145 (226)
..++.||+.|+.|||+++|+||||||+||++ +.++.+||+|||+++....... .....+++.|+|||.+.+..+
T Consensus 188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 9999999999999999999999999999999 7888999999999987654322 234567889999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC--c
Q 027233 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH--R 210 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~--~ 210 (226)
+.++||||||+++|||++ |..||.+...... .+...++++++++.+||+.||.+|||+.|+++| .
T Consensus 265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 999999999999999998 8999987653221 156688999999999999999999999999998 4
Q ss_pred ccccc
Q 027233 211 FLRRN 215 (226)
Q Consensus 211 ~~~~~ 215 (226)
+++.+
T Consensus 345 llq~~ 349 (353)
T 4ase_A 345 LLQAN 349 (353)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 55443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=301.59 Aligned_cols=207 Identities=36% Similarity=0.696 Sum_probs=188.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|+++++.++||||+++++++...+..++||||++|++|.+++...+++++..+..++.|++.||.|||++
T Consensus 54 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~ 133 (328)
T 3fe3_A 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133 (328)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566788999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCC-cchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~~~~l~~g 164 (226)
|++||||+|+||++ +.++.++|+|||++.............+++.|+|||.+.+..++ .++||||+|+++++|++|
T Consensus 134 ~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 210 (328)
T 3fe3_A 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210 (328)
T ss_dssp TCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred CEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence 99999999999999 68889999999999877666656667899999999999887765 799999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..||.+.+.... .+...++++.+++++||+.||.+|||++|+++||||+..
T Consensus 211 ~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 211 SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 999987653322 255678999999999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=301.90 Aligned_cols=203 Identities=32% Similarity=0.586 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++...+.+++..+..++.||+.||.|||++|++|
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 138 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 56899999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCc----cEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 90 RDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|||+|+||++. .++ .++|+|||++.............|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 139 rDlkp~NIll~---~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~ 215 (361)
T 2yab_A 139 FDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215 (361)
T ss_dssp CCCSGGGEEES---CTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred CCCCHHHEEEe---CCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99999999994 333 79999999998876655555667999999999999889999999999999999999999
Q ss_pred CCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||.+.+..... ...++.+++++|++||+.||.+|||++|+++||||+..
T Consensus 216 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 216 SPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999876533221 35678999999999999999999999999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=299.83 Aligned_cols=224 Identities=29% Similarity=0.528 Sum_probs=174.3
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
+|.+.......+.+|+.+++.+. ||||+++++++.+.+..++||||++|++|.+++...+.+++..+..++.|++.||.
T Consensus 41 vK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~ 120 (325)
T 3kn6_A 41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS 120 (325)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 45556667788899999999996 99999999999999999999999999999999999889999999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
|||++|++||||+|+||+++..+....++|+|||++....... ......++..|+|||.+.+..++.++|+||||++++
T Consensus 121 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY 200 (325)
T ss_dssp HHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHH
Confidence 9999999999999999999643334489999999997654432 233456789999999999899999999999999999
Q ss_pred HHHhCCCCCCCCCcccc---------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 160 ELLNGYPPFSGRNNVQL---------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~---------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
++++|..||.+...... ....++++++++|.+||+.||.+|||++|+++||||++....
T Consensus 201 ~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp HHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred HHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 99999999986543100 024579999999999999999999999999999999998777
Q ss_pred cCCCCCC
Q 027233 219 LRAPFHI 225 (226)
Q Consensus 219 ~~~~~~~ 225 (226)
...|...
T Consensus 281 ~~~~~~~ 287 (325)
T 3kn6_A 281 SSNPLMT 287 (325)
T ss_dssp CCSCCSH
T ss_pred CCCCCCC
Confidence 6666543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=307.50 Aligned_cols=212 Identities=31% Similarity=0.526 Sum_probs=188.4
Q ss_pred hhHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
......+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++...+.+++..+..++.||+.||.|||+
T Consensus 49 ~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~ 128 (444)
T 3soa_A 49 LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128 (444)
T ss_dssp CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34556778999999999999999999999999999999999999999999999988899999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|++||||||+||+++....++.++|+|||++........ .....|++.|+|||.+.+..++.++||||+|+++|+|++
T Consensus 129 ~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh
Confidence 9999999999999996444678899999999977654332 344678999999999998899999999999999999999
Q ss_pred CCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 164 GYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|..||.+.+..... ...++++++++|.+||+.||.+|||+.|+|+||||+..+
T Consensus 209 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 209 GYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275 (444)
T ss_dssp SSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred CCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence 99999776532211 346799999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=300.74 Aligned_cols=210 Identities=30% Similarity=0.529 Sum_probs=186.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++.....+++..+..++.||+.||.|||++
T Consensus 68 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (362)
T 2bdw_A 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147 (362)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34566789999999999999999999999999999999999999999999998888899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|++||||+|+||+++....+..++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999643345679999999998776555555567899999999999889999999999999999999999
Q ss_pred CCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||.+.+..... ...++++++++|.+||+.||.+|||+.|+++||||+..
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 228 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999775532111 34678999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=296.79 Aligned_cols=203 Identities=36% Similarity=0.684 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|+.+++.++||||+++++++...+..++||||+ +++|.+++...+.+++..++.++.|++.||.|||++|++|
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 131 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 457899999999999999999999999999999999999 7899999988889999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|||+|+||++ +.++.++|+|||++.............+++.|+|||.+.+..+ ++++||||+|++++++++|..||
T Consensus 132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 208 (336)
T 3h4j_B 132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208 (336)
T ss_dssp CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence 9999999999 6788999999999987766655566779999999999987765 78999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+...... .+..+++++.++|++||+.||.+|||++|+++||||+...
T Consensus 209 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 209 DDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp BCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred CCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 87543222 2556899999999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=296.92 Aligned_cols=211 Identities=27% Similarity=0.496 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++.... .+++..++.++.|++.||.|||++
T Consensus 42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 121 (321)
T 1tki_A 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3455678999999999999999999999999999999999999999999997654 799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|++||||+|+||+++. ..++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 122 givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999942 126889999999998876665555667899999999998888899999999999999999999
Q ss_pred CCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 166 PPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 166 ~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
.||.+....... ...++.++.++|.+||+.||.+|||+.|+++||||+.....
T Consensus 201 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 267 (321)
T 1tki_A 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred CCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence 999876543221 34789999999999999999999999999999999986443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=294.96 Aligned_cols=208 Identities=29% Similarity=0.572 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 136 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 136 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 35789999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCC-CCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++.... ....++|+|||++.............+++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999994211 1227999999999877655555566789999999999988999999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|.+....... ....+..+.++|++||+.||.+|||++|+++||||+...
T Consensus 217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 217 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 9775532221 356789999999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=290.81 Aligned_cols=206 Identities=29% Similarity=0.518 Sum_probs=183.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++... .+++..+..++.|++.||.|||++|+
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i 137 (297)
T 3fxz_A 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 137 (297)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567899999999999999999999999999999999999999999998864 79999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++|..
T Consensus 138 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 214 (297)
T 3fxz_A 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (297)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999 678899999999987765433 2344568999999999999999999999999999999999999
Q ss_pred CCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 167 PFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 167 p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
||.+...... .+..++..+.++|.+||+.||.+|||++|+++||||+..+.
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9987653221 15568899999999999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=293.01 Aligned_cols=205 Identities=31% Similarity=0.530 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+++++.++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|+
T Consensus 47 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 126 (337)
T 1o6l_A 47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126 (337)
T ss_dssp TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||||+||++ +.++.++|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 127 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 127 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCC
Confidence 999999999999 6888999999999976433 333445678999999999998999999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++++++++|++||+.||.+|| +++|+++||||++-
T Consensus 204 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 204 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9987653322 2567899999999999999999999 99999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=285.39 Aligned_cols=214 Identities=30% Similarity=0.521 Sum_probs=189.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++.....+++..+..++.|++.||.+||++
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (284)
T 3kk8_A 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124 (284)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566788999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|++||||+|+||+++..+....++|+|||.+.............++..|+|||...+..++.++|+||||++++++++|.
T Consensus 125 ~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 99999999999999543344569999999998776655555667899999999999999999999999999999999999
Q ss_pred CCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCccc
Q 027233 166 PPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 219 (226)
Q Consensus 166 ~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~ 219 (226)
.||.+....... ...+++++.+++.+||+.||.+|||++|+++||||+......
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred CCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 999766533211 346789999999999999999999999999999999865443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=297.76 Aligned_cols=211 Identities=27% Similarity=0.547 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
......+.+|+.++++++||||+++++++.+.+..++||||+.|++|.+++.... .+++..+..++.||+.||.|||++
T Consensus 89 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 168 (387)
T 1kob_A 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168 (387)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456689999999999999999999999999999999999999999999987654 799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|++||||+|+||+++. ...+.++|+|||++.............++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 169 givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 169 SIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp TEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred CeeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCC
Confidence 9999999999999942 235679999999998876655555667899999999999888999999999999999999999
Q ss_pred CCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 166 PPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 166 ~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
.||.+.+.... ....+++++.++|++||+.||.+|||+.|+++||||+.....
T Consensus 248 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 99987653221 134679999999999999999999999999999999876443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=294.77 Aligned_cols=206 Identities=34% Similarity=0.561 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|.++++.+ +||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 64 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 143 (353)
T 3txo_A 64 DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143 (353)
T ss_dssp HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556788999999998 79999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
||+||||||+||++ +.++.++|+|||++..... .......+|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 144 givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 220 (353)
T 3txo_A 144 GIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220 (353)
T ss_dssp TCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS
T ss_pred CCcccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC
Confidence 99999999999999 7888999999999976433 2334456789999999999988999999999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH------hHHhcCcccccc
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~------~~~l~~~~~~~~ 215 (226)
..||.+.+..+. .+..++.++.++|++||+.||.+||++ +|+++||||++.
T Consensus 221 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 221 HAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999987654322 256689999999999999999999998 899999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=284.63 Aligned_cols=207 Identities=30% Similarity=0.601 Sum_probs=185.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.....+++..++.++.|++.||.+||++|+
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (277)
T 3f3z_A 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127 (277)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 44678999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+|+||+|+||++...+.++.++|+|||.+.............++..|+|||...+. ++.++|+||||++++++++|..|
T Consensus 128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCC
Confidence 99999999999954456788999999999877666655666789999999998754 89999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|......... ...+++.+.++|++||+.||.+|||+.|+++||||++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 207 FSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9876543221 23678999999999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=286.61 Aligned_cols=202 Identities=35% Similarity=0.639 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|..+++.++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.||+.||.+||++|++
T Consensus 49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 128 (318)
T 1fot_A 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128 (318)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||+|+||++ +.++.++|+|||++...... .....+++.|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus 129 HrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 203 (318)
T 1fot_A 129 YRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203 (318)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCChheEEE---cCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 99999999999 68889999999999765432 33456899999999999899999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
.+.+.... .+..++.++.++|++||+.||.+|| +++++++||||++.
T Consensus 204 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 204 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 87654322 2567889999999999999999999 99999999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=292.99 Aligned_cols=204 Identities=30% Similarity=0.525 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+++++.++||||+++++++.+.+..++|+||+.|++|.+++.....+++..+..++.||+.||.|||++||+
T Consensus 58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~giv 137 (384)
T 4fr4_A 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137 (384)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 45678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc---cCCCcchhHHHHHHHHHHHHhCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
||||+|+||++ +.++.++|+|||++.............|++.|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 138 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~ 214 (384)
T 4fr4_A 138 HRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214 (384)
T ss_dssp CCCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred eccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCC
Confidence 99999999999 7888999999999988766665667789999999999863 45889999999999999999999
Q ss_pred CCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCC-HhHHhcCcccccc
Q 027233 166 PPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLS-FNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt-~~~~l~~~~~~~~ 215 (226)
.||....... ..+..++.++.++|++||+.||.+||+ ++++++||||++.
T Consensus 215 ~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 215 RPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 9997543321 125678999999999999999999998 9999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=283.36 Aligned_cols=211 Identities=33% Similarity=0.608 Sum_probs=189.4
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|++++++++||||+++++++.+.+..++++||+++++|.+++...+.+++..++.++.|++.||.+||++|++|
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 137 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 137 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 56789999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 169 (226)
+||+|+||++ +.++.++|+|||.+....... .....++..|+|||...+..++.++|+||||++++++++|..||.
T Consensus 138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 138 RDIKPENLLM---GYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp CCCSGGGEEE---CTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCHHHEEE---cCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 9999999999 678899999999986654322 334568899999999998889999999999999999999999998
Q ss_pred CCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCCCC
Q 027233 170 GRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFH 224 (226)
Q Consensus 170 ~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~~ 224 (226)
....... .+..++.+++++|.+||+.||.+|||++|+++||||+.......+|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~ 278 (284)
T 2vgo_A 214 SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278 (284)
T ss_dssp CSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC
T ss_pred CCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCcc
Confidence 7543221 256689999999999999999999999999999999998877777654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=295.33 Aligned_cols=207 Identities=33% Similarity=0.549 Sum_probs=184.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++|
T Consensus 128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 207 (373)
T 2x4f_A 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56778999999999999999999999999999999999999999999988754 46999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
++||||+|+||++.. +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 286 (373)
T 2x4f_A 208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286 (373)
T ss_dssp EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 999999999999843 3457899999999988766555555678999999999988889999999999999999999999
Q ss_pred CCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||.+.+..... ...++++++++|.+||+.||.+|||++|+++||||++.
T Consensus 287 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 287 PFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99876533211 35689999999999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=293.96 Aligned_cols=206 Identities=30% Similarity=0.573 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|..+++++ +||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.||+.||.|||++
T Consensus 93 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 172 (396)
T 4dc2_A 93 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172 (396)
T ss_dssp ---CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556788999999887 89999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
||+||||||+||++ +.++.++|+|||+++... ........+|++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 173 givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G 249 (396)
T 4dc2_A 173 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249 (396)
T ss_dssp TCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999 788999999999997633 33445567799999999999999999999999999999999999
Q ss_pred CCCCCCCCcc-------------------cccccCCChHHHHHHHHhhccCccccCCH------hHHhcCcccccc
Q 027233 165 YPPFSGRNNV-------------------QLIVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~------~~~l~~~~~~~~ 215 (226)
..||...... ...+..++.+++++|++||+.||.+||++ +|+++||||++-
T Consensus 250 ~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 250 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp SCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999643211 01256789999999999999999999985 799999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=282.83 Aligned_cols=205 Identities=32% Similarity=0.616 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.+.+|++++++++||||+++++++.+.+..++|+||+++++|.+++... ..+++..++.++.|++.||.+||+
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4578899999999999999999999999999999999999999999998543 679999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+|++|+||+|+||+++..+.++.++|+|||++.............++..|+|||.+. ..++.++|+||||++++++++|
T Consensus 143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence 999999999999999654556789999999998766555555667899999999876 5688999999999999999999
Q ss_pred CCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 165 YPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 165 ~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
..||.+....... ...+++++.++|++||+.||.+|||+.|+++||||+.
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 222 CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999876532221 3447899999999999999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=287.10 Aligned_cols=206 Identities=30% Similarity=0.573 Sum_probs=182.8
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|..+++++ +||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++
T Consensus 50 ~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44567789999999998 89999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccC-CCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|++||||+|+||++ +.++.++|+|||++.... .........+++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 130 ~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 206 (345)
T 3a8x_A 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206 (345)
T ss_dssp TCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CceecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhC
Confidence 99999999999999 688899999999997643 23334556789999999999999999999999999999999999
Q ss_pred CCCCCCCCcc-------------------cccccCCChHHHHHHHHhhccCccccCCH------hHHhcCcccccc
Q 027233 165 YPPFSGRNNV-------------------QLIVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~------~~~l~~~~~~~~ 215 (226)
..||...... ...+..++.+++++|++||+.||.+||++ +|+++||||++.
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 207 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp SCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999652110 01256789999999999999999999995 899999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=292.80 Aligned_cols=209 Identities=35% Similarity=0.542 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 170 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45678899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||+|+||+++..+.++.++|+|||++.............++..|+|||.+.+..++.++||||||++++++++|..||
T Consensus 171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 99999999999543347889999999998765544445567899999999999889999999999999999999999999
Q ss_pred CCCCcccc---------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 169 SGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 169 ~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
........ ....++.++.++|++||+.||.+|||+.|+++||||++...
T Consensus 251 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 251 YDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp CCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred CCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 76543321 13567899999999999999999999999999999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=289.01 Aligned_cols=202 Identities=30% Similarity=0.584 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++
T Consensus 84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 163 (350)
T 1rdq_E 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||+|+||++ +.++.++|+|||++...... .....|++.|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus 164 HrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 238 (350)
T 1rdq_E 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp CCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccCccceEEE---CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC
Confidence 99999999999 67889999999999876443 23456899999999999889999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
.+.+.... .+..++.++.++|++||+.||.+||+ ++|+++||||+..
T Consensus 239 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 87654322 25678999999999999999999998 9999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=292.00 Aligned_cols=207 Identities=28% Similarity=0.517 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++.+. ..+++..++.++.||+.||.|||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999999999999999999999999999888653 258999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|++||||+|+||+++.......++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++++|++
T Consensus 149 ~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 228 (351)
T 3c0i_A 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228 (351)
T ss_dssp TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH
Confidence 9999999999999995433445599999999987765432 344568999999999998889999999999999999999
Q ss_pred CCCCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|..||.+..... .....++.+++++|++||+.||.+|||+.|+++||||+..
T Consensus 229 g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 229 GCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp SSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCCCCCCcHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 999997653210 0135689999999999999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=290.02 Aligned_cols=204 Identities=34% Similarity=0.575 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|..+++.+ +||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|+
T Consensus 60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 139 (345)
T 1xjd_A 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139 (345)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 456788899999887 9999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++..... .......+|++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 140 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (345)
T 1xjd_A 140 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216 (345)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCC
Confidence 999999999999 6788999999999976433 233445678999999999999899999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHh-HHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFN-EFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.+++++|++||+.||.+||++. ++++||||++-
T Consensus 217 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 217 PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9987654322 2556889999999999999999999998 99999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=291.75 Aligned_cols=206 Identities=34% Similarity=0.559 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++...+++++..++.++.|++.||.|||++|++
T Consensus 59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv 138 (361)
T 3uc3_A 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138 (361)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34678899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcc-hhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p 167 (226)
||||+|+||+++. +..+.++|+|||++.............+++.|+|||.+.+..++.+ +||||||+++++|++|..|
T Consensus 139 H~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (361)
T 3uc3_A 139 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217 (361)
T ss_dssp SCCCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence 9999999999941 1233599999999876554444455678999999999988777655 8999999999999999999
Q ss_pred CCCCCccccc----------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQLI----------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~~----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+....... ...+++++.++|++||+.||.+|||++|+++||||...
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 218 FEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9875432111 22578999999999999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=287.24 Aligned_cols=204 Identities=30% Similarity=0.563 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+.+..++|+||+++++|.+++.....+++..++.++.|++.||.+||++|++
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iv 137 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 35779999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCc----cEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 89 HRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|+||+|+||+++ .++ .++|+|||++.............++..|+|||...+..++.++|+||||++++++++|
T Consensus 138 H~dikp~NIl~~---~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 214 (321)
T 2a2a_A 138 HFDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214 (321)
T ss_dssp CCCCSGGGEEES---CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCChHHEEEe---cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHC
Confidence 999999999994 444 7999999999877665555556789999999999988999999999999999999999
Q ss_pred CCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..||.+....... ...++..+.++|++||+.||.+|||++|+++||||+..
T Consensus 215 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 215 ASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 9999775433221 35678899999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=291.23 Aligned_cols=207 Identities=26% Similarity=0.391 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 146 (389)
T 3gni_B 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146 (389)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 566788999999999999999999999999999999999999999999999876 679999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC--------CccccccCCccccCcccccc--cCCCcchhHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV 154 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~sl 154 (226)
+|++||||||+||++ +.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|||||
T Consensus 147 ~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 147 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred CCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 999999999999999 67889999999987544221 11223467888999999987 578999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcccc--------------------------------------------------------cc
Q 027233 155 GAILFELLNGYPPFSGRNNVQL--------------------------------------------------------IV 178 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~--------------------------------------------------------~~ 178 (226)
|+++++|++|..||.+...... ..
T Consensus 224 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (389)
T 3gni_B 224 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303 (389)
T ss_dssp HHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------------------------
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccc
Confidence 9999999999999976543221 12
Q ss_pred cCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 179 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 179 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
..+++++.++|++||+.||.+|||++|+|+||||+...
T Consensus 304 ~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 304 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 34678899999999999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=303.61 Aligned_cols=207 Identities=36% Similarity=0.648 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++....++++..+..++.||+.||.|||++|+
T Consensus 78 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 157 (494)
T 3lij_A 78 SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157 (494)
T ss_dssp CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34678899999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||+++..+..+.++|+|||++.............+++.|+|||.+. ..++.++||||+|+++|++++|..|
T Consensus 158 vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~p 236 (494)
T 3lij_A 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236 (494)
T ss_dssp ECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCC
Confidence 999999999999644445679999999998776665556677999999999986 5689999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+....... ...+++.++++|++||+.+|.+|||+.|+|+||||+..
T Consensus 237 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 237 FGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9876543221 35688999999999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=284.79 Aligned_cols=205 Identities=30% Similarity=0.550 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++||||+++++++.+.+..++||||++ ++|.+++... ..+++..+..++.|++.||.|||++|+
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 140 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45678899999999999999999999999999999999996 5888888765 459999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|.
T Consensus 141 vH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 141 LHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp ECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence 999999999999 678899999999998765332 2334567899999999876 56899999999999999999999
Q ss_pred CCCCCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 166 PPFSGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 166 ~p~~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
.||.+....+.. ...+++++.++|++||+.||.+|||++|
T Consensus 218 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 218 PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp CSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 999765432211 2346789999999999999999999999
Q ss_pred HhcCccccccCc
Q 027233 206 FYHHRFLRRNSA 217 (226)
Q Consensus 206 ~l~~~~~~~~~~ 217 (226)
+++||||++...
T Consensus 298 ll~hp~f~~~~~ 309 (311)
T 3niz_A 298 AMNHPYFKDLDP 309 (311)
T ss_dssp HHTSGGGTTSCT
T ss_pred HhcCcccccCCc
Confidence 999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=301.38 Aligned_cols=208 Identities=35% Similarity=0.638 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|++++++++||||+++++++.+.+..++|+||+.|++|.+++...+.+++..+..++.||+.||.|||++|++
T Consensus 64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 143 (486)
T 3mwu_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143 (486)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45678999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||+|+||+++..+.++.++|+|||++.............+++.|+|||.+.+ .++.++||||+|++++++++|..||
T Consensus 144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999996545567899999999987766555556678999999999875 5899999999999999999999999
Q ss_pred CCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 169 SGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 169 ~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
.+....+.. ...++++++++|++||+.+|.+|||+.|+|+||||+....
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 223 YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp CCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 876543221 3567899999999999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=286.91 Aligned_cols=205 Identities=36% Similarity=0.596 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.....+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+.+++..+..++.||+.||.|||++|+
T Consensus 63 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 142 (327)
T 3a62_A 63 KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142 (327)
T ss_dssp --------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 143 vH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 219 (327)
T 3a62_A 143 IYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219 (327)
T ss_dssp CCCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EcccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence 999999999999 67889999999998764332 22344568999999999998889999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.++.++|++||+.||.+|| +++|+++||||++.
T Consensus 220 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 220 PFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp SCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9987654322 2567899999999999999999999 88999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=287.61 Aligned_cols=205 Identities=32% Similarity=0.591 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+..|.+++..+ +||+|+++++++.+.+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++|
T Consensus 62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g 141 (353)
T 2i0e_A 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141 (353)
T ss_dssp TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999998 899999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++||||+|+||++ +.++.++|+|||++..... .......+|++.|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 142 ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 218 (353)
T 2i0e_A 142 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218 (353)
T ss_dssp CBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EEeccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCC
Confidence 9999999999999 7888999999999976432 33345567899999999999899999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
.||.+.+.... .+..++.++.++|++||+.||.+||+ ++++++||||++-
T Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 219 APFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99987654322 25678999999999999999999994 6999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=280.41 Aligned_cols=206 Identities=31% Similarity=0.565 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++....++++..+..++.|++.||.+||++|++
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~ 131 (279)
T 3fdn_A 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131 (279)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCE
T ss_pred HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 35678999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||+|+||++ +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus 132 H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 207 (279)
T 3fdn_A 132 HRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207 (279)
T ss_dssp ECCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cccCChHhEEE---cCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence 99999999999 688899999999885544332 33456889999999999888999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
........ .+..++..+.++|.+||+.||.+|||++|+++||||+..+..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 208 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp CCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred CCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 87653322 255688999999999999999999999999999999986543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=299.20 Aligned_cols=204 Identities=35% Similarity=0.684 Sum_probs=184.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.+++.++||||+++++++...+..++|+||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 138 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 35678999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||+|+||++ +.++.++|+|||++.............+++.|+|||.+.+..+ +.++|+||+|+++++|++|..|
T Consensus 139 HrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P 215 (476)
T 2y94_A 139 HRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215 (476)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence 99999999999 6788999999999988766555556679999999999987765 6899999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+...... .+..+++++.++|++||+.||.+|||++|+++||||+..
T Consensus 216 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 216 FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp SCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 987653222 145678999999999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=289.31 Aligned_cols=204 Identities=31% Similarity=0.555 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++.....+++..++.++.|++.||.|||++|++
T Consensus 48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~giv 127 (323)
T 3tki_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127 (323)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 44678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g 164 (226)
||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..+ +.++||||||+++++|++|
T Consensus 128 H~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ccccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 99999999999 678899999999997654322 2234568999999999987765 6789999999999999999
Q ss_pred CCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 165 YPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
..||......... ...++.++.++|++||+.||.+|||++|+++||||+..
T Consensus 205 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 205 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp SCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 9999765432111 35688999999999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=286.65 Aligned_cols=203 Identities=24% Similarity=0.329 Sum_probs=158.7
Q ss_pred hhhhHHHHHHH--HHHHHHHhcCCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 027233 3 KKLNKHLKSCL--DCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76 (226)
Q Consensus 3 ~~~~~~~~~~~--~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~ 76 (226)
|.++....+.+ ..|+..+.+++||||+++++++.+++ ..++||||+++|+|.+++.. .+++++.+.+++.|++
T Consensus 32 K~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia 110 (303)
T 3hmm_A 32 KIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTA 110 (303)
T ss_dssp EEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHH
T ss_pred EEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHH
Confidence 44443333333 34566667889999999999987653 58999999999999999975 4789999999999999
Q ss_pred HHHHHHHhC--------CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCccccccc
Q 027233 77 AGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQ 143 (226)
Q Consensus 77 ~~l~~lh~~--------~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~ 143 (226)
.||+|||++ +|+||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||.+.+.
T Consensus 111 ~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp HHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred HHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccc
Confidence 999999987 89999999999999 7889999999999977654322 2235699999999998654
Q ss_pred ------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc-----------------------cccCC---------ChHH
Q 027233 144 ------RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL-----------------------IVPAL---------HPDC 185 (226)
Q Consensus 144 ------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----------------------~~~~~---------~~~~ 185 (226)
.++.++||||||+++|||++|..|+........ ..+.+ +..+
T Consensus 188 ~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l 267 (303)
T 3hmm_A 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267 (303)
T ss_dssp SCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHH
T ss_pred ccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHH
Confidence 467799999999999999999776543221100 01111 2368
Q ss_pred HHHHHHhhccCccccCCHhHHhcC
Q 027233 186 VDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 186 ~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.+++.+||+.||.+|||+.|+++.
T Consensus 268 ~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 268 AKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 899999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=302.53 Aligned_cols=208 Identities=34% Similarity=0.610 Sum_probs=187.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++.+.+..++|+||+.|++|.+++...+.+++..+..++.||+.||.|||++|+
T Consensus 68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 147 (484)
T 3nyv_A 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147 (484)
T ss_dssp SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45678999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||++...+.++.++|+|||++.............+++.|+|||.+.+ .++.++||||+|+++|+|++|..|
T Consensus 148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 226 (484)
T 3nyv_A 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226 (484)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence 9999999999996545678899999999988766665566779999999999875 689999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|.+.+..... ...++++++++|++||+.+|.+|||+.|+|+||||+...
T Consensus 227 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 227 FNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9876543221 356889999999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=279.01 Aligned_cols=209 Identities=29% Similarity=0.560 Sum_probs=186.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....++.+.+|+.++++++||||+++++++.+.+..++++||+++++|.+++...+.+++..++.++.|++.||.+||++
T Consensus 55 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 134 (294)
T 2rku_A 55 KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134 (294)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567889999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||...+..++.++|+||||++++++++|
T Consensus 135 ~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 211 (294)
T 2rku_A 135 RVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211 (294)
T ss_dssp TEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred CccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999 67889999999999776533 223445688899999999888899999999999999999999
Q ss_pred CCCCCCCCccc----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 165 YPPFSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 165 ~~p~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
..||......+ ..+..++..+.+++.+||+.||.+|||++|+++||||+....
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 212 KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 99998764322 125678899999999999999999999999999999987643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=279.30 Aligned_cols=205 Identities=32% Similarity=0.537 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.++++++||||+++++++.+++..++||||+++ ++.+++.. .+.+++..++.++.|++.||.+||++
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 120 (292)
T 3o0g_A 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34557888999999999999999999999999999999999975 55555544 57899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccC-CCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~~~~l~~ 163 (226)
|++||||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++++|++
T Consensus 121 ~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 197 (292)
T 3o0g_A 121 NVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred CeecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence 99999999999999 67889999999999876533 2234456789999999987665 7999999999999999998
Q ss_pred CCCCC-CCCCccc---------------------------------------ccccCCChHHHHHHHHhhccCccccCCH
Q 027233 164 GYPPF-SGRNNVQ---------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 164 g~~p~-~~~~~~~---------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
|..|| .+.+... .....++.+++++|++||+.||.+|||+
T Consensus 198 ~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 277 (292)
T 3o0g_A 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277 (292)
T ss_dssp TSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH
Confidence 88775 3322110 0123578899999999999999999999
Q ss_pred hHHhcCcccccc
Q 027233 204 NEFYHHRFLRRN 215 (226)
Q Consensus 204 ~~~l~~~~~~~~ 215 (226)
+|+++||||++.
T Consensus 278 ~e~l~hp~f~~~ 289 (292)
T 3o0g_A 278 EEALQHPYFSDF 289 (292)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhcCcccccC
Confidence 999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=284.03 Aligned_cols=207 Identities=29% Similarity=0.565 Sum_probs=186.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...++.+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++.....+++..++.++.|++.||.+||++|
T Consensus 82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 161 (335)
T 2owb_A 82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161 (335)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999999999999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
++|+||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 238 (335)
T 2owb_A 162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238 (335)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence 9999999999999 67889999999999776533 2234456889999999999888999999999999999999999
Q ss_pred CCCCCCCccc----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 166 PPFSGRNNVQ----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 166 ~p~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.||....... ..+..++..+.++|++||+.||.+|||++|+++||||+...
T Consensus 239 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 239 PPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 9998764322 12567889999999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=300.47 Aligned_cols=208 Identities=35% Similarity=0.652 Sum_probs=185.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++...+.+++..+..++.||+.||.|||++|+
T Consensus 88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 167 (504)
T 3q5i_A 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNI 167 (504)
T ss_dssp CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||+|+||+++..+....++|+|||++.............+++.|+|||.+. ..++.++||||+|++++++++|..|
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCC
Confidence 999999999999533333479999999998876665556677999999999987 4689999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|.+....... ...++++++++|++||+.||.+|||++|+|+||||+...
T Consensus 247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 9876543222 356899999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=283.95 Aligned_cols=205 Identities=29% Similarity=0.466 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+.++++++||||+++++++.+.+..++|+||+.++ +|.+++.....+++..++.++.|++.||.|||++|+
T Consensus 72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 151 (335)
T 3dls_A 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151 (335)
T ss_dssp TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3456778999999999999999999999999999999998666 999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..+ +.++||||||++++++++|..
T Consensus 152 vH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 152 IHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 999999999999 6788999999999988766655556678999999999987776 789999999999999999999
Q ss_pred CCCCCCccc----ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQ----LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||....... ..+..++.++.++|++||+.||.+|||++|+++||||+...
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 229 PFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp SCSSGGGGTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred chhhHHHHHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 997643321 12556799999999999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=282.73 Aligned_cols=210 Identities=28% Similarity=0.550 Sum_probs=178.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++...+.+++..+..++.|++.||.+||++
T Consensus 42 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~ 121 (311)
T 4agu_A 42 DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121 (311)
T ss_dssp -HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556788899999999999999999999999999999999999999999988888899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++||||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|++++++++
T Consensus 122 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 198 (311)
T 4agu_A 122 NCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198 (311)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh
Confidence 99999999999999 67889999999999776533 22344567889999999876 567999999999999999999
Q ss_pred CCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCccccCC
Q 027233 164 GYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 164 g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
|..||.+....+.. .+.++.++.+++++||+.||.+|||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 199 GVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC
Confidence 99999776432111 2467888999999999999999999
Q ss_pred HhHHhcCccccccCcc
Q 027233 203 FNEFYHHRFLRRNSAI 218 (226)
Q Consensus 203 ~~~~l~~~~~~~~~~~ 218 (226)
++|+++||||++....
T Consensus 279 ~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 279 CEQLLHHPYFENIREI 294 (311)
T ss_dssp HHHHHTSGGGTTCC--
T ss_pred HHHHhcChHHHhccCH
Confidence 9999999999986443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=276.17 Aligned_cols=206 Identities=29% Similarity=0.569 Sum_probs=178.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....+.+.+|+.++++++||||+++++++.. .+..++|+||+++++|.+++...+.+++..++.++.|++.||.+
T Consensus 65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~ 144 (290)
T 1t4h_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence 45677889999999999999999999999875 45689999999999999999988899999999999999999999
Q ss_pred HHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 82 lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
||++| ++|+||+|+||+++ ..++.++|+|||++...... ......++..|+|||.+. ..++.++|+||||++++
T Consensus 145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML 220 (290)
T ss_dssp HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHH
T ss_pred HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHH
Confidence 99999 99999999999993 26788999999999655433 234456899999999887 45899999999999999
Q ss_pred HHHhCCCCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 160 ELLNGYPPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++++|..||....... ......++++.++|.+||+.||.+|||++|+++||||++.
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 9999999997744321 1245567899999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=292.25 Aligned_cols=209 Identities=30% Similarity=0.609 Sum_probs=172.3
Q ss_pred HHHHHHHHHHhcC-CCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 11 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+|+.++.++ +||||+++++++.. .+..++||||++|++|.+++...+ .+++..+..++.||+.||.|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567888887544 89999999999875 567899999999999999998753 5999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++||+||||||+||+++....++.++|+|||++.............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_dssp HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH
T ss_pred HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh
Confidence 99999999999999995333378899999999987665544456678999999999998899999999999999999999
Q ss_pred CCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCccc
Q 027233 164 GYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 219 (226)
Q Consensus 164 g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~ 219 (226)
|..||.+....... ...++.++.++|++||+.||.+|||++|+++||||.......
T Consensus 259 g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~ 332 (400)
T 1nxk_A 259 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332 (400)
T ss_dssp SSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred CCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence 99999765432210 246889999999999999999999999999999998765443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=277.91 Aligned_cols=206 Identities=33% Similarity=0.628 Sum_probs=159.6
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|+.++++++||||+++++++.+.+..++++||+++++|.+++... .++++..++.++.|++.||.+||++|++
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 134 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL 134 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 467899999999999999999999999999999999999999999999875 5799999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||++++++++|..|
T Consensus 135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 678899999999997765332 22345678899999999888899999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
|........ .+..++.++.++|.+||+.||.+|||++++++||||.+.+..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 272 (278)
T 3cok_A 212 FDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272 (278)
T ss_dssp SCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred CCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence 976543221 245678999999999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=283.36 Aligned_cols=204 Identities=26% Similarity=0.516 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++.. ..+++..+..++.|++.||.|||++|+
T Consensus 84 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~i 162 (321)
T 2c30_A 84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGV 162 (321)
T ss_dssp CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3456788999999999999999999999999999999999999999998874 479999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||++ +.++.++|+|||++....... ......++..|+|||...+..++.++|+||||++++++++|..
T Consensus 163 vH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 163 IHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 678899999999987765432 2344568999999999998899999999999999999999999
Q ss_pred CCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||......... ...+++.+.+++.+||+.||.+|||++|+++||||...
T Consensus 240 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 240 PYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp TTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred CCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 99765432211 34578899999999999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=278.71 Aligned_cols=207 Identities=30% Similarity=0.584 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++.....+++..++.++.|++.||.+||++|++
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 130 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA 130 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 36789999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCC-CCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||+++... ....++|+|||.+.............++..|+|||...+..++.++|+||||++++++++|..|
T Consensus 131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 210 (283)
T 3bhy_A 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210 (283)
T ss_dssp CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCC
Confidence 999999999994211 1237999999999877655444556688999999999988899999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+....... ...++..+.+++++||+.||.+|||+.|+++||||+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 211 FLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9876533211 35678899999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=277.28 Aligned_cols=205 Identities=36% Similarity=0.670 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.+++.++||||+++++++...+..++++||+++++|.+++...+.+++..+..++.|++.||.+||++|++
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 133 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 35678999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+..+ +.++|+||||++++++++|..|
T Consensus 134 H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 210 (276)
T 2h6d_A 134 HRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210 (276)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999 6788999999999987765544455668889999999987665 5899999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|........ .+..++..+.++|.+||+.||.+|||++|+++||||+...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 211 FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred CCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 977543221 2556789999999999999999999999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=281.42 Aligned_cols=211 Identities=33% Similarity=0.582 Sum_probs=184.0
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+.+..++++||+++++|.+++...+.+++..+..++.|++.||.+||++|++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|+||+|+||++...+.++.++|+|||.+...... ......++..|+|||...+..++.++|+||||++++++++|..||
T Consensus 129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999954456788999999998654332 233456889999999999888999999999999999999999999
Q ss_pred CCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccC
Q 027233 169 SGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 220 (226)
Q Consensus 169 ~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~ 220 (226)
........ ....++.++.++|.+||+.||.+|||++|+++||||+......+
T Consensus 208 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 273 (304)
T 2jam_A 208 YEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273 (304)
T ss_dssp TTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCCC
T ss_pred CCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcccc
Confidence 76543211 13567899999999999999999999999999999998765443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=286.55 Aligned_cols=204 Identities=29% Similarity=0.496 Sum_probs=177.1
Q ss_pred HHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 12 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
...+|++++.++ +||||+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++|++||
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr 140 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR 140 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence 456788888888 7999999999999999999999999999999999988899999999999999999999999999999
Q ss_pred ccCCCCeEeeeCC-CCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 91 DLKPENILLSGLD-DDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 91 dl~~~nili~~~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||+|+||++.+.+ ....++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 9999999984322 2246999999999876543 2334556899999999998888899999999999999999999999
Q ss_pred CCCCcccc-----------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 169 SGRNNVQL-----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 169 ~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.+...... ....++.+++++|++||+.||.+|||+.|+++||||.+.
T Consensus 221 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 221 ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 86432110 135689999999999999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=286.66 Aligned_cols=204 Identities=35% Similarity=0.715 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+.++.+.+|+.+++++ +||||+++++++...+..++||||++|++|.+++.....+++..+..++.|++.||.|||+.|
T Consensus 141 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g 220 (365)
T 2y7j_A 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220 (365)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4467889999999999 899999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc------cCCCcchhHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~~~~~ 160 (226)
++|+||+|+||++ +.++.++|+|||++.............+++.|+|||.+.+ ..++.++|+||||+++++
T Consensus 221 i~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 221 IVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence 9999999999999 6788999999999987766555556778999999998853 357889999999999999
Q ss_pred HHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 161 LLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
|++|..||......... ....+..+.++|++||+.||.+|||++|+++||||++
T Consensus 298 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 298 LLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 99999999765432211 3467888999999999999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=296.59 Aligned_cols=205 Identities=31% Similarity=0.523 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~ 86 (226)
.....+.+|+++++.++||||+++++++...+..++||||++|++|.+++...+.+++..+..++.||+.||.|||+ +|
T Consensus 190 ~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g 269 (446)
T 4ejn_A 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269 (446)
T ss_dssp -----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 34467788999999999999999999999999999999999999999999988899999999999999999999998 99
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+||||+|+||++ +.++.++|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 270 iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 346 (446)
T 4ejn_A 270 VVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346 (446)
T ss_dssp CCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence 9999999999999 6788999999999976433 23344567899999999999999999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
.||.+.+.... .+..+++++.++|.+||+.||.+|| |++|+++||||++.
T Consensus 347 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 347 LPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99987654322 2567899999999999999999999 99999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=279.31 Aligned_cols=203 Identities=30% Similarity=0.535 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++||||+++++++...+..++||||+++ +|.+++... +.+++..+..++.|++.||.+||++|+
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (288)
T 1ob3_A 43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (288)
T ss_dssp CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 456788999999999999999999999999999999999965 999998865 579999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
+||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||||++++++++|.
T Consensus 122 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999 678899999999997664332 22344678999999998754 5899999999999999999999
Q ss_pred CCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 166 PPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 166 ~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
.||.+.+..+. ....++.++.++|++||+.||.+|||++|+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 278 (288)
T 1ob3_A 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (288)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99976542111 124578899999999999999999999999
Q ss_pred hcCcccccc
Q 027233 207 YHHRFLRRN 215 (226)
Q Consensus 207 l~~~~~~~~ 215 (226)
++||||++.
T Consensus 279 l~hp~f~~~ 287 (288)
T 1ob3_A 279 LEHAYFKEN 287 (288)
T ss_dssp HTSGGGGC-
T ss_pred hcCcchhhc
Confidence 999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=291.69 Aligned_cols=202 Identities=31% Similarity=0.561 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|..+++.++||||+++++++.+.+..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+|
T Consensus 113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givH 191 (410)
T 3v8s_A 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH 191 (410)
T ss_dssp CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 44588999999999999999999999999999999999999999999875 47999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccC----CCcchhHHHHHHHHHHHHh
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~~~~l~~ 163 (226)
|||||+||++ +.++.++|+|||++........ ....+|++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus 192 rDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 192 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 9999999999 7888999999999977654432 23567999999999997655 7789999999999999999
Q ss_pred CCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
|..||.+.+..... ...++.+++++|++||+.+|.+ |++++|+++||||++.
T Consensus 269 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 269 GDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp SSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred CCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999876532211 2368999999999999988888 9999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=298.26 Aligned_cols=204 Identities=32% Similarity=0.536 Sum_probs=184.0
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++...+ .+++..+..++.||+.||.|||++|
T Consensus 227 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g 306 (576)
T 2acx_A 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306 (576)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44568899999999999999999999999999999999999999999998754 4999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|+||||+|+||++ +.++.++|+|||++.............|++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 307 IvHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~ 383 (576)
T 2acx_A 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383 (576)
T ss_dssp EECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999 6888999999999988766555556689999999999998889999999999999999999999
Q ss_pred CCCCCCccc--------------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 167 PFSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
||....... ..+..++++++++|++||+.||.+|| +++|+++||||++.
T Consensus 384 PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 384 PFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp SSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred CCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 998754211 12566899999999999999999999 89999999999973
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=278.61 Aligned_cols=204 Identities=32% Similarity=0.499 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..+.+.+|++++++++||||+++++++..++..++||||++ ++|.+++... ..+++..+..++.|++.||.||
T Consensus 46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l 124 (317)
T 2pmi_A 46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124 (317)
T ss_dssp SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999996 6999998754 3589999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccc-cCCCcchhHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~ 160 (226)
|++|++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++++
T Consensus 125 H~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 125 HENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HHCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999999 67889999999999776533 22344568899999999876 468999999999999999
Q ss_pred HHhCCCCCCCCCcccc--------------------------------------------cccCCChHHHHHHHHhhccC
Q 027233 161 LLNGYPPFSGRNNVQL--------------------------------------------IVPALHPDCVDMCLKLLSAN 196 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~--------------------------------------------~~~~~~~~~~~~i~~~l~~~ 196 (226)
|++|..||.+.+.... ....++.++.++|.+||+.|
T Consensus 202 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 281 (317)
T 2pmi_A 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281 (317)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCC
Confidence 9999999976543110 01257889999999999999
Q ss_pred ccccCCHhHHhcCccccccC
Q 027233 197 TVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 197 p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|.+|||++|+++||||++..
T Consensus 282 P~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 282 PDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGSCCHHHHTTSGGGGGGC
T ss_pred cccCCCHHHHhCChhhhccc
Confidence 99999999999999999853
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=282.66 Aligned_cols=209 Identities=34% Similarity=0.552 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++.++ +||||+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|
T Consensus 52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (316)
T 2ac3_A 52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131 (316)
T ss_dssp CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3467889999999996 799999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--------ccccccCCccccCcccccc-----cCCCcchhHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS 153 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~s 153 (226)
++||||+|+||+++..+....++|+|||++....... ......++..|+|||.+.+ ..++.++||||
T Consensus 132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 211 (316)
T 2ac3_A 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211 (316)
T ss_dssp CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence 9999999999999532233449999999987653221 1123458899999999865 55789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccc-----------------------------ccccCCChHHHHHHHHhhccCccccCCHh
Q 027233 154 VGAILFELLNGYPPFSGRNNVQ-----------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
||+++++|++|..||.+....+ .....++.+++++|++||+.||.+|||++
T Consensus 212 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (316)
T 2ac3_A 212 LGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291 (316)
T ss_dssp HHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHH
Confidence 9999999999999998754221 00245788999999999999999999999
Q ss_pred HHhcCccccccC
Q 027233 205 EFYHHRFLRRNS 216 (226)
Q Consensus 205 ~~l~~~~~~~~~ 216 (226)
|+++||||++..
T Consensus 292 e~l~hp~~~~~~ 303 (316)
T 2ac3_A 292 QVLQHPWVQGCA 303 (316)
T ss_dssp HHHHSTTCC---
T ss_pred HHhcChhhcCCC
Confidence 999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=293.90 Aligned_cols=205 Identities=36% Similarity=0.630 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
...+.+|+.++++++||||+++++++.. +..++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 262 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3468899999999999999999999865 558999999999999999988889999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc---cCCCcchhHHHHHHHHHHHHhCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
|||+|+||+++..+....++|+|||++.............+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999995434455699999999988766555556678999999999853 567889999999999999999999
Q ss_pred CCCCCCccccc---------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||......... ...++..+.++|++||+.||.+|||++|+++||||++.
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99765432111 35678999999999999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=280.56 Aligned_cols=202 Identities=30% Similarity=0.536 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++.+ .+..++||||+++++|.+++. .+++++..++.++.|++.||.|||++|
T Consensus 79 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp --CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35678999999999999999999999986 578999999999999988644 457999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccC---CCcchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~~~~l~ 162 (226)
++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+.. .+.++|+||||+++++|+
T Consensus 158 ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 IIHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp EECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999 678899999999997765432 234456899999999987654 377899999999999999
Q ss_pred hCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 163 NGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 163 ~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+|..||........ ....++.++.++|.+||+.||.+|||+.|+++||||++
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999976543211 13468899999999999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=285.38 Aligned_cols=204 Identities=34% Similarity=0.586 Sum_probs=174.6
Q ss_pred HHHHHHHHHHH-HhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|..+ ++.++||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|+
T Consensus 81 ~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi 160 (373)
T 2r5t_A 81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160 (373)
T ss_dssp ----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 44556667776 56789999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||||+||++ +.++.++|+|||++..... .......+|++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 161 vHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 237 (373)
T 2r5t_A 161 VYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237 (373)
T ss_dssp CCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eecCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 999999999999 6888999999999976433 334456678999999999999999999999999999999999999
Q ss_pred CCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH----hHHhcCcccccc
Q 027233 167 PFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~----~~~l~~~~~~~~ 215 (226)
||.+.+.... .+..++.+++++|++||+.||.+||++ +++++||||+.-
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 238 PFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp TTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9987654322 256789999999999999999999987 699999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=275.69 Aligned_cols=206 Identities=36% Similarity=0.689 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...++.+.+|+++++++. ||||+++++++...+..++|+||+++++|.+++.....+++..++.++.|++.||.+||++
T Consensus 64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 143 (298)
T 1phk_A 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999995 9999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc------ccCCCcchhHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~~~~ 159 (226)
|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+. ...++.++|+||||++++
T Consensus 144 ~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~ 220 (298)
T 1phk_A 144 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220 (298)
T ss_dssp TEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred CcccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHH
Confidence 99999999999999 678899999999998776555555567889999999875 346788999999999999
Q ss_pred HHHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 160 ELLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++++|..||......... ...++..+.++|.+||+.||.+|||+.|+++||||+..
T Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 221 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 999999999765432211 24678999999999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=284.04 Aligned_cols=208 Identities=28% Similarity=0.461 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++.+.+..++||||++ ++|.+++.....+++..++.++.||+.||.|||++|+
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~i 153 (329)
T 3gbz_A 75 GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC 153 (329)
T ss_dssp -----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345677899999999999999999999999999999999996 5999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeC--CCCccEEEeeeccccccCCC-CccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~--~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~ 163 (226)
+||||+|+||+++.. +..+.++|+|||++...... .......++..|+|||.+.+. .++.++||||||++++++++
T Consensus 154 vH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 233 (329)
T 3gbz_A 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233 (329)
T ss_dssp CCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred ECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999532 23456999999999776533 223345578999999998764 47999999999999999999
Q ss_pred CCCCCCCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCccccCCH
Q 027233 164 GYPPFSGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 164 g~~p~~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
|..||.+....+.. ...++.++.++|++||+.||.+|||+
T Consensus 234 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 313 (329)
T 3gbz_A 234 KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313 (329)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence 99999765432111 12267899999999999999999999
Q ss_pred hHHhcCccccccC
Q 027233 204 NEFYHHRFLRRNS 216 (226)
Q Consensus 204 ~~~l~~~~~~~~~ 216 (226)
+|+++||||++..
T Consensus 314 ~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 314 KNALEHPYFSHND 326 (329)
T ss_dssp HHHHTSGGGSSSC
T ss_pred HHHhCCcccCCCC
Confidence 9999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=287.04 Aligned_cols=204 Identities=29% Similarity=0.520 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|..++..++||||+++++++.+.+..|+||||++|++|.+++.+.+ .+++..++.++.||+.||.|||++|
T Consensus 103 ~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g 182 (412)
T 2vd5_A 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182 (412)
T ss_dssp GGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345668999999999999999999999999999999999999999999998764 7999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCccccc-------ccCCCcchhHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAI 157 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~~ 157 (226)
|+||||||+||++ +.++.++|+|||++........ ....+|++.|+|||.+. +..++.++|+||||++
T Consensus 183 iiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 183 YVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp EECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred eeecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 9999999999999 7888999999999987654433 22457899999999986 3568899999999999
Q ss_pred HHHHHhCCCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCcccc---CCHhHHhcCcccccc
Q 027233 158 LFELLNGYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVDR---LSFNEFYHHRFLRRN 215 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~R---pt~~~~l~~~~~~~~ 215 (226)
+|+|++|..||.+.+..... ...++.+++++|++||+ +|.+| |+++|+++||||++-
T Consensus 260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999876533211 24689999999999999 99998 599999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=277.76 Aligned_cols=202 Identities=32% Similarity=0.544 Sum_probs=173.7
Q ss_pred HHHHHHHHHHhcC---CCCCeeeeeeEEEeCC-----eEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSV---NHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 11 ~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~ 80 (226)
..+.+|+.+++.+ +||||+++++++.... ..++++|++. ++|.+++..... +++..++.++.|++.||.
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 134 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 4666777777777 4999999999998754 5899999995 699999987654 899999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
|||++|++||||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+..++.++||||||+++++
T Consensus 135 ~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 211 (308)
T 3g33_A 135 FLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 211 (308)
T ss_dssp HHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHH
T ss_pred HHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHH
Confidence 9999999999999999999 6788999999999987766555566778999999999998999999999999999999
Q ss_pred HHhCCCCCCCCCccccc-------------------------------------ccCCChHHHHHHHHhhccCccccCCH
Q 027233 161 LLNGYPPFSGRNNVQLI-------------------------------------VPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~-------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
|++|..||.+.+..... .+.++.++.++|.+||+.||.+|||+
T Consensus 212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 291 (308)
T 3g33_A 212 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291 (308)
T ss_dssp TTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence 99999999765432111 24678899999999999999999999
Q ss_pred hHHhcCccccccC
Q 027233 204 NEFYHHRFLRRNS 216 (226)
Q Consensus 204 ~~~l~~~~~~~~~ 216 (226)
.|+|+||||+...
T Consensus 292 ~e~l~h~~~~~~~ 304 (308)
T 3g33_A 292 FRALQHSYLHKDE 304 (308)
T ss_dssp HHHHTSTTC----
T ss_pred HHHhcCccccCCC
Confidence 9999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=290.76 Aligned_cols=203 Identities=30% Similarity=0.576 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|..++..++||||+++++++.+.+..|+||||++|++|.+++.+ .+.+++..++.++.||+.||.|||++||+
T Consensus 118 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gii 197 (437)
T 4aw2_A 118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197 (437)
T ss_dssp TCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 34588999999999999999999999999999999999999999999987 46899999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCccccc-----ccCCCcchhHHHHHHHHHHH
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~~~l 161 (226)
||||||+||++ +.++.++|+|||++........ ....+|++.|+|||.+. ...++.++|+||||+++++|
T Consensus 198 HrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~el 274 (437)
T 4aw2_A 198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274 (437)
T ss_dssp CCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHH
T ss_pred ecccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHH
Confidence 99999999999 7888999999999977654432 23357899999999986 45689999999999999999
Q ss_pred HhCCCCCCCCCccccc---------------ccCCChHHHHHHHHhhccCccc--cCCHhHHhcCcccccc
Q 027233 162 LNGYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 215 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 215 (226)
++|..||.+.+..+.. ...++++++++|++||+.+|++ |++++|+++||||++.
T Consensus 275 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 275 LYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 9999999876533211 2348999999999999988888 9999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=285.47 Aligned_cols=209 Identities=33% Similarity=0.556 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--------------------------
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------------------- 60 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------- 60 (226)
....+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++...
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (345)
T 3hko_A 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148 (345)
T ss_dssp -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence 455678999999999999999999999999999999999999999999988521
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCc--cEEEeeeccccccCCCC-
Q 027233 61 --------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN- 123 (226)
Q Consensus 61 --------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~--~~~l~df~~~~~~~~~~- 123 (226)
..+++..++.++.|++.||.|||++|++||||+|+||++ +.++ .++|+|||.+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~~ 225 (345)
T 3hko_A 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLNN 225 (345)
T ss_dssp HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTTC
T ss_pred ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccCc
Confidence 123577888999999999999999999999999999999 4444 79999999997653321
Q ss_pred ----ccccccCCccccCcccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------ccCCCh
Q 027233 124 ----YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPALHP 183 (226)
Q Consensus 124 ----~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~ 183 (226)
......+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+....+.. ...+++
T Consensus 226 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (345)
T 3hko_A 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP 305 (345)
T ss_dssp C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCH
T ss_pred cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCH
Confidence 1234568899999999865 67889999999999999999999999876543221 234789
Q ss_pred HHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 184 DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 184 ~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
++.++|.+||+.+|.+|||+.|+++||||+..+..
T Consensus 306 ~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 306 LARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 99999999999999999999999999999987544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=281.73 Aligned_cols=207 Identities=29% Similarity=0.489 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+|+.+++.+ .||||+++++++...+..++|+||+.+++|.+++... ..+++..++.++.|++.||.+||++
T Consensus 71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~ 150 (327)
T 3lm5_A 71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150 (327)
T ss_dssp CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457889999999999 5799999999999999999999999999999998643 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|++||||+|+||+++....++.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 151 givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230 (327)
T ss_dssp TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999532337889999999998776555555567899999999999899999999999999999999999
Q ss_pred CCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||.+.+.... ....++..+.++|.+||+.||.+|||++|+++||||+..
T Consensus 231 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 231 SPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred CCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 99977654322 135688999999999999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=273.76 Aligned_cols=206 Identities=31% Similarity=0.547 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.+++.++||||+++++++.+.+..++|+||+++++|.+++.....+++..++.++.|++.||.+||++|+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (276)
T 2yex_A 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126 (276)
T ss_dssp THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34578999999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~ 163 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..+ +.++|+||||++++++++
T Consensus 127 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 127 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 999999999999 678899999999987654322 2234567889999999987665 678999999999999999
Q ss_pred CCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 164 GYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 164 g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|..||........ ....++..+.++|.+||+.||.+|||++|+++||||+...
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp SSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999987543211 1346789999999999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=280.32 Aligned_cols=208 Identities=29% Similarity=0.525 Sum_probs=177.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.++......+++..+..++.|++.||.+||++
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 143 (331)
T 4aaa_A 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143 (331)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556778899999999999999999999999999999999999999999888778899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++||||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||||++++++++
T Consensus 144 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 144 NIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp TCCCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred CEEccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 99999999999999 67889999999999765443 223445688999999998765 68899999999999999999
Q ss_pred CCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCccccCC
Q 027233 164 GYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 164 g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
|..||.+....... .+.++.++.++|++||+.||.+|||
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 99999876532111 2357899999999999999999999
Q ss_pred HhHHhcCccccccC
Q 027233 203 FNEFYHHRFLRRNS 216 (226)
Q Consensus 203 ~~~~l~~~~~~~~~ 216 (226)
+.|+++||||+...
T Consensus 301 ~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 301 CAELLHHDFFQMDG 314 (331)
T ss_dssp GGGGGGSHHHHGGG
T ss_pred HHHHhcCchhccCC
Confidence 99999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=291.64 Aligned_cols=204 Identities=32% Similarity=0.481 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||+
T Consensus 228 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~ 307 (543)
T 3c4z_A 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307 (543)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999999764 369999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+||+||||||+||++ +.++.++|+|||++........ .....|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 308 ~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt 384 (543)
T 3c4z_A 308 RNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384 (543)
T ss_dssp TTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred cCCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh
Confidence 999999999999999 7888999999999987655433 234579999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc--------------cccccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 164 GYPPFSGRNNV--------------QLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
|..||.+.... ...+..++.+++++|++||+.||.+||+ ++++++||||++.
T Consensus 385 G~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 385 ARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp SSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred CCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 99999875321 1125678999999999999999999996 4899999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=284.17 Aligned_cols=206 Identities=31% Similarity=0.512 Sum_probs=181.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+.+++..+..++.|++.||.+||++
T Consensus 71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 150 (360)
T 3eqc_A 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150 (360)
T ss_dssp CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 45667889999999999999999999999999999999999999999999999888999999999999999999999996
Q ss_pred -CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 86 -~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|++|+||+|+||++ +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 151 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 226 (360)
T 3eqc_A 151 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226 (360)
T ss_dssp HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHC-----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred CCEEcCCccHHHEEE---CCCCCEEEEECCCCccccccc-ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999 678899999999986553222 2345688999999999988999999999999999999999
Q ss_pred CCCCCCCCcccc------------------------------------------------------cccCCChHHHHHHH
Q 027233 165 YPPFSGRNNVQL------------------------------------------------------IVPALHPDCVDMCL 190 (226)
Q Consensus 165 ~~p~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~i~ 190 (226)
..||...+.... ....++.++.++|+
T Consensus 227 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 306 (360)
T 3eqc_A 227 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 306 (360)
T ss_dssp SCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHH
Confidence 999976432110 02346889999999
Q ss_pred HhhccCccccCCHhHHhcCcccccc
Q 027233 191 KLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 191 ~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+||+.||.+|||++|+++||||++.
T Consensus 307 ~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 307 KCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp HHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HHhhcChhhCCCHHHHhhChHhhcc
Confidence 9999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=273.19 Aligned_cols=207 Identities=23% Similarity=0.352 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~ 81 (226)
......+.+|+..+..+ +||||+++++++.+.+..++|+||+++++|.+++... ..+++..++.++.|++.||.+
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~ 130 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 34567888999999999 9999999999999999999999999999999999865 679999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCC----------------CCccEEEeeeccccccCCCCccccccCCccccCccccccc-C
Q 027233 82 LNSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-R 144 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~----------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~ 144 (226)
||++|++|+||+|+||+++... ....++|+|||.+....... ...++..|+|||.+.+. .
T Consensus 131 lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp HHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCT
T ss_pred HHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCC
Confidence 9999999999999999994221 44579999999987765432 23488999999998765 5
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcc--------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 145 YDEKVDMWSVGAILFELLNGYPPFSGRNNV--------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++.++||||||++++++++|..++...... ...+..+++++.++|.+||+.||.+|||+.|+++||||+..+
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 568999999999999999998776544322 223567899999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=274.27 Aligned_cols=207 Identities=35% Similarity=0.640 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|++++++++||||+++++++...+..++++|++++++|.+++.....+++..++.++.|++.||.+||++|++
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 143 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
|+||+|+||+++..+.+..++|+|||++.............++..|+|||...+ .++.++|+||||++++++++|..||
T Consensus 144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCC
Confidence 999999999996434456799999999987665544444557888999999875 4889999999999999999999999
Q ss_pred CCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 169 SGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 169 ~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+....... ...++.++.++|++||+.+|.+|||+.|+++||||++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 223 YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp CCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 875432211 256789999999999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=280.05 Aligned_cols=206 Identities=36% Similarity=0.638 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
....+.+|++++++++||||+++++++..++ .++|+||+++++|.+++.....+++..++.++.||+.||.+||++|++
T Consensus 58 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 136 (322)
T 2ycf_A 58 PALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136 (322)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3456889999999999999999999987665 899999999999999998888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHHhCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
||||+|+||+++..+.+..++|+|||.+.............++..|+|||.+. +..++.++|+||||++++++++|.
T Consensus 137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216 (322)
T ss_dssp CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999533334469999999998775544444556899999999874 456889999999999999999999
Q ss_pred CCCCCCCcccc---------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 166 PPFSGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.||........ ....++.++.++|++||+.||.+|||++|+++||||++.
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 217 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 99976543211 135678999999999999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=286.31 Aligned_cols=206 Identities=27% Similarity=0.458 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....+.+.+|++++++++||||+++++++... +..|+||||++ ++|.+++.....+++..++.++.||+.||.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~ 144 (432)
T 3n9x_A 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144 (432)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999998765 57999999995 6999999988889999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----------------------cccccCCccccCcc
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------------------AEKVCGSPLYMAPE 138 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----------------------~~~~~~~~~~~aPE 138 (226)
||++|++||||||+||++ +.++.++|+|||++........ .....++..|+|||
T Consensus 145 LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 145 IHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred HHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 999999999999999999 6788999999999987643321 24456899999999
Q ss_pred cc-cccCCCcchhHHHHHHHHHHHHhCCCC-----------CCCCCccc-------------------------------
Q 027233 139 VL-QFQRYDEKVDMWSVGAILFELLNGYPP-----------FSGRNNVQ------------------------------- 175 (226)
Q Consensus 139 ~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p-----------~~~~~~~~------------------------------- 175 (226)
.+ .+..++.++||||+|+++++|++|..| |.+.+...
T Consensus 222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~ 301 (432)
T 3n9x_A 222 LILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301 (432)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCH
T ss_pred HHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCH
Confidence 86 556789999999999999999985444 33322100
Q ss_pred ---------------------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 176 ---------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 176 ---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
...+.+++++.++|++||+.||.+|||++|+|+||||+...
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 00246799999999999999999999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=274.93 Aligned_cols=202 Identities=27% Similarity=0.395 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
........|+..+.++ +|+||+++++++.+.+..++||||+ +++|.+++...+ .+++..++.++.|++.||.|||++
T Consensus 98 ~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 176 (311)
T 3p1a_A 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3444555556555555 9999999999999999999999999 779999887654 699999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|++||||||+||++ +.++.++|+|||++.............++..|+|||.+.+ .++.++||||||++++++++|.
T Consensus 177 ~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp TEECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred CEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999 6788999999999987766555556678999999999875 7899999999999999999997
Q ss_pred CCCCCCCccc---------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 166 PPFSGRNNVQ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 166 ~p~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.++....... .....++.++.++|.+||+.||.+|||++|+++||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 253 ELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 6655432221 125568899999999999999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=280.59 Aligned_cols=210 Identities=26% Similarity=0.403 Sum_probs=179.7
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~ 78 (226)
+|.+.....+.+.+|+.++++++ ||||+++++++.+ ....++++||+++++|.++++ .+++..+..++.|++.|
T Consensus 66 vK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~ 142 (330)
T 3nsz_A 66 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA 142 (330)
T ss_dssp EEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHH
T ss_pred EEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHH
Confidence 44555556788999999999996 9999999999987 677999999999999999875 58899999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~ 157 (226)
|.+||++|++||||+|+||+++ ..+..++|+|||++.............++..|+|||.+.+ ..++.++||||||++
T Consensus 143 l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 220 (330)
T 3nsz_A 143 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 220 (330)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHH
Confidence 9999999999999999999994 2344899999999987766555556678899999999876 678999999999999
Q ss_pred HHHHHhCCCCCCCCCcccc------------------------------------------------cccCCChHHHHHH
Q 027233 158 LFELLNGYPPFSGRNNVQL------------------------------------------------IVPALHPDCVDMC 189 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~------------------------------------------------~~~~~~~~~~~~i 189 (226)
+++|++|..||........ ....+++++.++|
T Consensus 221 l~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 300 (330)
T 3nsz_A 221 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300 (330)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHH
T ss_pred HHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHH
Confidence 9999999999854321100 0122789999999
Q ss_pred HHhhccCccccCCHhHHhcCccccccC
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++||+.||.+|||++|+|+||||+...
T Consensus 301 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 301 DKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 999999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=271.47 Aligned_cols=204 Identities=25% Similarity=0.471 Sum_probs=178.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~ 126 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 567788999999999999999999999999999999999999999999999987 4679999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---------------ccccCCccccCcccccccCCCcch
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV 149 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~ 149 (226)
+|++||||+|+||++ +.++.++|+|||.+......... ....++..|+|||.+.+..++.++
T Consensus 127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (310)
T 3s95_A 127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203 (310)
T ss_dssp TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence 999999999999999 67889999999999776443221 134688999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 150 DMWSVGAILFELLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 150 Dv~slG~~~~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
||||||++++++++|..|+........ .+..+++.+.+++.+||+.||.+|||+.++++ +++.
T Consensus 204 Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 204 DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp HHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 999999999999999999876433221 15678899999999999999999999999987 4443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=277.68 Aligned_cols=205 Identities=26% Similarity=0.482 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-----------------------------------------------
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------------------------------------------- 39 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------------------------------------------- 39 (226)
....+.+.+|++++++++||||+++++++.+.+
T Consensus 45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (332)
T 3qd2_B 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124 (332)
T ss_dssp TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence 446788999999999999999999999886543
Q ss_pred ----------eEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCc
Q 027233 40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106 (226)
Q Consensus 40 ----------~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~ 106 (226)
..+++|||++|++|.+++..... .++..++.++.|++.||.|||++|++||||||+||++ +.++
T Consensus 125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~ 201 (332)
T 3qd2_B 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 201 (332)
T ss_dssp -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence 38999999999999999987643 4566789999999999999999999999999999999 6788
Q ss_pred cEEEeeeccccccCCCC-------------ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC-
Q 027233 107 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN- 172 (226)
Q Consensus 107 ~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~- 172 (226)
.++|+|||++....... ......++..|+|||.+.+..++.++|+||||++++++++|..|+....
T Consensus 202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~ 281 (332)
T 3qd2_B 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281 (332)
T ss_dssp CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH
T ss_pred CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH
Confidence 99999999998765432 1233468899999999998899999999999999999999887753221
Q ss_pred --------cccccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 173 --------NVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 173 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
.........++++.++|.+||+.||.+|||++|+++||||++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 111113445778899999999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=287.49 Aligned_cols=205 Identities=28% Similarity=0.463 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....+.+.+|++++++++||||+++++++.. .+..|+|+|++ +++|.+++.....+++..++.++.||+.||.|
T Consensus 93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 171 (458)
T 3rp9_A 93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171 (458)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999843 35799999998 67999999988889999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----------------------------ccccccCCcc
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPL 133 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----------------------------~~~~~~~~~~ 133 (226)
||++||+||||||+||++ +.++.++|+|||++....... .....++++.
T Consensus 172 LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 248 (458)
T 3rp9_A 172 VHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248 (458)
T ss_dssp HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred HHhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence 999999999999999999 678899999999997664321 1223467899
Q ss_pred ccCcccc-cccCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCCcc---------------------------
Q 027233 134 YMAPEVL-QFQRYDEKVDMWSVGAILFELLN-----------GYPPFSGRNNV--------------------------- 174 (226)
Q Consensus 134 ~~aPE~~-~~~~~~~~~Dv~slG~~~~~l~~-----------g~~p~~~~~~~--------------------------- 174 (226)
|+|||.+ .+..++.++|||||||++++|++ |..+|.+.+..
T Consensus 249 Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 328 (458)
T 3rp9_A 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF 328 (458)
T ss_dssp TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHH
T ss_pred ccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHH
Confidence 9999976 55679999999999999999998 56666553310
Q ss_pred ----------------------------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 175 ----------------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 175 ----------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
....+..+.++.+||++||+.||.+|||++|+|+||||+..
T Consensus 329 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 329 NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00124558899999999999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=276.78 Aligned_cols=203 Identities=30% Similarity=0.511 Sum_probs=171.1
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
.+.+|++++++++||||+++++++...+..++||||++ ++|.+++...+ .+++..+..++.|++.||.+||++|++||
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 124 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 45579999999999999999999999999999999996 59999988754 58999999999999999999999999999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||
T Consensus 125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 201 (324)
T 3mtl_A 125 DLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201 (324)
T ss_dssp SCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999 678899999999987654332 2234467899999999876 56899999999999999999999999
Q ss_pred CCCCccccc----------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 169 SGRNNVQLI----------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 169 ~~~~~~~~~----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.+.+..+.. ...+++++.++|++||+.||.+|||++|+++
T Consensus 202 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 875432111 2357889999999999999999999999999
Q ss_pred CccccccCcc
Q 027233 209 HRFLRRNSAI 218 (226)
Q Consensus 209 ~~~~~~~~~~ 218 (226)
||||......
T Consensus 282 hp~f~~~~~~ 291 (324)
T 3mtl_A 282 HPFFLSLGER 291 (324)
T ss_dssp SGGGGGGCST
T ss_pred Chhhhhcccc
Confidence 9999986443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=278.27 Aligned_cols=204 Identities=25% Similarity=0.368 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHHHHhcCC-----CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l 79 (226)
....+.+..|+.+++.+. ||||+++++++...+..++||||+ +++|.+++.... .+++..+..++.||+.||
T Consensus 72 ~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 455667888999999996 999999999999999999999999 899999998764 599999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeC----------------------CCCccEEEeeeccccccCCCCccccccCCccccCc
Q 027233 80 EILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~----------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 137 (226)
.|||++|++||||||+||+++.. +.++.++|+|||++...... .....++..|+||
T Consensus 151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aP 228 (360)
T 3llt_A 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAP 228 (360)
T ss_dssp HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCH
T ss_pred HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCc
Confidence 99999999999999999999421 12678999999999765432 2345689999999
Q ss_pred ccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc----------------------------------------
Q 027233 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---------------------------------------- 177 (226)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------------------------------------- 177 (226)
|.+.+..++.++||||||+++++|++|..||...+..+..
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 9999999999999999999999999999999765432111
Q ss_pred ----------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 178 ----------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 178 ----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
....++.+.++|++||+.||.+|||+.|+|+||||+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 011236788999999999999999999999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=281.08 Aligned_cols=205 Identities=31% Similarity=0.487 Sum_probs=173.9
Q ss_pred hHHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCC--eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+.+|+.+++++. ||||+++++++...+ ..|+||||++ ++|.+++.. ..+++..+..++.||+.||+||
T Consensus 48 ~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~L 125 (388)
T 3oz6_A 48 NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYL 125 (388)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 3456677889999999996 999999999997543 7899999996 699998876 4899999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC----------------------CccccccCCccccCcccc
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVL 140 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~----------------------~~~~~~~~~~~~~aPE~~ 140 (226)
|++|++||||||+||++ +.++.++|+|||++...... .......+++.|+|||.+
T Consensus 126 H~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 126 HSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred HhCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 99999999999999999 67889999999999765321 112234688999999998
Q ss_pred cc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------------------------------------------
Q 027233 141 QF-QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------------------------------------ 177 (226)
Q Consensus 141 ~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------------------------------------------ 177 (226)
.+ ..++.++||||+|+++++|++|..||.+.+.....
T Consensus 203 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (388)
T 3oz6_A 203 LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282 (388)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CC
T ss_pred cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHH
Confidence 76 67899999999999999999999999876532211
Q ss_pred ---------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 178 ---------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 178 ---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
....++++.++|++||+.||.+|||++|+|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 283 DIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 11668899999999999999999999999999998763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=272.53 Aligned_cols=205 Identities=27% Similarity=0.500 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|+
T Consensus 67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 146 (314)
T 3com_A 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146 (314)
T ss_dssp CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 356789999999999999999999999999999999999999999999974 4689999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||++++++++|..
T Consensus 147 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 147 IHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999 678899999999997665432 2334567889999999998889999999999999999999999
Q ss_pred CCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||........ ....++..+.++|.+||+.||.+|||+.++++||||+..+
T Consensus 224 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 224 PYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 9976543211 1445688999999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=297.47 Aligned_cols=205 Identities=32% Similarity=0.596 Sum_probs=185.3
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+..|..++..+ +||+|+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++|
T Consensus 383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g 462 (674)
T 3pfq_A 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462 (674)
T ss_dssp TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4556788999999998 799999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
|+||||||+||++ +.++.++|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 463 IiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~ 539 (674)
T 3pfq_A 463 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539 (674)
T ss_dssp EECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred eEeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCC
Confidence 9999999999999 7888999999999976432 33445667999999999999999999999999999999999999
Q ss_pred CCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCH-----hHHhcCcccccc
Q 027233 166 PPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRRN 215 (226)
Q Consensus 166 ~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~-----~~~l~~~~~~~~ 215 (226)
.||.+.+..+. .+..++.+++++|++||+.||.+|+++ +|+++||||++-
T Consensus 540 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 540 APFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99987654322 266789999999999999999999998 999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=278.59 Aligned_cols=207 Identities=25% Similarity=0.466 Sum_probs=174.4
Q ss_pred hHHHHHHHHHHHHHHhcCCC--CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|+.++++++| +||+++++++...+..++|||+ .+++|.+++...+.+++..+..++.|++.||.|||
T Consensus 47 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH 125 (343)
T 3dbq_A 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44566789999999999976 9999999999999999999995 48899999999889999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccc-----------cCCCcch
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~ 149 (226)
++|++||||+|+||+++ ++.++|+|||++........ .....+++.|+|||.+.+ ..++.++
T Consensus 126 ~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 126 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred hCCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 99999999999999993 56799999999977654322 234568999999999864 6688899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 150 DMWSVGAILFELLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 150 Dv~slG~~~~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||||||+++++|++|..||...... ...+...+.++.+++.+||+.||.+|||+.|+++||||+...
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 9999999999999999999764321 112455677899999999999999999999999999998654
Q ss_pred c
Q 027233 217 A 217 (226)
Q Consensus 217 ~ 217 (226)
.
T Consensus 282 ~ 282 (343)
T 3dbq_A 282 H 282 (343)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=291.77 Aligned_cols=203 Identities=32% Similarity=0.485 Sum_probs=168.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l 79 (226)
.....+.+.+|+.+++.++||||+++++++... ...|+||||+++ +|.+.+. ..+++..+..++.||+.||
T Consensus 101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL 177 (464)
T 3ttj_A 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 177 (464)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHH
Confidence 445677889999999999999999999999654 467999999965 5776665 3689999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
.|||++||+||||||+||++ +.++.++|+|||++.............+++.|+|||.+.+..++.++||||+|++++
T Consensus 178 ~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 178 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 99999999999999999999 678899999999998776655556677899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccccc-----------------------------------------ccC-----------CChHHHH
Q 027233 160 ELLNGYPPFSGRNNVQLI-----------------------------------------VPA-----------LHPDCVD 187 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~-----------------------------------------~~~-----------~~~~~~~ 187 (226)
+|++|..||.+.+..+.. +.. .++++.+
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 999999999876532111 000 1467999
Q ss_pred HHHHhhccCccccCCHhHHhcCccccc
Q 027233 188 MCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 188 ~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+|++||+.||.+|||++|+|+||||+.
T Consensus 335 Ll~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 335 LLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 999999999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=276.55 Aligned_cols=202 Identities=30% Similarity=0.497 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|++++++++||||+++++++...+..++||||+. ++|.+++.. ..++++..+..++.|++.||.+||++
T Consensus 95 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 173 (348)
T 1u5q_A 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4456789999999999999999999999999999999999996 688888754 46799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc---ccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++||||+|+||++ +.++.++|+|||++...... ....+++.|+|||.+. +..++.++||||||+++++|+
T Consensus 174 ~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 174 NMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp TCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred CeeeCCCCHHHEEE---CCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999 57889999999999765432 3456899999999984 467889999999999999999
Q ss_pred hCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 163 NGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 163 ~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+|..||.+...... .....+..+.++|.+||+.||.+|||++++++||||...
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999976543221 145678999999999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=277.43 Aligned_cols=204 Identities=30% Similarity=0.516 Sum_probs=177.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l 79 (226)
.....+.+.+|+++++.++||||+++++++... ...|+||||+ +++|.++++. .++++..+..++.||+.||
T Consensus 64 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L 141 (367)
T 1cm8_A 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 141 (367)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence 344567889999999999999999999999765 3469999999 8899999886 5899999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
.|||++|++||||+|+||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 142 RYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp HHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 99999999999999999999 67889999999999775432 334567899999999876 6789999999999999
Q ss_pred HHHHhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCc
Q 027233 159 FELLNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p 197 (226)
++|++|..||.+.+..+. .....++++.++|++||+.||
T Consensus 217 ~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP 296 (367)
T 1cm8_A 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296 (367)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence 999999999987643211 124568899999999999999
Q ss_pred cccCCHhHHhcCccccccC
Q 027233 198 VDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~~ 216 (226)
.+|||++|+|+||||+...
T Consensus 297 ~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 297 EQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TTSCCHHHHHHSGGGTTTC
T ss_pred hHCCCHHHHhcChHHHhhc
Confidence 9999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=271.06 Aligned_cols=214 Identities=30% Similarity=0.522 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEE--eCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
...+.+.+|++++++++||||+++++++. +.+..++||||++++ |.+++... ..+++..++.++.|++.||.+||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 126 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999984 456799999999765 87877653 57999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCcccccccC--CCcchhHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAIL 158 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~~ 158 (226)
++|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||...+.. .+.++|+||||+++
T Consensus 127 ~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 127 SQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp HTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred HCCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 9999999999999999 67889999999999766432 2223455888999999987644 37799999999999
Q ss_pred HHHHhCCCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCCCCC
Q 027233 159 FELLNGYPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHI 225 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~~~ 225 (226)
+++++|..||.+...... .+..++..+.++|++||+.||.+|||++|+++||||+........+..+
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~ 280 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCCCCC
T ss_pred HHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCCCCC
Confidence 999999999987653221 2556889999999999999999999999999999999876555554444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=286.58 Aligned_cols=203 Identities=13% Similarity=0.125 Sum_probs=168.6
Q ss_pred HHHHHHHHHHH---HHHhcCCCCCeeeee-------eEEEeCC-----------------eEEEEEeecCCCCHHHHHHh
Q 027233 7 KHLKSCLDCEL---NFLSSVNHPNIIRLF-------DAFQAEN-----------------CIFLVVEFCAGGNLSSYIRL 59 (226)
Q Consensus 7 ~~~~~~~~~E~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~ 59 (226)
....+.+.+|+ +.+++++||||++++ +++.+.+ ..+++|||+ +++|.+++..
T Consensus 114 ~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~ 192 (377)
T 3byv_A 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEV 192 (377)
T ss_dssp TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHh
Confidence 34567899999 555566899999998 6666553 388999999 6799999987
Q ss_pred cCCCCH-------HHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCc
Q 027233 60 HGRVPE-------QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132 (226)
Q Consensus 60 ~~~~~~-------~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 132 (226)
.+.+++ ..++.++.||+.||+|||++|++||||||+||++ +.++.++|+|||++..... ......+ .
T Consensus 193 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~ 266 (377)
T 3byv_A 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-R 266 (377)
T ss_dssp HHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-T
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-c
Confidence 655655 7888899999999999999999999999999999 6788999999999976433 2334456 8
Q ss_pred cccCccccccc-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------ccCCChHHHHHHHHhhcc
Q 027233 133 LYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------VPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 133 ~~~aPE~~~~~-----------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~i~~~l~~ 195 (226)
.|+|||.+.+. .++.++||||||+++++|++|..||.+....... ...+++++.++|.+||+.
T Consensus 267 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp TCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCS
T ss_pred CccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCC
Confidence 99999999877 8999999999999999999999999775543222 467899999999999999
Q ss_pred CccccCCHhHHhcCccccccC
Q 027233 196 NTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||.+|||+.|+++||||+...
T Consensus 347 dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 347 PKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp SGGGCCCHHHHHTSHHHHHHH
T ss_pred CchhCCCHHHHhhChHHHHHH
Confidence 999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=271.13 Aligned_cols=205 Identities=27% Similarity=0.509 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.. +++++..+..++.|++.||.+||++|+
T Consensus 62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i 140 (303)
T 3a7i_A 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 140 (303)
T ss_dssp TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3467899999999999999999999999999999999999999999999875 579999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||++++++++|..
T Consensus 141 ~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (303)
T 3a7i_A 141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217 (303)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCC
Confidence 999999999999 678899999999997765433 2234567889999999998889999999999999999999999
Q ss_pred CCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||....... .....++..+.+++.+||+.+|.+|||+.|+++||||....
T Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 218 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred CCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 997654322 22557889999999999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=273.40 Aligned_cols=206 Identities=31% Similarity=0.530 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l 79 (226)
...+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++.. ...+++..++.++.|++.||
T Consensus 55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 134 (303)
T 2vwi_A 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134 (303)
T ss_dssp -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999999999999999999999999974 34689999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC------ccccccCCccccCcccccc-cCCCcchhHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMW 152 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~ 152 (226)
.+||++|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+ ..++.++|+|
T Consensus 135 ~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred HHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 99999999999999999999 678899999999987654321 1233457889999999865 5688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc--------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL--------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
|||++++++++|..||........ ....++.++.+++.+||+.||.+|||+.|+++||||
T Consensus 212 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 999999999999999976543211 134678899999999999999999999999999999
Q ss_pred cccC
Q 027233 213 RRNS 216 (226)
Q Consensus 213 ~~~~ 216 (226)
+..+
T Consensus 292 ~~~~ 295 (303)
T 2vwi_A 292 QKAK 295 (303)
T ss_dssp ----
T ss_pred hcCC
Confidence 8753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=277.18 Aligned_cols=206 Identities=26% Similarity=0.470 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+.+.+|++++++++||||+++++++.... ..++||||++|++|.+++...+++++..++.++.|++.||.||
T Consensus 53 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l 132 (311)
T 3ork_A 53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132 (311)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999999987643 3599999999999999999888999999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
|++|++||||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++||||||+++
T Consensus 133 H~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 209 (311)
T 3ork_A 133 HQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209 (311)
T ss_dssp HHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHCCCCcCCCCHHHEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHH
Confidence 99999999999999999 577889999999997664332 12234579999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 159 FELLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++|++|..||.+....... ...++.++.++|.+||+.||.+||+..+++.|+|++..
T Consensus 210 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 210 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9999999999876543221 45589999999999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=271.74 Aligned_cols=210 Identities=30% Similarity=0.486 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|+.+++.++||||+++++++...+..++++||+++++|.+++.... .+++..+..++.|++.||.+||
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 139 (295)
T 2clq_A 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139 (295)
T ss_dssp C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999998652 4678899999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccC--CCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~~~~ 160 (226)
++|++|+||+|+||+++ ..++.++|+|||.+....... ......++..|+|||...+.. ++.++|+||||+++++
T Consensus 140 ~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 217 (295)
T 2clq_A 140 DNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217 (295)
T ss_dssp HTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHH
T ss_pred hCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999994 337889999999997764422 233456788999999987643 7889999999999999
Q ss_pred HHhCCCCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 161 LLNGYPPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 161 l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
+++|..||....... ..+..++.++.++|.+||+.||.+|||++|+++||||+..+..
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 218 MATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp HHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred HHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 999999997543221 2256789999999999999999999999999999999986543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=270.39 Aligned_cols=206 Identities=26% Similarity=0.406 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+.+.++...++.++||||+++++++.+.+..++|+||++ ++|.+++.. ...+++..++.++.|++.||.+|
T Consensus 47 ~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 125 (290)
T 3fme_A 47 QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125 (290)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3444556666667888899999999999999999999999996 588877754 46799999999999999999999
Q ss_pred HhC-CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccc----cccCCCcchhHHHHHHH
Q 027233 83 NSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 83 h~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~~ 157 (226)
|++ |++||||+|+||++ +.++.++|+|||.+.............++..|+|||.+ .+..++.++|+||+|++
T Consensus 126 H~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 126 HSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp HHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred hhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 998 99999999999999 67889999999999877665555556789999999996 55678899999999999
Q ss_pred HHHHHhCCCCCCCCCccc-------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 158 LFELLNGYPPFSGRNNVQ-------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++++++|..||....... .....+++++.+++.+||+.||.+|||++|+++||||+...
T Consensus 203 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 203 MIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 999999999997643211 11346889999999999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=280.25 Aligned_cols=206 Identities=26% Similarity=0.485 Sum_probs=174.8
Q ss_pred hHHHHHHHHHHHHHHhcCC--CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|+.++++++ |+||+++++++...+..++||| +.+++|.+++.....+++..+..++.||+.||.|||
T Consensus 94 ~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999996 5999999999999999999999 458899999998889999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccc-----------cCCCcch
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~ 149 (226)
++||+||||+|+||++ + ++.++|+|||++....... ......+++.|+|||.+.+ ..++.++
T Consensus 173 ~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 173 QHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp TTTCCCCCCCGGGEEE---S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HCCeeecCCCHHHEEE---E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 9999999999999999 2 4789999999998765432 1234568999999999864 3688899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 150 DMWSVGAILFELLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 150 Dv~slG~~~~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||||||+++++|++|..||...... ...+...+.++.++|++||+.||.+|||+.|+++||||+...
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 9999999999999999999764321 011444578899999999999999999999999999998653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=277.88 Aligned_cols=202 Identities=21% Similarity=0.396 Sum_probs=178.4
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.+|
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999999999999999998 665 46799999999999999999999
Q ss_pred Hh-CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCc-chhHHHHHHHHH
Q 027233 83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVDMWSVGAILF 159 (226)
Q Consensus 83 h~-~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dv~slG~~~~ 159 (226)
|+ +|++|+||+|+||++ +.++.++|+|||.+...... ......++..|+|||...+. .++. ++|+||||++++
T Consensus 168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 243 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243 (348)
T ss_dssp HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence 99 999999999999999 67889999999999776443 33445688999999999876 5555 999999999999
Q ss_pred HHHhCCCCCCCCCcccc-----------cc-------------------cCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 160 ELLNGYPPFSGRNNVQL-----------IV-------------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-----------~~-------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++++|..||........ .+ ..++.++.++|.+||+.||.+|||++|+++|
T Consensus 244 ~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999987654111 01 5688999999999999999999999999999
Q ss_pred ccccccC
Q 027233 210 RFLRRNS 216 (226)
Q Consensus 210 ~~~~~~~ 216 (226)
|||+...
T Consensus 324 p~f~~~~ 330 (348)
T 2pml_X 324 EWLADTN 330 (348)
T ss_dssp GGGTTCC
T ss_pred ccccCCC
Confidence 9999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=269.00 Aligned_cols=205 Identities=29% Similarity=0.531 Sum_probs=175.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+++++..++.++.|++.||.+||++
T Consensus 51 ~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 130 (294)
T 4eqm_A 51 KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130 (294)
T ss_dssp CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567789999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++||||+|+||++ +.++.++|+|||++....... ......+++.|+|||...+..++.++|+||||++++++++
T Consensus 131 ~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 207 (294)
T 4eqm_A 131 RIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207 (294)
T ss_dssp TCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999999999 678899999999997665432 2233568999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccc---------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 164 GYPPFSGRNNVQL---------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 164 g~~p~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
|..||.+...... ....+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 208 GEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp SSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999987654221 1466889999999999999999999666666666544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=278.88 Aligned_cols=201 Identities=27% Similarity=0.468 Sum_probs=172.3
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEe--------------------------------------CCeEEEEEeecCCCCH
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQA--------------------------------------ENCIFLVVEFCAGGNL 53 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L 53 (226)
...+|+++++.++||||+++++++.. ....++||||++ ++|
T Consensus 46 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 124 (383)
T 3eb0_A 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124 (383)
T ss_dssp SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEH
T ss_pred hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccH
Confidence 34579999999999999999999843 334889999997 577
Q ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcccccc
Q 027233 54 SSYIR----LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129 (226)
Q Consensus 54 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 129 (226)
.+.+. ....+++..++.++.||+.||.|||++|++||||+|+||+++ ..++.++|+|||++.............
T Consensus 125 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 202 (383)
T 3eb0_A 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYI 202 (383)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCC
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcc
Confidence 66664 346899999999999999999999999999999999999994 357889999999998776666556667
Q ss_pred CCccccCccccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc--------------------------------
Q 027233 130 GSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL-------------------------------- 176 (226)
Q Consensus 130 ~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------------------------------- 176 (226)
++..|+|||.+.+. .++.++||||+|+++++|++|..||.+.+..+.
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 282 (383)
T 3eb0_A 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282 (383)
T ss_dssp CCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC
T ss_pred cCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC
Confidence 89999999998764 489999999999999999999999987653211
Q ss_pred -------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 177 -------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 177 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.+...+.++.++|++||+.||.+|||+.|+++||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred cccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 134578899999999999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=280.86 Aligned_cols=207 Identities=26% Similarity=0.469 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~ 78 (226)
.+.+.+|+.++++++||||+++++++.. ....++|+||+. ++|.+++... ..+++..++.++.||+.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 4578899999999999999999999954 678999999995 6888887632 248999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeC-CCCccEEEeeeccccccCCC----CccccccCCccccCccccccc-CCCcchhHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~-~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~ 152 (226)
|.|||++||+||||+|+||++... +.++.++|+|||++...... .......++..|+|||.+.+. .++.++|||
T Consensus 141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 220 (405)
T 3rgf_A 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220 (405)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence 999999999999999999999532 35678999999999776532 122345689999999998764 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc---------------------------c----------------------------
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL---------------------------I---------------------------- 177 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~---------------------------~---------------------------- 177 (226)
|||+++++|++|..||.+...... .
T Consensus 221 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (405)
T 3rgf_A 221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300 (405)
T ss_dssp HHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence 999999999999999975432100 0
Q ss_pred --ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 178 --VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 178 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
....+..+.++|++||+.||.+|||++|+|+||||++.+.
T Consensus 301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 0112778999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=280.08 Aligned_cols=202 Identities=32% Similarity=0.485 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
....+.+.+|+.+++.++||||+++++++...+ ..++||||++ ++|.+++. ..+++..+..++.|++.||.
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~ 141 (371)
T 2xrw_A 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIK 141 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence 456678889999999999999999999997654 7899999996 58888886 46899999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
|||++|++||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++||||||+++++
T Consensus 142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 9999999999999999999 6788999999999987665544455678999999999998899999999999999999
Q ss_pred HHhCCCCCCCCCccccc-----------------------------------------c-----------cCCChHHHHH
Q 027233 161 LLNGYPPFSGRNNVQLI-----------------------------------------V-----------PALHPDCVDM 188 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~-----------------------------------------~-----------~~~~~~~~~~ 188 (226)
|++|..||.+.+..... + ...+.+++++
T Consensus 219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 99999999875432110 0 0015678999
Q ss_pred HHHhhccCccccCCHhHHhcCccccc
Q 027233 189 CLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 189 i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
|++||+.||.+|||++|+++||||+.
T Consensus 299 i~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHCcCChhhCCCHHHHhCCcchhh
Confidence 99999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=276.07 Aligned_cols=205 Identities=28% Similarity=0.458 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~ 80 (226)
....+.+.+|++++++++||||+++++++.. ....++|+||++ ++|.+++... ..+++..+..++.|++.||.
T Consensus 70 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 148 (362)
T 3pg1_A 70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148 (362)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence 3445889999999999999999999999854 346899999996 6888888755 37999999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~ 159 (226)
+||++|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+ ..++.++|+||||++++
T Consensus 149 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 149 VLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225 (362)
T ss_dssp HHHHTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred HHHHCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence 9999999999999999999 6788999999999976655555555678889999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCCcccc------------------------------------------cccCCChHHHHHHHHhhccCc
Q 027233 160 ELLNGYPPFSGRNNVQL------------------------------------------IVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~------------------------------------------~~~~~~~~~~~~i~~~l~~~p 197 (226)
++++|..||.+...... .....++.+.++|.+||+.||
T Consensus 226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 99999999987542111 134568889999999999999
Q ss_pred cccCCHhHHhcCcccccc
Q 027233 198 VDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~ 215 (226)
.+|||+.|+++||||+..
T Consensus 306 ~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 306 QRRISTEQALRHPYFESL 323 (362)
T ss_dssp GGSCCHHHHHTSGGGTTT
T ss_pred hhCCCHHHHHcCchhhhc
Confidence 999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=276.62 Aligned_cols=204 Identities=29% Similarity=0.522 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
....+.+.+|+++++.++||||+++++++... ...+++++++ +++|.+++.. .++++..+..++.||+.||.
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~ 146 (367)
T 2fst_X 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLK 146 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999998653 5689999999 7899998875 58999999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~ 159 (226)
|||++|++||||+|+||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||+|++++
T Consensus 147 ~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (367)
T 2fst_X 147 YIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221 (367)
T ss_dssp HHHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHH
T ss_pred HHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999 67889999999999765432 234568899999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCcc
Q 027233 160 ELLNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTV 198 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~ 198 (226)
+|++|..||.+.+..... ....++.+.++|++||+.||.
T Consensus 222 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 301 (367)
T 2fst_X 222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 301 (367)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcc
Confidence 999999999876532111 234678899999999999999
Q ss_pred ccCCHhHHhcCccccccCc
Q 027233 199 DRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 199 ~Rpt~~~~l~~~~~~~~~~ 217 (226)
+|||++|+|+||||+....
T Consensus 302 ~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 302 KRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp GSCCHHHHHTSGGGTTTCC
T ss_pred cCcCHHHHhcChhhhhccC
Confidence 9999999999999997543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=271.03 Aligned_cols=206 Identities=26% Similarity=0.430 Sum_probs=172.0
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... +++..++.++.|++.||++|
T Consensus 74 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L 153 (309)
T 3p86_A 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153 (309)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999999986543 99999999999999999999
Q ss_pred HhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 83 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 83 h~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
|++| ++||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||++++
T Consensus 154 H~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230 (309)
T ss_dssp HTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999 678899999999987554332 233456889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc--Cccccc
Q 027233 160 ELLNGYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRR 214 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~--~~~~~~ 214 (226)
++++|..||...+... ..+..+++.+.++|++||+.+|.+|||++|+++ .++++.
T Consensus 231 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999998765322 225678999999999999999999999999997 566554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=275.01 Aligned_cols=203 Identities=33% Similarity=0.508 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|++++++++||||+++++++...+..++|+||+++ +|.+++.... .+++..+..++.|++.||.|||++|++
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 134 (346)
T 1ua2_A 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134 (346)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 45788999999999999999999999999999999999965 8999887653 689999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHhCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 135 H~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999 678899999999998764432 23445688999999998654 57899999999999999999999
Q ss_pred CCCCCCccccc--------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 167 PFSGRNNVQLI--------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 167 p~~~~~~~~~~--------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
||.+.+..... ....+.+++++|++||+.||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 98765422110 1456789999999999999999999999999
Q ss_pred CccccccC
Q 027233 209 HRFLRRNS 216 (226)
Q Consensus 209 ~~~~~~~~ 216 (226)
||||+..+
T Consensus 292 h~~f~~~~ 299 (346)
T 1ua2_A 292 MKYFSNRP 299 (346)
T ss_dssp SGGGTSSS
T ss_pred ChhhhcCC
Confidence 99998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=271.37 Aligned_cols=213 Identities=28% Similarity=0.557 Sum_probs=175.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEE--------------eCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 71 (226)
.....+.+.+|++++++++||||+++++++. ..+..++|+||++ ++|.+++.. +++++..++.+
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~ 125 (320)
T 2i6l_A 48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLF 125 (320)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHH
Confidence 3556778999999999999999999999873 3467899999996 699999874 57999999999
Q ss_pred HHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC----CccccccCCccccCcccccc-cCCC
Q 027233 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYD 146 (226)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~ 146 (226)
+.|++.||.+||++|++||||+|+||+++ ..++.++|+|||.+...... .......++..|+|||...+ ..++
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 126 MYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 99999999999999999999999999995 35678999999999765432 12233456888999998765 6788
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcccc----------------------------------------cccCCChHHH
Q 027233 147 EKVDMWSVGAILFELLNGYPPFSGRNNVQL----------------------------------------IVPALHPDCV 186 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------------------------------~~~~~~~~~~ 186 (226)
.++|+||||++++++++|..||.+...... ....++.++.
T Consensus 204 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (320)
T 2i6l_A 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHH
T ss_pred chhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHH
Confidence 999999999999999999999987653211 1245799999
Q ss_pred HHHHHhhccCccccCCHhHHhcCccccccCcccCCC
Q 027233 187 DMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 187 ~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~ 222 (226)
++|++||+.||.+|||++|+++||||+........|
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~~ 319 (320)
T 2i6l_A 284 DFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319 (320)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred HHHHHHcCCCccccCCHHHHhCCcccccccCccCCC
Confidence 999999999999999999999999999876655544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=278.32 Aligned_cols=201 Identities=30% Similarity=0.499 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCCeeeeeeEEEeCC------eEEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 13 LDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
..+|+++++.++||||+++++++...+ ..++||||++++ +.+.+. ....+++..++.++.||+.||.||
T Consensus 79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L 157 (394)
T 4e7w_A 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157 (394)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 347999999999999999999986543 388999999764 433332 346799999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l 161 (226)
|++|++||||||+||+++ ..++.++|+|||++.............++..|+|||.+.+. .++.++||||+|+++++|
T Consensus 158 H~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 158 HSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp HHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999994 36889999999999877665555566789999999998654 589999999999999999
Q ss_pred HhCCCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCC
Q 027233 162 LNGYPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
++|..||.+.+..+. .....++++.++|.+||+.||.+|||
T Consensus 236 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 999999987653211 12347889999999999999999999
Q ss_pred HhHHhcCccccccC
Q 027233 203 FNEFYHHRFLRRNS 216 (226)
Q Consensus 203 ~~~~l~~~~~~~~~ 216 (226)
+.|+++||||++..
T Consensus 316 ~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 316 AIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHTSGGGSTTT
T ss_pred HHHHhcChhhhhhc
Confidence 99999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=277.10 Aligned_cols=204 Identities=29% Similarity=0.495 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.|||++|+
T Consensus 101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 180 (355)
T 1vzo_A 101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180 (355)
T ss_dssp SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 345677899999999 7999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccc--cCCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++++|++
T Consensus 181 vH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999 678899999999997654322 2234568999999999875 347889999999999999999
Q ss_pred CCCCCCCCCccc--------------ccccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
|..||....... ..+..++..+.++|.+||+.||.+|| |++|+++||||+..
T Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 258 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999997543211 12566889999999999999999999 99999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=273.18 Aligned_cols=204 Identities=25% Similarity=0.478 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe--------CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l 79 (226)
....+.+|++++++++||||+++++++.. .+..++||||+++ +|.+.+... ..+++..++.++.|++.||
T Consensus 59 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l 137 (351)
T 3mi9_A 59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137 (351)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence 34577899999999999999999999876 4568999999964 777777654 5799999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-----CccccccCCccccCcccccc-cCCCcchhHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~s 153 (226)
.+||++|++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++||||
T Consensus 138 ~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 214 (351)
T 3mi9_A 138 YYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214 (351)
T ss_dssp HHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHH
Confidence 99999999999999999999 67889999999999765422 22234567889999998875 45799999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccc--------------cc----------------------------CCChHHHHHHHH
Q 027233 154 VGAILFELLNGYPPFSGRNNVQLI--------------VP----------------------------ALHPDCVDMCLK 191 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~~--------------~~----------------------------~~~~~~~~~i~~ 191 (226)
||+++++|++|..||.+....... .+ ..++.+.++|++
T Consensus 215 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (351)
T 3mi9_A 215 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294 (351)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHH
Confidence 999999999999999876432111 00 026779999999
Q ss_pred hhccCccccCCHhHHhcCccccccC
Q 027233 192 LLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 192 ~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||+.||.+|||++|+++||||+...
T Consensus 295 ~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 295 LLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred HhcCChhhCCCHHHHhCCCCcCCCC
Confidence 9999999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=271.75 Aligned_cols=206 Identities=28% Similarity=0.482 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.. ...+++..+..++.|++.||.+||++|
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 137 (302)
T 2j7t_A 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137 (302)
T ss_dssp CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3457888999999999999999999999999999999999999999999876 457999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccc-----cccCCCcchhHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~-----~~~~~~~~~Dv~slG~~~~~ 160 (226)
++|+||+|+||++ +.++.++|+|||++...... .......++..|+|||.. .+..++.++|+||||+++++
T Consensus 138 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 138 IIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp CCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred cccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 9999999999999 67889999999987543211 112234578899999987 35678899999999999999
Q ss_pred HHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 161 LLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
+++|..||...+.... ....++.++.++|.+||+.||.+|||+.|+++||||+...
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999987543211 1456788999999999999999999999999999999854
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=268.82 Aligned_cols=209 Identities=30% Similarity=0.564 Sum_probs=179.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l 79 (226)
....++.+.+|++++++++||||+++++++.. .+..++|+||+++++|.+++... ..+++..++.++.|++.||
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 124 (279)
T 2w5a_A 45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124 (279)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence 45677889999999999999999999998754 57899999999999999999764 2499999999999999999
Q ss_pred HHHHhCC-----ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCcccccccCCCcchhHHH
Q 027233 80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~~-----i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
.+||++| ++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||
T Consensus 125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence 9999999 9999999999999 6788999999999877654322 23346788999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
||++++++++|..||...+... ..+..++.++.++|.+||+.||.+|||++|+++|+|+.+..+
T Consensus 202 lG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred HHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 9999999999999998765322 225568899999999999999999999999999999988643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=272.80 Aligned_cols=204 Identities=28% Similarity=0.506 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....+.+.+|++++++++||||+++++++... ...++++|++. ++|.+++.. ..+++..+..++.|++.||.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~ 143 (364)
T 3qyz_A 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKY 143 (364)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999998754 46899999995 599998875 479999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccc-cCCCcchhHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~ 156 (226)
||++|++||||+|+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+ ..++.++||||||+
T Consensus 144 LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 220 (364)
T 3qyz_A 144 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220 (364)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred HHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence 999999999999999999 6788999999999976643321 234468999999998654 45899999999999
Q ss_pred HHHHHHhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhcc
Q 027233 157 ILFELLNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~ 195 (226)
++++|++|..||.+.+..+.. ...+++++.++|++||+.
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 300 (364)
T 3qyz_A 221 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 300 (364)
T ss_dssp HHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCC
Confidence 999999999999876533221 245788999999999999
Q ss_pred CccccCCHhHHhcCcccccc
Q 027233 196 NTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||.+|||+.|+++||||+..
T Consensus 301 dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 301 NPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp STTTSCCHHHHHTSGGGTTT
T ss_pred ChhhCCCHHHHhcCcchhhc
Confidence 99999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=270.63 Aligned_cols=206 Identities=28% Similarity=0.513 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe------CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~ 78 (226)
...+.+.+|+.+++++ +||||+++++++.. .+..++||||+++++|.+++... ..+++..++.++.||+.|
T Consensus 62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~ 141 (326)
T 2x7f_A 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141 (326)
T ss_dssp STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence 3457889999999999 89999999999976 46899999999999999999864 479999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCccccc-----ccCCCcchhHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW 152 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~ 152 (226)
|.+||++|++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+. +..++.++|+|
T Consensus 142 l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 218 (326)
T 2x7f_A 142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218 (326)
T ss_dssp HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred HHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence 999999999999999999999 678899999999987654322 223446888999999986 56688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|||++++++++|..||........ ....++..+.++|.+||+.||.+|||++|+++||||++.+
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 999999999999999976543221 1456789999999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=269.76 Aligned_cols=209 Identities=25% Similarity=0.442 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeE------EEEEeecCCCCHHHHHHhcC------CCCHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQQ 74 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~ 74 (226)
....+.+.+|++++++++||||+++++++...+.. ++++||+.+++|.+++.... .+++..++.++.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q 145 (323)
T 3qup_A 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145 (323)
T ss_dssp CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence 34567899999999999999999999999876554 99999999999999997543 5899999999999
Q ss_pred HHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhH
Q 027233 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDM 151 (226)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv 151 (226)
++.||.|||++|++||||+|+||++ +.++.++|+|||.+......... ....++..|+|||.+.+..++.++||
T Consensus 146 i~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (323)
T 3qup_A 146 IACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222 (323)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence 9999999999999999999999999 67889999999999766443221 22345667999999998899999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCC-------HhHHhcCccc
Q 027233 152 WSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLS-------FNEFYHHRFL 212 (226)
Q Consensus 152 ~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-------~~~~l~~~~~ 212 (226)
||||++++++++ |..||.+...... ....++.++.+++.+||+.||.+||| ++++++|+|+
T Consensus 223 ~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 999999999999 9999987654322 25678899999999999999999999 8889999999
Q ss_pred cccCcc
Q 027233 213 RRNSAI 218 (226)
Q Consensus 213 ~~~~~~ 218 (226)
...+..
T Consensus 303 ~~~~~~ 308 (323)
T 3qup_A 303 LSTSQD 308 (323)
T ss_dssp ------
T ss_pred cCCCCC
Confidence 886543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=273.21 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=175.4
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~ 68 (226)
.....+.+.+|+.+++.+ +||||+++++++...+..|+||||+++++|.+++.... .++...+
T Consensus 126 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (370)
T 2psq_A 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205 (370)
T ss_dssp BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHH
Confidence 345667899999999999 89999999999999999999999999999999998753 4788999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCC
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~ 145 (226)
..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..+
T Consensus 206 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 282 (370)
T 2psq_A 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282 (370)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC
Confidence 9999999999999999999999999999999 678899999999997664432 1223445678999999998999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+.++|+||||+++|+|++ |..||.+...... .+..++.++.+++.+||+.+|.+|||+.|++++
T Consensus 283 ~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 283 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999 9999987653322 255678899999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=270.75 Aligned_cols=206 Identities=27% Similarity=0.499 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
......+.+|++++++++||||+++++++... +..++++||+. ++|.+++.. +.+++..+..++.|++.||.+
T Consensus 50 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~ 127 (353)
T 2b9h_A 50 PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKV 127 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHH
Confidence 44566788999999999999999999987654 67999999995 699998876 579999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----------cccccCCccccCcccccc-cCCCcch
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------AEKVCGSPLYMAPEVLQF-QRYDEKV 149 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~ 149 (226)
||++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..++.++
T Consensus 128 LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 128 LHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp HHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred HHHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchh
Confidence 999999999999999999 6788999999999976643221 112357889999998754 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCccc------------------------------------------ccccCCChHHHH
Q 027233 150 DMWSVGAILFELLNGYPPFSGRNNVQ------------------------------------------LIVPALHPDCVD 187 (226)
Q Consensus 150 Dv~slG~~~~~l~~g~~p~~~~~~~~------------------------------------------~~~~~~~~~~~~ 187 (226)
|+||||++++++++|..||.+.+... .....+++++.+
T Consensus 205 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGID 284 (353)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHH
Confidence 99999999999999999997654211 012468899999
Q ss_pred HHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 188 MCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 188 ~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
+|++||+.||.+|||++|+++||||+....
T Consensus 285 li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 285 LLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 999999999999999999999999998543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=270.12 Aligned_cols=200 Identities=25% Similarity=0.450 Sum_probs=173.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.+||+
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 169 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999999999999999999999999999999765 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++
T Consensus 170 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 246 (325)
T 3kul_A 170 LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246 (325)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999 6788999999999987654322 122334667999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++ |..||........ .+..++.++.+++.+||+.||.+|||+.|+++
T Consensus 247 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 247 VLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999 9999977654322 25568899999999999999999999999885
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=271.70 Aligned_cols=205 Identities=30% Similarity=0.656 Sum_probs=153.7
Q ss_pred HHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 027233 17 LNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (226)
Q Consensus 17 ~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (226)
...++.++||||+++++++.. .+..++||||++|++|.+++.... .+++..++.++.|++.||.|||++|++||
T Consensus 73 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~ 152 (336)
T 3fhr_A 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152 (336)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 334566799999999999876 456899999999999999998764 69999999999999999999999999999
Q ss_pred ccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 027233 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170 (226)
Q Consensus 91 dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 170 (226)
||+|+||+++..+.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||++++++++|..||..
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCHHHEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999643446679999999997664332 3345678899999999888889999999999999999999999976
Q ss_pred CCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCC
Q 027233 171 RNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222 (226)
Q Consensus 171 ~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~ 222 (226)
...... ....++.++.++|++||+.||.+|||++|+++||||+........|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~ 301 (336)
T 3fhr_A 232 NTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301 (336)
T ss_dssp -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCB
T ss_pred ccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCc
Confidence 543221 0246799999999999999999999999999999999875554444
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=268.73 Aligned_cols=203 Identities=24% Similarity=0.433 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC--eEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++..... +++..++.++.|++.||.|||
T Consensus 50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 129 (319)
T 4euu_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (319)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999988754 78999999999999999986533 899999999999999999999
Q ss_pred hCCceeeccCCCCeEeee-CCCCccEEEeeeccccccCCCCccccccCCccccCccccc--------ccCCCcchhHHHH
Q 027233 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVDMWSV 154 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~sl 154 (226)
++|++||||+|+||++.. .+.++.++|+|||++.............++..|+|||.+. +..++.++|||||
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 999999999999999732 2456679999999998876665555667899999999875 4678899999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccc---------------------------------------ccCCChHHHHHHHHhhcc
Q 027233 155 GAILFELLNGYPPFSGRNNVQLI---------------------------------------VPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~ 195 (226)
|++++++++|..||......... ...++..+.++|++||+.
T Consensus 210 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp HHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 99999999999999643321110 123455789999999999
Q ss_pred CccccCCHhHHhcCcc
Q 027233 196 NTVDRLSFNEFYHHRF 211 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~ 211 (226)
||.+|||++|+|+||-
T Consensus 290 dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 290 DQEKCWGFDQFFAETS 305 (319)
T ss_dssp CTTTSCCHHHHHHHHH
T ss_pred ChhhhccHHHhhhccH
Confidence 9999999999999984
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=266.87 Aligned_cols=201 Identities=27% Similarity=0.447 Sum_probs=175.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC-----------------------
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----------------------- 62 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------- 62 (226)
.....+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.....
T Consensus 66 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (314)
T 2ivs_A 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145 (314)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence 345667899999999999999999999999999999999999999999999987543
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcc
Q 027233 63 -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (226)
Q Consensus 63 -~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE 138 (226)
+++..++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 8899999999999999999999999999999999999 5778899999999976644322 22334567799999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
...+..++.++|+||||+++++|++ |..||.+...... .+..++.++.+++.+||+.||.+|||+.++
T Consensus 223 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9988889999999999999999999 9999987654322 255788999999999999999999999999
Q ss_pred hcC
Q 027233 207 YHH 209 (226)
Q Consensus 207 l~~ 209 (226)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=274.83 Aligned_cols=210 Identities=23% Similarity=0.366 Sum_probs=180.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~ 78 (226)
.......+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+ .+++..++.++.|++.|
T Consensus 114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 193 (367)
T 3l9p_A 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193 (367)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence 45566678899999999999999999999999999999999999999999998753 48899999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCcccccccCCCcchhHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
|.|||++|++||||||+||+++..+.+..++|+|||++...... .......++..|+|||.+.+..++.++||||||
T Consensus 194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 273 (367)
T 3l9p_A 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273 (367)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence 99999999999999999999953334556999999999754321 222344568889999999888999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 156 AILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 156 ~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+++++|++ |..||........ ....++..+.+++.+||+.+|.+|||+.+++++.++...
T Consensus 274 ~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 99999998 9999987654322 255678899999999999999999999999999877653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=275.46 Aligned_cols=201 Identities=31% Similarity=0.499 Sum_probs=169.1
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
...+|+++++.++||||+++++++... ...++|+||+++ +|.+.+.. ...+++..++.++.||+.||.|
T Consensus 93 ~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 171 (420)
T 1j1b_A 93 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171 (420)
T ss_dssp SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 345799999999999999999987542 236799999964 66665542 4679999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCcchhHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~ 160 (226)
||++||+||||||+||+++ .+.+.++|+|||++.............++..|+|||.+.+. .++.++||||||+++++
T Consensus 172 LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 249 (420)
T 1j1b_A 172 IHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249 (420)
T ss_dssp HHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHH
Confidence 9999999999999999994 24567899999999877655555556789999999998764 78999999999999999
Q ss_pred HHhCCCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccC
Q 027233 161 LLNGYPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
|++|..||.+.+..+. .....+.++.++|++||+.||.+||
T Consensus 250 ll~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~ 329 (420)
T 1j1b_A 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329 (420)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC
Confidence 9999999987643211 1235688999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 027233 202 SFNEFYHHRFLRRN 215 (226)
Q Consensus 202 t~~~~l~~~~~~~~ 215 (226)
|+.|+++||||++.
T Consensus 330 t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 330 TPLEACAHSFFDEL 343 (420)
T ss_dssp CHHHHHTSGGGGGG
T ss_pred CHHHHhCCHhhccc
Confidence 99999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=265.54 Aligned_cols=202 Identities=34% Similarity=0.526 Sum_probs=174.3
Q ss_pred HHHHHHHHHHhcC---CCCCeeeeeeEEE-----eCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 11 ~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~ 80 (226)
..+.+|+.+++.+ +||||+++++++. ..+..++++||++ ++|.+++.... .+++..++.++.|++.||.
T Consensus 56 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 134 (326)
T 1blx_A 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134 (326)
T ss_dssp CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence 3566777777766 8999999999987 4567899999996 69999998753 4899999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+||++|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+..++.++|+||||+++++
T Consensus 135 ~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 211 (326)
T 1blx_A 135 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211 (326)
T ss_dssp HHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred HHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 9999999999999999999 6788999999999977654444445668899999999988889999999999999999
Q ss_pred HHhCCCCCCCCCccc-------------------------------------ccccCCChHHHHHHHHhhccCccccCCH
Q 027233 161 LLNGYPPFSGRNNVQ-------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 161 l~~g~~p~~~~~~~~-------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
+++|..||.+..... .....++..+.++|.+||+.||.+|||+
T Consensus 212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 291 (326)
T 1blx_A 212 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291 (326)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence 999999997654221 1135678899999999999999999999
Q ss_pred hHHhcCccccccC
Q 027233 204 NEFYHHRFLRRNS 216 (226)
Q Consensus 204 ~~~l~~~~~~~~~ 216 (226)
.|+++||||++..
T Consensus 292 ~e~l~hp~~~~~~ 304 (326)
T 1blx_A 292 YSALSHPYFQDLE 304 (326)
T ss_dssp HHHHTSGGGTTCC
T ss_pred HHHhcCccccccc
Confidence 9999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=261.01 Aligned_cols=198 Identities=24% Similarity=0.457 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||.+||++|+
T Consensus 48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (269)
T 4hcu_A 48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 127 (269)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3467899999999999999999999999999999999999999999999764 468999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++ |
T Consensus 128 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g 204 (269)
T 4hcu_A 128 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204 (269)
T ss_dssp CCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ecCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCC
Confidence 999999999999 677899999999997664332 1222345667999999998899999999999999999999 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
..||........ .+...+..+.+++.+||+.+|.+|||+.|++++
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 205 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999987654322 255578999999999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=277.26 Aligned_cols=203 Identities=32% Similarity=0.482 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHHhcC------CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l 79 (226)
...+.+.+|+++++.+ .|+||+++++.+...+..++++|++. ++|.+++.... .+++..+..++.||+.||
T Consensus 135 ~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL 213 (429)
T 3kvw_A 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213 (429)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 3456778888888877 57799999999999999999999994 69999998764 489999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCcc--EEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
.|||++|++||||||+||++ +.++. ++|+|||++...... .....++..|+|||.+.+..++.++||||||++
T Consensus 214 ~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 288 (429)
T 3kvw_A 214 DALHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCI 288 (429)
T ss_dssp HHHHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHH
T ss_pred HHHHHCCeecCCCCHHHeEE---ccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHH
Confidence 99999999999999999999 45554 999999999765433 234568899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc------------------------------------------------------------
Q 027233 158 LFELLNGYPPFSGRNNVQLI------------------------------------------------------------ 177 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~------------------------------------------------------------ 177 (226)
+++|++|..||.+.+..+..
T Consensus 289 l~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (429)
T 3kvw_A 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPP 368 (429)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECST
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCc
Confidence 99999999999765432110
Q ss_pred ---------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 178 ---------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 178 ---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
....++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 369 ~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 369 ESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp TCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred cchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 112367899999999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=274.33 Aligned_cols=204 Identities=14% Similarity=0.101 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHHHhcC--CCCCeeeee-------eEEEeC-----------------CeEEEEEeecCCCCHHHHHHhc
Q 027233 7 KHLKSCLDCELNFLSSV--NHPNIIRLF-------DAFQAE-----------------NCIFLVVEFCAGGNLSSYIRLH 60 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~ 60 (226)
....+.+.+|+++++.+ +||||++++ +.+... ...++||||++ ++|.+++...
T Consensus 103 ~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 181 (371)
T 3q60_A 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH
T ss_pred ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh
Confidence 45667788885444444 699988755 444433 33899999997 8999999864
Q ss_pred -CCCCHHHH------HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCcc
Q 027233 61 -GRVPEQTA------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133 (226)
Q Consensus 61 -~~~~~~~~------~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 133 (226)
..++.... ..++.||+.||+|||++|++||||||+||++ +.++.++|+|||++...... .....++..
T Consensus 182 ~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~ 256 (371)
T 3q60_A 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVT 256 (371)
T ss_dssp HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGG
T ss_pred ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcC
Confidence 24455555 6777999999999999999999999999999 67889999999999866432 224456699
Q ss_pred ccCcccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc-------------------cccCCChHHHHHHHHh
Q 027233 134 YMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL-------------------IVPALHPDCVDMCLKL 192 (226)
Q Consensus 134 ~~aPE~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------------------~~~~~~~~~~~~i~~~ 192 (226)
|+|||.+.+ ..++.++||||||+++++|++|..||........ ....+++.+.++|.+|
T Consensus 257 y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp GCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred CcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHH
Confidence 999999987 7789999999999999999999999987632100 0246799999999999
Q ss_pred hccCccccCCHhHHhcCccccccC
Q 027233 193 LSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 193 l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|+.||.+|||+.|+++||||++..
T Consensus 337 L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 337 LNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred cCCChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=268.70 Aligned_cols=200 Identities=28% Similarity=0.458 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~ 69 (226)
....+.+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.... .+++..++
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (327)
T 1fvr_A 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145 (327)
T ss_dssp ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence 44667899999999999 89999999999999999999999999999999998654 68999999
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcch
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 149 (226)
.++.|++.||.+||++|++||||+|+||++ +.++.++|+|||++.............++..|+|||...+..++.++
T Consensus 146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 222 (327)
T 1fvr_A 146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222 (327)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchh
Confidence 999999999999999999999999999999 67889999999998754433333344567789999999888889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 150 DMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 150 Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|+||||++++++++ |..||.+...... .+..++.++.++|.+||+.+|.+|||++|++++
T Consensus 223 Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 223 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999998 9999987653221 245678999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=268.05 Aligned_cols=207 Identities=25% Similarity=0.417 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHhcCCCC------CeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHP------NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l 79 (226)
...+.+.+|+++++.++|+ +++++++++...+..++||||+ +++|.+++...+ ++++..+..++.|++.||
T Consensus 53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l 131 (339)
T 1z57_A 53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 4567889999999998765 4999999999999999999999 899999998765 688999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCC----------------CccEEEeeeccccccCCCCccccccCCccccCccccccc
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ 143 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 143 (226)
.|||++|++||||+|+||+++..+. ++.++|+|||.+...... .....++..|+|||.+.+.
T Consensus 132 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL 209 (339)
T ss_dssp HHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS
T ss_pred HHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCC
Confidence 9999999999999999999942111 567999999999765432 2345688999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc----------------------------------------------
Q 027233 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---------------------------------------------- 177 (226)
Q Consensus 144 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------------------------------------------- 177 (226)
.++.++|+||||++++++++|..||...+..+..
T Consensus 210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (339)
T 1z57_A 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289 (339)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence 9999999999999999999999999875432211
Q ss_pred --------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 178 --------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 178 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
....+.++.++|.+||+.||.+|||+.|+++||||+..+.
T Consensus 290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence 1112467899999999999999999999999999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=260.16 Aligned_cols=198 Identities=23% Similarity=0.456 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.+||++|+
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 125 (268)
T 3sxs_A 46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125 (268)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678999999999999999999999999999999999999999999998764 59999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+||||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 126 ~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (268)
T 3sxs_A 126 IHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202 (268)
T ss_dssp EESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTT
T ss_pred ecCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCC
Confidence 999999999999 67889999999999766544322 22334567999999988889999999999999999998 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
..||........ .+...++.+.+++.+||+.+|.+|||+.|++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 203 KMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999986653322 155578899999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=271.70 Aligned_cols=205 Identities=28% Similarity=0.406 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe-------EEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-------IFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGA 77 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~ 77 (226)
..+...+|++.++.++||||+++++++...+. .++||||+++ +|.+.+. ....+++..+..++.|++.
T Consensus 62 ~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 140 (360)
T 3e3p_A 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140 (360)
T ss_dssp CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHH
Confidence 34567778888899999999999999865332 8899999975 5554443 4567899999999999999
Q ss_pred HHHHHH--hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCcchhHHHH
Q 027233 78 GLEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV 154 (226)
Q Consensus 78 ~l~~lh--~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~sl 154 (226)
||.+|| ++|++||||+|+||+++ ..++.++|+|||++.............++..|+|||.+.+. .++.++|||||
T Consensus 141 al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 141 SIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp HHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 999999 99999999999999994 23789999999999877666555566789999999998654 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccc------------------------------------------ccCCChHHHHHHHHh
Q 027233 155 GAILFELLNGYPPFSGRNNVQLI------------------------------------------VPALHPDCVDMCLKL 192 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~~------------------------------------------~~~~~~~~~~~i~~~ 192 (226)
|++++++++|..||.+.+..... ....+.++.++|.+|
T Consensus 219 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 99999999999999876432111 112567899999999
Q ss_pred hccCccccCCHhHHhcCccccccC
Q 027233 193 LSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 193 l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|+.||.+|||+.|+++||||++..
T Consensus 299 L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 299 LQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp TCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred hccCccccCCHHHHhcCccccccC
Confidence 999999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=272.05 Aligned_cols=201 Identities=27% Similarity=0.446 Sum_probs=176.5
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~ 68 (226)
.....+.+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.... .+++..+
T Consensus 114 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 193 (382)
T 3tt0_A 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193 (382)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence 345567899999999999 99999999999999999999999999999999998754 4899999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCC
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~ 145 (226)
+.++.|++.||.+||++|++||||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+..+
T Consensus 194 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 270 (382)
T 3tt0_A 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence 9999999999999999999999999999999 678899999999997665432 2233446678999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+.++||||||++++++++ |..||.+...... .+..++.++.+++++||+.+|.+|||+.|++++
T Consensus 271 ~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 271 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999 9999987643222 256688999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=268.90 Aligned_cols=201 Identities=24% Similarity=0.456 Sum_probs=174.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc------------------------C
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------G 61 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~ 61 (226)
..+..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .
T Consensus 90 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T 1luf_A 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169 (343)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCC
Confidence 3456778999999999999999999999999999999999999999999999864 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcc
Q 027233 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPE 138 (226)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE 138 (226)
.+++..++.++.||+.||.+||++|++||||+|+||++ +.++.++|+|||++....... ......++..|+|||
T Consensus 170 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence 68999999999999999999999999999999999999 678899999999987654321 123345678899999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
.+.+..++.++|+||||++++++++ |..||.+...... .+..++.++.+++++||+.||.+|||+.++
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9988889999999999999999998 9999987653321 256788999999999999999999999999
Q ss_pred hcC
Q 027233 207 YHH 209 (226)
Q Consensus 207 l~~ 209 (226)
+++
T Consensus 327 ~~~ 329 (343)
T 1luf_A 327 HRI 329 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=265.28 Aligned_cols=208 Identities=25% Similarity=0.457 Sum_probs=172.9
Q ss_pred hHHHHHHHHHHHHHHhcCC--CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|++++++++ |+||+++++++...+..+++||+ .+++|.+++...+.+++..++.++.|++.||.+||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 144 (313)
T 3cek_A 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999996 59999999999999999999995 58899999998889999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccc-----------cCCCcch
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~ 149 (226)
++|++||||+|+||+++ ++.++|+|||.+........ .....++..|+|||...+ ..++.++
T Consensus 145 ~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 220 (313)
T 3cek_A 145 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220 (313)
T ss_dssp HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred HCCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence 99999999999999993 47899999999976644322 234468899999999865 4678899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 150 DMWSVGAILFELLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 150 Dv~slG~~~~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|+||||++++++++|..||...... ...+...+.++.++|++||+.||.+|||+.|+++||||+...
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 9999999999999999999764321 112455678999999999999999999999999999999865
Q ss_pred cc
Q 027233 217 AI 218 (226)
Q Consensus 217 ~~ 218 (226)
..
T Consensus 301 ~~ 302 (313)
T 3cek_A 301 HP 302 (313)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=279.66 Aligned_cols=213 Identities=28% Similarity=0.426 Sum_probs=168.3
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l 79 (226)
+|.+..+..+.+.+|+++++++ +||||+++++++.+.+..++|||++. ++|.+++.... ...+..+..++.||+.||
T Consensus 53 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL 131 (432)
T 3p23_A 53 VKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131 (432)
T ss_dssp EEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHH
T ss_pred EEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHH
Confidence 3444444455678899999999 89999999999999999999999995 69999998654 455566789999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCC--CCccEEEeeeccccccCCCC----ccccccCCccccCccccc---ccCCCcchh
Q 027233 80 EILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ---FQRYDEKVD 150 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~--~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~---~~~~~~~~D 150 (226)
.|||++||+||||||+||+++..+ ....++|+|||++....... ......+++.|+|||.+. ...++.++|
T Consensus 132 ~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~D 211 (432)
T 3p23_A 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211 (432)
T ss_dssp HHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHH
T ss_pred HHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHH
Confidence 999999999999999999995322 23458899999997765332 223456899999999987 456778999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 151 MWSVGAILFELLN-GYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 151 v~slG~~~~~l~~-g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|||||++++++++ |..||......... ....+..+.++|.+||+.||.+|||++|+++||||...
T Consensus 212 iwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 9999999999999 89998654322111 11234558999999999999999999999999999763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=270.58 Aligned_cols=202 Identities=30% Similarity=0.515 Sum_probs=170.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeE------EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l 79 (226)
.....+.+.+|+.+++.++||||+++++++...+.. ++++||+. ++|.+++. ..+++..+..++.|++.||
T Consensus 81 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL 157 (371)
T 4exu_A 81 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGL 157 (371)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHH
Confidence 344567889999999999999999999999876654 99999995 68888764 4699999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
.|||++|++||||+|+||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 158 ~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 158 KYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp HHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred HHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 99999999999999999999 67889999999999765433 234567899999999876 6789999999999999
Q ss_pred HHHHhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCc
Q 027233 159 FELLNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p 197 (226)
+++++|..||.+.+..+. ....+++++.++|++||+.||
T Consensus 233 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (371)
T 4exu_A 233 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 312 (371)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence 999999999987542211 134578999999999999999
Q ss_pred cccCCHhHHhcCcccccc
Q 027233 198 VDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~ 215 (226)
.+|||++|+++||||+..
T Consensus 313 ~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 313 DKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp TTSCCHHHHHTSGGGTTT
T ss_pred hhcCCHHHHhcCcccccC
Confidence 999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=260.86 Aligned_cols=200 Identities=27% Similarity=0.505 Sum_probs=163.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...+ .+++..++.++.|++.||.+||+
T Consensus 56 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 134 (281)
T 1mp8_A 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134 (281)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456778999999999999999999999984 456889999999999999998664 69999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||||+++++++
T Consensus 135 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 211 (281)
T 1mp8_A 135 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211 (281)
T ss_dssp TTCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred CCeecccccHHHEEE---CCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHH
Confidence 999999999999999 5678899999999977654322 22334567899999998888999999999999999999
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+ |..||.+....+. .+..+++.+.+++.+||+.||.+|||+.|++++
T Consensus 212 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 212 MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6 9999987654322 256788999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=260.88 Aligned_cols=198 Identities=22% Similarity=0.428 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.+||++|+
T Consensus 62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 141 (283)
T 3gen_A 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141 (283)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 346789999999999999999999999999999999999999999999986 4579999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++ |
T Consensus 142 ~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp CCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999 6788999999999976643321 122335667999999998889999999999999999998 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
..||........ .+...++.+.+++.+||+.+|.+|||+.|+++|
T Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 219 KMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999987653322 255678999999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=264.41 Aligned_cols=205 Identities=28% Similarity=0.471 Sum_probs=154.3
Q ss_pred HHHHHHHHHHH-HHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 8 ~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....+..|+. +++.++||||+++++++...+..++||||++ ++|.+++.. ...+++..+..++.|++.||.+
T Consensus 62 ~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 140 (327)
T 3aln_A 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140 (327)
T ss_dssp HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHH
Confidence 34445555555 7777899999999999999999999999996 488888764 4678999999999999999999
Q ss_pred HHhC-CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccc----cccCCCcchhHHHHHH
Q 027233 82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGA 156 (226)
Q Consensus 82 lh~~-~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~ 156 (226)
||++ |++|+||+|+||++ +.++.++|+|||++.............++..|+|||.+ .+..++.++|+||||+
T Consensus 141 lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 217 (327)
T 3aln_A 141 LKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGI 217 (327)
T ss_dssp HHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHH
T ss_pred HhccCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHH
Confidence 9999 99999999999999 67889999999999776555444445688999999998 4567889999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 157 ILFELLNGYPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
+++++++|..||........ ....++..+.+++.+||+.||.+|||+.|+++||||....
T Consensus 218 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 218 TLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999976432100 0235789999999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=270.53 Aligned_cols=200 Identities=30% Similarity=0.496 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHhcCC----------------------
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR---------------------- 62 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~---------------------- 62 (226)
....+.+.+|+++++++ +||||+++++++.+.+ ..++||||+++++|.+++.....
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (359)
T 3vhe_A 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145 (359)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------
T ss_pred HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccccc
Confidence 44567899999999999 7999999999988754 48999999999999999986543
Q ss_pred --------------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeE
Q 027233 63 --------------------------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENIL 98 (226)
Q Consensus 63 --------------------------------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil 98 (226)
+++..++.++.|++.||.|||++|++||||+|+||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIl 225 (359)
T 3vhe_A 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 225 (359)
T ss_dssp --------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred chhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 889999999999999999999999999999999999
Q ss_pred eeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 027233 99 LSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174 (226)
Q Consensus 99 i~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~ 174 (226)
+ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++|++ |..||.+....
T Consensus 226 l---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 226 L---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp E---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred E---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 9 6788999999999976543321 223456778999999998899999999999999999998 99999876532
Q ss_pred c------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 175 Q------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 175 ~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
. ..+..+++++.+++.+||+.||.+|||+.|+++|
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 2 1256688999999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=261.02 Aligned_cols=203 Identities=28% Similarity=0.468 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-------------CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 72 (226)
....+.+.+|+.++++++||||+++++++.+ .+..++|+||+++++|.+++.... .+++..++.++
T Consensus 43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 122 (303)
T 1zy4_A 43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122 (303)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHH
Confidence 4556789999999999999999999998754 457899999999999999998654 67889999999
Q ss_pred HHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---------------CccccccCCccccCc
Q 027233 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAP 137 (226)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---------------~~~~~~~~~~~~~aP 137 (226)
.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+||
T Consensus 123 ~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (303)
T 1zy4_A 123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199 (303)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred HHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence 999999999999999999999999999 67889999999998765421 112234578889999
Q ss_pred cccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCc---------------ccccccCCChHHHHHHHHhhccCccccC
Q 027233 138 EVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNN---------------VQLIVPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 138 E~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
|.+.+. .++.++|+||||++++++++ ||..... ........+..++++|++||+.||.+||
T Consensus 200 E~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (303)
T 1zy4_A 200 EVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276 (303)
T ss_dssp HHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC
T ss_pred ccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCc
Confidence 998754 68899999999999999998 4432110 1112345667799999999999999999
Q ss_pred CHhHHhcCcccccc
Q 027233 202 SFNEFYHHRFLRRN 215 (226)
Q Consensus 202 t~~~~l~~~~~~~~ 215 (226)
|++++++||||+..
T Consensus 277 s~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 277 GARTLLNSGWLPVK 290 (303)
T ss_dssp CHHHHHHSSCSCCC
T ss_pred CHHHHhCCCCcCCC
Confidence 99999999999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=272.42 Aligned_cols=202 Identities=29% Similarity=0.425 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHHhcCC--------CCCeeeeeeEEE----eCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 72 (226)
....+.+.+|++++++++ |+||+++++.+. .....++||||+ +++|.+++... ..+++..++.++
T Consensus 74 ~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 74 EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHH
Confidence 345678899999999995 788999999987 456799999999 66777776654 469999999999
Q ss_pred HHHHHHHHHHHhC-CceeeccCCCCeEeeeCCCCc---------------------------------------------
Q 027233 73 QQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDV--------------------------------------------- 106 (226)
Q Consensus 73 ~~i~~~l~~lh~~-~i~H~dl~~~nili~~~~~~~--------------------------------------------- 106 (226)
.||+.||.|||++ |++||||||+||+++ .++
T Consensus 153 ~qi~~aL~~lH~~~givHrDikp~NIll~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 153 QQVLQGLDYLHTKCRIIHTDIKPENILLS---VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHTTCEECCCCSGGGEEEC---CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHeeEe---ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999998 999999999999994 333
Q ss_pred ----cEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-----
Q 027233 107 ----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI----- 177 (226)
Q Consensus 107 ----~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----- 177 (226)
.++|+|||.+...... .....++..|+|||.+.+..++.++||||||+++++|++|..||...+.....
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 307 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH
T ss_pred ccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH
Confidence 7999999999776543 23456899999999999889999999999999999999999999765432110
Q ss_pred -----------------------------------------------------ccCCChHHHHHHHHhhccCccccCCHh
Q 027233 178 -----------------------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 178 -----------------------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
....+..+.++|.+||+.||.+|||++
T Consensus 308 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 387 (397)
T 1wak_A 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387 (397)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred HHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence 112245688999999999999999999
Q ss_pred HHhcCccccc
Q 027233 205 EFYHHRFLRR 214 (226)
Q Consensus 205 ~~l~~~~~~~ 214 (226)
|+|+||||+.
T Consensus 388 e~l~hp~~~~ 397 (397)
T 1wak_A 388 ECLRHPWLNS 397 (397)
T ss_dssp HHHTSGGGGC
T ss_pred HHhhCccccC
Confidence 9999999973
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=278.00 Aligned_cols=213 Identities=25% Similarity=0.481 Sum_probs=167.2
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCC-------CHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQ 73 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~ 73 (226)
+|.+..+..+.+.+|+++++++ +||||+++++++.+.+..++|+||++ ++|.+++...... ++..++.++.
T Consensus 44 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~ 122 (434)
T 2rio_A 44 VKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122 (434)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHH
T ss_pred EEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHH
Confidence 4444455566788999999987 89999999999999999999999995 6999999865432 2234567999
Q ss_pred HHHHHHHHHHhCCceeeccCCCCeEeeeC----------CCCccEEEeeeccccccCCCCc-----cccccCCccccCcc
Q 027233 74 QLGAGLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPE 138 (226)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nili~~~----------~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE 138 (226)
||+.||.|||++|++||||+|+||+++.. ..+..++|+|||++........ .....++..|+|||
T Consensus 123 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 202 (434)
T 2rio_A 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202 (434)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHH
T ss_pred HHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence 99999999999999999999999999532 2345799999999987654321 22346899999999
Q ss_pred cccc-------cCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccccc---------------ccCCChHHHHHHHHhhcc
Q 027233 139 VLQF-------QRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI---------------VPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 139 ~~~~-------~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~---------------~~~~~~~~~~~i~~~l~~ 195 (226)
.+.+ ..++.++||||||++++++++ |..||......... ...++.++.++|.+||+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 282 (434)
T 2rio_A 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282 (434)
T ss_dssp HHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCS
T ss_pred HhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhC
Confidence 9865 568899999999999999998 99999764322110 112357899999999999
Q ss_pred CccccCCHhHHhcCcccccc
Q 027233 196 NTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||.+|||+.|+++||||...
T Consensus 283 dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 283 DPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp SGGGSCCHHHHHTSGGGSCH
T ss_pred ChhhCCCHHHHHhCCccCCc
Confidence 99999999999999999653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=263.50 Aligned_cols=206 Identities=23% Similarity=0.362 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLG 76 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~ 76 (226)
......+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++
T Consensus 69 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 148 (322)
T 1p4o_A 69 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148 (322)
T ss_dssp HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999999753 3568999999999999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHH
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
.||.+||++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||
T Consensus 149 ~~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 225 (322)
T 1p4o_A 149 DGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 225 (322)
T ss_dssp HHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHH
Confidence 99999999999999999999999 6788999999999876543321 12234567899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC------cccccc
Q 027233 154 VGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH------RFLRRN 215 (226)
Q Consensus 154 lG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~------~~~~~~ 215 (226)
||++++++++ |..||.+.+... .....++..+.+++.+||+.+|.+|||+.|++++ ++++..
T Consensus 226 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 226 FGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp HHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 9999999999 889997754322 1256788999999999999999999999999986 666554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=268.08 Aligned_cols=203 Identities=26% Similarity=0.401 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----------------------
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------- 61 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------- 61 (226)
.....+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++....
T Consensus 88 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (344)
T 1rjb_A 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167 (344)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccc
Confidence 344667899999999999 89999999999999999999999999999999998653
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcc
Q 027233 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (226)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE 138 (226)
.+++..++.++.||+.||.+||++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||
T Consensus 168 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 27899999999999999999999999999999999999 5788999999999976644322 22334567899999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
...+..++.++|+||||+++++|++ |..||.+...... .+...+.++.+++.+||+.||.+|||+.+
T Consensus 245 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9988899999999999999999998 9999987653221 14567899999999999999999999999
Q ss_pred HhcCcc
Q 027233 206 FYHHRF 211 (226)
Q Consensus 206 ~l~~~~ 211 (226)
++++-.
T Consensus 325 l~~~l~ 330 (344)
T 1rjb_A 325 LTSFLG 330 (344)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=263.03 Aligned_cols=201 Identities=20% Similarity=0.349 Sum_probs=168.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++..... +++..++.++.|++.||.+||+
T Consensus 52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 445667899999999999999999999999999999999999999999999987654 9999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCC-----ccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~-----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
+|++||||+|+||+++..... ..++|+|||.+...... ....++..|+|||.+.+ ..++.++||||||+++
T Consensus 132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 999999999999999532111 12999999998655322 23346788999999987 6789999999999999
Q ss_pred HHHHhCC-CCCCCCCcc---------cccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 159 FELLNGY-PPFSGRNNV---------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 159 ~~l~~g~-~p~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++++|. .||...... ...+...+.++.+++++||+.||.+|||++|++++
T Consensus 209 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 209 WEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999954 555443322 11256678899999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=268.82 Aligned_cols=200 Identities=23% Similarity=0.426 Sum_probs=164.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+
T Consensus 86 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 165 (373)
T 2qol_A 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165 (373)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999999999999999999999999998764 69999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++
T Consensus 166 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 242 (373)
T 2qol_A 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242 (373)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHH
Confidence 999999999999999 6788999999999976644321 112234567999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++ |..||........ .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 243 llt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 243 VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 998 9999976653322 14567889999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=263.13 Aligned_cols=200 Identities=28% Similarity=0.424 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC------------------CCCHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQT 67 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~ 67 (226)
....+.+.+|+.+++++ +||||+++++++...+..++|+||+++++|.+++.... .+++..
T Consensus 67 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (313)
T 1t46_A 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (313)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHH
Confidence 34568899999999999 99999999999999999999999999999999998654 389999
Q ss_pred HHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccC
Q 027233 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 144 (226)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~ 144 (226)
++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..
T Consensus 147 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 223 (313)
T 1t46_A 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC
Confidence 99999999999999999999999999999999 5788999999999977654432 12234567899999998889
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 145 YDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++.++|+||||++++++++ |..||.+...... ....++.++.+++.+||+.||.+|||+.|++++
T Consensus 224 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9999999999999999998 9999987653221 145688999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=258.78 Aligned_cols=199 Identities=30% Similarity=0.481 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-- 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-- 86 (226)
..+.+.+|+++++.++||||+++++++...+..++|+||+++++|.+++. ..++++..++.++.|++.||.+||++|
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~ 127 (271)
T 3dtc_A 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIV 127 (271)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 35678999999999999999999999999999999999999999999886 458999999999999999999999999
Q ss_pred -ceeeccCCCCeEeeeCC-----CCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 87 -IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 87 -i~H~dl~~~nili~~~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
++||||+|+||+++... .++.++|+|||.+........ ....++..|+|||...+..++.++|+||||+++++
T Consensus 128 ~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 206 (271)
T 3dtc_A 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206 (271)
T ss_dssp CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred ceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHH
Confidence 88999999999995211 267799999999976654332 34568899999999998889999999999999999
Q ss_pred HHhCCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLNGYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++|..||.+.+... ..+..++..+.+++.+||+.+|.+|||+.|++++
T Consensus 207 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 207 LLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999998765322 1256778999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=272.31 Aligned_cols=200 Identities=31% Similarity=0.507 Sum_probs=173.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++...+ .++...+..++.|++.|++|||+
T Consensus 152 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 231 (377)
T 3cbl_A 152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231 (377)
T ss_dssp CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34566788999999999999999999999999899999999999999999998754 69999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccc---cccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
+|++||||+|+||++ +.++.++|+|||++.......... ...++..|+|||.+.+..++.++||||||++++++
T Consensus 232 ~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 232 KCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308 (377)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 999999999999999 678899999999987654332111 12245679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||.+...... .+...+.++.+++.+||+.||.+|||++++++
T Consensus 309 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 309 FSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 98 9999987654321 14567889999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=264.65 Aligned_cols=202 Identities=26% Similarity=0.480 Sum_probs=177.3
Q ss_pred HHHHHHHHHHhcCC--CCCeeeeeeEEEeCCeEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
+.+.+|+.++++++ |+||+++++++...+..++++|++.+ ++|.+++...+.+++..++.++.|++.||.+||++|+
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 170 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 170 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 55678999999995 69999999999999999999999976 8999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||+|+||+++ ..++.++|+|||++....... .....++..|+|||.+.+..+ +.++|+||||++++++++|..
T Consensus 171 vH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 247 (320)
T 3a99_A 171 LHRDIKDENILID--LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247 (320)
T ss_dssp ECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCCCHHHEEEe--CCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence 9999999999994 267889999999997765432 334568899999999876665 678999999999999999999
Q ss_pred CCCCCCcc----cccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNNV----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||...... ......++.++.++|++||+.||.+|||++|+++||||++.
T Consensus 248 pf~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 248 PFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCSHHHHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCChhhhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99764321 12356789999999999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=265.99 Aligned_cols=202 Identities=30% Similarity=0.515 Sum_probs=170.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe------EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l 79 (226)
.....+.+.+|+.++++++||||+++++++...+. .+++|||+. ++|.+++. .++++..+..++.||+.||
T Consensus 63 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al 139 (353)
T 3coi_A 63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGL 139 (353)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999987653 599999996 68888765 3699999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
.+||++|++||||+|+||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 140 ~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 140 KYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp HHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 99999999999999999999 67889999999999765432 234467899999999876 6788999999999999
Q ss_pred HHHHhCCCCCCCCCccc-----------------------------------------ccccCCChHHHHHHHHhhccCc
Q 027233 159 FELLNGYPPFSGRNNVQ-----------------------------------------LIVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i~~~l~~~p 197 (226)
+++++|..||.+.+..+ .....+++++.++|++||+.||
T Consensus 215 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 294 (353)
T 3coi_A 215 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294 (353)
T ss_dssp HHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc
Confidence 99999999998754211 1124678999999999999999
Q ss_pred cccCCHhHHhcCcccccc
Q 027233 198 VDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~ 215 (226)
.+|||++|+++||||+..
T Consensus 295 ~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 295 DKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp TTSCCHHHHHTSGGGTTT
T ss_pred ccCCCHHHHhcCcchhhc
Confidence 999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.95 Aligned_cols=199 Identities=25% Similarity=0.393 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|+.++++++||||+++++++...+ .+++++++.+++|.+++... ..+++..++.++.|++.||.|||++
T Consensus 58 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 136 (327)
T 3poz_A 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136 (327)
T ss_dssp --CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 345678999999999999999999999998765 77899999999999999874 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++||||||+||++ +.++.++|+|||++......... ....++..|+|||.+.+..++.++||||||+++++++
T Consensus 137 ~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 213 (327)
T 3poz_A 137 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213 (327)
T ss_dssp TCCCSCCCGGGEEE---EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CeeCCCCChheEEE---CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHH
Confidence 99999999999999 56788999999999876543322 2234567899999999999999999999999999999
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+ |..||.+...... .+...+.++.+++.+||+.+|.+|||+.|++++
T Consensus 214 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 214 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred hcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9 9999987654322 255678899999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=259.42 Aligned_cols=199 Identities=21% Similarity=0.418 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+.+.+|+.++++++||||+++++++..++..++++||++|++|.+++...+++++..++.++.|++.||.+||++|
T Consensus 75 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 154 (309)
T 2h34_A 75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 34567899999999999999999999999999999999999999999999998889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++|+||||++++++++|
T Consensus 155 i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 155 ATHRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp CCCSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred CCcCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence 9999999999999 6788999999999876644321 2344678899999999988899999999999999999999
Q ss_pred CCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccC-CHhHHhc
Q 027233 165 YPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp-t~~~~l~ 208 (226)
..||.+.... ......++.++.++|.+||+.||.+|| |++++++
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 232 SPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp SCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999765421 122567889999999999999999999 7887764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=260.74 Aligned_cols=204 Identities=28% Similarity=0.465 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH- 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~- 85 (226)
...+.+.++..+++.++||||+++++++...+..++||||+ ++.+..+... ...+++..++.++.|++.||.+||++
T Consensus 66 ~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 34455666667788889999999999999999999999999 6667666554 46899999999999999999999995
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc-----ccCCCcchhHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~~~ 160 (226)
|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+. +..++.++||||||+++++
T Consensus 145 ~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 221 (318)
T 2dyl_A 145 GVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221 (318)
T ss_dssp CCCCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHH
T ss_pred CEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHH
Confidence 99999999999999 678899999999997765554445566889999999984 4567889999999999999
Q ss_pred HHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 161 LLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+++|..||......... ...++.++.++|.+||+.||.+|||++|+++||||++.
T Consensus 222 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 222 LATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 99999999864321110 23578999999999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=259.30 Aligned_cols=197 Identities=24% Similarity=0.440 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++ ..+..++|+||+++++|.+++...+.+++..++.++.|++.||.+||++|+
T Consensus 60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 138 (291)
T 1xbb_A 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138 (291)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3467899999999999999999999999 556789999999999999999988889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+|+||+|+||++ +.++.++|+|||++......... ....++..|+|||...+..++.++|+||||++++++++
T Consensus 139 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 139 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp ECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred EcCCCCcceEEE---eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence 999999999999 56778999999999776543221 12234577999999988888999999999999999999
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+.+.... .+..++..+.+++.+||+.||.+|||+.++++
T Consensus 216 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 216 YGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999987653221 25668899999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=263.79 Aligned_cols=210 Identities=23% Similarity=0.366 Sum_probs=179.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~ 78 (226)
.......+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.|
T Consensus 73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 152 (327)
T 2yfx_A 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152 (327)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence 34566788999999999999999999999999999999999999999999998763 48899999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcchhHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 155 (226)
|.+||++|++||||+|+||+++..+.+..++|+|||.+....... ......++..|+|||...+..++.++|+||||
T Consensus 153 l~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999999999999999999999533356679999999987553322 12234567889999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 156 AILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 156 ~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
++++++++ |..||........ ....++..+.++|.+||+.||.+|||+.+++++.|+...
T Consensus 233 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 99999998 9999987543221 255688999999999999999999999999999987654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=283.30 Aligned_cols=213 Identities=26% Similarity=0.449 Sum_probs=179.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe------CCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLG 76 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~ 76 (226)
.....+.+.+|++++++++||||+++++++.. .+..++||||++|++|.+++.... .+++..++.++.|++
T Consensus 52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl 131 (676)
T 3qa8_A 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131 (676)
T ss_dssp CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence 45667889999999999999999999998755 677899999999999999998754 589999999999999
Q ss_pred HHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
.||.|||++|++||||+|+||+++..+....++|+|||.+.............++..|+|||.+.+..++.++|+||+|+
T Consensus 132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv 211 (676)
T 3qa8_A 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211 (676)
T ss_dssp HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence 99999999999999999999999643344459999999998876665555667899999999999899999999999999
Q ss_pred HHHHHHhCCCCCCCCCcc----------------------------------cccccCCChHHHHHHHHhhccCccccCC
Q 027233 157 ILFELLNGYPPFSGRNNV----------------------------------QLIVPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~----------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
+++++++|..||.+.... ......++..+.++|.+||+.||.+|||
T Consensus 212 iLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT 291 (676)
T 3qa8_A 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291 (676)
T ss_dssp HHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred HHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence 999999999999653100 0012335688999999999999999999
Q ss_pred HhHHhcCccccccCcc
Q 027233 203 FNEFYHHRFLRRNSAI 218 (226)
Q Consensus 203 ~~~~l~~~~~~~~~~~ 218 (226)
+.|+++||||+.-...
T Consensus 292 a~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 292 DPQNPNVGCFQALDSI 307 (676)
T ss_dssp CTTCCCCTTHHHHHHH
T ss_pred HHHHhcCHHHHHHHHH
Confidence 9999999999885433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=265.63 Aligned_cols=201 Identities=27% Similarity=0.367 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh 83 (226)
...+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.... .+++..++.++.|++.||.+||
T Consensus 77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 156 (321)
T 2qkw_B 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156 (321)
T ss_dssp SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence 456789999999999999999999999999999999999999999999986543 5899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
++|++||||+|+||++ +.++.++|+|||++....... ......++..|+|||...+..++.++||||||+++++
T Consensus 157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred CCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence 9999999999999999 688899999999987654322 1223457889999999988899999999999999999
Q ss_pred HHhCCCCCCCCCcccc---------------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 161 LLNGYPPFSGRNNVQL---------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
+++|..||........ .....+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 234 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp HHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999999875432211 02223567899999999999999999999997643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=270.44 Aligned_cols=195 Identities=24% Similarity=0.459 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++.+.+. +++..+..++.|++.||.|||++
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999999999999999987654 79999999999999999987653 79999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
|++||||+|+||++ +.++.++|+|||++....... ....++..|+|||.+.+..++.++||||||++++++++ |
T Consensus 309 ~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 309 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp TEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999 678899999999997553322 22346788999999998999999999999999999998 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||.+....+. .+..+++++.++|.+||+.||.+|||+.++++
T Consensus 384 ~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 384 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999987654322 25668899999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=259.61 Aligned_cols=203 Identities=29% Similarity=0.481 Sum_probs=176.2
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEe----------------CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 72 (226)
+.+.+|++++++++||||+++++++.. .+..+++|||+++++|.+++... ..+++..++.++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 467789999999999999999998854 45589999999999999999764 579999999999
Q ss_pred HHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHH
Q 027233 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||...+..++.++|+|
T Consensus 129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 205 (284)
T 2a19_B 129 EQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 205 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhH
Confidence 999999999999999999999999999 56788999999999877665555556789999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCc------ccccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 153 SVGAILFELLNGYPPFSGRNN------VQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|||++++++++|..|+..... .......++..+.++|.+||+.||.+|||+.|++++.+.-..+
T Consensus 206 slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 206 ALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHHHHHHhcCCcchhHHHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 999999999999988743211 1123566889999999999999999999999999998876654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=257.65 Aligned_cols=201 Identities=24% Similarity=0.422 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
....+.+.+|++++++++||||+++++++ ..+..++|+||+++++|.+++... ..+++..++.++.|++.||.+||++
T Consensus 51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 129 (287)
T 1u59_A 51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129 (287)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45677899999999999999999999999 456689999999999999999754 4699999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||++++++
T Consensus 130 ~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 130 NFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp TEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CEeeCCCchheEEE---cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999 5678899999999987654322 1223356789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 162 LN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
++ |..||......+ ..+..+++++.++|.+||+.+|.+|||+.+++++.+
T Consensus 207 lt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 207 LSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 98 999998765432 125678999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=257.54 Aligned_cols=198 Identities=26% Similarity=0.447 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|++++++++||||+++++++.+.+..++|+||++|++|.+++... ..+++..++.++.|++.||.+||++
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 130 (288)
T 3kfa_A 51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130 (288)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence 35678899999999999999999999999999999999999999999999874 3589999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++
T Consensus 131 ~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp TCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999 67889999999999776543322 22335667999999998899999999999999999999
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||...+.... .+..+++.+.+++++||+.||.+|||++|+++
T Consensus 208 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 208 YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999987653322 25668899999999999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=255.85 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+..+.+.+|+.++++++||||+++++++.++ ..++++||+++++|.+++.... .+++..++.++.|++.||.+||++
T Consensus 54 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 132 (281)
T 3cc6_A 54 LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132 (281)
T ss_dssp HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999998754 4689999999999999997754 599999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||++++++++
T Consensus 133 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt 209 (281)
T 3cc6_A 133 NCVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209 (281)
T ss_dssp TCCCCCCSGGGEEE---EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccCCCccceEEE---CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence 99999999999999 5678899999999876644321 223345678999999988889999999999999999998
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||........ .+..+++.+.+++.+||+.+|.+|||+.|++++
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 210 FGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999976543322 255678999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=254.83 Aligned_cols=198 Identities=24% Similarity=0.457 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++||||+++++++.+.+..++++||+++++|.+++.+. ..+++..++.++.|++.||.+||++|+
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 125 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3467899999999999999999999999999999999999999999999875 468999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||++++++++ |
T Consensus 126 ~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 126 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp CCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 999999999999 678889999999987654321 1123345678999999988889999999999999999999 8
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
..||........ .+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 203 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 203 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999987543221 255678999999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=263.98 Aligned_cols=206 Identities=24% Similarity=0.425 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHhcCCCCC------eeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l 79 (226)
...+.+.+|+.++++++|++ ++.+++++...+..++||||+ +++|.+++.... ++++..++.++.||+.||
T Consensus 58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L 136 (355)
T 2eu9_A 58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 55678889999999997665 899999999999999999999 677777776653 699999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeC----------------CCCccEEEeeeccccccCCCCccccccCCccccCccccccc
Q 027233 80 EILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ 143 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~----------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 143 (226)
.+||++|++||||+|+||++... +.++.++|+|||++...... .....++..|+|||.+.+.
T Consensus 137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 214 (355)
T 2eu9_A 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL 214 (355)
T ss_dssp HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC
T ss_pred HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC
Confidence 99999999999999999999422 24678999999999765433 2345689999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc----------------------------------------------
Q 027233 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI---------------------------------------------- 177 (226)
Q Consensus 144 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------------------------------------------- 177 (226)
.++.++|+||||+++++|++|..||.........
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (355)
T 2eu9_A 215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294 (355)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence 9999999999999999999999999875532211
Q ss_pred --------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 178 --------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 178 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
....+.++.++|++||+.||.+|||+.|+++||||++..
T Consensus 295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 001134788999999999999999999999999999853
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=258.49 Aligned_cols=200 Identities=24% Similarity=0.376 Sum_probs=167.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++.... .+++..+..++.|++.||.+|
T Consensus 51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l 130 (295)
T 3ugc_A 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130 (295)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence 45566789999999999999999999999864 356899999999999999998754 599999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
|++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++
T Consensus 131 H~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 131 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207 (295)
T ss_dssp HHTTCCCSCCSGGGEEE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hcCCcccCCCCHhhEEE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence 99999999999999999 5678899999999977644321 2233456679999999989999999999999999
Q ss_pred HHHHhCCCCCCCCCcc---------------------------cccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 159 FELLNGYPPFSGRNNV---------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++|..|+...... ...+..++.++.+++++||+.||.+|||+.|+++
T Consensus 208 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999887643110 1115568899999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=265.28 Aligned_cols=207 Identities=27% Similarity=0.455 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhcC----CCCCeeeeeeEEEeCCeEEEEEee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+|+.+++++ +|+||+++++++...+..++++|+ +.+++|.+++...+.+++..++.++.|++.||.+||
T Consensus 77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 344566799999988 899999999999988899999999 789999999998889999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCC-cchhHHHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELL 162 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~~~~l~ 162 (226)
++|++||||+|+||+++ ..++.++|+|||.+....... .....++..|+|||...+..+. .++|+||||+++++++
T Consensus 157 ~~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 157 SRGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp HHTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred HCCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 99999999999999994 267889999999987765433 3345688999999998766654 5899999999999999
Q ss_pred hCCCCCCCCCcc----cccccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcc
Q 027233 163 NGYPPFSGRNNV----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218 (226)
Q Consensus 163 ~g~~p~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 218 (226)
+|..||...... ......++.++.++|.+||+.+|.+|||++|+++||||+.....
T Consensus 234 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 234 CGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp HSSCSCCSHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred HCCCCCCChHHHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 999999764321 12256789999999999999999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=261.31 Aligned_cols=201 Identities=21% Similarity=0.401 Sum_probs=169.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+..+.+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.+||+
T Consensus 86 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 165 (333)
T 1mqb_A 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165 (333)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456678999999999999999999999999999999999999999999999865 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|++||||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++
T Consensus 166 ~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 242 (333)
T 1mqb_A 166 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242 (333)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred CCeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHH
Confidence 999999999999999 6788999999999977644321 122334667999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++ |..||........ ....++..+.+++.+||+.+|.+|||+.+++++
T Consensus 243 llt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 243 VMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998 9999976543221 145678999999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=253.83 Aligned_cols=200 Identities=16% Similarity=0.218 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.+++.+ +|+|++++++++......++++||+ +++|.+++...+ ++++..+..++.|++.||.+||++|
T Consensus 48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 126 (298)
T 1csn_A 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126 (298)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 445788999999999 8999999999999999999999999 999999998754 6999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeC--CCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 87 IIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 87 i~H~dl~~~nili~~~--~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
++||||+|+||+++.. .....++|+|||++........ .....++..|+|||...+..++.++||||||+
T Consensus 127 ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 206 (298)
T 1csn_A 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 206 (298)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHH
Confidence 9999999999999421 1223499999999977654322 23456889999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 157 ILFELLNGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++++++|..||.+...... ....+++++.+++.+||+.+|.+|||++++++.
T Consensus 207 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 207 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999987543211 134789999999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=257.82 Aligned_cols=200 Identities=26% Similarity=0.462 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-----eEEEEEeecCCCCHHHHHHh------cCCCCHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQL 75 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i 75 (226)
....+.+.+|+.++++++||||+++++++...+ ..++++||+++++|.+++.. ...+++..++.++.|+
T Consensus 77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi 156 (313)
T 3brb_A 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156 (313)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence 455678999999999999999999999987654 35999999999999999843 3468999999999999
Q ss_pred HHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcchhHH
Q 027233 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
+.||.+||++|++||||+|+||++ +.++.++|+|||++....... ......++..|+|||...+..++.++|+|
T Consensus 157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 233 (313)
T 3brb_A 157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233 (313)
T ss_dssp HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence 999999999999999999999999 678899999999987664332 12233467789999999988999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 153 SVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 153 slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|||++++++++ |..||.+...... .+..++.++.++|.+||+.+|.+|||+.+++++
T Consensus 234 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 8899987654322 256688999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=264.39 Aligned_cols=196 Identities=15% Similarity=0.157 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+.+.+|+..++.++||||+++++++.. .+..++||||+ +++|.+++...+.+++..++.++.||+.||.|||+
T Consensus 91 ~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp CCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34457789999999999999999999987 77899999999 99999999887799999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCc--cEEEeeeccccccCCCC--------ccccccCCccccCcccccccCCCcchhHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~--~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 154 (226)
+|++||||+|+||+++ .++ .++|+|||++....... ......++..|+|||...+..++.++|||||
T Consensus 170 ~~ivH~Dlkp~NIll~---~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 170 NEYVHGDIKAANLLLG---YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp TTEECSCCSGGGEEEE---SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred CCeeCCCcCHHHEEEc---cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 9999999999999994 344 89999999997654321 1134568899999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccc---------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 155 GAILFELLNGYPPFSGRNNVQLI---------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~~---------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|++++++++|..||......... ...++.++.++|.+||+.||.+|||++++++
T Consensus 247 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 247 GYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999653221110 1178889999999999999999999999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=261.88 Aligned_cols=200 Identities=28% Similarity=0.450 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~ 69 (226)
....+.+.+|+++++++ +||||+++++++...+..++|+||+++++|.+++.... .+++..++
T Consensus 81 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (334)
T 2pvf_A 81 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160 (334)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHH
Confidence 45567899999999999 89999999999999999999999999999999998654 38899999
Q ss_pred HHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCC
Q 027233 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++
T Consensus 161 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 237 (334)
T 2pvf_A 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237 (334)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC
Confidence 999999999999999999999999999999 6788999999999976654322 2233456789999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
.++||||||++++++++ |..||.+..... .....++.++.+++.+||+.+|.+|||+.|++++
T Consensus 238 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999 999998764322 1256678999999999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=266.76 Aligned_cols=207 Identities=25% Similarity=0.411 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhcCC-----------CCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhc--CCCCHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~ 70 (226)
...+.+.+|++++++++ |+||+++++++...+ ..++++|++ +++|.+++... ..+++..+..
T Consensus 57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ 135 (373)
T 1q8y_A 57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHH
T ss_pred cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHH
Confidence 45677889999999886 889999999987654 789999999 89999999874 4599999999
Q ss_pred HHHHHHHHHHHHHhC-CceeeccCCCCeEeeeC---CCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCC
Q 027233 71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD 146 (226)
Q Consensus 71 ~~~~i~~~l~~lh~~-~i~H~dl~~~nili~~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 146 (226)
++.||+.||.+||++ |++||||+|+||+++.. +....++|+|||++...... .....++..|+|||.+.+..++
T Consensus 136 i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~ 213 (373)
T 1q8y_A 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG 213 (373)
T ss_dssp HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCC
Confidence 999999999999998 99999999999999532 23457999999999776543 2334688999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcccc--------------------------------------------------
Q 027233 147 EKVDMWSVGAILFELLNGYPPFSGRNNVQL-------------------------------------------------- 176 (226)
Q Consensus 147 ~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------------------------------------------------- 176 (226)
.++||||||+++++|++|..||.+......
T Consensus 214 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (373)
T 1q8y_A 214 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293 (373)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchh
Confidence 999999999999999999999986432100
Q ss_pred --------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 177 --------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 177 --------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
.....+.++.++|++||+.||.+|||++|+++||||++...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 01234567899999999999999999999999999998543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=264.32 Aligned_cols=196 Identities=12% Similarity=0.163 Sum_probs=166.2
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeC----CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.....|+..++.++|+||+++++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||++
T Consensus 93 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 171 (364)
T 3op5_A 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH 171 (364)
T ss_dssp HHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3455677778888999999999998764 5589999999 99999999876 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
|++||||||+||+++. ..++.++|+|||++........ .....++..|+|||.+.+..++.++||||||++
T Consensus 172 ~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 172 EYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 9999999999999942 2678899999999976543221 123448999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc---------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 158 LFELLNGYPPFSGRNNVQLI---------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~---------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++|++|..||.+....... ....+.++.+++..|++.+|.+|||++++++
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 99999999999864322111 1567999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=256.65 Aligned_cols=199 Identities=27% Similarity=0.438 Sum_probs=161.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|+.++++++||||++++++. ..+..++|+||+++++|.+++... ..+++..++.++.|++.||.+||+
T Consensus 60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 138 (289)
T 3og7_A 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138 (289)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456678899999999999999999999965 456689999999999999999644 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC---CccccccCCccccCccccc---ccCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~~ 158 (226)
+|++||||+|+||++ +.++.++|+|||++...... .......++..|+|||.+. +..++.++||||||+++
T Consensus 139 ~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp TTCCCSCCCGGGEEE---ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred CCcccccCccceEEE---CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 999999999999999 57789999999998765432 2223456889999999986 56788899999999999
Q ss_pred HHHHhCCCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 159 FELLNGYPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++|..||........ ....++..+.+++.+||+.+|.+|||+.++++
T Consensus 216 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999987543221 13467899999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=258.83 Aligned_cols=195 Identities=18% Similarity=0.254 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+++++++ +||||+++++++...+..++||||+ +++|.+++... +.+++..+..++.|++.||.|||++|
T Consensus 47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345688999999999 9999999999999999999999999 99999999874 68999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCcc-----EEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~-----~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
++||||+|+||++ +.++. ++|+|||++........ .....++..|+|||.+.+..++.++|+||
T Consensus 126 iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 202 (330)
T 2izr_A 126 LIYRDVKPENFLI---GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA 202 (330)
T ss_dssp EECCCCCGGGEEE---CCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred eeccCCCHHHeee---ccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence 9999999999999 45555 99999999987644322 23456899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
||+++++|++|..||.+....... ....+ ++.+++.+|++.+|.+||+++++++
T Consensus 203 lG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 203 LGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999875432211 12244 9999999999999999999998875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=262.35 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+|++++++++||||+++++++...+..++|+||+.+++|.+++.... ++++..+..++.|++.||.+||++
T Consensus 71 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 150 (326)
T 3uim_A 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150 (326)
T ss_dssp CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3478999999999999999999999999999999999999999999998653 389999999999999999999999
Q ss_pred ---CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 86 ---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 86 ---~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
|++||||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++++
T Consensus 151 ~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 227 (326)
T 3uim_A 151 CDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227 (326)
T ss_dssp SSSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHH
T ss_pred CCCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHH
Confidence 99999999999999 6788999999999976643322 333458999999999988889999999999999999
Q ss_pred HHhCCCCCCCCCc--------------------cc---------ccccCCChHHHHHHHHhhccCccccCCHhHHhcCcc
Q 027233 161 LLNGYPPFSGRNN--------------------VQ---------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 211 (226)
Q Consensus 161 l~~g~~p~~~~~~--------------------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~ 211 (226)
+++|..||..... .. ......+..+.+++.+||+.||.+|||+.|+++|-.
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 9999999952100 00 001223467999999999999999999999998765
Q ss_pred cc
Q 027233 212 LR 213 (226)
Q Consensus 212 ~~ 213 (226)
-.
T Consensus 308 ~~ 309 (326)
T 3uim_A 308 GD 309 (326)
T ss_dssp TS
T ss_pred Cc
Confidence 33
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=255.23 Aligned_cols=193 Identities=28% Similarity=0.602 Sum_probs=161.6
Q ss_pred HHHHHHHHHHH-hcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 10 ~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~l 82 (226)
.+.+.+|+.++ +.++||||+++++++.. .+..++||||+++++|.+++.... .+++..++.++.|++.||.||
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 133 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34677888888 55599999999999877 677999999999999999998764 699999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
|++|++|+||+|+||+++....++.++|+|||++.... +..++.++|+||||+++++|+
T Consensus 134 H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHH
Confidence 99999999999999999533337889999999885432 134577899999999999999
Q ss_pred hCCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccCCCC
Q 027233 163 NGYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 223 (226)
Q Consensus 163 ~g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~~~ 223 (226)
+|..||......... ...++.++.++|.+||+.||.+|||++|+++||||+........|.
T Consensus 193 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 999999765322110 2567999999999999999999999999999999999876655554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=253.29 Aligned_cols=196 Identities=22% Similarity=0.380 Sum_probs=169.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....+.+.+|+.++++++||||+++++++.+. +..++++||+++++|.+++.... .+++..++.++.|++.||.|
T Consensus 47 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 126 (271)
T 3kmu_A 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126 (271)
T ss_dssp CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999999876 78899999999999999998765 48999999999999999999
Q ss_pred HHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCc---chhHHHHHH
Q 027233 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVDMWSVGA 156 (226)
Q Consensus 82 lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Dv~slG~ 156 (226)
||++| ++|+||+|+||++ +.++.++++||+++..... ....+++.|+|||.+.+...+. ++||||||+
T Consensus 127 lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~ 199 (271)
T 3kmu_A 127 LHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199 (271)
T ss_dssp HTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred HhcCCCceecCCCccceEEE---cCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence 99999 9999999999999 6788899998887654322 2345788999999988655444 799999999
Q ss_pred HHHHHHhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 157 ILFELLNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++++|..||........ .+..++.++.+++.+||+.||.+|||++|+++
T Consensus 200 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 200 LLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999987543322 25678999999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=262.87 Aligned_cols=199 Identities=25% Similarity=0.428 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--------------CCCCHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKF 71 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~ 71 (226)
.+..+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++... ..+++..++.+
T Consensus 90 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (333)
T 2i1m_A 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169 (333)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHH
Confidence 45677899999999999 8999999999999999999999999999999999753 35799999999
Q ss_pred HHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcc
Q 027233 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
+.|++.||.+||++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.+
T Consensus 170 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 246 (333)
T 2i1m_A 170 SSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246 (333)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH
Confidence 9999999999999999999999999999 5778999999999976543322 122345678999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 149 VDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+||||||+++++|++ |..||.+...... .+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 247 SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999998 8999987543221 14557899999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=259.63 Aligned_cols=200 Identities=30% Similarity=0.495 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCC-eEEEEEeecCCCCHHHHHHhcCC----------------CCHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTA 68 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~ 68 (226)
....+.+.+|+++++++ +||||+++++++...+ ..++++||+++++|.+++..... +++..+
T Consensus 71 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (316)
T 2xir_A 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150 (316)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHH
T ss_pred cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHH
Confidence 44567899999999999 7999999999987654 58999999999999999987644 789999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCC
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~ 145 (226)
+.++.|++.||.+||++|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..+
T Consensus 151 ~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 9999999999999999999999999999999 6788899999999976644322 223346778999999998899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+.++|+||||++++++++ |..||.+...... .+..+++.+.+++.+||+.||.+|||+.|+++|
T Consensus 228 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998 9999977553221 255678999999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=254.61 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEE-EeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+.+|+.++++++||||+++++++ ..++..++++||+++++|.+++... ..+++..++.++.|++.||.+||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH 145 (298)
T 3f66_A 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145 (298)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999985 4566889999999999999999764 46899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
++|++||||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++
T Consensus 146 ~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 146 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp HTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hCCccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999999 6788999999999976643221 2233456789999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 159 FELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 159 ~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++ |..||......+. .+..++..+.+++.+||+.+|.+|||+.|+++
T Consensus 223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999 5666665543322 15567899999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=261.68 Aligned_cols=201 Identities=24% Similarity=0.371 Sum_probs=171.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEE--eCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+.+|++++++++||||+++++++. ..+..++|+||+++++|.+++... ..+++..++.++.|++.||.+|
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 143 (327)
T 3lxl_A 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143 (327)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 4556678999999999999999999999886 456799999999999999999874 4699999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
|++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++||||||+++
T Consensus 144 H~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 144 GSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp HHTTEECSCCSGGGEEE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCCccCCCCChhhEEE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 99999999999999999 5678899999999987654322 2234467779999999888889999999999999
Q ss_pred HHHHhCCCCCCCCCcc--------------------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 159 FELLNGYPPFSGRNNV--------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++++|..||...... ......+++.+.++|++||+.||.+|||+.|++++
T Consensus 221 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 221 YELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999998643221 01145678999999999999999999999999643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=260.05 Aligned_cols=197 Identities=25% Similarity=0.379 Sum_probs=164.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
........|+.++++++||||+++++++.... ..++||||+++++|.+++... .+++..++.++.|++.||.|||
T Consensus 60 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH 138 (322)
T 3soc_A 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLH 138 (322)
T ss_dssp HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH
Confidence 34455667899999999999999999998743 479999999999999999764 6999999999999999999999
Q ss_pred hC----------CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccc-----cCC
Q 027233 84 SH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----QRY 145 (226)
Q Consensus 84 ~~----------~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-----~~~ 145 (226)
+. |++||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..+
T Consensus 139 ~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 215 (322)
T 3soc_A 139 EDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215 (322)
T ss_dssp CCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHH
T ss_pred hhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCC
Confidence 99 99999999999999 6788999999999977654322 233568999999999876 355
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCccccc------------------------cc---------CCChHHHHHHHHh
Q 027233 146 DEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------------------VP---------ALHPDCVDMCLKL 192 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------------------------~~---------~~~~~~~~~i~~~ 192 (226)
+.++||||||++++++++|..||.+....... .+ ..+.++.++|.+|
T Consensus 216 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (322)
T 3soc_A 216 FLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHH
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHH
Confidence 67889999999999999999999764332111 11 1123499999999
Q ss_pred hccCccccCCHhHHhc
Q 027233 193 LSANTVDRLSFNEFYH 208 (226)
Q Consensus 193 l~~~p~~Rpt~~~~l~ 208 (226)
|+.||.+|||+.|+++
T Consensus 296 l~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 296 WDHDAEARLSAGCVGE 311 (322)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=260.26 Aligned_cols=196 Identities=24% Similarity=0.420 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+.+.+|+.++++++||||+++++++.+ +..++|+||+.+++|.+++... +.+++..+..++.|++.||.|||++|++
T Consensus 59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 137 (325)
T 3kex_A 59 FQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137 (325)
T ss_dssp BCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4567789999999999999999998864 5688999999999999999865 5789999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||++++++++ |
T Consensus 138 H~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 214 (325)
T 3kex_A 138 HRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214 (325)
T ss_dssp CSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCC
Confidence 99999999999 6788999999999987654322 233456778999999998899999999999999999999 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
..||.+...... .+...+.++.+++.+||+.||.+|||+.+++++
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 215 AEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999987653322 155678899999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.16 Aligned_cols=197 Identities=25% Similarity=0.391 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|+.++++++||||+++++++...+ .+++++++.+++|.+++... ..+++..++.++.|++.||.|||++|
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 137 (327)
T 3lzb_A 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137 (327)
T ss_dssp CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 45678999999999999999999999998765 78899999999999999874 57999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc---ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++||||||+||++ +.++.++|+|||++......... ....++..|+|||.+.+..++.++||||||++++++++
T Consensus 138 ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 214 (327)
T 3lzb_A 138 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp CCCSCCCGGGEEE---EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcCCCCCHHHEEE---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence 9999999999999 56788999999999776443222 22345667999999999999999999999999999999
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+...... .+...+.++.+++++||+.||.+|||+.|+++
T Consensus 215 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 215 FGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999987654322 25568899999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=252.43 Aligned_cols=199 Identities=24% Similarity=0.360 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe-EEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+.+.+|+.++++++||||+++++++.+.+. .++++||+.+++|.+++... ..+++..++.++.|++.||.+||+
T Consensus 63 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 142 (298)
T 3pls_A 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142 (298)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3566788999999999999999999999976655 48999999999999999874 578999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-----ccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
+|++||||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||++++
T Consensus 143 ~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 219 (298)
T 3pls_A 143 QKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219 (298)
T ss_dssp TTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHH
Confidence 999999999999999 678899999999997553321 222345677899999999889999999999999999
Q ss_pred HHHhCCCC-CCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 160 ELLNGYPP-FSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 160 ~l~~g~~p-~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++++|..| |...+.... ....++..+.+++.+||+.+|.+|||+.++++
T Consensus 220 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 220 ELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99995555 544333221 15567889999999999999999999999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=253.24 Aligned_cols=200 Identities=28% Similarity=0.522 Sum_probs=164.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.....+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++.. ...+++..++.++.|++.||.+
T Consensus 72 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 151 (310)
T 2wqm_A 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151 (310)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999999999999999999999999999875 3568999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
||++|++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||...+..++.++|+||||+++++
T Consensus 152 LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 152 MHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred HhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999 678899999999987654332 2234467889999999998889999999999999999
Q ss_pred HHhCCCCCCCCCccc--------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLNGYPPFSGRNNVQ--------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++|..||.+..... .....++.++.+++.+||+.||.+|||+.++++
T Consensus 229 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 229 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999997643210 113567899999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=263.97 Aligned_cols=204 Identities=35% Similarity=0.486 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHhcCC-CC-----CeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l 79 (226)
...+.+..|+++++.++ |+ +|+++++++...+..++||||++ ++|.+++... ..+++..+..++.|++.||
T Consensus 92 ~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al 170 (382)
T 2vx3_A 92 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHH
Confidence 44567788999988884 55 49999999999999999999995 5999999875 4689999999999999999
Q ss_pred HHHH--hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 80 EILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 80 ~~lh--~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
.+|| +.||+||||||+||++.. +.++.++|+|||++...... .....++..|+|||.+.+..++.++||||||++
T Consensus 171 ~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 247 (382)
T 2vx3_A 171 LFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI 247 (382)
T ss_dssp HHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHH
Confidence 9999 579999999999999942 23677999999999776433 234568899999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc----------------------------ccC-----------------------------
Q 027233 158 LFELLNGYPPFSGRNNVQLI----------------------------VPA----------------------------- 180 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~----------------------------~~~----------------------------- 180 (226)
+++|++|..||.+.+..+.. +..
T Consensus 248 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (382)
T 2vx3_A 248 LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVE 327 (382)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhcc
Confidence 99999999999865432111 000
Q ss_pred -----------------CChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 181 -----------------LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 181 -----------------~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
.+.++.++|++||+.||.+|||++|+|+||||+..
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 328 TGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 01378999999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=264.88 Aligned_cols=200 Identities=28% Similarity=0.445 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEE-eCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+.+.+|+.++++++||||+++++++. .++..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 131 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 210 (373)
T 3c1x_A 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210 (373)
T ss_dssp SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356678999999999999999999999865 456789999999999999999865 358899999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
+|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||...+..++.++||||||+++|
T Consensus 211 ~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 211 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHH
Confidence 999999999999999 6788999999999976543221 12234567899999999899999999999999999
Q ss_pred HHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 160 ELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 160 ~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
++++ |..||......+. .+..++..+.+++.+||+.+|.+|||+.|++++
T Consensus 288 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999 6778876543322 145678999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=271.64 Aligned_cols=197 Identities=26% Similarity=0.448 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 338 (495)
T 1opk_A 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338 (495)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578999999999999999999999999999999999999999999999864 35899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++||||+|+||++ +.++.++|+|||++......... ....++..|+|||.+.+..++.++||||||+++++|++
T Consensus 339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 9999999999999 67889999999999776433221 22334568999999988889999999999999999999
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+.+.... .+..++.++.++|.+||+.||.+|||+.++++
T Consensus 416 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 416 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999987654322 15567899999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=257.11 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|++++++++||||+++++++... ...+++|||+++++|.+++... ..+++..++.++.|++.||.+||++
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 457889999999999999999999999876 6689999999999999999554 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||++++++
T Consensus 146 ~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 QYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp TEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CcccCCCchheEEE---cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999 5678899999999977654432 2234567779999999888899999999999999999
Q ss_pred HhCCCCCCCCCc--------------------------ccccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LNGYPPFSGRNN--------------------------VQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~g~~p~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++|..|+..... ....+..+++.+.+++.+||+.||.+|||++|+++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 999887542210 01114577899999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=257.55 Aligned_cols=198 Identities=26% Similarity=0.401 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....+.+.+|++++++++||||+++++++.+. ...++||||+++++|.+++... .+++..++.++.|++.||.+||+
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~ 152 (318)
T 3lxp_A 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence 45677899999999999999999999999874 6789999999999999998764 69999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++++
T Consensus 153 ~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 153 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred CCccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999 6788999999999987654432 223446777999999998889999999999999999
Q ss_pred HHhCCCCCCCCCcc--------------------------cccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLNGYPPFSGRNNV--------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~g~~p~~~~~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++|..||...... ......++.++.++|++||+.||.+|||++|+++
T Consensus 230 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999998653211 1125568899999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=249.92 Aligned_cols=191 Identities=27% Similarity=0.428 Sum_probs=165.0
Q ss_pred HHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q 027233 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH--I 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--i 87 (226)
+.+.+|++++++++||||+++++++.+.. ++||||+++++|.+++... ..+++..++.++.|++.||.+||++| +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 68899999999999999999999987665 6999999999999988655 47999999999999999999999999 9
Q ss_pred eeeccCCCCeEeeeCCCCcc-----EEEeeeccccccCCCCccccccCCccccCcccc--cccCCCcchhHHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|+||+|+||+++ .++. ++|+|||.+..... ......++..|+|||.+ ....++.++|+||||+++++
T Consensus 146 vH~dikp~Nil~~---~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~ 220 (287)
T 4f0f_A 146 VHRDLRSPNIFLQ---SLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220 (287)
T ss_dssp BCSCCSGGGEEES---CCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEe---ccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence 9999999999994 4433 99999999875443 23345688999999998 34567889999999999999
Q ss_pred HHhCCCCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLNGYPPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++|..||........ .+..+++.+.+++.+||+.||.+|||++|+++
T Consensus 221 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 221 ILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999986543222 25678899999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=269.29 Aligned_cols=196 Identities=24% Similarity=0.483 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++. .+..++||||+.+++|.+++... ..++...+..++.|++.||.|||++|
T Consensus 226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 304 (454)
T 1qcf_A 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304 (454)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4678999999999999999999999986 56689999999999999999854 36889999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+....++.++||||||++++++++
T Consensus 305 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~ 381 (454)
T 1qcf_A 305 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381 (454)
T ss_dssp CCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence 9999999999999 6788999999999977643221 122335677999999998889999999999999999999
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+.+..+. .+..++.++.+++.+||+.||.+|||++++++
T Consensus 382 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 382 GRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999987654322 15567899999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=252.66 Aligned_cols=195 Identities=24% Similarity=0.447 Sum_probs=162.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+.+.+|++++++++||||+++++++.. .+..++++||+++++|.+++..... +++..++.++.|++.||.+||++
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56778999999999999999999998754 4578999999999999999986643 89999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~-g 164 (226)
|++|+||+|+||++ +.++.++|+|||.+....... ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus 137 ~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 137 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp TCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccccCCCcceEEE---eCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCC
Confidence 99999999999999 678899999999987654332 23346788999999988889999999999999999998 9
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..||........ ....+++.+.++|++||+.||.+|||+.|+++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 212 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999987543221 25567899999999999999999999999885
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=254.75 Aligned_cols=199 Identities=26% Similarity=0.406 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.+..+.+.+|++++++++||||+++++++...+..++++||+++++|.+++... .++++..++.++.|++.||.+||
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 150 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 456788999999999999999999999999999999999999999999999743 46899999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+ .++.++|+||||+++++
T Consensus 151 ~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~ 226 (307)
T 2nru_A 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLE 226 (307)
T ss_dssp HTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHH
T ss_pred cCCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHH
Confidence 9999999999999999 6788999999999876544321 233467899999998875 47899999999999999
Q ss_pred HHhCCCCCCCCCccccc-------------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 161 LLNGYPPFSGRNNVQLI-------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+++|..||......... ....+..+.+++.+||+.+|.+|||+.+++++
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 227 IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999765432211 12234678999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=277.98 Aligned_cols=197 Identities=25% Similarity=0.451 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++.. +..++||||+++++|.+++...+.+++..+..++.||+.||.|||++||
T Consensus 412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 490 (635)
T 4fl3_A 412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 490 (635)
T ss_dssp GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 446789999999999999999999999865 4588999999999999999988889999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++|++
T Consensus 491 iHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 491 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp CCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eCCCCChHhEEE---eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 5677899999999977644321 122335677999999998899999999999999999998
Q ss_pred -CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 164 -GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 164 -g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|..||.+....+. .+..++.++.++|.+||+.||.+|||++++++
T Consensus 568 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 568 YGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999987654322 25678899999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=256.61 Aligned_cols=202 Identities=23% Similarity=0.323 Sum_probs=169.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA 77 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~ 77 (226)
.....+.+.+|+++++.++||||+++++++.. ....++|+||+.+++|.+++.. ...+++..++.++.|++.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 145 (317)
T 2buj_A 66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145 (317)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 45677889999999999999999999999863 3478999999999999999976 357999999999999999
Q ss_pred HHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc----------ccccCCccccCcccccccC---
Q 027233 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAPEVLQFQR--- 144 (226)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~--- 144 (226)
||.+||++|++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||.+.+..
T Consensus 146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 9999999999999999999999 67889999999988655321110 1234688899999986543
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhcCc
Q 027233 145 YDEKVDMWSVGAILFELLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 210 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~ 210 (226)
++.++||||||++++++++|..||...... ......++.++.++|.+||+.||.+|||+++++++-
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 688999999999999999999998642110 011356789999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=251.16 Aligned_cols=202 Identities=23% Similarity=0.461 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++.. +..++|+||+++++|.+++.... .+++..+..++.|++.||.+||++|
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678999999999999999999998864 45889999999999999987543 7999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++|+||+|+||++ +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++
T Consensus 130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999 67889999999999776543321 22345678999999988889999999999999999999
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc--Cccccc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRR 214 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~--~~~~~~ 214 (226)
|..||.+...... ....++.++.+++.+||+.+|.+|||++++++ ..++..
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 8999987553221 24677899999999999999999999999886 344443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=256.62 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=164.9
Q ss_pred hhhhhHHHHHHHHHHHHHHhc--CCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i 75 (226)
+|.+.....+.+..|.+++.. ++||||+++++++.. .+..++|+||+++++|.++++. ..+++..++.++.|+
T Consensus 36 vK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i 114 (301)
T 3q4u_A 36 VKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSI 114 (301)
T ss_dssp EEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHH
T ss_pred EEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHH
Confidence 455555566666777777776 799999999998654 3568999999999999999964 579999999999999
Q ss_pred HHHHHHHH--------hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-----ccccCCccccCcccccc
Q 027233 76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 76 ~~~l~~lh--------~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~ 142 (226)
+.||.||| ++|++||||||+||++ +.++.++|+|||++......... ....++..|+|||.+.+
T Consensus 115 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp HHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence 99999999 9999999999999999 67889999999999765443322 22368899999999876
Q ss_pred c------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCccccc----------------------ccCCChH
Q 027233 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSGRNNVQLI----------------------VPALHPD 184 (226)
Q Consensus 143 ~------~~~~~~Dv~slG~~~~~l~~g----------~~p~~~~~~~~~~----------------------~~~~~~~ 184 (226)
. .++.++||||||++++++++| ..||......... ....+.+
T Consensus 192 ~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (301)
T 3q4u_A 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS 271 (301)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHH
T ss_pred cCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHH
Confidence 6 455799999999999999999 7787553221110 1123467
Q ss_pred HHHHHHHhhccCccccCCHhHHhc
Q 027233 185 CVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+.+++++||+.||.+|||+.|+++
T Consensus 272 l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 272 LAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhhcChhhCCCHHHHHH
Confidence 999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=253.81 Aligned_cols=197 Identities=27% Similarity=0.428 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
+..+.+.+|++++++++||||+++++++.... .++++||+++++|.+++... ..+++..+..++.|++.||.+||++|
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45678999999999999999999999998765 78999999999999999865 57999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++++
T Consensus 142 i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 142 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp EECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred cccCCCchheEEE---cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999 5677899999999877654322 12334566799999998888899999999999999999
Q ss_pred h-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 N-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+ |..||.+...... ....++.++.+++.+||+.+|.+|||+.++++
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 219 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9 9999976543221 14568899999999999999999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=267.07 Aligned_cols=202 Identities=22% Similarity=0.420 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 300 (452)
T 1fmk_A 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300 (452)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678999999999999999999999876 6689999999999999999753 56899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||++++++++
T Consensus 301 ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 301 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eeCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 9999999999999 6788999999999976643322 122345678999999988899999999999999999999
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC--ccccc
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH--RFLRR 214 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~--~~~~~ 214 (226)
|..||.+....+. .+..++..+.+++.+||+.+|.+|||++++++. .++..
T Consensus 378 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 378 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 9999987653322 256688999999999999999999999999862 44443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=248.89 Aligned_cols=199 Identities=18% Similarity=0.197 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeE-EEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.+++.++|++++..+.. ....+..++++||+ +++|.+++.. ..++++..++.++.|++.||.+||++|
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (296)
T 3uzp_A 47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34578999999999988876655554 46678889999999 8999999984 457999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
++||||+|+||+++..+.++.++|+|||.+........ .....++..|+|||...+..++.++||||||+++
T Consensus 126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence 99999999999994333677899999999977654322 2345688999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 159 FELLNGYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++|..||.+....... ...+++++.+++.+||+.||.+|||++++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 9999999999875432111 3678999999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=252.87 Aligned_cols=195 Identities=32% Similarity=0.500 Sum_probs=162.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh 83 (226)
....+.+.+|++++++++||||+++++++.+ ..++||||+++++|.+++.... .++...++.++.|++.||.|||
T Consensus 42 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH 119 (307)
T 2eva_A 42 ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998764 3789999999999999998664 3788999999999999999999
Q ss_pred h---CCceeeccCCCCeEeeeCCCCc-cEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 84 S---HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 84 ~---~~i~H~dl~~~nili~~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
+ +|++||||+|+||+++ .++ .++|+|||.+...... .....++..|+|||...+..++.++||||||++++
T Consensus 120 ~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 194 (307)
T 2eva_A 120 SMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194 (307)
T ss_dssp TCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHH
T ss_pred hCCCCCeecCCCChhHEEEe---CCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHH
Confidence 9 8999999999999994 444 4899999998765432 22345889999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCcc-------------cccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 160 ELLNGYPPFSGRNNV-------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++++|..||...... ......++..+.+++.+||+.||.+|||++++++
T Consensus 195 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999754321 1125668899999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=248.87 Aligned_cols=200 Identities=18% Similarity=0.195 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeE-EEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|+++++.++|++++..+.. +...+..+++|||+ +++|.+++.. ..++++..+..++.|++.||.+||++
T Consensus 46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (296)
T 4hgt_A 46 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp --CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345578899999999988776666554 46778899999999 9999999985 35799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
|++||||+|+||+++..+.++.++|+|||.+........ .....++..|+|||...+..++.++||||||++
T Consensus 125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 4hgt_A 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHH
Confidence 999999999999995434677899999999977654322 234568899999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 158 LFELLNGYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++++++|..||.+....... ...+++++.+++.+||+.+|.+|||++++++
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999875433211 3667999999999999999999999999886
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.40 Aligned_cols=195 Identities=16% Similarity=0.234 Sum_probs=167.3
Q ss_pred HHHHHHHHHHhcCCCCCeee---------------eeeEEEe-CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 027233 11 SCLDCELNFLSSVNHPNIIR---------------LFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 72 (226)
+.+.+|++++++++||||++ +++++.. ++..++||||+ +++|.+++... ..+++..++.++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 46889999999999999887 6677766 67899999999 99999999876 689999999999
Q ss_pred HHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCc--cEEEeeeccccccCCCC--------ccccccCCccccCcccccc
Q 027233 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~--~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~ 142 (226)
.||+.||.|||++|++||||+|+||++ +.++ .++|+|||++....... ......++..|+|||...+
T Consensus 166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHENEYVHGNVTAENIFV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCGGGEEE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 999999999999999999999999999 4555 89999999997654321 1123468889999999998
Q ss_pred cCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-ccc--------------------ccCCChHHHHHHHHhhccCccccC
Q 027233 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLI--------------------VPALHPDCVDMCLKLLSANTVDRL 201 (226)
Q Consensus 143 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~--------------------~~~~~~~~~~~i~~~l~~~p~~Rp 201 (226)
..++.++||||||++++++++|..||...... ... ...++.++.+++.+||+.||.+||
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC
Confidence 89999999999999999999999999876411 111 125689999999999999999999
Q ss_pred CHhHHhcC
Q 027233 202 SFNEFYHH 209 (226)
Q Consensus 202 t~~~~l~~ 209 (226)
|++++++.
T Consensus 323 s~~~l~~~ 330 (352)
T 2jii_A 323 PYAMLRNN 330 (352)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=272.96 Aligned_cols=203 Identities=24% Similarity=0.431 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++++++||||+++++++.. +..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|
T Consensus 378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 456 (613)
T 2ozo_A 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456 (613)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999999999999999876 5589999999999999999754 46999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++|+
T Consensus 457 iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 457 FVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp CCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EEcCcCCHHHEEE---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999 5678999999999977643321 11223457899999999889999999999999999999
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHh---cCccccc
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY---HHRFLRR 214 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l---~~~~~~~ 214 (226)
+ |..||.+.+..+. .+..++.++.+++.+||+.+|.+|||+.+++ ++.|+.-
T Consensus 534 t~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 534 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 8 9999987654332 1566889999999999999999999999974 5555544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=252.93 Aligned_cols=204 Identities=23% Similarity=0.319 Sum_probs=164.0
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC--CCCCeeeeeeEEEeC----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i 75 (226)
+|.+..........|.+++..+ +||||+++++++... +..++||||+++++|.++++.. .+++..++.++.|+
T Consensus 65 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i 143 (337)
T 3mdy_A 65 VKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143 (337)
T ss_dssp EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred EEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHH
Confidence 3444444555566666666665 899999999999877 7899999999999999999754 79999999999999
Q ss_pred HHHHHHHHhC--------CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-----ccccCCccccCcccccc
Q 027233 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 76 ~~~l~~lh~~--------~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~ 142 (226)
+.||.|||++ |++||||||+||++ +.++.++|+|||++......... ....++..|+|||.+.+
T Consensus 144 ~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp HHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 9999999998 99999999999999 67889999999999766433221 23468899999999987
Q ss_pred cCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCCccccc----------------------ccCCChH
Q 027233 143 QRYDEK------VDMWSVGAILFELLNG----------YPPFSGRNNVQLI----------------------VPALHPD 184 (226)
Q Consensus 143 ~~~~~~------~Dv~slG~~~~~l~~g----------~~p~~~~~~~~~~----------------------~~~~~~~ 184 (226)
...+.. +||||||+++|+|++| ..||......... ....+.+
T Consensus 221 ~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (337)
T 3mdy_A 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ 300 (337)
T ss_dssp CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHH
T ss_pred ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHH
Confidence 665554 9999999999999999 6666543221110 1134567
Q ss_pred HHHHHHHhhccCccccCCHhHHhcC
Q 027233 185 CVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+.+++.+||+.||.+|||+.|++++
T Consensus 301 l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 301 MGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhhhChhhCCCHHHHHHH
Confidence 9999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=259.01 Aligned_cols=207 Identities=18% Similarity=0.221 Sum_probs=170.2
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQ 73 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ 73 (226)
+|.........+..|+++++.++ |+||+++++.+...+..++||||+++++|.+++.. ...+++..++.++.
T Consensus 100 vK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~ 179 (365)
T 3e7e_A 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179 (365)
T ss_dssp EEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHH
T ss_pred EEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHH
Confidence 34455556677888999998886 99999999999999999999999999999999974 45799999999999
Q ss_pred HHHHHHHHHHhCCceeeccCCCCeEeee--------CCCCccEEEeeeccccccC---CCCccccccCCccccCcccccc
Q 027233 74 QLGAGLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nili~~--------~~~~~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~ 142 (226)
||+.||.|||++||+||||||+||+++. ...++.++|+|||++.... .........|+..|+|||.+.+
T Consensus 180 qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp HHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred HHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 9999999999999999999999999942 1117889999999996543 2233345678999999999999
Q ss_pred cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 143 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..++.++||||||+++++|++|..||......... ....+..+.+++..||+.+|.+|++..+.+.
T Consensus 260 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 260 KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred CCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 99999999999999999999999998654332111 2234678999999999999999965444433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=254.86 Aligned_cols=203 Identities=26% Similarity=0.444 Sum_probs=155.2
Q ss_pred hHHHHHHHHHHHHHHhcCC-CCCeeeeeeEEE--------eCCeEEEEEeecCCCCHHHHHHh---cCCCCHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQ 73 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ 73 (226)
.....+.+.+|+.+++++. ||||+++++++. .....++++||+. ++|.+++.. .+++++..++.++.
T Consensus 65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~ 143 (337)
T 3ll6_A 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFY 143 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHH
Confidence 4556678899999999995 999999999984 3445899999995 799998865 45799999999999
Q ss_pred HHHHHHHHHHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc-------------ccccCCccccCcc
Q 027233 74 QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-------------EKVCGSPLYMAPE 138 (226)
Q Consensus 74 ~i~~~l~~lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~~aPE 138 (226)
|++.||.+||++| ++|+||+|+||++ +.++.++|+|||++......... ....++..|+|||
T Consensus 144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 144 QTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp HHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC----------------------------
T ss_pred HHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence 9999999999999 9999999999999 67889999999999776543221 1344788899999
Q ss_pred cc---cccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------ccCCChHHHHHHHHhhccCccccCCHhHHh
Q 027233 139 VL---QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------VPALHPDCVDMCLKLLSANTVDRLSFNEFY 207 (226)
Q Consensus 139 ~~---~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l 207 (226)
.+ .+..++.++||||||++++++++|..||......... ....+..+.+++++||+.||.+|||+.|++
T Consensus 221 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 300 (337)
T 3ll6_A 221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300 (337)
T ss_dssp ---CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHH
Confidence 98 5667889999999999999999999999765443222 455678899999999999999999999999
Q ss_pred cCccc
Q 027233 208 HHRFL 212 (226)
Q Consensus 208 ~~~~~ 212 (226)
++-+-
T Consensus 301 ~~l~~ 305 (337)
T 3ll6_A 301 HQLQE 305 (337)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=253.83 Aligned_cols=200 Identities=24% Similarity=0.377 Sum_probs=169.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (226)
.....+.+.+|++++++++||||+++++++... ...++|+||+++++|.+++... ..+++..++.++.|++.||.+|
T Consensus 82 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 161 (326)
T 2w1i_A 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161 (326)
T ss_dssp CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999988654 3689999999999999999876 4699999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
|++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++
T Consensus 162 H~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 238 (326)
T 2w1i_A 162 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238 (326)
T ss_dssp HHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCCEeccCCCcceEEE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHH
Confidence 99999999999999999 5678899999999977654322 1223456679999999888889999999999999
Q ss_pred HHHHhCCCCCCCCC----------c-----------------ccccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 159 FELLNGYPPFSGRN----------N-----------------VQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 159 ~~l~~g~~p~~~~~----------~-----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+++++|..|+.... . ....+..++.++.++|++||+.||.+|||+.|+++
T Consensus 239 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999998876321 0 01124567899999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=261.78 Aligned_cols=200 Identities=25% Similarity=0.450 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC--eEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh 83 (226)
..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++.... .+++..++.++.|++.||.|||
T Consensus 50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 129 (396)
T 4eut_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (396)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999998754 7899999999999999997653 3999999999999999999999
Q ss_pred hCCceeeccCCCCeEeee-CCCCccEEEeeeccccccCCCCccccccCCccccCcccccc--------cCCCcchhHHHH
Q 027233 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSV 154 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~sl 154 (226)
++|++||||+|+||++.. .+.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+|||
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 999999999999999732 24566799999999987765554555678999999999864 567789999999
Q ss_pred HHHHHHHHhCCCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhcc
Q 027233 155 GAILFELLNGYPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 155 G~~~~~l~~g~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~ 195 (226)
|++++++++|..||........ ....++..+.+++++||+.
T Consensus 210 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp HHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 9999999999999964332110 0123456789999999999
Q ss_pred CccccCCHhHHhc
Q 027233 196 NTVDRLSFNEFYH 208 (226)
Q Consensus 196 ~p~~Rpt~~~~l~ 208 (226)
||.+|||++|+++
T Consensus 290 dP~~R~s~~e~l~ 302 (396)
T 4eut_A 290 DQEKCWGFDQFFA 302 (396)
T ss_dssp CTTTSCCHHHHHH
T ss_pred ChhhhccHHHHHH
Confidence 9999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=252.21 Aligned_cols=204 Identities=24% Similarity=0.323 Sum_probs=168.9
Q ss_pred hhhhhHHHHHHHHHHHHHHhc--CCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i 75 (226)
+|.+.....+.+.+|.+++.. ++||||+++++++...+ ..++|+||+++++|.+++.+ .++++..++.++.|+
T Consensus 70 vK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i 148 (342)
T 1b6c_B 70 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST 148 (342)
T ss_dssp EEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHH
Confidence 455556667788889999887 68999999999998765 79999999999999999976 479999999999999
Q ss_pred HHHHHHHH--------hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccc
Q 027233 76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 76 ~~~l~~lh--------~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~ 142 (226)
+.||.+|| +.|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+
T Consensus 149 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp HHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred HHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 99999999 8999999999999999 6788999999999977654432 234468899999999876
Q ss_pred c------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCcccc-------------cccC---------CChH
Q 027233 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSGRNNVQL-------------IVPA---------LHPD 184 (226)
Q Consensus 143 ~------~~~~~~Dv~slG~~~~~l~~g----------~~p~~~~~~~~~-------------~~~~---------~~~~ 184 (226)
. .++.++||||||+++++|++| ..||........ .... .+..
T Consensus 226 ~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (342)
T 1b6c_B 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 305 (342)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHH
T ss_pred cccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHH
Confidence 5 234689999999999999999 778865432110 1111 2247
Q ss_pred HHHHHHHhhccCccccCCHhHHhcC
Q 027233 185 CVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+.+++.+||+.||.+|||++|++++
T Consensus 306 l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 306 MAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHH
Confidence 8999999999999999999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=268.60 Aligned_cols=197 Identities=22% Similarity=0.420 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++|+||+++++++.+ +..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|
T Consensus 305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 383 (535)
T 2h8h_A 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383 (535)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678999999999999999999999876 6689999999999999999753 46899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++|++
T Consensus 384 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 384 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred eeCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999 6788999999999976543211 122335678999999988899999999999999999999
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||.+....+. .+..++..+.++|.+||+.||.+|||++++++.
T Consensus 461 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 461 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999987653322 145678999999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=269.35 Aligned_cols=199 Identities=27% Similarity=0.505 Sum_probs=169.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+
T Consensus 431 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 509 (656)
T 2j0j_A 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509 (656)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456688999999999999999999999985 456899999999999999998654 68999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+|++||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++++
T Consensus 510 ~givHrDikp~NILl---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 586 (656)
T 2j0j_A 510 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586 (656)
T ss_dssp TTCCCSCCSGGGEEE---EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCccccccchHhEEE---eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999 5678999999999977644322 12334567899999998889999999999999999999
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+ |..||.+....+. .+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 587 t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 587 MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7 9999987643222 25678899999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=253.18 Aligned_cols=196 Identities=20% Similarity=0.324 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|+.++++++||||+++++++.+.+..++++||++|++|.+++...+ .+++..++.++.|++.||.+||++|+
T Consensus 72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 151 (319)
T 2y4i_B 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151 (319)
T ss_dssp CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567789999999999999999999999999999999999999999998754 68999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC------CccccccCCccccCcccccc---------cCCCcchhHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVDMW 152 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dv~ 152 (226)
+||||+|+||++ + ++.++|+|||++...... .......++..|+|||...+ ..++.++|||
T Consensus 152 ~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~ 227 (319)
T 2y4i_B 152 LHKDLKSKNVFY---D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227 (319)
T ss_dssp CCCCCCSTTEEE---C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred cccCCChhhEEE---e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence 999999999999 3 568999999987654321 12223457788999999864 3468899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|||++++++++|..||........ ....++.++.+++.+||+.||.+|||+.++++
T Consensus 228 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 228 ALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999987643221 13357889999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=254.07 Aligned_cols=212 Identities=25% Similarity=0.335 Sum_probs=161.3
Q ss_pred hhhhhHHHHHHHHHHHHHH--hcCCCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFL--SSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l--~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 74 (226)
+|.+.....+.+..|.+++ ..++|+||+++++.+.. ...+++||||+++++|.+++... ..++..++.++.|
T Consensus 41 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~q 119 (336)
T 3g2f_A 41 VKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHS 119 (336)
T ss_dssp EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHH
T ss_pred EEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHH
Confidence 3444444455555555554 45799999999986543 23678999999999999999765 5588999999999
Q ss_pred HHHHHHHHHhC---------CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---------ccccccCCccccC
Q 027233 75 LGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMA 136 (226)
Q Consensus 75 i~~~l~~lh~~---------~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~~a 136 (226)
++.||.|||++ |++||||||+||++ +.++.++|+|||++....... ......++..|+|
T Consensus 120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 196 (336)
T 3g2f_A 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196 (336)
T ss_dssp HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCC
T ss_pred HHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeC
Confidence 99999999999 99999999999999 678899999999997664321 1223468899999
Q ss_pred cccccc-------cCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------------------------ccC---
Q 027233 137 PEVLQF-------QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------------------VPA--- 180 (226)
Q Consensus 137 PE~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------------------------~~~--- 180 (226)
||.+.+ ..++.++||||||+++++|++|..||......... ...
T Consensus 197 PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (336)
T 3g2f_A 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276 (336)
T ss_dssp HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT
T ss_pred chhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc
Confidence 999876 45667899999999999999997665432221110 111
Q ss_pred -------CChHHHHHHHHhhccCccccCCHhHH------hcCccccccCc
Q 027233 181 -------LHPDCVDMCLKLLSANTVDRLSFNEF------YHHRFLRRNSA 217 (226)
Q Consensus 181 -------~~~~~~~~i~~~l~~~p~~Rpt~~~~------l~~~~~~~~~~ 217 (226)
.++++.++|.+||+.||.+|||+.|+ +-++|-++...
T Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 23479999999999999999999999 45777776543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=254.07 Aligned_cols=198 Identities=18% Similarity=0.209 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhcCCC-CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 10 KSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.+.+.+|+++++.++| +++..+..++...+..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||
T Consensus 46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI 124 (483)
T 3sv0_A 46 HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124 (483)
T ss_dssp SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4568899999999976 56667777778888999999999 9999999985 4589999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
+||||||+||+++..+.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|
T Consensus 125 vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204 (483)
T ss_dssp ECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred eecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence 9999999999995334677899999999987654332 12456889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 160 ELLNGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+|++|..||.+...... ....++.++.+++.+||+.+|.+||+++++++
T Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999987544211 13678999999999999999999999998774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.77 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCe-----EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
.+..+.+.+|++++++++||||+++++++...+. .|+||||++|++|.+++.. .+++..++.++.||+.+|.|
T Consensus 120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~ 197 (681)
T 2pzi_A 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSY 197 (681)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999987654 7999999999999998764 79999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
||++||+||||||+||+++ . +.++|+|||++...... ....+++.|+|||.+.+. ++.++||||||+++++|
T Consensus 198 lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 198 LHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269 (681)
T ss_dssp HHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred HHHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence 9999999999999999993 3 48999999999776543 345689999999998755 48899999999999999
Q ss_pred HhCCCCCCCCCccccc----ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 162 LNGYPPFSGRNNVQLI----VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
++|..||.+....... ....++.+.++|.+||+.||.+||+..+.+.|+|+.-
T Consensus 270 ~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 270 TLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhCCCCCcccccccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 9998887653221111 2224678999999999999999999999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=250.36 Aligned_cols=201 Identities=14% Similarity=0.104 Sum_probs=158.9
Q ss_pred HHHHHHHHHHHHHhcCCC-CCeee---------------------eeeEEEe-----CCeEEEEEeecCCCCHHHHHHh-
Q 027233 8 HLKSCLDCELNFLSSVNH-PNIIR---------------------LFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL- 59 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h-~~i~~---------------------~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~- 59 (226)
...+.+++|+.+++.++| ++... +..++.. ...++++++.+ +++|.++++.
T Consensus 120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l 198 (413)
T 3dzo_A 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 198 (413)
T ss_dssp -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHh
Confidence 346779999999999976 22111 1111111 22467777776 7899999852
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCcc
Q 027233 60 ------HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133 (226)
Q Consensus 60 ------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 133 (226)
...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++...... .....+ ..
T Consensus 199 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~ 272 (413)
T 3dzo_A 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RG 272 (413)
T ss_dssp HHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TT
T ss_pred hcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Cc
Confidence 2246788899999999999999999999999999999999 67888999999998765433 334456 89
Q ss_pred ccCcccc----------cccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------ccCCChHHHHHHHHhhccCc
Q 027233 134 YMAPEVL----------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------VPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 134 ~~aPE~~----------~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p 197 (226)
|+|||.+ .+..++.++||||||+++|+|++|..||......... ...++.++.++|.+||+.||
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPK 352 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSG
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCCh
Confidence 9999998 5556888999999999999999999999876543222 35689999999999999999
Q ss_pred cccCCHhHHhcCcccccc
Q 027233 198 VDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~ 215 (226)
.+|||+.|+++||||+..
T Consensus 353 ~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 353 EDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp GGSCCHHHHTTSHHHHHH
T ss_pred hhCcCHHHHHhCHHHHHH
Confidence 999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=227.67 Aligned_cols=171 Identities=16% Similarity=0.152 Sum_probs=148.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
.+..+.+.+|+..+++++||||+++++++..++..|+||||++|++|.++++.. .....+..++.|++.||.|||++|
T Consensus 72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g 149 (286)
T 3uqc_A 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG 149 (286)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC
Confidence 445688999999999999999999999999999999999999999999998643 456678899999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
++||||||+||++ +.++.++|++++. ++ +++.++|+||||+++|+|++|..
T Consensus 150 ivH~Dikp~NIll---~~~g~~kl~~~~~-------------------~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 150 VALSIDHPSRVRV---SIDGDVVLAYPAT-------------------MP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp CCCCCCSGGGEEE---ETTSCEEECSCCC-------------------CT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred CccCCCCcccEEE---cCCCCEEEEeccc-------------------cC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 9999999999999 5778888874432 22 36789999999999999999999
Q ss_pred CCCCCCcccc-----------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 167 PFSGRNNVQL-----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 167 p~~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
||.+.+.... ....+++++.++|.+||+.||.+| |+.|+++.
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9987654321 135689999999999999999999 99999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=246.47 Aligned_cols=193 Identities=21% Similarity=0.252 Sum_probs=152.7
Q ss_pred HHHHHHHHHHHhcCC---------CCCeeeeeeE-----------------EEe-------------CCeEEEEEeecCC
Q 027233 10 KSCLDCELNFLSSVN---------HPNIIRLFDA-----------------FQA-------------ENCIFLVVEFCAG 50 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~---------h~~i~~~~~~-----------------~~~-------------~~~~~lv~e~~~~ 50 (226)
.+.+.+|+.++++++ ||||+++.+. +.+ .+..++||||+++
T Consensus 67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~ 146 (336)
T 2vuw_A 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence 377888999988886 5555555544 433 6789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeeccCCCCeEeeeCC-----------------CCccEEEee
Q 027233 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIAD 112 (226)
Q Consensus 51 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~dl~~~nili~~~~-----------------~~~~~~l~d 112 (226)
+++.+.+.+ +.+++..++.++.||+.||.||| ++||+||||||+||+++..+ ....++|+|
T Consensus 147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D 225 (336)
T 2vuw_A 147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225 (336)
T ss_dssp CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence 876665543 57899999999999999999999 99999999999999995321 113899999
Q ss_pred eccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHH-HHHHHhCCCCCCCCC------------------c
Q 027233 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI-LFELLNGYPPFSGRN------------------N 173 (226)
Q Consensus 113 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~-~~~l~~g~~p~~~~~------------------~ 173 (226)
||+++..... ...++..|+|||.+.+.. +.++||||+|.+ .++++.|..||.... .
T Consensus 226 FG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 226 YTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300 (336)
T ss_dssp CTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCC
T ss_pred ccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCccc
Confidence 9999876532 346899999999998766 889999998777 667788998885421 0
Q ss_pred ccccccCCChHHHHHHHHhhccCccccCCHhHHh-cCcccc
Q 027233 174 VQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY-HHRFLR 213 (226)
Q Consensus 174 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l-~~~~~~ 213 (226)
.......++++++++|++||+.| |++|+| +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 01113346789999999999976 999999 999995
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=243.69 Aligned_cols=198 Identities=17% Similarity=0.141 Sum_probs=139.7
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.+..++++.+|+++|+++ .|+||+++++++++++..||||||++|++|.+.+...+++++. +++.||+.||.|+|+
T Consensus 281 ~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~ 357 (569)
T 4azs_A 281 SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK 357 (569)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH
Confidence 455677899999999999 7999999999999999999999999999999999988888865 478999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
+||+||||||+|||+ +.++.+||+|||+++..... ......+|++.|+|||.+.+. +..++|+||+|++++.+.+
T Consensus 358 ~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 358 QGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp TTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred CCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcc
Confidence 999999999999999 78889999999999766543 334456789999999998754 5678999999998877655
Q ss_pred CCCCCCCCCcccccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 164 GYPPFSGRNNVQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 164 g~~p~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
+..++..... . .......+..+...+...+|..|+.......++|..
T Consensus 434 ~~~~~~~~l~-~--~~~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 434 PWSNWLYAVW-Q--EPVERWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp THHHHHHHHH-T--SCGGGCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred ccchhHHHhh-c--CCCCCCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 4333211000 0 000111245566666667777776666666665554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-25 Score=184.84 Aligned_cols=147 Identities=19% Similarity=0.200 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.++++.+|++++++++||||+++..+....+..++||||++|++|.+++.. +..++.|++.+|.|||++||+
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIi 453 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVI 453 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCc
Confidence 466789999999999999999776666677778999999999999999875 568999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccc--cCCCcchhHHHHHHHH
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~~ 158 (226)
||||||+||++ +. .++|+|||+++....... .....+++.|+|||.+.. ..|+...|.|+...-.
T Consensus 454 HrDiKp~NILl---~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~ 528 (540)
T 3en9_A 454 HNDLTTSNFIF---DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILEL 528 (540)
T ss_dssp CTTCCTTSEEE---SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHH
T ss_pred cCCCCHHHEEE---CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHH
Confidence 99999999999 44 999999999988754322 124568999999999876 5677788999988877
Q ss_pred HHHHhCCCCC
Q 027233 159 FELLNGYPPF 168 (226)
Q Consensus 159 ~~l~~g~~p~ 168 (226)
.+-+.+..+|
T Consensus 529 l~~v~~r~rY 538 (540)
T 3en9_A 529 MKDVERRARY 538 (540)
T ss_dssp HHHHHTCSCC
T ss_pred HHHHHhcccc
Confidence 7777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-18 Score=134.65 Aligned_cols=96 Identities=17% Similarity=0.228 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.+..+.+|+.++++++ | +++.+++.. +..++||||++|++|.+ +. ......++.|++.|+.+||++|++
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~gii 215 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIV 215 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCE
Confidence 5678999999999999 5 666665544 45699999999999997 32 123557999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
||||+|+||++ + ++.++|+|||++...
T Consensus 216 HrDlkp~NILl---~-~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 216 HGDLSQYNVLV---S-EEGIWIIDFPQSVEV 242 (282)
T ss_dssp CSCCSTTSEEE---E-TTEEEECCCTTCEET
T ss_pred eCCCCHHHEEE---E-CCcEEEEECCCCeEC
Confidence 99999999999 5 788999999998643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=3e-15 Score=114.34 Aligned_cols=98 Identities=19% Similarity=0.233 Sum_probs=77.2
Q ss_pred HHHHHHHHHHHhcCCCCCe--eeeeeEEEeCCeEEEEEeecCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSVNHPNI--IRLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
...+.+|+.+++.+.|+++ +..++. +..++||||+.+ + +|.++... .++..+..++.|++.++.+|
T Consensus 114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 114 FIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHH
Confidence 3578999999999988765 333332 346799999942 2 78776442 23456788999999999999
Q ss_pred H-hCCceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 83 N-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 83 h-~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
| +.|++||||+|.||++ +. .++|+|||++...
T Consensus 187 H~~~givHrDlkp~NILl---~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAELVHADLSEYNIMY---ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSCEECSSCSTTSEEE---SS--SEEECCCTTCEET
T ss_pred HHHCCEEeCCCCHHHEEE---cC--cEEEEECcccccC
Confidence 9 9999999999999999 44 8999999999665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.27 E-value=5e-12 Score=101.01 Aligned_cols=102 Identities=17% Similarity=0.121 Sum_probs=72.5
Q ss_pred HHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecc
Q 027233 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (226)
Q Consensus 13 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (226)
...|...|.++.+.++.....+.... .++||||++|.+|..+.. ......++.|++.++.+||+.|++||||
T Consensus 160 A~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 160 AIKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 45688888888655554333332222 369999999988865321 2235678899999999999999999999
Q ss_pred CCCCeEeeeCCC-------CccEEEeeeccccccCCC
Q 027233 93 KPENILLSGLDD-------DVMLKIADFGLSCTLYPG 122 (226)
Q Consensus 93 ~~~nili~~~~~-------~~~~~l~df~~~~~~~~~ 122 (226)
||.||++..... ...+.|+||+.+....++
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence 999999953111 114899999988665443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.6e-11 Score=91.71 Aligned_cols=100 Identities=17% Similarity=0.197 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---
Q 027233 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS--- 84 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--- 84 (226)
....+.+|+.+++.+ .+..+++++++....+..|+|||+++|.+|.+.+. +......++.++..++..||+
T Consensus 52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~ 126 (263)
T 3tm0_A 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCc
Confidence 345789999999999 46778899999999999999999999999987521 122344678899999999998
Q ss_pred --------------------------------------------------------CCceeeccCCCCeEeeeCCCCccE
Q 027233 85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML 108 (226)
Q Consensus 85 --------------------------------------------------------~~i~H~dl~~~nili~~~~~~~~~ 108 (226)
..++|||+++.||+++ .+..+
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~ 203 (263)
T 3tm0_A 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVS 203 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEE
T ss_pred ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEE
Confidence 4489999999999993 44556
Q ss_pred EEeeeccc
Q 027233 109 KIADFGLS 116 (226)
Q Consensus 109 ~l~df~~~ 116 (226)
.|+||+.+
T Consensus 204 ~lIDwe~a 211 (263)
T 3tm0_A 204 GFIDLGRS 211 (263)
T ss_dssp EECCCTTC
T ss_pred EEEEchhc
Confidence 79999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=4.1e-10 Score=85.50 Aligned_cols=97 Identities=15% Similarity=0.172 Sum_probs=72.3
Q ss_pred HHHHHHHHHHHhcCCCCC--eeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 027233 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH- 86 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~- 86 (226)
...+.+|+.+++.+.+.+ +++++++....+..++|||+++|.+|. .. ..+ ...++.++...+..||+..
T Consensus 57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~ 128 (264)
T 1nd4_A 57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDP 128 (264)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCG
T ss_pred chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCC
Confidence 356789999999995434 567888888888899999999998884 11 122 2245667777777777643
Q ss_pred ---------------------------------------------------------ceeeccCCCCeEeeeCCCCccEE
Q 027233 87 ---------------------------------------------------------IIHRDLKPENILLSGLDDDVMLK 109 (226)
Q Consensus 87 ---------------------------------------------------------i~H~dl~~~nili~~~~~~~~~~ 109 (226)
++|||++|.||++ +.+..+.
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~ 205 (264)
T 1nd4_A 129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSG 205 (264)
T ss_dssp GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEE
T ss_pred CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEE
Confidence 9999999999999 3455567
Q ss_pred Eeeecccc
Q 027233 110 IADFGLSC 117 (226)
Q Consensus 110 l~df~~~~ 117 (226)
|+||+.+.
T Consensus 206 liD~~~a~ 213 (264)
T 1nd4_A 206 FIDCGRLG 213 (264)
T ss_dssp ECCCTTCE
T ss_pred EEcchhcc
Confidence 99999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=3.5e-09 Score=84.40 Aligned_cols=104 Identities=14% Similarity=0.324 Sum_probs=81.0
Q ss_pred HHHHHHHHHHHhcCC--CCCeeeeeeEEEeC---CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 10 KSCLDCELNFLSSVN--HPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
...+.+|+.+++.+. +..+++++.++.+. +..|+|||+++|.++.+. ....++......++.++...|..||+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 457889999999996 44578888887765 558999999999887541 12346778888899999999999997
Q ss_pred ----------------------------------------------------------CCceeeccCCCCeEeeeCCCC-
Q 027233 85 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDD- 105 (226)
Q Consensus 85 ----------------------------------------------------------~~i~H~dl~~~nili~~~~~~- 105 (226)
.+++|||+++.||+++ .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~ 234 (359)
T 3dxp_A 158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTE 234 (359)
T ss_dssp SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSS
T ss_pred CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCC
Confidence 3589999999999994 33
Q ss_pred -ccEEEeeeccccc
Q 027233 106 -VMLKIADFGLSCT 118 (226)
Q Consensus 106 -~~~~l~df~~~~~ 118 (226)
..+.++||+.+..
T Consensus 235 ~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 235 PRVLAVLDWELSTL 248 (359)
T ss_dssp SCEEEECCCTTCEE
T ss_pred CcEEEEECcccccc
Confidence 2368999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=8.5e-09 Score=80.25 Aligned_cols=156 Identities=22% Similarity=0.274 Sum_probs=97.1
Q ss_pred HHHHHHHHHHHHhcC-CCCC--eeeeeeEEEeCC---eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
....+.+|+.+++.+ .+.. +++++......+ ..|+||++++|.+|.+... ..++......++.++...++.|
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L 130 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL 130 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence 467899999999888 4333 344444433332 4578999999998875332 2566667777788888877777
Q ss_pred Hh----------------------------------------------------------CCceeeccCCCCeEeeeCCC
Q 027233 83 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD 104 (226)
Q Consensus 83 h~----------------------------------------------------------~~i~H~dl~~~nili~~~~~ 104 (226)
|+ ..++|||+++.||+++ .+
T Consensus 131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~--~~ 208 (304)
T 3sg8_A 131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFD--TE 208 (304)
T ss_dssp HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEE--TT
T ss_pred HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEe--CC
Confidence 75 1369999999999994 22
Q ss_pred -CccEEEeeeccccccCCCCccccccCCccccCcccccc-----cC---------CCcchhHHHHHHHHHHHHhCCCCC
Q 027233 105 -DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-----QR---------YDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 105 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~---------~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
...+.++||+.+.................-.+++.... .. .....+.|+++.+++.+.+|..+|
T Consensus 209 ~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 209 KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 45678999998755322100000000000012221110 00 011368999999999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=3.8e-07 Score=69.56 Aligned_cols=110 Identities=15% Similarity=0.183 Sum_probs=78.7
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 80 (226)
||.........+.+|...|+.+. +--+++++++..+.+..++||++++|.++.+..... ......+..++...+.
T Consensus 55 lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~ 130 (272)
T 4gkh_A 55 LKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLR 130 (272)
T ss_dssp EEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHH
T ss_pred EEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHH
Confidence 44444556678899999999883 334778888999999999999999998888765432 1222344555555555
Q ss_pred HHHh----------------------------------------------------------CCceeeccCCCCeEeeeC
Q 027233 81 ILNS----------------------------------------------------------HHIIHRDLKPENILLSGL 102 (226)
Q Consensus 81 ~lh~----------------------------------------------------------~~i~H~dl~~~nili~~~ 102 (226)
.||+ ..++|||+++.||++
T Consensus 131 ~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~--- 207 (272)
T 4gkh_A 131 RLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF--- 207 (272)
T ss_dssp HHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---
T ss_pred HhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE---
Confidence 5553 027899999999999
Q ss_pred CCCccEEEeeeccccc
Q 027233 103 DDDVMLKIADFGLSCT 118 (226)
Q Consensus 103 ~~~~~~~l~df~~~~~ 118 (226)
+.++.+-|+||+.+..
T Consensus 208 ~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 208 DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp ETTEEEEECCCTTCEE
T ss_pred ECCeEEEEEECccccc
Confidence 4555667999997743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.48 E-value=3.2e-06 Score=61.67 Aligned_cols=135 Identities=17% Similarity=0.113 Sum_probs=89.8
Q ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh-CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccc
Q 027233 51 GNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128 (226)
Q Consensus 51 ~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~ 128 (226)
.||.+.++..+ +++++++|.++.|.+.+|..+-. +.-...=+.|..|++ ..+|.+.+.+ ..+ .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s-----------~ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AAD-----------D 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-ccc-----------c
Confidence 48999998764 89999999999999999888732 221222335677777 4566665542 110 0
Q ss_pred cCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccCCChHHHHHHHHhhcc-------------
Q 027233 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVPALHPDCVDMCLKLLSA------------- 195 (226)
Q Consensus 129 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~i~~~l~~------------- 195 (226)
.....+.|||... ...+.+.=|||||+++|..+.-..|- .....+|+.+.++|..|.+-
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-------~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~ 169 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-------NEERELSPPLEQLIDHMANTVEADGSNDEGYEA 169 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-------TEEECCCHHHHHHHHHHTTCCC-----------
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-------ccchhhCHHHHHHHHHHHhcccccccccccccc
Confidence 1233466887753 34467889999999999998744432 23677899999999999866
Q ss_pred ------------CccccCCHhHHhc
Q 027233 196 ------------NTVDRLSFNEFYH 208 (226)
Q Consensus 196 ------------~p~~Rpt~~~~l~ 208 (226)
.+..|.+++++++
T Consensus 170 ~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 170 AEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ---------CCSCCCCCCSHHHHHH
T ss_pred cccccccccccccccCcCCHHHHHH
Confidence 2467888888875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=7.1e-06 Score=63.81 Aligned_cols=109 Identities=20% Similarity=0.212 Sum_probs=70.7
Q ss_pred HHHHHHHHHHHHHhcCCCC---CeeeeeeEEE-eCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
.....+.+|+.+++.+.+. .+++.+.+.. ..+..+++|++++|.++.+..- ..++......++.++...+..||
T Consensus 51 ~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 51 QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999542 3566666664 4567889999999988876311 12333333444444444444444
Q ss_pred h------------------------------------------------------------CCceeeccCCCCeEeeeCC
Q 027233 84 S------------------------------------------------------------HHIIHRDLKPENILLSGLD 103 (226)
Q Consensus 84 ~------------------------------------------------------------~~i~H~dl~~~nili~~~~ 103 (226)
+ ..++|||+++.||+++...
T Consensus 129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 208 (306)
T 3tdw_A 129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS 208 (306)
T ss_dssp HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence 2 1468999999999994211
Q ss_pred CCcc-EEEeeeccccc
Q 027233 104 DDVM-LKIADFGLSCT 118 (226)
Q Consensus 104 ~~~~-~~l~df~~~~~ 118 (226)
.++. +.|+||+.+..
T Consensus 209 ~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 209 RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SSCCEEEECCCTTCEE
T ss_pred CCCceEEEEehhhcCC
Confidence 1344 58999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=3.8e-05 Score=60.83 Aligned_cols=44 Identities=14% Similarity=0.139 Sum_probs=32.4
Q ss_pred HHHHHHHHHHhcCC-C--CCeeeeeeEEEeC---CeEEEEEeecCCCCHH
Q 027233 11 SCLDCELNFLSSVN-H--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLS 54 (226)
Q Consensus 11 ~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 54 (226)
..+.+|+.+++.+. + -.+++++.+..+. +..++|||+++|.++.
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 56788999998883 3 3467788776654 4578999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00042 Score=54.23 Aligned_cols=30 Identities=20% Similarity=0.354 Sum_probs=25.8
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
.+++|||+++.||++ +.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLL---GENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEE---CGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEE---eCCCcEEEEehhhcc
Confidence 579999999999999 456779999999763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00071 Score=52.96 Aligned_cols=35 Identities=20% Similarity=0.224 Sum_probs=26.0
Q ss_pred CCceeeccCCCCeEeeeCCC-CccEEEeeecccccc
Q 027233 85 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTL 119 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~-~~~~~l~df~~~~~~ 119 (226)
..++|||+++.||+++.... .+.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 46999999999999942100 267899999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0035 Score=48.23 Aligned_cols=29 Identities=28% Similarity=0.160 Sum_probs=23.6
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.++|||+.+.||+. .++.+.++||+.+..
T Consensus 174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD----TGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE----CSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE----CCCCEEEEecccccC
Confidence 38999999999995 345679999997754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0075 Score=48.31 Aligned_cols=31 Identities=26% Similarity=0.355 Sum_probs=24.6
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
...++|||+.+.||+++ . +.+.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~---~-~~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFAS---E-HETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEEC---S-SCEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEe---C-CCeEEEeCccccc
Confidence 35699999999999993 3 3489999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.38 E-value=0.01 Score=47.35 Aligned_cols=105 Identities=19% Similarity=0.229 Sum_probs=60.2
Q ss_pred HHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHH-----------H---HHh----c----CCCC--
Q 027233 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-----------Y---IRL----H----GRVP-- 64 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-----------~---~~~----~----~~~~-- 64 (226)
...+.+|.++++.|. +.-.+++++.+.+ . +|+||++|.+|.. . +.+ . +...
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 345668999998884 3333566655543 2 8999998855431 1 110 0 0111
Q ss_pred HHHHHHHHHHHHH-------------------HHHHH----Hh----CCceeeccCCCCeEeeeC-CCCccEEEeeeccc
Q 027233 65 EQTARKFLQQLGA-------------------GLEIL----NS----HHIIHRDLKPENILLSGL-DDDVMLKIADFGLS 116 (226)
Q Consensus 65 ~~~~~~~~~~i~~-------------------~l~~l----h~----~~i~H~dl~~~nili~~~-~~~~~~~l~df~~~ 116 (226)
...+.++..++.. .+..| .. ..++|+|+.+.||++... +..+.+.++||..+
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 2445555544322 12222 22 248999999999999531 11367899999987
Q ss_pred cc
Q 027233 117 CT 118 (226)
Q Consensus 117 ~~ 118 (226)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 53
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.023 Score=45.94 Aligned_cols=33 Identities=21% Similarity=0.356 Sum_probs=26.5
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeecccccc
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~ 119 (226)
+...++|||+++.||++ +.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~---~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMV---TQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEE---CSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEE---eCCC-CEEEeCcccccC
Confidence 45679999999999999 3443 999999887543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=94.41 E-value=0.05 Score=42.17 Aligned_cols=71 Identities=13% Similarity=0.155 Sum_probs=53.6
Q ss_pred hhhhhHHHHHHHHHHHHHHhcCC---CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~ 78 (226)
||.........+..|+..|+.|. ...+++++.+....+..++|||+++|.++.. ....++...
T Consensus 64 lK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~--------------~~~~~lG~~ 129 (312)
T 3jr1_A 64 VKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ--------------SSFTIFAEK 129 (312)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT--------------THHHHHHHH
T ss_pred EEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc--------------hhHHHHHHH
Confidence 34444445678899999999883 3568888888888889999999999876421 235678888
Q ss_pred HHHHHhCC
Q 027233 79 LEILNSHH 86 (226)
Q Consensus 79 l~~lh~~~ 86 (226)
|+.||..+
T Consensus 130 LA~LH~~~ 137 (312)
T 3jr1_A 130 IAQLHQIQ 137 (312)
T ss_dssp HHHHHHCC
T ss_pred HHHHHcCC
Confidence 99999864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.23 E-value=0.054 Score=41.79 Aligned_cols=31 Identities=29% Similarity=0.584 Sum_probs=24.4
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.+++|||+++.||++. .+..+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 3699999999999993 444557999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.95 E-value=0.13 Score=39.79 Aligned_cols=29 Identities=24% Similarity=0.190 Sum_probs=23.9
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
..++|||+++.||++ + + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~---~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILW---R-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEE---S-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeE---c-C-CCEEEECCCCCc
Confidence 458899999999999 4 3 789999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.08 E-value=0.13 Score=40.16 Aligned_cols=31 Identities=19% Similarity=0.356 Sum_probs=25.8
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
..++|||+.+.||++ +.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLV---GNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEE---CGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEE---eCCCeEEEEECCCCee
Confidence 359999999999999 5556799999987644
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.71 E-value=0.38 Score=37.89 Aligned_cols=28 Identities=32% Similarity=0.498 Sum_probs=22.8
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeecccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~ 117 (226)
+++|+|+.+.||++ +. +.+.++||+.+.
T Consensus 213 ~l~HgDl~~~Nil~---~~-~~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIIN---TN-KCLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEE---CC--CEEECCCTTCE
T ss_pred EEEeCCCCcccEEe---cC-CcEEEEEecCCC
Confidence 58999999999998 33 348999998774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.13 E-value=0.36 Score=39.47 Aligned_cols=36 Identities=25% Similarity=0.331 Sum_probs=24.3
Q ss_pred HHHHHHHhcCCCCCe-eeeeeEEEeCCeEEEEEeecCCCCH
Q 027233 14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL 53 (226)
Q Consensus 14 ~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 53 (226)
.+|..+++.|...++ +++++.+. +. .|++|++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence 578999998864444 56666652 22 49999987443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.93 E-value=3.5 Score=29.90 Aligned_cols=115 Identities=12% Similarity=0.138 Sum_probs=73.6
Q ss_pred CCCCeeeeeeEEEeCCeEEEEEeecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeC
Q 027233 24 NHPNIIRLFDAFQAENCIFLVVEFCA-GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL 102 (226)
Q Consensus 24 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~ 102 (226)
.+|+.++. ..-.+.+.+.+.++.-+ +.++.. -...+....++++.+|+....++ ..-+|--++|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f--- 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF--- 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE---
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE---
Confidence 58888877 46666666666555432 223332 23677888999999998876333 345688999999999
Q ss_pred CCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 027233 103 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (226)
Q Consensus 103 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 169 (226)
+.++.+++.-.|.-..+ +|. ..+...=.-+.=+++..++++...|.
T Consensus 113 ~~~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 78888888765543222 111 11223334456677778888877664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=84.70 E-value=0.25 Score=40.07 Aligned_cols=39 Identities=18% Similarity=0.253 Sum_probs=24.9
Q ss_pred HHHHHHHHHHhcCCCCCe-eeeeeEEEeCCeEEEEEeecCCCCH
Q 027233 11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL 53 (226)
Q Consensus 11 ~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 53 (226)
+.+.+|..+++.+...++ +++++.+. + .+|++|++|.+|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence 455579999988843333 56665543 2 278999986443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.85 E-value=5.5 Score=28.96 Aligned_cols=83 Identities=14% Similarity=0.113 Sum_probs=56.4
Q ss_pred CCCCeeeeeeEEEeCCeEEEEEeecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeC
Q 027233 24 NHPNIIRLFDAFQAENCIFLVVEFCA-GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL 102 (226)
Q Consensus 24 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~ 102 (226)
.||++ -...-.+++.+.+.++.-+ +.++.. + ...+....++++.+|+..... |...-.|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f--- 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMF--- 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEE---
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEE---
Confidence 57777 3344466777777666542 334443 3 367788888888888876441 22456788999999999
Q ss_pred CCCccEEEeeeccc
Q 027233 103 DDDVMLKIADFGLS 116 (226)
Q Consensus 103 ~~~~~~~l~df~~~ 116 (226)
+.++.+++.-.|.-
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 78888998766643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.87 E-value=0.58 Score=37.43 Aligned_cols=32 Identities=31% Similarity=0.378 Sum_probs=25.5
Q ss_pred ceeeccCCCCeEeee---CCCCccEEEeeeccccc
Q 027233 87 IIHRDLKPENILLSG---LDDDVMLKIADFGLSCT 118 (226)
Q Consensus 87 i~H~dl~~~nili~~---~~~~~~~~l~df~~~~~ 118 (226)
++|+|+.+.||++.. .+.+..+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999953 13456799999998854
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 226 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-61 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-55 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-62
Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 20/232 (8%)
Query: 2 LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK L K ++ L E+ S + HPNI+RL+ F ++L++E+ G +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ + EQ ++ +L L +S +IHRD+KPEN+L L LKIADFG
Sbjct: 96 ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGW 152
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
S P + +CG+ Y+ PE+++ + +DEKVD+WS+G + +E L G PPF +
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 176 LIV----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217
+ D+ +LL N R E H ++ NS+
Sbjct: 212 TYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 3e-61
Identities = 71/235 (30%), Positives = 119/235 (50%), Gaps = 18/235 (7%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K + ++ E+ L + HPNI+ L D +++ ++L+++ +GG L I
Sbjct: 39 IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
G E+ A + + Q+ ++ L+ I+HRDLKPEN+L LD+D + I+DFGLS
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
PG+ CG+P Y+APEVL + Y + VD WS+G I + LL GYPPF N+ +L
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 178 --------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 218
+ D L+ + R + + H ++ ++A+
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (487), Expect = 1e-60
Identities = 66/237 (27%), Positives = 117/237 (49%), Gaps = 16/237 (6%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
+ ++ K + E+ +S + HP ++ L DAF+ +N + ++ EF +GG L +
Sbjct: 58 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
H ++ E A ++++Q+ GL ++ ++ +H DLKPENI+ + LK+ DFGL+ L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-- 177
P + G+ + APEV + + DMWSVG + + LL+G PF G N+ + +
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
Query: 178 ------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
+ D D KLL A+ R++ ++ H +L +A R
Sbjct: 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (479), Expect = 2e-59
Identities = 61/239 (25%), Positives = 117/239 (48%), Gaps = 19/239 (7%)
Query: 2 LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
K +N K + E++ ++ ++HP +I L DAF+ + + L++EF +GG L I
Sbjct: 59 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118
Query: 59 LHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
++ E +++Q GL+ ++ H I+H D+KPENI+ +KI DFGL+
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
L P + + + APE++ + DMW++G + + LL+G PF+G ++++ +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
Query: 178 --------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 222
++ P+ D LL RL+ ++ H +L+ + + L +
Sbjct: 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-59
Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 23/230 (10%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
+KL K + E L + HPNI+R +D++++ + CI LV E G L +Y++
Sbjct: 45 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ + R + +Q+ GL+ L++ IIHRDLK +NI ++ +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
TL ++A+ V G+P +MAPE+ + ++YDE VD+++ G + E+ P+S N
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
Query: 177 IV-------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
I P+ ++ + N +R S + +H F +
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-58
Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 26/238 (10%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
K ++ + L+ E++ L+S +HPNI++L DAF EN +++++EFCAGG + + +
Sbjct: 42 AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
L + E + +Q L L+ + IIHRDLK NIL D +K+ADFG+S
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---FTLDGDIKLADFGVSA 158
Query: 118 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
+ G+P +MAPEV+ + YD K D+WS+G L E+ PP
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
Query: 172 NNVQLIV-------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216
N +++++ + D K L N R + ++ H F+ +S
Sbjct: 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-57
Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 2 LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + E + +S ++HP ++L+ FQ + ++ + + G L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
YIR G E R + ++ + LE L+ IIHRDLKPENIL L++D+ ++I DFG
Sbjct: 98 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154
Query: 116 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ L P + A G+ Y++PE+L + + D+W++G I+++L+ G PPF N
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214
Query: 173 NVQLIV----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
+ P D+ KLL + RL E + L+
Sbjct: 215 EYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (460), Expect = 4e-57
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 27/235 (11%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+KK++ K + E+ FL + HPN I+ + E+ +LV+E+C G
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ E GL L+SH++IHRD+K NIL L + ++K+ DFG
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ + P N G+P +MAPEV+ +YD KVD+WS+G EL PP N
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 173 NVQLIV------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + + L DR + HRF+ R
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-56
Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 18/231 (7%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
K + + E++ L+ H NI+ L ++F++ + ++ EF +G ++ I
Sbjct: 35 AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94
Query: 60 HG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ E+ ++ Q+ L+ L+SH+I H D++PENI+ +KI +FG +
Sbjct: 95 SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI- 177
L PG+ + +P Y APEV Q DMWS+G +++ LL+G PF N Q+I
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
Query: 178 -------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + +D +LL R++ +E H +L++
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-56
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + K + E+ + +PNI+ D++ + +++V+E+ AGG+L+ +
Sbjct: 52 QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
+ E ++ LE L+S+ +IHRD+K +NILL D +K+ DFG +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV- 178
+ + G+P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ +
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 179 ------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
L D + L + R S E H+FL+
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-55
Identities = 64/232 (27%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ K + E+ +NH N+++ + + N +L +E+C+GG L I
Sbjct: 38 VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE A++F QL AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154
Query: 121 PGNYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
N K+CG+ Y+APE+L+ + + E VD+WS G +L +L G P+ ++
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 177 IV-------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+ + + K+L N R++ + R+ +
Sbjct: 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-55
Identities = 70/249 (28%), Positives = 122/249 (48%), Gaps = 25/249 (10%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
LK L K+ + EL + P+I+R+ D ++ C+ +V+E GG L S I
Sbjct: 42 LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100
Query: 58 RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ G E+ A + ++ +G ++ L+S +I HRD+KPEN+L + + +LK+ DFG
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ N C +P Y+APEVL ++YD+ DMWS+G I++ LL GYPPF + +
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
Query: 176 LI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217
+ + + + LL R++ EF +H ++ +++
Sbjct: 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
Query: 218 ILRAPFHIP 226
+ + P H
Sbjct: 281 VPQTPLHTS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-55
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 26/234 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
+ + K L E+N L + HPNI+R +D + +++V+E+C GG+L+S I
Sbjct: 39 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98
Query: 58 --RLHGRVPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + E+ + + QL L+ H ++HRDLKP N+ L D +K+
Sbjct: 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 155
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ L +A+ G+P YM+PE + Y+EK D+WS+G +L+EL PPF+
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 170 GRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
+ +L I + ++ ++L+ R S E + +
Sbjct: 216 AFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-54
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 28/238 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
+ E+ L H NI+ + + +V ++C G +L ++ +
Sbjct: 40 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ +Q G++ L++ IIHRDLK NI L +D+ +KI DFGL+
Sbjct: 99 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKS 155
Query: 121 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ + + + GS L+MAPEV++ Q Y + D+++ G +L+EL+ G P+S NN
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 175 QLIV----------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHH-RFLRRN 215
I+ + + L +R F + L R+
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 172 bits (438), Expect = 3e-54
Identities = 75/233 (32%), Positives = 115/233 (49%), Gaps = 24/233 (10%)
Query: 3 KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ + L+ E++ L V+ HPNII+L D ++ FLV + G L Y+
Sbjct: 46 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ RK ++ L + L+ +I+HRDLKPENIL LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
G +VCG+P Y+APE+++ Y ++VDMWS G I++ LL G PPF R +
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
Query: 176 LI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
++ D+ + L R + E H F ++
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-54
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 5/227 (2%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ ++ +++ + EL L N P I+ + AF ++ I + +E GG+L ++
Sbjct: 39 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98
Query: 61 GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
GR+PEQ K + GL L H I+HRD+KP NIL ++ +K+ DFG+S L
Sbjct: 99 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIVP 179
+ A G+ YM+PE LQ Y + D+WS+G L E+ G P + +L +
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 180 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 226
D T R + R +L + P
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-50
Identities = 61/213 (28%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + HPN+I L + ++ + + L++E AGG L ++ + E+ A +FL+Q+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L + +KI DFGL+ + GN + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI--------------VPA 180
+APE++ ++ + DMWS+G I + LL+G PF G + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213
D +LL + R++ + H +++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-50
Identities = 70/231 (30%), Positives = 110/231 (47%), Gaps = 22/231 (9%)
Query: 2 LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
+K L K + D + + HP + +F FQ + +F V+E+ GG+L
Sbjct: 32 IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91
Query: 55 SYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+I+ + A + ++ GL+ L+S I++RDLK +NIL LD D +KIADFG
Sbjct: 92 YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFG 148
Query: 115 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ G+ CG+P Y+APE+L Q+Y+ VD WS G +L+E+L G PF G++
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208
Query: 174 VQLIV----------PALHPDCVDMCLKLLSANTVDRLSF-NEFYHHRFLR 213
+L L + D+ +KL RL + H R
Sbjct: 209 EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-48
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 16 ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
E+ L V+ +IRL D F+ + L++E +L +I G + E+ AR F
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
Q+ + ++ ++HRD+K ENIL+ + LK+ DFG L G+
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173
Query: 133 LYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSGRNNVQ----LIVPALHPDCVD 187
+Y PE +++ RY +WS+G +L++++ G PF + + +C
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 233
Query: 188 MCLKLLSANTVDRLSFNEFYHHRFLR 213
+ L+ DR +F E +H +++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 4e-48
Identities = 75/233 (32%), Positives = 119/233 (51%), Gaps = 26/233 (11%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + L E LS V HP IIR++ FQ IF+++++ GG L S
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+R R P A+ + ++ LE L+S II+RDLKPENIL LD + +KI DFG
Sbjct: 94 LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGF 150
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ + Y +CG+P Y+APEV+ + Y++ +D WS G +++E+L GY PF N ++
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
Query: 176 LIV----------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
P + D D+ +L++ + RL + +H + +
Sbjct: 209 TYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 8e-48
Identities = 47/224 (20%), Positives = 93/224 (41%), Gaps = 21/224 (9%)
Query: 2 LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
+K + E + ++ + H N+++L + + +++V E+ A G+L Y+R
Sbjct: 35 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94
Query: 60 HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
GR + KF + +E L ++ +HRDL N+L+ +D + K++DFGL+
Sbjct: 95 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQL 176
+ + APE L+ +++ K D+WS G +L+E+ G P+ +
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 177 -----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
P ++ + R SF +
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 1e-46
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
+K L L E +++NHP I+ ++D +AE ++V+E+ G
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 110
L + G + + A + + L + + IIHRD+KP NI++S + VM
Sbjct: 97 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
++ + V G+ Y++PE + D + D++S+G +L+E+L G PPF+G
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
Query: 171 RNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLS 202
+ V + L D + LK L+ N +R
Sbjct: 217 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-46
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ + LK L E N + +++P I+R+ +AE+ LV+E G L+ Y++ +
Sbjct: 45 EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
V ++ + + Q+ G++ L + +HRDL N+L L KI+DFGLS L
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRAD 160
Query: 123 NYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL- 176
K + APE + + ++ K D+WS G +++E + G P+ G ++
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220
Query: 177 ----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
+ D+ + + +R F
Sbjct: 221 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-45
Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 20/225 (8%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
+K + + S D E + ++HP +++L+ + I LV EF G LS Y
Sbjct: 34 IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
G +T + G+ L +IHRDL N L+ ++ ++K++DFG++
Sbjct: 94 QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRF 150
Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
+ Y + +PEV F RY K D+WS G +++E+ + G P+ R+N +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 176 LIV-----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
++ + DR +F+
Sbjct: 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-45
Identities = 46/225 (20%), Positives = 92/225 (40%), Gaps = 20/225 (8%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K + + S + E + +++H +++L+ + IF++ E+ A G L +Y+R
Sbjct: 33 IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92
Query: 60 -HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
R Q + + + +E L S +HRDL N L ++D ++K++DFGLS
Sbjct: 93 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149
Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQ 175
+ Y + PEVL + ++ K D+W+ G +++E+ G P+ N +
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 176 LIV-----------PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
+ +R +F +
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 3e-45
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E R + ++
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172
Query: 136 APEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL-------------IVPAL 181
APEVLQ YD D +S+G +LF+LL G+ PF + +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 182 HPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLR 213
P+ + LL + RL E F R
Sbjct: 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-44
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 21/222 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + K + E + +++P I+RL QAE + LV+E GG L ++
Sbjct: 44 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+P + L Q+ G++ L + +HRDL N+L L + KI+DFGLS L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKAL 159
Query: 120 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ + APE + F+++ + D+WS G ++E L+ G P+
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219
Query: 175 QL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
++ P P+ + DR F
Sbjct: 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-44
Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + D E L + HP + L AFQ + + V+E+ GG L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ E+ AR + ++ + LE L+S +++RD+K EN++ LD D +KI DFGL
Sbjct: 95 HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL 151
Query: 116 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +++
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 175 QL----------IVPALHPDCVDMCLKLLSANTVDRLSFN-----EFYHHRFLR 213
+L L P+ + LL + RL E HRF
Sbjct: 212 RLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-44
Identities = 51/241 (21%), Positives = 100/241 (41%), Gaps = 23/241 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + + E + + +HPN+I L + ++ EF G+L S++R +
Sbjct: 62 LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
G+ L+ + AG++ L + +HRDL NIL ++ +++ K++DFGLS L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178
Query: 120 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRN 172
+ APE +Q++++ D+WS G +++E+++ G P+
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 173 NVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHH-RFLRRNSAILR 220
N +I + L + R F + + + RN L+
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
Query: 221 A 221
A
Sbjct: 299 A 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-44
Identities = 49/222 (22%), Positives = 92/222 (41%), Gaps = 22/222 (9%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L + S E N + + H ++RL+ + I+++ E+ G+L +++
Sbjct: 42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100
Query: 60 HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ Q+ G+ + + IHRDL+ NIL + D + KIADFGL+
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLAR 157
Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNV 174
+ Y + + APE + + + K D+WS G +L E++ +G P+ G N
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 175 QLIV-----------PALHPDCVDMCLKLLSANTVDRLSFNE 205
++I + + DR +F+
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDY 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-43
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 28/228 (12%)
Query: 2 LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L + S E+N + S++H N+IRL+ + +V E G+L
Sbjct: 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99
Query: 56 YIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+R H G T ++ Q+ G+ L S IHRDL N+L L ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFG 156
Query: 115 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
L L + E + APE L+ + + D W G L+E+ G P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 170 GRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNE 205
G N Q++ D ++ ++ + DR +F
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-43
Identities = 69/260 (26%), Positives = 105/260 (40%), Gaps = 51/260 (19%)
Query: 2 LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
+KK+ +S E+ L ++HPNII L DAF ++ I LV +F
Sbjct: 28 IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + ++ GLE L+ H I+HRDLKP N+L LD++ +LK+ADF
Sbjct: 88 VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144
Query: 114 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
GL+ + N A + Y APE+L + Y VDMW+VG IL ELL P G
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204
Query: 172 NNVQL--------------------------------------IVPALHPDCVDMCLKLL 193
+++ I A D +D+ L
Sbjct: 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 264
Query: 194 SANTVDRLSFNEFYHHRFLR 213
N R++ + ++
Sbjct: 265 LFNPCARITATQALKMKYFS 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-43
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E + +HP+I++L EN +++++E C G L S++ + + + Q
Sbjct: 58 EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 132
L L L S +HRD+ N+L + + +K+ DFGLS + Y A K
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQL-----------IVPA 180
+MAPE + F+R+ D+W G ++E+L +G PF G N + + P
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
P + K + + R F E
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-43
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 32/234 (13%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
M + +K EL L + +HPNII L A + ++L +E+ GNL ++R
Sbjct: 45 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104
Query: 60 H----------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
+ Q F + G++ L+ IHRDL NIL+
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL- 162
++ + KIADFGLS +MA E L + Y D+WS G +L+E++
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 163 NGYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
G P+ G +L + D+ + +R SF +
Sbjct: 222 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-43
Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 22/222 (9%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L S E + + H +++L+ E I++V E+ + G+L +++
Sbjct: 46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104
Query: 60 HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 161
Query: 118 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNV 174
+ Y + + APE + R+ K D+WS G +L EL G P+ G N
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 175 QL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
++ P D+ + +R +F
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEY 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-42
Identities = 46/209 (22%), Positives = 77/209 (36%), Gaps = 18/209 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E ++SV++P++ RL + G L + Q + Q+
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
G+ L ++HRDL N+L + +KI DFGL+ L AE
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPA 180
+MA E + + Y + D+WS G ++EL+ G P+ G ++ P
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237
Query: 181 LHPDCVDMCLKLLSANTVDRLSFNEFYHH 209
D + +K + R F E
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-42
Identities = 53/249 (21%), Positives = 92/249 (36%), Gaps = 43/249 (17%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+ +K + + L EL ++ + +H NI+ L A I+L+ E+C G+L +Y+R
Sbjct: 75 LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 60 H-----------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
+ + F Q+ G+E L +HRDL N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194
Query: 97 ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWS 153
+L + ++KI DFGL+ + + +MAPE L Y K D+WS
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 154 VGAILFELLN-GYPPFSGRNNVQLIV------------PALHPDCVDMCLKLLSANTVDR 200
G +L+E+ + G P+ G + + + ++ R
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
Query: 201 LSFNEFYHH 209
SF
Sbjct: 312 PSFPNLTSF 320
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-42
Identities = 67/261 (25%), Positives = 103/261 (39%), Gaps = 52/261 (19%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
+KK+ + K + EL + ++H NI+RL F + E + LV+++
Sbjct: 50 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 56 ---YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
Y R +P + ++ QL L ++S I HRD+KP+N+LL D +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
FG + L G S Y AP + Y +D+WS G +L ELL G P F G
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 172 NNVQLIV---------------------------------------PALHPDCVDMCLKL 192
+ V +V P P+ + +C +L
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 193 LSANTVDRLSFNEFYHHRFLR 213
L RL+ E H F
Sbjct: 287 LEYTPTARLTPLEACAHSFFD 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 7e-42
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L + + E + + HPN+++L E +++ EF GNL Y+R
Sbjct: 47 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106
Query: 60 HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
R V Q+ + +E L + IHRDL N L + ++ ++K+ADFGLS
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163
Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ Y + APE L + ++ K D+W+ G +L+E+ G P+ G +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 175 QL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214
Q+ ++ N DR SF E H+
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAFET 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-41
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 26/231 (11%)
Query: 2 LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
+K LN+ S E + +HPN++ L ++E +V+ + G+L ++
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 57 IRLHGRVP-EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
IR P + F Q+ G++ L S +HRDL N +L D+ +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGL 176
Query: 116 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
+ +Y + +MA E LQ Q++ K D+WS G +L+EL+ G PP+
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 170 GRNNVQLIVPALH-----------PDCVDMCLKLLSANTVDRLSFNEFYHH 209
N + V L ++ LK R SF+E
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-40
Identities = 67/241 (27%), Positives = 98/241 (40%), Gaps = 46/241 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
L L + HPN++RLFD E + LV E + ++ VP +T +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ QL GL+ L+SH ++HRDLKP+NIL+ +K+ADFGL+ V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVV 176
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI------------ 177
+ Y APEVL Y VD+WSVG I E+ P F G ++V +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 178 -------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212
V + D+ LK L+ N R+S H +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 213 R 213
+
Sbjct: 297 Q 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 1e-40
Identities = 56/256 (21%), Positives = 106/256 (41%), Gaps = 48/256 (18%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K L + + + E ++ ++PNI++L + L+ E+ A G+L+ ++
Sbjct: 48 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107
Query: 58 RLHGR------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93
R + +Q+ AG+ L+ +HRDL
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167
Query: 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVD 150
N L + +++++KIADFGLS +Y +Y + +M PE + + RY + D
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224
Query: 151 MWSVGAILFELLN-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTV 198
+W+ G +L+E+ + G P+ G + ++I + ++ S
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 284
Query: 199 DRLSFNEFYHHRFLRR 214
DR SF HR L+R
Sbjct: 285 DRPSFCSI--HRILQR 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-40
Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 26/233 (11%)
Query: 2 LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L+K L E L +VN P +++L +F+ + +++V+E+ AGG + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++R GR E AR + Q+ E L+S +I+RDLKPEN+L +D +++ DFG
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGF 187
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ + + +CG+P +APE++ + Y++ VD W++G +++E+ GYPPF +Q
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 176 LIV----------PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 213
+ D D+ LL + R N+ +H++
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (342), Expect = 8e-40
Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 44/253 (17%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L+K ++ + S E++ L + H NI++L+D + + LV E G
Sbjct: 36 LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
+ TA+ FL QL G+ + ++HRDLKP+N+L ++ + LKIADFGL+
Sbjct: 96 GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152
Query: 121 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-- 177
P + Y AP+VL ++Y +D+WSVG I E++NG P F G + +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 178 -------------------------------------VPALHPDCVDMCLKLLSANTVDR 200
+ L +D+ K+L + R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 201 LSFNEFYHHRFLR 213
++ + H + +
Sbjct: 273 ITAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-40
Identities = 64/254 (25%), Positives = 103/254 (40%), Gaps = 45/254 (17%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
L + + S E++ L +NHPNI++L D EN ++LV EF
Sbjct: 37 LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+P + +L QL GL +SH ++HRDLKP+N+L+ + + +K+ADFGL+
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 153
Query: 121 -PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSGRNNVQLI- 177
P + Y APE+L +Y VD+WS+G I E++ F G + + +
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 178 --------------------------------------VPALHPDCVDMCLKLLSANTVD 199
VP L D + ++L +
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
Query: 200 RLSFNEFYHHRFLR 213
R+S H F +
Sbjct: 274 RISAKAALAHPFFQ 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 4e-39
Identities = 51/270 (18%), Positives = 94/270 (34%), Gaps = 59/270 (21%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
++ + E+ L + H N++ L + + + I+LV +FC
Sbjct: 45 MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + ++ +Q L GL ++ + I+HRD+K N+L + D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADF 161
Query: 114 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 167
GL+ N + Y PE+L +R Y +D+W G I+ E+ P
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 168 FSGRNNVQLI------------------------------------------VPALHPDC 185
G + P
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 186 VDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215
+D+ KLL + R+ ++ +H F +
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-38
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 32/233 (13%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K +N+ + E + + N +++RL +++E G+L SY+
Sbjct: 55 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
Query: 58 RLHGRV----------PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
R + ++ G+ LN++ +HRDL N + + +D
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171
Query: 108 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
+KI DFG++ +Y +Y K +M+PE L+ + D+WS G +L+E+
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 165 -YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
P+ G +N Q+ ++ N R SF E
Sbjct: 232 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-38
Identities = 48/242 (19%), Positives = 93/242 (38%), Gaps = 29/242 (11%)
Query: 2 LKKLNKHLKSC----LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
+K L E + +H NIIRL + ++ E+ G L +
Sbjct: 41 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100
Query: 57 IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
G L+ + AG++ L + + +HRDL NIL+ + +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 157
Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGR 171
L A + APE + ++++ D+WS G +++E++ G P+
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217
Query: 172 NNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 220
+N ++ + ++ R F + + ++R
Sbjct: 218 SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD-----IVSILDKLIR 272
Query: 221 AP 222
AP
Sbjct: 273 AP 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (332), Expect = 7e-38
Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 9/176 (5%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
+K L K + E+ L ++ PNII L D + LV E + +
Sbjct: 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ + R ++ ++ L+ +S I+HRD+KP N+++ + L++ D+GL+
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179
Query: 119 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+PG S + PE+ + +Q YD +DMWS+G +L ++ PF ++
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-37
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 39/240 (16%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
+K L S L E+ + + H NII L A + ++++VE+ + GNL Y
Sbjct: 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 57 IRLHG----------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
++ ++ + Q+ G+E L S IHRDL N+L
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167
Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157
+ +D ++KIADFGL+ ++ +Y +K +MAPE L + Y + D+WS G +
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 158 LFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
L+E+ G P+ G +L + M A R +F +
Sbjct: 227 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-37
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E L + P ++ L AFQ E + L++++ GG L +++ R E + ++ +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 132
+ LE L+ II+RD+K ENIL LD + + + DFGLS A CG+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLIV------------ 178
YMAP++++ +D+ VD WS+G +++ELL G PF+
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 179 --PALHPDCVDMCLKLLSANTVDRLSFN-----EFYHHRFLR 213
+ D+ +LL + RL E H F +
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-37
Identities = 59/249 (23%), Positives = 101/249 (40%), Gaps = 54/249 (21%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ L H NII + D +A +V G +L ++ + F
Sbjct: 56 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 127
L Q+ GL+ ++S +++HRDLKP N+L L+ LKI DFGL+ P + + +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 128 VCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---------- 176
+ Y APE++ + Y + +D+WSVG IL E+L+ P F G++ +
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
Query: 177 -------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205
+ P +D+ K+L+ N R+ +
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291
Query: 206 FYHHRFLRR 214
H +L +
Sbjct: 292 ALAHPYLEQ 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-36
Identities = 43/206 (20%), Positives = 75/206 (36%), Gaps = 27/206 (13%)
Query: 2 LKKLNKHLKSCL--DCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
+K + + + E+ + H NI+ A +N ++LV ++ G+L
Sbjct: 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90
Query: 56 YIRLHGRVPEQTARKFLQQLGA-------GLEILNSHHIIHRDLKPENILLSGLDDDVML 108
Y+ + E + L + I HRDLK +NIL + +
Sbjct: 91 YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTC 147
Query: 109 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAI 157
IAD GL+ G+ YMAPEVL ++ D++++G +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 158 LFELLNGYPPFSGRNNVQLIVPALHP 183
+E+ + QL L P
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVP 233
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 6e-36
Identities = 39/245 (15%), Positives = 75/245 (30%), Gaps = 31/245 (12%)
Query: 2 LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
+K K L E + I AE + +V+E +
Sbjct: 37 IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ +T Q+ + +E ++S + IHRD+KP+N L+ ++ I DFGL+
Sbjct: 97 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 120 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
+ + G+ Y + + D+ S+G +L G P+ G
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216
Query: 172 NNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY---HHR 210
+ + S D+ ++ +
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 211 FLRRN 215
F R+
Sbjct: 277 FHRQG 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-36
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 38/225 (16%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
EL LS + NH NI+ L A ++ E+C G+L +++R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 59 --LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ + F Q+ G+ L S + IHRDL NIL L + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192
Query: 117 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRN 172
+ + +MAPE + Y + D+WS G L+EL + G P+ G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 173 NVQLIVPALH------------PDCVDMCLKLLSANTVDRLSFNE 205
+ + D+ A+ + R +F +
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (312), Expect = 2e-35
Identities = 29/188 (15%), Positives = 66/188 (35%), Gaps = 12/188 (6%)
Query: 2 LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K + + L E + I ++ Q LV++
Sbjct: 35 IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 117
+ +T +Q+ A ++ ++ +++RD+KP+N L+ + M+ + DFG+
Sbjct: 95 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154
Query: 118 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + G+ YM+ + + D+ ++G + L G P+
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
Query: 170 GRNNVQLI 177
G
Sbjct: 215 GLKAATNK 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 6e-35
Identities = 67/254 (26%), Positives = 103/254 (40%), Gaps = 45/254 (17%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L ++ + S E+ L + H NI+RL D ++ + LV EFC + +G
Sbjct: 37 LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
+ + + FL QL GL +S +++HRDLKP+N+L ++ + LK+A+FGL+
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153
Query: 121 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG-YPPFSGRNNVQL-- 176
P + Y P+VL + Y +DMWS G I EL N P F G +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 177 -------------------------------------IVPALHPDCVDMCLKLLSANTVD 199
+VP L+ D+ LL N V
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 200 RLSFNEFYHHRFLR 213
R+S E H +
Sbjct: 274 RISAEEALQHPYFS 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-35
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 60/265 (22%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + +LV+ F
Sbjct: 48 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
G + H ++ E + + Q+ GL +++ IIHRDLKP N+ +++D LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ + + Y APEV L + RY + VD+WSVG I+ E++ G F
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 170 GRNNVQL-----------------------------------------IVPALHPDCVDM 188
G +++ I+ P V++
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
Query: 189 CLKLLSANTVDRLSFNEFYHHRFLR 213
K+L + R++ E H +
Sbjct: 281 LEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-34
Identities = 59/255 (23%), Positives = 101/255 (39%), Gaps = 43/255 (16%)
Query: 2 LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
+K L + ++ + + +H N++ L A + + ++VEFC GNLS+
Sbjct: 48 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107
Query: 56 YIRLHGR----------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
Y+R + + + Q+ G+E L S IHRDL NIL
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL- 166
Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
L + ++KI DFGL+ +Y + +MAPE + + Y + D+WS G
Sbjct: 167 --LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 157 ILFELLNGY-PPFSGRNNVQLIVPALH------------PDCVDMCLKLLSANTVDRLSF 203
+L+E+ + P+ G + L P+ L R +F
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 204 NEFYHH--RFLRRNS 216
+E H L+ N+
Sbjct: 285 SELVEHLGNLLQANA 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 6e-32
Identities = 58/187 (31%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + ++LV+E
Sbjct: 47 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + + L Q+ G++ L+S IIHRDLKP NI + D LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ F G
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 171 RNNVQLI 177
R+ +
Sbjct: 221 RDYIDQW 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 9e-32
Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 58/265 (21%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
+KKL++ +S + EL L + H N+I L D F E +V G
Sbjct: 48 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ + ++D LKI
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 163
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ + + + Y APE+ L + Y++ VD+WSVG I+ ELL G F G
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 171 RNNVQL-----------------------------------------IVPALHPDCVDMC 189
+++ + +P VD+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 190 LKLLSANTVDRLSFNEFYHHRFLRR 214
K+L ++ R++ + H + +
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (245), Expect = 4e-25
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 11/193 (5%)
Query: 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
K L+ D + S+ +I++L D F N + +V+ F G H
Sbjct: 61 KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 62 RVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 117
+P ++ +QL GL+ ++ IIH D+KPEN+L+ +D + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI 177
+ Y +PEVL + D+WS ++FEL+ G F
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
Query: 178 VPALHPDCVDMCL 190
H + L
Sbjct: 239 KDDDHIAQIIELL 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 3e-14
Identities = 20/147 (13%), Positives = 46/147 (31%), Gaps = 27/147 (18%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
L + + +++ +++E RV + + L +
Sbjct: 67 ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138
+ I+H DL N+L+ + + I DF S + + E + +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWRE-------ILERD 164
Query: 139 VLQF-----QRYDEKVDMWSVGAILFE 160
V + Y + D+ S + +
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 226 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 90.01 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=335.50 Aligned_cols=205 Identities=31% Similarity=0.566 Sum_probs=186.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+.+++++..+..++.||+.||+|||++||
T Consensus 48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i 127 (263)
T d2j4za1 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127 (263)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34667899999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||||+||++ +.++.++|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 128 vHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 128 IHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp CCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eeeeecccccee---cCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence 999999999999 678899999999997665433 3456789999999999999999999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
|.+.+..+. .+..++++++++|.+||+.||.+|||++|+|+||||+..+
T Consensus 204 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~s 262 (263)
T d2j4za1 204 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262 (263)
T ss_dssp TCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCcC
Confidence 987654322 2566899999999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=334.37 Aligned_cols=205 Identities=31% Similarity=0.553 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
+..+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||
T Consensus 45 ~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~I 124 (271)
T d1nvra_ 45 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124 (271)
T ss_dssp ----CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence 44567899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~ 163 (226)
+||||||+||++ +.++.++|+|||++....... ......||+.|+|||.+.+..+ +.++||||+|+++|+|++
T Consensus 125 iHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 125 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred ccCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence 999999999999 678899999999998764332 2345679999999999988776 578999999999999999
Q ss_pred CCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 164 GYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 164 g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|..||......... ...+++++.++|++||+.||.+|||++|+++||||+++
T Consensus 202 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 202 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp SSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999765432211 35679999999999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-54 Score=336.94 Aligned_cols=210 Identities=33% Similarity=0.618 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|+.++++++||||+++++++.+++..|+|||||+|++|.+++...+.+++..+..++.||+.||+|||++|+
T Consensus 49 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~i 128 (307)
T d1a06a_ 49 GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128 (307)
T ss_dssp ------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhcee
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||||+||++...+.++.++|+|||++.............||+.|+|||.+.+..++.++||||+|+++|+|++|..|
T Consensus 129 iHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCC
Confidence 99999999999965456788999999999877666555667799999999999999999999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
|.+....... ...+|++++++|++||+.||.+|||++|+++||||+....
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 209 FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp CCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred CCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence 9876432211 3568999999999999999999999999999999986543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=331.97 Aligned_cols=205 Identities=29% Similarity=0.529 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..++.+.+|++++++++||||+++++++.+++.+|+||||++|++|.+++.+ +.+++..+..++.||+.||.|||++||
T Consensus 59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~i 137 (293)
T d1yhwa1 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137 (293)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4567899999999999999999999999999999999999999999998765 579999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||||+||++ +.++.++|+|||++....... ......|++.|+|||.+.+..++.++||||+|+++|+|++|..
T Consensus 138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 999999999999 678899999999998775433 3455679999999999999999999999999999999999999
Q ss_pred CCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 167 PFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 167 p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
||.+.+..... +..++++++++|.+||+.||.+|||++|+|+||||+...
T Consensus 215 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 99876533221 456889999999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=325.45 Aligned_cols=204 Identities=29% Similarity=0.564 Sum_probs=179.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....++.+.+|++++++++||||+++++++.+ +..+++||||++|++|.+++.+...+++..+..++.||+.||.|
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999865 35689999999999999999988899999999999999999999
Q ss_pred HHhCC--ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 82 lh~~~--i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
||++| |+||||||+||+++ +.++.++|+|||+++..... ......||+.|+|||.+.+ .++.++||||+|+++|
T Consensus 128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily 203 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 203 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence 99998 99999999999994 34678999999999765433 3445679999999999875 5999999999999999
Q ss_pred HHHhCCCCCCCCCcccc-------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 160 ELLNGYPPFSGRNNVQL-------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
+|++|..||.+...... .....+++++++|.+||+.||++|||++|+|+||||+
T Consensus 204 el~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999976543221 1445788999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=328.15 Aligned_cols=205 Identities=31% Similarity=0.599 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||
T Consensus 50 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~i 129 (288)
T d1uu3a_ 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129 (288)
T ss_dssp TCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccE
Confidence 34567999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+||||||+||++ +.++.++|+|||+++...... ......||+.|+|||.+.+..++.++||||+|+++|+|++|
T Consensus 130 iHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g 206 (288)
T d1uu3a_ 130 IHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206 (288)
T ss_dssp ECSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred EcCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC
Confidence 999999999999 678899999999998765332 23345799999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc----------cccCCChHHHHHHHHhhccCccccCCHhH------HhcCcccccc
Q 027233 165 YPPFSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNE------FYHHRFLRRN 215 (226)
Q Consensus 165 ~~p~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~------~l~~~~~~~~ 215 (226)
..||.+.+.... .+..++++++++|++||+.||.+|||++| +++||||++-
T Consensus 207 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 207 LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999987654322 25678999999999999999999999998 5899999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-53 Score=333.74 Aligned_cols=210 Identities=30% Similarity=0.548 Sum_probs=187.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+ .+++++..+..++.||+.||.|||+
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~ 142 (350)
T d1koaa2 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142 (350)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345667899999999999999999999999999999999999999999999854 4579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+|++||||||+||++.. +.++.++|+|||++.............|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 143 ~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 143 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp TTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred cCCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 99999999999999942 23578999999999888776666677899999999999999999999999999999999999
Q ss_pred CCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccC
Q 027233 165 YPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 165 ~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
..||.+.+..+.. ...++++++++|++||+.||.+|||++|+|+||||+...
T Consensus 222 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999876543221 356889999999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=328.35 Aligned_cols=207 Identities=32% Similarity=0.520 Sum_probs=181.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
..+..+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+. +++++..+..++.||+.||.|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~ 128 (288)
T d2jfla1 49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128 (288)
T ss_dssp SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456678899999999999999999999999999999999999999999997654 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCccccc-----ccCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~~ 158 (226)
+||+||||||+||++ +.++.++|+|||++...... .......|++.|+|||.+. +..++.++||||+|+++
T Consensus 129 ~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil 205 (288)
T d2jfla1 129 NKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205 (288)
T ss_dssp TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred CCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence 999999999999999 67889999999998665432 1223466899999999973 45678999999999999
Q ss_pred HHHHhCCCCCCCCCccccc-------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 159 FELLNGYPPFSGRNNVQLI-------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|+|++|..||.+.+..+.. +..++++++++|++||+.||.+|||++|+++||||+..
T Consensus 206 yemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 206 IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999876543322 45678999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-53 Score=333.71 Aligned_cols=213 Identities=28% Similarity=0.553 Sum_probs=189.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...++.+.+|++++++++||||+++++++.+++..|+|||||+|++|.+++...+ ++++..++.++.||+.||.|||++
T Consensus 67 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~ 146 (352)
T d1koba_ 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146 (352)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456788999999999999999999999999999999999999999999876554 799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~ 165 (226)
||+||||||+||+++. ..++.++|+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 147 ~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 147 SIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp TEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred Ceeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence 9999999999999942 256789999999999887766666778999999999999999999999999999999999999
Q ss_pred CCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccC
Q 027233 166 PPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 220 (226)
Q Consensus 166 ~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~ 220 (226)
.||.+.+..... ...++++++++|++||+.||.+|||++|+|+||||++....+.
T Consensus 226 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~ 294 (352)
T d1koba_ 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294 (352)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhc
Confidence 999876543221 3568999999999999999999999999999999987644433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=324.21 Aligned_cols=207 Identities=29% Similarity=0.574 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
.++.+.+|++++++++||||+++++++.+.+..|+|||||+|++|.+++...+.+++..++.++.|++.||+|||++|++
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv 135 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 135 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee
Confidence 46789999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCC-CCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||||+||+++..+ ....++++|||++.............+++.|+|||.+.+..++.++||||+|+++|+|++|..|
T Consensus 136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999999995322 2336999999999887666555667789999999999999999999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
|.+.+..+.. ...+|.+++++|++||+.||.+|||++|+++||||+..
T Consensus 216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9876543221 45688999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=332.58 Aligned_cols=206 Identities=31% Similarity=0.520 Sum_probs=182.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS- 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~- 84 (226)
+...++.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~ 123 (322)
T d1s9ja_ 44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123 (322)
T ss_dssp CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4456778999999999999999999999999999999999999999999999988899999999999999999999997
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
+||+||||||+||++ +.++.++|+|||+|....... .....|++.|+|||.+.+..++.++||||+||++++|++|
T Consensus 124 ~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G 199 (322)
T d1s9ja_ 124 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199 (322)
T ss_dssp HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 499999999999999 678899999999998664322 3345799999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc------------------------------------------------------cccCCChHHHHHHH
Q 027233 165 YPPFSGRNNVQL------------------------------------------------------IVPALHPDCVDMCL 190 (226)
Q Consensus 165 ~~p~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~i~ 190 (226)
..||.+.+.... ....+|.+++++|+
T Consensus 200 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 279 (322)
T d1s9ja_ 200 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279 (322)
T ss_dssp SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHH
Confidence 999976542210 01235789999999
Q ss_pred HhhccCccccCCHhHHhcCcccccc
Q 027233 191 KLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 191 ~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+||+.||.+|||++|+|+||||++.
T Consensus 280 ~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 280 KCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HHcCCChhHCcCHHHHhhCHhhCcC
Confidence 9999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-52 Score=323.77 Aligned_cols=204 Identities=30% Similarity=0.471 Sum_probs=181.9
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
..+..+.+.+|++++++++||||+++++++.+++..|+|||||.+++|..++...+++++..++.++.||+.||.|||++
T Consensus 55 ~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34556789999999999999999999999999999999999999999988888888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc---cCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~~~~l~ 162 (226)
||+||||||+||++ +.++.++|+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 135 ~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~ 208 (309)
T d1u5ra_ 135 NMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (309)
T ss_dssp TCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred CEeccCCCcceEEE---CCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH
Confidence 99999999999999 6788999999999976543 234569999999999864 45889999999999999999
Q ss_pred hCCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 163 NGYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 163 ~g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+|..||.+...... ....+|++++++|.+||+.||.+|||++|+|+||||+..
T Consensus 209 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 209 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 99999987654322 144578999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=320.04 Aligned_cols=204 Identities=31% Similarity=0.605 Sum_probs=170.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l 79 (226)
.+...+.+.+|++++++++||||+++++++.+ ++.+|+|||||+|++|.+++.+ ...+++..++.++.||+.||
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al 122 (269)
T d2java1 43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122 (269)
T ss_dssp CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999998864 4668999999999999999864 35799999999999999999
Q ss_pred HHHHhCC-----ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccCCCcchhHHH
Q 027233 80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (226)
Q Consensus 80 ~~lh~~~-----i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 153 (226)
.|||++| |+||||||+||++ +.++.++|+|||++....... ......|++.|+|||.+.+..++.++||||
T Consensus 123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS 199 (269)
T d2java1 123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS 199 (269)
T ss_dssp HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence 9999876 9999999999999 678899999999998765443 234567899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcCccc
Q 027233 154 VGAILFELLNGYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 212 (226)
Q Consensus 154 lG~~~~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~ 212 (226)
||+++|+|++|..||.+.+..+. .+..+|++++++|++||+.||.+|||++|+++|||+
T Consensus 200 lGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 200 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999987654322 256789999999999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-51 Score=316.52 Aligned_cols=205 Identities=37% Similarity=0.693 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+..++.+.+|+.++++++ ||||+++++++.+++..|+||||++|++|.+++...+++++..++.++.||+.||+|||++
T Consensus 50 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~ 129 (277)
T d1phka_ 50 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 446678999999999996 9999999999999999999999999999999999889999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc------cCCCcchhHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILF 159 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~~~~ 159 (226)
|++||||+|+||++ +.++.++|+|||++.............|+..|.|||.+.+ ..++.++||||+|++++
T Consensus 130 ~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily 206 (277)
T d1phka_ 130 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206 (277)
T ss_dssp TEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred CCcccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence 99999999999999 7888999999999988776655566778999999999853 34678999999999999
Q ss_pred HHHhCCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccc
Q 027233 160 ELLNGYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 214 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~ 214 (226)
+|++|..||.+.+..... ...+|+++++++++||+.||.+|||++|+++||||++
T Consensus 207 eml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 207 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred hhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999877533221 3468999999999999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=323.05 Aligned_cols=203 Identities=32% Similarity=0.539 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+
T Consensus 48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii 127 (337)
T d1o6la_ 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence 45778899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCC-CCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
||||||+||++ +.++.++|+|||+++.... .......+||+.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 128 HRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~p 204 (337)
T d1o6la_ 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCC
Confidence 99999999999 6788999999999987644 3344567799999999999999999999999999999999999999
Q ss_pred CCCCCcccc----------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCccccc
Q 027233 168 FSGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 214 (226)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~ 214 (226)
|.+.+.... .+..+|++++++|++||+.||.+|++ ++|+++||||++
T Consensus 205 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 205 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 988764322 26779999999999999999999994 899999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=321.23 Aligned_cols=208 Identities=28% Similarity=0.509 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
....+.+|++++++++||||+++++++.+++.+|+|||||+|++|.+++...+ ++++..+..++.||+.||.|||++||
T Consensus 44 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~i 123 (321)
T d1tkia_ 44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123 (321)
T ss_dssp HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence 44568899999999999999999999999999999999999999999998765 79999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
+||||||+||+++. +....++|+|||++.............+++.|+|||...+..++.++||||+|+++|+|++|..|
T Consensus 124 iHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~P 202 (321)
T d1tkia_ 124 GHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202 (321)
T ss_dssp ECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred CcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCC
Confidence 99999999999942 24557999999999887666656667789999999999999999999999999999999999999
Q ss_pred CCCCCccccc--------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCc
Q 027233 168 FSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 217 (226)
Q Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 217 (226)
|.+.+..+.. ...+|++++++|++||+.||.+|||++|+++||||+....
T Consensus 203 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 203 FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp TCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred CCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 9876643221 3468999999999999999999999999999999987533
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-51 Score=317.82 Aligned_cols=202 Identities=35% Similarity=0.639 Sum_probs=184.8
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+.++++++||||+++++++.+++..|+||||+.|++|.+++.....+++..+..++.||+.||.|||++||+
T Consensus 47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ii 126 (316)
T d1fota_ 47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 126 (316)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEE
Confidence 45688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||||+||++ +.++.++|+|||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 127 HrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf 201 (316)
T d1fota_ 127 YRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201 (316)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccCchheeE---cCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence 99999999999 67889999999999876543 33567999999999999999999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
.+.+.... .+..+++++++++++||+.||.+|+ |++++++||||++-
T Consensus 202 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 202 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 87654322 2677899999999999999999996 99999999999873
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=322.73 Aligned_cols=210 Identities=30% Similarity=0.596 Sum_probs=182.1
Q ss_pred HHHHHHHHHHhcC-CCCCeeeeeeEEEe----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 027233 11 SCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 11 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (226)
+.+.+|+.++.++ +||||+++++++.+ ++.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH 128 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 4677899987655 89999999999875 46789999999999999999875 36999999999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~ 163 (226)
++||+||||||+||+++.....+.++|+|||+++............|++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt 208 (335)
T d2ozaa1 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208 (335)
T ss_dssp HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT
T ss_pred HcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh
Confidence 99999999999999996544567899999999988777666667789999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcCccccccCcccC
Q 027233 164 GYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 220 (226)
Q Consensus 164 g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~ 220 (226)
|..||.+....... ...+|++++++|++||+.||.+|||++|+++||||+.......
T Consensus 209 g~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp SSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 99999765432211 2357889999999999999999999999999999987654433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-50 Score=316.89 Aligned_cols=202 Identities=30% Similarity=0.584 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (226)
..+.+.+|+++++.++||||+++++++.+.+..++|+||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+
T Consensus 84 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~ii 163 (350)
T d1rdqe_ 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 45678899999999999999999999999999999999999999999999989999999999999999999999999999
Q ss_pred eeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 027233 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (226)
Q Consensus 89 H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 168 (226)
||||||+||++ +.++.++|+|||+++..... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 164 HRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 238 (350)
T d1rdqe_ 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp CCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCCHHHccc---CCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence 99999999999 67889999999999876543 33456899999999999999999999999999999999999999
Q ss_pred CCCCcccc----------cccCCChHHHHHHHHhhccCccccC-----CHhHHhcCcccccc
Q 027233 169 SGRNNVQL----------IVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 215 (226)
Q Consensus 169 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 215 (226)
.+.+.... .+..+++++.++|++||+.||.+|+ |++++++||||++.
T Consensus 239 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 87654322 2667899999999999999999994 99999999999873
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-49 Score=315.17 Aligned_cols=198 Identities=30% Similarity=0.517 Sum_probs=177.1
Q ss_pred HHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeeccC
Q 027233 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (226)
Q Consensus 14 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (226)
.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+++.+...+++..++.++.||+.||.|||++|++|||||
T Consensus 55 ~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK 134 (364)
T d1omwa3 55 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 134 (364)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeec
Confidence 34577888889999999999999999999999999999999999998999999999999999999999999999999999
Q ss_pred CCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 027233 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (226)
Q Consensus 94 ~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 172 (226)
|+||++ +.++.++|+|||++....... .....|++.|+|||.+. +..++.++||||||+++|+|++|..||.+..
T Consensus 135 P~NILl---~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 135 PANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp GGGEEE---CSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cceeEE---cCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 999999 688899999999998765443 34557999999999986 4568999999999999999999999998654
Q ss_pred cccc-------------cccCCChHHHHHHHHhhccCccccCC-----HhHHhcCcccccc
Q 027233 173 NVQL-------------IVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 215 (226)
Q Consensus 173 ~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~ 215 (226)
.... .+..++++++++|.+||+.||.+||| ++|+++||||++-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 211 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp SSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 3211 15678999999999999999999999 7999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=311.96 Aligned_cols=203 Identities=34% Similarity=0.596 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHh-cCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+..|..++. .++||||+++++++.+++..|+||||++||+|.+++.....+++..+..++.||+.||.|||++|+
T Consensus 45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~i 124 (320)
T d1xjda_ 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 124 (320)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3445666666655 689999999999999999999999999999999999998999999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||||+||++ +.++.++|+|||.+...... .......|++.|+|||.+.+..++.++||||+|+++|+|++|..
T Consensus 125 iHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 201 (320)
T d1xjda_ 125 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201 (320)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence 999999999999 78889999999999866543 33445678999999999999999999999999999999999999
Q ss_pred CCCCCCccccc----------ccCCChHHHHHHHHhhccCccccCCHh-HHhcCccccc
Q 027233 167 PFSGRNNVQLI----------VPALHPDCVDMCLKLLSANTVDRLSFN-EFYHHRFLRR 214 (226)
Q Consensus 167 p~~~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~~l~~~~~~~ 214 (226)
||.+.+..... +..+|++++++|++||+.||.+|||+. |+++||||++
T Consensus 202 PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 202 PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99876543222 566899999999999999999999996 8999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=312.03 Aligned_cols=204 Identities=31% Similarity=0.463 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 027233 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (226)
.+.+.+|++++++++||||+++++++..++..|+||||+.++++..+......+++..+..++.||+.||+|||++|++|
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH 123 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence 45788999999999999999999999999999999999988888777666678999999999999999999999999999
Q ss_pred eccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCC
Q 027233 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP 167 (226)
Q Consensus 90 ~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p 167 (226)
|||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++||||+|+++++|++|..|
T Consensus 124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 200 (299)
T d1ua2a_ 124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200 (299)
T ss_dssp CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence 9999999999 788999999999997765433 3344578999999998864 4579999999999999999999999
Q ss_pred CCCCCccccc--------------------------------------ccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 168 FSGRNNVQLI--------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 168 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|.+.+..+.. ....++++.++|++||+.||.+|||++|+|+|
T Consensus 201 f~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 201 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 9765432110 24568899999999999999999999999999
Q ss_pred ccccccC
Q 027233 210 RFLRRNS 216 (226)
Q Consensus 210 ~~~~~~~ 216 (226)
|||++.+
T Consensus 281 p~f~~~p 287 (299)
T d1ua2a_ 281 KYFSNRP 287 (299)
T ss_dssp GGGTSSS
T ss_pred HhhCCCC
Confidence 9998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=304.30 Aligned_cols=204 Identities=25% Similarity=0.457 Sum_probs=176.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+...++.+.+|++++++++||||+++++++..+ ..++||||+++++|.+++....++++..+..++.||+.||+|||++
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 126 (277)
T d1xbba_ 48 DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126 (277)
T ss_dssp -CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC
Confidence 344567899999999999999999999998654 5789999999999999999888999999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++||||||+||++ +.++.++++|||+++....... .....+++.|+|||.+.+..++.++||||||+++||+
T Consensus 127 ~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~el 203 (277)
T d1xbba_ 127 NFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203 (277)
T ss_dssp TEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CcccCCCcchhhcc---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHH
Confidence 99999999999999 5788999999999987654322 2234578899999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHH---hcCcccc
Q 027233 162 LN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEF---YHHRFLR 213 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~---l~~~~~~ 213 (226)
++ |..||.+.+..+. .+..+|.++++++.+||+.||.+|||++++ |+|+|++
T Consensus 204 lt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 204 FSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 97 8999987653322 256789999999999999999999999998 5677764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-49 Score=305.36 Aligned_cols=206 Identities=23% Similarity=0.436 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|++++++++||||+++++++...+..++||||+++++|.+++... +.+++..+..++.||+.||+|||+
T Consensus 67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 146 (299)
T d1jpaa_ 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4566778999999999999999999999999999999999999999999988875 479999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc------ccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
+|++||||||+||++ +.++.+||+|||+++........ ....+++.|+|||.+.+..++.++||||||+++
T Consensus 147 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 999999999999999 78889999999999876543221 123467889999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC--ccccc
Q 027233 159 FELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH--RFLRR 214 (226)
Q Consensus 159 ~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~--~~~~~ 214 (226)
|||++ |..||.+....+. .+...+.++.+++.+||+.||.+|||+.|+++. .++++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 99998 8999987654322 155678999999999999999999999998876 44443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=300.17 Aligned_cols=202 Identities=26% Similarity=0.474 Sum_probs=177.1
Q ss_pred HHHHHHHHHHhcCC--CCCeeeeeeEEEeCCeEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 11 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
.++.+|+.++++++ ||||+++++++.+.+..++||||+.+ +++.+++.+...+++..++.++.||+.||.|||++|+
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i 131 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 131 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34678999999996 89999999999999999999999975 6888999888899999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~~~~l~~g~~ 166 (226)
+||||||+||+++ .+++.++|+|||++...... ......|++.|+|||.+.+..+ +.++||||+|+++|+|++|..
T Consensus 132 iHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 132 LHRDIKDENILID--LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp ECSCCSGGGEEEE--TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcccceEEe--cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence 9999999999994 34578999999999765443 2345678999999999987665 567899999999999999999
Q ss_pred CCCCCCc----ccccccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 167 PFSGRNN----VQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 167 p~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||.+.+. ....+..+|++++++|++||+.||.+|||++|+++||||++.
T Consensus 209 Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 209 PFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCSHHHHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCchHHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9986532 122367789999999999999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=300.96 Aligned_cols=207 Identities=30% Similarity=0.529 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
...+.+.+|++++++++||||+++++++.+++..|+||||+.+ ++.+++.. .+.+++..+..++.||+.||.|||++
T Consensus 43 ~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~ 121 (298)
T d1gz8a_ 43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121 (298)
T ss_dssp -CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 3467899999999999999999999999999999999999965 55555433 35699999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCC-CccccccCCccccCcccccccC-CCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~~~~l~~ 163 (226)
||+||||||+||++ +.++.++|+|||.+...... .......+++.|+|||...... .+.++|+||+|+++|+|++
T Consensus 122 ~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 122 RVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp TCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CEEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence 99999999999999 67889999999999877543 3344567899999999877655 4789999999999999999
Q ss_pred CCCCCCCCCccccc---------------------------------------ccCCChHHHHHHHHhhccCccccCCHh
Q 027233 164 GYPPFSGRNNVQLI---------------------------------------VPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 164 g~~p~~~~~~~~~~---------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|..||.+.+..+.. ...++.+++++|++||+.||.+|||++
T Consensus 199 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ 278 (298)
T d1gz8a_ 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278 (298)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999765422110 335678999999999999999999999
Q ss_pred HHhcCccccccCcc
Q 027233 205 EFYHHRFLRRNSAI 218 (226)
Q Consensus 205 ~~l~~~~~~~~~~~ 218 (226)
|+++||||++-...
T Consensus 279 ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 279 AALAHPFFQDVTKP 292 (298)
T ss_dssp HHHTSGGGTTCCCC
T ss_pred HHhCCHhhccCCCC
Confidence 99999999876443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=299.90 Aligned_cols=210 Identities=25% Similarity=0.438 Sum_probs=180.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
.....+.+.+|++++++++||||+++++++.++ ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~ 127 (285)
T d1u59a_ 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127 (285)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 455677899999999999999999999998754 588999999999999998654 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
+|++||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||+|+++||
T Consensus 128 ~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E 204 (285)
T d1u59a_ 128 KNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 204 (285)
T ss_dssp TTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCeecCcCchhheee---ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHH
Confidence 999999999999999 5788999999999987654332 223457788999999998899999999999999999
Q ss_pred HHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHH---hcCccccccCccc
Q 027233 161 LLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEF---YHHRFLRRNSAIL 219 (226)
Q Consensus 161 l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~---l~~~~~~~~~~~~ 219 (226)
+++ |..||.+.+..+. .+..+|+++.+++.+||+.||.+|||+.++ |+|+|+.-.+...
T Consensus 205 ~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 205 ALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp HHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 998 8999987654322 256789999999999999999999999888 6788886554443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=299.63 Aligned_cols=200 Identities=27% Similarity=0.445 Sum_probs=169.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
+.+..+.+.+|+.++++++||||++++++..+ +..++||||++|++|.+++... .++++..+..++.||+.||+|||+
T Consensus 44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~ 122 (276)
T d1uwha_ 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122 (276)
T ss_dssp CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 45567889999999999999999999998754 5689999999999999999765 569999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccc---cCCCcchhHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~~ 158 (226)
+||+||||||+||++ +.++.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||+|+++
T Consensus 123 ~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp TTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred CCEeccccCHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence 999999999999999 678899999999997664322 2234568999999999864 3478899999999999
Q ss_pred HHHHhCCCCCCCCCcccc----------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 159 FELLNGYPPFSGRNNVQL----------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|||++|..||.+.+.... ....+++++++++.+||+.||.+|||++|++++
T Consensus 200 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999987653321 145678899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=305.74 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-----------------------
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------- 61 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------- 61 (226)
.....+.+.+|+.+++++ +||||+++++++.+.+..++|||||++|+|.+++.+..
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (325)
T d1rjba_ 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159 (325)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence 445667899999999998 89999999999999999999999999999999997642
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcc
Q 027233 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (226)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE 138 (226)
.+++..++.++.|++.||+|||++||+||||||+||++ +.++.++|+|||+++....... .....+++.|+|||
T Consensus 160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 37889999999999999999999999999999999999 6788999999999976654332 22345688999999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhH
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 205 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 205 (226)
.+.+..++.++||||||+++|||++ |..||.+...... .+...+++++++|.+||+.||.+|||++|
T Consensus 237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999999999999997 8999987654322 15668899999999999999999999999
Q ss_pred HhcC
Q 027233 206 FYHH 209 (226)
Q Consensus 206 ~l~~ 209 (226)
+++|
T Consensus 317 i~~~ 320 (325)
T d1rjba_ 317 LTSF 320 (325)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-47 Score=297.43 Aligned_cols=206 Identities=29% Similarity=0.487 Sum_probs=175.6
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
+....+.+.+|+.++++++||||+++++.+..++..+++++++.++.+..+....+.+++..+..++.||+.||.|||+.
T Consensus 40 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 119 (286)
T d1ob3a_ 40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119 (286)
T ss_dssp GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC
Confidence 34446789999999999999999999999999999999999998777777767678899999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-cccccCCccccCccccccc-CCCcchhHHHHHHHHHHHHh
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~l~~ 163 (226)
||+||||||+||++ +.++.++++|||.+........ .....+++.|.|||.+.+. .++.++|+||+|+++++|++
T Consensus 120 ~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp TCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred cEEecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH
Confidence 99999999999999 6788999999999987654332 3344678899999998654 56899999999999999999
Q ss_pred CCCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCCHh
Q 027233 164 GYPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 164 g~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
|..||.+.+..+. .....++++.++|++||+.||++|||++
T Consensus 197 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ 276 (286)
T d1ob3a_ 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (286)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999975532111 1455788999999999999999999999
Q ss_pred HHhcCccccc
Q 027233 205 EFYHHRFLRR 214 (226)
Q Consensus 205 ~~l~~~~~~~ 214 (226)
|+|+||||++
T Consensus 277 ell~Hp~f~~ 286 (286)
T d1ob3a_ 277 QALEHAYFKE 286 (286)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCcccCc
Confidence 9999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=292.76 Aligned_cols=198 Identities=24% Similarity=0.461 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+++.+|++++++++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||++++
T Consensus 43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~i 122 (263)
T d1sm2a_ 43 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122 (263)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccce
Confidence 4567999999999999999999999999999999999999999999998765 468899999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC-
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG- 164 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g- 164 (226)
+||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||+|+++||++++
T Consensus 123 iHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~ 199 (263)
T d1sm2a_ 123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199 (263)
T ss_dssp CCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCC
Confidence 999999999999 6788999999999977654332 2335678899999999999999999999999999999995
Q ss_pred CCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 165 YPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 165 ~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
..||......+. .+...++++.+++.+||+.||.+|||++|+++|
T Consensus 200 ~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 200 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 555655433221 155678999999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=298.88 Aligned_cols=203 Identities=33% Similarity=0.491 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhcC---CCCCeeeeeeEEEe-----CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 027233 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLE 80 (226)
Q Consensus 10 ~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~ 80 (226)
...+.+|+.+++.| +||||+++++++.. ....++++|+++++++....... ..+++..++.++.|++.||+
T Consensus 51 ~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~ 130 (305)
T d1blxa_ 51 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130 (305)
T ss_dssp BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 44566777777666 79999999998853 35689999999877665544433 46899999999999999999
Q ss_pred HHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 81 ~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
|||++||+||||||+||++ +..+.++|+|||.+.............||+.|+|||.+.+.+++.++||||+|+++++
T Consensus 131 yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~e 207 (305)
T d1blxa_ 131 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 207 (305)
T ss_dssp HHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred HHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHH
Confidence 9999999999999999999 6888999999999877665555667789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcccc-------------------------------------cccCCChHHHHHHHHhhccCccccCCH
Q 027233 161 LLNGYPPFSGRNNVQL-------------------------------------IVPALHPDCVDMCLKLLSANTVDRLSF 203 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~-------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 203 (226)
|++|..||.+.+..+. ....+++++++||++||+.||.+|||+
T Consensus 208 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa 287 (305)
T d1blxa_ 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287 (305)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 9999999976542211 134578899999999999999999999
Q ss_pred hHHhcCcccccc
Q 027233 204 NEFYHHRFLRRN 215 (226)
Q Consensus 204 ~~~l~~~~~~~~ 215 (226)
+|+|+||||++-
T Consensus 288 ~e~L~Hpff~~i 299 (305)
T d1blxa_ 288 YSALSHPYFQDL 299 (305)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhcChhhcCc
Confidence 999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-47 Score=293.01 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+++.+|++++++++||||+++++++.+++..+++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ 135 (287)
T d1opja_ 56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135 (287)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567999999999999999999999999999999999999999999999764 47899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCcc--ccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|+||||||+||++ +.++.+||+|||+++........ ....++..|+|||.+.+..++.++||||+|+++|+|++|
T Consensus 136 iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~ 212 (287)
T d1opja_ 136 FIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212 (287)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred cccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence 9999999999999 67889999999999876544322 233467889999999999999999999999999999997
Q ss_pred CCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 165 YPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 165 ~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
..|+....... ..+..+++++++++.+||+.||.+|||++|+++
T Consensus 213 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 213 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 66654332211 115678999999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=287.50 Aligned_cols=199 Identities=22% Similarity=0.423 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 41 ~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~ 120 (258)
T d1k2pa_ 41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120 (258)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC
Confidence 34578999999999999999999999999999999999999999999997654 57899999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
|+||||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||+|+++|||++
T Consensus 121 iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~ 197 (258)
T d1k2pa_ 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 197 (258)
T ss_dssp BCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhc
Confidence 9999999999999 6788999999999976654332 223557888999999999999999999999999999998
Q ss_pred CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||.+.+..+.. +...+.+++++|++||+.||.+|||++++++|
T Consensus 198 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 198 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 89999876543222 56678899999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=291.84 Aligned_cols=202 Identities=22% Similarity=0.420 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++++++++||||+++++++.+ +..++||||+++|+|.+++... .++++..+..++.||+.||.|||++|
T Consensus 51 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ 129 (272)
T d1qpca_ 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129 (272)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45679999999999999999999998755 5578999999999999987544 36999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--cccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
|+||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++|
T Consensus 130 ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~ 206 (272)
T d1qpca_ 130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (272)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhC
Confidence 9999999999999 7889999999999987754432 2345578899999999988899999999999999999996
Q ss_pred CCC-CCCCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc--Cccccc
Q 027233 165 YPP-FSGRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRR 214 (226)
Q Consensus 165 ~~p-~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~--~~~~~~ 214 (226)
..| +......+ ..+..+++++.+++.+||+.||.+|||++|+++ ++||..
T Consensus 207 ~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 554 44433221 125678999999999999999999999999998 888864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-46 Score=290.04 Aligned_cols=205 Identities=26% Similarity=0.475 Sum_probs=170.3
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
+.+..+.+.+|++++++++||||+++++++...+ ..|+||||++|++|.+++...+++++..+..++.||+.||.|
T Consensus 47 ~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~ 126 (277)
T d1o6ya_ 47 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126 (277)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999999987643 489999999999999999998999999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
||++|++||||||+||++ +.++..+++|||.+....... ......|++.|+|||.+.+..++.++||||+|++
T Consensus 127 lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 203 (277)
T d1o6ya_ 127 SHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 203 (277)
T ss_dssp HHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHhCCccCccccCccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHH
Confidence 999999999999999999 678889999999886554322 2334568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcccc--------------cccCCChHHHHHHHHhhccCccccCCHhHHhcCcccc
Q 027233 158 LFELLNGYPPFSGRNNVQL--------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 213 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~ 213 (226)
+|+|++|..||.+.+..+. ....+|+++.++|++||+.||.+||+..+.+.|+|.+
T Consensus 204 lyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 204 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999987654322 1457899999999999999999999444445566654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=295.71 Aligned_cols=210 Identities=25% Similarity=0.393 Sum_probs=178.7
Q ss_pred hhhhhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~ 78 (226)
+|.++....+++.+|+++++++ +||||+++++++.. ....++||||+.+++|.++. +.+++..++.++.||+.|
T Consensus 65 iK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~a 141 (328)
T d3bqca1 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 141 (328)
T ss_dssp EEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHH
T ss_pred EEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 3555555677899999999999 59999999999975 45699999999999998753 479999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCcchhHHHHHHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~ 157 (226)
|.|||++||+||||||+||+++ ..+..++|+|||.+.............++..|+|||...+. .++.++|+||+|++
T Consensus 142 L~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~ 219 (328)
T d3bqca1 142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219 (328)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhh
Confidence 9999999999999999999995 34557999999999887766666667789999999998765 47899999999999
Q ss_pred HHHHHhCCCCCCCCCcccc------------------------------------------------cccCCChHHHHHH
Q 027233 158 LFELLNGYPPFSGRNNVQL------------------------------------------------IVPALHPDCVDMC 189 (226)
Q Consensus 158 ~~~l~~g~~p~~~~~~~~~------------------------------------------------~~~~~~~~~~~~i 189 (226)
++++++|..||........ ....+++++.+||
T Consensus 220 l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 299 (328)
T d3bqca1 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299 (328)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHH
T ss_pred hHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHH
Confidence 9999999999865432100 0234678999999
Q ss_pred HHhhccCccccCCHhHHhcCccccccC
Q 027233 190 LKLLSANTVDRLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 190 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 216 (226)
++||+.||.+|||++|+|+||||+...
T Consensus 300 ~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 300 DKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=287.60 Aligned_cols=200 Identities=26% Similarity=0.484 Sum_probs=165.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|++++++++||||+++++++. ++..++||||+++++|.+++... +++++..++.++.||+.||.|||+
T Consensus 48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 48 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence 4566788999999999999999999999986 46789999999999999987654 479999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
+|++||||||+||++ +.++.++|+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||+
T Consensus 127 ~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l 203 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203 (273)
T ss_dssp TTCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred cCeeccccchhheee---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence 999999999999999 577889999999997764332 223445788999999999999999999999999999998
Q ss_pred h-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 163 N-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+ |..||.+.+..+. .+..+|++++++|.+||+.||.+|||++|++++
T Consensus 204 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 204 MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 7 8999987654322 266789999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=286.42 Aligned_cols=204 Identities=19% Similarity=0.324 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|+.++++++|||||++++++.+ +..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++|
T Consensus 55 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ 133 (285)
T d1fmka3 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133 (285)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh
Confidence 35679999999999999999999999855 5578999999999999988643 57999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC--ccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~g 164 (226)
++||||||+||++ +.++.++|+|||+++...... ......+++.|+|||.+.+..++.++||||+|+++|||++|
T Consensus 134 ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 134 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhC
Confidence 9999999999999 678899999999997664332 23345678999999999999999999999999999999997
Q ss_pred CCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhc--CccccccC
Q 027233 165 YPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRRNS 216 (226)
Q Consensus 165 ~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~--~~~~~~~~ 216 (226)
..|+....... ..+...+.+++++|.+||+.||.+|||++++++ ++||....
T Consensus 211 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 211 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 66654433221 126778999999999999999999999999988 88887754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=290.86 Aligned_cols=211 Identities=27% Similarity=0.442 Sum_probs=177.4
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~ 68 (226)
..+..+.+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.+. ..+++..+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence 345677899999999999 7999999999999999999999999999999999754 46899999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcc
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 148 (226)
..++.||+.|+.|+|++|++||||+|+||++ +.++.++|+|||++.............++..|+|||.+.+..++.+
T Consensus 130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 206 (309)
T d1fvra_ 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 206 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence 9999999999999999999999999999999 6788999999999976655444455568899999999999999999
Q ss_pred hhHHHHHHHHHHHHhCC-CCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC--ccccc
Q 027233 149 VDMWSVGAILFELLNGY-PPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH--RFLRR 214 (226)
Q Consensus 149 ~Dv~slG~~~~~l~~g~-~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~--~~~~~ 214 (226)
+||||||+++|+|++|. .||.+.+..+. .+..++++++++|.+||+.||++|||++|++++ .+++.
T Consensus 207 sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999965 56766543222 156688999999999999999999999999987 55555
Q ss_pred cCccc
Q 027233 215 NSAIL 219 (226)
Q Consensus 215 ~~~~~ 219 (226)
.+...
T Consensus 287 ~~~~~ 291 (309)
T d1fvra_ 287 RKTYV 291 (309)
T ss_dssp SSCSB
T ss_pred CcCCC
Confidence 44433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=285.13 Aligned_cols=200 Identities=21% Similarity=0.355 Sum_probs=166.7
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
....++.+.+|++++++++||||+++++++.+.+..++++||+.++++.+++... ..+++..+..++.|++.|+.|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~ 128 (283)
T d1mqba_ 49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128 (283)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence 4456678999999999999999999999999999999999999999999988765 579999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCcccccccCCCcchhHHHHHHHHHH
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~ 160 (226)
++|+||||||+||++ +.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++||
T Consensus 129 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 129 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred cccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHH
Confidence 999999999999999 788899999999997764332 1223457889999999999999999999999999999
Q ss_pred HHhCCCCCC-CCCccc-----------ccccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 161 LLNGYPPFS-GRNNVQ-----------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 161 l~~g~~p~~-~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
|+++..|+. .....+ ..+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 206 l~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 206 VMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999655544 332211 115567899999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=285.21 Aligned_cols=205 Identities=32% Similarity=0.505 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
....+++.+|+.++++++||||+++++++.+....+++++++.+++|..++...+.+++..+..++.|++.||+|||++|
T Consensus 42 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence 34678899999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-ccccccCCccccCcccccccC-CCcchhHHHHHHHHHHHHhC
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~~~~l~~g 164 (226)
|+||||||+||++ +.++.++|+|||.+....... ......++..|.|||.+.+.. ++.++||||+|+++++|++|
T Consensus 122 IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g 198 (292)
T d1unla_ 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred EeeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence 9999999999999 678889999999998775443 333445677789999887654 68999999999999999999
Q ss_pred CCCCCCCCccc----------------------------------------ccccCCChHHHHHHHHhhccCccccCCHh
Q 027233 165 YPPFSGRNNVQ----------------------------------------LIVPALHPDCVDMCLKLLSANTVDRLSFN 204 (226)
Q Consensus 165 ~~p~~~~~~~~----------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 204 (226)
..||....... .....+++.+.+||++||+.||.+|||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~ 278 (292)
T d1unla_ 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278 (292)
T ss_dssp SCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 98864322111 01455688999999999999999999999
Q ss_pred HHhcCccccc
Q 027233 205 EFYHHRFLRR 214 (226)
Q Consensus 205 ~~l~~~~~~~ 214 (226)
|+|+||||++
T Consensus 279 e~L~Hp~f~~ 288 (292)
T d1unla_ 279 EALQHPYFSD 288 (292)
T ss_dssp HHTTSGGGSS
T ss_pred HHhcChhhcC
Confidence 9999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=292.76 Aligned_cols=202 Identities=31% Similarity=0.487 Sum_probs=169.3
Q ss_pred HHHHHHHHHhcCCCCCeeeeeeEEEeC------CeEEEEEeecCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027233 12 CLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFLQQLGAGLEIL 82 (226)
Q Consensus 12 ~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~i~~~l~~l 82 (226)
...+|++++++++||||+++++++... ...++||||++++.+... ......+++..++.++.||+.||+||
T Consensus 59 ~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345799999999999999999998542 357899999976533332 23345799999999999999999999
Q ss_pred HhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHHHHH
Q 027233 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 83 h~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~~~l 161 (226)
|++||+||||||+||+++ .++..++|+|||++.............++..|+|||.+.+ ..++.++||||+|+++++|
T Consensus 139 H~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el 216 (350)
T d1q5ka_ 139 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216 (350)
T ss_dssp HTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence 999999999999999993 2345799999999988776666666788999999998764 5689999999999999999
Q ss_pred HhCCCCCCCCCcccc---------------------------------------cccCCChHHHHHHHHhhccCccccCC
Q 027233 162 LNGYPPFSGRNNVQL---------------------------------------IVPALHPDCVDMCLKLLSANTVDRLS 202 (226)
Q Consensus 162 ~~g~~p~~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt 202 (226)
++|..||...+..+. .....++++.+||++||+.||.+|||
T Consensus 217 ~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999976543211 13457889999999999999999999
Q ss_pred HhHHhcCcccccc
Q 027233 203 FNEFYHHRFLRRN 215 (226)
Q Consensus 203 ~~~~l~~~~~~~~ 215 (226)
++|+|+||||++.
T Consensus 297 a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 297 PLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHTSGGGGGG
T ss_pred HHHHhcCHhhccc
Confidence 9999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-46 Score=290.39 Aligned_cols=203 Identities=30% Similarity=0.500 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhcCCC-CCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
..+.+.+|++++++++| |||+++++++.+....++++||+.+++|.+++...+.+++..+..++.||+.|+.|+|++|+
T Consensus 71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i 150 (322)
T d1vzoa_ 71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150 (322)
T ss_dssp SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence 45678899999999966 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCC--CccccccCCccccCccccccc--CCCcchhHHHHHHHHHHHHh
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN 163 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~~~~l~~ 163 (226)
+||||||+||++ +.++.++|+|||++...... .......+++.|++||.+.+. .++.++||||+|+++|+|++
T Consensus 151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 999999999999 67889999999999766432 223456688999999998654 46789999999999999999
Q ss_pred CCCCCCCCCccccc--------------ccCCChHHHHHHHHhhccCccccC-----CHhHHhcCccccc
Q 027233 164 GYPPFSGRNNVQLI--------------VPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 214 (226)
Q Consensus 164 g~~p~~~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~~l~~~~~~~ 214 (226)
|..||.+....... +..+++++.++|++||+.||.+|| |++|+++||||++
T Consensus 228 G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999876543221 457899999999999999999999 5899999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=290.07 Aligned_cols=203 Identities=31% Similarity=0.533 Sum_probs=175.8
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l 79 (226)
.+...+.+.+|+++|++++||||+++++++...+ .+|+||||+ +.+|..+.+ ..++++..++.++.||+.||
T Consensus 57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL 134 (346)
T d1cm8a_ 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGL 134 (346)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHH
Confidence 4456778999999999999999999999997654 579999999 778888765 46899999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccc-cCCCcchhHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~~ 158 (226)
.|||++||+||||||+||++ +.++.++++|||.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++
T Consensus 135 ~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 135 RYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp HHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHHHhCCCcccccCcchhhc---ccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 99999999999999999999 78899999999999776443 334568999999999875 4568999999999999
Q ss_pred HHHHhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhccCc
Q 027233 159 FELLNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSANT 197 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~~p 197 (226)
++|++|..||.+.+.... .....++++.+||++||..||
T Consensus 210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence 999999999987643211 134568899999999999999
Q ss_pred cccCCHhHHhcCcccccc
Q 027233 198 VDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 198 ~~Rpt~~~~l~~~~~~~~ 215 (226)
.+|||++|+|+||||+..
T Consensus 290 ~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 290 EQRVTAGEALAHPYFESL 307 (346)
T ss_dssp TTSCCHHHHHHSGGGTTT
T ss_pred hHCcCHHHHhcChhhCcC
Confidence 999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=287.03 Aligned_cols=204 Identities=29% Similarity=0.530 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....+.+.+|+.+|++++||||+++++.+.... .++++ +++.|++|.++++.. .+++..++.++.|++.||+|
T Consensus 47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~y 124 (345)
T d1pmea_ 47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKY 124 (345)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHH
Confidence 455678899999999999999999999987643 34555 556699999999754 79999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC----ccccccCCccccCccccc-ccCCCcchhHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGA 156 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~ 156 (226)
||++||+||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+. +..++.++|+||+|+
T Consensus 125 LH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 201 (345)
T d1pmea_ 125 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201 (345)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred HHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence 999999999999999999 678899999999997654332 234456889999999984 456788999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc-----------------------------------------cccCCChHHHHHHHHhhcc
Q 027233 157 ILFELLNGYPPFSGRNNVQL-----------------------------------------IVPALHPDCVDMCLKLLSA 195 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~l~~ 195 (226)
++++|++|..||.+.+..+. ....+++++++++.+||+.
T Consensus 202 il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 281 (345)
T d1pmea_ 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281 (345)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred eehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC
Confidence 99999999999976542111 1346788999999999999
Q ss_pred CccccCCHhHHhcCcccccc
Q 027233 196 NTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 196 ~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||.+|||++|+|+||||+.-
T Consensus 282 dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 282 NPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp STTTSCCHHHHHTSGGGTTT
T ss_pred ChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999853
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=288.33 Aligned_cols=206 Identities=24% Similarity=0.434 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe--------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~ 78 (226)
+...+++.+|++++++++||||+++++.+.. ++..+++||++.++.+..+......+++..++.++.|++.|
T Consensus 50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~ 129 (318)
T d3blha1 50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129 (318)
T ss_dssp TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHH
Confidence 3455678899999999999999999998754 35689999999877777665666789999999999999999
Q ss_pred HHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-----ccccccCCccccCccccccc-CCCcchhHH
Q 027233 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (226)
Q Consensus 79 l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~ 152 (226)
|.|||++||+||||||+||++ +.++.++++|||++....... ......+++.|+|||.+.+. .++.++|||
T Consensus 130 l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Diw 206 (318)
T d3blha1 130 LYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206 (318)
T ss_dssp HHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcc
Confidence 999999999999999999999 688899999999997654322 22335689999999998755 688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccccc------------------------------------------ccCCChHHHHHHH
Q 027233 153 SVGAILFELLNGYPPFSGRNNVQLI------------------------------------------VPALHPDCVDMCL 190 (226)
Q Consensus 153 slG~~~~~l~~g~~p~~~~~~~~~~------------------------------------------~~~~~~~~~~~i~ 190 (226)
|+|+++++|++|..||.+.+..... ....++++.+||+
T Consensus 207 SlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 286 (318)
T d3blha1 207 GAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286 (318)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHH
T ss_pred cCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHH
Confidence 9999999999999999765432211 0113667889999
Q ss_pred HhhccCccccCCHhHHhcCcccccc
Q 027233 191 KLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 191 ~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
+||+.||++|||++|+|+||||+..
T Consensus 287 ~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHCcCChhHCcCHHHHHcChhhccC
Confidence 9999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=281.38 Aligned_cols=197 Identities=23% Similarity=0.430 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (226)
...+.+.+|++++++++||||+++++++.+ .+..++||||+++++|.+++.+.. .+++..+..++.||+.|+.|||+
T Consensus 42 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~ 121 (262)
T d1byga_ 42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121 (262)
T ss_dssp C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc
Confidence 456789999999999999999999998854 466899999999999999997653 58999999999999999999999
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~~- 163 (226)
++++||||+|+||++ +.++.++++|||.+...... .....++..|+|||.+.+..++.++||||||+++|||++
T Consensus 122 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~ 196 (262)
T d1byga_ 122 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 196 (262)
T ss_dssp TTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CceeccccchHhhee---cCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHC
Confidence 999999999999999 78899999999999765433 233457888999999998999999999999999999998
Q ss_pred CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 164 GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 164 g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
|..||...+..+. .+...+++++++|++||+.||.+|||+.+++++
T Consensus 197 ~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 197 GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp SCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 6888876544322 256688999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=286.21 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+..+.+.+|++++++++||||+++++++.+++ .+++++++.+++|.+++... ..+++..+..++.||+.||.|||++
T Consensus 52 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~ 130 (317)
T d1xkka_ 52 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130 (317)
T ss_dssp -CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 345678999999999999999999999998754 67788888899999988765 5799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l~ 162 (226)
||+||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+
T Consensus 131 ~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~ 207 (317)
T d1xkka_ 131 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207 (317)
T ss_dssp TCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CcccCcchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHH
Confidence 99999999999999 5778999999999987654332 22345789999999999999999999999999999999
Q ss_pred h-CCCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhcCc
Q 027233 163 N-GYPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 210 (226)
Q Consensus 163 ~-g~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~ 210 (226)
+ |..||.+.+..... +...++++.+++.+||+.||.+|||+.|+++|-
T Consensus 208 t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 208 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8 78999876543221 566889999999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=280.94 Aligned_cols=198 Identities=27% Similarity=0.421 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (226)
.+..+.+.+|+.++++++||||+++++++.+ +..++|+||++++++.+++... +.+++..+..++.||+.||.|||++
T Consensus 52 ~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 130 (273)
T d1u46a_ 52 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130 (273)
T ss_dssp CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 3456789999999999999999999999976 4678999999999999987665 4799999999999999999999999
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc----cccccCCccccCcccccccCCCcchhHHHHHHHHHHH
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~~l 161 (226)
|++||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|||
T Consensus 131 ~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~em 207 (273)
T d1u46a_ 131 RFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207 (273)
T ss_dssp TEECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CEeeeeecHHHhcc---ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHH
Confidence 99999999999999 5677899999999987654432 1233467789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 162 LN-GYPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 162 ~~-g~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++ |..||.+.+..+. .+..+|+++.++|.+||+.||.+|||++|+++
T Consensus 208 lt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 208 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 98 8999987643322 15668899999999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=280.89 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=176.1
Q ss_pred hhHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHH
Q 027233 5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQT 67 (226)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~ 67 (226)
........+.+|...+.++ +||||+++++++.+++..++||||+++|+|.+++.... .+++..
T Consensus 57 ~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 136 (299)
T d1fgka_ 57 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHH
T ss_pred cChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHH
Confidence 3455667888999999888 89999999999999999999999999999999997553 489999
Q ss_pred HHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccC
Q 027233 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR 144 (226)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~ 144 (226)
+..++.||+.||+|||++|++||||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+..
T Consensus 137 ~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 213 (299)
T d1fgka_ 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC
Confidence 99999999999999999999999999999999 688899999999997665432 223456788899999999999
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 145 YDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 145 ~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
++.++||||||+++|+|++ |..||.+...... .+..++++++++|.+||+.||.+|||+.|+++
T Consensus 214 y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999999999999999998 7888876553322 16678999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=288.41 Aligned_cols=204 Identities=31% Similarity=0.444 Sum_probs=164.4
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l 79 (226)
.....+++.+|+.++++++||||+++++.+.. .+..|+||||+.++.+ +.+. ..+++..++.++.|++.||
T Consensus 56 ~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl 132 (355)
T d2b1pa1 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGI 132 (355)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHH
Confidence 35566789999999999999999999999864 3689999999966544 4443 5789999999999999999
Q ss_pred HHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHHHH
Q 027233 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (226)
Q Consensus 80 ~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~~ 159 (226)
.|||++||+||||||+||++ +.++.++++|||.+.............+++.|+|||.+.+..+++++|+||+|++++
T Consensus 133 ~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ 209 (355)
T d2b1pa1 133 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_dssp HHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHH
Confidence 99999999999999999999 678889999999988777666666677899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccccc----------------------------------------------------ccCCChHHHH
Q 027233 160 ELLNGYPPFSGRNNVQLI----------------------------------------------------VPALHPDCVD 187 (226)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~----------------------------------------------------~~~~~~~~~~ 187 (226)
+|++|..||.+.+..... ....++++.+
T Consensus 210 ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 289 (355)
T d2b1pa1 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHH
Confidence 999999999765421110 1123567899
Q ss_pred HHHHhhccCccccCCHhHHhcCcccccc
Q 027233 188 MCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 188 ~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
||++||+.||++|||++|+|+||||+..
T Consensus 290 ll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 290 LLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-44 Score=279.73 Aligned_cols=200 Identities=24% Similarity=0.441 Sum_probs=172.5
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC------------------------
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------ 61 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------ 61 (226)
..+..+++.+|++++++++||||+++++++...+..++++||+++++|.+++....
T Consensus 56 ~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (301)
T d1lufa_ 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135 (301)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCC
Confidence 34567789999999999999999999999999999999999999999999996532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcc
Q 027233 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPE 138 (226)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE 138 (226)
.++...+..++.|++.||+|||+++++||||||+||++ +.++.+||+|||++....... ......++..|+|||
T Consensus 136 ~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 37888999999999999999999999999999999999 678899999999997654322 223455778899999
Q ss_pred cccccCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcccc-----------cccCCChHHHHHHHHhhccCccccCCHhHH
Q 027233 139 VLQFQRYDEKVDMWSVGAILFELLNGY-PPFSGRNNVQL-----------IVPALHPDCVDMCLKLLSANTVDRLSFNEF 206 (226)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~~~~l~~g~-~p~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~ 206 (226)
.+.+..++.++||||||+++|||++|. .||.+....+. .+..+++++.+++.+||+.+|.+|||+.|+
T Consensus 213 ~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 213 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999999999999985 56776554322 256789999999999999999999999999
Q ss_pred hc
Q 027233 207 YH 208 (226)
Q Consensus 207 l~ 208 (226)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=277.78 Aligned_cols=201 Identities=27% Similarity=0.390 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (226)
+....+++.+|++++++++||||+++++++.. ++..++||||+++++|.+++.... ..+...+..++.|++.||.|+|
T Consensus 68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH 147 (311)
T d1r0pa_ 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147 (311)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence 55667889999999999999999999999765 568999999999999999988554 5778889999999999999999
Q ss_pred hCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc-----cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 84 ~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
+.+++||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++
T Consensus 148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 9999999999999999 6788999999999987644322 2234578889999999989999999999999999
Q ss_pred HHHHhCCCCCCCCCccc------------ccccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 159 FELLNGYPPFSGRNNVQ------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
||+++|..||....... ..+...++++.+++.+||+.||.+|||+.|+++|
T Consensus 225 ~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 225 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999877765432211 1156678899999999999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=280.16 Aligned_cols=200 Identities=29% Similarity=0.474 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEe-CCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHH
Q 027233 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~ 68 (226)
....+.+.+|...+.++ +|+||+.+++++.. ++..++|||||++++|.+++... ..+++..+
T Consensus 57 ~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (299)
T d1ywna1 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence 34566777888888877 78999999998765 45689999999999999999753 24789999
Q ss_pred HHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC---ccccccCCccccCcccccccCC
Q 027233 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (226)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~ 145 (226)
..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++...... ......|++.|+|||.+.+..+
T Consensus 137 ~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 9999999999999999999999999999999 678899999999997654332 2234568899999999999999
Q ss_pred CcchhHHHHHHHHHHHHhC-CCCCCCCCcccc------------cccCCChHHHHHHHHhhccCccccCCHhHHhcC
Q 027233 146 DEKVDMWSVGAILFELLNG-YPPFSGRNNVQL------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 209 (226)
Q Consensus 146 ~~~~Dv~slG~~~~~l~~g-~~p~~~~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~ 209 (226)
+.++||||+|+++|||++| ..||.+...... .+...++++++++.+||+.||.+|||++|+++|
T Consensus 214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999986 567876543221 155688999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=284.54 Aligned_cols=204 Identities=28% Similarity=0.480 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 027233 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (226)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 81 (226)
....+.+.+|++++++++||||+++++++... ...+++++++.|++|.+++.. +++++..++.++.||+.||.|
T Consensus 58 ~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~ 136 (348)
T d2gfsa1 58 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHH
Confidence 44566789999999999999999999998632 334556677779999998864 589999999999999999999
Q ss_pred HHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCccccccc-CCCcchhHHHHHHHHHH
Q 027233 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (226)
Q Consensus 82 lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~~~~ 160 (226)
||++||+||||||+||++ +.++.++++|||.+...... .....++..|+|||...+. .++.++|+||+|+++++
T Consensus 137 LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 137 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred HHhCCCcccccCCccccc---cccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 999999999999999999 68889999999998665432 3345578889999987665 46889999999999999
Q ss_pred HHhCCCCCCCCCccccc-----------------------------------------ccCCChHHHHHHHHhhccCccc
Q 027233 161 LLNGYPPFSGRNNVQLI-----------------------------------------VPALHPDCVDMCLKLLSANTVD 199 (226)
Q Consensus 161 l~~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~i~~~l~~~p~~ 199 (226)
|++|..||.+.+..... ....++++++||++||+.||.+
T Consensus 212 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 291 (348)
T d2gfsa1 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291 (348)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhh
Confidence 99999999765432110 2457899999999999999999
Q ss_pred cCCHhHHhcCccccccC
Q 027233 200 RLSFNEFYHHRFLRRNS 216 (226)
Q Consensus 200 Rpt~~~~l~~~~~~~~~ 216 (226)
|||++|+|+||||+...
T Consensus 292 R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 292 RITAAQALAHAYFAQYH 308 (348)
T ss_dssp SCCHHHHHTSGGGTTTC
T ss_pred CcCHHHHhcCHhhCCCC
Confidence 99999999999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=274.42 Aligned_cols=207 Identities=23% Similarity=0.372 Sum_probs=178.2
Q ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHH
Q 027233 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQL 75 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i 75 (226)
..+....+.+|++++++++||||+++++.+..++..++||||+.+|+|.+++... ..++...+..++.|+
T Consensus 63 ~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 142 (308)
T d1p4oa_ 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142 (308)
T ss_dssp CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHH
Confidence 3455667899999999999999999999999999999999999999999998643 246889999999999
Q ss_pred HHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCcccccccCCCcchhHH
Q 027233 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (226)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 152 (226)
+.||.|||+++++||||||+||++ +.++.++|+|||++........ .....+++.|+|||.+.+..++.++|||
T Consensus 143 a~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~ 219 (308)
T d1p4oa_ 143 ADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 219 (308)
T ss_dssp HHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccc
Confidence 999999999999999999999999 7888999999999976654322 2334578899999999999999999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCccccc-----------ccCCChHHHHHHHHhhccCccccCCHhHHhc------Cccccc
Q 027233 153 SVGAILFELLNG-YPPFSGRNNVQLI-----------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH------HRFLRR 214 (226)
Q Consensus 153 slG~~~~~l~~g-~~p~~~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~------~~~~~~ 214 (226)
|+|++++||++| ..||.+.+..+.. +...++.+.+++.+||+.+|.+|||++|+++ +|+|+.
T Consensus 220 S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 220 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 999999999997 5777765532221 5678899999999999999999999999997 777765
Q ss_pred c
Q 027233 215 N 215 (226)
Q Consensus 215 ~ 215 (226)
.
T Consensus 300 ~ 300 (308)
T d1p4oa_ 300 V 300 (308)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=274.04 Aligned_cols=200 Identities=28% Similarity=0.434 Sum_probs=173.3
Q ss_pred hHHHHHHHHHHHHHHhcC-CCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC------------------CCCHH
Q 027233 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQ 66 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~ 66 (226)
....+..+.+|+.+++++ +||||+++++++.+.+..+++||||++++|.+++.... .+++.
T Consensus 66 ~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~ 145 (311)
T d1t46a_ 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHH
Confidence 345667899999999999 79999999999999999999999999999999997643 48899
Q ss_pred HHHHHHHHHHHHHHHHHhCCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc---cccccCCccccCccccccc
Q 027233 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ 143 (226)
Q Consensus 67 ~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~ 143 (226)
.+..++.||+.|++|||++|++||||||+||++ +..+.++++|||.++....... .....+++.|+|||.+.+.
T Consensus 146 ~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 222 (311)
T d1t46a_ 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC
Confidence 999999999999999999999999999999999 6788999999999987654322 2335678899999999999
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCccccc------------ccCCChHHHHHHHHhhccCccccCCHhHHhc
Q 027233 144 RYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLI------------VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 144 ~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
.++.++||||||+++|+|++ |..+|......... +...+.++.++|.+||+.||.+|||++|+++
T Consensus 223 ~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999998 55556554432221 4567899999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=264.96 Aligned_cols=203 Identities=24% Similarity=0.303 Sum_probs=159.2
Q ss_pred hhhhhHHHHHHHHH--HHHHHhcCCCCCeeeeeeEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 027233 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (226)
Q Consensus 2 ~~~~~~~~~~~~~~--E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i 75 (226)
+|.++.+..+.... |+..+.+++||||+++++++.+.+ ..++||||+++++|.+++++. ++++..+..++.|+
T Consensus 31 vK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~i 109 (303)
T d1vjya_ 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 109 (303)
T ss_dssp EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred EEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHH
Confidence 34444444444444 555556789999999999987643 589999999999999999865 78899999999999
Q ss_pred HHHHHHHHh--------CCceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCC-----ccccccCCccccCcccccc
Q 027233 76 GAGLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (226)
Q Consensus 76 ~~~l~~lh~--------~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~ 142 (226)
+.|+.++|+ +||+||||||+||++ +.++.+||+|||++....... ......|++.|+|||.+.+
T Consensus 110 a~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence 999999996 599999999999999 788899999999998765432 2234568999999999865
Q ss_pred c------CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-----------------------ccC---------CChH
Q 027233 143 Q------RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLI-----------------------VPA---------LHPD 184 (226)
Q Consensus 143 ~------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----------------------~~~---------~~~~ 184 (226)
. .++.++||||||+++||+++|..|+......... .+. ...+
T Consensus 187 ~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 266 (303)
T d1vjya_ 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 266 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHH
T ss_pred cccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHH
Confidence 4 2567899999999999999998776442211100 111 1235
Q ss_pred HHHHHHHhhccCccccCCHhHHhc
Q 027233 185 CVDMCLKLLSANTVDRLSFNEFYH 208 (226)
Q Consensus 185 ~~~~i~~~l~~~p~~Rpt~~~~l~ 208 (226)
+.+++++||+.||.+|||+.|+++
T Consensus 267 l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 267 MAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHH
Confidence 889999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-41 Score=260.56 Aligned_cols=205 Identities=18% Similarity=0.228 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHhcCCCCC-eeeeeeEEEeCCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+..|+++++.++|++ |+.+.+++.+.+..++||||+ +++|.+.+.. .+.+++..+..++.|++.||+|||++|
T Consensus 45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456889999999997666 555566677888999999999 5677666654 458999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCc--------cccccCCccccCcccccccCCCcchhHHHHHHHH
Q 027233 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (226)
Q Consensus 87 i~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~~ 158 (226)
|+||||||+||++...+.+..++++|||++........ .....|++.|+|||...+..++.++||||||+++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 99999999999985444566799999999987654321 2344689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccccc------------------ccCCChHHHHHHHHhhccCccccCCHh---HHhcCccccc
Q 027233 159 FELLNGYPPFSGRNNVQLI------------------VPALHPDCVDMCLKLLSANTVDRLSFN---EFYHHRFLRR 214 (226)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~---~~l~~~~~~~ 214 (226)
++|++|..||......... ...+|+++.+++.+|++.+|.+||+++ ++|+|+|.+.
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 9999999999765433221 457899999999999999999999987 5577877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-39 Score=252.60 Aligned_cols=213 Identities=16% Similarity=0.214 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027233 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (226)
Q Consensus 9 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (226)
..+.+.+|++.++.++ |+|++.+++++...+..++|||++ +++|.+++...+ .++...+..++.|++.||.+||++|
T Consensus 43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g 121 (293)
T d1csna_ 43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121 (293)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999996 589999999999999999999999 789999987754 7999999999999999999999999
Q ss_pred ceeeccCCCCeEeeeC--CCCccEEEeeeccccccCCCC--------ccccccCCccccCcccccccCCCcchhHHHHHH
Q 027233 87 IIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (226)
Q Consensus 87 i~H~dl~~~nili~~~--~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 156 (226)
|+||||||+||+++.. ...+.++|+|||+++...... ......||+.|+|||.+.+..++.++|+||||+
T Consensus 122 iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (293)
T d1csna_ 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201 (293)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhH
Confidence 9999999999999532 235679999999998764321 123456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc------------------cccCCChHHHHHHHHhhccCccccCCHhHHhc--CccccccC
Q 027233 157 ILFELLNGYPPFSGRNNVQL------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRRNS 216 (226)
Q Consensus 157 ~~~~l~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~--~~~~~~~~ 216 (226)
++++|++|..||.+...... ....+|+++.+++..|++.+|.+||+++.+.+ ...+++..
T Consensus 202 ~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 202 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 99999999999986543321 13568899999999999999999999887754 34444444
Q ss_pred cccCCC
Q 027233 217 AILRAP 222 (226)
Q Consensus 217 ~~~~~~ 222 (226)
.....|
T Consensus 282 ~~~~~~ 287 (293)
T d1csna_ 282 TTEDEN 287 (293)
T ss_dssp CCSCSC
T ss_pred CCCCCC
Confidence 433333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-37 Score=245.88 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=158.8
Q ss_pred HHHHHHHHHHHHHhcCC-----------CCCeeeeeeEEEe--CCeEEEEEeecCCCC-HHHHHHh--cCCCCHHHHHHH
Q 027233 8 HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQA--ENCIFLVVEFCAGGN-LSSYIRL--HGRVPEQTARKF 71 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~-L~~~~~~--~~~~~~~~~~~~ 71 (226)
...+.+.+|+++++.+. |+||+++++++.. ....+.++.++.... ....... ...+++..++.+
T Consensus 51 ~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i 130 (362)
T d1q8ya_ 51 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHH
Confidence 34567888999988875 5789999988764 355666666654443 3333322 347899999999
Q ss_pred HHHHHHHHHHHHh-CCceeeccCCCCeEeeeCCC---CccEEEeeeccccccCCCCccccccCCccccCcccccccCCCc
Q 027233 72 LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDD---DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE 147 (226)
Q Consensus 72 ~~~i~~~l~~lh~-~~i~H~dl~~~nili~~~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 147 (226)
+.|++.|+.+||+ .||+||||||+||+++..+. ...++++|||.+...... .....+++.|+|||...+..++.
T Consensus 131 ~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 208 (362)
T d1q8ya_ 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGC 208 (362)
T ss_dssp HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCT
T ss_pred HHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccCCCc
Confidence 9999999999997 89999999999999953221 134899999998765432 34566899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCccccc--------------------------------------------------
Q 027233 148 KVDMWSVGAILFELLNGYPPFSGRNNVQLI-------------------------------------------------- 177 (226)
Q Consensus 148 ~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------------------------------------------------- 177 (226)
++|+||+|+++++|++|..||.........
T Consensus 209 ~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (362)
T d1q8ya_ 209 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 288 (362)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHH
T ss_pred cccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhh
Confidence 999999999999999999998654321000
Q ss_pred --------ccCCChHHHHHHHHhhccCccccCCHhHHhcCcccccc
Q 027233 178 --------VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 215 (226)
Q Consensus 178 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~l~~~~~~~~ 215 (226)
....++++++||.+||+.||.+|||++|+|+||||++.
T Consensus 289 ~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 289 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 12245779999999999999999999999999999965
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.71 E-value=1.6e-18 Score=124.88 Aligned_cols=133 Identities=17% Similarity=0.129 Sum_probs=93.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027233 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (226)
Q Consensus 8 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (226)
........|+..+.++.|.+++..+++. . .+++||++++..+. .++...+..++.|++.++.+||++|+
T Consensus 56 ~~~~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~gi 124 (191)
T d1zara2 56 LAIRSARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGI 124 (191)
T ss_dssp HHHHHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCE
Confidence 3445667899999999999999887653 2 26899999876554 34455677899999999999999999
Q ss_pred eeeccCCCCeEeeeCCCCccEEEeeeccccccCCCCccccccCCccccCcccccccCCCcchhHHHHHHH
Q 027233 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (226)
Q Consensus 88 ~H~dl~~~nili~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 157 (226)
+||||||+||+++ + ..++|+|||.+....++....-....... -.+. -...++.++|+||+.--
T Consensus 125 iHrDiKP~NILv~---~-~~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 125 VHGDLSQYNVLVS---E-EGIWIIDFPQSVEVGEEGWREILERDVRN-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECSCCSTTSEEEE---T-TEEEECCCTTCEETTSTTHHHHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred EEccCChhheeee---C-CCEEEEECCCcccCCCCCcHHHHHHHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence 9999999999994 3 45889999998776543321100000000 0011 12556788999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.02 E-value=7.7e-06 Score=60.06 Aligned_cols=47 Identities=9% Similarity=0.014 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCHHHH
Q 027233 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56 (226)
Q Consensus 10 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 56 (226)
...+.+|...++.+. +--+++++.+...++..++||++++|.++.+.
T Consensus 53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 345778888888773 33367888888888999999999999887653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=2.9e-06 Score=62.10 Aligned_cols=49 Identities=16% Similarity=0.066 Sum_probs=35.8
Q ss_pred hHHHHHHHHHHHHHHhcCCC--CCeeeeeeEEEeCCeEEEEEeecCCCCHH
Q 027233 6 NKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLS 54 (226)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 54 (226)
.......+..|...++.+.. -.+++++....+.+..+++|++++|.++.
T Consensus 44 ~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 44 LSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 33344567888888888732 23567788888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.96 E-value=0.00067 Score=52.61 Aligned_cols=29 Identities=24% Similarity=0.343 Sum_probs=23.8
Q ss_pred CceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 86 ~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.++|||+++.||++ ++ +.++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv---~~-~~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFA---SE-HETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEE---CS-SCEEECCCTTCEE
T ss_pred ceeccCCcCCceeE---cC-CceEEechhhccc
Confidence 58999999999999 33 3589999988744
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.36 E-value=0.0037 Score=48.29 Aligned_cols=38 Identities=16% Similarity=0.141 Sum_probs=25.9
Q ss_pred HHHHHHHHHhcCC-CCCeeeeeeEEEeCCeEEEEEeecCCCCH
Q 027233 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNL 53 (226)
Q Consensus 12 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 53 (226)
...+|..+++.+. +.-.+++++++.+ ..|++|++|.+|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 4567888888884 4334577776643 478899987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.21 E-value=0.0054 Score=45.60 Aligned_cols=31 Identities=29% Similarity=0.564 Sum_probs=25.6
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.|++|||+.++|+++ +.+....+.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF---LGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhc---ccccceeEeccccccc
Confidence 479999999999999 4555668999998743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=90.01 E-value=0.18 Score=37.29 Aligned_cols=29 Identities=24% Similarity=0.232 Sum_probs=22.4
Q ss_pred CCceeeccCCCCeEeeeCCCCccEEEeeeccccc
Q 027233 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (226)
Q Consensus 85 ~~i~H~dl~~~nili~~~~~~~~~~l~df~~~~~ 118 (226)
.+++|||+++.||++ +++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~---~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILW---RDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEE---SSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEE---eCC--ceEEechhccc
Confidence 368999999999999 332 35789997743
|